id	sid	tid	token	lemma	pos
admet-2057	1	1	metal	metal	NOUN
admet-2057	1	2	-	-	PUNCT
admet-2057	1	3	organic	organic	ADJ
admet-2057	1	4	frameworks	framework	NOUN
admet-2057	1	5	:	:	PUNCT
admet-2057	1	6	doi	doi	NOUN
admet-2057	1	7	:	:	PUNCT
admet-2057	1	8	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	1	9	27	27	NUM
admet-2057	1	10	admet	admet	X
admet-2057	1	11	&	&	CCONJ
admet-2057	1	12	dmpk	dmpk	PROPN
admet-2057	1	13	12(1	12(1	PROPN
admet-2057	1	14	)	)	PUNCT
admet-2057	1	15	(	(	PUNCT
admet-2057	1	16	2024	2024	NUM
admet-2057	1	17	)	)	PUNCT
admet-2057	1	18	27	27	NUM
admet-2057	1	19	-	-	SYM
admet-2057	1	20	62	62	NUM
admet-2057	1	21	;	;	PUNCT
admet-2057	1	22	doi	doi	NOUN
admet-2057	1	23	:	:	PUNCT
admet-2057	1	24	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	VERB
admet-2057	1	25	open	open	ADJ
admet-2057	1	26	access	access	NOUN
admet-2057	1	27	:	:	PUNCT
admet-2057	1	28	issn	issn	PROPN
admet-2057	1	29	:	:	PUNCT
admet-2057	1	30	1848	1848	NUM
admet-2057	1	31	-	-	SYM
admet-2057	1	32	7718	7718	NUM
admet-2057	1	33	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-2057	1	34	review	review	NOUN
admet-2057	1	35	metal	metal	NOUN
admet-2057	1	36	-	-	PUNCT
admet-2057	1	37	organic	organic	ADJ
admet-2057	1	38	frameworks	framework	NOUN
admet-2057	1	39	:	:	PUNCT
admet-2057	1	40	drug	drug	NOUN
admet-2057	1	41	delivery	delivery	NOUN
admet-2057	1	42	applications	application	NOUN
admet-2057	1	43	and	and	CCONJ
admet-2057	1	44	future	future	ADJ
admet-2057	1	45	prospects	prospect	NOUN
admet-2057	1	46	prachi	prachi	PROPN
admet-2057	1	47	mhettar1	mhettar1	PROPN
admet-2057	1	48	,	,	PUNCT
admet-2057	1	49	niraj	niraj	VERB
admet-2057	1	50	kale1	kale1	PROPN
admet-2057	1	51	,	,	PUNCT
admet-2057	1	52	jidnyasa	jidnyasa	PROPN
admet-2057	1	53	pantwalawalkar1,2	pantwalawalkar1,2	PROPN
admet-2057	1	54	,	,	PUNCT
admet-2057	1	55	sopan	sopan	NOUN
admet-2057	1	56	nangare3	nangare3	PROPN
admet-2057	1	57	and	and	CCONJ
admet-2057	1	58	namdeo	namdeo	PROPN
admet-2057	1	59	jadhav1,4	jadhav1,4	PROPN
admet-2057	1	60	,	,	PUNCT
admet-2057	1	61	*	*	PROPN
admet-2057	1	62	1department	1department	NUM
admet-2057	1	63	of	of	ADP
admet-2057	1	64	pharmaceutics	pharmaceutic	NOUN
admet-2057	1	65	,	,	PUNCT
admet-2057	1	66	bharati	bharati	PROPN
admet-2057	1	67	vidyapeeth	vidyapeeth	PROPN
admet-2057	1	68	college	college	PROPN
admet-2057	1	69	of	of	ADP
admet-2057	1	70	pharmacy	pharmacy	NOUN
admet-2057	1	71	,	,	PUNCT
admet-2057	1	72	kolhapur	kolhapur	PROPN
admet-2057	1	73	416013	416013	NUM
admet-2057	1	74	maharashtra	maharashtra	PROPN
admet-2057	1	75	state	state	PROPN
admet-2057	1	76	,	,	PUNCT
admet-2057	1	77	india	india	PROPN
admet-2057	1	78	2department	2department	PROPN
admet-2057	1	79	of	of	ADP
admet-2057	1	80	pharmaceutics	pharmaceutic	NOUN
admet-2057	1	81	,	,	PUNCT
admet-2057	1	82	dr	dr	PROPN
admet-2057	1	83	.	.	PROPN
admet-2057	1	84	d.	d.	PROPN
admet-2057	1	85	y.	y.	PROPN
admet-2057	1	86	patil	patil	PROPN
admet-2057	1	87	institute	institute	PROPN
admet-2057	1	88	of	of	ADP
admet-2057	1	89	pharmaceutical	pharmaceutical	PROPN
admet-2057	1	90	sciences	sciences	PROPN
admet-2057	1	91	&	&	CCONJ
admet-2057	1	92	research	research	NOUN
admet-2057	1	93	,	,	PUNCT
admet-2057	1	94	pimpri	pimpri	NOUN
admet-2057	1	95	,	,	PUNCT
admet-2057	1	96	pune	pune	NOUN
admet-2057	1	97	411018	411018	NUM
admet-2057	1	98	,	,	PUNCT
admet-2057	1	99	maharashtra	maharashtra	PROPN
admet-2057	1	100	state	state	PROPN
admet-2057	1	101	,	,	PUNCT
admet-2057	1	102	india	india	PROPN
admet-2057	1	103	3department	3department	PROPN
admet-2057	1	104	of	of	ADP
admet-2057	1	105	pharmaceutical	pharmaceutical	ADJ
admet-2057	1	106	chemistry	chemistry	NOUN
admet-2057	1	107	,	,	PUNCT
admet-2057	1	108	h.	h.	PROPN
admet-2057	1	109	r	r	PROPN
admet-2057	1	110	patel	patel	PROPN
admet-2057	1	111	institute	institute	PROPN
admet-2057	1	112	of	of	ADP
admet-2057	1	113	pharmaceutical	pharmaceutical	NOUN
admet-2057	1	114	education	education	NOUN
admet-2057	1	115	and	and	CCONJ
admet-2057	1	116	research	research	NOUN
admet-2057	1	117	,	,	PUNCT
admet-2057	1	118	shirpur	shirpur	NOUN
admet-2057	1	119	425405	425405	NUM
admet-2057	1	120	,	,	PUNCT
admet-2057	1	121	maharashtra	maharashtra	PROPN
admet-2057	1	122	state	state	PROPN
admet-2057	1	123	,	,	PUNCT
admet-2057	1	124	india	india	PROPN
admet-2057	1	125	4krishna	4krishna	PROPN
admet-2057	1	126	vishwa	vishwa	PROPN
admet-2057	1	127	vidyapeeth	vidyapeeth	PROPN
admet-2057	1	128	,	,	PUNCT
admet-2057	1	129	krishna	krishna	PROPN
admet-2057	1	130	institute	institute	PROPN
admet-2057	1	131	of	of	ADP
admet-2057	1	132	pharmacy	pharmacy	PROPN
admet-2057	1	133	karad415539	karad415539	PROPN
admet-2057	1	134	,	,	PUNCT
admet-2057	1	135	maharashtra	maharashtra	PROPN
admet-2057	1	136	state	state	PROPN
admet-2057	1	137	,	,	PUNCT
admet-2057	1	138	india	india	PROPN
admet-2057	1	139	*	*	PUNCT
admet-2057	1	140	corresponding	correspond	VERB
admet-2057	1	141	author	author	NOUN
admet-2057	1	142	:	:	PUNCT
admet-2057	1	143	e	e	NOUN
admet-2057	1	144	-	-	NOUN
admet-2057	1	145	mail	mail	NOUN
admet-2057	1	146	:	:	PUNCT
admet-2057	1	147	nrjadhav@rediffmail.com	nrjadhav@rediffmail.com	X
admet-2057	1	148	received	receive	VERB
admet-2057	1	149	:	:	PUNCT
admet-2057	1	150	september	september	PROPN
admet-2057	1	151	1	1	NUM
admet-2057	1	152	,	,	PUNCT
admet-2057	1	153	2023	2023	NUM
admet-2057	1	154	;	;	PUNCT
admet-2057	1	155	revised	revise	VERB
admet-2057	1	156	:	:	PUNCT
admet-2057	1	157	november	november	PROPN
admet-2057	1	158	14	14	NUM
admet-2057	1	159	,	,	PUNCT
admet-2057	1	160	2023	2023	NUM
admet-2057	1	161	;	;	PUNCT
admet-2057	1	162	published	publish	VERB
admet-2057	1	163	:	:	PUNCT
admet-2057	1	164	november	november	PROPN
admet-2057	1	165	17	17	NUM
admet-2057	1	166	,	,	PUNCT
admet-2057	1	167	2023	2023	NUM
admet-2057	1	168	abstract	abstract	ADJ
admet-2057	1	169	background	background	NOUN
admet-2057	1	170	and	and	CCONJ
admet-2057	1	171	purpose	purpose	NOUN
admet-2057	1	172	:	:	PUNCT
admet-2057	1	173	metal	metal	NOUN
admet-2057	1	174	-	-	PUNCT
admet-2057	1	175	organic	organic	ADJ
admet-2057	1	176	frameworks	framework	NOUN
admet-2057	1	177	(	(	PUNCT
admet-2057	1	178	mofs	mof	NOUN
admet-2057	1	179	)	)	PUNCT
admet-2057	1	180	have	have	AUX
admet-2057	1	181	gained	gain	VERB
admet-2057	1	182	incredible	incredible	ADJ
admet-2057	1	183	consideration	consideration	NOUN
admet-2057	1	184	in	in	ADP
admet-2057	1	185	the	the	DET
admet-2057	1	186	biomedical	biomedical	ADJ
admet-2057	1	187	field	field	NOUN
admet-2057	1	188	due	due	ADP
admet-2057	1	189	to	to	ADP
admet-2057	1	190	their	their	PRON
admet-2057	1	191	flexible	flexible	ADJ
admet-2057	1	192	structural	structural	ADJ
admet-2057	1	193	configuration	configuration	NOUN
admet-2057	1	194	,	,	PUNCT
admet-2057	1	195	tunable	tunable	ADJ
admet-2057	1	196	pore	pore	ADJ
admet-2057	1	197	size	size	NOUN
admet-2057	1	198	and	and	CCONJ
admet-2057	1	199	tailorable	tailorable	ADJ
admet-2057	1	200	surface	surface	NOUN
admet-2057	1	201	modification	modification	NOUN
admet-2057	1	202	.	.	PUNCT
admet-2057	2	1	these	these	DET
admet-2057	2	2	inherent	inherent	ADJ
admet-2057	2	3	characteristics	characteristic	NOUN
admet-2057	2	4	of	of	ADP
admet-2057	2	5	mofs	mof	NOUN
admet-2057	2	6	portray	portray	VERB
admet-2057	2	7	numerous	numerous	ADJ
admet-2057	2	8	merits	merit	NOUN
admet-2057	2	9	as	as	ADP
admet-2057	2	10	potential	potential	ADJ
admet-2057	2	11	drug	drug	NOUN
admet-2057	2	12	carriers	carrier	NOUN
admet-2057	2	13	,	,	PUNCT
admet-2057	2	14	depicting	depict	VERB
admet-2057	2	15	improved	improved	ADJ
admet-2057	2	16	drug	drug	NOUN
admet-2057	2	17	loading	loading	NOUN
admet-2057	2	18	,	,	PUNCT
admet-2057	2	19	site	site	NOUN
admet-2057	2	20	-	-	PUNCT
admet-2057	2	21	specific	specific	ADJ
admet-2057	2	22	drug	drug	NOUN
admet-2057	2	23	delivery	delivery	NOUN
admet-2057	2	24	,	,	PUNCT
admet-2057	2	25	biocompatibility	biocompatibility	NOUN
admet-2057	2	26	,	,	PUNCT
admet-2057	2	27	biodegradability	biodegradability	NOUN
admet-2057	2	28	,	,	PUNCT
admet-2057	2	29	etc	etc	X
admet-2057	2	30	.	.	X
admet-2057	2	31	review	review	NOUN
admet-2057	2	32	approach	approach	NOUN
admet-2057	2	33	:	:	PUNCT
admet-2057	2	34	the	the	DET
admet-2057	2	35	current	current	ADJ
admet-2057	2	36	review	review	NOUN
admet-2057	2	37	article	article	NOUN
admet-2057	2	38	sheds	shed	VERB
admet-2057	2	39	light	light	NOUN
admet-2057	2	40	on	on	ADP
admet-2057	2	41	the	the	DET
admet-2057	2	42	synthesis	synthesis	NOUN
admet-2057	2	43	and	and	CCONJ
admet-2057	2	44	use	use	NOUN
admet-2057	2	45	of	of	ADP
admet-2057	2	46	mofs	mof	NOUN
admet-2057	2	47	in	in	ADP
admet-2057	2	48	drug	drug	NOUN
admet-2057	2	49	delivery	delivery	NOUN
admet-2057	2	50	applications	application	NOUN
admet-2057	2	51	.	.	PUNCT
admet-2057	3	1	in	in	ADP
admet-2057	3	2	the	the	DET
admet-2057	3	3	beginning	beginning	NOUN
admet-2057	3	4	,	,	PUNCT
admet-2057	3	5	a	a	DET
admet-2057	3	6	brief	brief	ADJ
admet-2057	3	7	overview	overview	NOUN
admet-2057	3	8	of	of	ADP
admet-2057	3	9	the	the	DET
admet-2057	3	10	key	key	ADJ
admet-2057	3	11	components	component	NOUN
admet-2057	3	12	and	and	CCONJ
admet-2057	3	13	efficient	efficient	ADJ
admet-2057	3	14	fabrication	fabrication	NOUN
admet-2057	3	15	techniques	technique	NOUN
admet-2057	3	16	for	for	ADP
admet-2057	3	17	mof	mof	ADJ
admet-2057	3	18	synthesis	synthesis	NOUN
admet-2057	3	19	,	,	PUNCT
admet-2057	3	20	along	along	ADP
admet-2057	3	21	with	with	ADP
admet-2057	3	22	its	its	PRON
admet-2057	3	23	characterization	characterization	NOUN
admet-2057	3	24	methods	method	NOUN
admet-2057	3	25	,	,	PUNCT
admet-2057	3	26	have	have	AUX
admet-2057	3	27	been	be	AUX
admet-2057	3	28	presented	present	VERB
admet-2057	3	29	.	.	PUNCT
admet-2057	4	1	the	the	DET
admet-2057	4	2	mofs	mofs	NOUN
admet-2057	4	3	-	-	PUNCT
admet-2057	4	4	based	base	VERB
admet-2057	4	5	formulations	formulation	NOUN
admet-2057	4	6	have	have	AUX
admet-2057	4	7	been	be	AUX
admet-2057	4	8	critically	critically	ADV
admet-2057	4	9	discussed	discuss	VERB
admet-2057	4	10	.	.	PUNCT
admet-2057	5	1	the	the	DET
admet-2057	5	2	application	application	NOUN
admet-2057	5	3	of	of	ADP
admet-2057	5	4	the	the	DET
admet-2057	5	5	design	design	NOUN
admet-2057	5	6	of	of	ADP
admet-2057	5	7	experiments	experiment	NOUN
admet-2057	5	8	(	(	PUNCT
admet-2057	5	9	doe	doe	NOUN
admet-2057	5	10	)	)	PUNCT
admet-2057	5	11	approach	approach	NOUN
admet-2057	5	12	to	to	PART
admet-2057	5	13	optimize	optimize	VERB
admet-2057	5	14	mofs	mof	NOUN
admet-2057	5	15	has	have	AUX
admet-2057	5	16	been	be	AUX
admet-2057	5	17	elucidated	elucidate	VERB
admet-2057	5	18	.	.	PUNCT
admet-2057	6	1	the	the	DET
admet-2057	6	2	mofs	mofs	NOUN
admet-2057	6	3	-	-	PUNCT
admet-2057	6	4	based	base	VERB
admet-2057	6	5	formulations	formulation	NOUN
admet-2057	6	6	,	,	PUNCT
admet-2057	6	7	especially	especially	ADV
admet-2057	6	8	the	the	DET
admet-2057	6	9	application	application	NOUN
admet-2057	6	10	of	of	ADP
admet-2057	6	11	stimuliresponsive	stimuliresponsive	ADJ
admet-2057	6	12	mofs	mof	NOUN
admet-2057	6	13	for	for	ADP
admet-2057	6	14	site	site	NOUN
admet-2057	6	15	-	-	PUNCT
admet-2057	6	16	specific	specific	ADJ
admet-2057	6	17	drug	drug	NOUN
admet-2057	6	18	delivery	delivery	NOUN
admet-2057	6	19	,	,	PUNCT
admet-2057	6	20	have	have	AUX
admet-2057	6	21	been	be	AUX
admet-2057	6	22	deciphered	decipher	VERB
admet-2057	6	23	.	.	PUNCT
admet-2057	7	1	along	along	ADP
admet-2057	7	2	with	with	ADP
admet-2057	7	3	drug	drug	NOUN
admet-2057	7	4	release	release	NOUN
admet-2057	7	5	kinetic	kinetic	NOUN
admet-2057	7	6	models	model	NOUN
admet-2057	7	7	,	,	PUNCT
admet-2057	7	8	several	several	ADJ
admet-2057	7	9	administration	administration	NOUN
admet-2057	7	10	methods	method	NOUN
admet-2057	7	11	for	for	ADP
admet-2057	7	12	mofs	mof	NOUN
admet-2057	7	13	have	have	AUX
admet-2057	7	14	also	also	ADV
admet-2057	7	15	been	be	AUX
admet-2057	7	16	enunciated	enunciate	VERB
admet-2057	7	17	.	.	PUNCT
admet-2057	8	1	subsequently	subsequently	ADV
admet-2057	8	2	,	,	PUNCT
admet-2057	8	3	mofs	mof	NOUN
admet-2057	8	4	as	as	ADP
admet-2057	8	5	future	future	ADJ
admet-2057	8	6	potential	potential	ADJ
admet-2057	8	7	drug	drug	NOUN
admet-2057	8	8	carriers	carrier	NOUN
admet-2057	8	9	have	have	AUX
admet-2057	8	10	been	be	AUX
admet-2057	8	11	elaborated	elaborate	VERB
admet-2057	8	12	.	.	PUNCT
admet-2057	9	1	key	key	ADJ
admet-2057	9	2	results	result	NOUN
admet-2057	9	3	and	and	CCONJ
admet-2057	9	4	conclusion	conclusion	NOUN
admet-2057	9	5	:	:	PUNCT
admet-2057	9	6	recently	recently	ADV
admet-2057	9	7	,	,	PUNCT
admet-2057	9	8	mofs	mof	NOUN
admet-2057	9	9	have	have	AUX
admet-2057	9	10	emerged	emerge	VERB
admet-2057	9	11	as	as	ADP
admet-2057	9	12	versatile	versatile	ADJ
admet-2057	9	13	drug	drug	NOUN
admet-2057	9	14	delivery	delivery	NOUN
admet-2057	9	15	carriers	carrier	NOUN
admet-2057	9	16	possessing	possess	VERB
admet-2057	9	17	customization	customization	NOUN
admet-2057	9	18	potential	potential	NOUN
admet-2057	9	19	and	and	CCONJ
admet-2057	9	20	meeting	meet	VERB
admet-2057	9	21	the	the	DET
admet-2057	9	22	needs	need	NOUN
admet-2057	9	23	of	of	ADP
admet-2057	9	24	spatio	spatio	PROPN
admet-2057	9	25	-	-	PUNCT
admet-2057	9	26	temporal	temporal	ADJ
admet-2057	9	27	drug	drug	NOUN
admet-2057	9	28	delivery	delivery	NOUN
admet-2057	9	29	.	.	PUNCT
admet-2057	10	1	researchers	researcher	NOUN
admet-2057	10	2	have	have	AUX
admet-2057	10	3	devised	devise	VERB
admet-2057	10	4	several	several	ADJ
admet-2057	10	5	environment	environment	NOUN
admet-2057	10	6	-	-	PUNCT
admet-2057	10	7	friendly	friendly	ADJ
admet-2057	10	8	approaches	approach	NOUN
admet-2057	10	9	for	for	ADP
admet-2057	10	10	mof	mof	ADJ
admet-2057	10	11	construction	construction	NOUN
admet-2057	10	12	and	and	CCONJ
admet-2057	10	13	surface	surface	NOUN
admet-2057	10	14	modification	modification	NOUN
admet-2057	10	15	.	.	PUNCT
admet-2057	11	1	owing	owe	VERB
admet-2057	11	2	to	to	ADP
admet-2057	11	3	stimuli	stimulus	NOUN
admet-2057	11	4	-	-	PUNCT
admet-2057	11	5	responsive	responsive	ADJ
admet-2057	11	6	potential	potential	NOUN
admet-2057	11	7	,	,	PUNCT
admet-2057	11	8	mofs	mof	NOUN
admet-2057	11	9	have	have	AUX
admet-2057	11	10	demonstrated	demonstrate	VERB
admet-2057	11	11	their	their	PRON
admet-2057	11	12	prominent	prominent	ADJ
admet-2057	11	13	therapeutic	therapeutic	ADJ
admet-2057	11	14	efficacy	efficacy	NOUN
admet-2057	11	15	via	via	ADP
admet-2057	11	16	several	several	ADJ
admet-2057	11	17	routes	route	NOUN
admet-2057	11	18	of	of	ADP
admet-2057	11	19	administration	administration	NOUN
admet-2057	11	20	.	.	PUNCT
admet-2057	12	1	the	the	DET
admet-2057	12	2	numerous	numerous	ADJ
admet-2057	12	3	benefits	benefit	NOUN
admet-2057	12	4	of	of	ADP
admet-2057	12	5	mofs	mof	NOUN
admet-2057	12	6	would	would	AUX
admet-2057	12	7	certainly	certainly	ADV
admet-2057	12	8	open	open	VERB
admet-2057	12	9	up	up	ADP
admet-2057	12	10	a	a	DET
admet-2057	12	11	new	new	ADJ
admet-2057	12	12	vista	vista	NOUN
admet-2057	12	13	for	for	ADP
admet-2057	12	14	its	its	PRON
admet-2057	12	15	novel	novel	ADJ
admet-2057	12	16	drug	drug	NOUN
admet-2057	12	17	delivery	delivery	NOUN
admet-2057	12	18	applications	application	NOUN
admet-2057	12	19	.	.	PUNCT
admet-2057	13	1	©	©	PROPN
admet-2057	13	2	2023	2023	NUM
admet-2057	13	3	by	by	ADP
admet-2057	13	4	the	the	DET
admet-2057	13	5	authors	author	NOUN
admet-2057	13	6	.	.	PUNCT
admet-2057	14	1	this	this	DET
admet-2057	14	2	article	article	NOUN
admet-2057	14	3	is	be	AUX
admet-2057	14	4	an	an	DET
admet-2057	14	5	open	open	ADJ
admet-2057	14	6	-	-	PUNCT
admet-2057	14	7	access	access	NOUN
admet-2057	14	8	article	article	NOUN
admet-2057	14	9	distributed	distribute	VERB
admet-2057	14	10	under	under	ADP
admet-2057	14	11	the	the	DET
admet-2057	14	12	terms	term	NOUN
admet-2057	14	13	and	and	CCONJ
admet-2057	14	14	conditions	condition	NOUN
admet-2057	14	15	of	of	ADP
admet-2057	14	16	the	the	DET
admet-2057	14	17	creative	creative	ADJ
admet-2057	14	18	commons	common	NOUN
admet-2057	14	19	attribution	attribution	NOUN
admet-2057	14	20	license	license	NOUN
admet-2057	14	21	(	(	PUNCT
admet-2057	14	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-2057	14	23	)	)	PUNCT
admet-2057	14	24	.	.	PUNCT
admet-2057	15	1	keywords	keyword	NOUN
admet-2057	15	2	stimuli	stimuli	VERB
admet-2057	15	3	-	-	PUNCT
admet-2057	15	4	responsive	responsive	ADJ
admet-2057	15	5	;	;	PUNCT
admet-2057	15	6	drug	drug	NOUN
admet-2057	15	7	loading	loading	NOUN
admet-2057	15	8	;	;	PUNCT
admet-2057	15	9	formulation	formulation	NOUN
admet-2057	15	10	development	development	NOUN
admet-2057	15	11	introduction	introduction	NOUN
admet-2057	15	12	conventional	conventional	ADJ
admet-2057	15	13	drug	drug	NOUN
admet-2057	15	14	delivery	delivery	NOUN
admet-2057	15	15	systems	system	NOUN
admet-2057	15	16	(	(	PUNCT
admet-2057	15	17	dds	dds	PROPN
admet-2057	15	18	)	)	PUNCT
admet-2057	15	19	are	be	AUX
admet-2057	15	20	available	available	ADJ
admet-2057	15	21	in	in	ADP
admet-2057	15	22	a	a	DET
admet-2057	15	23	range	range	NOUN
admet-2057	15	24	of	of	ADP
admet-2057	15	25	dosage	dosage	NOUN
admet-2057	15	26	forms	form	NOUN
admet-2057	15	27	,	,	PUNCT
admet-2057	15	28	including	include	VERB
admet-2057	15	29	tablets	tablet	NOUN
admet-2057	15	30	,	,	PUNCT
admet-2057	15	31	capsules	capsule	NOUN
admet-2057	15	32	,	,	PUNCT
admet-2057	15	33	granules	granule	NOUN
admet-2057	15	34	,	,	PUNCT
admet-2057	15	35	ointments	ointment	NOUN
admet-2057	15	36	,	,	PUNCT
admet-2057	15	37	syrups	syrup	NOUN
admet-2057	15	38	for	for	ADP
admet-2057	15	39	oral	oral	ADJ
admet-2057	15	40	administration	administration	NOUN
admet-2057	15	41	,	,	PUNCT
admet-2057	15	42	and	and	CCONJ
admet-2057	15	43	suppositories	suppository	NOUN
admet-2057	15	44	or	or	CCONJ
admet-2057	15	45	solutions	solution	NOUN
admet-2057	15	46	for	for	ADP
admet-2057	15	47	intravenous	intravenous	ADJ
admet-2057	15	48	administration	administration	NOUN
admet-2057	15	49	.	.	PUNCT
admet-2057	16	1	conventional	conventional	PROPN
admet-2057	16	2	dds	dds	PROPN
admet-2057	16	3	fail	fail	VERB
admet-2057	16	4	to	to	PART
admet-2057	16	5	sustain	sustain	VERB
admet-2057	16	6	the	the	DET
admet-2057	16	7	release	release	NOUN
admet-2057	16	8	owing	owe	VERB
admet-2057	16	9	to	to	ADP
admet-2057	16	10	an	an	DET
admet-2057	16	11	array	array	NOUN
admet-2057	16	12	of	of	ADP
admet-2057	16	13	drawbacks	drawback	NOUN
admet-2057	16	14	,	,	PUNCT
admet-2057	16	15	such	such	ADJ
admet-2057	16	16	as	as	ADP
admet-2057	16	17	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	16	18	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	16	19	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-2057	16	20	mailto:nrjadhav@rediffmail.com	mailto:nrjadhav@rediffmail.com	X
admet-2057	17	1	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-2057	17	2	p.	p.	PROPN
admet-2057	17	3	mhettar	mhettar	PROPN
admet-2057	17	4	et	et	PROPN
admet-2057	17	5	al	al	PROPN
admet-2057	17	6	.	.	PROPN
admet-2057	17	7	admet	admet	PROPN
admet-2057	17	8	&	&	CCONJ
admet-2057	17	9	dmpk	dmpk	PROPN
admet-2057	17	10	12(1	12(1	PROPN
admet-2057	17	11	)	)	PUNCT
admet-2057	17	12	(	(	PUNCT
admet-2057	17	13	2024	2024	NUM
admet-2057	17	14	)	)	PUNCT
admet-2057	17	15	27	27	NUM
admet-2057	17	16	-	-	SYM
admet-2057	17	17	62	62	NUM
admet-2057	17	18	28	28	NUM
admet-2057	17	19	frequent	frequent	ADJ
admet-2057	17	20	administration	administration	NOUN
admet-2057	17	21	,	,	PUNCT
admet-2057	17	22	a	a	DET
admet-2057	17	23	maximum	maximum	ADJ
admet-2057	17	24	dose	dose	NOUN
admet-2057	17	25	demand	demand	NOUN
admet-2057	17	26	,	,	PUNCT
admet-2057	17	27	inadequate	inadequate	ADJ
admet-2057	17	28	availability	availability	NOUN
admet-2057	17	29	at	at	ADP
admet-2057	17	30	target	target	NOUN
admet-2057	17	31	sites	site	NOUN
admet-2057	17	32	,	,	PUNCT
admet-2057	17	33	fluctuations	fluctuation	NOUN
admet-2057	17	34	in	in	ADP
admet-2057	17	35	plasma	plasma	NOUN
admet-2057	17	36	drug	drug	NOUN
admet-2057	17	37	level	level	NOUN
admet-2057	17	38	,	,	PUNCT
admet-2057	17	39	challenges	challenge	NOUN
admet-2057	17	40	in	in	ADP
admet-2057	17	41	drug	drug	NOUN
admet-2057	17	42	level	level	NOUN
admet-2057	17	43	monitoring	monitoring	NOUN
admet-2057	17	44	,	,	PUNCT
admet-2057	17	45	poor	poor	ADJ
admet-2057	17	46	bioavailability	bioavailability	NOUN
admet-2057	17	47	concern	concern	NOUN
admet-2057	17	48	,	,	PUNCT
admet-2057	17	49	serious	serious	ADJ
admet-2057	17	50	adverse	adverse	ADJ
admet-2057	17	51	/	/	SYM
admet-2057	17	52	undesirable	undesirable	ADJ
admet-2057	17	53	effects	effect	NOUN
admet-2057	17	54	,	,	PUNCT
admet-2057	17	55	and	and	CCONJ
admet-2057	17	56	premature	premature	ADJ
admet-2057	17	57	elimination	elimination	NOUN
admet-2057	17	58	from	from	ADP
admet-2057	17	59	the	the	DET
admet-2057	17	60	body	body	NOUN
admet-2057	17	61	[	[	X
admet-2057	17	62	1	1	NUM
admet-2057	17	63	]	]	PUNCT
admet-2057	17	64	.	.	PUNCT
admet-2057	18	1	with	with	ADP
admet-2057	18	2	the	the	DET
admet-2057	18	3	continued	continue	VERB
admet-2057	18	4	advancement	advancement	NOUN
admet-2057	18	5	in	in	ADP
admet-2057	18	6	the	the	DET
admet-2057	18	7	field	field	NOUN
admet-2057	18	8	of	of	ADP
admet-2057	18	9	nanotechnology	nanotechnology	NOUN
admet-2057	18	10	,	,	PUNCT
admet-2057	18	11	it	it	PRON
admet-2057	18	12	has	have	AUX
admet-2057	18	13	taken	take	VERB
admet-2057	18	14	a	a	DET
admet-2057	18	15	lot	lot	NOUN
admet-2057	18	16	of	of	ADP
admet-2057	18	17	work	work	NOUN
admet-2057	18	18	to	to	PART
admet-2057	18	19	create	create	VERB
admet-2057	18	20	nanocarriers	nanocarrier	NOUN
admet-2057	18	21	for	for	ADP
admet-2057	18	22	controlled	control	VERB
admet-2057	18	23	drug	drug	NOUN
admet-2057	18	24	release	release	NOUN
admet-2057	18	25	,	,	PUNCT
admet-2057	18	26	which	which	PRON
admet-2057	18	27	will	will	AUX
admet-2057	18	28	increase	increase	VERB
admet-2057	18	29	therapy	therapy	NOUN
admet-2057	18	30	effectiveness	effectiveness	NOUN
admet-2057	18	31	while	while	SCONJ
admet-2057	18	32	lowering	lower	VERB
admet-2057	18	33	adverse	adverse	ADJ
admet-2057	18	34	effects	effect	NOUN
admet-2057	18	35	[	[	X
admet-2057	18	36	2	2	NUM
admet-2057	18	37	]	]	PUNCT
admet-2057	18	38	.	.	PUNCT
admet-2057	19	1	metal	metal	NOUN
admet-2057	19	2	-	-	PUNCT
admet-2057	19	3	organic	organic	ADJ
admet-2057	19	4	frameworks	framework	NOUN
admet-2057	19	5	(	(	PUNCT
admet-2057	19	6	mofs	mof	NOUN
admet-2057	19	7	)	)	PUNCT
admet-2057	19	8	are	be	AUX
admet-2057	19	9	porous	porous	ADJ
admet-2057	19	10	compounds	compound	NOUN
admet-2057	19	11	comprising	comprise	VERB
admet-2057	19	12	metal	metal	NOUN
admet-2057	19	13	ions	ion	NOUN
admet-2057	19	14	and	and	CCONJ
admet-2057	19	15	coordinated	coordinate	VERB
admet-2057	19	16	organic	organic	ADJ
admet-2057	19	17	linkers	linker	NOUN
admet-2057	19	18	,	,	PUNCT
admet-2057	19	19	first	first	ADV
admet-2057	19	20	reported	report	VERB
admet-2057	19	21	in	in	ADP
admet-2057	19	22	1989	1989	NUM
admet-2057	19	23	[	[	X
admet-2057	19	24	3	3	NUM
admet-2057	19	25	]	]	PUNCT
admet-2057	19	26	.	.	PUNCT
admet-2057	20	1	mofs	mof	NOUN
admet-2057	20	2	can	can	AUX
admet-2057	20	3	be	be	AUX
admet-2057	20	4	designed	design	VERB
admet-2057	20	5	in	in	ADP
admet-2057	20	6	a	a	DET
admet-2057	20	7	variety	variety	NOUN
admet-2057	20	8	of	of	ADP
admet-2057	20	9	ways	way	NOUN
admet-2057	20	10	to	to	PART
admet-2057	20	11	have	have	VERB
admet-2057	20	12	elevated	elevate	VERB
admet-2057	20	13	porosity	porosity	NOUN
admet-2057	20	14	structures	structure	NOUN
admet-2057	20	15	owing	owe	VERB
admet-2057	20	16	to	to	ADP
admet-2057	20	17	the	the	DET
admet-2057	20	18	adaptable	adaptable	ADJ
admet-2057	20	19	mix	mix	NOUN
admet-2057	20	20	of	of	ADP
admet-2057	20	21	metal	metal	NOUN
admet-2057	20	22	inorganic	inorganic	ADJ
admet-2057	20	23	centres	centre	NOUN
admet-2057	20	24	and	and	CCONJ
admet-2057	20	25	organic	organic	ADJ
admet-2057	20	26	ligands	ligand	NOUN
admet-2057	20	27	,	,	PUNCT
admet-2057	20	28	which	which	PRON
admet-2057	20	29	distinguishes	distinguish	VERB
admet-2057	20	30	them	they	PRON
admet-2057	20	31	from	from	ADP
admet-2057	20	32	other	other	ADJ
admet-2057	20	33	nanostructures	nanostructure	NOUN
admet-2057	20	34	.	.	PUNCT
admet-2057	21	1	considering	consider	VERB
admet-2057	21	2	their	their	PRON
admet-2057	21	3	distinctive	distinctive	ADJ
admet-2057	21	4	qualities	quality	NOUN
admet-2057	21	5	,	,	PUNCT
admet-2057	21	6	including	include	VERB
admet-2057	21	7	huge	huge	ADJ
admet-2057	21	8	porosity	porosity	NOUN
admet-2057	21	9	,	,	PUNCT
admet-2057	21	10	an	an	DET
admet-2057	21	11	array	array	NOUN
admet-2057	21	12	of	of	ADP
admet-2057	21	13	porous	porous	ADJ
admet-2057	21	14	designs	design	NOUN
admet-2057	21	15	,	,	PUNCT
admet-2057	21	16	huge	huge	ADJ
admet-2057	21	17	surface	surface	NOUN
admet-2057	21	18	areas	area	NOUN
admet-2057	21	19	extended	extend	VERB
admet-2057	21	20	up	up	ADP
admet-2057	21	21	to	to	ADP
admet-2057	21	22	8000	8000	NUM
admet-2057	21	23	m2	m2	PROPN
admet-2057	21	24	g-1	g-1	PROPN
admet-2057	21	25	,	,	PUNCT
admet-2057	21	26	and	and	CCONJ
admet-2057	21	27	customizable	customizable	ADJ
admet-2057	21	28	frameworks	framework	NOUN
admet-2057	21	29	,	,	PUNCT
admet-2057	21	30	these	these	DET
admet-2057	21	31	materials	material	NOUN
admet-2057	21	32	have	have	AUX
admet-2057	21	33	attracted	attract	VERB
admet-2057	21	34	significant	significant	ADJ
admet-2057	21	35	limelight	limelight	NOUN
admet-2057	21	36	as	as	ADP
admet-2057	21	37	an	an	DET
admet-2057	21	38	emergent	emergent	ADJ
admet-2057	21	39	and	and	CCONJ
admet-2057	21	40	potential	potential	ADJ
admet-2057	21	41	group	group	NOUN
admet-2057	21	42	of	of	ADP
admet-2057	21	43	porous	porous	ADJ
admet-2057	21	44	materials	material	NOUN
admet-2057	21	45	for	for	ADP
admet-2057	21	46	a	a	DET
admet-2057	21	47	variety	variety	NOUN
admet-2057	21	48	of	of	ADP
admet-2057	21	49	applications	application	NOUN
admet-2057	21	50	[	[	X
admet-2057	21	51	4,5	4,5	NUM
admet-2057	21	52	]	]	PUNCT
admet-2057	21	53	.	.	PUNCT
admet-2057	22	1	considering	consider	VERB
admet-2057	22	2	their	their	PRON
admet-2057	22	3	numerous	numerous	ADJ
admet-2057	22	4	benefits	benefit	NOUN
admet-2057	22	5	and	and	CCONJ
admet-2057	22	6	broad	broad	ADJ
admet-2057	22	7	applicability	applicability	NOUN
admet-2057	22	8	,	,	PUNCT
admet-2057	22	9	the	the	DET
admet-2057	22	10	scientific	scientific	ADJ
admet-2057	22	11	community	community	NOUN
admet-2057	22	12	has	have	AUX
admet-2057	22	13	paid	pay	VERB
admet-2057	22	14	a	a	DET
admet-2057	22	15	great	great	ADJ
admet-2057	22	16	deal	deal	NOUN
admet-2057	22	17	of	of	ADP
admet-2057	22	18	attention	attention	NOUN
admet-2057	22	19	in	in	ADP
admet-2057	22	20	the	the	DET
admet-2057	22	21	past	past	ADJ
admet-2057	22	22	10	10	NUM
admet-2057	22	23	years	year	NOUN
admet-2057	22	24	to	to	ADP
admet-2057	22	25	the	the	DET
admet-2057	22	26	investigation	investigation	NOUN
admet-2057	22	27	of	of	ADP
admet-2057	22	28	novel	novel	ADJ
admet-2057	22	29	approaches	approach	NOUN
admet-2057	22	30	for	for	ADP
admet-2057	22	31	mof	mof	ADJ
admet-2057	22	32	synthesis	synthesis	NOUN
admet-2057	22	33	[	[	X
admet-2057	22	34	6	6	NUM
admet-2057	22	35	]	]	PUNCT
admet-2057	22	36	.	.	PUNCT
admet-2057	23	1	essentially	essentially	ADV
admet-2057	23	2	,	,	PUNCT
admet-2057	23	3	these	these	DET
admet-2057	23	4	conjugates	conjugate	NOUN
admet-2057	23	5	are	be	AUX
admet-2057	23	6	made	make	VERB
admet-2057	23	7	up	up	ADP
admet-2057	23	8	of	of	ADP
admet-2057	23	9	two	two	NUM
admet-2057	23	10	ingredients	ingredient	NOUN
admet-2057	23	11	:	:	PUNCT
admet-2057	23	12	metal	metal	NOUN
admet-2057	23	13	ions	ion	NOUN
admet-2057	23	14	and	and	CCONJ
admet-2057	23	15	organic	organic	ADJ
admet-2057	23	16	linkers	linker	NOUN
admet-2057	23	17	.	.	PUNCT
admet-2057	24	1	most	most	ADJ
admet-2057	24	2	synthesis	synthesis	NOUN
admet-2057	24	3	methods	method	NOUN
admet-2057	24	4	include	include	VERB
admet-2057	24	5	heating	heat	VERB
admet-2057	24	6	a	a	DET
admet-2057	24	7	mixture	mixture	NOUN
admet-2057	24	8	of	of	ADP
admet-2057	24	9	bridging	bridge	VERB
admet-2057	24	10	ligand	ligand	NOUN
admet-2057	24	11	-	-	PUNCT
admet-2057	24	12	metal	metal	NOUN
admet-2057	24	13	salts	salt	NOUN
admet-2057	24	14	dissolved	dissolve	VERB
admet-2057	24	15	in	in	ADP
admet-2057	24	16	a	a	DET
admet-2057	24	17	solvent	solvent	ADJ
admet-2057	24	18	solution	solution	NOUN
admet-2057	24	19	utilising	utilise	VERB
admet-2057	24	20	microwaves	microwave	NOUN
admet-2057	24	21	,	,	PUNCT
admet-2057	24	22	electrical	electrical	ADJ
admet-2057	24	23	heating	heating	NOUN
admet-2057	24	24	equipment	equipment	NOUN
admet-2057	24	25	,	,	PUNCT
admet-2057	24	26	ultrasonic	ultrasonic	ADJ
admet-2057	24	27	radiation	radiation	NOUN
admet-2057	24	28	,	,	PUNCT
admet-2057	24	29	mechanical	mechanical	ADJ
admet-2057	24	30	energy	energy	NOUN
admet-2057	24	31	,	,	PUNCT
admet-2057	24	32	etc	etc	X
admet-2057	24	33	.	.	X
admet-2057	25	1	[	[	X
admet-2057	25	2	7	7	NUM
admet-2057	25	3	]	]	PUNCT
admet-2057	25	4	.	.	PUNCT
admet-2057	26	1	in	in	ADP
admet-2057	26	2	recent	recent	ADJ
admet-2057	26	3	times	time	NOUN
admet-2057	26	4	,	,	PUNCT
admet-2057	26	5	mofs	mof	NOUN
admet-2057	26	6	have	have	AUX
admet-2057	26	7	been	be	AUX
admet-2057	26	8	thoroughly	thoroughly	ADV
admet-2057	26	9	investigated	investigate	VERB
admet-2057	26	10	as	as	ADP
admet-2057	26	11	potential	potential	ADJ
admet-2057	26	12	drug	drug	NOUN
admet-2057	26	13	delivery	delivery	NOUN
admet-2057	26	14	system	system	NOUN
admet-2057	26	15	due	due	ADP
admet-2057	26	16	to	to	ADP
admet-2057	26	17	their	their	PRON
admet-2057	26	18	formidable	formidable	ADJ
admet-2057	26	19	structural	structural	ADJ
admet-2057	26	20	attributes	attribute	NOUN
admet-2057	26	21	[	[	X
admet-2057	26	22	8	8	NUM
admet-2057	26	23	]	]	PUNCT
admet-2057	26	24	.	.	PUNCT
admet-2057	27	1	currently	currently	ADV
admet-2057	27	2	,	,	PUNCT
admet-2057	27	3	the	the	DET
admet-2057	27	4	cambridge	cambridge	PROPN
admet-2057	27	5	structural	structural	ADJ
admet-2057	27	6	database	database	NOUN
admet-2057	27	7	(	(	PUNCT
admet-2057	27	8	csd	csd	NOUN
admet-2057	27	9	)	)	PUNCT
admet-2057	27	10	has	have	AUX
admet-2057	27	11	roughly	roughly	ADV
admet-2057	27	12	synthesised	synthesise	VERB
admet-2057	27	13	99,075	99,075	NUM
admet-2057	27	14	mof	mof	NOUN
admet-2057	27	15	and	and	CCONJ
admet-2057	27	16	mof	mof	ADJ
admet-2057	27	17	-	-	PUNCT
admet-2057	27	18	type	type	NOUN
admet-2057	27	19	compounds	compound	NOUN
admet-2057	27	20	.	.	PUNCT
admet-2057	28	1	as	as	SCONJ
admet-2057	28	2	evidenced	evidence	VERB
admet-2057	28	3	by	by	ADP
admet-2057	28	4	the	the	DET
admet-2057	28	5	expanding	expand	VERB
admet-2057	28	6	number	number	NOUN
admet-2057	28	7	of	of	ADP
admet-2057	28	8	studies	study	NOUN
admet-2057	28	9	examining	examine	VERB
admet-2057	28	10	their	their	PRON
admet-2057	28	11	uses	use	NOUN
admet-2057	28	12	,	,	PUNCT
admet-2057	28	13	mofs	mof	NOUN
admet-2057	28	14	have	have	AUX
admet-2057	28	15	drawn	draw	VERB
admet-2057	28	16	rising	rise	VERB
admet-2057	28	17	interest	interest	NOUN
admet-2057	28	18	for	for	ADP
admet-2057	28	19	diverse	diverse	ADJ
admet-2057	28	20	applications	application	NOUN
admet-2057	28	21	,	,	PUNCT
admet-2057	28	22	such	such	ADJ
admet-2057	28	23	as	as	ADP
admet-2057	28	24	intriguing	intriguing	ADJ
admet-2057	28	25	and	and	CCONJ
admet-2057	28	26	burgeoning	burgeon	VERB
admet-2057	28	27	porous	porous	ADJ
admet-2057	28	28	hybrid	hybrid	ADJ
admet-2057	28	29	materials	material	NOUN
admet-2057	28	30	[	[	X
admet-2057	28	31	9	9	NUM
admet-2057	28	32	]	]	PUNCT
admet-2057	28	33	.	.	PUNCT
admet-2057	29	1	in	in	ADP
admet-2057	29	2	addition	addition	NOUN
admet-2057	29	3	to	to	ADP
admet-2057	29	4	mofs	mof	NOUN
admet-2057	29	5	'	'	PART
admet-2057	29	6	beneficial	beneficial	ADJ
admet-2057	29	7	characteristics	characteristic	NOUN
admet-2057	29	8	for	for	ADP
admet-2057	29	9	drug	drug	NOUN
admet-2057	29	10	delivery	delivery	NOUN
admet-2057	29	11	applications	application	NOUN
admet-2057	29	12	,	,	PUNCT
admet-2057	29	13	adding	add	VERB
admet-2057	29	14	a	a	DET
admet-2057	29	15	guest	guest	NOUN
admet-2057	29	16	material	material	NOUN
admet-2057	29	17	or	or	CCONJ
admet-2057	29	18	encasing	encase	VERB
admet-2057	29	19	a	a	DET
admet-2057	29	20	mof	mof	NOUN
admet-2057	29	21	in	in	ADP
admet-2057	29	22	a	a	DET
admet-2057	29	23	host	host	NOUN
admet-2057	29	24	material	material	NOUN
admet-2057	29	25	has	have	AUX
admet-2057	29	26	been	be	AUX
admet-2057	29	27	speculated	speculate	VERB
admet-2057	29	28	to	to	PART
admet-2057	29	29	boost	boost	VERB
admet-2057	29	30	a	a	DET
admet-2057	29	31	mof	mof	NOUN
admet-2057	29	32	's	's	PART
admet-2057	29	33	effectiveness	effectiveness	NOUN
admet-2057	29	34	,	,	PUNCT
admet-2057	29	35	resulting	result	VERB
admet-2057	29	36	in	in	ADP
admet-2057	29	37	mof	mof	NOUN
admet-2057	29	38	-	-	PUNCT
admet-2057	29	39	composites	composite	NOUN
admet-2057	29	40	[	[	X
admet-2057	29	41	10	10	NUM
admet-2057	29	42	]	]	PUNCT
admet-2057	29	43	.	.	PUNCT
admet-2057	30	1	with	with	ADP
admet-2057	30	2	the	the	DET
admet-2057	30	3	ongoing	ongoing	ADJ
admet-2057	30	4	advancement	advancement	NOUN
admet-2057	30	5	in	in	ADP
admet-2057	30	6	mofs	mof	NOUN
admet-2057	30	7	,	,	PUNCT
admet-2057	30	8	stimuli	stimuli	VERB
admet-2057	30	9	-	-	PUNCT
admet-2057	30	10	responsive	responsive	ADJ
admet-2057	30	11	mofs	mof	NOUN
admet-2057	30	12	are	be	AUX
admet-2057	30	13	a	a	DET
admet-2057	30	14	prominent	prominent	ADJ
admet-2057	30	15	candidate	candidate	NOUN
admet-2057	30	16	for	for	ADP
admet-2057	30	17	targeted	target	VERB
admet-2057	30	18	delivery	delivery	NOUN
admet-2057	30	19	because	because	SCONJ
admet-2057	30	20	of	of	ADP
admet-2057	30	21	their	their	PRON
admet-2057	30	22	modulation	modulation	NOUN
admet-2057	30	23	in	in	ADP
admet-2057	30	24	the	the	DET
admet-2057	30	25	local	local	ADJ
admet-2057	30	26	physiological	physiological	ADJ
admet-2057	30	27	system	system	NOUN
admet-2057	30	28	,	,	PUNCT
admet-2057	30	29	which	which	PRON
admet-2057	30	30	responds	respond	VERB
admet-2057	30	31	to	to	ADP
admet-2057	30	32	the	the	DET
admet-2057	30	33	change	change	NOUN
admet-2057	30	34	in	in	ADP
admet-2057	30	35	a	a	DET
admet-2057	30	36	milieu	milieu	NOUN
admet-2057	30	37	of	of	ADP
admet-2057	30	38	the	the	DET
admet-2057	30	39	normal	normal	ADJ
admet-2057	30	40	physiological	physiological	ADJ
admet-2057	30	41	system	system	NOUN
admet-2057	30	42	.	.	PUNCT
admet-2057	31	1	a	a	DET
admet-2057	31	2	physical	physical	ADJ
admet-2057	31	3	or	or	CCONJ
admet-2057	31	4	chemical	chemical	NOUN
admet-2057	31	5	alteration	alteration	NOUN
admet-2057	31	6	in	in	ADP
admet-2057	31	7	the	the	DET
admet-2057	31	8	physiological	physiological	ADJ
admet-2057	31	9	microenvironment	microenvironment	NOUN
admet-2057	31	10	can	can	AUX
admet-2057	31	11	release	release	VERB
admet-2057	31	12	drugs	drug	NOUN
admet-2057	31	13	to	to	ADP
admet-2057	31	14	the	the	DET
admet-2057	31	15	targeted	target	VERB
admet-2057	31	16	site	site	NOUN
admet-2057	31	17	[	[	X
admet-2057	31	18	11	11	NUM
admet-2057	31	19	]	]	PUNCT
admet-2057	31	20	.	.	PUNCT
admet-2057	32	1	thus	thus	ADV
admet-2057	32	2	,	,	PUNCT
admet-2057	32	3	the	the	DET
admet-2057	32	4	mofs	mof	NOUN
admet-2057	32	5	could	could	AUX
admet-2057	32	6	be	be	AUX
admet-2057	32	7	the	the	DET
admet-2057	32	8	choice	choice	NOUN
admet-2057	32	9	for	for	ADP
admet-2057	32	10	future	future	ADJ
admet-2057	32	11	carriers	carrier	NOUN
admet-2057	32	12	for	for	ADP
admet-2057	32	13	drug	drug	NOUN
admet-2057	32	14	delivery	delivery	NOUN
admet-2057	32	15	applications	application	NOUN
admet-2057	32	16	.	.	PUNCT
admet-2057	33	1	synthesis	synthesis	NOUN
admet-2057	33	2	of	of	ADP
admet-2057	33	3	mofs	mof	NOUN
admet-2057	33	4	the	the	DET
admet-2057	33	5	synthesis	synthesis	NOUN
admet-2057	33	6	of	of	ADP
admet-2057	33	7	mofs	mof	NOUN
admet-2057	33	8	is	be	AUX
admet-2057	33	9	influenced	influence	VERB
admet-2057	33	10	by	by	ADP
admet-2057	33	11	a	a	DET
admet-2057	33	12	variety	variety	NOUN
admet-2057	33	13	of	of	ADP
admet-2057	33	14	variables	variable	NOUN
admet-2057	33	15	,	,	PUNCT
admet-2057	33	16	including	include	VERB
admet-2057	33	17	reaction	reaction	NOUN
admet-2057	33	18	duration	duration	NOUN
admet-2057	33	19	and	and	CCONJ
admet-2057	33	20	temperature	temperature	NOUN
admet-2057	33	21	,	,	PUNCT
admet-2057	33	22	solvent	solvent	ADJ
admet-2057	33	23	type	type	NOUN
admet-2057	33	24	,	,	PUNCT
admet-2057	33	25	the	the	DET
admet-2057	33	26	type	type	NOUN
admet-2057	33	27	of	of	ADP
admet-2057	33	28	metal	metal	NOUN
admet-2057	33	29	ions	ion	NOUN
admet-2057	33	30	and	and	CCONJ
admet-2057	33	31	organic	organic	ADJ
admet-2057	33	32	linkers	linker	NOUN
admet-2057	33	33	,	,	PUNCT
admet-2057	33	34	structural	structural	ADJ
admet-2057	33	35	features	feature	NOUN
admet-2057	33	36	,	,	PUNCT
admet-2057	33	37	anion	anion	NOUN
admet-2057	33	38	-	-	PUNCT
admet-2057	33	39	cation	cation	NOUN
admet-2057	33	40	existence	existence	NOUN
admet-2057	33	41	,	,	PUNCT
admet-2057	33	42	and	and	CCONJ
admet-2057	33	43	crystallisation	crystallisation	NOUN
admet-2057	33	44	kinetics	kinetic	NOUN
admet-2057	33	45	,	,	PUNCT
admet-2057	33	46	that	that	PRON
admet-2057	33	47	may	may	AUX
admet-2057	33	48	result	result	VERB
admet-2057	33	49	in	in	ADP
admet-2057	33	50	nucleation	nucleation	NOUN
admet-2057	33	51	and	and	CCONJ
admet-2057	33	52	crystal	crystal	NOUN
admet-2057	33	53	growth	growth	NOUN
admet-2057	33	54	.	.	PUNCT
admet-2057	34	1	mofs	mof	NOUN
admet-2057	34	2	are	be	AUX
admet-2057	34	3	typically	typically	ADV
admet-2057	34	4	synthesized	synthesize	VERB
admet-2057	34	5	in	in	ADP
admet-2057	34	6	the	the	DET
admet-2057	34	7	liquid	liquid	ADJ
admet-2057	34	8	phase	phase	NOUN
admet-2057	34	9	by	by	ADP
admet-2057	34	10	combining	combine	VERB
admet-2057	34	11	mixtures	mixture	NOUN
admet-2057	34	12	of	of	ADP
admet-2057	34	13	the	the	DET
admet-2057	34	14	linkers	linker	NOUN
admet-2057	34	15	and	and	CCONJ
admet-2057	34	16	the	the	DET
admet-2057	34	17	metal	metal	NOUN
admet-2057	34	18	ions	ion	NOUN
admet-2057	34	19	.	.	PUNCT
admet-2057	35	1	the	the	DET
admet-2057	35	2	solvent	solvent	NOUN
admet-2057	35	3	is	be	AUX
admet-2057	35	4	chosen	choose	VERB
admet-2057	35	5	according	accord	VERB
admet-2057	35	6	to	to	ADP
admet-2057	35	7	its	its	PRON
admet-2057	35	8	reaction	reaction	NOUN
admet-2057	35	9	capacity	capacity	NOUN
admet-2057	35	10	,	,	PUNCT
admet-2057	35	11	solubility	solubility	NOUN
admet-2057	35	12	,	,	PUNCT
admet-2057	35	13	and	and	CCONJ
admet-2057	35	14	redox	redox	ADJ
admet-2057	35	15	capacity	capacity	NOUN
admet-2057	35	16	.	.	PUNCT
admet-2057	36	1	the	the	DET
admet-2057	36	2	thermodynamics	thermodynamic	NOUN
admet-2057	36	3	and	and	CCONJ
admet-2057	36	4	energy	energy	NOUN
admet-2057	36	5	of	of	ADP
admet-2057	36	6	activation	activation	NOUN
admet-2057	36	7	of	of	ADP
admet-2057	36	8	each	each	DET
admet-2057	36	9	reaction	reaction	NOUN
admet-2057	36	10	are	be	AUX
admet-2057	36	11	significantly	significantly	ADV
admet-2057	36	12	influenced	influence	VERB
admet-2057	36	13	by	by	ADP
admet-2057	36	14	the	the	DET
admet-2057	36	15	solvent	solvent	NOUN
admet-2057	36	16	.	.	PUNCT
admet-2057	37	1	despite	despite	SCONJ
admet-2057	37	2	challenges	challenge	NOUN
admet-2057	37	3	with	with	ADP
admet-2057	37	4	single	single	ADJ
admet-2057	37	5	-	-	PUNCT
admet-2057	37	6	crystal	crystal	NOUN
admet-2057	37	7	formation	formation	NOUN
admet-2057	37	8	,	,	PUNCT
admet-2057	37	9	solid	solid	ADJ
admet-2057	37	10	-	-	PUNCT
admet-2057	37	11	state	state	NOUN
admet-2057	37	12	synthetic	synthetic	ADJ
admet-2057	37	13	techniques	technique	NOUN
admet-2057	37	14	have	have	AUX
admet-2057	37	15	occasionally	occasionally	ADV
admet-2057	37	16	been	be	AUX
admet-2057	37	17	employed	employ	VERB
admet-2057	37	18	.	.	PUNCT
admet-2057	38	1	mof	mof	NOUN
admet-2057	38	2	crystals	crystal	NOUN
admet-2057	38	3	have	have	AUX
admet-2057	38	4	frequently	frequently	ADV
admet-2057	38	5	been	be	AUX
admet-2057	38	6	grown	grow	VERB
admet-2057	38	7	via	via	ADP
admet-2057	38	8	the	the	DET
admet-2057	38	9	gradual	gradual	ADJ
admet-2057	38	10	evaporation	evaporation	NOUN
admet-2057	38	11	of	of	ADP
admet-2057	38	12	the	the	DET
admet-2057	38	13	resulting	result	VERB
admet-2057	38	14	solution	solution	NOUN
admet-2057	38	15	[	[	X
admet-2057	38	16	12	12	NUM
admet-2057	38	17	]	]	PUNCT
admet-2057	38	18	.	.	PUNCT
admet-2057	39	1	mofs	mof	NOUN
admet-2057	39	2	are	be	AUX
admet-2057	39	3	synthesised	synthesise	VERB
admet-2057	39	4	by	by	ADP
admet-2057	39	5	various	various	ADJ
admet-2057	39	6	methods	method	NOUN
admet-2057	39	7	,	,	PUNCT
admet-2057	39	8	such	such	ADJ
admet-2057	39	9	as	as	ADP
admet-2057	39	10	conventional	conventional	ADJ
admet-2057	39	11	methods	method	NOUN
admet-2057	39	12	,	,	PUNCT
admet-2057	39	13	microwaveassisted	microwaveassisted	ADJ
admet-2057	39	14	synthesis	synthesis	NOUN
admet-2057	39	15	,	,	PUNCT
admet-2057	39	16	dry	dry	ADJ
admet-2057	39	17	gel	gel	NOUN
admet-2057	39	18	conversion	conversion	NOUN
admet-2057	39	19	,	,	PUNCT
admet-2057	39	20	ionothermal	ionothermal	ADJ
admet-2057	39	21	synthesis	synthesis	NOUN
admet-2057	39	22	,	,	PUNCT
admet-2057	39	23	diffusion	diffusion	NOUN
admet-2057	39	24	synthesis	synthesis	NOUN
admet-2057	39	25	,	,	PUNCT
admet-2057	39	26	microfluidic	microfluidic	ADJ
admet-2057	39	27	methods	method	NOUN
admet-2057	39	28	,	,	PUNCT
admet-2057	39	29	reversephase	reversephase	NOUN
admet-2057	39	30	microemulsions	microemulsion	NOUN
admet-2057	39	31	,	,	PUNCT
admet-2057	39	32	electrochemical	electrochemical	ADJ
admet-2057	39	33	synthesis	synthesis	NOUN
admet-2057	39	34	,	,	PUNCT
admet-2057	39	35	mechanochemical	mechanochemical	ADJ
admet-2057	39	36	methods	method	NOUN
admet-2057	39	37	,	,	PUNCT
admet-2057	39	38	and	and	CCONJ
admet-2057	39	39	sonochemical	sonochemical	ADJ
admet-2057	39	40	methods	method	NOUN
admet-2057	39	41	[	[	X
admet-2057	39	42	13	13	NUM
admet-2057	39	43	]	]	PUNCT
admet-2057	39	44	.	.	PUNCT
admet-2057	40	1	along	along	ADP
admet-2057	40	2	with	with	ADP
admet-2057	40	3	their	their	PRON
admet-2057	40	4	peculiarities	peculiarity	NOUN
admet-2057	40	5	,	,	PUNCT
admet-2057	40	6	the	the	DET
admet-2057	40	7	limitations	limitation	NOUN
admet-2057	40	8	of	of	ADP
admet-2057	40	9	such	such	ADJ
admet-2057	40	10	methods	method	NOUN
admet-2057	40	11	are	be	AUX
admet-2057	40	12	briefly	briefly	ADV
admet-2057	40	13	discussed	discuss	VERB
admet-2057	40	14	below	below	ADV
admet-2057	40	15	in	in	ADP
admet-2057	40	16	table	table	NOUN
admet-2057	40	17	1	1	NUM
admet-2057	40	18	.	.	PUNCT
admet-2057	40	19	admet	admet	PROPN
admet-2057	40	20	&	&	CCONJ
admet-2057	40	21	dmpk	dmpk	PROPN
admet-2057	40	22	12(1	12(1	PROPN
admet-2057	40	23	)	)	PUNCT
admet-2057	40	24	(	(	PUNCT
admet-2057	40	25	2024	2024	NUM
admet-2057	40	26	)	)	PUNCT
admet-2057	40	27	27	27	NUM
admet-2057	40	28	-	-	SYM
admet-2057	40	29	62	62	NUM
admet-2057	40	30	drug	drug	NOUN
admet-2057	40	31	delivery	delivery	NOUN
admet-2057	40	32	applications	application	NOUN
admet-2057	40	33	of	of	ADP
admet-2057	40	34	metal	metal	NOUN
admet-2057	40	35	-	-	PUNCT
admet-2057	40	36	organic	organic	ADJ
admet-2057	40	37	framework	framework	NOUN
admet-2057	40	38	doi	doi	NOUN
admet-2057	40	39	:	:	PUNCT
admet-2057	40	40	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	40	41	29	29	NUM
admet-2057	40	42	table	table	NOUN
admet-2057	40	43	1	1	NUM
admet-2057	40	44	:	:	PUNCT
admet-2057	40	45	methods	method	NOUN
admet-2057	40	46	of	of	ADP
admet-2057	40	47	mof	mof	ADJ
admet-2057	40	48	synthesis	synthesis	NOUN
admet-2057	40	49	along	along	ADP
admet-2057	40	50	with	with	ADP
admet-2057	40	51	their	their	PRON
admet-2057	40	52	properties	property	NOUN
admet-2057	40	53	and	and	CCONJ
admet-2057	40	54	limitations	limitation	VERB
admet-2057	40	55	synthesis	synthesis	NOUN
admet-2057	40	56	method	method	NOUN
admet-2057	40	57	properties	property	NOUN
admet-2057	40	58	ref	ref	VERB
admet-2057	40	59	.	.	PUNCT
admet-2057	41	1	conventional	conventional	ADJ
admet-2057	41	2	conventional	conventional	ADJ
admet-2057	41	3	synthesis	synthesis	NOUN
admet-2057	41	4	methodology	methodology	NOUN
admet-2057	41	5	entails	entail	VERB
admet-2057	41	6	a	a	DET
admet-2057	41	7	mixture	mixture	NOUN
admet-2057	41	8	of	of	ADP
admet-2057	41	9	polar	polar	ADJ
admet-2057	41	10	solvent	solvent	NOUN
admet-2057	41	11	and	and	CCONJ
admet-2057	41	12	a	a	DET
admet-2057	41	13	metal	metal	NOUN
admet-2057	41	14	precursor	precursor	NOUN
admet-2057	41	15	in	in	ADP
admet-2057	41	16	sealed	seal	VERB
admet-2057	41	17	vessels	vessel	NOUN
admet-2057	41	18	at	at	ADP
admet-2057	41	19	specified	specified	ADJ
admet-2057	41	20	reaction	reaction	NOUN
admet-2057	41	21	conditions	condition	NOUN
admet-2057	41	22	.	.	PUNCT
admet-2057	42	1	according	accord	VERB
admet-2057	42	2	to	to	ADP
admet-2057	42	3	reports	report	NOUN
admet-2057	42	4	,	,	PUNCT
admet-2057	42	5	this	this	DET
admet-2057	42	6	method	method	NOUN
admet-2057	42	7	might	might	AUX
admet-2057	42	8	produce	produce	VERB
admet-2057	42	9	crystalline	crystalline	NOUN
admet-2057	42	10	mofs	mof	NOUN
admet-2057	42	11	with	with	ADP
admet-2057	42	12	a	a	DET
admet-2057	42	13	higher	high	ADJ
admet-2057	42	14	output	output	NOUN
admet-2057	42	15	.	.	PUNCT
admet-2057	43	1	this	this	PRON
admet-2057	43	2	is	be	AUX
admet-2057	43	3	supported	support	VERB
admet-2057	43	4	by	by	ADP
admet-2057	43	5	the	the	DET
admet-2057	43	6	higher	high	ADJ
admet-2057	43	7	solubility	solubility	NOUN
admet-2057	43	8	of	of	ADP
admet-2057	43	9	precursors	precursor	NOUN
admet-2057	43	10	under	under	ADP
admet-2057	43	11	high	high	ADJ
admet-2057	43	12	pressure	pressure	NOUN
admet-2057	43	13	and	and	CCONJ
admet-2057	43	14	temperature	temperature	NOUN
admet-2057	43	15	.	.	PUNCT
admet-2057	44	1	this	this	DET
admet-2057	44	2	method	method	NOUN
admet-2057	44	3	has	have	VERB
admet-2057	44	4	several	several	ADJ
admet-2057	44	5	benefits	benefit	NOUN
admet-2057	44	6	,	,	PUNCT
admet-2057	44	7	such	such	ADJ
admet-2057	44	8	as	as	ADP
admet-2057	44	9	the	the	DET
admet-2057	44	10	fact	fact	NOUN
admet-2057	44	11	that	that	SCONJ
admet-2057	44	12	it	it	PRON
admet-2057	44	13	can	can	AUX
admet-2057	44	14	be	be	AUX
admet-2057	44	15	used	use	VERB
admet-2057	44	16	because	because	SCONJ
admet-2057	44	17	it	it	PRON
admet-2057	44	18	does	do	AUX
admet-2057	44	19	n't	not	PART
admet-2057	44	20	depend	depend	VERB
admet-2057	44	21	on	on	ADP
admet-2057	44	22	a	a	DET
admet-2057	44	23	complicated	complicated	ADJ
admet-2057	44	24	reaction	reaction	NOUN
admet-2057	44	25	setup	setup	NOUN
admet-2057	44	26	.	.	PUNCT
admet-2057	45	1	solvothermal	solvothermal	ADJ
admet-2057	45	2	synthesis	synthesis	NOUN
admet-2057	45	3	can	can	AUX
admet-2057	45	4	take	take	VERB
admet-2057	45	5	several	several	ADJ
admet-2057	45	6	days	day	NOUN
admet-2057	45	7	and	and	CCONJ
admet-2057	45	8	frequently	frequently	ADV
admet-2057	45	9	calls	call	VERB
admet-2057	45	10	for	for	ADP
admet-2057	45	11	high	high	ADJ
admet-2057	45	12	pressure	pressure	NOUN
admet-2057	45	13	and	and	CCONJ
admet-2057	45	14	temperature	temperature	NOUN
admet-2057	45	15	conditions	condition	NOUN
admet-2057	45	16	.	.	PUNCT
admet-2057	46	1	consequently	consequently	ADV
admet-2057	46	2	,	,	PUNCT
admet-2057	46	3	safety	safety	NOUN
admet-2057	46	4	concerns	concern	NOUN
admet-2057	46	5	and	and	CCONJ
admet-2057	46	6	time	time	NOUN
admet-2057	46	7	-	-	PUNCT
admet-2057	46	8	consuming	consume	VERB
admet-2057	46	9	(	(	PUNCT
admet-2057	46	10	expensive	expensive	ADJ
admet-2057	46	11	)	)	PUNCT
admet-2057	46	12	issues	issue	NOUN
admet-2057	46	13	prevent	prevent	VERB
admet-2057	46	14	the	the	DET
admet-2057	46	15	large	large	ADJ
admet-2057	46	16	-	-	PUNCT
admet-2057	46	17	scale	scale	NOUN
admet-2057	46	18	manufacture	manufacture	NOUN
admet-2057	46	19	of	of	ADP
admet-2057	46	20	nano	nano	NOUN
admet-2057	46	21	mofs	mof	NOUN
admet-2057	46	22	(	(	PUNCT
admet-2057	46	23	nmofs	nmof	NOUN
admet-2057	46	24	)	)	PUNCT
admet-2057	46	25	by	by	ADP
admet-2057	46	26	the	the	DET
admet-2057	46	27	hydro	hydro	NOUN
admet-2057	46	28	/	/	SYM
admet-2057	46	29	solvothermal	solvothermal	ADJ
admet-2057	46	30	approach	approach	NOUN
admet-2057	46	31	.	.	PUNCT
admet-2057	47	1	additionally	additionally	ADV
admet-2057	47	2	,	,	PUNCT
admet-2057	47	3	these	these	DET
admet-2057	47	4	syntheses	synthesis	NOUN
admet-2057	47	5	frequently	frequently	ADV
admet-2057	47	6	call	call	VERB
admet-2057	47	7	for	for	ADP
admet-2057	47	8	hazardous	hazardous	ADJ
admet-2057	47	9	solvents	solvent	NOUN
admet-2057	47	10	like	like	ADP
admet-2057	47	11	dmf	dmf	PROPN
admet-2057	47	12	.	.	PUNCT
admet-2057	48	1	[	[	X
admet-2057	48	2	14	14	NUM
admet-2057	48	3	]	]	X
admet-2057	48	4	microwave	microwave	NOUN
admet-2057	48	5	for	for	ADP
admet-2057	48	6	the	the	DET
admet-2057	48	7	rapid	rapid	ADJ
admet-2057	48	8	synthesis	synthesis	NOUN
admet-2057	48	9	of	of	ADP
admet-2057	48	10	mofs	mof	NOUN
admet-2057	48	11	,	,	PUNCT
admet-2057	48	12	the	the	DET
admet-2057	48	13	microwave	microwave	NOUN
admet-2057	48	14	method	method	NOUN
admet-2057	48	15	is	be	AUX
admet-2057	48	16	extensively	extensively	ADV
admet-2057	48	17	used	use	VERB
admet-2057	48	18	.	.	PUNCT
admet-2057	49	1	by	by	ADP
admet-2057	49	2	exposing	expose	VERB
admet-2057	49	3	the	the	DET
admet-2057	49	4	reaction	reaction	NOUN
admet-2057	49	5	mixture	mixture	NOUN
admet-2057	49	6	to	to	PART
admet-2057	49	7	microwave	microwave	NOUN
admet-2057	49	8	radiation	radiation	NOUN
admet-2057	49	9	,	,	PUNCT
admet-2057	49	10	mofs	mof	NOUN
admet-2057	49	11	are	be	AUX
admet-2057	49	12	synthesized	synthesize	VERB
admet-2057	49	13	.	.	PUNCT
admet-2057	50	1	the	the	DET
admet-2057	50	2	morphology	morphology	NOUN
admet-2057	50	3	of	of	ADP
admet-2057	50	4	the	the	DET
admet-2057	50	5	ingredients	ingredient	NOUN
admet-2057	50	6	can	can	AUX
admet-2057	50	7	be	be	AUX
admet-2057	50	8	altered	alter	VERB
admet-2057	50	9	by	by	ADP
admet-2057	50	10	the	the	DET
admet-2057	50	11	mw	mw	PROPN
admet-2057	50	12	approach	approach	NOUN
admet-2057	50	13	,	,	PUNCT
admet-2057	50	14	which	which	PRON
admet-2057	50	15	also	also	ADV
admet-2057	50	16	improves	improve	VERB
admet-2057	50	17	the	the	DET
admet-2057	50	18	performance	performance	NOUN
admet-2057	50	19	of	of	ADP
admet-2057	50	20	special	special	ADJ
admet-2057	50	21	mof	mof	ADJ
admet-2057	50	22	structures	structure	NOUN
admet-2057	50	23	.	.	PUNCT
admet-2057	51	1	the	the	DET
admet-2057	51	2	approach	approach	NOUN
admet-2057	51	3	has	have	VERB
admet-2057	51	4	many	many	ADJ
admet-2057	51	5	benefits	benefit	NOUN
admet-2057	51	6	,	,	PUNCT
admet-2057	51	7	including	include	VERB
admet-2057	51	8	monodispersed	monodisperse	VERB
admet-2057	51	9	mofs	mof	NOUN
admet-2057	51	10	,	,	PUNCT
admet-2057	51	11	high	high	ADJ
admet-2057	51	12	yield	yield	NOUN
admet-2057	51	13	,	,	PUNCT
admet-2057	51	14	minimal	minimal	ADJ
admet-2057	51	15	toxicity	toxicity	NOUN
admet-2057	51	16	,	,	PUNCT
admet-2057	51	17	and	and	CCONJ
admet-2057	51	18	quick	quick	ADJ
admet-2057	51	19	processing	processing	NOUN
admet-2057	51	20	times	time	NOUN
admet-2057	51	21	.	.	PUNCT
admet-2057	52	1	[	[	X
admet-2057	52	2	15,16	15,16	NUM
admet-2057	52	3	]	]	X
admet-2057	52	4	dry	dry	ADJ
admet-2057	52	5	gel	gel	NOUN
admet-2057	52	6	conversion	conversion	NOUN
admet-2057	52	7	a	a	DET
admet-2057	52	8	gel	gel	NOUN
admet-2057	52	9	precursor	precursor	NOUN
admet-2057	52	10	forms	form	NOUN
admet-2057	52	11	,	,	PUNCT
admet-2057	52	12	and	and	CCONJ
admet-2057	52	13	after	after	ADP
admet-2057	52	14	being	be	AUX
admet-2057	52	15	exposed	expose	VERB
admet-2057	52	16	to	to	ADP
admet-2057	52	17	solvent	solvent	ADJ
admet-2057	52	18	vapour	vapour	NOUN
admet-2057	52	19	,	,	PUNCT
admet-2057	52	20	it	it	PRON
admet-2057	52	21	is	be	AUX
admet-2057	52	22	transformed	transform	VERB
admet-2057	52	23	into	into	ADP
admet-2057	52	24	a	a	DET
admet-2057	52	25	crystalline	crystalline	NOUN
admet-2057	52	26	mof	mof	NOUN
admet-2057	52	27	.	.	PUNCT
admet-2057	53	1	the	the	DET
admet-2057	53	2	mof	mof	PROPN
admet-2057	53	3	crystal	crystal	NOUN
admet-2057	53	4	growth	growth	NOUN
admet-2057	53	5	is	be	AUX
admet-2057	53	6	guided	guide	VERB
admet-2057	53	7	by	by	ADP
admet-2057	53	8	solvent	solvent	ADJ
admet-2057	53	9	vapour	vapour	NOUN
admet-2057	53	10	,	,	PUNCT
admet-2057	53	11	which	which	PRON
admet-2057	53	12	serves	serve	VERB
admet-2057	53	13	as	as	ADP
admet-2057	53	14	a	a	DET
admet-2057	53	15	template	template	NOUN
admet-2057	53	16	.	.	PUNCT
admet-2057	54	1	the	the	DET
admet-2057	54	2	popularity	popularity	NOUN
admet-2057	54	3	of	of	ADP
admet-2057	54	4	a	a	DET
admet-2057	54	5	recently	recently	ADV
admet-2057	54	6	created	create	VERB
admet-2057	54	7	technique	technique	NOUN
admet-2057	54	8	is	be	AUX
admet-2057	54	9	attributed	attribute	VERB
admet-2057	54	10	to	to	ADP
admet-2057	54	11	its	its	PRON
admet-2057	54	12	many	many	ADJ
admet-2057	54	13	benefits	benefit	NOUN
admet-2057	54	14	,	,	PUNCT
admet-2057	54	15	including	include	VERB
admet-2057	54	16	feasibility	feasibility	NOUN
admet-2057	54	17	,	,	PUNCT
admet-2057	54	18	high	high	ADJ
admet-2057	54	19	efficiency	efficiency	NOUN
admet-2057	54	20	,	,	PUNCT
admet-2057	54	21	high	high	ADJ
admet-2057	54	22	yield	yield	NOUN
admet-2057	54	23	,	,	PUNCT
admet-2057	54	24	minimal	minimal	ADJ
admet-2057	54	25	waste	waste	NOUN
admet-2057	54	26	,	,	PUNCT
admet-2057	54	27	reaction	reaction	NOUN
admet-2057	54	28	volume	volume	NOUN
admet-2057	54	29	reduction	reduction	NOUN
admet-2057	54	30	,	,	PUNCT
admet-2057	54	31	etc	etc	X
admet-2057	54	32	.	.	X
admet-2057	55	1	the	the	DET
admet-2057	55	2	two	two	NUM
admet-2057	55	3	mofs	mof	NOUN
admet-2057	55	4	were	be	AUX
admet-2057	55	5	produced	produce	VERB
admet-2057	55	6	using	use	VERB
admet-2057	55	7	water	water	NOUN
admet-2057	55	8	as	as	ADP
admet-2057	55	9	the	the	DET
admet-2057	55	10	solvent	solvent	PROPN
admet-2057	55	11	medium	medium	NOUN
admet-2057	55	12	instead	instead	ADV
admet-2057	55	13	of	of	ADP
admet-2057	55	14	a	a	DET
admet-2057	55	15	traditional	traditional	ADJ
admet-2057	55	16	organic	organic	ADJ
admet-2057	55	17	solvent	solvent	NOUN
admet-2057	55	18	like	like	ADP
admet-2057	55	19	dmf	dmf	PROPN
admet-2057	55	20	,	,	PUNCT
admet-2057	55	21	which	which	PRON
admet-2057	55	22	is	be	AUX
admet-2057	55	23	used	use	VERB
admet-2057	55	24	in	in	ADP
admet-2057	55	25	traditional	traditional	ADJ
admet-2057	55	26	synthesis	synthesis	NOUN
admet-2057	55	27	techniques	technique	NOUN
admet-2057	55	28	,	,	PUNCT
admet-2057	55	29	making	make	VERB
admet-2057	55	30	the	the	DET
admet-2057	55	31	process	process	NOUN
admet-2057	55	32	more	more	ADV
admet-2057	55	33	environmentally	environmentally	ADV
admet-2057	55	34	friendly	friendly	ADJ
admet-2057	55	35	and	and	CCONJ
admet-2057	55	36	economically	economically	ADV
admet-2057	55	37	viable	viable	ADJ
admet-2057	55	38	.	.	PUNCT
admet-2057	56	1	[	[	X
admet-2057	56	2	15,17	15,17	X
admet-2057	56	3	]	]	X
admet-2057	56	4	ionothermal	ionothermal	NOUN
admet-2057	56	5	the	the	DET
admet-2057	56	6	strategy	strategy	NOUN
admet-2057	56	7	substitutes	substitute	VERB
admet-2057	56	8	organic	organic	ADJ
admet-2057	56	9	solvents	solvent	NOUN
admet-2057	56	10	and	and	CCONJ
admet-2057	56	11	solvents	solvent	NOUN
admet-2057	56	12	like	like	ADP
admet-2057	56	13	water	water	NOUN
admet-2057	56	14	with	with	ADP
admet-2057	56	15	ionic	ionic	ADJ
admet-2057	56	16	liquids	liquid	NOUN
admet-2057	56	17	(	(	PUNCT
admet-2057	56	18	ils	ils	NOUN
admet-2057	56	19	)	)	PUNCT
admet-2057	56	20	.	.	PUNCT
admet-2057	57	1	the	the	DET
admet-2057	57	2	mixture	mixture	NOUN
admet-2057	57	3	of	of	ADP
admet-2057	57	4	metal	metal	NOUN
admet-2057	57	5	salts	salt	NOUN
admet-2057	57	6	and	and	CCONJ
admet-2057	57	7	linkers	linker	NOUN
admet-2057	57	8	is	be	AUX
admet-2057	57	9	dissolved	dissolve	VERB
admet-2057	57	10	in	in	ADP
admet-2057	57	11	il	il	PROPN
admet-2057	57	12	and	and	CCONJ
admet-2057	57	13	heated	heat	VERB
admet-2057	57	14	in	in	ADP
admet-2057	57	15	order	order	NOUN
admet-2057	57	16	to	to	PART
admet-2057	57	17	get	get	VERB
admet-2057	57	18	mofs	mof	NOUN
admet-2057	57	19	.	.	PUNCT
admet-2057	58	1	due	due	ADP
admet-2057	58	2	to	to	ADP
admet-2057	58	3	their	their	PRON
admet-2057	58	4	unique	unique	ADJ
admet-2057	58	5	qualities	quality	NOUN
admet-2057	58	6	,	,	PUNCT
admet-2057	58	7	such	such	ADJ
admet-2057	58	8	as	as	ADP
admet-2057	58	9	their	their	PRON
admet-2057	58	10	excellent	excellent	ADJ
admet-2057	58	11	solvating	solvate	VERB
admet-2057	58	12	properties	property	NOUN
admet-2057	58	13	(	(	PUNCT
admet-2057	58	14	the	the	DET
admet-2057	58	15	ability	ability	NOUN
admet-2057	58	16	to	to	PART
admet-2057	58	17	dissolve	dissolve	VERB
admet-2057	58	18	an	an	DET
admet-2057	58	19	array	array	NOUN
admet-2057	58	20	of	of	ADP
admet-2057	58	21	metal	metal	NOUN
admet-2057	58	22	salts	salt	NOUN
admet-2057	58	23	and	and	CCONJ
admet-2057	58	24	linkers	linker	NOUN
admet-2057	58	25	)	)	PUNCT
admet-2057	58	26	,	,	PUNCT
admet-2057	58	27	zero	zero	NUM
admet-2057	58	28	vapour	vapour	NOUN
admet-2057	58	29	pressure	pressure	NOUN
admet-2057	58	30	,	,	PUNCT
admet-2057	58	31	high	high	ADJ
admet-2057	58	32	thermal	thermal	ADJ
admet-2057	58	33	stability	stability	NOUN
admet-2057	58	34	,	,	PUNCT
admet-2057	58	35	and	and	CCONJ
admet-2057	58	36	ease	ease	NOUN
admet-2057	58	37	of	of	ADP
admet-2057	58	38	recycling	recycling	NOUN
admet-2057	58	39	,	,	PUNCT
admet-2057	58	40	ils	ils	X
admet-2057	58	41	have	have	AUX
admet-2057	58	42	gained	gain	VERB
admet-2057	58	43	significant	significant	ADJ
admet-2057	58	44	attention	attention	NOUN
admet-2057	58	45	as	as	ADP
admet-2057	58	46	a	a	DET
admet-2057	58	47	solvent	solvent	NOUN
admet-2057	58	48	.	.	PUNCT
admet-2057	59	1	[	[	X
admet-2057	59	2	17	17	NUM
admet-2057	59	3	]	]	PUNCT
admet-2057	59	4	diffusion	diffusion	NOUN
admet-2057	59	5	synthesis	synthesis	NOUN
admet-2057	59	6	the	the	DET
admet-2057	59	7	diffusion	diffusion	NOUN
admet-2057	59	8	technique	technique	NOUN
admet-2057	59	9	uses	use	VERB
admet-2057	59	10	gas	gas	NOUN
admet-2057	59	11	,	,	PUNCT
admet-2057	59	12	liquid	liquid	NOUN
admet-2057	59	13	,	,	PUNCT
admet-2057	59	14	and	and	CCONJ
admet-2057	59	15	gel	gel	NOUN
admet-2057	59	16	-	-	PUNCT
admet-2057	59	17	phase	phase	NOUN
admet-2057	59	18	diffusion	diffusion	NOUN
admet-2057	59	19	.	.	PUNCT
admet-2057	60	1	the	the	DET
admet-2057	60	2	center	center	ADJ
admet-2057	60	3	metal	metal	NOUN
admet-2057	60	4	ions	ion	NOUN
admet-2057	60	5	and	and	CCONJ
admet-2057	60	6	organic	organic	ADJ
admet-2057	60	7	linkers	linker	NOUN
admet-2057	60	8	are	be	AUX
admet-2057	60	9	dissolved	dissolve	VERB
admet-2057	60	10	in	in	ADP
admet-2057	60	11	an	an	DET
admet-2057	60	12	incompatible	incompatible	ADJ
admet-2057	60	13	solvent	solvent	NOUN
admet-2057	60	14	using	use	VERB
admet-2057	60	15	the	the	DET
admet-2057	60	16	liquid	liquid	ADJ
admet-2057	60	17	-	-	PUNCT
admet-2057	60	18	phase	phase	NOUN
admet-2057	60	19	diffusion	diffusion	NOUN
admet-2057	60	20	technique	technique	NOUN
admet-2057	60	21	.	.	PUNCT
admet-2057	61	1	metal	metal	NOUN
admet-2057	61	2	ions	ion	NOUN
admet-2057	61	3	and	and	CCONJ
admet-2057	61	4	organic	organic	ADJ
admet-2057	61	5	ligands	ligand	NOUN
admet-2057	61	6	interact	interact	VERB
admet-2057	61	7	at	at	ADP
admet-2057	61	8	the	the	DET
admet-2057	61	9	surface	surface	NOUN
admet-2057	61	10	,	,	PUNCT
admet-2057	61	11	forming	form	VERB
admet-2057	61	12	mof	mof	ADJ
admet-2057	61	13	crystals	crystal	NOUN
admet-2057	61	14	.	.	PUNCT
admet-2057	62	1	in	in	ADP
admet-2057	62	2	the	the	DET
admet-2057	62	3	gel	gel	NOUN
admet-2057	62	4	diffusion	diffusion	NOUN
admet-2057	62	5	approach	approach	NOUN
admet-2057	62	6	,	,	PUNCT
admet-2057	62	7	the	the	DET
admet-2057	62	8	two	two	NUM
admet-2057	62	9	divisions	division	NOUN
admet-2057	62	10	of	of	ADP
admet-2057	62	11	a	a	DET
admet-2057	62	12	set	set	NOUN
admet-2057	62	13	of	of	ADP
admet-2057	62	14	mofs	mof	NOUN
admet-2057	62	15	are	be	AUX
admet-2057	62	16	obtained	obtain	VERB
admet-2057	62	17	as	as	ADP
admet-2057	62	18	gel	gel	NOUN
admet-2057	62	19	phase	phase	NOUN
admet-2057	62	20	crystals	crystal	NOUN
admet-2057	62	21	by	by	ADP
admet-2057	62	22	mixing	mix	VERB
admet-2057	62	23	a	a	DET
admet-2057	62	24	solution	solution	NOUN
admet-2057	62	25	containing	contain	VERB
admet-2057	62	26	metal	metal	NOUN
admet-2057	62	27	ions	ion	NOUN
admet-2057	62	28	and	and	CCONJ
admet-2057	62	29	a	a	DET
admet-2057	62	30	gel	gel	NOUN
admet-2057	62	31	component	component	NOUN
admet-2057	62	32	dispersed	disperse	VERB
admet-2057	62	33	with	with	ADP
admet-2057	62	34	organic	organic	ADJ
admet-2057	62	35	ligands	ligand	NOUN
admet-2057	62	36	for	for	ADP
admet-2057	62	37	a	a	DET
admet-2057	62	38	predetermined	predetermine	VERB
admet-2057	62	39	time	time	NOUN
admet-2057	62	40	.	.	PUNCT
admet-2057	63	1	the	the	DET
admet-2057	63	2	volatile	volatile	ADJ
admet-2057	63	3	organic	organic	ADJ
admet-2057	63	4	ligand	ligand	NOUN
admet-2057	63	5	solution	solution	NOUN
admet-2057	63	6	is	be	AUX
admet-2057	63	7	the	the	DET
admet-2057	63	8	solvent	solvent	NOUN
admet-2057	63	9	in	in	ADP
admet-2057	63	10	the	the	DET
admet-2057	63	11	gas	gas	NOUN
admet-2057	63	12	-	-	PUNCT
admet-2057	63	13	phase	phase	NOUN
admet-2057	63	14	diffusion	diffusion	NOUN
admet-2057	63	15	procedure	procedure	NOUN
admet-2057	63	16	.	.	PUNCT
admet-2057	64	1	mofs	mof	NOUN
admet-2057	64	2	develop	develop	VERB
admet-2057	64	3	as	as	SCONJ
admet-2057	64	4	the	the	DET
admet-2057	64	5	reaction	reaction	NOUN
admet-2057	64	6	between	between	ADP
admet-2057	64	7	the	the	DET
admet-2057	64	8	metal	metal	NOUN
admet-2057	64	9	ion	ion	NOUN
admet-2057	64	10	solution	solution	NOUN
admet-2057	64	11	and	and	CCONJ
admet-2057	64	12	the	the	DET
admet-2057	64	13	linker	linker	NOUN
admet-2057	64	14	mixture	mixture	NOUN
admet-2057	64	15	is	be	AUX
admet-2057	64	16	adequately	adequately	ADV
admet-2057	64	17	reacted	react	VERB
admet-2057	64	18	.	.	PUNCT
admet-2057	65	1	a	a	DET
admet-2057	65	2	unique	unique	ADJ
admet-2057	65	3	method	method	NOUN
admet-2057	65	4	that	that	PRON
admet-2057	65	5	operates	operate	VERB
admet-2057	65	6	in	in	ADP
admet-2057	65	7	mild	mild	ADJ
admet-2057	65	8	reaction	reaction	NOUN
admet-2057	65	9	conditions	condition	NOUN
admet-2057	65	10	makes	make	VERB
admet-2057	65	11	it	it	PRON
admet-2057	65	12	advantageous	advantageous	ADJ
admet-2057	65	13	for	for	ADP
admet-2057	65	14	the	the	DET
admet-2057	65	15	synthesis	synthesis	NOUN
admet-2057	65	16	of	of	ADP
admet-2057	65	17	sensitive	sensitive	ADJ
admet-2057	65	18	mofs	mof	NOUN
admet-2057	65	19	.	.	PUNCT
admet-2057	66	1	[	[	X
admet-2057	66	2	18,19	18,19	X
admet-2057	66	3	]	]	X
admet-2057	66	4	microfluidic	microfluidic	NOUN
admet-2057	66	5	a	a	DET
admet-2057	66	6	microfluidic	microfluidic	ADJ
admet-2057	66	7	setup	setup	NOUN
admet-2057	66	8	is	be	AUX
admet-2057	66	9	used	use	VERB
admet-2057	66	10	to	to	PART
admet-2057	66	11	synthesize	synthesize	VERB
admet-2057	66	12	mofs	mof	NOUN
admet-2057	66	13	.	.	PUNCT
admet-2057	67	1	the	the	DET
admet-2057	67	2	syringe	syringe	NOUN
admet-2057	67	3	pumps	pump	NOUN
admet-2057	67	4	are	be	AUX
admet-2057	67	5	used	use	VERB
admet-2057	67	6	for	for	ADP
admet-2057	67	7	introducing	introduce	VERB
admet-2057	67	8	reactant	reactant	NOUN
admet-2057	67	9	solutions	solution	NOUN
admet-2057	67	10	via	via	ADP
admet-2057	67	11	microchannels	microchannel	NOUN
admet-2057	67	12	,	,	PUNCT
admet-2057	67	13	while	while	SCONJ
admet-2057	67	14	a	a	DET
admet-2057	67	15	mixing	mix	VERB
admet-2057	67	16	chamber	chamber	NOUN
admet-2057	67	17	is	be	AUX
admet-2057	67	18	used	use	VERB
admet-2057	67	19	to	to	PART
admet-2057	67	20	combine	combine	VERB
admet-2057	67	21	both	both	PRON
admet-2057	67	22	of	of	ADP
admet-2057	67	23	them	they	PRON
admet-2057	67	24	.	.	PUNCT
admet-2057	68	1	the	the	DET
admet-2057	68	2	mof	mof	NOUN
admet-2057	68	3	is	be	AUX
admet-2057	68	4	subsequently	subsequently	ADV
admet-2057	68	5	produced	produce	VERB
admet-2057	68	6	by	by	ADP
admet-2057	68	7	passing	pass	VERB
admet-2057	68	8	the	the	DET
admet-2057	68	9	combined	combine	VERB
admet-2057	68	10	solution	solution	NOUN
admet-2057	68	11	through	through	ADP
admet-2057	68	12	a	a	DET
admet-2057	68	13	reaction	reaction	NOUN
admet-2057	68	14	chamber	chamber	NOUN
admet-2057	68	15	.	.	PUNCT
admet-2057	69	1	to	to	PART
admet-2057	69	2	facilitate	facilitate	VERB
admet-2057	69	3	the	the	DET
admet-2057	69	4	formation	formation	NOUN
admet-2057	69	5	of	of	ADP
admet-2057	69	6	the	the	DET
admet-2057	69	7	mof	mof	NOUN
admet-2057	69	8	,	,	PUNCT
admet-2057	69	9	the	the	DET
admet-2057	69	10	reaction	reaction	NOUN
admet-2057	69	11	chamber	chamber	PROPN
admet-2057	69	12	is	be	AUX
admet-2057	69	13	normally	normally	ADV
admet-2057	69	14	heated	heated	ADJ
admet-2057	69	15	to	to	ADP
admet-2057	69	16	a	a	DET
admet-2057	69	17	specified	specified	ADJ
admet-2057	69	18	temperature	temperature	NOUN
admet-2057	69	19	.	.	PUNCT
admet-2057	70	1	to	to	PART
admet-2057	70	2	meet	meet	VERB
admet-2057	70	3	the	the	DET
admet-2057	70	4	constantly	constantly	ADV
admet-2057	70	5	rising	rise	VERB
admet-2057	70	6	commercial	commercial	ADJ
admet-2057	70	7	needs	need	NOUN
admet-2057	70	8	,	,	PUNCT
admet-2057	70	9	it	it	PRON
admet-2057	70	10	is	be	AUX
admet-2057	70	11	crucial	crucial	ADJ
admet-2057	70	12	to	to	PART
admet-2057	70	13	investigate	investigate	VERB
admet-2057	70	14	quick	quick	ADJ
admet-2057	70	15	and	and	CCONJ
admet-2057	70	16	sustainable	sustainable	ADJ
admet-2057	70	17	mof	mof	ADJ
admet-2057	70	18	synthesis	synthesis	NOUN
admet-2057	70	19	methods	method	NOUN
admet-2057	70	20	.	.	PUNCT
admet-2057	71	1	[	[	X
admet-2057	71	2	20,21	20,21	NUM
admet-2057	71	3	]	]	SYM
admet-2057	71	4	reverse	reverse	NOUN
admet-2057	71	5	phase	phase	NOUN
admet-2057	71	6	microemulsion	microemulsion	NOUN
admet-2057	71	7	researchers	researcher	NOUN
admet-2057	71	8	frequently	frequently	ADV
admet-2057	71	9	use	use	VERB
admet-2057	71	10	the	the	DET
admet-2057	71	11	reverse	reverse	ADJ
admet-2057	71	12	phase	phase	NOUN
admet-2057	71	13	microemulsion	microemulsion	NOUN
admet-2057	71	14	technique	technique	NOUN
admet-2057	71	15	for	for	ADP
admet-2057	71	16	synthesizing	synthesize	VERB
admet-2057	71	17	uniform	uniform	ADJ
admet-2057	71	18	mofs	mof	NOUN
admet-2057	71	19	by	by	ADP
admet-2057	71	20	introducing	introduce	VERB
admet-2057	71	21	components	component	NOUN
admet-2057	71	22	to	to	ADP
admet-2057	71	23	aqueous	aqueous	ADJ
admet-2057	71	24	spherical	spherical	NOUN
admet-2057	71	25	that	that	PRON
admet-2057	71	26	are	be	AUX
admet-2057	71	27	reverse	reverse	ADJ
admet-2057	71	28	micellemarinized	micellemarinize	VERB
admet-2057	71	29	for	for	ADP
admet-2057	71	30	a	a	DET
admet-2057	71	31	reaction	reaction	NOUN
admet-2057	71	32	.	.	PUNCT
admet-2057	72	1	although	although	SCONJ
admet-2057	72	2	it	it	PRON
admet-2057	72	3	permits	permit	VERB
admet-2057	72	4	size	size	NOUN
admet-2057	72	5	control	control	NOUN
admet-2057	72	6	,	,	PUNCT
admet-2057	72	7	the	the	DET
admet-2057	72	8	limited	limited	ADJ
admet-2057	72	9	yield	yield	NOUN
admet-2057	72	10	limits	limit	VERB
admet-2057	72	11	its	its	PRON
admet-2057	72	12	usefulness	usefulness	NOUN
admet-2057	72	13	.	.	PUNCT
admet-2057	73	1	[	[	X
admet-2057	73	2	22	22	NUM
admet-2057	73	3	]	]	X
admet-2057	73	4	electrochemical	electrochemical	ADJ
admet-2057	73	5	electrochemical	electrochemical	ADJ
admet-2057	73	6	synthesis	synthesis	NOUN
admet-2057	73	7	includes	include	VERB
admet-2057	73	8	two	two	NUM
admet-2057	73	9	approaches	approach	NOUN
admet-2057	73	10	called	call	VERB
admet-2057	73	11	the	the	DET
admet-2057	73	12	direct	direct	ADJ
admet-2057	73	13	and	and	CCONJ
admet-2057	73	14	indirect	indirect	ADJ
admet-2057	73	15	approach	approach	NOUN
admet-2057	73	16	of	of	ADP
admet-2057	73	17	mof	mof	ADJ
admet-2057	73	18	synthesis	synthesis	NOUN
admet-2057	73	19	.	.	PUNCT
admet-2057	74	1	direct	direct	ADJ
admet-2057	74	2	method	method	NOUN
admet-2057	74	3	based	base	VERB
admet-2057	74	4	on	on	ADP
admet-2057	74	5	the	the	DET
admet-2057	74	6	continuous	continuous	ADJ
admet-2057	74	7	anodic	anodic	ADJ
admet-2057	74	8	dissolution	dissolution	NOUN
admet-2057	74	9	of	of	ADP
admet-2057	74	10	metal	metal	NOUN
admet-2057	74	11	ions	ion	NOUN
admet-2057	74	12	into	into	ADP
admet-2057	74	13	the	the	DET
admet-2057	74	14	organic	organic	ADJ
admet-2057	74	15	linker	linker	NOUN
admet-2057	74	16	-	-	PUNCT
admet-2057	74	17	electrolyte	electrolyte	NOUN
admet-2057	74	18	combination	combination	NOUN
admet-2057	74	19	to	to	PART
admet-2057	74	20	fabricate	fabricate	VERB
admet-2057	74	21	the	the	DET
admet-2057	74	22	mofs	mof	NOUN
admet-2057	74	23	.	.	PUNCT
admet-2057	75	1	in	in	ADP
admet-2057	75	2	comparison	comparison	NOUN
admet-2057	75	3	,	,	PUNCT
admet-2057	75	4	the	the	DET
admet-2057	75	5	indirect	indirect	ADJ
admet-2057	75	6	method	method	NOUN
admet-2057	75	7	produces	produce	VERB
admet-2057	75	8	the	the	DET
admet-2057	75	9	intermediates	intermediate	NOUN
admet-2057	75	10	via	via	ADP
admet-2057	75	11	an	an	DET
admet-2057	75	12	electrochemical	electrochemical	ADJ
admet-2057	75	13	reaction	reaction	NOUN
admet-2057	75	14	employed	employ	VERB
admet-2057	75	15	to	to	PART
admet-2057	75	16	synthesis	synthesis	VERB
admet-2057	75	17	mofs	mof	NOUN
admet-2057	75	18	.	.	PUNCT
admet-2057	76	1	protic	protic	ADJ
admet-2057	76	2	solvents	solvent	NOUN
admet-2057	76	3	are	be	AUX
admet-2057	76	4	frequently	frequently	ADV
admet-2057	76	5	used	use	VERB
admet-2057	76	6	to	to	PART
admet-2057	76	7	prevent	prevent	VERB
admet-2057	76	8	the	the	DET
admet-2057	76	9	breakdown	breakdown	NOUN
admet-2057	76	10	of	of	ADP
admet-2057	76	11	metals	metal	NOUN
admet-2057	76	12	via	via	ADP
admet-2057	76	13	complete	complete	ADJ
admet-2057	76	14	utilization	utilization	NOUN
admet-2057	76	15	of	of	ADP
admet-2057	76	16	linkers	linker	NOUN
admet-2057	76	17	,	,	PUNCT
admet-2057	76	18	which	which	PRON
admet-2057	76	19	offer	offer	VERB
admet-2057	76	20	high	high	ADJ
admet-2057	76	21	yield	yield	NOUN
admet-2057	76	22	and	and	CCONJ
admet-2057	76	23	function	function	NOUN
admet-2057	76	24	under	under	ADP
admet-2057	76	25	benign	benign	ADJ
admet-2057	76	26	experimental	experimental	ADJ
admet-2057	76	27	conditions	condition	NOUN
admet-2057	76	28	.	.	PUNCT
admet-2057	77	1	[	[	X
admet-2057	77	2	23	23	NUM
admet-2057	77	3	]	]	PUNCT
admet-2057	77	4	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	77	5	p.	p.	NOUN
admet-2057	77	6	mhettar	mhettar	NOUN
admet-2057	77	7	et	et	PROPN
admet-2057	77	8	al	al	PROPN
admet-2057	77	9	.	.	PROPN
admet-2057	77	10	admet	admet	PROPN
admet-2057	77	11	&	&	CCONJ
admet-2057	77	12	dmpk	dmpk	PROPN
admet-2057	77	13	12(1	12(1	PROPN
admet-2057	77	14	)	)	PUNCT
admet-2057	77	15	(	(	PUNCT
admet-2057	77	16	2024	2024	NUM
admet-2057	77	17	)	)	PUNCT
admet-2057	77	18	27	27	NUM
admet-2057	77	19	-	-	SYM
admet-2057	77	20	62	62	NUM
admet-2057	77	21	30	30	NUM
admet-2057	77	22	synthesis	synthesis	NOUN
admet-2057	77	23	method	method	NOUN
admet-2057	77	24	properties	property	NOUN
admet-2057	77	25	ref	ref	VERB
admet-2057	77	26	.	.	PUNCT
admet-2057	78	1	mechanochemical	mechanochemical	ADJ
admet-2057	78	2	this	this	DET
admet-2057	78	3	approach	approach	NOUN
admet-2057	78	4	of	of	ADP
admet-2057	78	5	mof	mof	ADJ
admet-2057	78	6	synthesis	synthesis	NOUN
admet-2057	78	7	uses	use	VERB
admet-2057	78	8	metallic	metallic	ADJ
admet-2057	78	9	precursors	precursor	NOUN
admet-2057	78	10	and	and	CCONJ
admet-2057	78	11	linking	link	VERB
admet-2057	78	12	organic	organic	ADJ
admet-2057	78	13	ligands	ligand	NOUN
admet-2057	78	14	.	.	PUNCT
admet-2057	79	1	when	when	SCONJ
admet-2057	79	2	these	these	DET
admet-2057	79	3	two	two	NUM
admet-2057	79	4	components	component	NOUN
admet-2057	79	5	react	react	VERB
admet-2057	79	6	chemically	chemically	ADV
admet-2057	79	7	,	,	PUNCT
admet-2057	79	8	coordination	coordination	NOUN
admet-2057	79	9	complexes	complex	NOUN
admet-2057	79	10	are	be	AUX
admet-2057	79	11	formed	form	VERB
admet-2057	79	12	,	,	PUNCT
admet-2057	79	13	and	and	CCONJ
admet-2057	79	14	intramolecular	intramolecular	ADJ
admet-2057	79	15	interactions	interaction	NOUN
admet-2057	79	16	are	be	AUX
admet-2057	79	17	reoriented	reorient	VERB
admet-2057	79	18	.	.	PUNCT
admet-2057	80	1	a	a	DET
admet-2057	80	2	mechanical	mechanical	ADJ
admet-2057	80	3	deformation	deformation	NOUN
admet-2057	80	4	of	of	ADP
admet-2057	80	5	intramolecular	intramolecular	ADJ
admet-2057	80	6	ties	tie	NOUN
admet-2057	80	7	occurs	occur	VERB
admet-2057	80	8	before	before	ADP
admet-2057	80	9	the	the	DET
admet-2057	80	10	chemical	chemical	NOUN
admet-2057	80	11	reaction	reaction	NOUN
admet-2057	80	12	and	and	CCONJ
admet-2057	80	13	synthesis	synthesis	NOUN
admet-2057	80	14	of	of	ADP
admet-2057	80	15	the	the	DET
admet-2057	80	16	metal	metal	NOUN
admet-2057	80	17	-	-	PUNCT
admet-2057	80	18	organic	organic	ADJ
admet-2057	80	19	complex	complex	NOUN
admet-2057	80	20	.	.	PUNCT
admet-2057	81	1	the	the	DET
admet-2057	81	2	current	current	ADJ
admet-2057	81	3	technique	technique	NOUN
admet-2057	81	4	utilized	utilize	VERB
admet-2057	81	5	mechanical	mechanical	ADJ
admet-2057	81	6	pressure	pressure	NOUN
admet-2057	81	7	to	to	PART
admet-2057	81	8	directly	directly	ADV
admet-2057	81	9	grind	grind	VERB
admet-2057	81	10	reacting	react	VERB
admet-2057	81	11	species	specie	NOUN
admet-2057	81	12	with	with	ADP
admet-2057	81	13	or	or	CCONJ
admet-2057	81	14	without	without	ADP
admet-2057	81	15	the	the	DET
admet-2057	81	16	use	use	NOUN
admet-2057	81	17	of	of	ADP
admet-2057	81	18	a	a	DET
admet-2057	81	19	solvent	solvent	NOUN
admet-2057	81	20	.	.	PUNCT
admet-2057	82	1	mechanochemical	mechanochemical	ADJ
admet-2057	82	2	milling	milling	NOUN
admet-2057	82	3	is	be	AUX
admet-2057	82	4	able	able	ADJ
admet-2057	82	5	to	to	PART
admet-2057	82	6	overcome	overcome	VERB
admet-2057	82	7	the	the	DET
admet-2057	82	8	low	low	ADJ
admet-2057	82	9	melting	melting	NOUN
admet-2057	82	10	point	point	NOUN
admet-2057	82	11	of	of	ADP
admet-2057	82	12	the	the	DET
admet-2057	82	13	reactants	reactant	NOUN
admet-2057	82	14	and	and	CCONJ
admet-2057	82	15	form	form	VERB
admet-2057	82	16	the	the	DET
admet-2057	82	17	desired	desire	VERB
admet-2057	82	18	mof	mof	ADJ
admet-2057	82	19	structure	structure	NOUN
admet-2057	82	20	.	.	PUNCT
admet-2057	83	1	also	also	ADV
admet-2057	83	2	the	the	DET
admet-2057	83	3	solvents	solvent	NOUN
admet-2057	83	4	,	,	PUNCT
admet-2057	83	5	which	which	PRON
admet-2057	83	6	can	can	AUX
admet-2057	83	7	be	be	AUX
admet-2057	83	8	costly	costly	ADJ
admet-2057	83	9	and	and	CCONJ
admet-2057	83	10	dangerous	dangerous	ADJ
admet-2057	83	11	for	for	ADP
admet-2057	83	12	the	the	DET
admet-2057	83	13	environment	environment	NOUN
admet-2057	83	14	,	,	PUNCT
admet-2057	83	15	are	be	AUX
admet-2057	83	16	not	not	PART
admet-2057	83	17	needed	need	VERB
admet-2057	83	18	when	when	SCONJ
admet-2057	83	19	using	use	VERB
admet-2057	83	20	this	this	DET
admet-2057	83	21	method	method	NOUN
admet-2057	83	22	confirms	confirm	VERB
admet-2057	83	23	as	as	ADP
admet-2057	83	24	a	a	DET
admet-2057	83	25	green	green	ADJ
admet-2057	83	26	method	method	NOUN
admet-2057	83	27	of	of	ADP
admet-2057	83	28	synthesis	synthesis	NOUN
admet-2057	83	29	.	.	PUNCT
admet-2057	84	1	[	[	X
admet-2057	84	2	24	24	NUM
admet-2057	84	3	-	-	SYM
admet-2057	84	4	26	26	NUM
admet-2057	84	5	]	]	PUNCT
admet-2057	84	6	sonochemical	sonochemical	ADJ
admet-2057	84	7	the	the	DET
admet-2057	84	8	precursor	precursor	NOUN
admet-2057	84	9	solution	solution	NOUN
admet-2057	84	10	interacts	interact	VERB
admet-2057	84	11	with	with	ADP
admet-2057	84	12	ultrasonic	ultrasonic	ADJ
admet-2057	84	13	waves	wave	NOUN
admet-2057	84	14	(	(	PUNCT
admet-2057	84	15	20	20	NUM
admet-2057	84	16	-	-	SYM
admet-2057	84	17	1000	1000	NUM
admet-2057	84	18	khz	khz	NOUN
admet-2057	84	19	)	)	PUNCT
admet-2057	84	20	,	,	PUNCT
admet-2057	84	21	leading	lead	VERB
admet-2057	84	22	to	to	ADP
admet-2057	84	23	alternate	alternate	ADJ
admet-2057	84	24	compression	compression	NOUN
admet-2057	84	25	and	and	CCONJ
admet-2057	84	26	refraction	refraction	NOUN
admet-2057	84	27	areas	area	NOUN
admet-2057	84	28	and	and	CCONJ
admet-2057	84	29	creating	create	VERB
admet-2057	84	30	homogeneous	homogeneous	ADJ
admet-2057	84	31	nano	nano	NOUN
admet-2057	84	32	-	-	PUNCT
admet-2057	84	33	mof	mof	ADJ
admet-2057	84	34	(	(	PUNCT
admet-2057	84	35	nmof	nmof	NOUN
admet-2057	84	36	)	)	PUNCT
admet-2057	84	37	via	via	ADP
admet-2057	84	38	synthesis	synthesis	NOUN
admet-2057	84	39	.	.	PUNCT
admet-2057	85	1	this	this	PRON
admet-2057	85	2	is	be	AUX
admet-2057	85	3	a	a	DET
admet-2057	85	4	swift	swift	ADJ
admet-2057	85	5	and	and	CCONJ
admet-2057	85	6	environmentally	environmentally	ADV
admet-2057	85	7	friendly	friendly	ADJ
admet-2057	85	8	approach	approach	NOUN
admet-2057	85	9	to	to	ADP
admet-2057	85	10	creating	create	VERB
admet-2057	85	11	mofs	mof	NOUN
admet-2057	85	12	.	.	PUNCT
admet-2057	86	1	this	this	DET
admet-2057	86	2	process	process	NOUN
admet-2057	86	3	,	,	PUNCT
admet-2057	86	4	which	which	PRON
admet-2057	86	5	uses	use	VERB
admet-2057	86	6	homogeneous	homogeneous	ADJ
admet-2057	86	7	and	and	CCONJ
admet-2057	86	8	rapid	rapid	ADJ
admet-2057	86	9	nucleation	nucleation	NOUN
admet-2057	86	10	,	,	PUNCT
admet-2057	86	11	can	can	AUX
admet-2057	86	12	result	result	VERB
admet-2057	86	13	in	in	ADP
admet-2057	86	14	substantially	substantially	ADV
admet-2057	86	15	smaller	small	ADJ
admet-2057	86	16	particles	particle	NOUN
admet-2057	86	17	and	and	CCONJ
admet-2057	86	18	a	a	DET
admet-2057	86	19	shorter	short	ADJ
admet-2057	86	20	crystallization	crystallization	NOUN
admet-2057	86	21	period	period	NOUN
admet-2057	86	22	than	than	ADP
admet-2057	86	23	conventional	conventional	ADJ
admet-2057	86	24	synthesis	synthesis	NOUN
admet-2057	86	25	methodologies	methodology	NOUN
admet-2057	86	26	.	.	PUNCT
admet-2057	87	1	[	[	X
admet-2057	87	2	12,27	12,27	NUM
admet-2057	87	3	]	]	PUNCT
admet-2057	87	4	characterization	characterization	NOUN
admet-2057	87	5	methods	method	NOUN
admet-2057	87	6	to	to	PART
admet-2057	87	7	compare	compare	VERB
admet-2057	87	8	and	and	CCONJ
admet-2057	87	9	thoroughly	thoroughly	ADV
admet-2057	87	10	describe	describe	VERB
admet-2057	87	11	the	the	DET
admet-2057	87	12	created	create	VERB
admet-2057	87	13	mofs	mof	NOUN
admet-2057	87	14	'	'	PART
admet-2057	87	15	characteristics	characteristic	NOUN
admet-2057	87	16	,	,	PUNCT
admet-2057	87	17	including	include	VERB
admet-2057	87	18	their	their	PRON
admet-2057	87	19	size	size	NOUN
admet-2057	87	20	,	,	PUNCT
admet-2057	87	21	shape	shape	NOUN
admet-2057	87	22	,	,	PUNCT
admet-2057	87	23	surface	surface	NOUN
admet-2057	87	24	morphology	morphology	NOUN
admet-2057	87	25	,	,	PUNCT
admet-2057	87	26	and	and	CCONJ
admet-2057	87	27	thermal	thermal	ADJ
admet-2057	87	28	stability	stability	NOUN
admet-2057	87	29	.	.	PUNCT
admet-2057	88	1	the	the	DET
admet-2057	88	2	below	below	ADV
admet-2057	88	3	-	-	PUNCT
admet-2057	88	4	mentioned	mention	VERB
admet-2057	88	5	characterization	characterization	NOUN
admet-2057	88	6	techniques	technique	NOUN
admet-2057	88	7	include	include	VERB
admet-2057	88	8	tga	tga	PROPN
admet-2057	88	9	(	(	PUNCT
admet-2057	88	10	thermogravimetric	thermogravimetric	ADJ
admet-2057	88	11	analysis	analysis	NOUN
admet-2057	88	12	)	)	PUNCT
admet-2057	88	13	,	,	PUNCT
admet-2057	88	14	nmr	nmr	NOUN
admet-2057	88	15	(	(	PUNCT
admet-2057	88	16	nuclear	nuclear	ADJ
admet-2057	88	17	magnetic	magnetic	ADJ
admet-2057	88	18	resonance	resonance	NOUN
admet-2057	88	19	)	)	PUNCT
admet-2057	88	20	,	,	PUNCT
admet-2057	88	21	vibrational	vibrational	ADJ
admet-2057	88	22	spectroscopy	spectroscopy	NOUN
admet-2057	88	23	,	,	PUNCT
admet-2057	88	24	sem	sem	NOUN
admet-2057	88	25	(	(	PUNCT
admet-2057	88	26	scanning	scan	VERB
admet-2057	88	27	electron	electron	NOUN
admet-2057	88	28	microscopy	microscopy	NOUN
admet-2057	88	29	)	)	PUNCT
admet-2057	88	30	,	,	PUNCT
admet-2057	88	31	pxrd	pxrd	NOUN
admet-2057	88	32	(	(	PUNCT
admet-2057	88	33	powder	powder	NOUN
admet-2057	88	34	x	x	NOUN
admet-2057	88	35	-	-	NOUN
admet-2057	88	36	ray	ray	NOUN
admet-2057	88	37	diffraction	diffraction	NOUN
admet-2057	88	38	)	)	PUNCT
admet-2057	88	39	,	,	PUNCT
admet-2057	88	40	scxrd	scxrd	INTJ
admet-2057	88	41	(	(	PUNCT
admet-2057	88	42	single	single	ADJ
admet-2057	88	43	crystal	crystal	NOUN
admet-2057	88	44	x	x	PROPN
admet-2057	88	45	-	-	NOUN
admet-2057	88	46	ray	ray	NOUN
admet-2057	88	47	diffraction	diffraction	NOUN
admet-2057	88	48	)	)	PUNCT
admet-2057	88	49	,	,	PUNCT
admet-2057	88	50	etc	etc	X
admet-2057	88	51	.	.	X
admet-2057	88	52	,	,	PUNCT
admet-2057	88	53	along	along	ADP
admet-2057	88	54	with	with	ADP
admet-2057	88	55	characterising	characterise	VERB
admet-2057	88	56	certain	certain	ADJ
admet-2057	88	57	mof	mof	NOUN
admet-2057	88	58	properties	property	NOUN
admet-2057	88	59	as	as	SCONJ
admet-2057	88	60	depicted	depict	VERB
admet-2057	88	61	in	in	ADP
admet-2057	88	62	figure	figure	NOUN
admet-2057	88	63	1	1	NUM
admet-2057	89	1	[	[	X
admet-2057	89	2	28	28	NUM
admet-2057	89	3	]	]	PUNCT
admet-2057	89	4	.	.	PUNCT
admet-2057	90	1	tga	tga	PROPN
admet-2057	90	2	,	,	PUNCT
admet-2057	90	3	which	which	PRON
admet-2057	90	4	analyses	analyse	VERB
admet-2057	90	5	a	a	DET
admet-2057	90	6	sample	sample	NOUN
admet-2057	90	7	's	's	PART
admet-2057	90	8	mass	mass	NOUN
admet-2057	90	9	in	in	ADP
admet-2057	90	10	relation	relation	NOUN
admet-2057	90	11	to	to	ADP
admet-2057	90	12	temperature	temperature	NOUN
admet-2057	90	13	,	,	PUNCT
admet-2057	90	14	is	be	AUX
admet-2057	90	15	a	a	DET
admet-2057	90	16	direct	direct	ADJ
admet-2057	90	17	technique	technique	NOUN
admet-2057	90	18	for	for	ADP
admet-2057	90	19	examining	examine	VERB
admet-2057	90	20	the	the	DET
admet-2057	90	21	thermal	thermal	ADJ
admet-2057	90	22	stability	stability	NOUN
admet-2057	90	23	of	of	ADP
admet-2057	90	24	mofs	mof	NOUN
admet-2057	90	25	.	.	PUNCT
admet-2057	91	1	mass	mass	ADJ
admet-2057	91	2	spectrometers	spectrometer	NOUN
admet-2057	91	3	and	and	CCONJ
admet-2057	91	4	thermogravimetric	thermogravimetric	ADJ
admet-2057	91	5	analysers	analyser	NOUN
admet-2057	91	6	frequently	frequently	ADV
admet-2057	91	7	work	work	VERB
admet-2057	91	8	together	together	ADV
admet-2057	91	9	.	.	PUNCT
admet-2057	92	1	figure	figure	VERB
admet-2057	92	2	1	1	NUM
admet-2057	92	3	.	.	PUNCT
admet-2057	92	4	mof	mof	NOUN
admet-2057	92	5	characterization	characterization	NOUN
admet-2057	92	6	techniques	technique	NOUN
admet-2057	92	7	admet	admet	X
admet-2057	92	8	&	&	CCONJ
admet-2057	92	9	dmpk	dmpk	PROPN
admet-2057	92	10	12(1	12(1	PROPN
admet-2057	92	11	)	)	PUNCT
admet-2057	92	12	(	(	PUNCT
admet-2057	92	13	2024	2024	NUM
admet-2057	92	14	)	)	PUNCT
admet-2057	92	15	27	27	NUM
admet-2057	92	16	-	-	SYM
admet-2057	92	17	62	62	NUM
admet-2057	92	18	drug	drug	NOUN
admet-2057	92	19	delivery	delivery	NOUN
admet-2057	92	20	applications	application	NOUN
admet-2057	92	21	of	of	ADP
admet-2057	92	22	metal	metal	NOUN
admet-2057	92	23	-	-	PUNCT
admet-2057	92	24	organic	organic	ADJ
admet-2057	92	25	framework	framework	NOUN
admet-2057	92	26	doi	doi	NOUN
admet-2057	92	27	:	:	PUNCT
admet-2057	92	28	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	92	29	31	31	NUM
admet-2057	92	30	as	as	ADP
admet-2057	92	31	a	a	DET
admet-2057	92	32	result	result	NOUN
admet-2057	92	33	,	,	PUNCT
admet-2057	92	34	it	it	PRON
admet-2057	92	35	is	be	AUX
admet-2057	92	36	able	able	ADJ
admet-2057	92	37	to	to	PART
admet-2057	92	38	identify	identify	VERB
admet-2057	92	39	the	the	DET
admet-2057	92	40	molecules	molecule	NOUN
admet-2057	92	41	responsible	responsible	ADJ
admet-2057	92	42	for	for	ADP
admet-2057	92	43	the	the	DET
admet-2057	92	44	sample	sample	NOUN
admet-2057	92	45	mass	mass	NOUN
admet-2057	92	46	change	change	NOUN
admet-2057	92	47	as	as	ADV
admet-2057	92	48	well	well	ADV
admet-2057	92	49	as	as	ADP
admet-2057	92	50	the	the	DET
admet-2057	92	51	temperature	temperature	NOUN
admet-2057	92	52	at	at	ADP
admet-2057	92	53	which	which	PRON
admet-2057	92	54	this	this	DET
admet-2057	92	55	mass	mass	ADJ
admet-2057	92	56	shift	shift	NOUN
admet-2057	92	57	occurs	occur	VERB
admet-2057	92	58	[	[	X
admet-2057	92	59	29	29	NUM
admet-2057	92	60	]	]	PUNCT
admet-2057	92	61	.	.	PUNCT
admet-2057	93	1	tga	tga	PROPN
admet-2057	93	2	is	be	AUX
admet-2057	93	3	a	a	DET
admet-2057	93	4	useful	useful	ADJ
admet-2057	93	5	tool	tool	NOUN
admet-2057	93	6	for	for	ADP
admet-2057	93	7	characterising	characterise	VERB
admet-2057	93	8	mofs	mof	NOUN
admet-2057	93	9	that	that	PRON
admet-2057	93	10	may	may	AUX
admet-2057	93	11	be	be	AUX
admet-2057	93	12	used	use	VERB
admet-2057	93	13	to	to	PART
admet-2057	93	14	ascertain	ascertain	VERB
admet-2057	93	15	their	their	PRON
admet-2057	93	16	thermal	thermal	ADJ
admet-2057	93	17	stability	stability	NOUN
admet-2057	93	18	,	,	PUNCT
admet-2057	93	19	activation	activation	NOUN
admet-2057	93	20	conditions	condition	NOUN
admet-2057	93	21	,	,	PUNCT
admet-2057	93	22	and	and	CCONJ
admet-2057	93	23	porosity	porosity	NOUN
admet-2057	93	24	.	.	PUNCT
admet-2057	94	1	it	it	PRON
admet-2057	94	2	has	have	AUX
admet-2057	94	3	also	also	ADV
admet-2057	94	4	been	be	AUX
admet-2057	94	5	extensively	extensively	ADV
admet-2057	94	6	used	use	VERB
admet-2057	94	7	to	to	PART
admet-2057	94	8	quantify	quantify	VERB
admet-2057	94	9	the	the	DET
admet-2057	94	10	compositional	compositional	ADJ
admet-2057	94	11	makeup	makeup	NOUN
admet-2057	94	12	of	of	ADP
admet-2057	94	13	mofs	mof	NOUN
admet-2057	95	1	[	[	X
admet-2057	95	2	30	30	NUM
admet-2057	95	3	]	]	PUNCT
admet-2057	95	4	.	.	PUNCT
admet-2057	96	1	sem	sem	PROPN
admet-2057	96	2	is	be	AUX
admet-2057	96	3	a	a	DET
admet-2057	96	4	crucial	crucial	ADJ
admet-2057	96	5	technique	technique	NOUN
admet-2057	96	6	to	to	PART
admet-2057	96	7	analyse	analyse	VERB
admet-2057	96	8	the	the	DET
admet-2057	96	9	varying	vary	VERB
admet-2057	96	10	surfacearchitecture	surfacearchitecture	NOUN
admet-2057	96	11	attributes	attribute	VERB
admet-2057	96	12	like	like	ADP
admet-2057	96	13	size	size	NOUN
admet-2057	96	14	,	,	PUNCT
admet-2057	96	15	surface	surface	NOUN
admet-2057	96	16	morphology	morphology	NOUN
admet-2057	96	17	,	,	PUNCT
admet-2057	96	18	and	and	CCONJ
admet-2057	96	19	elemental	elemental	ADJ
admet-2057	96	20	configuration	configuration	NOUN
admet-2057	96	21	of	of	ADP
admet-2057	96	22	mofs	mof	NOUN
admet-2057	96	23	[	[	X
admet-2057	96	24	31	31	NUM
admet-2057	96	25	]	]	PUNCT
admet-2057	96	26	.	.	PUNCT
admet-2057	97	1	this	this	DET
admet-2057	97	2	technique	technique	NOUN
admet-2057	97	3	scans	scan	VERB
admet-2057	97	4	the	the	DET
admet-2057	97	5	surface	surface	NOUN
admet-2057	97	6	of	of	ADP
admet-2057	97	7	a	a	DET
admet-2057	97	8	solid	solid	ADJ
admet-2057	97	9	sample	sample	NOUN
admet-2057	97	10	with	with	ADP
admet-2057	97	11	an	an	DET
admet-2057	97	12	electron	electron	NOUN
admet-2057	97	13	beam	beam	NOUN
admet-2057	97	14	with	with	ADP
admet-2057	97	15	an	an	DET
admet-2057	97	16	intensity	intensity	NOUN
admet-2057	97	17	of	of	ADP
admet-2057	97	18	almost	almost	ADV
admet-2057	97	19	5	5	NUM
admet-2057	97	20	kev	kev	NOUN
admet-2057	97	21	.	.	PUNCT
admet-2057	98	1	the	the	DET
admet-2057	98	2	concentrated	concentrated	ADJ
admet-2057	98	3	incident	incident	NOUN
admet-2057	98	4	beam	beam	NOUN
admet-2057	98	5	's	's	PART
admet-2057	98	6	electrons	electron	NOUN
admet-2057	98	7	impact	impact	NOUN
admet-2057	98	8	the	the	DET
admet-2057	98	9	specimen	speciman	NOUN
admet-2057	98	10	's	's	PART
admet-2057	98	11	surface	surface	NOUN
admet-2057	98	12	and	and	CCONJ
admet-2057	98	13	produce	produce	VERB
admet-2057	98	14	secondary	secondary	ADJ
admet-2057	98	15	electrons	electron	NOUN
admet-2057	98	16	.	.	PUNCT
admet-2057	99	1	these	these	DET
admet-2057	99	2	electrons	electron	NOUN
admet-2057	99	3	are	be	AUX
admet-2057	99	4	captured	capture	VERB
admet-2057	99	5	using	use	VERB
admet-2057	99	6	a	a	DET
admet-2057	99	7	detector	detector	NOUN
admet-2057	99	8	and	and	CCONJ
admet-2057	99	9	used	use	VERB
admet-2057	99	10	to	to	PART
admet-2057	99	11	generate	generate	VERB
admet-2057	99	12	the	the	DET
admet-2057	99	13	sample	sample	NOUN
admet-2057	99	14	image	image	NOUN
admet-2057	99	15	[	[	X
admet-2057	99	16	32	32	NUM
admet-2057	99	17	]	]	PUNCT
admet-2057	99	18	.	.	PUNCT
admet-2057	100	1	in	in	ADP
admet-2057	100	2	the	the	DET
admet-2057	100	3	transmission	transmission	NOUN
admet-2057	100	4	electron	electron	NOUN
admet-2057	100	5	microscopy	microscopy	NOUN
admet-2057	100	6	(	(	PUNCT
admet-2057	100	7	tem	tem	NOUN
admet-2057	100	8	)	)	PUNCT
admet-2057	100	9	experiment	experiment	NOUN
admet-2057	100	10	,	,	PUNCT
admet-2057	100	11	a	a	DET
admet-2057	100	12	high	high	ADJ
admet-2057	100	13	-	-	PUNCT
admet-2057	100	14	energy	energy	NOUN
admet-2057	100	15	electron	electron	NOUN
admet-2057	100	16	beam	beam	NOUN
admet-2057	100	17	(	(	PUNCT
admet-2057	100	18	200	200	NUM
admet-2057	100	19	kev	kev	NOUN
admet-2057	100	20	)	)	PUNCT
admet-2057	100	21	is	be	AUX
admet-2057	100	22	focused	focus	VERB
admet-2057	100	23	on	on	ADP
admet-2057	100	24	a	a	DET
admet-2057	100	25	thin	thin	ADJ
admet-2057	100	26	sample	sample	NOUN
admet-2057	100	27	(	(	PUNCT
admet-2057	100	28	usually	usually	ADV
admet-2057	100	29	less	less	ADJ
admet-2057	100	30	than	than	ADP
admet-2057	100	31	200	200	NUM
admet-2057	100	32	nm	nm	NOUN
admet-2057	100	33	)	)	PUNCT
admet-2057	100	34	formed	form	VERB
admet-2057	100	35	of	of	ADP
admet-2057	100	36	a	a	DET
admet-2057	100	37	carbon	carbon	NOUN
admet-2057	100	38	grid	grid	NOUN
admet-2057	100	39	where	where	SCONJ
admet-2057	100	40	a	a	DET
admet-2057	100	41	drop	drop	NOUN
admet-2057	100	42	sample	sample	NOUN
admet-2057	100	43	has	have	AUX
admet-2057	100	44	been	be	AUX
admet-2057	100	45	evaporated	evaporate	VERB
admet-2057	100	46	.	.	PUNCT
admet-2057	101	1	the	the	DET
admet-2057	101	2	electrons	electron	NOUN
admet-2057	101	3	travelling	travel	VERB
admet-2057	101	4	through	through	ADP
admet-2057	101	5	the	the	DET
admet-2057	101	6	sample	sample	NOUN
admet-2057	101	7	,	,	PUNCT
admet-2057	101	8	or	or	CCONJ
admet-2057	101	9	being	be	AUX
admet-2057	101	10	transmitted	transmit	VERB
admet-2057	101	11	,	,	PUNCT
admet-2057	101	12	are	be	AUX
admet-2057	101	13	dispersed	disperse	VERB
admet-2057	101	14	at	at	ADP
admet-2057	101	15	multiple	multiple	ADJ
admet-2057	101	16	angles	angle	NOUN
admet-2057	101	17	and	and	CCONJ
admet-2057	101	18	then	then	ADV
admet-2057	101	19	concentrated	concentrate	VERB
admet-2057	101	20	on	on	ADP
admet-2057	101	21	a	a	DET
admet-2057	101	22	detector	detector	NOUN
admet-2057	101	23	using	use	VERB
admet-2057	101	24	a	a	DET
admet-2057	101	25	lens	lens	NOUN
admet-2057	101	26	system	system	NOUN
admet-2057	101	27	to	to	PART
admet-2057	101	28	produce	produce	VERB
admet-2057	101	29	micrographs	micrograph	NOUN
admet-2057	101	30	with	with	ADP
admet-2057	101	31	great	great	ADJ
admet-2057	101	32	lateral	lateral	ADJ
admet-2057	101	33	spatial	spatial	ADJ
admet-2057	101	34	resolution	resolution	NOUN
admet-2057	101	35	.	.	PUNCT
admet-2057	102	1	high	high	ADJ
admet-2057	102	2	magnification	magnification	NOUN
admet-2057	102	3	ranging	range	VERB
admet-2057	102	4	from	from	ADP
admet-2057	102	5	50	50	NUM
admet-2057	102	6	to	to	PART
admet-2057	102	7	106	106	NUM
admet-2057	102	8	and	and	CCONJ
admet-2057	102	9	the	the	DET
admet-2057	102	10	potential	potential	NOUN
admet-2057	102	11	to	to	PART
admet-2057	102	12	furnish	furnish	VERB
admet-2057	102	13	image	image	NOUN
admet-2057	102	14	and	and	CCONJ
admet-2057	102	15	diffraction	diffraction	NOUN
admet-2057	102	16	pattern	pattern	NOUN
admet-2057	102	17	information	information	NOUN
admet-2057	102	18	are	be	AUX
admet-2057	102	19	big	big	ADJ
admet-2057	102	20	pluses	plus	NOUN
admet-2057	102	21	of	of	ADP
admet-2057	102	22	tem	tem	PROPN
admet-2057	102	23	.	.	PUNCT
admet-2057	103	1	this	this	PRON
admet-2057	103	2	is	be	AUX
admet-2057	103	3	particularly	particularly	ADV
admet-2057	103	4	important	important	ADJ
admet-2057	103	5	for	for	ADP
admet-2057	103	6	mof	mof	X
admet-2057	103	7	nps	nps	PROPN
admet-2057	103	8	because	because	SCONJ
admet-2057	103	9	it	it	PRON
admet-2057	103	10	demonstrates	demonstrate	VERB
admet-2057	103	11	crystalline	crystalline	ADJ
admet-2057	103	12	structure	structure	NOUN
admet-2057	103	13	[	[	X
admet-2057	103	14	32	32	NUM
admet-2057	103	15	]	]	PUNCT
admet-2057	103	16	.	.	PUNCT
admet-2057	104	1	nmr	nmr	NOUN
admet-2057	104	2	spectroscopy	spectroscopy	NOUN
admet-2057	104	3	is	be	AUX
admet-2057	104	4	widely	widely	ADV
admet-2057	104	5	employed	employ	VERB
admet-2057	104	6	in	in	ADP
admet-2057	104	7	the	the	DET
admet-2057	104	8	chemical	chemical	NOUN
admet-2057	104	9	sciences	science	NOUN
admet-2057	104	10	as	as	ADP
admet-2057	104	11	a	a	DET
admet-2057	104	12	structural	structural	ADJ
admet-2057	104	13	characterization	characterization	NOUN
admet-2057	104	14	tool	tool	NOUN
admet-2057	104	15	.	.	PUNCT
admet-2057	105	1	the	the	DET
admet-2057	105	2	utilisation	utilisation	NOUN
admet-2057	105	3	of	of	ADP
admet-2057	105	4	solid	solid	ADJ
admet-2057	105	5	-	-	PUNCT
admet-2057	105	6	state	state	NOUN
admet-2057	105	7	nmr	nmr	NOUN
admet-2057	105	8	spectroscopy	spectroscopy	NOUN
admet-2057	105	9	(	(	PUNCT
admet-2057	105	10	ssnmr	ssnmr	NOUN
admet-2057	105	11	)	)	PUNCT
admet-2057	105	12	is	be	AUX
admet-2057	105	13	required	require	VERB
admet-2057	105	14	for	for	ADP
admet-2057	105	15	the	the	DET
admet-2057	105	16	investigation	investigation	NOUN
admet-2057	105	17	of	of	ADP
admet-2057	105	18	host	host	NOUN
admet-2057	105	19	-	-	PUNCT
admet-2057	105	20	guest	guest	NOUN
admet-2057	105	21	interactions	interaction	NOUN
admet-2057	105	22	in	in	ADP
admet-2057	105	23	mof	mof	ADJ
admet-2057	105	24	-	-	PUNCT
admet-2057	105	25	biomolecule	biomolecule	NOUN
admet-2057	105	26	systems	system	NOUN
admet-2057	105	27	[	[	X
admet-2057	105	28	33	33	NUM
admet-2057	105	29	]	]	PUNCT
admet-2057	105	30	.	.	PUNCT
admet-2057	106	1	ssnmr	ssnmr	PROPN
admet-2057	106	2	is	be	AUX
admet-2057	106	3	an	an	DET
admet-2057	106	4	effective	effective	ADJ
admet-2057	106	5	method	method	NOUN
admet-2057	106	6	for	for	ADP
admet-2057	106	7	mof	mof	ADJ
admet-2057	106	8	characterisation	characterisation	NOUN
admet-2057	106	9	since	since	SCONJ
admet-2057	106	10	it	it	PRON
admet-2057	106	11	provides	provide	VERB
admet-2057	106	12	details	detail	NOUN
admet-2057	106	13	complementary	complementary	ADJ
admet-2057	106	14	to	to	ADP
admet-2057	106	15	x	x	ADJ
admet-2057	106	16	-	-	NOUN
admet-2057	106	17	ray	ray	NOUN
admet-2057	106	18	diffraction	diffraction	NOUN
admet-2057	106	19	(	(	PUNCT
admet-2057	106	20	xrd	xrd	PROPN
admet-2057	106	21	)	)	PUNCT
admet-2057	106	22	.	.	PUNCT
admet-2057	107	1	researchers	researcher	NOUN
admet-2057	107	2	are	be	AUX
admet-2057	107	3	making	make	VERB
admet-2057	107	4	innovative	innovative	ADJ
admet-2057	107	5	efforts	effort	NOUN
admet-2057	107	6	in	in	ADP
admet-2057	107	7	the	the	DET
admet-2057	107	8	three	three	NUM
admet-2057	107	9	key	key	ADJ
admet-2057	107	10	aspects	aspect	NOUN
admet-2057	107	11	of	of	ADP
admet-2057	107	12	ssnmr	ssnmr	NOUN
admet-2057	107	13	for	for	ADP
admet-2057	107	14	mof	mof	ADJ
admet-2057	107	15	characterization	characterization	NOUN
admet-2057	107	16	:	:	PUNCT
admet-2057	107	17	investigating	investigate	VERB
admet-2057	107	18	the	the	DET
admet-2057	107	19	metal	metal	NOUN
admet-2057	107	20	centre	centre	NOUN
admet-2057	107	21	,	,	PUNCT
admet-2057	107	22	focusing	focus	VERB
admet-2057	107	23	linker	linker	NOUN
admet-2057	107	24	molecules	molecule	NOUN
admet-2057	107	25	,	,	PUNCT
admet-2057	107	26	and	and	CCONJ
admet-2057	107	27	investigating	investigate	VERB
admet-2057	107	28	guests	guest	NOUN
admet-2057	107	29	.	.	PUNCT
admet-2057	108	1	mofs	mof	NOUN
admet-2057	108	2	have	have	VERB
admet-2057	108	3	a	a	DET
admet-2057	108	4	lower	low	ADJ
admet-2057	108	5	density	density	NOUN
admet-2057	108	6	,	,	PUNCT
admet-2057	108	7	and	and	CCONJ
admet-2057	108	8	the	the	DET
admet-2057	108	9	inserted	insert	VERB
admet-2057	108	10	metals	metal	NOUN
admet-2057	108	11	are	be	AUX
admet-2057	108	12	frequently	frequently	ADV
admet-2057	108	13	quadrupolar	quadrupolar	ADJ
admet-2057	108	14	nuclei	nucleus	NOUN
admet-2057	108	15	,	,	PUNCT
admet-2057	108	16	rendering	render	VERB
admet-2057	108	17	ssnmr	ssnmr	ADJ
admet-2057	108	18	identification	identification	NOUN
admet-2057	108	19	problematic	problematic	ADJ
admet-2057	108	20	.	.	PUNCT
admet-2057	109	1	awhile	awhile	ADV
admet-2057	109	2	back	back	ADV
admet-2057	109	3	,	,	PUNCT
admet-2057	109	4	researchers	researcher	NOUN
admet-2057	109	5	used	use	VERB
admet-2057	109	6	ssnmr	ssnmr	NOUN
admet-2057	109	7	to	to	PART
admet-2057	109	8	investigate	investigate	VERB
admet-2057	109	9	the	the	DET
admet-2057	109	10	structures	structure	NOUN
admet-2057	109	11	of	of	ADP
admet-2057	109	12	metal	metal	NOUN
admet-2057	109	13	centres	centre	NOUN
admet-2057	109	14	in	in	ADP
admet-2057	109	15	prominent	prominent	ADJ
admet-2057	109	16	mofs	mof	NOUN
admet-2057	109	17	at	at	ADP
admet-2057	109	18	a	a	DET
admet-2057	109	19	high	high	ADJ
admet-2057	109	20	magnetic	magnetic	ADJ
admet-2057	109	21	field	field	NOUN
admet-2057	109	22	of	of	ADP
admet-2057	109	23	21.1	21.1	NUM
admet-2057	109	24	t	t	NOUN
admet-2057	109	25	,	,	PUNCT
admet-2057	109	26	mentioning	mention	VERB
admet-2057	109	27	multiple	multiple	ADJ
admet-2057	109	28	critical	critical	ADJ
admet-2057	109	29	topics	topic	NOUN
admet-2057	109	30	such	such	ADJ
admet-2057	109	31	as	as	ADP
admet-2057	109	32	(	(	PUNCT
admet-2057	109	33	1	1	X
admet-2057	109	34	)	)	PUNCT
admet-2057	109	35	resolving	resolve	VERB
admet-2057	109	36	chemically	chemically	ADV
admet-2057	109	37	and	and	CCONJ
admet-2057	109	38	crystallographically	crystallographically	ADV
admet-2057	109	39	non	non	ADJ
admet-2057	109	40	-	-	ADJ
admet-2057	109	41	equivalent	equivalent	ADJ
admet-2057	109	42	metal	metal	NOUN
admet-2057	109	43	sites	site	NOUN
admet-2057	109	44	;	;	PUNCT
admet-2057	109	45	(	(	PUNCT
admet-2057	109	46	2	2	X
admet-2057	109	47	)	)	PUNCT
admet-2057	109	48	investigating	investigate	VERB
admet-2057	109	49	the	the	DET
admet-2057	109	50	roots	root	NOUN
admet-2057	109	51	of	of	ADP
admet-2057	109	52	disorder	disorder	NOUN
admet-2057	109	53	around	around	ADP
admet-2057	109	54	metals	metal	NOUN
admet-2057	109	55	;	;	PUNCT
admet-2057	109	56	(	(	PUNCT
admet-2057	109	57	3	3	X
admet-2057	109	58	)	)	PUNCT
admet-2057	109	59	refining	refine	VERB
admet-2057	109	60	local	local	ADJ
admet-2057	109	61	metal	metal	NOUN
admet-2057	109	62	geometry	geometry	NOUN
admet-2057	109	63	;	;	PUNCT
admet-2057	109	64	(	(	PUNCT
admet-2057	109	65	4	4	X
admet-2057	109	66	)	)	PUNCT
admet-2057	109	67	probing	probe	VERB
admet-2057	109	68	the	the	DET
admet-2057	109	69	effects	effect	NOUN
admet-2057	109	70	of	of	ADP
admet-2057	109	71	activation	activation	NOUN
admet-2057	109	72	and	and	CCONJ
admet-2057	109	73	adsorption	adsorption	NOUN
admet-2057	109	74	on	on	ADP
admet-2057	109	75	the	the	DET
admet-2057	109	76	metal	metal	NOUN
admet-2057	109	77	local	local	ADJ
admet-2057	109	78	environment	environment	NOUN
admet-2057	109	79	;	;	PUNCT
admet-2057	109	80	and	and	CCONJ
admet-2057	109	81	(	(	PUNCT
admet-2057	109	82	5	5	X
admet-2057	109	83	)	)	PUNCT
admet-2057	109	84	tracking	tracking	NOUN
admet-2057	109	85	in	in	ADP
admet-2057	109	86	situ	situ	ADJ
admet-2057	109	87	phase	phase	NOUN
admet-2057	109	88	transitions	transition	NOUN
admet-2057	109	89	in	in	ADP
admet-2057	109	90	mofs	mof	NOUN
admet-2057	109	91	[	[	X
admet-2057	109	92	34	34	NUM
admet-2057	109	93	]	]	PUNCT
admet-2057	109	94	.	.	PUNCT
admet-2057	110	1	scxrd	scxrd	PROPN
admet-2057	110	2	has	have	AUX
admet-2057	110	3	unquestionably	unquestionably	ADV
admet-2057	110	4	been	be	AUX
admet-2057	110	5	regarded	regard	VERB
admet-2057	110	6	as	as	ADP
admet-2057	110	7	the	the	DET
admet-2057	110	8	most	most	ADV
admet-2057	110	9	straightforward	straightforward	ADJ
admet-2057	110	10	technique	technique	NOUN
admet-2057	110	11	in	in	ADP
admet-2057	110	12	the	the	DET
admet-2057	110	13	structural	structural	ADJ
admet-2057	110	14	elucidation	elucidation	NOUN
admet-2057	110	15	of	of	ADP
admet-2057	110	16	crystallographic	crystallographic	ADJ
admet-2057	110	17	frameworks	framework	NOUN
admet-2057	110	18	for	for	ADP
admet-2057	110	19	conclusively	conclusively	ADV
admet-2057	110	20	clarifying	clarify	VERB
admet-2057	110	21	the	the	DET
admet-2057	110	22	structure	structure	NOUN
admet-2057	110	23	-	-	PUNCT
admet-2057	110	24	property	property	NOUN
admet-2057	110	25	correlations	correlation	NOUN
admet-2057	110	26	.	.	PUNCT
admet-2057	111	1	this	this	DET
admet-2057	111	2	handy	handy	ADJ
admet-2057	111	3	tool	tool	NOUN
admet-2057	111	4	can	can	AUX
admet-2057	111	5	be	be	AUX
admet-2057	111	6	used	use	VERB
admet-2057	111	7	to	to	PART
admet-2057	111	8	directly	directly	ADV
admet-2057	111	9	see	see	VERB
admet-2057	111	10	precise	precise	ADJ
admet-2057	111	11	and	and	CCONJ
admet-2057	111	12	comprehensive	comprehensive	ADJ
admet-2057	111	13	structural	structural	ADJ
admet-2057	111	14	information	information	NOUN
admet-2057	111	15	such	such	ADJ
admet-2057	111	16	as	as	ADP
admet-2057	111	17	atomic	atomic	ADJ
admet-2057	111	18	coordinates	coordinate	NOUN
admet-2057	111	19	,	,	PUNCT
admet-2057	111	20	bond	bond	NOUN
admet-2057	111	21	angles	angle	NOUN
admet-2057	111	22	,	,	PUNCT
admet-2057	111	23	bond	bond	NOUN
admet-2057	111	24	lengths	length	NOUN
admet-2057	111	25	,	,	PUNCT
admet-2057	111	26	and	and	CCONJ
admet-2057	111	27	atomic	atomic	ADJ
admet-2057	111	28	occupancies	occupancy	NOUN
admet-2057	111	29	[	[	X
admet-2057	111	30	35	35	NUM
admet-2057	111	31	]	]	PUNCT
admet-2057	111	32	.	.	PUNCT
admet-2057	112	1	on	on	ADP
admet-2057	112	2	the	the	DET
admet-2057	112	3	other	other	ADJ
admet-2057	112	4	hand	hand	NOUN
admet-2057	112	5	,	,	PUNCT
admet-2057	112	6	the	the	DET
admet-2057	112	7	size	size	NOUN
admet-2057	112	8	and	and	CCONJ
admet-2057	112	9	quality	quality	NOUN
admet-2057	112	10	of	of	ADP
admet-2057	112	11	the	the	DET
admet-2057	112	12	crystal	crystal	NOUN
admet-2057	112	13	produced	produce	VERB
admet-2057	112	14	,	,	PUNCT
admet-2057	112	15	as	as	ADP
admet-2057	112	16	with	with	ADP
admet-2057	112	17	xrd	xrd	NOUN
admet-2057	112	18	on	on	ADP
admet-2057	112	19	any	any	DET
admet-2057	112	20	material	material	NOUN
admet-2057	112	21	,	,	PUNCT
admet-2057	112	22	are	be	AUX
admet-2057	112	23	the	the	DET
admet-2057	112	24	key	key	ADJ
admet-2057	112	25	constraints	constraint	NOUN
admet-2057	112	26	in	in	ADP
admet-2057	112	27	gathering	gather	VERB
admet-2057	112	28	valid	valid	ADJ
admet-2057	112	29	data	datum	NOUN
admet-2057	112	30	.	.	PUNCT
admet-2057	113	1	in	in	ADP
admet-2057	113	2	general	general	ADJ
admet-2057	113	3	,	,	PUNCT
admet-2057	113	4	crystals	crystal	NOUN
admet-2057	113	5	should	should	AUX
admet-2057	113	6	be	be	AUX
admet-2057	113	7	larger	large	ADJ
admet-2057	113	8	than	than	ADP
admet-2057	113	9	5	5	NUM
admet-2057	113	10	-	-	SYM
admet-2057	113	11	10	10	NUM
admet-2057	113	12	μm	μm	NOUN
admet-2057	113	13	,	,	PUNCT
admet-2057	113	14	which	which	PRON
admet-2057	113	15	can	can	AUX
admet-2057	113	16	be	be	AUX
admet-2057	113	17	difficult	difficult	ADJ
admet-2057	113	18	to	to	PART
admet-2057	113	19	achieve	achieve	VERB
admet-2057	113	20	for	for	ADP
admet-2057	113	21	particular	particular	ADJ
admet-2057	113	22	mof	mof	NOUN
admet-2057	113	23	classes	class	NOUN
admet-2057	113	24	.	.	PUNCT
admet-2057	114	1	infrared	infrared	PROPN
admet-2057	114	2	(	(	PUNCT
admet-2057	114	3	ir	ir	NOUN
admet-2057	114	4	)	)	PUNCT
admet-2057	114	5	and	and	CCONJ
admet-2057	114	6	raman	raman	NOUN
admet-2057	114	7	spectroscopy	spectroscopy	NOUN
admet-2057	114	8	are	be	AUX
admet-2057	114	9	the	the	DET
admet-2057	114	10	two	two	NUM
admet-2057	114	11	basic	basic	ADJ
admet-2057	114	12	types	type	NOUN
admet-2057	114	13	of	of	ADP
admet-2057	114	14	vibrational	vibrational	ADJ
admet-2057	114	15	spectroscopy	spectroscopy	NOUN
admet-2057	114	16	.	.	PUNCT
admet-2057	115	1	ir	ir	PROPN
admet-2057	115	2	spectroscopy	spectroscopy	NOUN
admet-2057	115	3	relies	rely	VERB
admet-2057	115	4	on	on	ADP
admet-2057	115	5	absorbing	absorb	VERB
admet-2057	115	6	infrared	infrared	ADJ
admet-2057	115	7	light	light	NOUN
admet-2057	115	8	,	,	PUNCT
admet-2057	115	9	which	which	PRON
admet-2057	115	10	induces	induce	VERB
admet-2057	115	11	a	a	DET
admet-2057	115	12	direct	direct	ADJ
admet-2057	115	13	transition	transition	NOUN
admet-2057	115	14	between	between	ADP
admet-2057	115	15	the	the	DET
admet-2057	115	16	vibrational	vibrational	ADJ
admet-2057	115	17	energy	energy	NOUN
admet-2057	115	18	levels	level	NOUN
admet-2057	115	19	of	of	ADP
admet-2057	115	20	molecules	molecule	NOUN
admet-2057	115	21	,	,	PUNCT
admet-2057	115	22	whereas	whereas	SCONJ
admet-2057	115	23	raman	raman	NOUN
admet-2057	115	24	spectroscopy	spectroscopy	NOUN
admet-2057	115	25	relies	rely	VERB
admet-2057	115	26	on	on	ADP
admet-2057	115	27	photon	photon	NOUN
admet-2057	115	28	inelastic	inelastic	ADJ
admet-2057	115	29	scattering	scattering	NOUN
admet-2057	115	30	.	.	PUNCT
admet-2057	116	1	since	since	SCONJ
admet-2057	116	2	they	they	PRON
admet-2057	116	3	are	be	AUX
admet-2057	116	4	sensitive	sensitive	ADJ
admet-2057	116	5	to	to	ADP
admet-2057	116	6	various	various	ADJ
admet-2057	116	7	types	type	NOUN
admet-2057	116	8	of	of	ADP
admet-2057	116	9	vibrations	vibration	NOUN
admet-2057	116	10	,	,	PUNCT
admet-2057	116	11	the	the	DET
admet-2057	116	12	two	two	NUM
admet-2057	116	13	strategies	strategy	NOUN
admet-2057	116	14	are	be	AUX
admet-2057	116	15	complimentary	complimentary	ADJ
admet-2057	116	16	.	.	PUNCT
admet-2057	117	1	the	the	DET
admet-2057	117	2	infrared	infrared	ADJ
admet-2057	117	3	area	area	NOUN
admet-2057	117	4	is	be	AUX
admet-2057	117	5	potentially	potentially	ADV
admet-2057	117	6	split	split	VERB
admet-2057	117	7	into	into	ADP
admet-2057	117	8	three	three	NUM
admet-2057	117	9	subregions	subregion	NOUN
admet-2057	117	10	.	.	PUNCT
admet-2057	118	1	the	the	DET
admet-2057	118	2	fundamental	fundamental	ADJ
admet-2057	118	3	vibrations	vibration	NOUN
admet-2057	118	4	are	be	AUX
admet-2057	118	5	usually	usually	ADV
admet-2057	118	6	noticed	notice	VERB
admet-2057	118	7	in	in	ADP
admet-2057	118	8	the	the	DET
admet-2057	118	9	mid	mid	NOUN
admet-2057	118	10	-	-	ADJ
admet-2057	118	11	infrared	infrared	ADJ
admet-2057	118	12	(	(	PUNCT
admet-2057	118	13	4000	4000	NUM
admet-2057	118	14	-	-	SYM
admet-2057	118	15	400	400	NUM
admet-2057	118	16	cm-1	cm-1	NOUN
admet-2057	118	17	)	)	PUNCT
admet-2057	118	18	.	.	PUNCT
admet-2057	119	1	overtones	overtone	NOUN
admet-2057	119	2	and	and	CCONJ
admet-2057	119	3	combination	combination	NOUN
admet-2057	119	4	modes	mode	NOUN
admet-2057	119	5	are	be	AUX
admet-2057	119	6	most	most	ADV
admet-2057	119	7	commonly	commonly	ADV
admet-2057	119	8	recognised	recognise	VERB
admet-2057	119	9	in	in	ADP
admet-2057	119	10	the	the	DET
admet-2057	119	11	near	near	ADV
admet-2057	119	12	-	-	PUNCT
admet-2057	119	13	infrared	infrared	ADJ
admet-2057	119	14	(	(	PUNCT
admet-2057	119	15	14000	14000	NUM
admet-2057	119	16	-	-	SYM
admet-2057	119	17	4000	4000	NUM
admet-2057	119	18	cm-1	cm-1	NOUN
admet-2057	119	19	)	)	PUNCT
admet-2057	119	20	.	.	PUNCT
admet-2057	120	1	the	the	DET
admet-2057	120	2	low	low	ADJ
admet-2057	120	3	-	-	PUNCT
admet-2057	120	4	energy	energy	NOUN
admet-2057	120	5	far	far	ADV
admet-2057	120	6	-	-	PUNCT
admet-2057	120	7	infrared	infrared	ADJ
admet-2057	120	8	(	(	PUNCT
admet-2057	120	9	ca	ca	NOUN
admet-2057	120	10	.	.	NOUN
admet-2057	120	11	400	400	NUM
admet-2057	120	12	to-10	to-10	NUM
admet-2057	120	13	cm-1	cm-1	NOUN
admet-2057	120	14	)	)	PUNCT
admet-2057	120	15	contains	contain	VERB
admet-2057	120	16	the	the	DET
admet-2057	120	17	terahertz	terahertz	NOUN
admet-2057	120	18	region	region	NOUN
admet-2057	120	19	,	,	PUNCT
admet-2057	120	20	which	which	PRON
admet-2057	120	21	can	can	AUX
admet-2057	120	22	be	be	AUX
admet-2057	120	23	used	use	VERB
admet-2057	120	24	to	to	PART
admet-2057	120	25	monitor	monitor	VERB
admet-2057	120	26	intermolecular	intermolecular	ADJ
admet-2057	120	27	vibrations	vibration	NOUN
admet-2057	120	28	(	(	PUNCT
admet-2057	120	29	external	external	ADJ
admet-2057	120	30	modes	mode	NOUN
admet-2057	120	31	)	)	PUNCT
admet-2057	120	32	.	.	PUNCT
admet-2057	121	1	in	in	ADP
admet-2057	121	2	summary	summary	NOUN
admet-2057	121	3	,	,	PUNCT
admet-2057	121	4	ir	ir	PROPN
admet-2057	121	5	is	be	AUX
admet-2057	121	6	more	more	ADV
admet-2057	121	7	responsive	responsive	ADJ
admet-2057	121	8	to	to	ADP
admet-2057	121	9	hetero	hetero	NOUN
admet-2057	121	10	-	-	PUNCT
admet-2057	121	11	nuclear	nuclear	ADJ
admet-2057	121	12	functional	functional	ADJ
admet-2057	121	13	groups	group	NOUN
admet-2057	121	14	(	(	PUNCT
admet-2057	121	15	polar	polar	ADJ
admet-2057	121	16	functional	functional	ADJ
admet-2057	121	17	groups	group	NOUN
admet-2057	121	18	)	)	PUNCT
admet-2057	121	19	than	than	ADP
admet-2057	121	20	raman	raman	NOUN
admet-2057	121	21	is	be	AUX
admet-2057	121	22	to	to	PART
admet-2057	121	23	homonuclear	homonuclear	VERB
admet-2057	121	24	molecular	molecular	ADJ
admet-2057	121	25	bonds	bond	NOUN
admet-2057	121	26	.	.	PUNCT
admet-2057	122	1	consequently	consequently	ADV
admet-2057	122	2	,	,	PUNCT
admet-2057	122	3	the	the	DET
admet-2057	122	4	ir	ir	PROPN
admet-2057	122	5	and	and	CCONJ
admet-2057	122	6	raman	raman	ADJ
admet-2057	122	7	spectra	spectra	NOUN
admet-2057	122	8	typically	typically	ADV
admet-2057	122	9	vary	vary	VERB
admet-2057	122	10	.	.	PUNCT
admet-2057	123	1	due	due	ADP
admet-2057	123	2	to	to	ADP
admet-2057	123	3	the	the	DET
admet-2057	123	4	differing	differ	VERB
admet-2057	123	5	basis	basis	NOUN
admet-2057	123	6	sets	set	NOUN
admet-2057	123	7	,	,	PUNCT
admet-2057	123	8	both	both	DET
admet-2057	123	9	methods	method	NOUN
admet-2057	123	10	(	(	PUNCT
admet-2057	123	11	ir	ir	X
admet-2057	123	12	and	and	CCONJ
admet-2057	123	13	raman	raman	NOUN
admet-2057	123	14	)	)	PUNCT
admet-2057	123	15	are	be	AUX
admet-2057	123	16	thought	think	VERB
admet-2057	123	17	to	to	PART
admet-2057	123	18	be	be	AUX
admet-2057	123	19	highly	highly	ADV
admet-2057	123	20	complementary	complementary	ADJ
admet-2057	123	21	[	[	X
admet-2057	123	22	36	36	NUM
admet-2057	123	23	]	]	PUNCT
admet-2057	123	24	.	.	PUNCT
admet-2057	124	1	guest	guest	NOUN
admet-2057	124	2	molecules	molecule	NOUN
admet-2057	124	3	immobilized	immobilize	VERB
admet-2057	124	4	on	on	ADP
admet-2057	124	5	activated	activate	VERB
admet-2057	124	6	metal	metal	NOUN
admet-2057	124	7	centres	centre	NOUN
admet-2057	124	8	have	have	AUX
admet-2057	124	9	been	be	AUX
admet-2057	124	10	discovered	discover	VERB
admet-2057	124	11	to	to	PART
admet-2057	124	12	possess	possess	VERB
admet-2057	124	13	a	a	DET
admet-2057	124	14	wide	wide	ADJ
admet-2057	124	15	range	range	NOUN
admet-2057	124	16	of	of	ADP
admet-2057	124	17	vibrational	vibrational	ADJ
admet-2057	124	18	frequencies	frequency	NOUN
admet-2057	124	19	and	and	CCONJ
admet-2057	124	20	intensities	intensity	NOUN
admet-2057	124	21	,	,	PUNCT
admet-2057	124	22	allowing	allow	VERB
admet-2057	124	23	ir	ir	NOUN
admet-2057	124	24	spectroscopy	spectroscopy	VERB
admet-2057	124	25	to	to	PART
admet-2057	124	26	precisely	precisely	ADV
admet-2057	124	27	ensure	ensure	VERB
admet-2057	124	28	the	the	DET
admet-2057	124	29	presence	presence	NOUN
admet-2057	124	30	of	of	ADP
admet-2057	124	31	single	single	ADJ
admet-2057	124	32	metal	metal	NOUN
admet-2057	124	33	sites	site	NOUN
admet-2057	124	34	in	in	ADP
admet-2057	124	35	both	both	CCONJ
admet-2057	124	36	amorphous	amorphous	ADJ
admet-2057	124	37	and	and	CCONJ
admet-2057	124	38	crystalline	crystalline	ADJ
admet-2057	124	39	substances	substance	NOUN
admet-2057	124	40	.	.	PUNCT
admet-2057	125	1	based	base	VERB
admet-2057	125	2	on	on	ADP
admet-2057	125	3	these	these	PRON
admet-2057	125	4	,	,	PUNCT
admet-2057	125	5	ir	ir	PROPN
admet-2057	125	6	spectroscopy	spectroscopy	NOUN
admet-2057	125	7	can	can	AUX
admet-2057	125	8	provide	provide	VERB
admet-2057	125	9	useful	useful	ADJ
admet-2057	125	10	and	and	CCONJ
admet-2057	125	11	relevant	relevant	ADJ
admet-2057	125	12	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	125	13	p.	p.	NOUN
admet-2057	125	14	mhettar	mhettar	NOUN
admet-2057	125	15	et	et	PROPN
admet-2057	125	16	al	al	PROPN
admet-2057	125	17	.	.	PROPN
admet-2057	125	18	admet	admet	PROPN
admet-2057	125	19	&	&	CCONJ
admet-2057	125	20	dmpk	dmpk	PROPN
admet-2057	125	21	12(1	12(1	PROPN
admet-2057	125	22	)	)	PUNCT
admet-2057	125	23	(	(	PUNCT
admet-2057	125	24	2024	2024	NUM
admet-2057	125	25	)	)	PUNCT
admet-2057	125	26	27	27	NUM
admet-2057	125	27	-	-	SYM
admet-2057	125	28	62	62	NUM
admet-2057	125	29	32	32	NUM
admet-2057	125	30	insight	insight	NOUN
admet-2057	125	31	into	into	ADP
admet-2057	125	32	metal	metal	NOUN
admet-2057	125	33	sites	site	NOUN
admet-2057	125	34	by	by	ADP
admet-2057	125	35	analysing	analyse	VERB
admet-2057	125	36	the	the	DET
admet-2057	125	37	adsorption	adsorption	NOUN
admet-2057	125	38	performance	performance	NOUN
admet-2057	125	39	of	of	ADP
admet-2057	125	40	appropriate	appropriate	ADJ
admet-2057	125	41	molecules	molecule	NOUN
admet-2057	125	42	such	such	ADJ
admet-2057	125	43	as	as	ADP
admet-2057	125	44	co	co	NOUN
admet-2057	125	45	,	,	PUNCT
admet-2057	125	46	co2	co2	NOUN
admet-2057	125	47	,	,	PUNCT
admet-2057	125	48	no	no	INTJ
admet-2057	125	49	,	,	PUNCT
admet-2057	125	50	and	and	CCONJ
admet-2057	125	51	h2	h2	NOUN
admet-2057	125	52	.	.	PUNCT
admet-2057	126	1	co	co	NOUN
admet-2057	126	2	,	,	PUNCT
admet-2057	126	3	in	in	ADP
admet-2057	126	4	particular	particular	ADJ
admet-2057	126	5	,	,	PUNCT
admet-2057	126	6	is	be	AUX
admet-2057	126	7	a	a	DET
admet-2057	126	8	common	common	ADJ
admet-2057	126	9	probe	probe	NOUN
admet-2057	126	10	due	due	ADP
admet-2057	126	11	to	to	ADP
admet-2057	126	12	its	its	PRON
admet-2057	126	13	tiny	tiny	ADJ
admet-2057	126	14	size	size	NOUN
admet-2057	126	15	and	and	CCONJ
admet-2057	126	16	sensitivity	sensitivity	NOUN
admet-2057	126	17	to	to	PART
admet-2057	126	18	reactivity	reactivity	VERB
admet-2057	126	19	with	with	ADP
admet-2057	126	20	cationic	cationic	ADJ
admet-2057	126	21	or	or	CCONJ
admet-2057	126	22	metallic	metallic	ADJ
admet-2057	126	23	sites	site	NOUN
admet-2057	126	24	[	[	X
admet-2057	126	25	35	35	NUM
admet-2057	126	26	]	]	SYM
admet-2057	126	27	.	.	PUNCT
admet-2057	127	1	drug	drug	NOUN
admet-2057	127	2	loading	loading	NOUN
admet-2057	127	3	strategies	strategy	NOUN
admet-2057	127	4	to	to	PART
admet-2057	127	5	mof	mof	VERB
admet-2057	127	6	mofs	mof	NOUN
admet-2057	127	7	exhibit	exhibit	VERB
admet-2057	127	8	the	the	DET
admet-2057	127	9	distinctive	distinctive	ADJ
admet-2057	127	10	features	feature	NOUN
admet-2057	127	11	of	of	ADP
admet-2057	127	12	extensive	extensive	ADJ
admet-2057	127	13	surface	surface	NOUN
admet-2057	127	14	area	area	NOUN
admet-2057	127	15	and	and	CCONJ
admet-2057	127	16	structural	structural	ADJ
admet-2057	127	17	divergence	divergence	NOUN
admet-2057	127	18	that	that	PRON
admet-2057	127	19	simplify	simplify	VERB
admet-2057	127	20	drug	drug	NOUN
admet-2057	127	21	loading	loading	NOUN
admet-2057	127	22	on	on	ADP
admet-2057	127	23	the	the	DET
admet-2057	127	24	exterior	exterior	NOUN
admet-2057	127	25	or	or	CCONJ
admet-2057	127	26	enclosed	enclose	VERB
admet-2057	127	27	inside	inside	ADP
admet-2057	127	28	the	the	DET
admet-2057	127	29	pores	pore	NOUN
admet-2057	127	30	by	by	ADP
admet-2057	127	31	various	various	ADJ
admet-2057	127	32	loading	loading	NOUN
admet-2057	127	33	strategies	strategy	NOUN
admet-2057	127	34	.	.	PUNCT
admet-2057	128	1	two	two	NUM
admet-2057	128	2	types	type	NOUN
admet-2057	128	3	of	of	ADP
admet-2057	128	4	drugloading	drugloade	VERB
admet-2057	128	5	strategies	strategy	NOUN
admet-2057	128	6	are	be	AUX
admet-2057	128	7	widely	widely	ADV
admet-2057	128	8	used	use	VERB
admet-2057	128	9	,	,	PUNCT
admet-2057	128	10	called	call	VERB
admet-2057	128	11	the	the	DET
admet-2057	128	12	one	one	NUM
admet-2057	128	13	-	-	PUNCT
admet-2057	128	14	step	step	NOUN
admet-2057	128	15	and	and	CCONJ
admet-2057	128	16	the	the	DET
admet-2057	128	17	two	two	NUM
admet-2057	128	18	-	-	PUNCT
admet-2057	128	19	step	step	NOUN
admet-2057	128	20	methods	method	NOUN
admet-2057	128	21	[	[	X
admet-2057	128	22	37	37	NUM
admet-2057	128	23	]	]	PUNCT
admet-2057	128	24	.	.	PUNCT
admet-2057	129	1	one	one	NUM
admet-2057	129	2	-	-	PUNCT
admet-2057	129	3	step	step	NOUN
admet-2057	129	4	in	in	ADP
admet-2057	129	5	a	a	DET
admet-2057	129	6	one	one	NUM
admet-2057	129	7	-	-	PUNCT
admet-2057	129	8	step	step	NOUN
admet-2057	129	9	method	method	NOUN
admet-2057	129	10	,	,	PUNCT
admet-2057	129	11	therapeutic	therapeutic	ADJ
admet-2057	129	12	actives	active	NOUN
admet-2057	129	13	are	be	AUX
admet-2057	129	14	directly	directly	ADV
admet-2057	129	15	integrated	integrate	VERB
admet-2057	129	16	with	with	ADP
admet-2057	129	17	the	the	DET
admet-2057	129	18	mofs	mof	NOUN
admet-2057	129	19	during	during	ADP
admet-2057	129	20	synthesis	synthesis	NOUN
admet-2057	129	21	.	.	PUNCT
admet-2057	130	1	this	this	DET
admet-2057	130	2	strategy	strategy	NOUN
admet-2057	130	3	employs	employ	VERB
admet-2057	130	4	uniform	uniform	ADJ
admet-2057	130	5	distribution	distribution	NOUN
admet-2057	130	6	and	and	CCONJ
admet-2057	130	7	high	high	ADJ
admet-2057	130	8	drug	drug	NOUN
admet-2057	130	9	-	-	PUNCT
admet-2057	130	10	loading	loading	NOUN
admet-2057	130	11	capacity	capacity	NOUN
admet-2057	130	12	.	.	PUNCT
admet-2057	131	1	nevertheless	nevertheless	ADV
admet-2057	131	2	,	,	PUNCT
admet-2057	131	3	controlling	control	VERB
admet-2057	131	4	particle	particle	NOUN
admet-2057	131	5	size	size	NOUN
admet-2057	131	6	,	,	PUNCT
admet-2057	131	7	morphology	morphology	NOUN
admet-2057	131	8	,	,	PUNCT
admet-2057	131	9	and	and	CCONJ
admet-2057	131	10	physiochemical	physiochemical	ADJ
admet-2057	131	11	characteristics	characteristic	NOUN
admet-2057	131	12	of	of	ADP
admet-2057	131	13	prevailing	prevail	VERB
admet-2057	131	14	mofs	mof	NOUN
admet-2057	131	15	is	be	AUX
admet-2057	131	16	challenging	challenge	VERB
admet-2057	131	17	.	.	PUNCT
admet-2057	132	1	additionally	additionally	ADV
admet-2057	132	2	,	,	PUNCT
admet-2057	132	3	it	it	PRON
admet-2057	132	4	is	be	AUX
admet-2057	132	5	crucial	crucial	ADJ
admet-2057	132	6	to	to	PART
admet-2057	132	7	take	take	VERB
admet-2057	132	8	extra	extra	ADJ
admet-2057	132	9	precautions	precaution	NOUN
admet-2057	132	10	to	to	PART
admet-2057	132	11	ensure	ensure	VERB
admet-2057	132	12	that	that	SCONJ
admet-2057	132	13	a	a	DET
admet-2057	132	14	drug	drug	NOUN
admet-2057	132	15	is	be	AUX
admet-2057	132	16	not	not	PART
admet-2057	132	17	damaged	damage	VERB
admet-2057	132	18	during	during	ADP
admet-2057	132	19	the	the	DET
admet-2057	132	20	synthesis	synthesis	NOUN
admet-2057	132	21	process	process	NOUN
admet-2057	132	22	[	[	X
admet-2057	132	23	38	38	NUM
admet-2057	132	24	]	]	PUNCT
admet-2057	132	25	.	.	PUNCT
admet-2057	133	1	one	one	NUM
admet-2057	133	2	-	-	PUNCT
admet-2057	133	3	pot	pot	NOUN
admet-2057	133	4	method	method	NOUN
admet-2057	133	5	the	the	DET
admet-2057	133	6	one	one	NUM
admet-2057	133	7	-	-	PUNCT
admet-2057	133	8	pot	pot	NOUN
admet-2057	133	9	method	method	NOUN
admet-2057	133	10	includes	include	VERB
admet-2057	133	11	the	the	DET
admet-2057	133	12	co	co	NOUN
admet-2057	133	13	-	-	NOUN
admet-2057	133	14	precipitation	precipitation	NOUN
admet-2057	133	15	of	of	ADP
admet-2057	133	16	the	the	DET
admet-2057	133	17	drug	drug	NOUN
admet-2057	133	18	with	with	ADP
admet-2057	133	19	the	the	DET
admet-2057	133	20	mof	mof	NOUN
admet-2057	133	21	amidst	amidst	ADP
admet-2057	133	22	the	the	DET
admet-2057	133	23	synthesis	synthesis	NOUN
admet-2057	133	24	.	.	PUNCT
admet-2057	134	1	as	as	ADP
admet-2057	134	2	a	a	DET
admet-2057	134	3	result	result	NOUN
admet-2057	134	4	,	,	PUNCT
admet-2057	134	5	drug	drug	NOUN
admet-2057	134	6	molecules	molecule	NOUN
admet-2057	134	7	are	be	AUX
admet-2057	134	8	homogenously	homogenously	ADV
admet-2057	134	9	distributed	distribute	VERB
admet-2057	134	10	inside	inside	ADP
admet-2057	134	11	the	the	DET
admet-2057	134	12	pores	pore	NOUN
admet-2057	134	13	of	of	ADP
admet-2057	134	14	mofs	mof	NOUN
admet-2057	134	15	[	[	X
admet-2057	134	16	39	39	NUM
admet-2057	134	17	]	]	PUNCT
admet-2057	134	18	.	.	PUNCT
admet-2057	135	1	it	it	PRON
admet-2057	135	2	is	be	AUX
admet-2057	135	3	a	a	DET
admet-2057	135	4	cost	cost	NOUN
admet-2057	135	5	-	-	PUNCT
admet-2057	135	6	effective	effective	ADJ
admet-2057	135	7	technique	technique	NOUN
admet-2057	135	8	for	for	ADP
admet-2057	135	9	drug	drug	NOUN
admet-2057	135	10	loading	loading	NOUN
admet-2057	135	11	during	during	ADP
admet-2057	135	12	the	the	DET
admet-2057	135	13	synthesis	synthesis	NOUN
admet-2057	135	14	of	of	ADP
admet-2057	135	15	mofs	mof	NOUN
admet-2057	135	16	.	.	PUNCT
admet-2057	136	1	it	it	PRON
admet-2057	136	2	speeds	speed	VERB
admet-2057	136	3	up	up	ADP
admet-2057	136	4	the	the	DET
admet-2057	136	5	reaction	reaction	NOUN
admet-2057	136	6	process	process	NOUN
admet-2057	136	7	,	,	PUNCT
admet-2057	136	8	minimises	minimise	NOUN
admet-2057	136	9	waste	waste	VERB
admet-2057	136	10	and	and	CCONJ
admet-2057	136	11	gets	get	VERB
admet-2057	136	12	beyond	beyond	ADP
admet-2057	136	13	the	the	DET
admet-2057	136	14	mofs	mof	NOUN
admet-2057	136	15	'	'	PART
admet-2057	136	16	restrictively	restrictively	ADV
admet-2057	136	17	tiny	tiny	ADJ
admet-2057	136	18	porous	porous	ADJ
admet-2057	136	19	structure	structure	NOUN
admet-2057	136	20	[	[	X
admet-2057	136	21	37	37	NUM
admet-2057	136	22	]	]	PUNCT
admet-2057	136	23	.	.	PUNCT
admet-2057	137	1	zeolitic	zeolitic	ADJ
admet-2057	137	2	imidazolate	imidazolate	NOUN
admet-2057	137	3	framework	framework	NOUN
admet-2057	137	4	(	(	PUNCT
admet-2057	137	5	zif	zif	NOUN
admet-2057	137	6	)	)	PUNCT
admet-2057	137	7	crystals	crystal	NOUN
admet-2057	137	8	have	have	AUX
admet-2057	137	9	been	be	AUX
admet-2057	137	10	demonstrated	demonstrate	VERB
admet-2057	137	11	by	by	ADP
admet-2057	137	12	zheng	zheng	PROPN
admet-2057	137	13	et	et	PROPN
admet-2057	137	14	al	al	PROPN
admet-2057	137	15	.	.	PUNCT
admet-2057	138	1	[	[	X
admet-2057	138	2	40	40	NUM
admet-2057	138	3	]	]	PUNCT
admet-2057	138	4	to	to	PART
admet-2057	138	5	be	be	AUX
admet-2057	138	6	capable	capable	ADJ
admet-2057	138	7	of	of	ADP
admet-2057	138	8	entrapping	entrap	VERB
admet-2057	138	9	large	large	ADJ
admet-2057	138	10	drug	drug	NOUN
admet-2057	138	11	and	and	CCONJ
admet-2057	138	12	dye	dye	NOUN
admet-2057	138	13	molecules	molecule	NOUN
admet-2057	138	14	.	.	PUNCT
admet-2057	139	1	molecule	molecule	NOUN
admet-2057	139	2	loadings	loading	NOUN
admet-2057	139	3	can	can	AUX
admet-2057	139	4	be	be	AUX
admet-2057	139	5	adjusted	adjust	VERB
admet-2057	139	6	and	and	CCONJ
admet-2057	139	7	uniformly	uniformly	ADV
admet-2057	139	8	dispersed	disperse	VERB
admet-2057	139	9	throughout	throughout	ADP
admet-2057	139	10	the	the	DET
admet-2057	139	11	crystals	crystal	NOUN
admet-2057	139	12	.	.	PUNCT
admet-2057	140	1	additionally	additionally	ADV
admet-2057	140	2	,	,	PUNCT
admet-2057	140	3	scientists	scientist	NOUN
admet-2057	140	4	have	have	AUX
admet-2057	140	5	shown	show	VERB
admet-2057	140	6	that	that	SCONJ
admet-2057	140	7	the	the	DET
admet-2057	140	8	one	one	NUM
admet-2057	140	9	-	-	PUNCT
admet-2057	140	10	pot	pot	NOUN
admet-2057	140	11	method	method	NOUN
admet-2057	140	12	may	may	AUX
admet-2057	140	13	be	be	AUX
admet-2057	140	14	used	use	VERB
admet-2057	140	15	to	to	PART
admet-2057	140	16	concurrently	concurrently	ADV
admet-2057	140	17	encapsulate	encapsulate	VERB
admet-2057	140	18	target	target	NOUN
admet-2057	140	19	molecules	molecule	NOUN
admet-2057	140	20	and	and	CCONJ
admet-2057	140	21	metal	metal	NOUN
admet-2057	140	22	nanoparticles	nanoparticle	NOUN
admet-2057	140	23	(	(	PUNCT
admet-2057	140	24	nps	nps	PROPN
admet-2057	140	25	)	)	PUNCT
admet-2057	140	26	inside	inside	ADP
admet-2057	140	27	zifs	zifs	PROPN
admet-2057	140	28	.	.	PUNCT
admet-2057	141	1	co	co	NOUN
admet-2057	142	1	-	-	NOUN
admet-2057	142	2	crystallization	crystallization	NOUN
admet-2057	142	3	in	in	ADP
admet-2057	142	4	laboratory	laboratory	NOUN
admet-2057	142	5	research	research	NOUN
admet-2057	142	6	or	or	CCONJ
admet-2057	142	7	industry	industry	NOUN
admet-2057	142	8	,	,	PUNCT
admet-2057	142	9	it	it	PRON
admet-2057	142	10	is	be	AUX
admet-2057	142	11	frequently	frequently	ADV
admet-2057	142	12	used	use	VERB
admet-2057	142	13	for	for	ADP
admet-2057	142	14	drug	drug	NOUN
admet-2057	142	15	loading	loading	NOUN
admet-2057	142	16	.	.	PUNCT
admet-2057	143	1	drug	drug	NOUN
admet-2057	143	2	and	and	CCONJ
admet-2057	143	3	mof	mof	ADJ
admet-2057	143	4	co	co	NOUN
admet-2057	143	5	-	-	NOUN
admet-2057	143	6	crystallization	crystallization	NOUN
admet-2057	143	7	could	could	AUX
admet-2057	143	8	result	result	VERB
admet-2057	143	9	in	in	ADP
admet-2057	143	10	a	a	DET
admet-2057	143	11	3d	3d	NUM
admet-2057	143	12	supramolecular	supramolecular	ADJ
admet-2057	143	13	structure	structure	NOUN
admet-2057	143	14	incorporating	incorporate	VERB
admet-2057	143	15	the	the	DET
admet-2057	143	16	actives	active	NOUN
admet-2057	143	17	under	under	ADP
admet-2057	143	18	minimal	minimal	ADJ
admet-2057	143	19	reaction	reaction	NOUN
admet-2057	143	20	conditions	condition	NOUN
admet-2057	143	21	.	.	PUNCT
admet-2057	144	1	most	most	ADV
admet-2057	144	2	notably	notably	ADV
admet-2057	144	3	,	,	PUNCT
admet-2057	144	4	co	co	NOUN
admet-2057	144	5	-	-	NOUN
admet-2057	144	6	crystallization	crystallization	NOUN
admet-2057	144	7	does	do	AUX
admet-2057	144	8	not	not	PART
admet-2057	144	9	change	change	VERB
admet-2057	144	10	the	the	DET
admet-2057	144	11	drug	drug	NOUN
admet-2057	144	12	's	's	PART
admet-2057	144	13	physicochemical	physicochemical	ADJ
admet-2057	144	14	characteristics	characteristic	NOUN
admet-2057	144	15	,	,	PUNCT
admet-2057	144	16	which	which	PRON
admet-2057	144	17	can	can	AUX
admet-2057	144	18	be	be	AUX
admet-2057	144	19	utilised	utilise	VERB
admet-2057	144	20	to	to	PART
admet-2057	144	21	increase	increase	VERB
admet-2057	144	22	the	the	DET
admet-2057	144	23	drug	drug	NOUN
admet-2057	144	24	's	's	PART
admet-2057	144	25	solubility	solubility	NOUN
admet-2057	144	26	and	and	CCONJ
admet-2057	144	27	loading	loading	NOUN
admet-2057	144	28	effectiveness	effectiveness	NOUN
admet-2057	144	29	[	[	X
admet-2057	144	30	37	37	NUM
admet-2057	144	31	]	]	PUNCT
admet-2057	144	32	.	.	PUNCT
admet-2057	145	1	terekhova	terekhova	PROPN
admet-2057	145	2	and	and	CCONJ
admet-2057	145	3	colleagues	colleague	NOUN
admet-2057	145	4	[	[	X
admet-2057	145	5	41	41	NUM
admet-2057	145	6	]	]	PUNCT
admet-2057	145	7	demonstrated	demonstrate	VERB
admet-2057	145	8	that	that	SCONJ
admet-2057	145	9	leflunomide	leflunomide	ADJ
admet-2057	145	10	could	could	AUX
admet-2057	145	11	be	be	AUX
admet-2057	145	12	loaded	load	VERB
admet-2057	145	13	into	into	ADP
admet-2057	145	14	γ	γ	PROPN
admet-2057	145	15	-	-	PUNCT
admet-2057	145	16	cd	cd	NOUN
admet-2057	145	17	-	-	PUNCT
admet-2057	145	18	mof	mof	VERB
admet-2057	145	19	by	by	ADP
admet-2057	145	20	impregnation	impregnation	NOUN
admet-2057	145	21	and	and	CCONJ
admet-2057	145	22	co	co	NOUN
admet-2057	145	23	-	-	NOUN
admet-2057	145	24	crystallization	crystallization	NOUN
admet-2057	145	25	strategies	strategy	NOUN
admet-2057	145	26	,	,	PUNCT
admet-2057	145	27	and	and	CCONJ
admet-2057	145	28	the	the	DET
admet-2057	145	29	drug	drug	NOUN
admet-2057	145	30	loading	loading	NOUN
admet-2057	145	31	was	be	AUX
admet-2057	145	32	equivalent	equivalent	ADJ
admet-2057	145	33	to	to	ADP
admet-2057	145	34	or	or	CCONJ
admet-2057	145	35	greater	great	ADJ
admet-2057	145	36	than	than	ADP
admet-2057	145	37	that	that	PRON
admet-2057	145	38	achieved	achieve	VERB
admet-2057	145	39	by	by	ADP
admet-2057	145	40	an	an	DET
admet-2057	145	41	impregnation	impregnation	NOUN
admet-2057	145	42	approach	approach	NOUN
admet-2057	145	43	.	.	PUNCT
admet-2057	146	1	drugs	drug	NOUN
admet-2057	146	2	as	as	ADP
admet-2057	146	3	organic	organic	ADJ
admet-2057	146	4	linkers	linker	NOUN
admet-2057	146	5	for	for	ADP
admet-2057	146	6	mofs	mof	NOUN
admet-2057	146	7	drugs	drug	NOUN
admet-2057	146	8	or	or	CCONJ
admet-2057	146	9	their	their	PRON
admet-2057	146	10	prodrugs	prodrug	NOUN
admet-2057	146	11	could	could	AUX
admet-2057	146	12	act	act	VERB
admet-2057	146	13	as	as	ADP
admet-2057	146	14	organic	organic	ADJ
admet-2057	146	15	ligands	ligand	NOUN
admet-2057	146	16	to	to	PART
admet-2057	146	17	create	create	VERB
admet-2057	146	18	mofs	mof	NOUN
admet-2057	146	19	and	and	CCONJ
admet-2057	146	20	serve	serve	VERB
admet-2057	146	21	as	as	ADP
admet-2057	146	22	mof	mof	ADJ
admet-2057	146	23	reservoirs	reservoir	NOUN
admet-2057	146	24	by	by	ADP
admet-2057	146	25	coordinating	coordinate	VERB
admet-2057	146	26	their	their	PRON
admet-2057	146	27	respective	respective	ADJ
admet-2057	146	28	functionalities	functionality	NOUN
admet-2057	146	29	with	with	ADP
admet-2057	146	30	particular	particular	ADJ
admet-2057	146	31	metal	metal	NOUN
admet-2057	146	32	ions	ion	NOUN
admet-2057	146	33	[	[	X
admet-2057	146	34	37	37	NUM
admet-2057	146	35	]	]	PUNCT
admet-2057	146	36	.	.	PUNCT
admet-2057	147	1	vassaki	vassaki	NOUN
admet-2057	147	2	and	and	CCONJ
admet-2057	147	3	co	co	NOUN
admet-2057	147	4	-	-	NOUN
admet-2057	147	5	worker	worker	NOUN
admet-2057	147	6	’s	’s	PART
admet-2057	147	7	[	[	X
admet-2057	147	8	42	42	NUM
admet-2057	147	9	]	]	PUNCT
admet-2057	147	10	reported	report	VERB
admet-2057	147	11	phosphonate	phosphonate	ADJ
admet-2057	147	12	mof	mof	VERB
admet-2057	147	13	-	-	PUNCT
admet-2057	147	14	based	base	VERB
admet-2057	147	15	drug	drug	NOUN
admet-2057	147	16	delivery	delivery	NOUN
admet-2057	147	17	systems	system	NOUN
admet-2057	147	18	.	.	PUNCT
admet-2057	148	1	they	they	PRON
admet-2057	148	2	used	use	VERB
admet-2057	148	3	a	a	DET
admet-2057	148	4	number	number	NOUN
admet-2057	148	5	of	of	ADP
admet-2057	148	6	anti	anti	ADJ
admet-2057	148	7	-	-	ADJ
admet-2057	148	8	osteoporosis	osteoporosis	ADJ
admet-2057	148	9	bisphosphonate	bisphosphonate	NOUN
admet-2057	148	10	drugs	drug	NOUN
admet-2057	148	11	(	(	PUNCT
admet-2057	148	12	etidronate	etidronate	ADJ
admet-2057	148	13	,	,	PUNCT
admet-2057	148	14	pamidronate	pamidronate	ADJ
admet-2057	148	15	,	,	PUNCT
admet-2057	148	16	alendronate	alendronate	ADJ
admet-2057	148	17	,	,	PUNCT
admet-2057	148	18	and	and	CCONJ
admet-2057	148	19	neridronate	neridronate	NOUN
admet-2057	148	20	)	)	PUNCT
admet-2057	148	21	and	and	CCONJ
admet-2057	148	22	bio	bio	ADJ
admet-2057	148	23	-	-	ADJ
admet-2057	148	24	suitable	suitable	ADJ
admet-2057	148	25	metal	metal	NOUN
admet-2057	148	26	ions	ion	NOUN
admet-2057	148	27	(	(	PUNCT
admet-2057	148	28	such	such	ADJ
admet-2057	148	29	as	as	ADP
admet-2057	148	30	ca2+and	ca2+and	PROPN
admet-2057	148	31	mg2	mg2	PROPN
admet-2057	148	32	+	+	PROPN
admet-2057	148	33	)	)	PUNCT
admet-2057	148	34	as	as	ADP
admet-2057	148	35	the	the	DET
admet-2057	148	36	organic	organic	ADJ
admet-2057	148	37	ligands	ligand	NOUN
admet-2057	148	38	.	.	PUNCT
admet-2057	149	1	two	two	NUM
admet-2057	149	2	-	-	PUNCT
admet-2057	149	3	step	step	NOUN
admet-2057	149	4	the	the	DET
admet-2057	149	5	second	second	ADJ
admet-2057	149	6	method	method	NOUN
admet-2057	149	7	of	of	ADP
admet-2057	149	8	drug	drug	NOUN
admet-2057	149	9	loading	loading	NOUN
admet-2057	149	10	involves	involve	VERB
admet-2057	149	11	encapsulating	encapsulate	VERB
admet-2057	149	12	drugs	drug	NOUN
admet-2057	149	13	within	within	ADP
admet-2057	149	14	the	the	DET
admet-2057	149	15	structure	structure	NOUN
admet-2057	149	16	of	of	ADP
admet-2057	149	17	nmofs	nmof	NOUN
admet-2057	149	18	that	that	PRON
admet-2057	149	19	have	have	AUX
admet-2057	149	20	already	already	ADV
admet-2057	149	21	been	be	AUX
admet-2057	149	22	manufactured	manufacture	VERB
admet-2057	149	23	in	in	ADP
admet-2057	149	24	order	order	NOUN
admet-2057	149	25	to	to	PART
admet-2057	149	26	preserve	preserve	VERB
admet-2057	149	27	particle	particle	NOUN
admet-2057	149	28	form	form	NOUN
admet-2057	149	29	.	.	PUNCT
admet-2057	150	1	drugs	drug	NOUN
admet-2057	150	2	are	be	AUX
admet-2057	150	3	typically	typically	ADV
admet-2057	150	4	predicted	predict	VERB
admet-2057	150	5	to	to	PART
admet-2057	150	6	be	be	AUX
admet-2057	150	7	entrapped	entrap	VERB
admet-2057	150	8	into	into	ADP
admet-2057	150	9	the	the	DET
admet-2057	150	10	scaffolds	scaffold	NOUN
admet-2057	150	11	by	by	ADP
admet-2057	150	12	hydrogen	hydrogen	NOUN
admet-2057	150	13	bonding	bonding	NOUN
admet-2057	150	14	,	,	PUNCT
admet-2057	150	15	interaction	interaction	NOUN
admet-2057	150	16	,	,	PUNCT
admet-2057	150	17	or	or	CCONJ
admet-2057	150	18	other	other	ADJ
admet-2057	150	19	host	host	NOUN
admet-2057	150	20	-	-	PUNCT
admet-2057	150	21	guest	guest	NOUN
admet-2057	150	22	interaction	interaction	NOUN
admet-2057	150	23	when	when	SCONJ
admet-2057	150	24	their	their	PRON
admet-2057	150	25	molecular	molecular	ADJ
admet-2057	150	26	dimensions	dimension	NOUN
admet-2057	150	27	are	be	AUX
admet-2057	150	28	less	less	ADJ
admet-2057	150	29	than	than	ADP
admet-2057	150	30	the	the	DET
admet-2057	150	31	pore	pore	ADJ
admet-2057	150	32	diameter	diameter	NOUN
admet-2057	150	33	of	of	ADP
admet-2057	150	34	nmofs	nmof	NOUN
admet-2057	150	35	.	.	PUNCT
admet-2057	151	1	however	however	ADV
admet-2057	151	2	,	,	PUNCT
admet-2057	151	3	larger	large	ADJ
admet-2057	151	4	molecules	molecule	NOUN
admet-2057	151	5	of	of	ADP
admet-2057	151	6	drugs	drug	NOUN
admet-2057	151	7	with	with	ADP
admet-2057	151	8	opposing	oppose	VERB
admet-2057	151	9	charges	charge	NOUN
admet-2057	151	10	are	be	AUX
admet-2057	151	11	likely	likely	ADJ
admet-2057	151	12	to	to	PART
admet-2057	151	13	be	be	AUX
admet-2057	151	14	adsorbed	adsorb	VERB
admet-2057	151	15	by	by	ADP
admet-2057	151	16	nmofs	nmof	NOUN
admet-2057	151	17	by	by	ADP
admet-2057	151	18	electrostatic	electrostatic	ADJ
admet-2057	151	19	interaction	interaction	NOUN
admet-2057	151	20	[	[	X
admet-2057	151	21	38	38	NUM
admet-2057	151	22	]	]	PUNCT
admet-2057	151	23	.	.	PUNCT
admet-2057	152	1	admet	admet	PROPN
admet-2057	152	2	&	&	CCONJ
admet-2057	152	3	dmpk	dmpk	PROPN
admet-2057	152	4	12(1	12(1	PROPN
admet-2057	152	5	)	)	PUNCT
admet-2057	152	6	(	(	PUNCT
admet-2057	152	7	2024	2024	NUM
admet-2057	152	8	)	)	PUNCT
admet-2057	152	9	27	27	NUM
admet-2057	152	10	-	-	SYM
admet-2057	152	11	62	62	NUM
admet-2057	152	12	drug	drug	NOUN
admet-2057	152	13	delivery	delivery	NOUN
admet-2057	152	14	applications	application	NOUN
admet-2057	152	15	of	of	ADP
admet-2057	152	16	metal	metal	NOUN
admet-2057	152	17	-	-	PUNCT
admet-2057	152	18	organic	organic	ADJ
admet-2057	152	19	framework	framework	NOUN
admet-2057	152	20	doi	doi	NOUN
admet-2057	152	21	:	:	PUNCT
admet-2057	152	22	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	152	23	33	33	NUM
admet-2057	152	24	impregnation	impregnation	NOUN
admet-2057	152	25	due	due	ADP
admet-2057	152	26	to	to	ADP
admet-2057	152	27	their	their	PRON
admet-2057	152	28	porous	porous	ADJ
admet-2057	152	29	structure	structure	NOUN
admet-2057	152	30	and	and	CCONJ
admet-2057	152	31	accessibility	accessibility	NOUN
admet-2057	152	32	to	to	ADP
admet-2057	152	33	metal	metal	NOUN
admet-2057	152	34	ions	ion	NOUN
admet-2057	152	35	and	and	CCONJ
admet-2057	152	36	tiny	tiny	ADJ
admet-2057	152	37	molecules	molecule	NOUN
admet-2057	152	38	,	,	PUNCT
admet-2057	152	39	mofs	mof	NOUN
admet-2057	152	40	can	can	AUX
admet-2057	152	41	be	be	AUX
admet-2057	152	42	impregnated	impregnate	VERB
admet-2057	152	43	with	with	ADP
admet-2057	152	44	precursors	precursor	NOUN
admet-2057	152	45	by	by	ADP
admet-2057	152	46	a	a	DET
admet-2057	152	47	diffusion	diffusion	NOUN
admet-2057	152	48	/	/	SYM
admet-2057	152	49	deposition	deposition	NOUN
admet-2057	152	50	method	method	NOUN
admet-2057	152	51	.	.	PUNCT
admet-2057	153	1	the	the	DET
admet-2057	153	2	process	process	NOUN
admet-2057	153	3	usually	usually	ADV
admet-2057	153	4	entails	entail	VERB
admet-2057	153	5	two	two	NUM
admet-2057	153	6	steps	step	NOUN
admet-2057	153	7	:	:	PUNCT
admet-2057	153	8	the	the	DET
admet-2057	153	9	mof	mof	ADJ
admet-2057	153	10	solids	solid	NOUN
admet-2057	153	11	were	be	AUX
admet-2057	153	12	submerged	submerge	VERB
admet-2057	153	13	in	in	ADP
admet-2057	153	14	the	the	DET
admet-2057	153	15	precursor	precursor	NOUN
admet-2057	153	16	-	-	PUNCT
admet-2057	153	17	containing	contain	VERB
admet-2057	153	18	solution	solution	NOUN
admet-2057	153	19	for	for	ADP
admet-2057	153	20	impregnation	impregnation	NOUN
admet-2057	153	21	,	,	PUNCT
admet-2057	153	22	and	and	CCONJ
admet-2057	153	23	the	the	DET
admet-2057	153	24	precursors	precursor	NOUN
admet-2057	153	25	that	that	PRON
admet-2057	153	26	were	be	AUX
admet-2057	153	27	adsorbed	adsorb	VERB
admet-2057	153	28	either	either	CCONJ
admet-2057	153	29	became	become	VERB
admet-2057	153	30	the	the	DET
admet-2057	153	31	final	final	ADJ
admet-2057	153	32	active	active	ADJ
admet-2057	153	33	species	specie	NOUN
admet-2057	153	34	or	or	CCONJ
admet-2057	153	35	underwent	undergo	VERB
admet-2057	153	36	additional	additional	ADJ
admet-2057	153	37	reactions	reaction	NOUN
admet-2057	153	38	(	(	PUNCT
admet-2057	153	39	by	by	ADP
admet-2057	153	40	reduction	reduction	NOUN
admet-2057	153	41	,	,	PUNCT
admet-2057	153	42	decomposition	decomposition	NOUN
admet-2057	153	43	or	or	CCONJ
admet-2057	153	44	other	other	ADJ
admet-2057	153	45	chemical	chemical	ADJ
admet-2057	153	46	pathways	pathway	NOUN
admet-2057	153	47	)	)	PUNCT
admet-2057	153	48	to	to	PART
admet-2057	153	49	create	create	VERB
admet-2057	153	50	new	new	ADJ
admet-2057	153	51	functional	functional	ADJ
admet-2057	153	52	phases	phase	NOUN
admet-2057	153	53	inside	inside	ADP
admet-2057	153	54	the	the	DET
admet-2057	153	55	mof	mof	ADJ
admet-2057	153	56	matrices	matrix	NOUN
admet-2057	153	57	.	.	PUNCT
admet-2057	154	1	mofs	mof	NOUN
admet-2057	154	2	offer	offer	VERB
admet-2057	154	3	a	a	DET
admet-2057	154	4	constrained	constrain	VERB
admet-2057	154	5	environment	environment	NOUN
admet-2057	154	6	to	to	PART
admet-2057	154	7	restrict	restrict	VERB
admet-2057	154	8	the	the	DET
admet-2057	154	9	expansion	expansion	NOUN
admet-2057	154	10	of	of	ADP
admet-2057	154	11	these	these	DET
admet-2057	154	12	useful	useful	ADJ
admet-2057	154	13	species	specie	NOUN
admet-2057	154	14	and	and	CCONJ
admet-2057	154	15	prevent	prevent	VERB
admet-2057	154	16	their	their	PRON
admet-2057	154	17	aggregation	aggregation	NOUN
admet-2057	154	18	.	.	PUNCT
admet-2057	155	1	as	as	ADP
admet-2057	155	2	a	a	DET
admet-2057	155	3	result	result	NOUN
admet-2057	155	4	,	,	PUNCT
admet-2057	155	5	very	very	ADV
admet-2057	155	6	stable	stable	ADJ
admet-2057	155	7	mofs	mof	NOUN
admet-2057	155	8	are	be	AUX
admet-2057	155	9	frequently	frequently	ADV
admet-2057	155	10	needed	need	VERB
admet-2057	155	11	since	since	SCONJ
admet-2057	155	12	a	a	DET
admet-2057	155	13	series	series	NOUN
admet-2057	155	14	of	of	ADP
admet-2057	155	15	reactions	reaction	NOUN
admet-2057	155	16	may	may	AUX
admet-2057	155	17	be	be	AUX
admet-2057	155	18	required	require	VERB
admet-2057	155	19	before	before	ADP
admet-2057	155	20	the	the	DET
admet-2057	155	21	synthesis	synthesis	NOUN
admet-2057	155	22	of	of	ADP
admet-2057	155	23	final	final	ADJ
admet-2057	155	24	mof	mof	ADJ
admet-2057	155	25	composites	composite	NOUN
admet-2057	156	1	[	[	X
admet-2057	156	2	43	43	NUM
admet-2057	156	3	]	]	PUNCT
admet-2057	156	4	.	.	PUNCT
admet-2057	157	1	devautour	devautour	NOUN
admet-2057	157	2	-	-	PUNCT
admet-2057	157	3	vinot	vinot	PROPN
admet-2057	157	4	et	et	NOUN
admet-2057	157	5	al	al	PROPN
admet-2057	157	6	.	.	PUNCT
admet-2057	158	1	[	[	X
admet-2057	158	2	44	44	NUM
admet-2057	158	3	]	]	PUNCT
admet-2057	158	4	performed	perform	VERB
admet-2057	158	5	caffeine	caffeine	NOUN
admet-2057	158	6	encapsulation	encapsulation	NOUN
admet-2057	158	7	by	by	ADP
admet-2057	158	8	the	the	DET
admet-2057	158	9	simple	simple	ADJ
admet-2057	158	10	impregnation	impregnation	NOUN
admet-2057	158	11	method	method	NOUN
admet-2057	158	12	in	in	ADP
admet-2057	158	13	a	a	DET
admet-2057	158	14	series	series	NOUN
admet-2057	158	15	of	of	ADP
admet-2057	158	16	uio-66(zr)-family	uio-66(zr)-family	ADJ
admet-2057	158	17	mofs	mof	NOUN
admet-2057	158	18	.	.	PUNCT
admet-2057	159	1	mechanochemical	mechanochemical	ADJ
admet-2057	159	2	method	method	NOUN
admet-2057	159	3	this	this	DET
admet-2057	159	4	method	method	NOUN
admet-2057	159	5	involves	involve	VERB
admet-2057	159	6	mechanically	mechanically	ADV
admet-2057	159	7	combining	combine	VERB
admet-2057	159	8	drugs	drug	NOUN
admet-2057	159	9	and	and	CCONJ
admet-2057	159	10	mofs	mof	NOUN
admet-2057	159	11	in	in	ADP
admet-2057	159	12	a	a	DET
admet-2057	159	13	solid	solid	ADJ
admet-2057	159	14	state	state	NOUN
admet-2057	159	15	,	,	PUNCT
admet-2057	159	16	which	which	PRON
admet-2057	159	17	is	be	AUX
admet-2057	159	18	solvent	solvent	NOUN
admet-2057	159	19	-	-	PUNCT
admet-2057	159	20	free	free	ADJ
admet-2057	159	21	,	,	PUNCT
admet-2057	159	22	environmentally	environmentally	ADV
admet-2057	159	23	friendly	friendly	ADJ
admet-2057	159	24	,	,	PUNCT
admet-2057	159	25	and	and	CCONJ
admet-2057	159	26	cost	cost	NOUN
admet-2057	159	27	-	-	PUNCT
admet-2057	159	28	effective	effective	ADJ
admet-2057	159	29	[	[	X
admet-2057	159	30	37	37	NUM
admet-2057	159	31	]	]	PUNCT
admet-2057	159	32	.	.	PUNCT
admet-2057	160	1	nadizadeh	nadizadeh	NOUN
admet-2057	160	2	et	et	PROPN
admet-2057	160	3	al	al	PROPN
admet-2057	160	4	.	.	PUNCT
admet-2057	161	1	[	[	X
admet-2057	161	2	45	45	NUM
admet-2057	161	3	]	]	PUNCT
admet-2057	161	4	synthesized	synthesize	VERB
admet-2057	161	5	,	,	PUNCT
admet-2057	161	6	ibuprofen	ibuprofen	NOUN
admet-2057	161	7	(	(	PUNCT
admet-2057	161	8	ibu	ibu	PROPN
admet-2057	161	9	)	)	PUNCT
admet-2057	161	10	-loadednmofs	-loadednmof	NOUN
admet-2057	161	11	{	{	PUNCT
admet-2057	161	12	cu2(1,4	cu2(1,4	NOUN
admet-2057	161	13	-	-	PUNCT
admet-2057	161	14	bdc)2(dabco)}n	bdc)2(dabco)}n	NOUN
admet-2057	161	15	and	and	CCONJ
admet-2057	161	16	{	{	PUNCT
admet-2057	161	17	cu2(1,4	cu2(1,4	NOUN
admet-2057	161	18	-	-	PUNCT
admet-2057	161	19	bdcnh2)2(dabco)}n	bdcnh2)2(dabco)}n	NOUN
admet-2057	161	20	(	(	PUNCT
admet-2057	161	21	bdc	bdc	NOUN
admet-2057	161	22	=	=	NOUN
admet-2057	161	23	benzenedicarboxilic	benzenedicarboxilic	NOUN
admet-2057	161	24	acid	acid	NOUN
admet-2057	161	25	,	,	PUNCT
admet-2057	161	26	and	and	CCONJ
admet-2057	161	27	dabco	dabco	NOUN
admet-2057	161	28	=	=	NOUN
admet-2057	161	29	diazabicyclooctane	diazabicyclooctane	NOUN
admet-2057	161	30	)	)	PUNCT
admet-2057	161	31	by	by	ADP
admet-2057	161	32	ball	ball	NOUN
admet-2057	161	33	-	-	PUNCT
admet-2057	161	34	milling	milling	NOUN
admet-2057	161	35	at	at	ADP
admet-2057	161	36	room	room	NOUN
admet-2057	161	37	temperature	temperature	NOUN
admet-2057	161	38	in	in	ADP
admet-2057	161	39	2	2	NUM
admet-2057	161	40	hours	hour	NOUN
admet-2057	161	41	.	.	PUNCT
admet-2057	162	1	noorian	noorian	PROPN
admet-2057	162	2	et	et	PROPN
admet-2057	162	3	al	al	PROPN
admet-2057	162	4	.	.	PUNCT
admet-2057	163	1	[	[	X
admet-2057	163	2	46	46	NUM
admet-2057	163	3	]	]	PUNCT
admet-2057	163	4	used	use	VERB
admet-2057	163	5	a	a	DET
admet-2057	163	6	simple	simple	ADJ
admet-2057	163	7	ball	ball	NOUN
admet-2057	163	8	milling	milling	NOUN
admet-2057	163	9	technique	technique	NOUN
admet-2057	163	10	to	to	PART
admet-2057	163	11	load	load	VERB
admet-2057	163	12	the	the	DET
admet-2057	163	13	model	model	NOUN
admet-2057	163	14	drugs	drug	NOUN
admet-2057	163	15	5	5	NUM
admet-2057	163	16	-	-	PUNCT
admet-2057	163	17	fluorouracil	fluorouracil	NOUN
admet-2057	163	18	,	,	PUNCT
admet-2057	163	19	caffeine	caffeine	NOUN
admet-2057	163	20	,	,	PUNCT
admet-2057	163	21	para	para	NOUN
admet-2057	163	22	-	-	PUNCT
admet-2057	163	23	aminobenzoic	aminobenzoic	NOUN
admet-2057	163	24	acid	acid	NOUN
admet-2057	163	25	,	,	PUNCT
admet-2057	163	26	and	and	CCONJ
admet-2057	163	27	benzocaine	benzocaine	NOUN
admet-2057	163	28	efficiently	efficiently	ADV
admet-2057	163	29	.	.	PUNCT
admet-2057	164	1	covalent	covalent	NOUN
admet-2057	164	2	binding	bind	VERB
admet-2057	164	3	the	the	DET
admet-2057	164	4	covalent	covalent	NOUN
admet-2057	164	5	binding	bind	VERB
admet-2057	164	6	method	method	NOUN
admet-2057	164	7	uses	use	VERB
admet-2057	164	8	organic	organic	ADJ
admet-2057	164	9	linkers	linker	NOUN
admet-2057	164	10	and	and	CCONJ
admet-2057	164	11	inorganic	inorganic	ADJ
admet-2057	164	12	metal	metal	NOUN
admet-2057	164	13	clusters	cluster	NOUN
admet-2057	164	14	to	to	PART
admet-2057	164	15	form	form	VERB
admet-2057	164	16	covalent	covalent	ADJ
admet-2057	164	17	bonds	bond	NOUN
admet-2057	164	18	in	in	ADP
admet-2057	164	19	the	the	DET
admet-2057	164	20	mof	mof	ADJ
admet-2057	164	21	structure	structure	NOUN
admet-2057	164	22	.	.	PUNCT
admet-2057	165	1	even	even	ADV
admet-2057	165	2	though	though	SCONJ
admet-2057	165	3	the	the	DET
admet-2057	165	4	attractive	attractive	ADJ
admet-2057	165	5	technique	technique	NOUN
admet-2057	165	6	inserts	insert	VERB
admet-2057	165	7	different	different	ADJ
admet-2057	165	8	cargos	cargo	NOUN
admet-2057	165	9	into	into	ADP
admet-2057	165	10	mofs	mof	NOUN
admet-2057	165	11	,	,	PUNCT
admet-2057	165	12	there	there	PRON
admet-2057	165	13	are	be	VERB
admet-2057	165	14	frequently	frequently	ADV
admet-2057	165	15	issues	issue	NOUN
admet-2057	165	16	with	with	ADP
admet-2057	165	17	the	the	DET
admet-2057	165	18	drugs	drug	NOUN
admet-2057	165	19	slowly	slowly	ADV
admet-2057	165	20	leaking	leak	VERB
admet-2057	165	21	out	out	ADP
admet-2057	165	22	due	due	ADP
admet-2057	165	23	to	to	ADP
admet-2057	165	24	the	the	DET
admet-2057	165	25	very	very	ADV
admet-2057	165	26	weak	weak	ADJ
admet-2057	165	27	interaction	interaction	NOUN
admet-2057	165	28	force	force	NOUN
admet-2057	165	29	between	between	ADP
admet-2057	165	30	the	the	DET
admet-2057	165	31	drugs	drug	NOUN
admet-2057	165	32	and	and	CCONJ
admet-2057	165	33	mofs	mof	NOUN
admet-2057	165	34	[	[	X
admet-2057	165	35	37	37	NUM
admet-2057	165	36	]	]	PUNCT
admet-2057	165	37	.	.	PUNCT
admet-2057	166	1	morris	morris	PROPN
admet-2057	166	2	et	et	PROPN
admet-2057	166	3	al	al	PROPN
admet-2057	166	4	.	.	PUNCT
admet-2057	167	1	[	[	X
admet-2057	167	2	47	47	NUM
admet-2057	167	3	]	]	PUNCT
admet-2057	167	4	developed	develop	VERB
admet-2057	167	5	the	the	DET
admet-2057	167	6	uio-66	uio-66	PROPN
admet-2057	167	7	-	-	PUNCT
admet-2057	167	8	n3	n3	ADJ
admet-2057	167	9	(	(	PUNCT
admet-2057	167	10	zr6o4oh4(c8h3o4n3)6	zr6o4oh4(c8h3o4n3)6	PROPN
admet-2057	167	11	)	)	PUNCT
admet-2057	167	12	nanostructures	nanostructure	NOUN
admet-2057	167	13	of	of	ADP
admet-2057	167	14	a	a	DET
admet-2057	167	15	mof	mof	NOUN
admet-2057	167	16	.	.	PUNCT
admet-2057	167	17	using	use	VERB
admet-2057	167	18	a	a	DET
admet-2057	167	19	strainpromoted	strainpromote	VERB
admet-2057	167	20	click	click	NOUN
admet-2057	167	21	reaction	reaction	NOUN
admet-2057	167	22	,	,	PUNCT
admet-2057	167	23	oligonucleotides	oligonucleotide	NOUN
admet-2057	167	24	were	be	AUX
admet-2057	167	25	covalently	covalently	ADV
admet-2057	167	26	functionalized	functionalize	VERB
admet-2057	167	27	onto	onto	ADP
admet-2057	167	28	the	the	DET
admet-2057	167	29	mof	mof	NOUN
admet-2057	167	30	's	's	PART
admet-2057	167	31	surface	surface	NOUN
admet-2057	167	32	.	.	PUNCT
admet-2057	168	1	formulation	formulation	NOUN
admet-2057	168	2	development	development	NOUN
admet-2057	168	3	for	for	ADP
admet-2057	168	4	mof	mof	NUM
admet-2057	168	5	as	as	SCONJ
admet-2057	168	6	previously	previously	ADV
admet-2057	168	7	reported	report	VERB
admet-2057	168	8	,	,	PUNCT
admet-2057	168	9	controlling	control	VERB
admet-2057	168	10	particle	particle	NOUN
admet-2057	168	11	size	size	NOUN
admet-2057	168	12	is	be	AUX
admet-2057	168	13	an	an	DET
admet-2057	168	14	important	important	ADJ
admet-2057	168	15	constraint	constraint	NOUN
admet-2057	168	16	in	in	ADP
admet-2057	168	17	the	the	DET
admet-2057	168	18	field	field	NOUN
admet-2057	168	19	of	of	ADP
admet-2057	168	20	biomedicine	biomedicine	NOUN
admet-2057	168	21	,	,	PUNCT
admet-2057	168	22	particularly	particularly	ADV
admet-2057	168	23	when	when	SCONJ
admet-2057	168	24	taking	take	VERB
admet-2057	168	25	into	into	ADP
admet-2057	168	26	account	account	NOUN
admet-2057	168	27	how	how	SCONJ
admet-2057	168	28	they	they	PRON
admet-2057	168	29	are	be	AUX
admet-2057	168	30	administered	administer	VERB
admet-2057	168	31	via	via	ADP
admet-2057	168	32	the	the	DET
admet-2057	168	33	most	most	ADV
admet-2057	168	34	popular	popular	ADJ
admet-2057	168	35	routes	route	NOUN
admet-2057	168	36	(	(	PUNCT
admet-2057	168	37	e.g.	e.g.	ADV
admet-2057	168	38	,	,	PUNCT
admet-2057	168	39	oral	oral	ADJ
admet-2057	168	40	,	,	PUNCT
admet-2057	168	41	intravenous	intravenous	ADJ
admet-2057	168	42	,	,	PUNCT
admet-2057	168	43	intranasal	intranasal	NOUN
admet-2057	168	44	,	,	PUNCT
admet-2057	168	45	cutaneous	cutaneous	ADJ
admet-2057	168	46	,	,	PUNCT
admet-2057	168	47	ophthalmic	ophthalmic	ADJ
admet-2057	168	48	,	,	PUNCT
admet-2057	168	49	otic	otic	NOUN
admet-2057	168	50	,	,	PUNCT
admet-2057	168	51	and	and	CCONJ
admet-2057	168	52	so	so	ADV
admet-2057	168	53	on	on	ADV
admet-2057	168	54	)	)	PUNCT
admet-2057	169	1	[	[	X
admet-2057	169	2	48	48	NUM
admet-2057	169	3	]	]	PUNCT
admet-2057	169	4	.	.	PUNCT
admet-2057	170	1	the	the	DET
admet-2057	170	2	nps	nps	PROPN
admet-2057	170	3	'	'	PART
admet-2057	170	4	physicochemical	physicochemical	ADJ
admet-2057	170	5	characterristics	characterristic	NOUN
admet-2057	170	6	,	,	PUNCT
admet-2057	170	7	such	such	ADJ
admet-2057	170	8	as	as	ADP
admet-2057	170	9	particle	particle	NOUN
admet-2057	170	10	size	size	NOUN
admet-2057	170	11	,	,	PUNCT
admet-2057	170	12	surface	surface	NOUN
admet-2057	170	13	charge	charge	NOUN
admet-2057	170	14	,	,	PUNCT
admet-2057	170	15	rheological	rheological	ADJ
admet-2057	170	16	characteristics	characteristic	NOUN
admet-2057	170	17	,	,	PUNCT
admet-2057	170	18	and	and	CCONJ
admet-2057	170	19	colloidal	colloidal	NOUN
admet-2057	170	20	stability	stability	NOUN
admet-2057	170	21	,	,	PUNCT
admet-2057	170	22	will	will	AUX
admet-2057	170	23	dictate	dictate	VERB
admet-2057	170	24	how	how	SCONJ
admet-2057	170	25	well	well	ADV
admet-2057	170	26	they	they	PRON
admet-2057	170	27	interact	interact	VERB
admet-2057	170	28	with	with	ADP
admet-2057	170	29	various	various	ADJ
admet-2057	170	30	biological	biological	ADJ
admet-2057	170	31	components	component	NOUN
admet-2057	170	32	and/or	and/or	CCONJ
admet-2057	170	33	frameworks	framework	NOUN
admet-2057	170	34	(	(	PUNCT
admet-2057	170	35	formulations	formulation	NOUN
admet-2057	170	36	)	)	PUNCT
admet-2057	170	37	,	,	PUNCT
admet-2057	170	38	how	how	SCONJ
admet-2057	170	39	they	they	PRON
admet-2057	170	40	are	be	AUX
admet-2057	170	41	distributed	distribute	VERB
admet-2057	170	42	in	in	ADP
admet-2057	170	43	the	the	DET
admet-2057	170	44	body	body	NOUN
admet-2057	170	45	,	,	PUNCT
admet-2057	170	46	and	and	CCONJ
admet-2057	170	47	how	how	SCONJ
admet-2057	170	48	effective	effective	ADJ
admet-2057	170	49	they	they	PRON
admet-2057	170	50	are	be	AUX
admet-2057	170	51	.	.	PUNCT
admet-2057	171	1	as	as	ADP
admet-2057	171	2	a	a	DET
admet-2057	171	3	result	result	NOUN
admet-2057	171	4	,	,	PUNCT
admet-2057	171	5	careful	careful	ADJ
admet-2057	171	6	control	control	NOUN
admet-2057	171	7	over	over	ADP
admet-2057	171	8	the	the	DET
admet-2057	171	9	particle	particle	NOUN
admet-2057	171	10	size	size	NOUN
admet-2057	171	11	yields	yield	VERB
admet-2057	171	12	a	a	DET
admet-2057	171	13	necessary	necessary	ADJ
admet-2057	171	14	foundation	foundation	NOUN
admet-2057	171	15	for	for	ADP
admet-2057	171	16	successfully	successfully	ADV
admet-2057	171	17	implementing	implement	VERB
admet-2057	171	18	any	any	DET
admet-2057	171	19	form	form	NOUN
admet-2057	171	20	of	of	ADP
admet-2057	171	21	nps	nps	PROPN
admet-2057	171	22	in	in	ADP
admet-2057	171	23	biological	biological	ADJ
admet-2057	171	24	applications	application	NOUN
admet-2057	171	25	[	[	X
admet-2057	171	26	49	49	NUM
admet-2057	171	27	]	]	PUNCT
admet-2057	171	28	.	.	PUNCT
admet-2057	172	1	in	in	ADP
admet-2057	172	2	the	the	DET
admet-2057	172	3	case	case	NOUN
admet-2057	172	4	of	of	ADP
admet-2057	172	5	nmofs	nmof	NOUN
admet-2057	172	6	as	as	ADP
admet-2057	172	7	nanocarriers	nanocarrier	NOUN
admet-2057	172	8	for	for	ADP
admet-2057	172	9	the	the	DET
admet-2057	172	10	delivery	delivery	NOUN
admet-2057	172	11	of	of	ADP
admet-2057	172	12	therapeutics	therapeutic	NOUN
admet-2057	172	13	,	,	PUNCT
admet-2057	172	14	recent	recent	ADJ
admet-2057	172	15	studies	study	NOUN
admet-2057	172	16	have	have	AUX
admet-2057	172	17	concentrated	concentrate	VERB
admet-2057	172	18	on	on	ADP
admet-2057	172	19	morphology	morphology	NOUN
admet-2057	172	20	,	,	PUNCT
admet-2057	172	21	particle	particle	NOUN
admet-2057	172	22	size	size	NOUN
admet-2057	172	23	,	,	PUNCT
admet-2057	172	24	and	and	CCONJ
admet-2057	172	25	particle	particle	NOUN
admet-2057	172	26	size	size	NOUN
admet-2057	172	27	distribution	distribution	NOUN
admet-2057	172	28	,	,	PUNCT
admet-2057	172	29	which	which	PRON
admet-2057	172	30	determine	determine	VERB
admet-2057	172	31	the	the	DET
admet-2057	172	32	final	final	ADJ
admet-2057	172	33	formulation	formulation	NOUN
admet-2057	172	34	according	accord	VERB
admet-2057	172	35	to	to	ADP
admet-2057	172	36	the	the	DET
admet-2057	172	37	route	route	NOUN
admet-2057	172	38	of	of	ADP
admet-2057	172	39	administration	administration	NOUN
admet-2057	172	40	[	[	X
admet-2057	172	41	48	48	NUM
admet-2057	172	42	]	]	PUNCT
admet-2057	172	43	.	.	PUNCT
admet-2057	173	1	as	as	SCONJ
admet-2057	173	2	previously	previously	ADV
admet-2057	173	3	mentioned	mention	VERB
admet-2057	173	4	,	,	PUNCT
admet-2057	173	5	controlling	control	VERB
admet-2057	173	6	particle	particle	NOUN
admet-2057	173	7	size	size	NOUN
admet-2057	173	8	is	be	AUX
admet-2057	173	9	the	the	DET
admet-2057	173	10	biggest	big	ADJ
admet-2057	173	11	task	task	NOUN
admet-2057	173	12	during	during	ADP
admet-2057	173	13	the	the	DET
admet-2057	173	14	administration	administration	NOUN
admet-2057	173	15	of	of	ADP
admet-2057	173	16	the	the	DET
admet-2057	173	17	formulation	formulation	NOUN
admet-2057	173	18	via	via	ADP
admet-2057	173	19	various	various	ADJ
admet-2057	173	20	routes	route	NOUN
admet-2057	173	21	,	,	PUNCT
admet-2057	173	22	and	and	CCONJ
admet-2057	173	23	it	it	PRON
admet-2057	173	24	is	be	AUX
admet-2057	173	25	also	also	ADV
admet-2057	173	26	important	important	ADJ
admet-2057	173	27	to	to	PART
admet-2057	173	28	design	design	VERB
admet-2057	173	29	a	a	DET
admet-2057	173	30	stable	stable	ADJ
admet-2057	173	31	and	and	CCONJ
admet-2057	173	32	reproducible	reproducible	ADJ
admet-2057	173	33	formulation	formulation	NOUN
admet-2057	173	34	.	.	PUNCT
admet-2057	174	1	when	when	SCONJ
admet-2057	174	2	administering	administer	VERB
admet-2057	174	3	nmofs	nmof	NOUN
admet-2057	174	4	in	in	ADP
admet-2057	174	5	vivo	vivo	NOUN
admet-2057	174	6	,	,	PUNCT
admet-2057	174	7	specific	specific	ADJ
admet-2057	174	8	sets	set	NOUN
admet-2057	174	9	of	of	ADP
admet-2057	174	10	criteria	criterion	NOUN
admet-2057	174	11	must	must	AUX
admet-2057	174	12	be	be	AUX
admet-2057	174	13	met	meet	VERB
admet-2057	174	14	in	in	ADP
admet-2057	174	15	order	order	NOUN
admet-2057	174	16	to	to	PART
admet-2057	174	17	prevent	prevent	VERB
admet-2057	174	18	embolism	embolism	NOUN
admet-2057	174	19	,	,	PUNCT
admet-2057	174	20	including	include	VERB
admet-2057	174	21	uniform	uniform	ADJ
admet-2057	174	22	particle	particle	NOUN
admet-2057	174	23	sizes	size	NOUN
admet-2057	174	24	(	(	PUNCT
admet-2057	174	25	˂200	˂200	PROPN
admet-2057	174	26	nm	nm	NOUN
admet-2057	174	27	)	)	PUNCT
admet-2057	174	28	and	and	CCONJ
admet-2057	174	29	highly	highly	ADV
admet-2057	174	30	stable	stable	ADJ
admet-2057	174	31	water	water	NOUN
admet-2057	174	32	-	-	PUNCT
admet-2057	174	33	based	base	VERB
admet-2057	174	34	suspensions	suspension	NOUN
admet-2057	174	35	(	(	PUNCT
admet-2057	174	36	free	free	ADJ
admet-2057	174	37	of	of	ADP
admet-2057	174	38	aggregates	aggregate	NOUN
admet-2057	174	39	or	or	CCONJ
admet-2057	174	40	precipitation	precipitation	NOUN
admet-2057	174	41	)	)	PUNCT
admet-2057	175	1	[	[	X
admet-2057	175	2	50	50	NUM
admet-2057	175	3	]	]	PUNCT
admet-2057	175	4	.	.	PUNCT
admet-2057	176	1	in	in	ADP
admet-2057	176	2	the	the	DET
admet-2057	176	3	case	case	NOUN
admet-2057	176	4	of	of	ADP
admet-2057	176	5	optimisation	optimisation	NOUN
admet-2057	176	6	of	of	ADP
admet-2057	176	7	mofs	mof	NOUN
admet-2057	176	8	by	by	ADP
admet-2057	176	9	the	the	DET
admet-2057	176	10	doe	doe	NOUN
admet-2057	176	11	approach	approach	NOUN
admet-2057	176	12	,	,	PUNCT
admet-2057	176	13	mofs	mof	NOUN
admet-2057	176	14	are	be	AUX
admet-2057	176	15	promising	promise	VERB
admet-2057	176	16	candidates	candidate	NOUN
admet-2057	176	17	for	for	ADP
admet-2057	176	18	doe	doe	NOUN
admet-2057	176	19	applications	application	NOUN
admet-2057	176	20	.	.	PUNCT
admet-2057	177	1	by	by	ADP
admet-2057	177	2	properly	properly	ADV
admet-2057	177	3	optimising	optimise	VERB
admet-2057	177	4	synthesis	synthesis	NOUN
admet-2057	177	5	parameters	parameter	NOUN
admet-2057	177	6	,	,	PUNCT
admet-2057	177	7	including	include	VERB
admet-2057	177	8	residence	residence	NOUN
admet-2057	177	9	time	time	NOUN
admet-2057	177	10	,	,	PUNCT
admet-2057	177	11	linker	linker	NOUN
admet-2057	177	12	concentration	concentration	NOUN
admet-2057	177	13	,	,	PUNCT
admet-2057	177	14	metal	metal	NOUN
admet-2057	177	15	/	/	SYM
admet-2057	177	16	linker	linker	NOUN
admet-2057	177	17	volumetric	volumetric	NOUN
admet-2057	177	18	ratio	ratio	NOUN
admet-2057	177	19	,	,	PUNCT
admet-2057	177	20	and	and	CCONJ
admet-2057	177	21	solvent	solvent	NOUN
admet-2057	177	22	selection	selection	NOUN
admet-2057	177	23	,	,	PUNCT
admet-2057	177	24	there	there	PRON
admet-2057	177	25	are	be	VERB
admet-2057	177	26	multiple	multiple	ADJ
admet-2057	177	27	orders	order	NOUN
admet-2057	177	28	of	of	ADP
admet-2057	177	29	magnitude	magnitude	NOUN
admet-2057	177	30	[	[	X
admet-2057	177	31	51	51	NUM
admet-2057	177	32	]	]	PUNCT
admet-2057	177	33	.	.	PUNCT
admet-2057	178	1	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	178	2	p.	p.	NOUN
admet-2057	178	3	mhettar	mhettar	NOUN
admet-2057	178	4	et	et	PROPN
admet-2057	178	5	al	al	PROPN
admet-2057	178	6	.	.	PROPN
admet-2057	178	7	admet	admet	PROPN
admet-2057	178	8	&	&	CCONJ
admet-2057	178	9	dmpk	dmpk	PROPN
admet-2057	178	10	12(1	12(1	PROPN
admet-2057	178	11	)	)	PUNCT
admet-2057	178	12	(	(	PUNCT
admet-2057	178	13	2024	2024	NUM
admet-2057	178	14	)	)	PUNCT
admet-2057	178	15	27	27	NUM
admet-2057	178	16	-	-	SYM
admet-2057	178	17	62	62	NUM
admet-2057	178	18	34	34	NUM
admet-2057	178	19	design	design	NOUN
admet-2057	178	20	of	of	ADP
admet-2057	178	21	experiment	experiment	NOUN
admet-2057	178	22	to	to	PART
admet-2057	178	23	develop	develop	VERB
admet-2057	178	24	an	an	DET
admet-2057	178	25	effective	effective	ADJ
admet-2057	178	26	formulation	formulation	NOUN
admet-2057	178	27	of	of	ADP
admet-2057	178	28	any	any	DET
admet-2057	178	29	drug	drug	NOUN
admet-2057	178	30	,	,	PUNCT
admet-2057	178	31	the	the	DET
admet-2057	178	32	screening	screening	NOUN
admet-2057	178	33	and	and	CCONJ
admet-2057	178	34	optimisation	optimisation	NOUN
admet-2057	178	35	of	of	ADP
admet-2057	178	36	components	component	NOUN
admet-2057	178	37	involved	involve	VERB
admet-2057	178	38	in	in	ADP
admet-2057	178	39	it	it	PRON
admet-2057	178	40	are	be	AUX
admet-2057	178	41	extremely	extremely	ADV
admet-2057	178	42	crucial	crucial	ADJ
admet-2057	178	43	.	.	PUNCT
admet-2057	179	1	they	they	PRON
admet-2057	179	2	also	also	ADV
admet-2057	179	3	need	need	VERB
admet-2057	179	4	to	to	PART
admet-2057	179	5	be	be	AUX
admet-2057	179	6	optimized	optimize	VERB
admet-2057	179	7	to	to	PART
admet-2057	179	8	identify	identify	VERB
admet-2057	179	9	and	and	CCONJ
admet-2057	179	10	screen	screen	VERB
admet-2057	179	11	the	the	DET
admet-2057	179	12	various	various	ADJ
admet-2057	179	13	parameters	parameter	NOUN
admet-2057	179	14	that	that	PRON
admet-2057	179	15	are	be	AUX
admet-2057	179	16	likely	likely	ADJ
admet-2057	179	17	to	to	PART
admet-2057	179	18	impact	impact	VERB
admet-2057	179	19	the	the	DET
admet-2057	179	20	final	final	ADJ
admet-2057	179	21	formulation	formulation	NOUN
admet-2057	179	22	.	.	PUNCT
admet-2057	180	1	to	to	PART
admet-2057	180	2	optimise	optimise	VERB
admet-2057	180	3	formulation	formulation	NOUN
admet-2057	180	4	,	,	PUNCT
admet-2057	180	5	the	the	DET
admet-2057	180	6	most	most	ADV
admet-2057	180	7	popular	popular	ADJ
admet-2057	180	8	design	design	NOUN
admet-2057	180	9	of	of	ADP
admet-2057	180	10	experiment	experiment	NOUN
admet-2057	180	11	(	(	PUNCT
admet-2057	180	12	doe	doe	NOUN
admet-2057	180	13	)	)	PUNCT
admet-2057	180	14	tools	tool	NOUN
admet-2057	180	15	have	have	AUX
admet-2057	180	16	been	be	AUX
admet-2057	180	17	used	use	VERB
admet-2057	180	18	.	.	PUNCT
admet-2057	181	1	in	in	ADP
admet-2057	181	2	this	this	DET
admet-2057	181	3	regard	regard	NOUN
admet-2057	181	4	,	,	PUNCT
admet-2057	181	5	understanding	understanding	NOUN
admet-2057	181	6	and	and	CCONJ
admet-2057	181	7	optimising	optimise	VERB
admet-2057	181	8	the	the	DET
admet-2057	181	9	variables	variable	NOUN
admet-2057	181	10	that	that	PRON
admet-2057	181	11	affect	affect	VERB
admet-2057	181	12	the	the	DET
admet-2057	181	13	production	production	NOUN
admet-2057	181	14	of	of	ADP
admet-2057	181	15	nps	nps	PROPN
admet-2057	181	16	has	have	AUX
admet-2057	181	17	been	be	AUX
admet-2057	181	18	facilitated	facilitate	VERB
admet-2057	181	19	by	by	ADP
admet-2057	181	20	focusing	focus	VERB
admet-2057	181	21	on	on	ADP
admet-2057	181	22	quality	quality	NOUN
admet-2057	181	23	manufacturing	manufacturing	NOUN
admet-2057	181	24	.	.	PUNCT
admet-2057	182	1	doe	doe	NOUN
admet-2057	182	2	techniques	technique	NOUN
admet-2057	182	3	have	have	AUX
admet-2057	182	4	been	be	AUX
admet-2057	182	5	used	use	VERB
admet-2057	182	6	to	to	ADP
admet-2057	182	7	this	this	DET
admet-2057	182	8	end	end	NOUN
admet-2057	182	9	to	to	PART
admet-2057	182	10	produce	produce	VERB
admet-2057	182	11	high	high	ADJ
admet-2057	182	12	-	-	PUNCT
admet-2057	182	13	quality	quality	NOUN
admet-2057	182	14	formulations	formulation	NOUN
admet-2057	182	15	by	by	ADP
admet-2057	182	16	learning	learn	VERB
admet-2057	182	17	sufficient	sufficient	ADJ
admet-2057	182	18	about	about	ADP
admet-2057	182	19	the	the	DET
admet-2057	182	20	process	process	NOUN
admet-2057	182	21	[	[	X
admet-2057	182	22	52	52	NUM
admet-2057	182	23	]	]	PUNCT
admet-2057	182	24	.	.	PUNCT
admet-2057	183	1	doe	doe	NOUN
admet-2057	183	2	is	be	AUX
admet-2057	183	3	a	a	DET
admet-2057	183	4	potent	potent	ADJ
admet-2057	183	5	tool	tool	NOUN
admet-2057	183	6	that	that	PRON
admet-2057	183	7	particularly	particularly	ADV
admet-2057	183	8	seeks	seek	VERB
admet-2057	183	9	to	to	PART
admet-2057	183	10	optimise	optimise	VERB
admet-2057	183	11	and	and	CCONJ
admet-2057	183	12	reduce	reduce	VERB
admet-2057	183	13	the	the	DET
admet-2057	183	14	number	number	NOUN
admet-2057	183	15	of	of	ADP
admet-2057	183	16	trials	trial	NOUN
admet-2057	183	17	statistically	statistically	ADV
admet-2057	183	18	,	,	PUNCT
admet-2057	183	19	recognise	recognise	VERB
admet-2057	183	20	the	the	DET
admet-2057	183	21	impact	impact	NOUN
admet-2057	183	22	of	of	ADP
admet-2057	183	23	the	the	DET
admet-2057	183	24	explored	explore	VERB
admet-2057	183	25	variables	variable	NOUN
admet-2057	183	26	on	on	ADP
admet-2057	183	27	the	the	DET
admet-2057	183	28	results	result	NOUN
admet-2057	183	29	,	,	PUNCT
admet-2057	183	30	and	and	CCONJ
admet-2057	183	31	anticipate	anticipate	VERB
admet-2057	183	32	the	the	DET
admet-2057	183	33	response	response	NOUN
admet-2057	183	34	of	of	ADP
admet-2057	183	35	unproven	unproven	ADJ
admet-2057	183	36	circumstances	circumstance	NOUN
admet-2057	183	37	within	within	ADP
admet-2057	183	38	the	the	DET
admet-2057	183	39	range	range	NOUN
admet-2057	183	40	of	of	ADP
admet-2057	183	41	the	the	DET
admet-2057	183	42	investigated	investigate	VERB
admet-2057	183	43	experimental	experimental	ADJ
admet-2057	183	44	areas	area	NOUN
admet-2057	183	45	[	[	X
admet-2057	183	46	51	51	NUM
admet-2057	183	47	]	]	PUNCT
admet-2057	183	48	.	.	PUNCT
admet-2057	184	1	regarding	regard	VERB
admet-2057	184	2	mof	mof	ADJ
admet-2057	184	3	formulation	formulation	NOUN
admet-2057	184	4	optimisation	optimisation	NOUN
admet-2057	184	5	,	,	PUNCT
admet-2057	184	6	the	the	DET
admet-2057	184	7	process	process	NOUN
admet-2057	184	8	of	of	ADP
admet-2057	184	9	optimisation	optimisation	NOUN
admet-2057	184	10	started	start	VERB
admet-2057	184	11	with	with	ADP
admet-2057	184	12	the	the	DET
admet-2057	184	13	synthesis	synthesis	NOUN
admet-2057	184	14	of	of	ADP
admet-2057	184	15	mofs	mof	NOUN
admet-2057	184	16	.	.	PUNCT
admet-2057	185	1	yingpeng	yingpeng	PROPN
admet-2057	185	2	li	li	PROPN
admet-2057	185	3	and	and	CCONJ
admet-2057	185	4	co	co	NOUN
admet-2057	185	5	-	-	NOUN
admet-2057	185	6	workers	worker	NOUN
admet-2057	185	7	[	[	X
admet-2057	185	8	53	53	NUM
admet-2057	185	9	]	]	PUNCT
admet-2057	185	10	designed	design	VERB
admet-2057	185	11	the	the	DET
admet-2057	185	12	hong	hong	PROPN
admet-2057	185	13	kong	kong	PROPN
admet-2057	185	14	university	university	PROPN
admet-2057	185	15	of	of	ADP
admet-2057	185	16	science	science	NOUN
admet-2057	185	17	and	and	CCONJ
admet-2057	185	18	technology	technology	NOUN
admet-2057	185	19	hkust-1	hkust-1	PROPN
admet-2057	185	20	for	for	ADP
admet-2057	185	21	the	the	DET
admet-2057	185	22	efficient	efficient	ADJ
admet-2057	185	23	delivery	delivery	NOUN
admet-2057	185	24	of	of	ADP
admet-2057	185	25	5	5	NUM
admet-2057	185	26	-	-	PUNCT
admet-2057	185	27	fu	fu	NOUN
admet-2057	185	28	.	.	PUNCT
admet-2057	186	1	researchers	researcher	NOUN
admet-2057	186	2	employed	employ	VERB
admet-2057	186	3	a	a	DET
admet-2057	186	4	central	central	ADJ
admet-2057	186	5	composite	composite	ADJ
admet-2057	186	6	design	design	NOUN
admet-2057	186	7	to	to	PART
admet-2057	186	8	optimise	optimise	VERB
admet-2057	186	9	the	the	DET
admet-2057	186	10	percent	percent	NOUN
admet-2057	186	11	drug	drug	NOUN
admet-2057	186	12	loading	loading	NOUN
admet-2057	186	13	.	.	PUNCT
admet-2057	187	1	they	they	PRON
admet-2057	187	2	employed	employ	VERB
admet-2057	187	3	three	three	NUM
admet-2057	187	4	independent	independent	ADJ
admet-2057	187	5	variables	variable	NOUN
admet-2057	187	6	for	for	ADP
admet-2057	187	7	the	the	DET
admet-2057	187	8	optimisation	optimisation	NOUN
admet-2057	187	9	:	:	PUNCT
admet-2057	187	10	contact	contact	NOUN
admet-2057	187	11	time	time	NOUN
admet-2057	187	12	,	,	PUNCT
admet-2057	187	13	ethanol	ethanol	NOUN
admet-2057	187	14	concentration	concentration	NOUN
admet-2057	187	15	and	and	CCONJ
admet-2057	187	16	the	the	DET
admet-2057	187	17	5	5	NUM
admet-2057	187	18	-	-	PUNCT
admet-2057	187	19	fu	fu	NOUN
admet-2057	187	20	:	:	PUNCT
admet-2057	187	21	material	material	NOUN
admet-2057	187	22	ratio	ratio	NOUN
admet-2057	187	23	.	.	PUNCT
admet-2057	188	1	the	the	DET
admet-2057	188	2	effect	effect	NOUN
admet-2057	188	3	of	of	ADP
admet-2057	188	4	these	these	DET
admet-2057	188	5	variables	variable	NOUN
admet-2057	188	6	is	be	AUX
admet-2057	188	7	checked	check	VERB
admet-2057	188	8	at	at	ADP
admet-2057	188	9	three	three	NUM
admet-2057	188	10	experimental	experimental	ADJ
admet-2057	188	11	levels	level	NOUN
admet-2057	188	12	,	,	PUNCT
admet-2057	188	13	1	1	NUM
admet-2057	188	14	,	,	PUNCT
admet-2057	188	15	0	0	NUM
admet-2057	188	16	,	,	PUNCT
admet-2057	188	17	and	and	CCONJ
admet-2057	188	18	-1	-1	CCONJ
admet-2057	188	19	,	,	PUNCT
admet-2057	188	20	which	which	PRON
admet-2057	188	21	are	be	AUX
admet-2057	188	22	tested	test	VERB
admet-2057	188	23	against	against	ADP
admet-2057	188	24	response	response	NOUN
admet-2057	188	25	variables	variable	NOUN
admet-2057	188	26	such	such	ADJ
admet-2057	188	27	as	as	ADP
admet-2057	188	28	drug	drug	NOUN
admet-2057	188	29	entrapment	entrapment	NOUN
admet-2057	188	30	efficiency	efficiency	NOUN
admet-2057	188	31	and	and	CCONJ
admet-2057	188	32	percent	percent	NOUN
admet-2057	188	33	drug	drug	NOUN
admet-2057	188	34	loading	loading	NOUN
admet-2057	188	35	.	.	PUNCT
admet-2057	189	1	the	the	DET
admet-2057	189	2	designed	design	VERB
admet-2057	189	3	three	three	NUM
admet-2057	189	4	batches	batch	NOUN
admet-2057	189	5	showed	show	VERB
admet-2057	189	6	40.23	40.23	NUM
admet-2057	189	7	,	,	PUNCT
admet-2057	189	8	34.58	34.58	NUM
admet-2057	189	9	,	,	PUNCT
admet-2057	189	10	and	and	CCONJ
admet-2057	189	11	38.43	38.43	NUM
admet-2057	189	12	%	%	NOUN
admet-2057	189	13	,	,	PUNCT
admet-2057	189	14	percent	percent	NOUN
admet-2057	189	15	drug	drug	NOUN
admet-2057	189	16	loading	loading	NOUN
admet-2057	189	17	,	,	PUNCT
admet-2057	189	18	respectively	respectively	ADV
admet-2057	189	19	,	,	PUNCT
admet-2057	189	20	with	with	ADP
admet-2057	189	21	a	a	DET
admet-2057	189	22	standard	standard	ADJ
admet-2057	189	23	deviation	deviation	NOUN
admet-2057	189	24	of	of	ADP
admet-2057	189	25	2.89	2.89	NUM
admet-2057	189	26	and	and	CCONJ
admet-2057	189	27	p	p	NOUN
admet-2057	189	28	-	-	PUNCT
admet-2057	189	29	value	value	NOUN
admet-2057	189	30	˂	˂	PROPN
admet-2057	189	31	0.05	0.05	NUM
admet-2057	189	32	,	,	PUNCT
admet-2057	189	33	proving	prove	VERB
admet-2057	189	34	that	that	SCONJ
admet-2057	189	35	the	the	DET
admet-2057	189	36	optimized	optimize	VERB
admet-2057	189	37	process	process	NOUN
admet-2057	189	38	was	be	AUX
admet-2057	189	39	stable	stable	ADJ
admet-2057	189	40	and	and	CCONJ
admet-2057	189	41	reproducible	reproducible	ADJ
admet-2057	189	42	.	.	PUNCT
admet-2057	190	1	in	in	ADP
admet-2057	190	2	a	a	DET
admet-2057	190	3	similar	similar	ADJ
admet-2057	190	4	vein	vein	NOUN
admet-2057	190	5	,	,	PUNCT
admet-2057	190	6	p.	p.	NOUN
admet-2057	190	7	kush	kush	NOUN
admet-2057	190	8	et	et	PROPN
admet-2057	190	9	al	al	PROPN
admet-2057	190	10	.	.	PUNCT
admet-2057	191	1	[	[	X
admet-2057	191	2	54	54	NUM
admet-2057	191	3	]	]	PUNCT
admet-2057	191	4	reported	report	VERB
admet-2057	191	5	the	the	DET
admet-2057	191	6	optimisation	optimisation	NOUN
admet-2057	191	7	and	and	CCONJ
admet-2057	191	8	synthesis	synthesis	NOUN
admet-2057	191	9	of	of	ADP
admet-2057	191	10	mil-101	mil-101	NOUN
admet-2057	191	11	-	-	PUNCT
admet-2057	191	12	nh2	nh2	NOUN
admet-2057	191	13	by	by	ADP
admet-2057	191	14	the	the	DET
admet-2057	191	15	microwave	microwave	NOUN
admet-2057	191	16	-	-	PUNCT
admet-2057	191	17	assisted	assist	VERB
admet-2057	191	18	method	method	NOUN
admet-2057	191	19	.	.	PUNCT
admet-2057	192	1	further	further	ADJ
admet-2057	192	2	researchers	researcher	NOUN
admet-2057	192	3	and	and	CCONJ
admet-2057	192	4	team	team	NOUN
admet-2057	192	5	used	use	VERB
admet-2057	192	6	the	the	DET
admet-2057	192	7	central	central	ADJ
admet-2057	192	8	composite	composite	ADJ
admet-2057	192	9	design	design	NOUN
admet-2057	192	10	for	for	ADP
admet-2057	192	11	the	the	DET
admet-2057	192	12	optimisation	optimisation	NOUN
admet-2057	192	13	,	,	PUNCT
admet-2057	192	14	including	include	VERB
admet-2057	192	15	three	three	NUM
admet-2057	192	16	independent	independent	ADJ
admet-2057	192	17	variables	variable	NOUN
admet-2057	192	18	:	:	PUNCT
admet-2057	192	19	reactant	reactant	NOUN
admet-2057	192	20	composition	composition	NOUN
admet-2057	192	21	,	,	PUNCT
admet-2057	192	22	ph	ph	NOUN
admet-2057	192	23	and	and	CCONJ
admet-2057	192	24	temperature	temperature	NOUN
admet-2057	192	25	.	.	PUNCT
admet-2057	193	1	the	the	DET
admet-2057	193	2	resultant	resultant	NOUN
admet-2057	193	3	variables	variable	NOUN
admet-2057	193	4	were	be	AUX
admet-2057	193	5	observed	observe	VERB
admet-2057	193	6	in	in	ADP
admet-2057	193	7	percent	percent	NOUN
admet-2057	193	8	yield	yield	NOUN
admet-2057	193	9	,	,	PUNCT
admet-2057	193	10	size	size	NOUN
admet-2057	193	11	of	of	ADP
admet-2057	193	12	mof	mof	NOUN
admet-2057	193	13	and	and	CCONJ
admet-2057	193	14	surface	surface	NOUN
admet-2057	193	15	area	area	NOUN
admet-2057	193	16	.	.	PUNCT
admet-2057	194	1	the	the	DET
admet-2057	194	2	anova	anova	PROPN
admet-2057	194	3	test	test	NOUN
admet-2057	194	4	showed	show	VERB
admet-2057	194	5	that	that	SCONJ
admet-2057	194	6	the	the	DET
admet-2057	194	7	p	p	ADJ
admet-2057	194	8	-	-	PUNCT
admet-2057	194	9	value	value	NOUN
admet-2057	194	10	˂	˂	PROPN
admet-2057	194	11	0.05	0.05	NUM
admet-2057	194	12	,	,	PUNCT
admet-2057	194	13	revealing	reveal	VERB
admet-2057	194	14	a	a	DET
admet-2057	194	15	significant	significant	ADJ
admet-2057	194	16	impact	impact	NOUN
admet-2057	194	17	of	of	ADP
admet-2057	194	18	selected	select	VERB
admet-2057	194	19	independent	independent	ADJ
admet-2057	194	20	variables	variable	NOUN
admet-2057	194	21	on	on	ADP
admet-2057	194	22	selected	select	VERB
admet-2057	194	23	dependent	dependent	ADJ
admet-2057	194	24	responses	response	NOUN
admet-2057	194	25	.	.	PUNCT
admet-2057	195	1	types	type	NOUN
admet-2057	195	2	of	of	ADP
admet-2057	195	3	drug	drug	NOUN
admet-2057	195	4	delivery	delivery	NOUN
admet-2057	195	5	systems	system	NOUN
admet-2057	195	6	during	during	ADP
admet-2057	195	7	the	the	DET
admet-2057	195	8	last	last	ADJ
admet-2057	195	9	few	few	ADJ
admet-2057	195	10	decades	decade	NOUN
admet-2057	195	11	,	,	PUNCT
admet-2057	195	12	dds	dds	PROPN
admet-2057	195	13	has	have	AUX
admet-2057	195	14	taken	take	VERB
admet-2057	195	15	advantage	advantage	NOUN
admet-2057	195	16	of	of	ADP
admet-2057	195	17	mofs	mof	NOUN
admet-2057	195	18	and	and	CCONJ
admet-2057	195	19	novel	novel	ADJ
admet-2057	195	20	frameworks	framework	NOUN
admet-2057	195	21	[	[	X
admet-2057	195	22	55	55	NUM
admet-2057	195	23	]	]	PUNCT
admet-2057	195	24	.	.	PUNCT
admet-2057	196	1	drug	drug	PROPN
admet-2057	196	2	administration	administration	PROPN
admet-2057	196	3	has	have	AUX
admet-2057	196	4	always	always	ADV
admet-2057	196	5	been	be	AUX
admet-2057	196	6	a	a	DET
admet-2057	196	7	challenge	challenge	NOUN
admet-2057	196	8	for	for	ADP
admet-2057	196	9	formulation	formulation	NOUN
admet-2057	196	10	scientists	scientist	NOUN
admet-2057	196	11	by	by	ADP
admet-2057	196	12	virtue	virtue	NOUN
admet-2057	196	13	of	of	ADP
admet-2057	196	14	the	the	DET
admet-2057	196	15	low	low	ADJ
admet-2057	196	16	aqueous	aqueous	ADJ
admet-2057	196	17	or	or	CCONJ
admet-2057	196	18	lipidic	lipidic	ADJ
admet-2057	196	19	solubility	solubility	NOUN
admet-2057	196	20	,	,	PUNCT
admet-2057	196	21	stability	stability	NOUN
admet-2057	196	22	-	-	PUNCT
admet-2057	196	23	related	relate	VERB
admet-2057	196	24	concerns	concern	NOUN
admet-2057	196	25	,	,	PUNCT
admet-2057	196	26	toxicity	toxicity	NOUN
admet-2057	196	27	and	and	CCONJ
admet-2057	196	28	limited	limited	ADJ
admet-2057	196	29	biodistribution	biodistribution	NOUN
admet-2057	196	30	.	.	PUNCT
admet-2057	197	1	but	but	CCONJ
admet-2057	197	2	the	the	DET
admet-2057	197	3	advancement	advancement	NOUN
admet-2057	197	4	of	of	ADP
admet-2057	197	5	mofs	mof	NOUN
admet-2057	197	6	in	in	ADP
admet-2057	197	7	dds	dds	PROPN
admet-2057	197	8	has	have	AUX
admet-2057	197	9	recognised	recognise	VERB
admet-2057	197	10	that	that	SCONJ
admet-2057	197	11	mofs	mof	NOUN
admet-2057	197	12	can	can	AUX
admet-2057	197	13	address	address	VERB
admet-2057	197	14	these	these	DET
admet-2057	197	15	issues	issue	NOUN
admet-2057	197	16	[	[	X
admet-2057	197	17	48	48	NUM
admet-2057	197	18	]	]	PUNCT
admet-2057	197	19	.	.	PUNCT
admet-2057	198	1	their	their	PRON
admet-2057	198	2	amphiphilic	amphiphilic	ADJ
admet-2057	198	3	internal	internal	ADJ
admet-2057	198	4	environment	environment	NOUN
admet-2057	198	5	,	,	PUNCT
admet-2057	198	6	multifaceted	multifaceted	ADJ
admet-2057	198	7	composition	composition	NOUN
admet-2057	198	8	,	,	PUNCT
admet-2057	198	9	and	and	CCONJ
admet-2057	198	10	adaptive	adaptive	ADJ
admet-2057	198	11	porosity	porosity	NOUN
admet-2057	198	12	make	make	VERB
admet-2057	198	13	them	they	PRON
admet-2057	198	14	particularly	particularly	ADV
admet-2057	198	15	appealing	appeal	VERB
admet-2057	198	16	for	for	ADP
admet-2057	198	17	hosting	host	VERB
admet-2057	198	18	large	large	ADJ
admet-2057	198	19	numbers	number	NOUN
admet-2057	198	20	of	of	ADP
admet-2057	198	21	guest	guest	NOUN
admet-2057	198	22	moieties	moiety	NOUN
admet-2057	198	23	with	with	ADP
admet-2057	198	24	varying	vary	VERB
admet-2057	198	25	physicochemical	physicochemical	ADJ
admet-2057	198	26	features	feature	NOUN
admet-2057	198	27	.	.	PUNCT
admet-2057	199	1	along	along	ADP
admet-2057	199	2	with	with	ADP
admet-2057	199	3	the	the	DET
admet-2057	199	4	wide	wide	ADJ
admet-2057	199	5	array	array	NOUN
admet-2057	199	6	of	of	ADP
admet-2057	199	7	therapeutic	therapeutic	ADJ
admet-2057	199	8	compounds	compound	NOUN
admet-2057	199	9	,	,	PUNCT
admet-2057	199	10	the	the	DET
admet-2057	199	11	different	different	ADJ
admet-2057	199	12	types	type	NOUN
admet-2057	199	13	of	of	ADP
admet-2057	199	14	active	active	ADJ
admet-2057	199	15	constituents	constituent	NOUN
admet-2057	199	16	can	can	AUX
admet-2057	199	17	also	also	ADV
admet-2057	199	18	be	be	AUX
admet-2057	199	19	entrapped	entrap	VERB
admet-2057	199	20	as	as	ADP
admet-2057	199	21	a	a	DET
admet-2057	199	22	core	core	NOUN
admet-2057	199	23	part	part	NOUN
admet-2057	199	24	of	of	ADP
admet-2057	199	25	the	the	DET
admet-2057	199	26	mof	mof	NOUN
admet-2057	199	27	[	[	X
admet-2057	199	28	56	56	NUM
admet-2057	199	29	]	]	PUNCT
admet-2057	199	30	.	.	PUNCT
admet-2057	200	1	in	in	ADP
admet-2057	200	2	parallel	parallel	NOUN
admet-2057	200	3	,	,	PUNCT
admet-2057	200	4	as	as	SCONJ
admet-2057	200	5	it	it	PRON
admet-2057	200	6	is	be	AUX
admet-2057	200	7	possible	possible	ADJ
admet-2057	200	8	to	to	PART
admet-2057	200	9	introduce	introduce	VERB
admet-2057	200	10	a	a	DET
admet-2057	200	11	large	large	ADJ
admet-2057	200	12	variety	variety	NOUN
admet-2057	200	13	of	of	ADP
admet-2057	200	14	stimuli	stimulus	NOUN
admet-2057	200	15	-	-	PUNCT
admet-2057	200	16	responsive	responsive	ADJ
admet-2057	200	17	groups	group	NOUN
admet-2057	200	18	ranging	range	VERB
admet-2057	200	19	from	from	ADP
admet-2057	200	20	porphyrin	porphyrin	NOUN
admet-2057	200	21	,	,	PUNCT
admet-2057	200	22	which	which	PRON
admet-2057	200	23	is	be	AUX
admet-2057	200	24	responsive	responsive	ADJ
admet-2057	200	25	to	to	ADP
admet-2057	200	26	light	light	ADJ
admet-2057	200	27	,	,	PUNCT
admet-2057	200	28	ph	ph	ADJ
admet-2057	200	29	-	-	ADJ
admet-2057	200	30	responsive	responsive	ADJ
admet-2057	200	31	imidazolyl	imidazolyl	NOUN
admet-2057	200	32	,	,	PUNCT
admet-2057	200	33	etc	etc	X
admet-2057	200	34	.	.	X
admet-2057	200	35	,	,	PUNCT
admet-2057	200	36	groups	group	NOUN
admet-2057	200	37	into	into	ADP
admet-2057	200	38	the	the	DET
admet-2057	200	39	mof	mof	ADJ
admet-2057	200	40	skeleton	skeleton	NOUN
admet-2057	200	41	,	,	PUNCT
admet-2057	200	42	the	the	DET
admet-2057	200	43	system	system	NOUN
admet-2057	200	44	can	can	AUX
admet-2057	200	45	be	be	AUX
admet-2057	200	46	designed	design	VERB
admet-2057	200	47	to	to	PART
admet-2057	200	48	release	release	VERB
admet-2057	200	49	drugs	drug	NOUN
admet-2057	200	50	under	under	ADP
admet-2057	200	51	stimuli	stimulus	NOUN
admet-2057	200	52	of	of	ADP
admet-2057	200	53	interest	interest	NOUN
admet-2057	200	54	.	.	PUNCT
admet-2057	201	1	in	in	ADP
admet-2057	201	2	this	this	DET
admet-2057	201	3	part	part	NOUN
admet-2057	201	4	,	,	PUNCT
admet-2057	201	5	we	we	PRON
admet-2057	201	6	will	will	AUX
admet-2057	201	7	get	get	VERB
admet-2057	201	8	insights	insight	NOUN
admet-2057	201	9	into	into	ADP
admet-2057	201	10	different	different	ADJ
admet-2057	201	11	types	type	NOUN
admet-2057	201	12	of	of	ADP
admet-2057	201	13	drug	drug	NOUN
admet-2057	201	14	delivery	delivery	NOUN
admet-2057	201	15	systems	system	NOUN
admet-2057	201	16	,	,	PUNCT
admet-2057	201	17	which	which	PRON
admet-2057	201	18	can	can	AUX
admet-2057	201	19	be	be	AUX
admet-2057	201	20	either	either	CCONJ
admet-2057	201	21	nonresponsive	nonresponsive	ADJ
admet-2057	201	22	,	,	PUNCT
admet-2057	201	23	single	single	ADJ
admet-2057	201	24	stimuli	stimulus	NOUN
admet-2057	201	25	-	-	PUNCT
admet-2057	201	26	responsive	responsive	ADJ
admet-2057	201	27	or	or	CCONJ
admet-2057	201	28	multi	multi	ADJ
admet-2057	201	29	-	-	ADJ
admet-2057	201	30	stimuli	stimulus	NOUN
admet-2057	201	31	responsive	responsive	ADJ
admet-2057	201	32	[	[	X
admet-2057	201	33	57	57	NUM
admet-2057	201	34	]	]	PUNCT
admet-2057	201	35	.	.	PUNCT
admet-2057	202	1	nonresponsive	nonresponsive	ADJ
admet-2057	202	2	mof	mof	X
admet-2057	202	3	nonresponsive	nonresponsive	ADJ
admet-2057	202	4	dds	dds	PROPN
admet-2057	202	5	based	base	VERB
admet-2057	202	6	on	on	ADP
admet-2057	202	7	mof	mof	X
admet-2057	202	8	does	do	AUX
admet-2057	202	9	not	not	PART
admet-2057	202	10	show	show	VERB
admet-2057	202	11	any	any	DET
admet-2057	202	12	response	response	NOUN
admet-2057	202	13	to	to	ADP
admet-2057	202	14	external	external	ADJ
admet-2057	202	15	stimuli	stimulus	NOUN
admet-2057	202	16	.	.	PUNCT
admet-2057	203	1	in	in	ADP
admet-2057	203	2	such	such	ADJ
admet-2057	203	3	systems	system	NOUN
admet-2057	203	4	,	,	PUNCT
admet-2057	203	5	drug	drug	NOUN
admet-2057	203	6	release	release	NOUN
admet-2057	203	7	can	can	AUX
admet-2057	203	8	result	result	VERB
admet-2057	203	9	from	from	ADP
admet-2057	203	10	dissolution	dissolution	NOUN
admet-2057	203	11	,	,	PUNCT
admet-2057	203	12	diffusion	diffusion	NOUN
admet-2057	203	13	or	or	CCONJ
admet-2057	203	14	ion	ion	NOUN
admet-2057	203	15	exchange	exchange	NOUN
admet-2057	203	16	mechanisms	mechanism	NOUN
admet-2057	203	17	and	and	CCONJ
admet-2057	203	18	with	with	ADP
admet-2057	203	19	a	a	DET
admet-2057	203	20	change	change	NOUN
admet-2057	203	21	in	in	ADP
admet-2057	203	22	the	the	DET
admet-2057	203	23	release	release	NOUN
admet-2057	203	24	mechanism	mechanism	NOUN
admet-2057	203	25	,	,	PUNCT
admet-2057	203	26	the	the	DET
admet-2057	203	27	drug	drug	NOUN
admet-2057	203	28	release	release	NOUN
admet-2057	203	29	profile	profile	NOUN
admet-2057	203	30	also	also	ADV
admet-2057	203	31	changes	change	VERB
admet-2057	203	32	.	.	PUNCT
admet-2057	204	1	if	if	SCONJ
admet-2057	204	2	the	the	DET
admet-2057	204	3	drug	drug	NOUN
admet-2057	204	4	release	release	NOUN
admet-2057	204	5	from	from	ADP
admet-2057	204	6	the	the	DET
admet-2057	204	7	mof	mof	X
admet-2057	204	8	occurs	occur	NOUN
admet-2057	204	9	owing	owe	VERB
admet-2057	204	10	to	to	ADP
admet-2057	204	11	slow	slow	VERB
admet-2057	204	12	degradation	degradation	NOUN
admet-2057	204	13	or	or	CCONJ
admet-2057	204	14	merely	merely	ADV
admet-2057	204	15	by	by	ADP
admet-2057	204	16	diffusion	diffusion	NOUN
admet-2057	204	17	,	,	PUNCT
admet-2057	204	18	the	the	DET
admet-2057	204	19	drug	drug	NOUN
admet-2057	204	20	release	release	NOUN
admet-2057	204	21	will	will	AUX
admet-2057	204	22	be	be	AUX
admet-2057	204	23	sustained	sustain	VERB
admet-2057	204	24	for	for	ADP
admet-2057	204	25	a	a	DET
admet-2057	204	26	longer	long	ADJ
admet-2057	204	27	time	time	NOUN
admet-2057	204	28	.	.	PUNCT
admet-2057	205	1	on	on	ADP
admet-2057	205	2	the	the	DET
admet-2057	205	3	other	other	ADJ
admet-2057	205	4	hand	hand	NOUN
admet-2057	205	5	,	,	PUNCT
admet-2057	205	6	if	if	SCONJ
admet-2057	205	7	under	under	ADP
admet-2057	205	8	any	any	DET
admet-2057	205	9	specific	specific	ADJ
admet-2057	205	10	condition	condition	NOUN
admet-2057	205	11	or	or	CCONJ
admet-2057	205	12	in	in	ADP
admet-2057	205	13	specific	specific	ADJ
admet-2057	205	14	media	medium	NOUN
admet-2057	205	15	,	,	PUNCT
admet-2057	205	16	dissolution	dissolution	NOUN
admet-2057	205	17	of	of	ADP
admet-2057	205	18	mof	mof	PROPN
admet-2057	205	19	occurs	occur	NOUN
admet-2057	205	20	,	,	PUNCT
admet-2057	205	21	the	the	DET
admet-2057	205	22	resulting	result	VERB
admet-2057	205	23	drug	drug	NOUN
admet-2057	205	24	release	release	NOUN
admet-2057	205	25	will	will	AUX
admet-2057	205	26	be	be	AUX
admet-2057	205	27	a	a	DET
admet-2057	205	28	burst	burst	ADJ
admet-2057	205	29	release	release	NOUN
admet-2057	205	30	.	.	PUNCT
admet-2057	206	1	in	in	ADP
admet-2057	206	2	general	general	ADJ
admet-2057	206	3	,	,	PUNCT
admet-2057	206	4	for	for	ADP
admet-2057	206	5	reducing	reduce	VERB
admet-2057	206	6	toxic	toxic	ADJ
admet-2057	206	7	effects	effect	NOUN
admet-2057	206	8	and	and	CCONJ
admet-2057	206	9	getting	get	VERB
admet-2057	206	10	steady	steady	ADJ
admet-2057	206	11	blood	blood	NOUN
admet-2057	206	12	concentrations	concentration	NOUN
admet-2057	206	13	,	,	PUNCT
admet-2057	206	14	one	one	PRON
admet-2057	206	15	might	might	AUX
admet-2057	206	16	believe	believe	VERB
admet-2057	206	17	that	that	SCONJ
admet-2057	206	18	a	a	DET
admet-2057	206	19	sustained	sustained	ADJ
admet-2057	206	20	release	release	NOUN
admet-2057	206	21	is	be	AUX
admet-2057	206	22	preferable	preferable	ADJ
admet-2057	206	23	.	.	PUNCT
admet-2057	207	1	furthermore	furthermore	ADV
admet-2057	207	2	,	,	PUNCT
admet-2057	207	3	the	the	DET
admet-2057	207	4	sustained	sustain	VERB
admet-2057	207	5	release	release	NOUN
admet-2057	207	6	can	can	AUX
admet-2057	207	7	protect	protect	VERB
admet-2057	207	8	the	the	DET
admet-2057	207	9	drug	drug	NOUN
admet-2057	207	10	from	from	ADP
admet-2057	207	11	admet	admet	PROPN
admet-2057	207	12	&	&	CCONJ
admet-2057	207	13	dmpk	dmpk	PROPN
admet-2057	207	14	12(1	12(1	PROPN
admet-2057	207	15	)	)	PUNCT
admet-2057	207	16	(	(	PUNCT
admet-2057	207	17	2024	2024	NUM
admet-2057	207	18	)	)	PUNCT
admet-2057	207	19	27	27	NUM
admet-2057	207	20	-	-	SYM
admet-2057	207	21	62	62	NUM
admet-2057	207	22	drug	drug	NOUN
admet-2057	207	23	delivery	delivery	NOUN
admet-2057	207	24	applications	application	NOUN
admet-2057	207	25	of	of	ADP
admet-2057	207	26	metal	metal	NOUN
admet-2057	207	27	-	-	PUNCT
admet-2057	207	28	organic	organic	ADJ
admet-2057	207	29	framework	framework	NOUN
admet-2057	207	30	doi	doi	NOUN
admet-2057	207	31	:	:	PUNCT
admet-2057	207	32	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	207	33	35	35	NUM
admet-2057	207	34	undergoing	undergo	VERB
admet-2057	207	35	any	any	DET
admet-2057	207	36	degradation	degradation	NOUN
admet-2057	207	37	as	as	SCONJ
admet-2057	207	38	it	it	PRON
admet-2057	207	39	increases	increase	VERB
admet-2057	207	40	its	its	PRON
admet-2057	207	41	plasma	plasma	NOUN
admet-2057	207	42	half	half	ADJ
admet-2057	207	43	-	-	PUNCT
admet-2057	207	44	life	life	NOUN
admet-2057	207	45	,	,	PUNCT
admet-2057	207	46	resulting	result	VERB
admet-2057	207	47	in	in	ADP
admet-2057	207	48	better	well	ADJ
admet-2057	207	49	bioavailability	bioavailability	NOUN
admet-2057	207	50	and	and	CCONJ
admet-2057	207	51	enhanced	enhance	VERB
admet-2057	207	52	efficacy	efficacy	NOUN
admet-2057	207	53	.	.	PUNCT
admet-2057	208	1	sustained	sustained	ADJ
admet-2057	208	2	release	release	NOUN
admet-2057	208	3	is	be	AUX
admet-2057	208	4	not	not	PART
admet-2057	208	5	always	always	ADV
admet-2057	208	6	preferred	prefer	VERB
admet-2057	208	7	as	as	SCONJ
admet-2057	208	8	it	it	PRON
admet-2057	208	9	allows	allow	VERB
admet-2057	208	10	the	the	DET
admet-2057	208	11	drug	drug	NOUN
admet-2057	208	12	to	to	PART
admet-2057	208	13	remain	remain	VERB
admet-2057	208	14	in	in	ADP
admet-2057	208	15	the	the	DET
admet-2057	208	16	blood	blood	NOUN
admet-2057	208	17	for	for	ADP
admet-2057	208	18	a	a	DET
admet-2057	208	19	prolonged	prolonged	ADJ
admet-2057	208	20	period	period	NOUN
admet-2057	208	21	.	.	PUNCT
admet-2057	209	1	the	the	DET
admet-2057	209	2	release	release	NOUN
admet-2057	209	3	profile	profile	NOUN
admet-2057	209	4	is	be	AUX
admet-2057	209	5	solely	solely	ADV
admet-2057	209	6	dependent	dependent	ADJ
admet-2057	209	7	on	on	ADP
admet-2057	209	8	the	the	DET
admet-2057	209	9	application	application	NOUN
admet-2057	209	10	,	,	PUNCT
admet-2057	209	11	and	and	CCONJ
admet-2057	209	12	accordingly	accordingly	ADV
admet-2057	209	13	,	,	PUNCT
admet-2057	209	14	one	one	PRON
admet-2057	209	15	should	should	AUX
admet-2057	209	16	go	go	VERB
admet-2057	209	17	for	for	ADP
admet-2057	209	18	a	a	DET
admet-2057	209	19	selection	selection	NOUN
admet-2057	209	20	of	of	ADP
admet-2057	209	21	mof	mof	NOUN
admet-2057	209	22	.	.	PUNCT
admet-2057	209	23	to	to	PART
admet-2057	209	24	tackle	tackle	VERB
admet-2057	209	25	the	the	DET
admet-2057	209	26	problem	problem	NOUN
admet-2057	209	27	of	of	ADP
admet-2057	209	28	premature	premature	ADJ
admet-2057	209	29	drug	drug	NOUN
admet-2057	209	30	release	release	NOUN
admet-2057	209	31	,	,	PUNCT
admet-2057	209	32	assorted	assort	VERB
admet-2057	209	33	preventive	preventive	ADJ
admet-2057	209	34	measures	measure	NOUN
admet-2057	209	35	can	can	AUX
admet-2057	209	36	be	be	AUX
admet-2057	209	37	taken	take	VERB
admet-2057	209	38	,	,	PUNCT
admet-2057	209	39	which	which	PRON
admet-2057	209	40	comprise	comprise	VERB
admet-2057	209	41	coating	coating	NOUN
admet-2057	209	42	lipid	lipid	NOUN
admet-2057	209	43	or	or	CCONJ
admet-2057	209	44	silica	silica	NOUN
admet-2057	209	45	layers	layer	NOUN
admet-2057	209	46	and	and	CCONJ
admet-2057	209	47	exosomes	exosome	NOUN
admet-2057	209	48	on	on	ADP
admet-2057	209	49	the	the	DET
admet-2057	209	50	surface	surface	NOUN
admet-2057	209	51	of	of	ADP
admet-2057	209	52	mof	mof	NOUN
admet-2057	209	53	,	,	PUNCT
admet-2057	209	54	which	which	PRON
admet-2057	209	55	also	also	ADV
admet-2057	209	56	results	result	VERB
admet-2057	209	57	in	in	ADP
admet-2057	209	58	improved	improve	VERB
admet-2057	209	59	solubility	solubility	NOUN
admet-2057	209	60	of	of	ADP
admet-2057	209	61	mof	mof	NOUN
admet-2057	210	1	[	[	X
admet-2057	210	2	58	58	NUM
admet-2057	210	3	]	]	PUNCT
admet-2057	210	4	.	.	PUNCT
admet-2057	211	1	stimuli	stimuli	VERB
admet-2057	211	2	-	-	PUNCT
admet-2057	211	3	responsive	responsive	ADJ
admet-2057	211	4	mof	mof	NOUN
admet-2057	211	5	as	as	SCONJ
admet-2057	211	6	mentioned	mention	VERB
admet-2057	211	7	earlier	early	ADV
admet-2057	211	8	,	,	PUNCT
admet-2057	211	9	mofs	mof	NOUN
admet-2057	211	10	are	be	AUX
admet-2057	211	11	exceptional	exceptional	ADJ
admet-2057	211	12	drug	drug	NOUN
admet-2057	211	13	carriers	carrier	NOUN
admet-2057	211	14	because	because	SCONJ
admet-2057	211	15	they	they	PRON
admet-2057	211	16	have	have	VERB
admet-2057	211	17	the	the	DET
admet-2057	211	18	least	least	ADJ
admet-2057	211	19	cytotoxicity	cytotoxicity	NOUN
admet-2057	211	20	,	,	PUNCT
admet-2057	211	21	superior	superior	ADJ
admet-2057	211	22	loading	loading	NOUN
admet-2057	211	23	capacity	capacity	NOUN
admet-2057	211	24	,	,	PUNCT
admet-2057	211	25	and	and	CCONJ
admet-2057	211	26	compelling	compelling	ADJ
admet-2057	211	27	cell	cell	NOUN
admet-2057	211	28	and	and	CCONJ
admet-2057	211	29	tissue	tissue	NOUN
admet-2057	211	30	permeation	permeation	NOUN
admet-2057	211	31	.	.	PUNCT
admet-2057	212	1	even	even	ADV
admet-2057	212	2	so	so	ADV
admet-2057	212	3	,	,	PUNCT
admet-2057	212	4	one	one	NUM
admet-2057	212	5	of	of	ADP
admet-2057	212	6	the	the	DET
admet-2057	212	7	dominant	dominant	ADJ
admet-2057	212	8	issues	issue	NOUN
admet-2057	212	9	with	with	ADP
admet-2057	212	10	mof	mof	X
admet-2057	212	11	is	be	AUX
admet-2057	212	12	the	the	DET
admet-2057	212	13	premature	premature	ADJ
admet-2057	212	14	release	release	NOUN
admet-2057	212	15	of	of	ADP
admet-2057	212	16	entrapped	entrapped	ADJ
admet-2057	212	17	drugs	drug	NOUN
admet-2057	212	18	.	.	PUNCT
admet-2057	213	1	to	to	PART
admet-2057	213	2	tackle	tackle	VERB
admet-2057	213	3	this	this	DET
admet-2057	213	4	problem	problem	NOUN
admet-2057	213	5	,	,	PUNCT
admet-2057	213	6	strategically	strategically	ADV
admet-2057	213	7	designed	design	VERB
admet-2057	213	8	mofs	mof	NOUN
admet-2057	213	9	responsive	responsive	ADJ
admet-2057	213	10	to	to	ADP
admet-2057	213	11	external	external	ADJ
admet-2057	213	12	stimuli	stimulus	NOUN
admet-2057	213	13	can	can	AUX
admet-2057	213	14	be	be	AUX
admet-2057	213	15	a	a	DET
admet-2057	213	16	satisfactory	satisfactory	ADJ
admet-2057	213	17	solution	solution	NOUN
admet-2057	213	18	[	[	X
admet-2057	213	19	59	59	NUM
admet-2057	213	20	]	]	PUNCT
admet-2057	213	21	.	.	PUNCT
admet-2057	214	1	the	the	DET
admet-2057	214	2	mofs	mof	NOUN
admet-2057	214	3	are	be	AUX
admet-2057	214	4	especially	especially	ADV
admet-2057	214	5	useful	useful	ADJ
admet-2057	214	6	when	when	SCONJ
admet-2057	214	7	the	the	DET
admet-2057	214	8	external	external	ADJ
admet-2057	214	9	stimuli	stimulus	NOUN
admet-2057	214	10	are	be	AUX
admet-2057	214	11	specific	specific	ADJ
admet-2057	214	12	to	to	ADP
admet-2057	214	13	disease	disease	NOUN
admet-2057	214	14	pathology	pathology	NOUN
admet-2057	214	15	,	,	PUNCT
admet-2057	214	16	allowing	allow	VERB
admet-2057	214	17	the	the	DET
admet-2057	214	18	mofs	mof	NOUN
admet-2057	214	19	to	to	PART
admet-2057	214	20	respond	respond	VERB
admet-2057	214	21	specifically	specifically	ADV
admet-2057	214	22	to	to	ADP
admet-2057	214	23	the	the	DET
admet-2057	214	24	pathological	pathological	ADJ
admet-2057	214	25	triggers	trigger	NOUN
admet-2057	214	26	.	.	PUNCT
admet-2057	215	1	generally	generally	ADV
admet-2057	215	2	,	,	PUNCT
admet-2057	215	3	the	the	DET
admet-2057	215	4	stimuli	stimulus	NOUN
admet-2057	215	5	can	can	AUX
admet-2057	215	6	be	be	AUX
admet-2057	215	7	categorized	categorize	VERB
admet-2057	215	8	into	into	ADP
admet-2057	215	9	external	external	ADJ
admet-2057	215	10	and	and	CCONJ
admet-2057	215	11	internal	internal	ADJ
admet-2057	215	12	groups	group	NOUN
admet-2057	215	13	.	.	PUNCT
admet-2057	216	1	the	the	DET
admet-2057	216	2	internal	internal	ADJ
admet-2057	216	3	stimuli	stimulus	NOUN
admet-2057	216	4	include	include	VERB
admet-2057	216	5	temperature	temperature	NOUN
admet-2057	216	6	,	,	PUNCT
admet-2057	216	7	concentration	concentration	NOUN
admet-2057	216	8	of	of	ADP
admet-2057	216	9	enzymes	enzyme	NOUN
admet-2057	216	10	between	between	ADP
admet-2057	216	11	diseased	diseased	ADJ
admet-2057	216	12	cells	cell	NOUN
admet-2057	216	13	and	and	CCONJ
admet-2057	216	14	normal	normal	ADJ
admet-2057	216	15	cells	cell	NOUN
admet-2057	216	16	,	,	PUNCT
admet-2057	216	17	temperature	temperature	NOUN
admet-2057	216	18	,	,	PUNCT
admet-2057	216	19	hypoxia	hypoxia	NOUN
admet-2057	216	20	,	,	PUNCT
admet-2057	216	21	ph	ph	ADJ
admet-2057	216	22	and	and	CCONJ
admet-2057	216	23	redox	redox	ADJ
admet-2057	216	24	potential	potential	NOUN
admet-2057	216	25	.	.	PUNCT
admet-2057	217	1	this	this	DET
admet-2057	217	2	type	type	NOUN
admet-2057	217	3	of	of	ADP
admet-2057	217	4	stimulus	stimulus	NOUN
admet-2057	217	5	,	,	PUNCT
admet-2057	217	6	as	as	SCONJ
admet-2057	217	7	illustrated	illustrate	VERB
admet-2057	217	8	in	in	ADP
admet-2057	217	9	figure	figure	NOUN
admet-2057	217	10	2	2	NUM
admet-2057	217	11	,	,	PUNCT
admet-2057	217	12	depends	depend	VERB
admet-2057	217	13	on	on	ADP
admet-2057	217	14	the	the	DET
admet-2057	217	15	various	various	ADJ
admet-2057	217	16	physicochemical	physicochemical	ADJ
admet-2057	217	17	environments	environment	NOUN
admet-2057	217	18	available	available	ADJ
admet-2057	217	19	at	at	ADP
admet-2057	217	20	the	the	DET
admet-2057	217	21	site	site	NOUN
admet-2057	217	22	of	of	ADP
admet-2057	217	23	action	action	NOUN
admet-2057	217	24	.	.	PUNCT
admet-2057	218	1	on	on	ADP
admet-2057	218	2	the	the	DET
admet-2057	218	3	contrary	contrary	NOUN
admet-2057	218	4	,	,	PUNCT
admet-2057	218	5	external	external	ADJ
admet-2057	218	6	stimuli	stimulus	NOUN
admet-2057	218	7	depend	depend	VERB
admet-2057	218	8	on	on	ADP
admet-2057	218	9	external	external	ADJ
admet-2057	218	10	factors	factor	NOUN
admet-2057	218	11	like	like	ADP
admet-2057	218	12	light	light	NOUN
admet-2057	218	13	,	,	PUNCT
admet-2057	218	14	ultrasound	ultrasound	NOUN
admet-2057	218	15	,	,	PUNCT
admet-2057	218	16	heat	heat	NOUN
admet-2057	218	17	,	,	PUNCT
admet-2057	218	18	electric	electric	ADJ
admet-2057	218	19	current	current	ADJ
admet-2057	218	20	and	and	CCONJ
admet-2057	218	21	magnetic	magnetic	ADJ
admet-2057	218	22	field	field	NOUN
admet-2057	218	23	.	.	PUNCT
admet-2057	219	1	by	by	ADP
admet-2057	219	2	this	this	DET
admet-2057	219	3	virtue	virtue	NOUN
admet-2057	219	4	,	,	PUNCT
admet-2057	219	5	optimal	optimal	ADJ
admet-2057	219	6	spatio	spatio	NOUN
admet-2057	219	7	-	-	PUNCT
admet-2057	219	8	temporal	temporal	ADJ
admet-2057	219	9	drug	drug	NOUN
admet-2057	219	10	release	release	NOUN
admet-2057	219	11	in	in	ADP
admet-2057	219	12	a	a	DET
admet-2057	219	13	controlled	control	VERB
admet-2057	219	14	manner	manner	NOUN
admet-2057	219	15	can	can	AUX
admet-2057	219	16	be	be	AUX
admet-2057	219	17	attained	attain	VERB
admet-2057	219	18	[	[	X
admet-2057	219	19	9	9	NUM
admet-2057	219	20	]	]	PUNCT
admet-2057	219	21	.	.	PUNCT
admet-2057	220	1	in	in	ADP
admet-2057	220	2	the	the	DET
admet-2057	220	3	stimuli	stimulus	NOUN
admet-2057	220	4	-	-	PUNCT
admet-2057	220	5	responsive	responsive	ADJ
admet-2057	220	6	mof	mof	NOUN
admet-2057	220	7	,	,	PUNCT
admet-2057	220	8	drug	drug	NOUN
admet-2057	220	9	release	release	NOUN
admet-2057	220	10	can	can	AUX
admet-2057	220	11	be	be	AUX
admet-2057	220	12	attained	attain	VERB
admet-2057	220	13	by	by	ADP
admet-2057	220	14	a	a	DET
admet-2057	220	15	single	single	ADJ
admet-2057	220	16	stimulus	stimulus	NOUN
admet-2057	220	17	or	or	CCONJ
admet-2057	220	18	by	by	ADP
admet-2057	220	19	the	the	DET
admet-2057	220	20	combination	combination	NOUN
admet-2057	220	21	of	of	ADP
admet-2057	220	22	multiple	multiple	ADJ
admet-2057	220	23	stimuli	stimulus	NOUN
admet-2057	220	24	.	.	PUNCT
admet-2057	221	1	figure	figure	NOUN
admet-2057	221	2	2	2	NUM
admet-2057	221	3	.	.	PUNCT
admet-2057	222	1	different	different	ADJ
admet-2057	222	2	stimuli	stimulus	NOUN
admet-2057	222	3	for	for	ADP
admet-2057	222	4	stimuli	stimulus	NOUN
admet-2057	222	5	-	-	PUNCT
admet-2057	222	6	responsive	responsive	ADJ
admet-2057	222	7	mofs	mof	NOUN
admet-2057	222	8	single	single	ADJ
admet-2057	222	9	stimuli	stimuli	VERB
admet-2057	222	10	responsive	responsive	ADJ
admet-2057	222	11	mof	mof	NOUN
admet-2057	222	12	in	in	ADP
admet-2057	222	13	this	this	DET
admet-2057	222	14	type	type	NOUN
admet-2057	222	15	of	of	ADP
admet-2057	222	16	system	system	NOUN
admet-2057	222	17	,	,	PUNCT
admet-2057	222	18	drug	drug	NOUN
admet-2057	222	19	release	release	NOUN
admet-2057	222	20	can	can	AUX
admet-2057	222	21	be	be	AUX
admet-2057	222	22	attained	attain	VERB
admet-2057	222	23	by	by	ADP
admet-2057	222	24	the	the	DET
admet-2057	222	25	application	application	NOUN
admet-2057	222	26	of	of	ADP
admet-2057	222	27	single	single	ADJ
admet-2057	222	28	external	external	ADJ
admet-2057	222	29	or	or	CCONJ
admet-2057	222	30	internal	internal	ADJ
admet-2057	222	31	stimuli	stimulus	NOUN
admet-2057	222	32	,	,	PUNCT
admet-2057	222	33	which	which	PRON
admet-2057	222	34	can	can	AUX
admet-2057	222	35	be	be	AUX
admet-2057	222	36	either	either	CCONJ
admet-2057	222	37	ph	ph	ADJ
admet-2057	222	38	,	,	PUNCT
admet-2057	222	39	temperature	temperature	NOUN
admet-2057	222	40	,	,	PUNCT
admet-2057	222	41	light	light	NOUN
admet-2057	222	42	,	,	PUNCT
admet-2057	222	43	redox	redox	NOUN
admet-2057	222	44	or	or	CCONJ
admet-2057	222	45	atp	atp	PROPN
admet-2057	222	46	.	.	PUNCT
admet-2057	222	47	a.	a.	PROPN
admet-2057	222	48	ph	ph	PROPN
admet-2057	222	49	-	-	PUNCT
admet-2057	222	50	responsive	responsive	ADJ
admet-2057	222	51	among	among	ADP
admet-2057	222	52	the	the	DET
admet-2057	222	53	assorted	assorted	ADJ
admet-2057	222	54	classes	class	NOUN
admet-2057	222	55	of	of	ADP
admet-2057	222	56	mofs	mof	NOUN
admet-2057	222	57	responsive	responsive	ADJ
admet-2057	222	58	to	to	ADP
admet-2057	222	59	external	external	ADJ
admet-2057	222	60	stimuli	stimulus	NOUN
admet-2057	222	61	,	,	PUNCT
admet-2057	222	62	ph	ph	ADJ
admet-2057	222	63	-	-	PUNCT
admet-2057	222	64	responsive	responsive	ADJ
admet-2057	222	65	mofs	mof	NOUN
admet-2057	222	66	are	be	AUX
admet-2057	222	67	one	one	NUM
admet-2057	222	68	of	of	ADP
admet-2057	222	69	the	the	DET
admet-2057	222	70	most	most	ADV
admet-2057	222	71	studied	study	VERB
admet-2057	222	72	,	,	PUNCT
admet-2057	222	73	notably	notably	ADV
admet-2057	222	74	for	for	ADP
admet-2057	222	75	cancer	cancer	NOUN
admet-2057	222	76	therapy	therapy	NOUN
admet-2057	222	77	.	.	PUNCT
admet-2057	223	1	the	the	DET
admet-2057	223	2	change	change	NOUN
admet-2057	223	3	in	in	ADP
admet-2057	223	4	the	the	DET
admet-2057	223	5	ph	ph	NOUN
admet-2057	223	6	of	of	ADP
admet-2057	223	7	the	the	DET
admet-2057	223	8	external	external	ADJ
admet-2057	223	9	environment	environment	NOUN
admet-2057	223	10	may	may	AUX
admet-2057	223	11	result	result	VERB
admet-2057	223	12	in	in	ADP
admet-2057	223	13	the	the	DET
admet-2057	223	14	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	223	15	p.	p.	NOUN
admet-2057	223	16	mhettar	mhettar	NOUN
admet-2057	223	17	et	et	PROPN
admet-2057	223	18	al	al	PROPN
admet-2057	223	19	.	.	PROPN
admet-2057	223	20	admet	admet	PROPN
admet-2057	223	21	&	&	CCONJ
admet-2057	223	22	dmpk	dmpk	PROPN
admet-2057	223	23	12(1	12(1	PROPN
admet-2057	223	24	)	)	PUNCT
admet-2057	223	25	(	(	PUNCT
admet-2057	223	26	2024	2024	NUM
admet-2057	223	27	)	)	PUNCT
admet-2057	223	28	27	27	NUM
admet-2057	223	29	-	-	SYM
admet-2057	223	30	62	62	NUM
admet-2057	223	31	36	36	NUM
admet-2057	223	32	ph	ph	VERB
admet-2057	223	33	-	-	PUNCT
admet-2057	223	34	responsive	responsive	ADJ
admet-2057	223	35	breakdown	breakdown	NOUN
admet-2057	223	36	of	of	ADP
admet-2057	223	37	the	the	DET
admet-2057	223	38	mof	mof	ADJ
admet-2057	223	39	structure	structure	NOUN
admet-2057	223	40	[	[	X
admet-2057	223	41	57	57	NUM
admet-2057	223	42	]	]	PUNCT
admet-2057	223	43	.	.	PUNCT
admet-2057	224	1	the	the	DET
admet-2057	224	2	release	release	NOUN
admet-2057	224	3	of	of	ADP
admet-2057	224	4	the	the	DET
admet-2057	224	5	drug	drug	NOUN
admet-2057	224	6	is	be	AUX
admet-2057	224	7	due	due	ADJ
admet-2057	224	8	to	to	ADP
admet-2057	224	9	the	the	DET
admet-2057	224	10	structural	structural	ADJ
admet-2057	224	11	breakdown	breakdown	NOUN
admet-2057	224	12	of	of	ADP
admet-2057	224	13	mof	mof	ADJ
admet-2057	224	14	structures	structure	NOUN
admet-2057	224	15	due	due	ADJ
admet-2057	224	16	to	to	ADP
admet-2057	224	17	ph	ph	ADJ
admet-2057	224	18	-	-	ADJ
admet-2057	224	19	dependent	dependent	ADJ
admet-2057	224	20	instability	instability	NOUN
admet-2057	224	21	.	.	PUNCT
admet-2057	225	1	in	in	ADP
admet-2057	225	2	addition	addition	NOUN
admet-2057	225	3	,	,	PUNCT
admet-2057	225	4	mofs	mof	NOUN
admet-2057	225	5	responsive	responsive	ADJ
admet-2057	225	6	to	to	ADP
admet-2057	225	7	ph	ph	NOUN
admet-2057	225	8	have	have	AUX
admet-2057	225	9	been	be	AUX
admet-2057	225	10	widely	widely	ADV
admet-2057	225	11	investigated	investigate	VERB
admet-2057	225	12	for	for	ADP
admet-2057	225	13	the	the	DET
admet-2057	225	14	oral	oral	ADJ
admet-2057	225	15	delivery	delivery	NOUN
admet-2057	225	16	of	of	ADP
admet-2057	225	17	chemotherapeutics	chemotherapeutic	NOUN
admet-2057	225	18	and	and	CCONJ
admet-2057	225	19	anti	anti	ADJ
admet-2057	225	20	-	-	ADJ
admet-2057	225	21	inflammatory	inflammatory	ADJ
admet-2057	225	22	agents	agent	NOUN
admet-2057	225	23	[	[	X
admet-2057	225	24	60	60	NUM
admet-2057	225	25	]	]	PUNCT
admet-2057	225	26	.	.	PUNCT
admet-2057	226	1	in	in	ADP
admet-2057	226	2	contrast	contrast	NOUN
admet-2057	226	3	to	to	ADP
admet-2057	226	4	cancer	cancer	NOUN
admet-2057	226	5	therapy	therapy	NOUN
admet-2057	226	6	,	,	PUNCT
admet-2057	226	7	in	in	ADP
admet-2057	226	8	the	the	DET
admet-2057	226	9	case	case	NOUN
admet-2057	226	10	of	of	ADP
admet-2057	226	11	oral	oral	ADJ
admet-2057	226	12	delivery	delivery	NOUN
admet-2057	226	13	of	of	ADP
admet-2057	226	14	anti	anti	ADJ
admet-2057	226	15	-	-	ADJ
admet-2057	226	16	inflammatory	inflammatory	ADJ
admet-2057	226	17	agents	agent	NOUN
admet-2057	226	18	in	in	ADP
admet-2057	226	19	the	the	DET
admet-2057	226	20	acidified	acidify	VERB
admet-2057	226	21	medium	medium	NOUN
admet-2057	226	22	,	,	PUNCT
admet-2057	226	23	the	the	DET
admet-2057	226	24	burst	burst	ADJ
admet-2057	226	25	effect	effect	NOUN
admet-2057	226	26	must	must	AUX
admet-2057	226	27	be	be	AUX
admet-2057	226	28	smaller	small	ADJ
admet-2057	226	29	in	in	ADP
admet-2057	226	30	the	the	DET
admet-2057	226	31	acidic	acidic	ADJ
admet-2057	226	32	medium	medium	NOUN
admet-2057	226	33	,	,	PUNCT
admet-2057	226	34	i.e.	i.e.	X
admet-2057	226	35	,	,	PUNCT
admet-2057	226	36	in	in	ADP
admet-2057	226	37	the	the	DET
admet-2057	226	38	stomach	stomach	NOUN
admet-2057	226	39	and	and	CCONJ
admet-2057	226	40	the	the	DET
admet-2057	226	41	drug	drug	NOUN
admet-2057	226	42	release	release	NOUN
admet-2057	226	43	is	be	AUX
admet-2057	226	44	mostly	mostly	ADV
admet-2057	226	45	expected	expect	VERB
admet-2057	226	46	in	in	ADP
admet-2057	226	47	intestinal	intestinal	ADJ
admet-2057	226	48	conditions	condition	NOUN
admet-2057	226	49	.	.	PUNCT
admet-2057	227	1	the	the	DET
admet-2057	227	2	most	most	ADV
admet-2057	227	3	preferable	preferable	ADJ
admet-2057	227	4	mechanism	mechanism	NOUN
admet-2057	227	5	for	for	ADP
admet-2057	227	6	the	the	DET
admet-2057	227	7	ph	ph	ADJ
admet-2057	227	8	responsiveness	responsiveness	NOUN
admet-2057	227	9	of	of	ADP
admet-2057	227	10	the	the	DET
admet-2057	227	11	mofs	mof	NOUN
admet-2057	227	12	is	be	AUX
admet-2057	227	13	the	the	DET
admet-2057	227	14	utilization	utilization	NOUN
admet-2057	227	15	of	of	ADP
admet-2057	227	16	the	the	DET
admet-2057	227	17	bond	bond	NOUN
admet-2057	227	18	breaking	break	VERB
admet-2057	227	19	by	by	ADP
admet-2057	227	20	the	the	DET
admet-2057	227	21	protonation	protonation	NOUN
admet-2057	227	22	.	.	PUNCT
admet-2057	228	1	when	when	SCONJ
admet-2057	228	2	exposed	expose	VERB
admet-2057	228	3	to	to	ADP
admet-2057	228	4	acidic	acidic	ADJ
admet-2057	228	5	circumstances	circumstance	NOUN
admet-2057	228	6	,	,	PUNCT
admet-2057	228	7	mofs	mof	NOUN
admet-2057	228	8	made	make	VERB
admet-2057	228	9	with	with	ADP
admet-2057	228	10	an	an	DET
admet-2057	228	11	organic	organic	ADJ
admet-2057	228	12	ligand	ligand	NOUN
admet-2057	228	13	containing	contain	VERB
admet-2057	228	14	ionizable	ionizable	ADJ
admet-2057	228	15	chemical	chemical	NOUN
admet-2057	228	16	groups	group	NOUN
admet-2057	228	17	are	be	AUX
admet-2057	228	18	prone	prone	ADJ
admet-2057	228	19	to	to	PART
admet-2057	228	20	be	be	AUX
admet-2057	228	21	protonated	protonate	VERB
admet-2057	228	22	for	for	ADP
admet-2057	228	23	charge	charge	NOUN
admet-2057	228	24	reversal	reversal	NOUN
admet-2057	228	25	;	;	PUNCT
admet-2057	228	26	nevertheless	nevertheless	ADV
admet-2057	228	27	,	,	PUNCT
admet-2057	228	28	they	they	PRON
admet-2057	228	29	stay	stay	AUX
admet-2057	228	30	deionized	deionize	VERB
admet-2057	228	31	or	or	CCONJ
admet-2057	228	32	deprotonated	deprotonate	VERB
admet-2057	228	33	when	when	SCONJ
admet-2057	228	34	ph	ph	NOUN
admet-2057	228	35	is	be	AUX
admet-2057	228	36	about	about	ADV
admet-2057	228	37	7.4	7.4	NUM
admet-2057	228	38	.	.	PUNCT
admet-2057	229	1	in	in	ADP
admet-2057	229	2	another	another	DET
admet-2057	229	3	approach	approach	NOUN
admet-2057	229	4	,	,	PUNCT
admet-2057	229	5	the	the	DET
admet-2057	229	6	mofs	mof	NOUN
admet-2057	229	7	are	be	AUX
admet-2057	229	8	attached	attach	VERB
admet-2057	229	9	to	to	ADP
admet-2057	229	10	the	the	DET
admet-2057	229	11	therapeutic	therapeutic	ADJ
admet-2057	229	12	agent	agent	NOUN
admet-2057	229	13	using	use	VERB
admet-2057	229	14	covalent	covalent	ADJ
admet-2057	229	15	bonds	bond	NOUN
admet-2057	229	16	,	,	PUNCT
admet-2057	229	17	which	which	PRON
admet-2057	229	18	results	result	VERB
admet-2057	229	19	in	in	ADP
admet-2057	229	20	a	a	DET
admet-2057	229	21	highly	highly	ADV
admet-2057	229	22	selective	selective	ADJ
admet-2057	229	23	targeting	targeting	NOUN
admet-2057	229	24	response	response	NOUN
admet-2057	229	25	.	.	PUNCT
admet-2057	230	1	this	this	DET
admet-2057	230	2	method	method	NOUN
admet-2057	230	3	involves	involve	VERB
admet-2057	230	4	hydrolysing	hydrolyse	VERB
admet-2057	230	5	acid	acid	NOUN
admet-2057	230	6	labile	labile	ADJ
admet-2057	230	7	bonds	bond	NOUN
admet-2057	230	8	between	between	ADP
admet-2057	230	9	mof	mof	ADJ
admet-2057	230	10	and	and	CCONJ
admet-2057	230	11	therapeutic	therapeutic	ADJ
admet-2057	230	12	agent	agent	NOUN
admet-2057	230	13	at	at	ADP
admet-2057	230	14	low	low	ADJ
admet-2057	230	15	ph	ph	VERB
admet-2057	230	16	,	,	PUNCT
admet-2057	230	17	which	which	PRON
admet-2057	230	18	releases	release	VERB
admet-2057	230	19	the	the	DET
admet-2057	230	20	therapeutics	therapeutic	NOUN
admet-2057	230	21	[	[	X
admet-2057	230	22	61	61	NUM
admet-2057	230	23	]	]	PUNCT
admet-2057	230	24	.	.	PUNCT
admet-2057	231	1	for	for	ADP
admet-2057	231	2	the	the	DET
admet-2057	231	3	first	first	ADJ
admet-2057	231	4	time	time	NOUN
admet-2057	231	5	,	,	PUNCT
admet-2057	231	6	sun	sun	PROPN
admet-2057	231	7	et	et	PROPN
admet-2057	231	8	al	al	PROPN
admet-2057	231	9	.	.	PUNCT
admet-2057	232	1	[	[	X
admet-2057	232	2	62	62	NUM
admet-2057	232	3	]	]	PUNCT
admet-2057	232	4	outlined	outline	VERB
admet-2057	232	5	a	a	DET
admet-2057	232	6	drug	drug	NOUN
admet-2057	232	7	delivery	delivery	NOUN
admet-2057	232	8	system	system	NOUN
admet-2057	232	9	5	5	NUM
admet-2057	232	10	-	-	NUM
admet-2057	232	11	fu@zif-8	fu@zif-8	NOUN
admet-2057	232	12	(	(	PUNCT
admet-2057	232	13	5	5	NUM
admet-2057	232	14	-	-	PUNCT
admet-2057	232	15	fu	fu	NOUN
admet-2057	232	16	=	=	ADJ
admet-2057	232	17	5	5	NUM
admet-2057	232	18	-	-	PUNCT
admet-2057	232	19	fluorouracil	fluorouracil	NOUN
admet-2057	232	20	)	)	PUNCT
admet-2057	232	21	.	.	PUNCT
admet-2057	233	1	for	for	ADP
admet-2057	233	2	this	this	DET
admet-2057	233	3	delivery	delivery	NOUN
admet-2057	233	4	system	system	NOUN
admet-2057	233	5	,	,	PUNCT
admet-2057	233	6	the	the	DET
admet-2057	233	7	induced	induce	VERB
admet-2057	233	8	controlled	control	VERB
admet-2057	233	9	drug	drug	NOUN
admet-2057	233	10	release	release	NOUN
admet-2057	233	11	was	be	AUX
admet-2057	233	12	obtained	obtain	VERB
admet-2057	233	13	and	and	CCONJ
admet-2057	233	14	the	the	DET
admet-2057	233	15	system	system	NOUN
admet-2057	233	16	showed	show	VERB
admet-2057	233	17	a	a	DET
admet-2057	233	18	booming	booming	ADJ
admet-2057	233	19	drug	drug	NOUN
admet-2057	233	20	loading	loading	NOUN
admet-2057	233	21	capacity	capacity	NOUN
admet-2057	233	22	of	of	ADP
admet-2057	233	23	up	up	ADP
admet-2057	233	24	to	to	PART
admet-2057	233	25	60	60	NUM
admet-2057	233	26	%	%	NOUN
admet-2057	233	27	.	.	PUNCT
admet-2057	234	1	the	the	DET
admet-2057	234	2	drug	drug	NOUN
admet-2057	234	3	release	release	NOUN
admet-2057	234	4	experiments	experiment	NOUN
admet-2057	234	5	showed	show	VERB
admet-2057	234	6	that	that	SCONJ
admet-2057	234	7	in	in	ADP
admet-2057	234	8	phosphate	phosphate	ADJ
admet-2057	234	9	buffer	buffer	NOUN
admet-2057	234	10	saline	saline	NOUN
admet-2057	234	11	(	(	PUNCT
admet-2057	234	12	pbs	pbs	PROPN
admet-2057	234	13	)	)	PUNCT
admet-2057	234	14	,	,	PUNCT
admet-2057	234	15	5	5	NUM
admet-2057	234	16	-	-	PUNCT
admet-2057	234	17	fu	fu	NOUN
admet-2057	234	18	demonstrated	demonstrate	VERB
admet-2057	234	19	faster	fast	ADJ
admet-2057	234	20	drug	drug	NOUN
admet-2057	234	21	release	release	NOUN
admet-2057	234	22	at	at	ADP
admet-2057	234	23	ph	ph	NOUN
admet-2057	234	24	5.0	5.0	NUM
admet-2057	234	25	than	than	ADP
admet-2057	234	26	at	at	ADP
admet-2057	234	27	ph	ph	PROPN
admet-2057	234	28	7.4	7.4	NUM
admet-2057	234	29	.	.	PUNCT
admet-2057	235	1	the	the	DET
admet-2057	235	2	percent	percent	NOUN
admet-2057	235	3	drug	drug	NOUN
admet-2057	235	4	release	release	NOUN
admet-2057	235	5	demonstrated	demonstrate	VERB
admet-2057	235	6	that	that	SCONJ
admet-2057	235	7	>	>	ADP
admet-2057	235	8	45	45	NUM
admet-2057	235	9	%	%	NOUN
admet-2057	235	10	of	of	ADP
admet-2057	235	11	drug	drug	NOUN
admet-2057	235	12	release	release	NOUN
admet-2057	235	13	is	be	AUX
admet-2057	235	14	obtained	obtain	VERB
admet-2057	235	15	in	in	ADP
admet-2057	235	16	the	the	DET
admet-2057	235	17	first	first	ADJ
admet-2057	235	18	hour	hour	NOUN
admet-2057	235	19	at	at	ADP
admet-2057	235	20	ph	ph	ADJ
admet-2057	235	21	5.0	5.0	NUM
admet-2057	235	22	,	,	PUNCT
admet-2057	235	23	while	while	SCONJ
admet-2057	235	24	on	on	ADP
admet-2057	235	25	the	the	DET
admet-2057	235	26	other	other	ADJ
admet-2057	235	27	hand	hand	NOUN
admet-2057	235	28	,	,	PUNCT
admet-2057	235	29	only	only	ADV
admet-2057	235	30	17	17	NUM
admet-2057	235	31	%	%	NOUN
admet-2057	235	32	was	be	AUX
admet-2057	235	33	obtained	obtain	VERB
admet-2057	235	34	at	at	ADP
admet-2057	235	35	ph	ph	PROPN
admet-2057	235	36	7.4	7.4	NUM
admet-2057	235	37	.	.	PUNCT
admet-2057	236	1	in	in	ADP
admet-2057	236	2	another	another	DET
admet-2057	236	3	work	work	NOUN
admet-2057	236	4	,	,	PUNCT
admet-2057	236	5	duan	duan	PROPN
admet-2057	236	6	et	et	PROPN
admet-2057	236	7	al	al	PROPN
admet-2057	236	8	.	.	PUNCT
admet-2057	237	1	[	[	X
admet-2057	237	2	60	60	NUM
admet-2057	237	3	]	]	PUNCT
admet-2057	237	4	synthesized	synthesize	VERB
admet-2057	237	5	ph	ph	ADJ
admet-2057	237	6	-	-	PUNCT
admet-2057	237	7	responsive	responsive	ADJ
admet-2057	237	8	nps	nps	PROPN
admet-2057	237	9	based	base	VERB
admet-2057	237	10	on	on	ADP
admet-2057	237	11	mofs	mof	NOUN
admet-2057	237	12	for	for	ADP
admet-2057	237	13	the	the	DET
admet-2057	237	14	delivery	delivery	NOUN
admet-2057	237	15	of	of	ADP
admet-2057	237	16	drugs	drug	NOUN
admet-2057	237	17	.	.	PUNCT
admet-2057	238	1	this	this	DET
admet-2057	238	2	system	system	NOUN
admet-2057	238	3	was	be	AUX
admet-2057	238	4	utilized	utilize	VERB
admet-2057	238	5	for	for	ADP
admet-2057	238	6	cancer	cancer	NOUN
admet-2057	238	7	immunotherapy	immunotherapy	NOUN
admet-2057	238	8	,	,	PUNCT
admet-2057	238	9	containing	contain	VERB
admet-2057	238	10	tumor	tumor	NOUN
admet-2057	238	11	-	-	PUNCT
admet-2057	238	12	associated	associate	VERB
admet-2057	238	13	antigens	antigen	NOUN
admet-2057	238	14	(	(	PUNCT
admet-2057	238	15	taas	taas	NOUN
admet-2057	238	16	)	)	PUNCT
admet-2057	238	17	and	and	CCONJ
admet-2057	238	18	immunostimulatory	immunostimulatory	ADJ
admet-2057	238	19	unmethylated	unmethylated	ADJ
admet-2057	238	20	cytosine	cytosine	NOUN
admet-2057	238	21	phosphateguanine	phosphateguanine	VERB
admet-2057	238	22	oligonucleotide	oligonucleotide	NOUN
admet-2057	238	23	(	(	PUNCT
admet-2057	238	24	cpg	cpg	NOUN
admet-2057	238	25	)	)	PUNCT
admet-2057	238	26	.	.	PUNCT
admet-2057	239	1	at	at	ADP
admet-2057	239	2	ph	ph	PROPN
admet-2057	239	3	5.0	5.0	NUM
admet-2057	239	4	,	,	PUNCT
admet-2057	239	5	around	around	ADV
admet-2057	239	6	60	60	NUM
admet-2057	239	7	%	%	NOUN
admet-2057	239	8	antigen	antigen	NOUN
admet-2057	239	9	release	release	NOUN
admet-2057	239	10	was	be	AUX
admet-2057	239	11	obtained	obtain	VERB
admet-2057	239	12	and	and	CCONJ
admet-2057	239	13	enhanced	enhance	VERB
admet-2057	239	14	antitumor	antitumor	PROPN
admet-2057	239	15	activity	activity	NOUN
admet-2057	239	16	was	be	AUX
admet-2057	239	17	exhibited	exhibit	VERB
admet-2057	239	18	when	when	SCONJ
admet-2057	239	19	in	in	ADP
admet-2057	239	20	-	-	PUNCT
admet-2057	239	21	vivo	vivo	NOUN
admet-2057	239	22	studies	study	NOUN
admet-2057	239	23	were	be	AUX
admet-2057	239	24	carried	carry	VERB
admet-2057	239	25	out	out	ADP
admet-2057	239	26	on	on	ADP
admet-2057	239	27	b16	b16	NOUN
admet-2057	239	28	-	-	PUNCT
admet-2057	239	29	ova	ova	ADJ
admet-2057	239	30	melanoma	melanoma	NOUN
admet-2057	239	31	cancers	cancer	NOUN
admet-2057	239	32	.	.	PUNCT
admet-2057	240	1	in	in	ADP
admet-2057	240	2	the	the	DET
admet-2057	240	3	recent	recent	ADJ
admet-2057	240	4	era	era	NOUN
admet-2057	240	5	,	,	PUNCT
admet-2057	240	6	s.	s.	PROPN
admet-2057	240	7	guillen	guillen	PROPN
admet-2057	240	8	and	and	CCONJ
admet-2057	240	9	his	his	PRON
admet-2057	240	10	team	team	NOUN
admet-2057	240	11	[	[	X
admet-2057	240	12	63	63	NUM
admet-2057	240	13	]	]	PUNCT
admet-2057	240	14	developed	develop	VERB
admet-2057	240	15	the	the	DET
admet-2057	240	16	ph	ph	ADJ
admet-2057	240	17	-	-	ADJ
admet-2057	240	18	responsive	responsive	ADJ
admet-2057	240	19	thin	thin	ADJ
admet-2057	240	20	film	film	NOUN
admet-2057	240	21	mil-88	mil-88	NOUN
admet-2057	240	22	to	to	PART
admet-2057	240	23	analyse	analyse	VERB
admet-2057	240	24	its	its	PRON
admet-2057	240	25	potential	potential	NOUN
admet-2057	240	26	against	against	ADP
admet-2057	240	27	healthy	healthy	ADJ
admet-2057	240	28	and	and	CCONJ
admet-2057	240	29	inflammatory	inflammatory	ADJ
admet-2057	240	30	or	or	CCONJ
admet-2057	240	31	cancerous	cancerous	ADJ
admet-2057	240	32	cells	cell	NOUN
admet-2057	240	33	.	.	PUNCT
admet-2057	241	1	the	the	DET
admet-2057	241	2	real	real	ADJ
admet-2057	241	3	-	-	PUNCT
admet-2057	241	4	time	time	NOUN
admet-2057	241	5	observations	observation	NOUN
admet-2057	241	6	of	of	ADP
admet-2057	241	7	the	the	DET
admet-2057	241	8	designed	design	VERB
admet-2057	241	9	film	film	NOUN
admet-2057	241	10	were	be	AUX
admet-2057	241	11	made	make	VERB
admet-2057	241	12	using	use	VERB
admet-2057	241	13	surface	surface	NOUN
admet-2057	241	14	plasmon	plasmon	NOUN
admet-2057	241	15	resonance	resonance	NOUN
admet-2057	241	16	spectroscopy	spectroscopy	NOUN
admet-2057	241	17	.	.	PUNCT
admet-2057	242	1	the	the	DET
admet-2057	242	2	dissociation	dissociation	NOUN
admet-2057	242	3	constant	constant	ADJ
admet-2057	242	4	of	of	ADP
admet-2057	242	5	the	the	DET
admet-2057	242	6	ph	ph	ADJ
admet-2057	242	7	-	-	PUNCT
admet-2057	242	8	responsive	responsive	ADJ
admet-2057	242	9	film	film	NOUN
admet-2057	242	10	was	be	AUX
admet-2057	242	11	measured	measure	VERB
admet-2057	242	12	in	in	ADP
admet-2057	242	13	an	an	DET
admet-2057	242	14	acidic	acidic	ADJ
admet-2057	242	15	microenvironment	microenvironment	NOUN
admet-2057	242	16	(	(	PUNCT
admet-2057	242	17	ph	ph	NOUN
admet-2057	242	18	6.3	6.3	NUM
admet-2057	242	19	)	)	PUNCT
admet-2057	242	20	,	,	PUNCT
admet-2057	242	21	which	which	PRON
admet-2057	242	22	was	be	AUX
admet-2057	242	23	found	find	VERB
admet-2057	242	24	to	to	PART
admet-2057	242	25	be	be	AUX
admet-2057	242	26	6.10	6.10	NUM
admet-2057	242	27	±	±	NUM
admet-2057	242	28	0.86	0.86	NUM
admet-2057	242	29	ms−1	ms−1	NOUN
admet-2057	242	30	,	,	PUNCT
admet-2057	242	31	while	while	SCONJ
admet-2057	242	32	in	in	ADP
admet-2057	242	33	neutral	neutral	ADJ
admet-2057	242	34	ph	ph	ADJ
admet-2057	242	35	conditions	condition	NOUN
admet-2057	242	36	,	,	PUNCT
admet-2057	242	37	it	it	PRON
admet-2057	242	38	was	be	AUX
admet-2057	242	39	ten	ten	NUM
admet-2057	242	40	times	time	NOUN
admet-2057	242	41	less	less	ADJ
admet-2057	242	42	in	in	ADP
admet-2057	242	43	dissociation	dissociation	NOUN
admet-2057	242	44	than	than	ADP
admet-2057	242	45	in	in	ADP
admet-2057	242	46	an	an	DET
admet-2057	242	47	acidic	acidic	ADJ
admet-2057	242	48	medium	medium	NOUN
admet-2057	242	49	.	.	PUNCT
admet-2057	243	1	the	the	DET
admet-2057	243	2	mil-88	mil-88	NUM
admet-2057	243	3	film	film	NOUN
admet-2057	243	4	was	be	AUX
admet-2057	243	5	also	also	ADV
admet-2057	243	6	examined	examine	VERB
admet-2057	243	7	by	by	ADP
admet-2057	243	8	quartz	quartz	NOUN
admet-2057	243	9	crystal	crystal	PROPN
admet-2057	243	10	microbalance	microbalance	NOUN
admet-2057	243	11	(	(	PUNCT
admet-2057	243	12	qcm	qcm	PROPN
admet-2057	243	13	)	)	PUNCT
admet-2057	243	14	to	to	PART
admet-2057	243	15	demonstrate	demonstrate	VERB
admet-2057	243	16	ibu	ibu	PROPN
admet-2057	243	17	loading	loading	NOUN
admet-2057	243	18	ability	ability	NOUN
admet-2057	243	19	,	,	PUNCT
admet-2057	243	20	which	which	PRON
admet-2057	243	21	was	be	AUX
admet-2057	243	22	nearly	nearly	ADV
admet-2057	243	23	6.0	6.0	NUM
admet-2057	243	24	μg	μg	NOUN
admet-2057	243	25	cm-2	cm-2	NOUN
admet-2057	243	26	.	.	PUNCT
admet-2057	244	1	moreover	moreover	ADV
admet-2057	244	2	,	,	PUNCT
admet-2057	244	3	the	the	DET
admet-2057	244	4	drug	drug	NOUN
admet-2057	244	5	release	release	NOUN
admet-2057	244	6	profile	profile	NOUN
admet-2057	244	7	of	of	ADP
admet-2057	244	8	the	the	DET
admet-2057	244	9	film	film	NOUN
admet-2057	244	10	was	be	AUX
admet-2057	244	11	performed	perform	VERB
admet-2057	244	12	in	in	ADP
admet-2057	244	13	both	both	CCONJ
admet-2057	244	14	acidic	acidic	ADJ
admet-2057	244	15	and	and	CCONJ
admet-2057	244	16	neutral	neutral	ADJ
admet-2057	244	17	ph	ph	ADJ
admet-2057	244	18	conditions	condition	NOUN
admet-2057	244	19	(	(	PUNCT
admet-2057	244	20	ph	ph	NOUN
admet-2057	244	21	6.3	6.3	NUM
admet-2057	244	22	and	and	CCONJ
admet-2057	244	23	7.4	7.4	NUM
admet-2057	244	24	)	)	PUNCT
admet-2057	244	25	,	,	PUNCT
admet-2057	244	26	respectively	respectively	ADV
admet-2057	244	27	,	,	PUNCT
admet-2057	244	28	to	to	PART
admet-2057	244	29	simulate	simulate	VERB
admet-2057	244	30	the	the	DET
admet-2057	244	31	normal	normal	ADJ
admet-2057	244	32	body	body	NOUN
admet-2057	244	33	and	and	CCONJ
admet-2057	244	34	inflammatory	inflammatory	ADJ
admet-2057	244	35	or	or	CCONJ
admet-2057	244	36	cancerous	cancerous	ADJ
admet-2057	244	37	cell	cell	NOUN
admet-2057	244	38	conditions	condition	NOUN
admet-2057	244	39	.	.	PUNCT
admet-2057	245	1	over	over	ADP
admet-2057	245	2	a	a	DET
admet-2057	245	3	span	span	NOUN
admet-2057	245	4	of	of	ADP
admet-2057	245	5	55	55	NUM
admet-2057	245	6	h	h	NOUN
admet-2057	245	7	of	of	ADP
admet-2057	245	8	testing	testing	NOUN
admet-2057	245	9	,	,	PUNCT
admet-2057	245	10	it	it	PRON
admet-2057	245	11	came	come	VERB
admet-2057	245	12	to	to	PART
admet-2057	245	13	light	light	NOUN
admet-2057	245	14	that	that	SCONJ
admet-2057	245	15	the	the	DET
admet-2057	245	16	amount	amount	NOUN
admet-2057	245	17	of	of	ADP
admet-2057	245	18	ibu	ibu	PROPN
admet-2057	245	19	released	release	VERB
admet-2057	245	20	in	in	ADP
admet-2057	245	21	acidic	acidic	ADJ
admet-2057	245	22	ph	ph	ADJ
admet-2057	245	23	settings	setting	NOUN
admet-2057	245	24	was	be	AUX
admet-2057	245	25	much	much	ADV
admet-2057	245	26	larger	large	ADJ
admet-2057	245	27	than	than	ADP
admet-2057	245	28	that	that	PRON
admet-2057	245	29	in	in	ADP
admet-2057	245	30	neutral	neutral	ADJ
admet-2057	245	31	ph	ph	VERB
admet-2057	245	32	,	,	PUNCT
admet-2057	245	33	i.e.	i.e.	X
admet-2057	245	34	,	,	PUNCT
admet-2057	245	35	a	a	DET
admet-2057	245	36	healthy	healthy	ADJ
admet-2057	245	37	body	body	NOUN
admet-2057	245	38	system	system	NOUN
admet-2057	245	39	.	.	PUNCT
admet-2057	246	1	in	in	ADP
admet-2057	246	2	an	an	DET
admet-2057	246	3	acidic	acidic	ADJ
admet-2057	246	4	environment	environment	NOUN
admet-2057	246	5	,	,	PUNCT
admet-2057	246	6	the	the	DET
admet-2057	246	7	cleavage	cleavage	NOUN
admet-2057	246	8	of	of	ADP
admet-2057	246	9	bonds	bond	NOUN
admet-2057	246	10	between	between	ADP
admet-2057	246	11	the	the	DET
admet-2057	246	12	fe3	fe3	NOUN
admet-2057	246	13	+	+	NOUN
admet-2057	246	14	and	and	CCONJ
admet-2057	246	15	carboxylate	carboxylate	NOUN
admet-2057	246	16	ligands	ligand	NOUN
admet-2057	246	17	triggers	trigger	VERB
admet-2057	246	18	the	the	DET
admet-2057	246	19	release	release	NOUN
admet-2057	246	20	of	of	ADP
admet-2057	246	21	ibu	ibu	PROPN
admet-2057	246	22	.	.	PUNCT
admet-2057	247	1	the	the	DET
admet-2057	247	2	findings	finding	NOUN
admet-2057	247	3	of	of	ADP
admet-2057	247	4	the	the	DET
admet-2057	247	5	present	present	ADJ
admet-2057	247	6	study	study	NOUN
admet-2057	247	7	point	point	VERB
admet-2057	247	8	out	out	ADP
admet-2057	247	9	its	its	PRON
admet-2057	247	10	potential	potential	NOUN
admet-2057	247	11	in	in	ADP
admet-2057	247	12	future	future	ADJ
admet-2057	247	13	applications	application	NOUN
admet-2057	247	14	as	as	ADP
admet-2057	247	15	a	a	DET
admet-2057	247	16	ph	ph	ADJ
admet-2057	247	17	-	-	ADJ
admet-2057	247	18	responsive	responsive	ADJ
admet-2057	247	19	mof	mof	ADJ
admet-2057	247	20	device	device	NOUN
admet-2057	247	21	.	.	PUNCT
admet-2057	248	1	in	in	ADP
admet-2057	248	2	2023	2023	NUM
admet-2057	248	3	,	,	PUNCT
admet-2057	248	4	zi	zi	NOUN
admet-2057	248	5	-	-	PROPN
admet-2057	248	6	jian	jian	PROPN
admet-2057	248	7	zhang	zhang	PROPN
admet-2057	248	8	et	et	PROPN
admet-2057	248	9	al	al	PROPN
admet-2057	248	10	.	.	PUNCT
admet-2057	249	1	[	[	X
admet-2057	249	2	64	64	NUM
admet-2057	249	3	]	]	PUNCT
admet-2057	249	4	came	come	VERB
admet-2057	249	5	up	up	ADP
admet-2057	249	6	with	with	ADP
admet-2057	249	7	a	a	DET
admet-2057	249	8	new	new	ADJ
admet-2057	249	9	approach	approach	NOUN
admet-2057	249	10	for	for	ADP
admet-2057	249	11	osteoarthritis	osteoarthritis	NOUN
admet-2057	249	12	(	(	PUNCT
admet-2057	249	13	oa	oa	NOUN
admet-2057	249	14	)	)	PUNCT
admet-2057	249	15	therapy	therapy	NOUN
admet-2057	249	16	via	via	ADP
admet-2057	249	17	the	the	DET
admet-2057	249	18	co	co	NOUN
admet-2057	249	19	-	-	NOUN
admet-2057	249	20	delivery	delivery	NOUN
admet-2057	249	21	of	of	ADP
admet-2057	249	22	ph	ph	ADJ
admet-2057	249	23	-	-	ADJ
admet-2057	249	24	responsive	responsive	ADJ
admet-2057	249	25	mil-101	mil-101	NOUN
admet-2057	249	26	-	-	PUNCT
admet-2057	249	27	nh2	nh2	NOUN
admet-2057	249	28	for	for	ADP
admet-2057	249	29	co	co	NOUN
admet-2057	249	30	-	-	NOUN
admet-2057	249	31	delivery	delivery	NOUN
admet-2057	249	32	of	of	ADP
admet-2057	249	33	curcumin	curcumin	NOUN
admet-2057	249	34	(	(	PUNCT
admet-2057	249	35	ccm	ccm	NOUN
admet-2057	249	36	)	)	PUNCT
admet-2057	249	37	and	and	CCONJ
admet-2057	249	38	small	small	ADJ
admet-2057	249	39	interfering	interfere	VERB
admet-2057	249	40	rna	rna	NOUN
admet-2057	249	41	(	(	PUNCT
admet-2057	249	42	sirna	sirna	PROPN
admet-2057	249	43	)	)	PUNCT
admet-2057	249	44	for	for	ADP
admet-2057	249	45	hypoxia	hypoxia	NOUN
admet-2057	249	46	-	-	PUNCT
admet-2057	249	47	inducible	inducible	ADJ
admet-2057	249	48	factor	factor	NOUN
admet-2057	249	49	(	(	PUNCT
admet-2057	249	50	hif-2α	hif-2α	PROPN
admet-2057	249	51	)	)	PUNCT
admet-2057	249	52	.	.	PUNCT
admet-2057	250	1	hif-2α	hif-2α	NOUN
admet-2057	250	2	aggravates	aggravate	VERB
admet-2057	250	3	the	the	DET
admet-2057	250	4	hypoxia	hypoxia	NOUN
admet-2057	250	5	in	in	ADP
admet-2057	250	6	oa	oa	NOUN
admet-2057	250	7	,	,	PUNCT
admet-2057	250	8	characterised	characterise	VERB
admet-2057	250	9	by	by	ADP
admet-2057	250	10	chronic	chronic	ADJ
admet-2057	250	11	,	,	PUNCT
admet-2057	250	12	severe	severe	ADJ
admet-2057	250	13	inflammation	inflammation	NOUN
admet-2057	250	14	and	and	CCONJ
admet-2057	250	15	irreversible	irreversible	ADJ
admet-2057	250	16	cartilage	cartilage	NOUN
admet-2057	250	17	loss	loss	NOUN
admet-2057	250	18	and	and	CCONJ
admet-2057	250	19	is	be	AUX
admet-2057	250	20	strongly	strongly	ADV
admet-2057	250	21	connected	connect	VERB
admet-2057	250	22	with	with	ADP
admet-2057	250	23	decreased	decrease	VERB
admet-2057	250	24	joint	joint	ADJ
admet-2057	250	25	lubrication	lubrication	NOUN
admet-2057	250	26	effectiveness	effectiveness	NOUN
admet-2057	250	27	.	.	PUNCT
admet-2057	251	1	still	still	ADV
admet-2057	251	2	,	,	PUNCT
admet-2057	251	3	pending	pende	VERB
admet-2057	251	4	concerns	concern	NOUN
admet-2057	251	5	include	include	VERB
admet-2057	251	6	the	the	DET
admet-2057	251	7	poor	poor	ADJ
admet-2057	251	8	response	response	NOUN
admet-2057	251	9	to	to	ADP
admet-2057	251	10	monotherapy	monotherapy	NOUN
admet-2057	251	11	approaches	approach	NOUN
admet-2057	251	12	,	,	PUNCT
admet-2057	251	13	unfavourable	unfavourable	ADJ
admet-2057	251	14	bioavailability	bioavailability	NOUN
admet-2057	251	15	-	-	PUNCT
admet-2057	251	16	induced	induce	VERB
admet-2057	251	17	poor	poor	ADJ
admet-2057	251	18	effectiveness	effectiveness	NOUN
admet-2057	251	19	,	,	PUNCT
admet-2057	251	20	short	short	ADJ
admet-2057	251	21	retention	retention	NOUN
admet-2057	251	22	,	,	PUNCT
admet-2057	251	23	and	and	CCONJ
admet-2057	251	24	inadequate	inadequate	ADJ
admet-2057	251	25	stimulus	stimulus	ADJ
admet-2057	251	26	reactivity	reactivity	NOUN
admet-2057	251	27	.	.	PUNCT
admet-2057	252	1	herein	herein	NOUN
admet-2057	252	2	,	,	PUNCT
admet-2057	252	3	the	the	DET
admet-2057	252	4	si	si	NOUN
admet-2057	252	5	-	-	PUNCT
admet-2057	252	6	rna@ccm	rna@ccm	NOUN
admet-2057	252	7	-	-	PUNCT
admet-2057	252	8	loaded	load	VERB
admet-2057	252	9	-	-	PUNCT
admet-2057	252	10	mil-101nh2	mil-101nh2	NOUN
admet-2057	252	11	system	system	NOUN
admet-2057	252	12	,	,	PUNCT
admet-2057	252	13	designed	design	VERB
admet-2057	252	14	by	by	ADP
admet-2057	252	15	the	the	DET
admet-2057	252	16	encapsulation	encapsulation	NOUN
admet-2057	252	17	of	of	ADP
admet-2057	252	18	ccm	ccm	PROPN
admet-2057	252	19	and	and	CCONJ
admet-2057	252	20	si	si	NOUN
admet-2057	252	21	-	-	NOUN
admet-2057	252	22	rna	rna	NOUN
admet-2057	252	23	in	in	ADP
admet-2057	252	24	mil-101	mil-101	NOUN
admet-2057	252	25	-	-	PUNCT
admet-2057	252	26	nh2	nh2	NOUN
admet-2057	252	27	,	,	PUNCT
admet-2057	252	28	has	have	VERB
admet-2057	252	29	the	the	DET
admet-2057	252	30	ability	ability	NOUN
admet-2057	252	31	to	to	PART
admet-2057	252	32	protect	protect	VERB
admet-2057	252	33	ccm	ccm	NOUN
admet-2057	252	34	and	and	CCONJ
admet-2057	252	35	si	si	NOUN
admet-2057	252	36	-	-	NOUN
admet-2057	252	37	rna	rna	NOUN
admet-2057	252	38	by	by	ADP
admet-2057	252	39	nuclease	nuclease	NOUN
admet-2057	252	40	degradation	degradation	NOUN
admet-2057	252	41	from	from	ADP
admet-2057	252	42	lysosomal	lysosomal	ADJ
admet-2057	252	43	escape	escape	NOUN
admet-2057	252	44	.	.	PUNCT
admet-2057	253	1	in	in	ADP
admet-2057	253	2	acidic	acidic	ADJ
admet-2057	253	3	media	medium	NOUN
admet-2057	253	4	,	,	PUNCT
admet-2057	253	5	the	the	DET
admet-2057	253	6	mil-101	mil-101	NOUN
admet-2057	253	7	-	-	PUNCT
admet-2057	253	8	nh2	nh2	NOUN
admet-2057	253	9	started	start	VERB
admet-2057	253	10	disintegrating	disintegrate	VERB
admet-2057	253	11	,	,	PUNCT
admet-2057	253	12	leading	lead	VERB
admet-2057	253	13	to	to	ADP
admet-2057	253	14	the	the	DET
admet-2057	253	15	release	release	NOUN
admet-2057	253	16	of	of	ADP
admet-2057	253	17	encapsulated	encapsulate	VERB
admet-2057	253	18	ccm	ccm	NOUN
admet-2057	253	19	to	to	AUX
admet-2057	253	20	minimise	minimise	VERB
admet-2057	253	21	pro	pro	ADJ
admet-2057	253	22	-	-	ADJ
admet-2057	253	23	inflammatory	inflammatory	ADJ
admet-2057	253	24	cytokinin	cytokinin	NOUN
admet-2057	253	25	’s	’s	PART
admet-2057	253	26	level	level	NOUN
admet-2057	253	27	while	while	SCONJ
admet-2057	253	28	releasing	release	VERB
admet-2057	253	29	sirna	sirna	PROPN
admet-2057	253	30	in	in	ADP
admet-2057	253	31	order	order	NOUN
admet-2057	253	32	to	to	PART
admet-2057	253	33	act	act	VERB
admet-2057	253	34	as	as	ADP
admet-2057	253	35	gene	gene	NOUN
admet-2057	253	36	-	-	PUNCT
admet-2057	253	37	silencing	silence	VERB
admet-2057	253	38	therapy	therapy	NOUN
admet-2057	253	39	by	by	ADP
admet-2057	253	40	cleaving	cleave	VERB
admet-2057	253	41	the	the	DET
admet-2057	253	42	target	target	NOUN
admet-2057	253	43	hif-2	hif-2	PUNCT
admet-2057	253	44	mrna	mrna	PROPN
admet-2057	253	45	.	.	PUNCT
admet-2057	254	1	eventually	eventually	ADV
admet-2057	254	2	,	,	PUNCT
admet-2057	254	3	demonstrating	demonstrate	VERB
admet-2057	254	4	the	the	DET
admet-2057	254	5	effectiveness	effectiveness	NOUN
admet-2057	254	6	of	of	ADP
admet-2057	254	7	therapy	therapy	NOUN
admet-2057	254	8	through	through	ADP
admet-2057	254	9	the	the	DET
admet-2057	254	10	inhibition	inhibition	NOUN
admet-2057	254	11	of	of	ADP
admet-2057	254	12	oa	oa	NOUN
admet-2057	254	13	's	's	PART
admet-2057	254	14	inflammation	inflammation	ADJ
admet-2057	254	15	mechanism	mechanism	NOUN
admet-2057	254	16	and	and	CCONJ
admet-2057	254	17	cartilage	cartilage	NOUN
admet-2057	254	18	deterioration	deterioration	NOUN
admet-2057	254	19	by	by	ADP
admet-2057	254	20	suppressing	suppress	VERB
admet-2057	254	21	hif-2	hif-2	DET
admet-2057	254	22	genes	gene	NOUN
admet-2057	254	23	,	,	PUNCT
admet-2057	254	24	owing	owe	VERB
admet-2057	254	25	to	to	ADP
admet-2057	254	26	the	the	DET
admet-2057	254	27	findings	finding	NOUN
admet-2057	254	28	of	of	ADP
admet-2057	254	29	in	in	ADP
admet-2057	254	30	-	-	PUNCT
admet-2057	254	31	vitro	vitro	X
admet-2057	254	32	and	and	CCONJ
admet-2057	254	33	in	in	ADP
admet-2057	254	34	-	-	PUNCT
admet-2057	254	35	vivo	vivo	NOUN
admet-2057	254	36	studies	study	NOUN
admet-2057	254	37	,	,	PUNCT
admet-2057	254	38	the	the	DET
admet-2057	254	39	phresponsive	phresponsive	ADJ
admet-2057	254	40	mil-101	mil-101	NOUN
admet-2057	254	41	-	-	PUNCT
admet-2057	254	42	nh2	nh2	NOUN
admet-2057	254	43	has	have	VERB
admet-2057	254	44	potential	potential	NOUN
admet-2057	254	45	for	for	ADP
admet-2057	254	46	oa	oa	PROPN
admet-2057	254	47	therapy	therapy	NOUN
admet-2057	254	48	and	and	CCONJ
admet-2057	254	49	may	may	AUX
admet-2057	254	50	provide	provide	VERB
admet-2057	254	51	a	a	DET
admet-2057	254	52	platform	platform	NOUN
admet-2057	254	53	for	for	ADP
admet-2057	254	54	future	future	ADJ
admet-2057	254	55	oa	oa	PROPN
admet-2057	254	56	therapies	therapy	NOUN
admet-2057	254	57	.	.	PUNCT
admet-2057	255	1	admet	admet	PROPN
admet-2057	255	2	&	&	CCONJ
admet-2057	255	3	dmpk	dmpk	PROPN
admet-2057	255	4	12(1	12(1	PROPN
admet-2057	255	5	)	)	PUNCT
admet-2057	255	6	(	(	PUNCT
admet-2057	255	7	2024	2024	NUM
admet-2057	255	8	)	)	PUNCT
admet-2057	255	9	27	27	NUM
admet-2057	255	10	-	-	SYM
admet-2057	255	11	62	62	NUM
admet-2057	255	12	drug	drug	NOUN
admet-2057	255	13	delivery	delivery	NOUN
admet-2057	255	14	applications	application	NOUN
admet-2057	255	15	of	of	ADP
admet-2057	255	16	metal	metal	NOUN
admet-2057	255	17	-	-	PUNCT
admet-2057	255	18	organic	organic	ADJ
admet-2057	255	19	framework	framework	NOUN
admet-2057	255	20	doi	doi	NOUN
admet-2057	255	21	:	:	PUNCT
admet-2057	255	22	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	VERB
admet-2057	255	23	37	37	NUM
admet-2057	255	24	b.	b.	NOUN
admet-2057	255	25	light	light	NOUN
admet-2057	255	26	responsive	responsive	ADJ
admet-2057	255	27	as	as	ADP
admet-2057	255	28	the	the	DET
admet-2057	255	29	light	light	ADJ
admet-2057	255	30	-	-	PUNCT
admet-2057	255	31	responsive	responsive	ADJ
admet-2057	255	32	approach	approach	NOUN
admet-2057	255	33	has	have	VERB
admet-2057	255	34	the	the	DET
admet-2057	255	35	upper	upper	ADJ
admet-2057	255	36	hand	hand	NOUN
admet-2057	255	37	in	in	ADP
admet-2057	255	38	being	be	AUX
admet-2057	255	39	eco	eco	NOUN
admet-2057	255	40	-	-	PUNCT
admet-2057	255	41	friendly	friendly	ADJ
admet-2057	255	42	,	,	PUNCT
admet-2057	255	43	as	as	ADV
admet-2057	255	44	well	well	ADV
admet-2057	255	45	as	as	ADP
admet-2057	255	46	serving	serve	VERB
admet-2057	255	47	some	some	DET
admet-2057	255	48	advantages	advantage	NOUN
admet-2057	255	49	such	such	ADJ
admet-2057	255	50	as	as	ADP
admet-2057	255	51	spatial	spatial	ADJ
admet-2057	255	52	and	and	CCONJ
admet-2057	255	53	temporal	temporal	ADJ
admet-2057	255	54	control	control	NOUN
admet-2057	255	55	over	over	ADP
admet-2057	255	56	release	release	NOUN
admet-2057	255	57	,	,	PUNCT
admet-2057	255	58	a	a	DET
admet-2057	255	59	non	non	ADJ
admet-2057	255	60	-	-	ADJ
admet-2057	255	61	invasive	invasive	ADJ
admet-2057	255	62	approach	approach	NOUN
admet-2057	255	63	,	,	PUNCT
admet-2057	255	64	easy	easy	ADJ
admet-2057	255	65	fine	fine	NOUN
admet-2057	255	66	-	-	PUNCT
admet-2057	255	67	tuning	tuning	NOUN
admet-2057	255	68	,	,	PUNCT
admet-2057	255	69	and	and	CCONJ
admet-2057	255	70	operability	operability	NOUN
admet-2057	255	71	,	,	PUNCT
admet-2057	255	72	it	it	PRON
admet-2057	255	73	has	have	AUX
admet-2057	255	74	gained	gain	VERB
admet-2057	255	75	many	many	ADJ
admet-2057	255	76	researchers	researcher	NOUN
admet-2057	255	77	limelight	limelight	VERB
admet-2057	255	78	for	for	ADP
admet-2057	255	79	designing	design	VERB
admet-2057	255	80	drug	drug	NOUN
admet-2057	255	81	delivery	delivery	NOUN
admet-2057	255	82	applications	application	NOUN
admet-2057	255	83	[	[	X
admet-2057	255	84	65	65	NUM
admet-2057	255	85	]	]	PUNCT
admet-2057	255	86	.	.	PUNCT
admet-2057	256	1	all	all	DET
admet-2057	256	2	these	these	DET
admet-2057	256	3	applications	application	NOUN
admet-2057	256	4	considered	consider	VERB
admet-2057	256	5	,	,	PUNCT
admet-2057	256	6	the	the	DET
admet-2057	256	7	light	light	ADJ
admet-2057	256	8	-	-	PUNCT
admet-2057	256	9	responsive	responsive	ADJ
admet-2057	256	10	approach	approach	NOUN
admet-2057	256	11	has	have	AUX
admet-2057	256	12	been	be	AUX
admet-2057	256	13	used	use	VERB
admet-2057	256	14	to	to	PART
admet-2057	256	15	deliver	deliver	VERB
admet-2057	256	16	the	the	DET
admet-2057	256	17	mofs	mof	NOUN
admet-2057	256	18	to	to	PART
admet-2057	256	19	attain	attain	VERB
admet-2057	256	20	spatiotemporal	spatiotemporal	ADJ
admet-2057	256	21	delivery	delivery	NOUN
admet-2057	256	22	.	.	PUNCT
admet-2057	257	1	the	the	DET
admet-2057	257	2	prime	prime	ADJ
admet-2057	257	3	mechanism	mechanism	NOUN
admet-2057	257	4	involved	involve	VERB
admet-2057	257	5	in	in	ADP
admet-2057	257	6	light	light	ADJ
admet-2057	257	7	-	-	PUNCT
admet-2057	257	8	responsive	responsive	ADJ
admet-2057	257	9	delivery	delivery	NOUN
admet-2057	257	10	is	be	AUX
admet-2057	257	11	the	the	DET
admet-2057	257	12	light	light	ADV
admet-2057	257	13	-	-	PUNCT
admet-2057	257	14	mediated	mediate	VERB
admet-2057	257	15	chemical	chemical	NOUN
admet-2057	257	16	bond	bond	NOUN
admet-2057	257	17	cleavage	cleavage	NOUN
admet-2057	257	18	,	,	PUNCT
admet-2057	257	19	reversible	reversible	ADJ
admet-2057	257	20	or	or	CCONJ
admet-2057	257	21	irreversible	irreversible	ADJ
admet-2057	257	22	conformational	conformational	ADJ
admet-2057	257	23	changes	change	NOUN
admet-2057	257	24	or	or	CCONJ
admet-2057	257	25	photothermal	photothermal	ADJ
admet-2057	257	26	transformation	transformation	NOUN
admet-2057	257	27	of	of	ADP
admet-2057	257	28	molecules	molecule	NOUN
admet-2057	257	29	or	or	CCONJ
admet-2057	257	30	groups	group	NOUN
admet-2057	257	31	[	[	X
admet-2057	257	32	66	66	NUM
admet-2057	257	33	]	]	PUNCT
admet-2057	257	34	.	.	PUNCT
admet-2057	258	1	also	also	ADV
admet-2057	258	2	,	,	PUNCT
admet-2057	258	3	the	the	DET
admet-2057	258	4	ligand	ligand	NOUN
admet-2057	258	5	-	-	PUNCT
admet-2057	258	6	based	base	VERB
admet-2057	258	7	approach	approach	NOUN
admet-2057	258	8	can	can	AUX
admet-2057	258	9	be	be	AUX
admet-2057	258	10	utilized	utilize	VERB
admet-2057	258	11	for	for	ADP
admet-2057	258	12	designing	design	VERB
admet-2057	258	13	light	light	ADJ
admet-2057	258	14	-	-	PUNCT
admet-2057	258	15	responsive	responsive	ADJ
admet-2057	258	16	mofs	mof	NOUN
admet-2057	258	17	by	by	ADP
admet-2057	258	18	incorporating	incorporate	VERB
admet-2057	258	19	light	light	ADJ
admet-2057	258	20	-	-	PUNCT
admet-2057	258	21	responsive	responsive	ADJ
admet-2057	258	22	molecules	molecule	NOUN
admet-2057	258	23	as	as	ADP
admet-2057	258	24	ligands	ligand	NOUN
admet-2057	258	25	.	.	PUNCT
admet-2057	259	1	for	for	ADP
admet-2057	259	2	attaining	attain	VERB
admet-2057	259	3	light	light	ADJ
admet-2057	259	4	-	-	PUNCT
admet-2057	259	5	responsive	responsive	ADJ
admet-2057	259	6	mofs	mof	NOUN
admet-2057	259	7	like	like	ADP
admet-2057	259	8	uio	uio	PROPN
admet-2057	259	9	-	-	PUNCT
admet-2057	259	10	abz	abz	PROPN
admet-2057	259	11	and	and	CCONJ
admet-2057	259	12	porphyrin	porphyrin	NOUN
admet-2057	259	13	mofs	mof	NOUN
admet-2057	259	14	,	,	PUNCT
admet-2057	259	15	approaches	approach	NOUN
admet-2057	259	16	like	like	ADP
admet-2057	259	17	integrating	integrate	VERB
admet-2057	259	18	photoactive	photoactive	ADJ
admet-2057	259	19	moieties	moiety	NOUN
admet-2057	259	20	like	like	ADP
admet-2057	259	21	indocyanine	indocyanine	NOUN
admet-2057	259	22	green	green	NOUN
admet-2057	259	23	(	(	PUNCT
admet-2057	259	24	icg	icg	NOUN
admet-2057	259	25	)	)	PUNCT
admet-2057	259	26	,	,	PUNCT
admet-2057	259	27	porphyrin	porphyrin	NOUN
admet-2057	259	28	,	,	PUNCT
admet-2057	259	29	anthracene	anthracene	VERB
admet-2057	259	30	and	and	CCONJ
admet-2057	259	31	its	its	PRON
admet-2057	259	32	derivatives	derivative	NOUN
admet-2057	259	33	and	and	CCONJ
admet-2057	259	34	,	,	PUNCT
admet-2057	259	35	azobenzenedicarboxylate	azobenzenedicarboxylate	NOUN
admet-2057	259	36	(	(	PUNCT
admet-2057	259	37	azb	azb	PROPN
admet-2057	259	38	)	)	PUNCT
admet-2057	259	39	into	into	ADP
admet-2057	259	40	the	the	DET
admet-2057	259	41	mof	mof	ADJ
admet-2057	259	42	structure	structure	NOUN
admet-2057	259	43	or	or	CCONJ
admet-2057	259	44	by	by	ADP
admet-2057	259	45	scheming	scheme	VERB
admet-2057	259	46	reactive	reactive	ADJ
admet-2057	259	47	oxygen	oxygen	NOUN
admet-2057	259	48	species	specie	NOUN
admet-2057	259	49	are	be	AUX
admet-2057	259	50	being	be	AUX
admet-2057	259	51	utilized	utilize	VERB
admet-2057	259	52	.	.	PUNCT
admet-2057	260	1	these	these	DET
admet-2057	260	2	systems	system	NOUN
admet-2057	260	3	can	can	AUX
admet-2057	260	4	generate	generate	VERB
admet-2057	260	5	singlet	singlet	ADJ
admet-2057	260	6	oxygen	oxygen	NOUN
admet-2057	260	7	(	(	PUNCT
admet-2057	260	8	1o2	1o2	NUM
admet-2057	260	9	)	)	PUNCT
admet-2057	260	10	in	in	ADP
admet-2057	260	11	the	the	DET
admet-2057	260	12	presence	presence	NOUN
admet-2057	260	13	of	of	ADP
admet-2057	260	14	visible	visible	ADJ
admet-2057	260	15	and	and	CCONJ
admet-2057	260	16	nir	nir	NOUN
admet-2057	260	17	,	,	PUNCT
admet-2057	260	18	which	which	PRON
admet-2057	260	19	abolishes	abolish	VERB
admet-2057	260	20	mof	mof	ADJ
admet-2057	260	21	structure	structure	NOUN
admet-2057	260	22	to	to	PART
admet-2057	260	23	release	release	VERB
admet-2057	260	24	drug	drug	NOUN
admet-2057	260	25	molecules	molecule	NOUN
admet-2057	260	26	.	.	PUNCT
admet-2057	261	1	this	this	DET
admet-2057	261	2	approach	approach	NOUN
admet-2057	261	3	is	be	AUX
admet-2057	261	4	collectively	collectively	ADV
admet-2057	261	5	recognized	recognize	VERB
admet-2057	261	6	as	as	ADP
admet-2057	261	7	photodynamic	photodynamic	ADJ
admet-2057	261	8	therapy	therapy	NOUN
admet-2057	261	9	[	[	X
admet-2057	261	10	66	66	NUM
admet-2057	261	11	-	-	SYM
admet-2057	261	12	68	68	NUM
admet-2057	261	13	]	]	PUNCT
admet-2057	261	14	.	.	PUNCT
admet-2057	262	1	in	in	ADP
admet-2057	262	2	line	line	NOUN
admet-2057	262	3	with	with	ADP
admet-2057	262	4	this	this	PRON
admet-2057	262	5	,	,	PUNCT
admet-2057	262	6	park	park	NOUN
admet-2057	262	7	et	et	PROPN
admet-2057	262	8	al	al	PROPN
admet-2057	262	9	.	.	PUNCT
admet-2057	263	1	[	[	X
admet-2057	263	2	69	69	NUM
admet-2057	263	3	]	]	X
admet-2057	263	4	utilized	utilize	VERB
admet-2057	263	5	photodynamic	photodynamic	ADJ
admet-2057	263	6	therapy	therapy	NOUN
admet-2057	263	7	for	for	ADP
admet-2057	263	8	targeted	target	VERB
admet-2057	263	9	delivery	delivery	NOUN
admet-2057	263	10	by	by	ADP
admet-2057	263	11	intending	intend	VERB
admet-2057	263	12	nir	nir	ADJ
admet-2057	263	13	light	light	ADV
admet-2057	263	14	-	-	PUNCT
admet-2057	263	15	induced	induce	VERB
admet-2057	263	16	reactive	reactive	ADJ
admet-2057	263	17	oxygen	oxygen	NOUN
admet-2057	263	18	species	specie	NOUN
admet-2057	263	19	(	(	PUNCT
admet-2057	263	20	ros	ros	PROPN
admet-2057	263	21	)	)	PUNCT
admet-2057	263	22	generating	generate	VERB
admet-2057	263	23	zr(iv)-based	zr(iv)-based	ADJ
admet-2057	263	24	porphyrinic	porphyrinic	ADJ
admet-2057	263	25	mof	mof	X
admet-2057	263	26	(	(	PUNCT
admet-2057	263	27	zr	zr	NOUN
admet-2057	263	28	-	-	PUNCT
admet-2057	263	29	mof	mof	ADJ
admet-2057	263	30	)	)	PUNCT
admet-2057	263	31	.	.	PUNCT
admet-2057	264	1	these	these	DET
admet-2057	264	2	mofs	mof	NOUN
admet-2057	264	3	had	have	VERB
admet-2057	264	4	the	the	DET
admet-2057	264	5	ability	ability	NOUN
admet-2057	264	6	to	to	PART
admet-2057	264	7	accumulate	accumulate	VERB
admet-2057	264	8	at	at	ADP
admet-2057	264	9	tumor	tumor	NOUN
admet-2057	264	10	sites	site	NOUN
admet-2057	264	11	through	through	ADP
admet-2057	264	12	enhanced	enhanced	ADJ
admet-2057	264	13	permeability	permeability	NOUN
admet-2057	264	14	and	and	CCONJ
admet-2057	264	15	retention	retention	NOUN
admet-2057	264	16	(	(	PUNCT
admet-2057	264	17	epr	epr	ADJ
admet-2057	264	18	)	)	PUNCT
admet-2057	264	19	effects	effect	NOUN
admet-2057	264	20	upon	upon	SCONJ
admet-2057	264	21	injecting	inject	VERB
admet-2057	264	22	.	.	PUNCT
admet-2057	265	1	while	while	SCONJ
admet-2057	265	2	targeting	target	VERB
admet-2057	265	3	ability	ability	NOUN
admet-2057	265	4	is	be	AUX
admet-2057	265	5	unsatisfactory	unsatisfactory	ADJ
admet-2057	265	6	,	,	PUNCT
admet-2057	265	7	there	there	PRON
admet-2057	265	8	may	may	AUX
admet-2057	265	9	be	be	AUX
admet-2057	265	10	an	an	DET
admet-2057	265	11	increased	increase	VERB
admet-2057	265	12	chance	chance	NOUN
admet-2057	265	13	of	of	ADP
admet-2057	265	14	side	side	NOUN
admet-2057	265	15	effects	effect	NOUN
admet-2057	265	16	.	.	PUNCT
admet-2057	266	1	to	to	PART
admet-2057	266	2	overcome	overcome	VERB
admet-2057	266	3	this	this	DET
admet-2057	266	4	challenge	challenge	NOUN
admet-2057	266	5	,	,	PUNCT
admet-2057	266	6	folic	folic	ADJ
admet-2057	266	7	acid	acid	NOUN
admet-2057	266	8	modification	modification	NOUN
admet-2057	266	9	of	of	ADP
admet-2057	266	10	zr	zr	PROPN
admet-2057	266	11	-	-	ADJ
admet-2057	266	12	mof	mof	PROPN
admet-2057	266	13	was	be	AUX
admet-2057	266	14	done	do	VERB
admet-2057	266	15	,	,	PUNCT
admet-2057	266	16	which	which	PRON
admet-2057	266	17	resulted	result	VERB
admet-2057	266	18	in	in	ADP
admet-2057	266	19	improved	improved	ADJ
admet-2057	266	20	targeting	target	VERB
admet-2057	266	21	and	and	CCONJ
admet-2057	266	22	improved	improve	VERB
admet-2057	266	23	photodynamic	photodynamic	ADJ
admet-2057	266	24	therapy	therapy	NOUN
admet-2057	266	25	efficacy	efficacy	NOUN
admet-2057	266	26	.	.	PUNCT
admet-2057	267	1	in	in	ADP
admet-2057	267	2	another	another	DET
admet-2057	267	3	case	case	NOUN
admet-2057	267	4	,	,	PUNCT
admet-2057	267	5	liu	liu	PROPN
admet-2057	267	6	and	and	CCONJ
admet-2057	267	7	co	co	NOUN
admet-2057	267	8	-	-	NOUN
admet-2057	267	9	workers	worker	NOUN
admet-2057	267	10	[	[	X
admet-2057	267	11	70	70	NUM
admet-2057	267	12	]	]	PUNCT
admet-2057	267	13	designed	design	VERB
admet-2057	267	14	the	the	DET
admet-2057	267	15	double	double	ADJ
admet-2057	267	16	silica	silica	NOUN
admet-2057	267	17	-	-	PUNCT
admet-2057	267	18	shelled	shell	VERB
admet-2057	267	19	upconversion	upconversion	NOUN
admet-2057	267	20	nanoparticles	nanoparticle	NOUN
admet-2057	267	21	(	(	PUNCT
admet-2057	267	22	ucnps	ucnps	ADJ
admet-2057	267	23	)	)	PUNCT
admet-2057	267	24	nanostructure	nanostructure	PROPN
admet-2057	267	25	proficient	proficient	NOUN
admet-2057	267	26	at	at	ADP
admet-2057	267	27	delivering	deliver	VERB
admet-2057	267	28	bio	bio	ADJ
admet-2057	267	29	-	-	PUNCT
admet-2057	267	30	reductive	reductive	ADJ
admet-2057	267	31	tirapazamine	tirapazamine	NOUN
admet-2057	267	32	(	(	PUNCT
admet-2057	267	33	tpz	tpz	NOUN
admet-2057	267	34	,	,	PUNCT
admet-2057	267	35	a	a	DET
admet-2057	267	36	prodrug	prodrug	NOUN
admet-2057	267	37	)	)	PUNCT
admet-2057	267	38	and	and	CCONJ
admet-2057	267	39	photosensitizer	photosensitizer	NOUN
admet-2057	267	40	(	(	PUNCT
admet-2057	267	41	ps	ps	NOUN
admet-2057	267	42	)	)	PUNCT
admet-2057	267	43	molecules	molecule	NOUN
admet-2057	267	44	.	.	PUNCT
admet-2057	268	1	this	this	DET
admet-2057	268	2	system	system	NOUN
admet-2057	268	3	could	could	AUX
admet-2057	268	4	achieve	achieve	VERB
admet-2057	268	5	a	a	DET
admet-2057	268	6	synergistic	synergistic	ADJ
admet-2057	268	7	effect	effect	NOUN
admet-2057	268	8	first	first	ADV
admet-2057	268	9	by	by	ADP
admet-2057	268	10	uc	uc	PROPN
admet-2057	268	11	-	-	PUNCT
admet-2057	268	12	based	base	VERB
admet-2057	268	13	photodynamic	photodynamic	ADJ
admet-2057	268	14	therapy	therapy	NOUN
admet-2057	268	15	under	under	ADP
admet-2057	268	16	a	a	DET
admet-2057	268	17	standard	standard	ADJ
admet-2057	268	18	oxygen	oxygen	NOUN
admet-2057	268	19	environment	environment	NOUN
admet-2057	268	20	and	and	CCONJ
admet-2057	268	21	when	when	SCONJ
admet-2057	268	22	oxygen	oxygen	NOUN
admet-2057	268	23	is	be	AUX
admet-2057	268	24	depleted	deplete	VERB
admet-2057	268	25	by	by	ADP
admet-2057	268	26	uc	uc	PROPN
admet-2057	268	27	-	-	PUNCT
admet-2057	268	28	pdt	pdt	PROPN
admet-2057	268	29	,	,	PUNCT
admet-2057	268	30	the	the	DET
admet-2057	268	31	cytotoxicity	cytotoxicity	NOUN
admet-2057	268	32	of	of	ADP
admet-2057	268	33	activated	activated	ADJ
admet-2057	268	34	tpz	tpz	NOUN
admet-2057	268	35	is	be	AUX
admet-2057	268	36	then	then	ADV
admet-2057	268	37	produced	produce	VERB
admet-2057	268	38	.	.	PUNCT
admet-2057	269	1	in	in	ADP
admet-2057	269	2	contrast	contrast	NOUN
admet-2057	269	3	to	to	ADP
admet-2057	269	4	uc	uc	NOUN
admet-2057	269	5	-	-	PUNCT
admet-2057	269	6	pdt	pdt	PROPN
admet-2057	269	7	alone	alone	ADV
admet-2057	269	8	,	,	PUNCT
admet-2057	269	9	treatment	treatment	NOUN
admet-2057	269	10	with	with	ADP
admet-2057	269	11	tpz	tpz	NOUN
admet-2057	269	12	-	-	PUNCT
admet-2057	269	13	uc	uc	ADJ
admet-2057	269	14	/	/	SYM
admet-2057	269	15	ps	ps	NOUN
admet-2057	269	16	and	and	CCONJ
admet-2057	269	17	nir	nir	ADJ
admet-2057	269	18	laser	laser	NOUN
admet-2057	269	19	resulted	result	VERB
admet-2057	269	20	in	in	ADP
admet-2057	269	21	noticeably	noticeably	ADV
admet-2057	269	22	decreased	decrease	VERB
admet-2057	269	23	tumour	tumour	NOUN
admet-2057	269	24	growth	growth	NOUN
admet-2057	269	25	,	,	PUNCT
admet-2057	269	26	suggesting	suggest	VERB
admet-2057	269	27	that	that	SCONJ
admet-2057	269	28	the	the	DET
admet-2057	269	29	way	way	NOUN
admet-2057	269	30	tpz	tpz	NOUN
admet-2057	269	31	is	be	AUX
admet-2057	269	32	given	give	VERB
admet-2057	269	33	has	have	VERB
admet-2057	269	34	a	a	DET
admet-2057	269	35	significant	significant	ADJ
admet-2057	269	36	impact	impact	NOUN
admet-2057	269	37	on	on	ADP
admet-2057	269	38	the	the	DET
admet-2057	269	39	effectiveness	effectiveness	NOUN
admet-2057	269	40	of	of	ADP
admet-2057	269	41	treatments	treatment	NOUN
admet-2057	269	42	for	for	ADP
admet-2057	269	43	the	the	DET
admet-2057	269	44	much	much	ADV
admet-2057	269	45	-	-	PUNCT
admet-2057	269	46	amended	amend	VERB
admet-2057	269	47	cytotoxicity	cytotoxicity	NOUN
admet-2057	269	48	of	of	ADP
admet-2057	269	49	tpz	tpz	NOUN
admet-2057	269	50	under	under	ADP
admet-2057	269	51	pdt	pdt	NOUN
admet-2057	269	52	-	-	PUNCT
admet-2057	269	53	induced	induce	VERB
admet-2057	269	54	hypoxia	hypoxia	NOUN
admet-2057	269	55	.	.	PUNCT
admet-2057	270	1	in	in	ADP
admet-2057	270	2	2018	2018	NUM
admet-2057	270	3	,	,	PUNCT
admet-2057	270	4	dandan	dandan	PROPN
admet-2057	270	5	xu	xu	PROPN
admet-2057	271	1	[	[	X
admet-2057	271	2	71	71	NUM
admet-2057	271	3	]	]	PUNCT
admet-2057	271	4	created	create	VERB
admet-2057	271	5	the	the	DET
admet-2057	271	6	znpc@zif-8	znpc@zif-8	PROPN
admet-2057	271	7	with	with	ADP
admet-2057	271	8	a	a	DET
admet-2057	271	9	one	one	NUM
admet-2057	271	10	-	-	PUNCT
admet-2057	271	11	step	step	NOUN
admet-2057	271	12	coprecipitation	coprecipitation	NOUN
admet-2057	271	13	approach	approach	NOUN
admet-2057	271	14	.	.	PUNCT
admet-2057	272	1	znpc@zif-8	znpc@zif-8	PROPN
admet-2057	272	2	contains	contain	VERB
admet-2057	272	3	the	the	DET
admet-2057	272	4	waterinsoluble	waterinsoluble	ADJ
admet-2057	272	5	photosensitizer	photosensitizer	NOUN
admet-2057	272	6	zinc(ii	zinc(ii	NUM
admet-2057	272	7	)	)	PUNCT
admet-2057	272	8	phthalocyanine	phthalocyanine	NOUN
admet-2057	272	9	(	(	PUNCT
admet-2057	272	10	znpc	znpc	NOUN
admet-2057	272	11	)	)	PUNCT
admet-2057	272	12	,	,	PUNCT
admet-2057	272	13	a	a	DET
admet-2057	272	14	typical	typical	ADJ
admet-2057	272	15	hydrophobic	hydrophobic	NOUN
admet-2057	272	16	ps	ps	NOUN
admet-2057	272	17	.	.	PROPN
admet-2057	272	18	zif-8	zif-8	NOUN
admet-2057	272	19	's	's	PART
admet-2057	272	20	micropores	micropore	NOUN
admet-2057	272	21	serve	serve	VERB
admet-2057	272	22	as	as	ADP
admet-2057	272	23	molecular	molecular	ADJ
admet-2057	272	24	cages	cage	NOUN
admet-2057	272	25	that	that	PRON
admet-2057	272	26	keep	keep	VERB
admet-2057	272	27	hydrophobic	hydrophobic	NOUN
admet-2057	272	28	znpc	znpc	NOUN
admet-2057	272	29	monomeric	monomeric	ADJ
admet-2057	272	30	and	and	CCONJ
admet-2057	272	31	prevent	prevent	VERB
admet-2057	272	32	it	it	PRON
admet-2057	272	33	from	from	ADP
admet-2057	272	34	self	self	NOUN
admet-2057	272	35	-	-	PUNCT
admet-2057	272	36	aggregating	aggregating	NOUN
admet-2057	272	37	.	.	PUNCT
admet-2057	273	1	this	this	PRON
admet-2057	273	2	allows	allow	VERB
admet-2057	273	3	the	the	DET
admet-2057	273	4	encapsulated	encapsulate	VERB
admet-2057	273	5	znpc	znpc	NOUN
admet-2057	273	6	to	to	PART
admet-2057	273	7	produce	produce	VERB
admet-2057	273	8	lethal	lethal	ADJ
admet-2057	273	9	1o2	1o2	NUM
admet-2057	273	10	in	in	ADP
admet-2057	273	11	the	the	DET
admet-2057	273	12	presence	presence	NOUN
admet-2057	273	13	of	of	ADP
admet-2057	273	14	light	light	ADJ
admet-2057	273	15	irradiation	irradiation	NOUN
admet-2057	273	16	(	(	PUNCT
admet-2057	273	17	650	650	NUM
admet-2057	273	18	nm	nm	NOUN
admet-2057	273	19	)	)	PUNCT
admet-2057	273	20	in	in	ADP
admet-2057	273	21	an	an	DET
admet-2057	273	22	aqueous	aqueous	ADJ
admet-2057	273	23	environment	environment	NOUN
admet-2057	273	24	.	.	PUNCT
admet-2057	274	1	cancer	cancer	NOUN
admet-2057	274	2	cells	cell	NOUN
admet-2057	274	3	can	can	AUX
admet-2057	274	4	endocytoze	endocytoze	VERB
admet-2057	274	5	the	the	DET
admet-2057	274	6	znpc@zif-8	znpc@zif-8	PROPN
admet-2057	274	7	nano	nano	NOUN
admet-2057	274	8	-	-	PUNCT
admet-2057	274	9	system	system	NOUN
admet-2057	274	10	that	that	PRON
admet-2057	274	11	has	have	AUX
admet-2057	274	12	been	be	AUX
admet-2057	274	13	created	create	VERB
admet-2057	274	14	,	,	PUNCT
admet-2057	274	15	and	and	CCONJ
admet-2057	274	16	it	it	PRON
admet-2057	274	17	exhibits	exhibit	VERB
admet-2057	274	18	red	red	ADJ
admet-2057	274	19	fluorescence	fluorescence	NOUN
admet-2057	274	20	emission	emission	NOUN
admet-2057	274	21	with	with	ADP
admet-2057	274	22	good	good	ADJ
admet-2057	274	23	photodynamic	photodynamic	ADJ
admet-2057	274	24	activity	activity	NOUN
admet-2057	274	25	for	for	ADP
admet-2057	274	26	cancer	cancer	NOUN
admet-2057	274	27	therapy	therapy	NOUN
admet-2057	274	28	in	in	ADP
admet-2057	274	29	vitro	vitro	X
admet-2057	274	30	.	.	PUNCT
admet-2057	275	1	the	the	DET
admet-2057	275	2	self	self	NOUN
admet-2057	275	3	-	-	PUNCT
admet-2057	275	4	quenching	quenching	NOUN
admet-2057	275	5	of	of	ADP
admet-2057	275	6	znpc	znpc	NOUN
admet-2057	275	7	's	's	PART
admet-2057	275	8	fluorescence	fluorescence	NOUN
admet-2057	275	9	emission	emission	NOUN
admet-2057	275	10	can	can	AUX
admet-2057	275	11	also	also	ADV
admet-2057	275	12	be	be	AUX
admet-2057	275	13	used	use	VERB
admet-2057	275	14	to	to	PART
admet-2057	275	15	monitor	monitor	VERB
admet-2057	275	16	the	the	DET
admet-2057	275	17	acid	acid	NOUN
admet-2057	275	18	sensitivity	sensitivity	NOUN
admet-2057	275	19	of	of	ADP
admet-2057	275	20	znpc@zif-8	znpc@zif-8	PROPN
admet-2057	275	21	,	,	PUNCT
admet-2057	275	22	which	which	PRON
admet-2057	275	23	would	would	AUX
admet-2057	275	24	fully	fully	ADV
admet-2057	275	25	degenerate	degenerate	VERB
admet-2057	275	26	following	follow	VERB
admet-2057	275	27	pdt	pdt	PROPN
admet-2057	275	28	.	.	PUNCT
admet-2057	276	1	the	the	DET
admet-2057	276	2	use	use	NOUN
admet-2057	276	3	of	of	ADP
admet-2057	276	4	mofs	mof	NOUN
admet-2057	276	5	as	as	SCONJ
admet-2057	276	6	nano	nano	NOUN
admet-2057	276	7	-	-	NOUN
admet-2057	276	8	carriers	carrier	NOUN
admet-2057	276	9	in	in	ADP
admet-2057	276	10	this	this	DET
admet-2057	276	11	research	research	NOUN
admet-2057	276	12	provides	provide	VERB
admet-2057	276	13	the	the	DET
admet-2057	276	14	path	path	NOUN
admet-2057	276	15	for	for	ADP
admet-2057	276	16	an	an	DET
admet-2057	276	17	easy	easy	ADJ
admet-2057	276	18	solution	solution	NOUN
admet-2057	276	19	to	to	ADP
admet-2057	276	20	the	the	DET
admet-2057	276	21	issue	issue	NOUN
admet-2057	276	22	of	of	ADP
admet-2057	276	23	the	the	DET
admet-2057	276	24	solubility	solubility	NOUN
admet-2057	276	25	and	and	CCONJ
admet-2057	276	26	bioavailability	bioavailability	NOUN
admet-2057	276	27	of	of	ADP
admet-2057	276	28	hydrophobic	hydrophobic	NOUN
admet-2057	276	29	ps	ps	NOUN
admet-2057	276	30	.	.	PUNCT
admet-2057	277	1	in	in	ADP
admet-2057	277	2	2019	2019	NUM
admet-2057	277	3	,	,	PUNCT
admet-2057	277	4	aziza	aziza	PROPN
admet-2057	277	5	sharsheeva	sharsheeva	PROPN
admet-2057	277	6	and	and	CCONJ
admet-2057	277	7	coworkers	coworker	NOUN
admet-2057	278	1	[	[	X
admet-2057	278	2	72	72	NUM
admet-2057	278	3	]	]	PUNCT
admet-2057	278	4	proposed	propose	VERB
admet-2057	278	5	a	a	DET
admet-2057	278	6	study	study	NOUN
admet-2057	278	7	in	in	ADP
admet-2057	278	8	which	which	PRON
admet-2057	278	9	the	the	DET
admet-2057	278	10	research	research	NOUN
admet-2057	278	11	team	team	NOUN
admet-2057	278	12	combined	combine	VERB
admet-2057	278	13	drug	drug	NOUN
admet-2057	278	14	delivery	delivery	NOUN
admet-2057	278	15	nanocarriers	nanocarrier	VERB
admet-2057	278	16	with	with	ADP
admet-2057	278	17	a	a	DET
admet-2057	278	18	semiconductor	semiconductor	NOUN
admet-2057	278	19	photocatalytic	photocatalytic	ADJ
admet-2057	278	20	component	component	NOUN
admet-2057	278	21	that	that	PRON
admet-2057	278	22	could	could	AUX
admet-2057	278	23	produce	produce	VERB
admet-2057	278	24	a	a	DET
admet-2057	278	25	local	local	ADJ
admet-2057	278	26	ph	ph	NOUN
admet-2057	278	27	gradient	gradient	NOUN
admet-2057	278	28	in	in	ADP
admet-2057	278	29	response	response	NOUN
admet-2057	278	30	to	to	ADP
admet-2057	278	31	electromagnetic	electromagnetic	ADJ
admet-2057	278	32	radiation	radiation	NOUN
admet-2057	278	33	from	from	ADP
admet-2057	278	34	the	the	DET
admet-2057	278	35	outside	outside	NOUN
admet-2057	278	36	.	.	PUNCT
admet-2057	279	1	to	to	PART
admet-2057	279	2	put	put	VERB
admet-2057	279	3	this	this	DET
admet-2057	279	4	theory	theory	NOUN
admet-2057	279	5	to	to	ADP
admet-2057	279	6	the	the	DET
admet-2057	279	7	test	test	NOUN
admet-2057	279	8	,	,	PUNCT
admet-2057	279	9	researchers	researcher	NOUN
admet-2057	279	10	looked	look	VERB
admet-2057	279	11	into	into	ADP
admet-2057	279	12	a	a	DET
admet-2057	279	13	model	model	NOUN
admet-2057	279	14	drug	drug	NOUN
admet-2057	279	15	-	-	PUNCT
admet-2057	279	16	releasing	release	VERB
admet-2057	279	17	nanocomposite	nanocomposite	NOUN
admet-2057	279	18	made	make	VERB
admet-2057	279	19	of	of	ADP
admet-2057	279	20	zif-8	zif-8	NUM
admet-2057	279	21	,	,	PUNCT
admet-2057	279	22	photocatalytic	photocatalytic	ADJ
admet-2057	279	23	titania	titania	NOUN
admet-2057	279	24	nanotubes	nanotube	NOUN
admet-2057	279	25	,	,	PUNCT
admet-2057	279	26	and	and	CCONJ
admet-2057	279	27	the	the	DET
admet-2057	279	28	anticancer	anticancer	NOUN
admet-2057	279	29	agent	agent	NOUN
admet-2057	279	30	doxorubicin	doxorubicin	PROPN
admet-2057	279	31	(	(	PUNCT
admet-2057	279	32	dox	dox	NOUN
admet-2057	279	33	)	)	PUNCT
admet-2057	279	34	.	.	PUNCT
admet-2057	280	1	compared	compare	VERB
admet-2057	280	2	to	to	ADP
admet-2057	280	3	the	the	DET
admet-2057	280	4	release	release	NOUN
admet-2057	280	5	duration	duration	NOUN
admet-2057	280	6	in	in	ADP
admet-2057	280	7	systems	system	NOUN
admet-2057	280	8	without	without	ADP
admet-2057	280	9	a	a	DET
admet-2057	280	10	photocatalyst	photocatalyst	NOUN
admet-2057	280	11	,	,	PUNCT
admet-2057	280	12	which	which	PRON
admet-2057	280	13	normally	normally	ADV
admet-2057	280	14	ranges	range	VERB
admet-2057	280	15	from	from	ADP
admet-2057	280	16	several	several	ADJ
admet-2057	280	17	hours	hour	NOUN
admet-2057	280	18	to	to	ADP
admet-2057	280	19	several	several	ADJ
admet-2057	280	20	days	day	NOUN
admet-2057	280	21	,	,	PUNCT
admet-2057	280	22	this	this	DET
admet-2057	280	23	outcome	outcome	NOUN
admet-2057	280	24	was	be	AUX
admet-2057	280	25	accomplished	accomplish	VERB
admet-2057	280	26	with	with	ADP
admet-2057	280	27	locally	locally	ADV
admet-2057	280	28	applied	apply	VERB
admet-2057	280	29	uv	uv	NOUN
admet-2057	280	30	irradiation	irradiation	NOUN
admet-2057	280	31	in	in	ADP
admet-2057	280	32	just	just	ADV
admet-2057	280	33	40	40	NUM
admet-2057	280	34	minutes	minute	NOUN
admet-2057	280	35	,	,	PUNCT
admet-2057	280	36	which	which	PRON
admet-2057	280	37	was	be	AUX
admet-2057	280	38	a	a	DET
admet-2057	280	39	comparatively	comparatively	ADV
admet-2057	280	40	very	very	ADV
admet-2057	280	41	short	short	ADJ
admet-2057	280	42	period	period	NOUN
admet-2057	280	43	.	.	PUNCT
admet-2057	281	1	the	the	DET
admet-2057	281	2	chances	chance	NOUN
admet-2057	281	3	of	of	ADP
admet-2057	281	4	survival	survival	NOUN
admet-2057	281	5	of	of	ADP
admet-2057	281	6	patients	patient	NOUN
admet-2057	281	7	with	with	ADP
admet-2057	281	8	malignant	malignant	ADJ
admet-2057	281	9	tumours	tumour	NOUN
admet-2057	281	10	could	could	AUX
admet-2057	281	11	be	be	AUX
admet-2057	281	12	significantly	significantly	ADV
admet-2057	281	13	improved	improve	VERB
admet-2057	281	14	by	by	ADP
admet-2057	281	15	immunotherapy	immunotherapy	NOUN
admet-2057	281	16	testing	testing	NOUN
admet-2057	281	17	utilising	utilise	VERB
admet-2057	281	18	immunoadjuvants	immunoadjuvant	NOUN
admet-2057	281	19	and	and	CCONJ
admet-2057	281	20	tumour	tumour	NOUN
admet-2057	281	21	antigens	antigen	NOUN
admet-2057	281	22	.	.	PUNCT
admet-2057	282	1	mofs	mof	NOUN
admet-2057	282	2	have	have	AUX
admet-2057	282	3	been	be	AUX
admet-2057	282	4	widely	widely	ADV
admet-2057	282	5	used	use	VERB
admet-2057	282	6	in	in	ADP
admet-2057	282	7	cancer	cancer	NOUN
admet-2057	282	8	therapy	therapy	NOUN
admet-2057	282	9	as	as	ADP
admet-2057	282	10	efficient	efficient	ADJ
admet-2057	282	11	carriers	carrier	NOUN
admet-2057	282	12	because	because	SCONJ
admet-2057	282	13	of	of	ADP
admet-2057	282	14	their	their	PRON
admet-2057	282	15	exceptional	exceptional	ADJ
admet-2057	282	16	histocompatibility	histocompatibility	NOUN
admet-2057	282	17	and	and	CCONJ
admet-2057	282	18	minimal	minimal	ADJ
admet-2057	282	19	toxicity	toxicity	NOUN
admet-2057	282	20	.	.	PUNCT
admet-2057	283	1	considering	consider	VERB
admet-2057	283	2	this	this	PRON
admet-2057	283	3	,	,	PUNCT
admet-2057	283	4	zhijin	zhijin	NOUN
admet-2057	283	5	fan	fan	PROPN
admet-2057	283	6	et	et	PROPN
admet-2057	283	7	al	al	PROPN
admet-2057	283	8	.	.	PUNCT
admet-2057	284	1	[	[	X
admet-2057	284	2	73	73	NUM
admet-2057	284	3	]	]	PUNCT
admet-2057	284	4	used	use	VERB
admet-2057	284	5	a	a	DET
admet-2057	284	6	specific	specific	ADJ
admet-2057	284	7	mof	mof	ADJ
admet-2057	284	8	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	284	9	p.	p.	NOUN
admet-2057	284	10	mhettar	mhettar	NOUN
admet-2057	284	11	et	et	PROPN
admet-2057	284	12	al	al	PROPN
admet-2057	284	13	.	.	PROPN
admet-2057	284	14	admet	admet	PROPN
admet-2057	284	15	&	&	CCONJ
admet-2057	284	16	dmpk	dmpk	PROPN
admet-2057	284	17	12(1	12(1	PROPN
admet-2057	284	18	)	)	PUNCT
admet-2057	284	19	(	(	PUNCT
admet-2057	284	20	2024	2024	NUM
admet-2057	284	21	)	)	PUNCT
admet-2057	284	22	27	27	NUM
admet-2057	284	23	-	-	SYM
admet-2057	284	24	62	62	NUM
admet-2057	284	25	38	38	NUM
admet-2057	284	26	(	(	PUNCT
admet-2057	284	27	mil101	mil101	PROPN
admet-2057	284	28	-	-	PUNCT
admet-2057	284	29	nh2	nh2	NOUN
admet-2057	284	30	)	)	PUNCT
admet-2057	284	31	as	as	SCONJ
admet-2057	284	32	the	the	DET
admet-2057	284	33	core	core	NOUN
admet-2057	284	34	carrier	carrier	NOUN
admet-2057	284	35	to	to	PART
admet-2057	284	36	develop	develop	VERB
admet-2057	284	37	a	a	DET
admet-2057	284	38	multimodal	multimodal	ADJ
admet-2057	284	39	imaging	imaging	NOUN
admet-2057	284	40	-	-	PUNCT
admet-2057	284	41	guided	guide	VERB
admet-2057	284	42	synergistic	synergistic	ADJ
admet-2057	284	43	cancer	cancer	NOUN
admet-2057	284	44	photoimmunotherapy	photoimmunotherapy	NOUN
admet-2057	284	45	.	.	PUNCT
admet-2057	285	1	the	the	DET
admet-2057	285	2	mof	mof	NOUN
admet-2057	285	3	was	be	AUX
admet-2057	285	4	dual	dual	ADV
admet-2057	285	5	-	-	PUNCT
admet-2057	285	6	dressed	dressed	ADJ
admet-2057	285	7	in	in	ADP
admet-2057	285	8	photoacoustic	photoacoustic	ADJ
admet-2057	285	9	and	and	CCONJ
admet-2057	285	10	fluorescent	fluorescent	ADJ
admet-2057	285	11	signal	signal	NOUN
admet-2057	285	12	donors	donor	NOUN
admet-2057	285	13	(	(	PUNCT
admet-2057	285	14	indocyanine	indocyanine	NOUN
admet-2057	285	15	green	green	NOUN
admet-2057	285	16	,	,	PUNCT
admet-2057	285	17	icg	icg	NOUN
admet-2057	285	18	)	)	PUNCT
admet-2057	285	19	,	,	PUNCT
admet-2057	285	20	immune	immune	ADJ
admet-2057	285	21	adjuvants	adjuvant	NOUN
admet-2057	285	22	(	(	PUNCT
admet-2057	285	23	cytosine	cytosine	NOUN
admet-2057	285	24	-	-	PUNCT
admet-2057	285	25	phosphate	phosphate	NOUN
admet-2057	285	26	-	-	PUNCT
admet-2057	285	27	guanine	guanine	NOUN
admet-2057	285	28	sequence	sequence	NOUN
admet-2057	285	29	,	,	PUNCT
admet-2057	285	30	cpg	cpg	NOUN
admet-2057	285	31	)	)	PUNCT
admet-2057	285	32	,	,	PUNCT
admet-2057	285	33	and	and	CCONJ
admet-2057	285	34	was	be	AUX
admet-2057	285	35	given	give	VERB
admet-2057	285	36	the	the	DET
admet-2057	285	37	name	name	NOUN
admet-2057	285	38	icg	icg	NOUN
admet-2057	285	39	-	-	PUNCT
admet-2057	285	40	cpg@mof	cpg@mof	NOUN
admet-2057	285	41	.	.	PUNCT
admet-2057	286	1	through	through	ADP
admet-2057	286	2	the	the	DET
admet-2057	286	3	epr	epr	PROPN
admet-2057	286	4	effect	effect	NOUN
admet-2057	286	5	,	,	PUNCT
admet-2057	286	6	this	this	DET
admet-2057	286	7	nanocarrier	nanocarrier	NOUN
admet-2057	286	8	might	might	AUX
admet-2057	286	9	passively	passively	ADV
admet-2057	286	10	target	target	VERB
admet-2057	286	11	the	the	DET
admet-2057	286	12	tumour	tumour	NOUN
admet-2057	286	13	site	site	NOUN
admet-2057	286	14	and	and	CCONJ
admet-2057	286	15	produce	produce	VERB
admet-2057	286	16	multimodal	multimodal	NOUN
admet-2057	286	17	tumour	tumour	NOUN
admet-2057	286	18	imaging	imaging	NOUN
admet-2057	286	19	(	(	PUNCT
admet-2057	286	20	fluorescent	fluorescent	NOUN
admet-2057	286	21	,	,	PUNCT
admet-2057	286	22	photoacoustic	photoacoustic	ADJ
admet-2057	286	23	,	,	PUNCT
admet-2057	286	24	photothermal	photothermal	ADJ
admet-2057	286	25	,	,	PUNCT
admet-2057	286	26	and	and	CCONJ
admet-2057	286	27	magnetic	magnetic	ADJ
admet-2057	286	28	resonance	resonance	NOUN
admet-2057	286	29	imaging	imaging	NOUN
admet-2057	286	30	)	)	PUNCT
admet-2057	286	31	.	.	PUNCT
admet-2057	287	1	synergistic	synergistic	ADJ
admet-2057	287	2	cancer	cancer	NOUN
admet-2057	287	3	photoimmunotherapy	photoimmunotherapy	NOUN
admet-2057	287	4	was	be	AUX
admet-2057	287	5	accomplished	accomplish	VERB
admet-2057	287	6	through	through	ADP
admet-2057	287	7	simultaneous	simultaneous	ADJ
admet-2057	287	8	photodynamic	photodynamic	ADJ
admet-2057	287	9	and	and	CCONJ
admet-2057	287	10	photothermal	photothermal	ADJ
admet-2057	287	11	approaches	approach	NOUN
admet-2057	287	12	with	with	ADP
admet-2057	287	13	808	808	NUM
admet-2057	287	14	nm	nm	ADJ
admet-2057	287	15	laser	laser	NOUN
admet-2057	287	16	irradiation	irradiation	NOUN
admet-2057	287	17	.	.	PUNCT
admet-2057	288	1	immunoadjuvant	immunoadjuvant	PROPN
admet-2057	288	2	was	be	AUX
admet-2057	288	3	successsfully	successsfully	ADV
admet-2057	288	4	released	release	VERB
admet-2057	288	5	into	into	ADP
admet-2057	288	6	the	the	DET
admet-2057	288	7	tumour	tumour	NOUN
admet-2057	288	8	microenvironment	microenvironment	NOUN
admet-2057	288	9	under	under	ADP
admet-2057	288	10	gsh	gsh	PROPN
admet-2057	288	11	control	control	PROPN
admet-2057	288	12	thanks	thank	NOUN
admet-2057	288	13	to	to	ADP
admet-2057	288	14	icg	icg	NOUN
admet-2057	288	15	-	-	PUNCT
admet-2057	288	16	cpg@mof	cpg@mof	NOUN
admet-2057	288	17	.	.	PUNCT
admet-2057	289	1	furthermore	furthermore	ADV
admet-2057	289	2	,	,	PUNCT
admet-2057	289	3	the	the	DET
admet-2057	289	4	immune	immune	ADJ
admet-2057	289	5	system	system	NOUN
admet-2057	289	6	might	might	AUX
admet-2057	289	7	be	be	AUX
admet-2057	289	8	stimulated	stimulate	VERB
admet-2057	289	9	by	by	ADP
admet-2057	289	10	the	the	DET
admet-2057	289	11	secreted	secrete	VERB
admet-2057	289	12	tumour	tumour	NOUN
admet-2057	289	13	-	-	PUNCT
admet-2057	289	14	associated	associate	VERB
admet-2057	289	15	antigen	antigen	NOUN
admet-2057	289	16	and	and	CCONJ
admet-2057	289	17	cpg	cpg	NOUN
admet-2057	289	18	to	to	PART
admet-2057	289	19	cause	cause	VERB
admet-2057	289	20	the	the	DET
admet-2057	289	21	transition	transition	NOUN
admet-2057	289	22	of	of	ADP
admet-2057	289	23	tumour	tumour	NOUN
admet-2057	289	24	cells	cell	NOUN
admet-2057	289	25	from	from	ADP
admet-2057	289	26	cold	cold	ADJ
admet-2057	289	27	to	to	ADP
admet-2057	289	28	hot	hot	ADJ
admet-2057	289	29	.	.	PUNCT
admet-2057	290	1	this	this	PRON
admet-2057	290	2	dramatically	dramatically	ADV
admet-2057	290	3	increased	increase	VERB
admet-2057	290	4	tumour	tumour	NOUN
admet-2057	290	5	cytotoxicity	cytotoxicity	NOUN
admet-2057	290	6	and	and	CCONJ
admet-2057	290	7	led	lead	VERB
admet-2057	290	8	to	to	ADP
admet-2057	290	9	high	high	ADJ
admet-2057	290	10	cure	cure	NOUN
admet-2057	290	11	rates	rate	NOUN
admet-2057	290	12	with	with	ADP
admet-2057	290	13	few	few	ADJ
admet-2057	290	14	side	side	NOUN
admet-2057	290	15	effects	effect	NOUN
admet-2057	290	16	.	.	PUNCT
admet-2057	291	1	a	a	DET
admet-2057	291	2	promising	promising	ADJ
admet-2057	291	3	method	method	NOUN
admet-2057	291	4	for	for	ADP
admet-2057	291	5	the	the	DET
admet-2057	291	6	detection	detection	NOUN
admet-2057	291	7	and	and	CCONJ
admet-2057	291	8	treatment	treatment	NOUN
admet-2057	291	9	of	of	ADP
admet-2057	291	10	cancer	cancer	NOUN
admet-2057	291	11	is	be	AUX
admet-2057	291	12	offered	offer	VERB
admet-2057	291	13	by	by	ADP
admet-2057	291	14	this	this	DET
admet-2057	291	15	approach	approach	NOUN
admet-2057	291	16	,	,	PUNCT
admet-2057	291	17	which	which	PRON
admet-2057	291	18	combines	combine	VERB
admet-2057	291	19	multimodal	multimodal	ADJ
admet-2057	291	20	imaging	imaging	NOUN
admet-2057	291	21	and	and	CCONJ
admet-2057	291	22	cancer	cancer	NOUN
admet-2057	291	23	photoimmunotherapy	photoimmunotherapy	NOUN
admet-2057	291	24	.	.	PUNCT
admet-2057	292	1	c.	c.	PROPN
admet-2057	292	2	thermoresponsive	thermoresponsive	VERB
admet-2057	292	3	the	the	DET
admet-2057	292	4	thermoresponsive	thermoresponsive	ADJ
admet-2057	292	5	mofs	mof	NOUN
admet-2057	292	6	have	have	VERB
admet-2057	292	7	the	the	DET
admet-2057	292	8	ability	ability	NOUN
admet-2057	292	9	to	to	PART
admet-2057	292	10	release	release	VERB
admet-2057	292	11	the	the	DET
admet-2057	292	12	active	active	ADJ
admet-2057	292	13	moiety	moiety	NOUN
admet-2057	292	14	under	under	ADP
admet-2057	292	15	the	the	DET
admet-2057	292	16	influence	influence	NOUN
admet-2057	292	17	of	of	ADP
admet-2057	292	18	a	a	DET
admet-2057	292	19	temperature	temperature	NOUN
admet-2057	292	20	change	change	NOUN
admet-2057	292	21	.	.	PUNCT
admet-2057	293	1	in	in	ADP
admet-2057	293	2	the	the	DET
admet-2057	293	3	case	case	NOUN
admet-2057	293	4	of	of	ADP
admet-2057	293	5	thermoresponsive	thermoresponsive	ADJ
admet-2057	293	6	mofs	mof	NOUN
admet-2057	293	7	,	,	PUNCT
admet-2057	293	8	the	the	DET
admet-2057	293	9	π	π	PROPN
admet-2057	293	10	-	-	PUNCT
admet-2057	293	11	π	π	ADJ
admet-2057	293	12	interactions	interaction	NOUN
admet-2057	293	13	between	between	ADP
admet-2057	293	14	host	host	NOUN
admet-2057	293	15	and	and	CCONJ
admet-2057	293	16	guest	guest	NOUN
admet-2057	293	17	get	get	AUX
admet-2057	293	18	cleaved	cleave	VERB
admet-2057	293	19	with	with	ADP
admet-2057	293	20	a	a	DET
admet-2057	293	21	rise	rise	NOUN
admet-2057	293	22	in	in	ADP
admet-2057	293	23	temperature	temperature	NOUN
admet-2057	293	24	,	,	PUNCT
admet-2057	293	25	causing	cause	VERB
admet-2057	293	26	the	the	DET
admet-2057	293	27	drug	drug	NOUN
admet-2057	293	28	to	to	PART
admet-2057	293	29	get	get	AUX
admet-2057	293	30	resealed	reseal	VERB
admet-2057	293	31	[	[	PUNCT
admet-2057	293	32	74	74	NUM
admet-2057	293	33	]	]	PUNCT
admet-2057	293	34	.	.	PUNCT
admet-2057	294	1	from	from	ADP
admet-2057	294	2	the	the	DET
admet-2057	294	3	class	class	NOUN
admet-2057	294	4	of	of	ADP
admet-2057	294	5	numerous	numerous	ADJ
admet-2057	294	6	thermosensitive	thermosensitive	ADJ
admet-2057	294	7	materials	material	NOUN
admet-2057	294	8	,	,	PUNCT
admet-2057	294	9	poly(n	poly(n	NOUN
admet-2057	294	10	-	-	PUNCT
admet-2057	294	11	isopropylacrylamide	isopropylacrylamide	NOUN
admet-2057	294	12	)	)	PUNCT
admet-2057	294	13	(	(	PUNCT
admet-2057	294	14	pnipam	pnipam	NOUN
admet-2057	294	15	)	)	PUNCT
admet-2057	294	16	is	be	AUX
admet-2057	294	17	recognized	recognize	VERB
admet-2057	294	18	as	as	ADP
admet-2057	294	19	a	a	DET
admet-2057	294	20	popular	popular	ADJ
admet-2057	294	21	thermosresponsive	thermosresponsive	ADJ
admet-2057	294	22	material	material	NOUN
admet-2057	294	23	having	have	VERB
admet-2057	294	24	a	a	DET
admet-2057	294	25	low	low	ADJ
admet-2057	294	26	critical	critical	ADJ
admet-2057	294	27	solution	solution	NOUN
admet-2057	294	28	temperature	temperature	NOUN
admet-2057	294	29	.	.	PUNCT
admet-2057	295	1	this	this	DET
admet-2057	295	2	material	material	NOUN
admet-2057	295	3	gets	get	AUX
admet-2057	295	4	easily	easily	ADV
admet-2057	295	5	dissolved	dissolve	VERB
admet-2057	295	6	in	in	ADP
admet-2057	295	7	water	water	NOUN
admet-2057	295	8	below	below	ADP
admet-2057	295	9	its	its	PRON
admet-2057	295	10	cloud	cloud	NOUN
admet-2057	295	11	point	point	NOUN
admet-2057	295	12	,	,	PUNCT
admet-2057	295	13	which	which	PRON
admet-2057	295	14	is	be	AUX
admet-2057	295	15	tc	tc	NUM
admet-2057	295	16	≈31	≈31	ADJ
admet-2057	295	17	°	°	PROPN
admet-2057	295	18	c	c	NOUN
admet-2057	295	19	,	,	PUNCT
admet-2057	295	20	due	due	ADP
admet-2057	295	21	to	to	ADP
admet-2057	295	22	its	its	PRON
admet-2057	295	23	hydrophilic	hydrophilic	ADJ
admet-2057	295	24	nature	nature	NOUN
admet-2057	295	25	while	while	SCONJ
admet-2057	295	26	remaining	remain	VERB
admet-2057	295	27	undissolved	undissolve	VERB
admet-2057	295	28	above	above	ADP
admet-2057	295	29	the	the	DET
admet-2057	295	30	cloud	cloud	ADJ
admet-2057	295	31	temperature	temperature	NOUN
admet-2057	295	32	[	[	X
admet-2057	295	33	75	75	NUM
admet-2057	295	34	]	]	PUNCT
admet-2057	295	35	.	.	PUNCT
admet-2057	296	1	with	with	ADP
admet-2057	296	2	this	this	DET
admet-2057	296	3	background	background	NOUN
admet-2057	296	4	,	,	PUNCT
admet-2057	296	5	nagata	nagata	PROPN
admet-2057	296	6	et	et	PROPN
admet-2057	296	7	al	al	PROPN
admet-2057	296	8	.	.	PUNCT
admet-2057	297	1	[	[	X
admet-2057	297	2	76	76	NUM
admet-2057	297	3	]	]	X
admet-2057	297	4	utilized	utilize	VERB
admet-2057	297	5	thermoresponsive	thermoresponsive	ADJ
admet-2057	297	6	polymer	polymer	NOUN
admet-2057	297	7	(	(	PUNCT
admet-2057	297	8	pnipam	pnipam	NOUN
admet-2057	297	9	)	)	PUNCT
admet-2057	297	10	for	for	ADP
admet-2057	297	11	the	the	DET
admet-2057	297	12	preparation	preparation	NOUN
admet-2057	297	13	of	of	ADP
admet-2057	297	14	thermoresponsive	thermoresponsive	ADJ
admet-2057	297	15	mofs	mof	NOUN
admet-2057	297	16	(	(	PUNCT
admet-2057	297	17	uio-66	uio-66	NOUN
admet-2057	297	18	-	-	PUNCT
admet-2057	297	19	pnipam	pnipam	NOUN
admet-2057	297	20	)	)	PUNCT
admet-2057	297	21	by	by	ADP
admet-2057	297	22	surface	surface	NOUN
admet-2057	297	23	modification	modification	NOUN
admet-2057	297	24	.	.	PUNCT
admet-2057	298	1	through	through	ADP
admet-2057	298	2	conformational	conformational	ADJ
admet-2057	298	3	variations	variation	NOUN
admet-2057	298	4	of	of	ADP
admet-2057	298	5	pnipam	pnipam	NOUN
admet-2057	298	6	implanted	implant	VERB
admet-2057	298	7	onto	onto	ADP
admet-2057	298	8	the	the	DET
admet-2057	298	9	mof	mof	NOUN
admet-2057	298	10	,	,	PUNCT
admet-2057	298	11	this	this	DET
admet-2057	298	12	accomplished	accomplished	ADJ
admet-2057	298	13	polymer	polymer	NOUN
admet-2057	298	14	-	-	PUNCT
admet-2057	298	15	modified	modify	VERB
admet-2057	298	16	mof	mof	NOUN
admet-2057	298	17	nanocarrier	nanocarrier	NOUN
admet-2057	298	18	demonstrated	demonstrate	VERB
admet-2057	298	19	regulated	regulated	ADJ
admet-2057	298	20	release	release	NOUN
admet-2057	298	21	of	of	ADP
admet-2057	298	22	the	the	DET
admet-2057	298	23	encapsulated	encapsulate	VERB
admet-2057	298	24	guest	guest	NOUN
admet-2057	298	25	molecules	molecule	NOUN
admet-2057	298	26	such	such	ADJ
admet-2057	298	27	as	as	ADP
admet-2057	298	28	resorufin	resorufin	NOUN
admet-2057	298	29	,	,	PUNCT
admet-2057	298	30	caffeine	caffeine	NOUN
admet-2057	298	31	,	,	PUNCT
admet-2057	298	32	and	and	CCONJ
admet-2057	298	33	procainamide	procainamide	ADJ
admet-2057	298	34	with	with	ADP
admet-2057	298	35	temperature	temperature	NOUN
admet-2057	298	36	variation	variation	NOUN
admet-2057	298	37	.	.	PUNCT
admet-2057	299	1	drug	drug	NOUN
admet-2057	299	2	-	-	PUNCT
admet-2057	299	3	loaded	load	VERB
admet-2057	299	4	uio-66	uio-66	NOUN
admet-2057	299	5	-	-	PUNCT
admet-2057	299	6	pnipam	pnipam	NOUN
admet-2057	299	7	showed	show	VERB
admet-2057	299	8	fast	fast	ADJ
admet-2057	299	9	drug	drug	NOUN
admet-2057	299	10	release	release	NOUN
admet-2057	299	11	at	at	ADP
admet-2057	299	12	a	a	DET
admet-2057	299	13	low	low	ADJ
admet-2057	299	14	temperature	temperature	NOUN
admet-2057	299	15	(	(	PUNCT
admet-2057	299	16	25	25	NUM
admet-2057	299	17	°	°	NOUN
admet-2057	299	18	c	c	NOUN
admet-2057	299	19	)	)	PUNCT
admet-2057	299	20	.	.	PUNCT
admet-2057	300	1	however	however	ADV
admet-2057	300	2	,	,	PUNCT
admet-2057	300	3	at	at	ADP
admet-2057	300	4	a	a	DET
admet-2057	300	5	high	high	ADJ
admet-2057	300	6	temperature	temperature	NOUN
admet-2057	300	7	(	(	PUNCT
admet-2057	300	8	40	40	NUM
admet-2057	300	9	°	°	NOUN
admet-2057	300	10	c	c	NOUN
admet-2057	300	11	)	)	PUNCT
admet-2057	300	12	,	,	PUNCT
admet-2057	300	13	the	the	DET
admet-2057	300	14	drug	drug	NOUN
admet-2057	300	15	release	release	NOUN
admet-2057	300	16	phenomena	phenomenon	NOUN
admet-2057	300	17	were	be	AUX
admet-2057	300	18	suppressed	suppress	VERB
admet-2057	300	19	above	above	ADP
admet-2057	300	20	its	its	PRON
admet-2057	300	21	tc	tc	X
admet-2057	300	22	(	(	PUNCT
admet-2057	300	23	31	31	NUM
admet-2057	300	24	°	°	NOUN
admet-2057	300	25	c	c	NOUN
admet-2057	300	26	)	)	PUNCT
admet-2057	300	27	.	.	PUNCT
admet-2057	301	1	on	on	ADP
admet-2057	301	2	the	the	DET
admet-2057	301	3	other	other	ADJ
admet-2057	301	4	hand	hand	NOUN
admet-2057	301	5	,	,	PUNCT
admet-2057	301	6	the	the	DET
admet-2057	301	7	tumors	tumor	NOUN
admet-2057	301	8	have	have	VERB
admet-2057	301	9	the	the	DET
admet-2057	301	10	ability	ability	NOUN
admet-2057	301	11	to	to	PART
admet-2057	301	12	undergo	undergo	VERB
admet-2057	301	13	localized	localized	ADJ
admet-2057	301	14	heating	heating	NOUN
admet-2057	301	15	,	,	PUNCT
admet-2057	301	16	which	which	PRON
admet-2057	301	17	results	result	VERB
admet-2057	301	18	in	in	ADP
admet-2057	301	19	an	an	DET
admet-2057	301	20	increased	increase	VERB
admet-2057	301	21	temperature	temperature	NOUN
admet-2057	301	22	of	of	ADP
admet-2057	301	23	the	the	DET
admet-2057	301	24	nanocarriers	nanocarrier	NOUN
admet-2057	301	25	within	within	ADP
admet-2057	301	26	the	the	DET
admet-2057	301	27	tumors	tumor	NOUN
admet-2057	301	28	.	.	PUNCT
admet-2057	302	1	in	in	ADP
admet-2057	302	2	this	this	DET
admet-2057	302	3	regard	regard	NOUN
admet-2057	302	4	,	,	PUNCT
admet-2057	302	5	the	the	DET
admet-2057	302	6	mof	mof	NOUN
admet-2057	302	7	's	's	PART
admet-2057	302	8	structural	structural	ADJ
admet-2057	302	9	changes	change	NOUN
admet-2057	302	10	brought	bring	VERB
admet-2057	302	11	on	on	ADP
admet-2057	302	12	by	by	ADP
admet-2057	302	13	the	the	DET
admet-2057	302	14	temperature	temperature	NOUN
admet-2057	302	15	shift	shift	NOUN
admet-2057	302	16	result	result	NOUN
admet-2057	302	17	in	in	ADP
admet-2057	302	18	cargo	cargo	NOUN
admet-2057	302	19	release	release	NOUN
admet-2057	302	20	.	.	PUNCT
admet-2057	303	1	it	it	PRON
admet-2057	303	2	is	be	AUX
admet-2057	303	3	crucial	crucial	ADJ
admet-2057	303	4	for	for	ADP
admet-2057	303	5	these	these	DET
admet-2057	303	6	systems	system	NOUN
admet-2057	303	7	that	that	PRON
admet-2057	303	8	mofs	mof	NOUN
admet-2057	303	9	maintain	maintain	VERB
admet-2057	303	10	their	their	PRON
admet-2057	303	11	stability	stability	NOUN
admet-2057	303	12	at	at	ADP
admet-2057	303	13	37	37	NUM
admet-2057	303	14	°	°	NOUN
admet-2057	303	15	c	c	NOUN
admet-2057	303	16	,	,	PUNCT
admet-2057	303	17	which	which	PRON
admet-2057	303	18	is	be	AUX
admet-2057	303	19	the	the	DET
admet-2057	303	20	average	average	ADJ
admet-2057	303	21	body	body	NOUN
admet-2057	303	22	temperature	temperature	NOUN
admet-2057	303	23	[	[	X
admet-2057	303	24	77	77	NUM
admet-2057	303	25	]	]	PUNCT
admet-2057	303	26	.	.	PUNCT
admet-2057	304	1	in	in	ADP
admet-2057	304	2	another	another	DET
admet-2057	304	3	study	study	NOUN
admet-2057	304	4	,	,	PUNCT
admet-2057	304	5	by	by	ADP
admet-2057	304	6	using	use	VERB
admet-2057	304	7	zinc	zinc	NOUN
admet-2057	304	8	ions	ion	NOUN
admet-2057	304	9	,	,	PUNCT
admet-2057	304	10	the	the	DET
admet-2057	304	11	biomolecular	biomolecular	ADJ
admet-2057	304	12	linker	linker	NOUN
admet-2057	304	13	adenine	adenine	NOUN
admet-2057	304	14	,	,	PUNCT
admet-2057	304	15	and	and	CCONJ
admet-2057	304	16	carboxylate	carboxylate	NOUN
admet-2057	304	17	-	-	PUNCT
admet-2057	304	18	based	base	VERB
admet-2057	304	19	ligands	ligand	NOUN
admet-2057	304	20	,	,	PUNCT
admet-2057	304	21	two	two	NUM
admet-2057	304	22	zinc	zinc	NOUN
admet-2057	304	23	-	-	PUNCT
admet-2057	304	24	based	base	VERB
admet-2057	304	25	porous	porous	ADJ
admet-2057	304	26	mofs	mof	NOUN
admet-2057	304	27	,	,	PUNCT
admet-2057	304	28	zju-64	zju-64	NUM
admet-2057	304	29	and	and	CCONJ
admet-2057	304	30	zju-64	zju-64	PROPN
admet-2057	304	31	-	-	PUNCT
admet-2057	304	32	ch3	ch3	PROPN
admet-2057	304	33	,	,	PUNCT
admet-2057	304	34	sharing	share	VERB
admet-2057	304	35	the	the	DET
admet-2057	304	36	same	same	ADJ
admet-2057	304	37	crystal	crystal	NOUN
admet-2057	304	38	structure	structure	NOUN
admet-2057	304	39	,	,	PUNCT
admet-2057	304	40	have	have	AUX
admet-2057	304	41	been	be	AUX
admet-2057	304	42	synthesised	synthesise	VERB
admet-2057	304	43	by	by	ADP
admet-2057	304	44	wenxin	wenxin	PROPN
admet-2057	304	45	lin	lin	PROPN
admet-2057	305	1	[	[	X
admet-2057	305	2	78	78	NUM
admet-2057	305	3	]	]	PUNCT
admet-2057	305	4	resulting	result	VERB
admet-2057	305	5	in	in	ADP
admet-2057	305	6	3d	3d	NUM
admet-2057	305	7	frameworks	framework	NOUN
admet-2057	305	8	with	with	ADP
admet-2057	305	9	1d	1d	NUM
admet-2057	305	10	channels	channel	NOUN
admet-2057	305	11	(	(	PUNCT
admet-2057	305	12	about	about	ADP
admet-2057	305	13	1.6	1.6	NUM
admet-2057	305	14	nm	nm	NOUN
admet-2057	305	15	and	and	CCONJ
admet-2057	305	16	1.9	1.9	NUM
admet-2057	305	17	nm	nm	NOUN
admet-2057	305	18	)	)	PUNCT
admet-2057	305	19	.	.	PUNCT
admet-2057	306	1	the	the	DET
admet-2057	306	2	3-(4,5	3-(4,5	NUM
admet-2057	306	3	-	-	PUNCT
admet-2057	306	4	dimethylthiazol-2	dimethylthiazol-2	NUM
admet-2057	306	5	-	-	PUNCT
admet-2057	306	6	yl	yl	NOUN
admet-2057	306	7	)	)	PUNCT
admet-2057	306	8	-2,5	-2,5	ADJ
admet-2057	306	9	-	-	PUNCT
admet-2057	306	10	diphenyl	diphenyl	NOUN
admet-2057	306	11	tetrazolium	tetrazolium	NOUN
admet-2057	306	12	(	(	PUNCT
admet-2057	306	13	mtt	mtt	NOUN
admet-2057	306	14	)	)	PUNCT
admet-2057	306	15	assay	assay	PROPN
admet-2057	306	16	,	,	PUNCT
admet-2057	306	17	microscope	microscope	NOUN
admet-2057	306	18	images	image	NOUN
admet-2057	306	19	,	,	PUNCT
admet-2057	306	20	and	and	CCONJ
admet-2057	306	21	cell	cell	NOUN
admet-2057	306	22	-	-	PUNCT
admet-2057	306	23	cycle	cycle	NOUN
admet-2057	306	24	analysis	analysis	NOUN
admet-2057	306	25	of	of	ADP
admet-2057	306	26	the	the	DET
admet-2057	306	27	materials	material	NOUN
admet-2057	306	28	zju-64	zju-64	NUM
admet-2057	306	29	and	and	CCONJ
admet-2057	306	30	zju-64	zju-64	PROPN
admet-2057	306	31	-	-	PROPN
admet-2057	306	32	ch3	ch3	PROPN
admet-2057	306	33	demonstrate	demonstrate	VERB
admet-2057	306	34	low	low	ADJ
admet-2057	306	35	toxicity	toxicity	NOUN
admet-2057	306	36	,	,	PUNCT
admet-2057	306	37	indicating	indicate	VERB
admet-2057	306	38	their	their	PRON
admet-2057	306	39	potential	potential	ADJ
admet-2057	306	40	applications	application	NOUN
admet-2057	306	41	for	for	ADP
admet-2057	306	42	human	human	ADJ
admet-2057	306	43	health	health	NOUN
admet-2057	306	44	care	care	NOUN
admet-2057	306	45	.	.	PUNCT
admet-2057	307	1	methotrexate	methotrexate	NOUN
admet-2057	307	2	(	(	PUNCT
admet-2057	307	3	mtx	mtx	NOUN
admet-2057	307	4	)	)	PUNCT
admet-2057	307	5	,	,	PUNCT
admet-2057	307	6	an	an	DET
admet-2057	307	7	anticancer	anticancer	NOUN
admet-2057	307	8	medication	medication	NOUN
admet-2057	307	9	,	,	PUNCT
admet-2057	307	10	may	may	AUX
admet-2057	307	11	be	be	AUX
admet-2057	307	12	successfully	successfully	ADV
admet-2057	307	13	loaded	load	VERB
admet-2057	307	14	into	into	ADP
admet-2057	307	15	mofs	mof	NOUN
admet-2057	307	16	using	use	VERB
admet-2057	307	17	a	a	DET
admet-2057	307	18	straightforward	straightforward	ADJ
admet-2057	307	19	impregnation	impregnation	NOUN
admet-2057	307	20	process	process	NOUN
admet-2057	307	21	.	.	PUNCT
admet-2057	308	1	the	the	DET
admet-2057	308	2	drug	drug	NOUN
admet-2057	308	3	payloads	payload	NOUN
admet-2057	308	4	for	for	ADP
admet-2057	308	5	zju-64	zju-64	NUM
admet-2057	308	6	and	and	CCONJ
admet-2057	308	7	zju-64	zju-64	PROPN
admet-2057	308	8	-	-	PROPN
admet-2057	308	9	ch3	ch3	PROPN
admet-2057	308	10	are	be	AUX
admet-2057	308	11	approximately	approximately	ADV
admet-2057	308	12	13.45	13.45	NUM
admet-2057	308	13	and	and	CCONJ
admet-2057	308	14	10.63	10.63	NUM
admet-2057	308	15	wt.%	wt.%	NOUN
admet-2057	308	16	,	,	PUNCT
admet-2057	308	17	respectively	respectively	ADV
admet-2057	308	18	.	.	PUNCT
admet-2057	309	1	for	for	ADP
admet-2057	309	2	several	several	ADJ
admet-2057	309	3	days	day	NOUN
admet-2057	309	4	,	,	PUNCT
admet-2057	309	5	the	the	DET
admet-2057	309	6	sustained	sustained	ADJ
admet-2057	309	7	drug	drug	NOUN
admet-2057	309	8	-	-	PUNCT
admet-2057	309	9	release	release	NOUN
admet-2057	309	10	behaviour	behaviour	NOUN
admet-2057	309	11	of	of	ADP
admet-2057	309	12	mtx	mtx	NOUN
admet-2057	309	13	from	from	ADP
admet-2057	309	14	mtx	mtx	NOUN
admet-2057	309	15	-	-	PUNCT
admet-2057	309	16	loaded	load	VERB
admet-2057	309	17	zju-64	zju-64	NUM
admet-2057	309	18	and	and	CCONJ
admet-2057	309	19	zju-64	zju-64	PROPN
admet-2057	309	20	-	-	PROPN
admet-2057	309	21	ch3	ch3	PROPN
admet-2057	309	22	is	be	AUX
admet-2057	309	23	observed	observe	VERB
admet-2057	309	24	.	.	PUNCT
admet-2057	310	1	the	the	DET
admet-2057	310	2	temperature	temperature	NOUN
admet-2057	310	3	-	-	PUNCT
admet-2057	310	4	responsive	responsive	ADJ
admet-2057	310	5	drug	drug	NOUN
admet-2057	310	6	delivery	delivery	NOUN
admet-2057	310	7	of	of	ADP
admet-2057	310	8	zju-64	zju-64	NUM
admet-2057	310	9	and	and	CCONJ
admet-2057	310	10	zju-64	zju-64	PROPN
admet-2057	310	11	-	-	PROPN
admet-2057	310	12	ch3	ch3	PROPN
admet-2057	310	13	demonstrates	demonstrate	VERB
admet-2057	310	14	that	that	SCONJ
admet-2057	310	15	hyperthermia	hyperthermia	NOUN
admet-2057	310	16	can	can	AUX
admet-2057	310	17	regulate	regulate	VERB
admet-2057	310	18	the	the	DET
admet-2057	310	19	drug	drug	NOUN
admet-2057	310	20	release	release	NOUN
admet-2057	310	21	.	.	PUNCT
admet-2057	311	1	it	it	PRON
admet-2057	311	2	paves	pave	VERB
admet-2057	311	3	the	the	DET
admet-2057	311	4	way	way	NOUN
admet-2057	311	5	for	for	ADP
admet-2057	311	6	a	a	DET
admet-2057	311	7	novel	novel	ADJ
admet-2057	311	8	therapy	therapy	NOUN
admet-2057	311	9	that	that	PRON
admet-2057	311	10	combines	combine	VERB
admet-2057	311	11	drug	drug	NOUN
admet-2057	311	12	therapy	therapy	NOUN
admet-2057	311	13	and	and	CCONJ
admet-2057	311	14	thermal	thermal	ADJ
admet-2057	311	15	therapy	therapy	NOUN
admet-2057	311	16	to	to	PART
admet-2057	311	17	kill	kill	VERB
admet-2057	311	18	more	more	ADJ
admet-2057	311	19	cancer	cancer	NOUN
admet-2057	311	20	cells	cell	NOUN
admet-2057	311	21	while	while	SCONJ
admet-2057	311	22	causing	cause	VERB
admet-2057	311	23	fewer	few	ADJ
admet-2057	311	24	side	side	ADJ
admet-2057	311	25	effects	effect	NOUN
admet-2057	311	26	.	.	PUNCT
admet-2057	312	1	this	this	PRON
admet-2057	312	2	demonstrates	demonstrate	VERB
admet-2057	312	3	the	the	DET
admet-2057	312	4	usefulness	usefulness	NOUN
admet-2057	312	5	of	of	ADP
admet-2057	312	6	zju-64	zju-64	NUM
admet-2057	312	7	and	and	CCONJ
admet-2057	312	8	zju-64	zju-64	PROPN
admet-2057	312	9	-	-	PUNCT
admet-2057	312	10	ch3	ch3	PROPN
admet-2057	312	11	as	as	ADP
admet-2057	312	12	"	"	PUNCT
admet-2057	312	13	smart	smart	ADJ
admet-2057	312	14	"	"	PUNCT
admet-2057	312	15	drug	drug	NOUN
admet-2057	312	16	carriers	carrier	NOUN
admet-2057	312	17	with	with	ADP
admet-2057	312	18	greater	great	ADJ
admet-2057	312	19	therapeutic	therapeutic	ADJ
admet-2057	312	20	efficacy	efficacy	NOUN
admet-2057	312	21	.	.	PUNCT
admet-2057	313	1	in	in	ADP
admet-2057	313	2	another	another	DET
admet-2057	313	3	study	study	NOUN
admet-2057	313	4	,	,	PUNCT
admet-2057	313	5	the	the	DET
admet-2057	313	6	design	design	NOUN
admet-2057	313	7	,	,	PUNCT
admet-2057	313	8	synthesis	synthesis	NOUN
admet-2057	313	9	,	,	PUNCT
admet-2057	313	10	characterization	characterization	NOUN
admet-2057	313	11	,	,	PUNCT
admet-2057	313	12	and	and	CCONJ
admet-2057	313	13	application	application	NOUN
admet-2057	313	14	of	of	ADP
admet-2057	313	15	an	an	DET
admet-2057	313	16	adsorbent	adsorbent	NOUN
admet-2057	313	17	-	-	PUNCT
admet-2057	313	18	heaterthermometer	heaterthermometer	NOUN
admet-2057	313	19	nanomaterial	nanomaterial	NOUN
admet-2057	313	20	,	,	PUNCT
admet-2057	313	21	(	(	PUNCT
admet-2057	313	22	zif-8,euxtby)@aunp	zif-8,euxtby)@aunp	NUM
admet-2057	313	23	,	,	PUNCT
admet-2057	313	24	based	base	VERB
admet-2057	313	25	on	on	ADP
admet-2057	313	26	zif-8	zif-8	NUM
admet-2057	313	27	(	(	PUNCT
admet-2057	313	28	adsorbent	adsorbent	NOUN
admet-2057	313	29	)	)	PUNCT
admet-2057	313	30	,	,	PUNCT
admet-2057	313	31	incorporating	incorporate	VERB
admet-2057	313	32	eu3	eu3	NOUN
admet-2057	313	33	+	+	CCONJ
admet-2057	313	34	and/or	and/or	CCONJ
admet-2057	313	35	tb3	tb3	NOUN
admet-2057	313	36	+	+	NUM
admet-2057	313	37	ions	ion	NOUN
admet-2057	313	38	(	(	PUNCT
admet-2057	313	39	thermometer	thermometer	NOUN
admet-2057	313	40	)	)	PUNCT
admet-2057	313	41	,	,	PUNCT
admet-2057	313	42	and	and	CCONJ
admet-2057	313	43	gold	gold	NOUN
admet-2057	313	44	nanoparticles	nanoparticle	NOUN
admet-2057	313	45	(	(	PUNCT
admet-2057	313	46	aunps	aunps	ADJ
admet-2057	313	47	,	,	PUNCT
admet-2057	313	48	heater	heater	NOUN
admet-2057	313	49	)	)	PUNCT
admet-2057	313	50	was	be	AUX
admet-2057	313	51	done	do	VERB
admet-2057	313	52	by	by	ADP
admet-2057	313	53	josé	josé	PROPN
admet-2057	313	54	yago	yago	PROPN
admet-2057	313	55	r.	r.	PROPN
admet-2057	313	56	silva	silva	PROPN
admet-2057	314	1	[	[	X
admet-2057	314	2	79	79	NUM
admet-2057	314	3	]	]	PUNCT
admet-2057	314	4	.	.	PUNCT
admet-2057	315	1	these	these	DET
admet-2057	315	2	admet	admet	PROPN
admet-2057	315	3	&	&	CCONJ
admet-2057	315	4	dmpk	dmpk	PROPN
admet-2057	315	5	12(1	12(1	PROPN
admet-2057	315	6	)	)	PUNCT
admet-2057	315	7	(	(	PUNCT
admet-2057	315	8	2024	2024	NUM
admet-2057	315	9	)	)	PUNCT
admet-2057	315	10	27	27	NUM
admet-2057	315	11	-	-	SYM
admet-2057	315	12	62	62	NUM
admet-2057	315	13	drug	drug	NOUN
admet-2057	315	14	delivery	delivery	NOUN
admet-2057	315	15	applications	application	NOUN
admet-2057	315	16	of	of	ADP
admet-2057	315	17	metal	metal	NOUN
admet-2057	315	18	-	-	PUNCT
admet-2057	315	19	organic	organic	ADJ
admet-2057	315	20	framework	framework	NOUN
admet-2057	315	21	doi	doi	NOUN
admet-2057	315	22	:	:	PUNCT
admet-2057	315	23	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	316	1	39	39	NUM
admet-2057	316	2	composite	composite	ADJ
admet-2057	316	3	materials	material	NOUN
admet-2057	316	4	were	be	AUX
admet-2057	316	5	identified	identify	VERB
admet-2057	316	6	as	as	ADP
admet-2057	316	7	core	core	NOUN
admet-2057	316	8	-	-	PUNCT
admet-2057	316	9	shell	shell	NOUN
admet-2057	316	10	nanocrystals	nanocrystal	NOUN
admet-2057	316	11	,	,	PUNCT
admet-2057	316	12	with	with	ADP
admet-2057	316	13	the	the	DET
admet-2057	316	14	crystalline	crystalline	NOUN
admet-2057	316	15	zif-8	zif-8	ADV
admet-2057	316	16	acting	act	VERB
admet-2057	316	17	as	as	ADP
admet-2057	316	18	the	the	DET
admet-2057	316	19	shell	shell	NOUN
admet-2057	316	20	and	and	CCONJ
admet-2057	316	21	the	the	DET
admet-2057	316	22	lanthanide	lanthanide	ADJ
admet-2057	316	23	ions	ion	NOUN
admet-2057	316	24	being	be	AUX
admet-2057	316	25	incorporated	incorporate	VERB
admet-2057	316	26	into	into	ADP
admet-2057	316	27	or	or	CCONJ
admet-2057	316	28	chemosorbed	chemosorbe	VERB
admet-2057	316	29	onto	onto	ADP
admet-2057	316	30	the	the	DET
admet-2057	316	31	aunps	aunps	NOUN
admet-2057	316	32	,	,	PUNCT
admet-2057	316	33	which	which	PRON
admet-2057	316	34	serve	serve	VERB
admet-2057	316	35	as	as	ADP
admet-2057	316	36	the	the	DET
admet-2057	316	37	structure	structure	NOUN
admet-2057	316	38	's	's	PART
admet-2057	316	39	core	core	NOUN
admet-2057	316	40	.	.	PUNCT
admet-2057	317	1	the	the	DET
admet-2057	317	2	aunps	aunps	PROPN
admet-2057	317	3	serve	serve	VERB
admet-2057	317	4	as	as	ADP
admet-2057	317	5	heaters	heater	NOUN
admet-2057	317	6	,	,	PUNCT
admet-2057	317	7	the	the	DET
admet-2057	317	8	zif-8	zif-8	NUM
admet-2057	317	9	shell	shell	NOUN
admet-2057	317	10	as	as	ADP
admet-2057	317	11	a	a	DET
admet-2057	317	12	drug	drug	NOUN
admet-2057	317	13	adsorbent	adsorbent	NOUN
admet-2057	317	14	,	,	PUNCT
admet-2057	317	15	and	and	CCONJ
admet-2057	317	16	the	the	DET
admet-2057	317	17	ligand	ligand	ADJ
admet-2057	317	18	and	and	CCONJ
admet-2057	317	19	lanthanide	lanthanide	ADJ
admet-2057	317	20	ion	ion	NOUN
admet-2057	317	21	luminescence	luminescence	NOUN
admet-2057	317	22	intensities	intensity	NOUN
admet-2057	317	23	are	be	AUX
admet-2057	317	24	employed	employ	VERB
admet-2057	317	25	to	to	PART
admet-2057	317	26	measure	measure	VERB
admet-2057	317	27	temperature	temperature	NOUN
admet-2057	317	28	.	.	PUNCT
admet-2057	318	1	as	as	SCONJ
admet-2057	318	2	demonstrated	demonstrate	VERB
admet-2057	318	3	with	with	ADP
admet-2057	318	4	the	the	DET
admet-2057	318	5	examples	example	NOUN
admet-2057	318	6	of	of	ADP
admet-2057	318	7	5	5	NUM
admet-2057	318	8	-	-	PUNCT
admet-2057	318	9	fu	fu	NOUN
admet-2057	318	10	and	and	CCONJ
admet-2057	318	11	caffeine	caffeine	NOUN
admet-2057	318	12	,	,	PUNCT
admet-2057	318	13	visible	visible	ADJ
admet-2057	318	14	irradiation	irradiation	NOUN
admet-2057	318	15	can	can	AUX
admet-2057	318	16	be	be	AUX
admet-2057	318	17	used	use	VERB
admet-2057	318	18	to	to	PART
admet-2057	318	19	activate	activate	VERB
admet-2057	318	20	this	this	DET
admet-2057	318	21	thermoresponsive	thermoresponsive	ADJ
admet-2057	318	22	material	material	NOUN
admet-2057	318	23	and	and	CCONJ
admet-2057	318	24	cause	cause	VERB
admet-2057	318	25	it	it	PRON
admet-2057	318	26	to	to	PART
admet-2057	318	27	release	release	VERB
admet-2057	318	28	tiny	tiny	ADJ
admet-2057	318	29	molecules	molecule	NOUN
admet-2057	318	30	under	under	ADP
admet-2057	318	31	regulated	regulated	ADJ
admet-2057	318	32	conditions	condition	NOUN
admet-2057	318	33	.	.	PUNCT
admet-2057	319	1	it	it	PRON
admet-2057	319	2	has	have	AUX
admet-2057	319	3	been	be	AUX
admet-2057	319	4	demonstrated	demonstrate	VERB
admet-2057	319	5	through	through	ADP
admet-2057	319	6	computer	computer	NOUN
admet-2057	319	7	simulations	simulation	NOUN
admet-2057	319	8	and	and	CCONJ
admet-2057	319	9	calculations	calculation	NOUN
admet-2057	319	10	using	use	VERB
admet-2057	319	11	the	the	DET
admet-2057	319	12	transition	transition	NOUN
admet-2057	319	13	state	state	NOUN
admet-2057	319	14	theory	theory	NOUN
admet-2057	319	15	that	that	SCONJ
admet-2057	319	16	the	the	DET
admet-2057	319	17	diffusion	diffusion	NOUN
admet-2057	319	18	of	of	ADP
admet-2057	319	19	tiny	tiny	ADJ
admet-2057	319	20	molecules	molecule	NOUN
admet-2057	319	21	between	between	ADP
admet-2057	319	22	adjacent	adjacent	ADJ
admet-2057	319	23	pores	pore	NOUN
admet-2057	319	24	in	in	ADP
admet-2057	319	25	zif-8	zif-8	NUM
admet-2057	319	26	is	be	AUX
admet-2057	319	27	extremely	extremely	ADV
admet-2057	319	28	constrained	constrain	VERB
admet-2057	319	29	and	and	CCONJ
admet-2057	319	30	involves	involve	VERB
admet-2057	319	31	high	high	ADJ
admet-2057	319	32	-	-	PUNCT
admet-2057	319	33	energy	energy	NOUN
admet-2057	319	34	barriers	barrier	NOUN
admet-2057	319	35	.	.	PUNCT
admet-2057	320	1	these	these	DET
admet-2057	320	2	results	result	NOUN
admet-2057	320	3	suggest	suggest	VERB
admet-2057	320	4	that	that	SCONJ
admet-2057	320	5	these	these	DET
admet-2057	320	6	molecules	molecule	NOUN
admet-2057	320	7	are	be	AUX
admet-2057	320	8	uploaded	upload	VERB
admet-2057	320	9	onto	onto	ADP
admet-2057	320	10	and	and	CCONJ
admet-2057	320	11	released	release	VERB
admet-2057	320	12	from	from	ADP
admet-2057	320	13	the	the	DET
admet-2057	320	14	zif-8	zif-8	NUM
admet-2057	320	15	surface	surface	NOUN
admet-2057	320	16	instead	instead	ADV
admet-2057	320	17	of	of	ADP
admet-2057	320	18	being	be	AUX
admet-2057	320	19	inside	inside	ADP
admet-2057	320	20	the	the	DET
admet-2057	320	21	holes	hole	NOUN
admet-2057	320	22	.	.	PUNCT
admet-2057	321	1	this	this	PRON
admet-2057	321	2	is	be	AUX
admet-2057	321	3	the	the	DET
admet-2057	321	4	first	first	ADJ
admet-2057	321	5	report	report	NOUN
admet-2057	321	6	of	of	ADP
admet-2057	321	7	zif-8	zif-8	NUM
admet-2057	321	8	nanocrystals	nanocrystal	NOUN
admet-2057	321	9	(	(	PUNCT
admet-2057	321	10	adsorbents	adsorbent	NOUN
admet-2057	321	11	)	)	PUNCT
admet-2057	321	12	containing	contain	VERB
admet-2057	321	13	both	both	DET
admet-2057	321	14	heaters	heater	NOUN
admet-2057	321	15	for	for	ADP
admet-2057	321	16	regulated	regulated	ADJ
admet-2057	321	17	drug	drug	NOUN
admet-2057	321	18	release	release	NOUN
admet-2057	321	19	in	in	ADP
admet-2057	321	20	a	a	DET
admet-2057	321	21	physiological	physiological	ADJ
admet-2057	321	22	temperature	temperature	NOUN
admet-2057	321	23	range	range	NOUN
admet-2057	321	24	and	and	CCONJ
admet-2057	321	25	lanthanide	lanthanide	ADJ
admet-2057	321	26	ions	ion	NOUN
admet-2057	321	27	as	as	ADP
admet-2057	321	28	sensitive	sensitive	ADJ
admet-2057	321	29	nanothermometers	nanothermometer	NOUN
admet-2057	321	30	.	.	PUNCT
admet-2057	322	1	these	these	DET
admet-2057	322	2	findings	finding	NOUN
admet-2057	322	3	offer	offer	VERB
admet-2057	322	4	a	a	DET
admet-2057	322	5	proof	proof	NOUN
admet-2057	322	6	-	-	PUNCT
admet-2057	322	7	of	of	ADP
admet-2057	322	8	-	-	PUNCT
admet-2057	322	9	concept	concept	NOUN
admet-2057	322	10	that	that	PRON
admet-2057	322	11	may	may	AUX
admet-2057	322	12	be	be	AUX
admet-2057	322	13	extended	extend	VERB
admet-2057	322	14	to	to	ADP
admet-2057	322	15	other	other	ADJ
admet-2057	322	16	types	type	NOUN
admet-2057	322	17	of	of	ADP
admet-2057	322	18	materials	material	NOUN
admet-2057	322	19	and	and	CCONJ
admet-2057	322	20	a	a	DET
admet-2057	322	21	fresh	fresh	ADJ
admet-2057	322	22	viewpoint	viewpoint	NOUN
admet-2057	322	23	on	on	ADP
admet-2057	322	24	the	the	DET
admet-2057	322	25	creation	creation	NOUN
admet-2057	322	26	of	of	ADP
admet-2057	322	27	multifunctional	multifunctional	ADJ
admet-2057	322	28	,	,	PUNCT
admet-2057	322	29	self	self	NOUN
admet-2057	322	30	-	-	PUNCT
admet-2057	322	31	assembling	assemble	VERB
admet-2057	322	32	,	,	PUNCT
admet-2057	322	33	thermoresponsive	thermoresponsive	ADJ
admet-2057	322	34	adsorbing	adsorbing	NOUN
admet-2057	322	35	materials	material	NOUN
admet-2057	322	36	that	that	PRON
admet-2057	322	37	are	be	AUX
admet-2057	322	38	quick	quick	ADJ
admet-2057	322	39	to	to	PART
admet-2057	322	40	prepare	prepare	VERB
admet-2057	322	41	and	and	CCONJ
admet-2057	322	42	easy	easy	ADJ
admet-2057	322	43	to	to	PART
admet-2057	322	44	regulate	regulate	VERB
admet-2057	322	45	.	.	PUNCT
admet-2057	323	1	in	in	ADP
admet-2057	323	2	another	another	DET
admet-2057	323	3	study	study	NOUN
admet-2057	323	4	,	,	PUNCT
admet-2057	323	5	wei	wei	PROPN
admet-2057	323	6	wu	wu	PROPN
admet-2057	323	7	and	and	CCONJ
admet-2057	323	8	team	team	NOUN
admet-2057	324	1	[	[	X
admet-2057	324	2	80	80	NUM
admet-2057	324	3	]	]	PUNCT
admet-2057	324	4	created	create	VERB
admet-2057	324	5	soap	soap	NOUN
admet-2057	324	6	-	-	PUNCT
admet-2057	324	7	free	free	ADJ
admet-2057	324	8	emulsion	emulsion	NOUN
admet-2057	324	9	polymerization	polymerization	NOUN
admet-2057	324	10	,	,	PUNCT
admet-2057	324	11	a	a	DET
admet-2057	324	12	core	core	NOUN
admet-2057	324	13	-	-	PUNCT
admet-2057	324	14	shell	shell	NOUN
admet-2057	324	15	nmofs@poly(n	nmofs@poly(n	NOUN
admet-2057	324	16	-	-	PUNCT
admet-2057	324	17	isopropylacrylamide	isopropylacrylamide	NOUN
admet-2057	324	18	)	)	PUNCT
admet-2057	324	19	(	(	PUNCT
admet-2057	324	20	pnipam	pnipam	NOUN
admet-2057	324	21	)	)	PUNCT
admet-2057	324	22	microgel	microgel	NOUN
admet-2057	324	23	hybrid	hybrid	VERB
admet-2057	324	24	through	through	ADP
admet-2057	324	25	one	one	NUM
admet-2057	324	26	-	-	PUNCT
admet-2057	324	27	pot	pot	NOUN
admet-2057	324	28	.	.	PUNCT
admet-2057	325	1	by	by	ADP
admet-2057	325	2	adjusting	adjust	VERB
admet-2057	325	3	the	the	DET
admet-2057	325	4	concentration	concentration	NOUN
admet-2057	325	5	of	of	ADP
admet-2057	325	6	the	the	DET
admet-2057	325	7	monomer	monomer	NOUN
admet-2057	325	8	and	and	CCONJ
admet-2057	325	9	crosslinker	crosslinker	NOUN
admet-2057	325	10	in	in	ADP
admet-2057	325	11	the	the	DET
admet-2057	325	12	reaction	reaction	NOUN
admet-2057	325	13	,	,	PUNCT
admet-2057	325	14	the	the	DET
admet-2057	325	15	pnipam	pnipam	NOUN
admet-2057	325	16	microgel	microgel	NOUN
admet-2057	325	17	layer	layer	NOUN
admet-2057	325	18	on	on	ADP
admet-2057	325	19	the	the	DET
admet-2057	325	20	surface	surface	NOUN
admet-2057	325	21	of	of	ADP
admet-2057	325	22	nmofs	nmof	NOUN
admet-2057	325	23	can	can	AUX
admet-2057	325	24	form	form	VERB
admet-2057	325	25	in	in	ADP
admet-2057	325	26	any	any	DET
admet-2057	325	27	pattern	pattern	NOUN
admet-2057	325	28	.	.	PUNCT
admet-2057	326	1	by	by	ADP
admet-2057	326	2	adjusting	adjust	VERB
admet-2057	326	3	the	the	DET
admet-2057	326	4	temperature	temperature	NOUN
admet-2057	326	5	below	below	ADP
admet-2057	326	6	and	and	CCONJ
admet-2057	326	7	above	above	ADP
admet-2057	326	8	the	the	DET
admet-2057	326	9	lower	low	ADJ
admet-2057	326	10	critical	critical	ADJ
admet-2057	326	11	solution	solution	NOUN
admet-2057	326	12	temperature	temperature	NOUN
admet-2057	326	13	,	,	PUNCT
admet-2057	326	14	reversible	reversible	ADJ
admet-2057	326	15	swelling	swelling	NOUN
admet-2057	326	16	-	-	PUNCT
admet-2057	326	17	collapsing	collapse	VERB
admet-2057	326	18	behaviours	behaviour	NOUN
admet-2057	326	19	of	of	ADP
admet-2057	326	20	the	the	DET
admet-2057	326	21	hybrid	hybrid	NOUN
admet-2057	326	22	are	be	AUX
admet-2057	326	23	achieved	achieve	VERB
admet-2057	326	24	.	.	PUNCT
admet-2057	327	1	when	when	SCONJ
admet-2057	327	2	employed	employ	VERB
admet-2057	327	3	as	as	ADP
admet-2057	327	4	a	a	DET
admet-2057	327	5	water	water	NOUN
admet-2057	327	6	lubrication	lubrication	NOUN
admet-2057	327	7	additive	additive	NOUN
admet-2057	327	8	,	,	PUNCT
admet-2057	327	9	the	the	DET
admet-2057	327	10	hybrid	hybrid	NOUN
admet-2057	327	11	permits	permit	VERB
admet-2057	327	12	a	a	DET
admet-2057	327	13	decrease	decrease	NOUN
admet-2057	327	14	in	in	ADP
admet-2057	327	15	friction	friction	NOUN
admet-2057	327	16	coefficient	coefficient	NOUN
admet-2057	327	17	and	and	CCONJ
admet-2057	327	18	wear	wear	VERB
admet-2057	327	19	volume	volume	NOUN
admet-2057	327	20	.	.	PUNCT
admet-2057	328	1	in	in	ADP
admet-2057	328	2	vitro	vitro	X
admet-2057	328	3	thermal	thermal	ADJ
admet-2057	328	4	-	-	PUNCT
admet-2057	328	5	responsive	responsive	ADJ
admet-2057	328	6	drug	drug	NOUN
admet-2057	328	7	release	release	NOUN
admet-2057	328	8	is	be	AUX
admet-2057	328	9	shown	show	VERB
admet-2057	328	10	by	by	ADP
admet-2057	328	11	manipulating	manipulate	VERB
admet-2057	328	12	the	the	DET
admet-2057	328	13	pnipam	pnipam	NOUN
admet-2057	328	14	nanolayer	nanolayer	PROPN
admet-2057	328	15	's	's	PART
admet-2057	328	16	swelling	swell	VERB
admet-2057	328	17	and	and	CCONJ
admet-2057	328	18	collapsing	collapse	VERB
admet-2057	328	19	states	state	NOUN
admet-2057	328	20	on	on	ADP
admet-2057	328	21	the	the	DET
admet-2057	328	22	diclofenac	diclofenac	ADJ
admet-2057	328	23	sodium	sodium	NOUN
admet-2057	328	24	-	-	PUNCT
admet-2057	328	25	loaded	load	VERB
admet-2057	328	26	hybrid	hybrid	NOUN
admet-2057	328	27	.	.	PUNCT
admet-2057	329	1	additionally	additionally	ADV
admet-2057	329	2	,	,	PUNCT
admet-2057	329	3	the	the	DET
admet-2057	329	4	hybrid	hybrid	NOUN
admet-2057	329	5	's	's	PART
admet-2057	329	6	strong	strong	ADJ
admet-2057	329	7	biocompatibility	biocompatibility	NOUN
admet-2057	329	8	is	be	AUX
admet-2057	329	9	confirmed	confirm	VERB
admet-2057	329	10	through	through	ADP
admet-2057	329	11	the	the	DET
admet-2057	329	12	cultivation	cultivation	NOUN
admet-2057	329	13	of	of	ADP
admet-2057	329	14	hela	hela	PROPN
admet-2057	329	15	and	and	CCONJ
admet-2057	329	16	beas-2b	beas-2b	ADV
admet-2057	329	17	cells	cell	NOUN
admet-2057	329	18	.	.	PUNCT
admet-2057	330	1	these	these	DET
admet-2057	330	2	findings	finding	NOUN
admet-2057	330	3	build	build	VERB
admet-2057	330	4	a	a	DET
admet-2057	330	5	nmofs@microgel	nmofs@microgel	ADV
admet-2057	330	6	hybrid	hybrid	ADJ
admet-2057	330	7	capable	capable	ADJ
admet-2057	330	8	of	of	ADP
admet-2057	330	9	reducing	reduce	VERB
admet-2057	330	10	wear	wear	NOUN
admet-2057	330	11	and	and	CCONJ
admet-2057	330	12	friction	friction	NOUN
admet-2057	330	13	while	while	SCONJ
admet-2057	330	14	enabling	enable	VERB
admet-2057	330	15	thermally	thermally	ADV
admet-2057	330	16	responsive	responsive	ADJ
admet-2057	330	17	drug	drug	NOUN
admet-2057	330	18	release	release	NOUN
admet-2057	330	19	.	.	PUNCT
admet-2057	331	1	in	in	ADP
admet-2057	331	2	2021	2021	NUM
admet-2057	331	3	,	,	PUNCT
admet-2057	331	4	to	to	PART
admet-2057	331	5	increase	increase	VERB
admet-2057	331	6	the	the	DET
admet-2057	331	7	anticancer	anticancer	NOUN
admet-2057	331	8	potential	potential	NOUN
admet-2057	331	9	of	of	ADP
admet-2057	331	10	norcantharidin	norcantharidin	PROPN
admet-2057	331	11	(	(	PUNCT
admet-2057	331	12	nctd	nctd	NOUN
admet-2057	331	13	)	)	PUNCT
admet-2057	331	14	and	and	CCONJ
admet-2057	331	15	lower	low	ADJ
admet-2057	331	16	the	the	DET
admet-2057	331	17	dosage	dosage	NOUN
admet-2057	331	18	of	of	ADP
admet-2057	331	19	the	the	DET
admet-2057	331	20	medication	medication	NOUN
admet-2057	331	21	,	,	PUNCT
admet-2057	331	22	xiu	xiu	PROPN
admet-2057	331	23	-	-	PUNCT
admet-2057	331	24	yan	yan	PROPN
admet-2057	331	25	li	li	PROPN
admet-2057	332	1	[	[	X
admet-2057	332	2	81	81	NUM
admet-2057	332	3	]	]	PUNCT
admet-2057	332	4	created	create	VERB
admet-2057	332	5	a	a	DET
admet-2057	332	6	nanomaterial	nanomaterial	ADJ
admet-2057	332	7	carrier	carrier	NOUN
admet-2057	332	8	,	,	PUNCT
admet-2057	332	9	nctd	nctd	NOUN
admet-2057	332	10	-	-	PUNCT
admet-2057	332	11	loaded	load	VERB
admet-2057	332	12	irmof-3	irmof-3	NOUN
admet-2057	332	13	coated	coat	VERB
admet-2057	332	14	with	with	ADP
admet-2057	332	15	a	a	DET
admet-2057	332	16	temperature	temperature	NOUN
admet-2057	332	17	-	-	PUNCT
admet-2057	332	18	sensitive	sensitive	ADJ
admet-2057	332	19	gel	gel	NOUN
admet-2057	332	20	(	(	PUNCT
admet-2057	332	21	nctd	nctd	NOUN
admet-2057	332	22	-	-	PUNCT
admet-2057	332	23	irmof-3	irmof-3	NOUN
admet-2057	332	24	-	-	PUNCT
admet-2057	332	25	gel	gel	NOUN
admet-2057	332	26	)	)	PUNCT
admet-2057	332	27	.	.	PUNCT
admet-2057	333	1	a	a	DET
admet-2057	333	2	coordination	coordination	NOUN
admet-2057	333	3	reaction	reaction	NOUN
admet-2057	333	4	produced	produce	VERB
admet-2057	333	5	nctd	nctd	NOUN
admet-2057	333	6	-	-	PUNCT
admet-2057	333	7	irmof-3	irmof-3	NOUN
admet-2057	333	8	-	-	PUNCT
admet-2057	333	9	gel	gel	NOUN
admet-2057	333	10	.	.	PUNCT
admet-2057	334	1	we	we	PRON
admet-2057	334	2	looked	look	VERB
admet-2057	334	3	into	into	ADP
admet-2057	334	4	the	the	DET
admet-2057	334	5	apparent	apparent	ADJ
admet-2057	334	6	properties	property	NOUN
admet-2057	334	7	and	and	CCONJ
admet-2057	334	8	in	in	ADP
admet-2057	334	9	-	-	PUNCT
admet-2057	334	10	vitro	vitro	X
admet-2057	334	11	release	release	NOUN
admet-2057	334	12	of	of	ADP
admet-2057	334	13	nctd	nctd	NOUN
admet-2057	334	14	-	-	PUNCT
admet-2057	334	15	irmof-3	irmof-3	NOUN
admet-2057	334	16	-	-	PUNCT
admet-2057	334	17	gel	gel	NOUN
admet-2057	334	18	.	.	PUNCT
admet-2057	335	1	the	the	DET
admet-2057	335	2	anti	anti	ADJ
admet-2057	335	3	-	-	ADJ
admet-2057	335	4	liver	liver	ADJ
admet-2057	335	5	cancer	cancer	NOUN
admet-2057	335	6	effectiveness	effectiveness	NOUN
admet-2057	335	7	of	of	ADP
admet-2057	335	8	nctd	nctd	NOUN
admet-2057	335	9	-	-	PUNCT
admet-2057	335	10	irmof-3	irmof-3	NOUN
admet-2057	335	11	-	-	PUNCT
admet-2057	335	12	gel	gel	NOUN
admet-2057	335	13	in	in	ADP
admet-2057	335	14	in	in	ADP
admet-2057	335	15	-	-	PUNCT
admet-2057	335	16	vitro	vitro	X
admet-2057	335	17	models	model	NOUN
admet-2057	335	18	was	be	AUX
admet-2057	335	19	assessed	assess	VERB
admet-2057	335	20	using	use	VERB
admet-2057	335	21	cell	cell	NOUN
admet-2057	335	22	cytotoxicity	cytotoxicity	NOUN
admet-2057	335	23	tests	test	NOUN
admet-2057	335	24	,	,	PUNCT
admet-2057	335	25	flow	flow	NOUN
admet-2057	335	26	cytometry	cytometry	NOUN
admet-2057	335	27	,	,	PUNCT
admet-2057	335	28	and	and	CCONJ
admet-2057	335	29	apoptosis	apoptosis	NOUN
admet-2057	335	30	investigations	investigation	NOUN
admet-2057	335	31	in	in	ADP
admet-2057	335	32	mouse	mouse	NOUN
admet-2057	335	33	hepatoma	hepatoma	NOUN
admet-2057	335	34	(	(	PUNCT
admet-2057	335	35	hepa1	hepa1	NOUN
admet-2057	335	36	-	-	PUNCT
admet-2057	335	37	6	6	NUM
admet-2057	335	38	)	)	PUNCT
admet-2057	335	39	cells	cell	NOUN
admet-2057	335	40	.	.	PUNCT
admet-2057	336	1	nctd	nctd	NOUN
admet-2057	336	2	-	-	PUNCT
admet-2057	336	3	irmof-3	irmof-3	NOUN
admet-2057	336	4	-	-	PUNCT
admet-2057	336	5	gel	gel	NOUN
admet-2057	336	6	had	have	VERB
admet-2057	336	7	consistent	consistent	ADJ
admet-2057	336	8	particle	particle	NOUN
admet-2057	336	9	size	size	NOUN
admet-2057	336	10	distribution	distribution	NOUN
admet-2057	336	11	and	and	CCONJ
admet-2057	336	12	its	its	PRON
admet-2057	336	13	particle	particle	NOUN
admet-2057	336	14	size	size	NOUN
admet-2057	336	15	ranged	range	VERB
admet-2057	336	16	from	from	ADP
admet-2057	336	17	50	50	NUM
admet-2057	336	18	to	to	PART
admet-2057	336	19	100	100	NUM
admet-2057	336	20	nm	nm	NOUN
admet-2057	336	21	.	.	PUNCT
admet-2057	337	1	the	the	DET
admet-2057	337	2	release	release	NOUN
admet-2057	337	3	curve	curve	NOUN
admet-2057	337	4	demonstrated	demonstrate	VERB
admet-2057	337	5	the	the	DET
admet-2057	337	6	clear	clear	ADJ
admet-2057	337	7	sustained	sustain	VERB
admet-2057	337	8	-	-	PUNCT
admet-2057	337	9	release	release	NOUN
admet-2057	337	10	impact	impact	NOUN
admet-2057	337	11	of	of	ADP
admet-2057	337	12	nctd	nctd	NOUN
admet-2057	337	13	-	-	PUNCT
admet-2057	337	14	irmof-3	irmof-3	NOUN
admet-2057	337	15	-	-	PUNCT
admet-2057	337	16	gel	gel	NOUN
admet-2057	337	17	.	.	PUNCT
admet-2057	338	1	according	accord	VERB
admet-2057	338	2	to	to	ADP
admet-2057	338	3	the	the	DET
admet-2057	338	4	results	result	NOUN
admet-2057	338	5	of	of	ADP
admet-2057	338	6	the	the	DET
admet-2057	338	7	cytotoxicity	cytotoxicity	NOUN
admet-2057	338	8	tests	test	NOUN
admet-2057	338	9	,	,	PUNCT
admet-2057	338	10	the	the	DET
admet-2057	338	11	free	free	ADJ
admet-2057	338	12	drug	drug	NOUN
admet-2057	338	13	nctd	nctd	VERB
admet-2057	338	14	and	and	CCONJ
admet-2057	338	15	nctd	nctd	VERB
admet-2057	338	16	-	-	PUNCT
admet-2057	338	17	irmof-3	irmof-3	NOUN
admet-2057	338	18	-	-	PUNCT
admet-2057	338	19	gel	gel	NOUN
admet-2057	338	20	treatments	treatment	NOUN
admet-2057	338	21	significantly	significantly	ADV
admet-2057	338	22	reduced	reduce	VERB
admet-2057	338	23	the	the	DET
admet-2057	338	24	proliferative	proliferative	ADJ
admet-2057	338	25	ability	ability	NOUN
admet-2057	338	26	of	of	ADP
admet-2057	338	27	hepa1	hepa1	PROPN
admet-2057	338	28	-	-	PUNCT
admet-2057	338	29	6	6	NUM
admet-2057	338	30	cells	cell	NOUN
admet-2057	338	31	,	,	PUNCT
admet-2057	338	32	and	and	CCONJ
admet-2057	338	33	the	the	DET
admet-2057	338	34	inhibition	inhibition	NOUN
admet-2057	338	35	rate	rate	NOUN
admet-2057	338	36	rose	rise	VERB
admet-2057	338	37	with	with	ADP
admet-2057	338	38	increasing	increase	VERB
admet-2057	338	39	drug	drug	NOUN
admet-2057	338	40	concentration	concentration	NOUN
admet-2057	338	41	.	.	PUNCT
admet-2057	339	1	the	the	DET
admet-2057	339	2	hepa1	hepa1	PROPN
admet-2057	339	3	-	-	PUNCT
admet-2057	339	4	6	6	NUM
admet-2057	339	5	cell	cell	NOUN
admet-2057	339	6	cycle	cycle	NOUN
admet-2057	339	7	was	be	AUX
admet-2057	339	8	found	find	VERB
admet-2057	339	9	by	by	ADP
admet-2057	339	10	flow	flow	NOUN
admet-2057	339	11	cytometry	cytometry	NOUN
admet-2057	339	12	to	to	PART
admet-2057	339	13	be	be	AUX
admet-2057	339	14	blocked	block	VERB
admet-2057	339	15	by	by	ADP
admet-2057	339	16	nctd	nctd	ADJ
admet-2057	339	17	-	-	PUNCT
admet-2057	339	18	irmof-3	irmof-3	NOUN
admet-2057	339	19	-	-	PUNCT
admet-2057	339	20	gel	gel	NOUN
admet-2057	339	21	in	in	ADP
admet-2057	339	22	the	the	DET
admet-2057	339	23	s	s	NOUN
admet-2057	339	24	and	and	CCONJ
admet-2057	339	25	g2	g2	PROPN
admet-2057	339	26	/	/	SYM
admet-2057	339	27	m	m	PROPN
admet-2057	339	28	phases	phase	NOUN
admet-2057	339	29	,	,	PUNCT
admet-2057	339	30	and	and	CCONJ
admet-2057	339	31	the	the	DET
admet-2057	339	32	thermosensitive	thermosensitive	ADJ
admet-2057	339	33	gel	gel	NOUN
admet-2057	339	34	nanoparticles	nanoparticle	NOUN
admet-2057	339	35	may	may	AUX
admet-2057	339	36	prevent	prevent	VERB
admet-2057	339	37	cell	cell	NOUN
admet-2057	339	38	growth	growth	NOUN
admet-2057	339	39	by	by	ADP
admet-2057	339	40	causing	cause	VERB
admet-2057	339	41	cell	cell	NOUN
admet-2057	339	42	cycle	cycle	NOUN
admet-2057	339	43	arrest	arrest	NOUN
admet-2057	339	44	.	.	PUNCT
admet-2057	340	1	studies	study	NOUN
admet-2057	340	2	on	on	ADP
admet-2057	340	3	apoptosis	apoptosis	NOUN
admet-2057	340	4	demonstrated	demonstrate	VERB
admet-2057	340	5	that	that	SCONJ
admet-2057	340	6	nctd	nctd	NOUN
admet-2057	340	7	-	-	PUNCT
admet-2057	340	8	irmof-3	irmof-3	NOUN
admet-2057	340	9	-	-	PUNCT
admet-2057	340	10	gel	gel	NOUN
admet-2057	340	11	caused	cause	VERB
admet-2057	340	12	hepa1	hepa1	PROPN
admet-2057	340	13	-	-	PUNCT
admet-2057	340	14	6	6	NUM
admet-2057	340	15	cells	cell	NOUN
admet-2057	340	16	to	to	PART
admet-2057	340	17	die	die	VERB
admet-2057	340	18	.	.	PUNCT
admet-2057	341	1	the	the	DET
admet-2057	341	2	outcomes	outcome	NOUN
admet-2057	341	3	suggested	suggest	VERB
admet-2057	341	4	that	that	SCONJ
admet-2057	341	5	the	the	DET
admet-2057	341	6	nctd	nctd	VERB
admet-2057	341	7	-	-	PUNCT
admet-2057	341	8	irmof-3	irmof-3	NOUN
admet-2057	341	9	-	-	PUNCT
admet-2057	341	10	gel	gel	NOUN
admet-2057	341	11	would	would	AUX
admet-2057	341	12	be	be	AUX
admet-2057	341	13	useful	useful	ADJ
admet-2057	341	14	for	for	ADP
admet-2057	341	15	treating	treat	VERB
admet-2057	341	16	liver	liver	NOUN
admet-2057	341	17	cancer	cancer	NOUN
admet-2057	341	18	.	.	PUNCT
admet-2057	342	1	d.	d.	PROPN
admet-2057	342	2	redox	redox	PROPN
admet-2057	342	3	responsive	responsive	ADJ
admet-2057	342	4	when	when	SCONJ
admet-2057	342	5	it	it	PRON
admet-2057	342	6	comes	come	VERB
admet-2057	342	7	to	to	ADP
admet-2057	342	8	smart	smart	ADJ
admet-2057	342	9	stimuli	stimulus	NOUN
admet-2057	342	10	-	-	PUNCT
admet-2057	342	11	responsive	responsive	ADJ
admet-2057	342	12	delivery	delivery	NOUN
admet-2057	342	13	systems	system	NOUN
admet-2057	342	14	,	,	PUNCT
admet-2057	342	15	redox	redox	NOUN
admet-2057	342	16	-	-	PUNCT
admet-2057	342	17	responsive	responsive	ADJ
admet-2057	342	18	mofs	mof	NOUN
admet-2057	342	19	have	have	AUX
admet-2057	342	20	become	become	VERB
admet-2057	342	21	a	a	DET
admet-2057	342	22	topic	topic	NOUN
admet-2057	342	23	of	of	ADP
admet-2057	342	24	interest	interest	NOUN
admet-2057	342	25	.	.	PUNCT
admet-2057	343	1	this	this	DET
admet-2057	343	2	drug	drug	NOUN
admet-2057	343	3	delivery	delivery	NOUN
admet-2057	343	4	system	system	NOUN
admet-2057	343	5	is	be	AUX
admet-2057	343	6	based	base	VERB
admet-2057	343	7	on	on	ADP
admet-2057	343	8	the	the	DET
admet-2057	343	9	different	different	ADJ
admet-2057	343	10	redox	redox	ADJ
admet-2057	343	11	concentrations	concentration	NOUN
admet-2057	343	12	in	in	ADP
admet-2057	343	13	normal	normal	ADJ
admet-2057	343	14	and	and	CCONJ
admet-2057	343	15	tumor	tumor	NOUN
admet-2057	343	16	cells	cell	NOUN
admet-2057	343	17	[	[	X
admet-2057	343	18	82	82	NUM
admet-2057	343	19	]	]	PUNCT
admet-2057	343	20	.	.	PUNCT
admet-2057	344	1	redox	redox	ADJ
admet-2057	344	2	-	-	PUNCT
admet-2057	344	3	responsive	responsive	ADJ
admet-2057	344	4	frameworks	framework	NOUN
admet-2057	344	5	have	have	VERB
admet-2057	344	6	a	a	DET
admet-2057	344	7	sweeping	sweeping	ADJ
admet-2057	344	8	influence	influence	NOUN
admet-2057	344	9	on	on	ADP
admet-2057	344	10	the	the	DET
admet-2057	344	11	delivery	delivery	NOUN
admet-2057	344	12	of	of	ADP
admet-2057	344	13	antigens	antigen	NOUN
admet-2057	344	14	and	and	CCONJ
admet-2057	344	15	other	other	ADJ
admet-2057	344	16	immunological	immunological	ADJ
admet-2057	344	17	areas	area	NOUN
admet-2057	344	18	.	.	PUNCT
admet-2057	345	1	glutathione	glutathione	NOUN
admet-2057	345	2	(	(	PUNCT
admet-2057	345	3	gsh	gsh	PROPN
admet-2057	345	4	)	)	PUNCT
admet-2057	345	5	is	be	AUX
admet-2057	345	6	present	present	ADJ
admet-2057	345	7	in	in	ADP
admet-2057	345	8	much	much	ADV
admet-2057	345	9	higher	high	ADJ
admet-2057	345	10	quantities	quantity	NOUN
admet-2057	345	11	in	in	ADP
admet-2057	345	12	tumor	tumor	NOUN
admet-2057	345	13	cells	cell	NOUN
admet-2057	345	14	than	than	ADP
admet-2057	345	15	in	in	ADP
admet-2057	345	16	normal	normal	ADJ
admet-2057	345	17	body	body	NOUN
admet-2057	345	18	cells	cell	NOUN
admet-2057	345	19	and	and	CCONJ
admet-2057	345	20	acts	act	VERB
admet-2057	345	21	as	as	ADP
admet-2057	345	22	a	a	DET
admet-2057	345	23	potential	potential	ADJ
admet-2057	345	24	reducing	reduce	VERB
admet-2057	345	25	agent	agent	NOUN
admet-2057	345	26	.	.	PUNCT
admet-2057	346	1	the	the	DET
admet-2057	346	2	rapid	rapid	ADJ
admet-2057	346	3	splitting	splitting	NOUN
admet-2057	346	4	of	of	ADP
admet-2057	346	5	the	the	DET
admet-2057	346	6	redox	redox	NOUN
admet-2057	346	7	-	-	PUNCT
admet-2057	346	8	sensitive	sensitive	ADJ
admet-2057	346	9	s	s	PROPN
admet-2057	346	10	-	-	PUNCT
admet-2057	346	11	s	s	NOUN
admet-2057	346	12	bond	bond	NOUN
admet-2057	346	13	in	in	ADP
admet-2057	346	14	the	the	DET
admet-2057	346	15	presence	presence	NOUN
admet-2057	346	16	of	of	ADP
admet-2057	346	17	gsh	gsh	PROPN
admet-2057	346	18	makes	make	VERB
admet-2057	346	19	it	it	PRON
admet-2057	346	20	an	an	DET
admet-2057	346	21	intriguing	intriguing	ADJ
admet-2057	346	22	receptor	receptor	NOUN
admet-2057	346	23	location	location	NOUN
admet-2057	346	24	for	for	ADP
admet-2057	346	25	the	the	DET
admet-2057	346	26	development	development	NOUN
admet-2057	346	27	of	of	ADP
admet-2057	346	28	redox	redox	NOUN
admet-2057	346	29	-	-	PUNCT
admet-2057	346	30	responsive	responsive	ADJ
admet-2057	346	31	drug	drug	NOUN
admet-2057	346	32	delivery	delivery	NOUN
admet-2057	346	33	systems	system	NOUN
admet-2057	346	34	.	.	PUNCT
admet-2057	347	1	considering	consider	VERB
admet-2057	347	2	this	this	PRON
admet-2057	347	3	,	,	PUNCT
admet-2057	347	4	zhao	zhao	PROPN
admet-2057	347	5	et	et	PROPN
admet-2057	347	6	al	al	PROPN
admet-2057	347	7	.	.	PUNCT
admet-2057	348	1	[	[	X
admet-2057	348	2	83	83	NUM
admet-2057	348	3	]	]	PUNCT
admet-2057	348	4	synthesized	synthesize	VERB
admet-2057	348	5	a	a	DET
admet-2057	348	6	mof	mof	ADJ
admet-2057	348	7	system	system	NOUN
admet-2057	348	8	sensitive	sensitive	ADJ
admet-2057	348	9	to	to	ADP
admet-2057	348	10	gsh	gsh	PROPN
admet-2057	348	11	,	,	PUNCT
admet-2057	348	12	which	which	PRON
admet-2057	348	13	consists	consist	VERB
admet-2057	348	14	of	of	ADP
admet-2057	348	15	mn2	mn2	VERB
admet-2057	348	16	+	+	NUM
admet-2057	348	17	ions	ion	NOUN
admet-2057	348	18	and	and	CCONJ
admet-2057	348	19	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	348	20	p.	p.	NOUN
admet-2057	348	21	mhettar	mhettar	NOUN
admet-2057	348	22	et	et	PROPN
admet-2057	348	23	al	al	PROPN
admet-2057	348	24	.	.	PROPN
admet-2057	348	25	admet	admet	PROPN
admet-2057	348	26	&	&	CCONJ
admet-2057	348	27	dmpk	dmpk	PROPN
admet-2057	348	28	12(1	12(1	PROPN
admet-2057	348	29	)	)	PUNCT
admet-2057	348	30	(	(	PUNCT
admet-2057	348	31	2024	2024	NUM
admet-2057	348	32	)	)	PUNCT
admet-2057	348	33	27	27	NUM
admet-2057	348	34	-	-	SYM
admet-2057	348	35	62	62	NUM
admet-2057	348	36	40	40	NUM
admet-2057	348	37	disulfide	disulfide	NOUN
admet-2057	348	38	(	(	PUNCT
admet-2057	348	39	s	s	NOUN
admet-2057	348	40	-	-	PUNCT
admet-2057	348	41	s)-containing	s)-containe	VERB
admet-2057	348	42	dithiodiglycolic	dithiodiglycolic	ADJ
admet-2057	348	43	acid	acid	NOUN
admet-2057	348	44	as	as	ADP
admet-2057	348	45	a	a	DET
admet-2057	348	46	ligand	ligand	NOUN
admet-2057	348	47	.	.	PUNCT
admet-2057	349	1	this	this	DET
admet-2057	349	2	system	system	NOUN
admet-2057	349	3	(	(	PUNCT
admet-2057	349	4	mn	mn	PROPN
admet-2057	349	5	-	-	PUNCT
admet-2057	349	6	s	s	X
admet-2057	349	7	-	-	PUNCT
admet-2057	349	8	s	s	NOUN
admet-2057	349	9	)	)	PUNCT
admet-2057	349	10	has	have	VERB
admet-2057	349	11	the	the	DET
admet-2057	349	12	dox	dox	NOUN
admet-2057	349	13	loaded	load	VERB
admet-2057	349	14	via	via	ADP
admet-2057	349	15	hydrophobic	hydrophobic	NOUN
admet-2057	349	16	interactions	interaction	NOUN
admet-2057	349	17	.	.	PUNCT
admet-2057	350	1	mn	mn	PROPN
admet-2057	350	2	-	-	PUNCT
admet-2057	350	3	s	s	PROPN
admet-2057	350	4	-	-	PUNCT
admet-2057	350	5	s	s	NOUN
admet-2057	350	6	was	be	AUX
admet-2057	350	7	coated	coat	VERB
admet-2057	350	8	with	with	ADP
admet-2057	350	9	polydopamine	polydopamine	PROPN
admet-2057	350	10	(	(	PUNCT
admet-2057	350	11	pda	pda	NOUN
admet-2057	350	12	)	)	PUNCT
admet-2057	350	13	and	and	CCONJ
admet-2057	350	14	further	far	ADV
admet-2057	350	15	enhanced	enhance	VERB
admet-2057	350	16	with	with	ADP
admet-2057	350	17	polyethylene	polyethylene	NOUN
admet-2057	350	18	glycol	glycol	NOUN
admet-2057	350	19	(	(	PUNCT
admet-2057	350	20	peg	peg	NOUN
admet-2057	350	21	)	)	PUNCT
admet-2057	350	22	to	to	PART
admet-2057	350	23	create	create	VERB
admet-2057	350	24	mn	mn	PROPN
admet-2057	350	25	-	-	PUNCT
admet-2057	350	26	ss	ss	PROPN
admet-2057	350	27	/	/	SYM
admet-2057	350	28	dox@pda	dox@pda	NOUN
admet-2057	350	29	-	-	PUNCT
admet-2057	350	30	peg	peg	NOUN
admet-2057	350	31	ncps	ncps	NOUN
admet-2057	350	32	.	.	PUNCT
admet-2057	351	1	for	for	ADP
admet-2057	351	2	the	the	DET
admet-2057	351	3	effective	effective	ADJ
admet-2057	351	4	release	release	NOUN
admet-2057	351	5	of	of	ADP
admet-2057	351	6	the	the	DET
admet-2057	351	7	dox	dox	NOUN
admet-2057	351	8	encapsulated	encapsulate	VERB
admet-2057	351	9	in	in	ADP
admet-2057	351	10	the	the	DET
admet-2057	351	11	ncps	ncps	NOUN
admet-2057	351	12	,	,	PUNCT
admet-2057	351	13	the	the	DET
admet-2057	351	14	disulfide	disulfide	NOUN
admet-2057	351	15	bond	bond	NOUN
admet-2057	351	16	was	be	AUX
admet-2057	351	17	severed	sever	VERB
admet-2057	351	18	in	in	ADP
admet-2057	351	19	the	the	DET
admet-2057	351	20	presence	presence	NOUN
admet-2057	351	21	of	of	ADP
admet-2057	351	22	gsh	gsh	PROPN
admet-2057	351	23	.	.	PUNCT
admet-2057	352	1	magnetic	magnetic	ADJ
admet-2057	352	2	resonance	resonance	NOUN
admet-2057	352	3	imaging	imaging	NOUN
admet-2057	352	4	(	(	PUNCT
admet-2057	352	5	mri	mri	NOUN
admet-2057	352	6	)	)	PUNCT
admet-2057	352	7	also	also	ADV
admet-2057	352	8	revealed	reveal	VERB
admet-2057	352	9	a	a	DET
admet-2057	352	10	higher	high	ADJ
admet-2057	352	11	t1	t1	NOUN
admet-2057	352	12	contrast	contrast	NOUN
admet-2057	352	13	for	for	ADP
admet-2057	352	14	the	the	DET
admet-2057	352	15	mn2	mn2	NOUN
admet-2057	352	16	+	+	X
admet-2057	352	17	in	in	ADP
admet-2057	352	18	ncps	ncps	PROPN
admet-2057	352	19	.	.	PUNCT
admet-2057	353	1	the	the	DET
admet-2057	353	2	simple	simple	ADJ
admet-2057	353	3	approach	approach	NOUN
admet-2057	353	4	used	use	VERB
admet-2057	353	5	for	for	ADP
admet-2057	353	6	attaining	attain	VERB
admet-2057	353	7	redoxinduced	redoxinduced	ADJ
admet-2057	353	8	release	release	NOUN
admet-2057	353	9	is	be	AUX
admet-2057	353	10	post	post	ADJ
admet-2057	353	11	-	-	ADJ
admet-2057	353	12	synthetic	synthetic	ADJ
admet-2057	353	13	modification	modification	NOUN
admet-2057	353	14	.	.	PUNCT
admet-2057	354	1	this	this	PRON
admet-2057	354	2	can	can	AUX
admet-2057	354	3	be	be	AUX
admet-2057	354	4	done	do	VERB
admet-2057	354	5	by	by	ADP
admet-2057	354	6	loading	load	VERB
admet-2057	354	7	the	the	DET
admet-2057	354	8	mofs	mof	NOUN
admet-2057	354	9	with	with	ADP
admet-2057	354	10	the	the	DET
admet-2057	354	11	active	active	ADJ
admet-2057	354	12	moieties	moiety	NOUN
admet-2057	354	13	and	and	CCONJ
admet-2057	354	14	then	then	ADV
admet-2057	354	15	blocking	block	VERB
admet-2057	354	16	the	the	DET
admet-2057	354	17	pores	pore	NOUN
admet-2057	354	18	with	with	ADP
admet-2057	354	19	a	a	DET
admet-2057	354	20	disulphide	disulphide	ADV
admet-2057	354	21	-	-	PUNCT
admet-2057	354	22	containing	contain	VERB
admet-2057	354	23	surface	surface	NOUN
admet-2057	354	24	coating	coating	NOUN
admet-2057	354	25	.	.	PUNCT
admet-2057	355	1	the	the	DET
admet-2057	355	2	release	release	NOUN
admet-2057	355	3	occurs	occur	VERB
admet-2057	355	4	when	when	SCONJ
admet-2057	355	5	mofs	mof	NOUN
admet-2057	355	6	come	come	VERB
admet-2057	355	7	in	in	ADP
admet-2057	355	8	contact	contact	NOUN
admet-2057	355	9	with	with	ADP
admet-2057	355	10	gsh	gsh	PROPN
admet-2057	355	11	present	present	ADJ
admet-2057	355	12	in	in	ADP
admet-2057	355	13	cells	cell	NOUN
admet-2057	355	14	,	,	PUNCT
admet-2057	355	15	which	which	PRON
admet-2057	355	16	causes	cause	VERB
admet-2057	355	17	the	the	DET
admet-2057	355	18	coating	coating	NOUN
admet-2057	355	19	breakdown[84	breakdown[84	PROPN
admet-2057	355	20	]	]	PUNCT
admet-2057	355	21	.	.	PUNCT
admet-2057	356	1	in	in	ADP
admet-2057	356	2	this	this	DET
admet-2057	356	3	line	line	NOUN
admet-2057	356	4	,	,	PUNCT
admet-2057	356	5	ma	ma	PROPN
admet-2057	356	6	and	and	CCONJ
admet-2057	356	7	co	co	NOUN
admet-2057	356	8	-	-	NOUN
admet-2057	356	9	workers	worker	NOUN
admet-2057	356	10	[	[	X
admet-2057	356	11	85	85	NUM
admet-2057	356	12	]	]	PUNCT
admet-2057	356	13	used	use	VERB
admet-2057	356	14	cystamine	cystamine	NOUN
admet-2057	356	15	to	to	PART
admet-2057	356	16	coat	coat	VERB
admet-2057	356	17	zif-8	zif-8	NUM
admet-2057	356	18	material	material	NOUN
admet-2057	356	19	for	for	ADP
admet-2057	356	20	redox	redox	NOUN
admet-2057	356	21	-	-	PUNCT
admet-2057	356	22	induced	induce	VERB
admet-2057	356	23	paclitaxel	paclitaxel	PROPN
admet-2057	356	24	(	(	PUNCT
admet-2057	356	25	ptx	ptx	NOUN
admet-2057	356	26	)	)	PUNCT
admet-2057	356	27	release	release	NOUN
admet-2057	356	28	.	.	PUNCT
admet-2057	357	1	researchers	researcher	NOUN
admet-2057	357	2	used	use	VERB
admet-2057	357	3	cystamine	cystamine	NOUN
admet-2057	357	4	as	as	ADP
admet-2057	357	5	the	the	DET
admet-2057	357	6	linker	linker	NOUN
admet-2057	357	7	and	and	CCONJ
admet-2057	357	8	a	a	DET
admet-2057	357	9	redox	redox	NOUN
admet-2057	357	10	-	-	PUNCT
admet-2057	357	11	sensitive	sensitive	ADJ
admet-2057	357	12	substance	substance	NOUN
admet-2057	357	13	to	to	PART
admet-2057	357	14	create	create	VERB
admet-2057	357	15	a	a	DET
admet-2057	357	16	redox	redox	NOUN
admet-2057	357	17	-	-	PUNCT
admet-2057	357	18	responsive	responsive	ADJ
admet-2057	357	19	ptx	ptx	NOUN
admet-2057	357	20	drug	drug	NOUN
admet-2057	357	21	delivery	delivery	NOUN
admet-2057	357	22	platform	platform	NOUN
admet-2057	357	23	based	base	VERB
admet-2057	357	24	on	on	ADP
admet-2057	357	25	mofs	mof	NOUN
admet-2057	357	26	.	.	PUNCT
admet-2057	358	1	zif-8	zif-8	PUNCT
admet-2057	358	2	served	serve	VERB
admet-2057	358	3	as	as	ADP
admet-2057	358	4	the	the	DET
admet-2057	358	5	drug	drug	NOUN
admet-2057	358	6	delivery	delivery	NOUN
admet-2057	358	7	vehicle	vehicle	NOUN
admet-2057	358	8	.	.	PUNCT
admet-2057	359	1	tem	tem	PROPN
admet-2057	359	2	was	be	AUX
admet-2057	359	3	used	use	VERB
admet-2057	359	4	to	to	PART
admet-2057	359	5	analyse	analyse	VERB
admet-2057	359	6	the	the	DET
admet-2057	359	7	morphology	morphology	NOUN
admet-2057	359	8	of	of	ADP
admet-2057	359	9	zif-8	zif-8	NUM
admet-2057	359	10	,	,	PUNCT
admet-2057	359	11	and	and	CCONJ
admet-2057	359	12	xrd	xrd	NOUN
admet-2057	359	13	was	be	AUX
admet-2057	359	14	used	use	VERB
admet-2057	359	15	to	to	PART
admet-2057	359	16	analyse	analyse	VERB
admet-2057	359	17	the	the	DET
admet-2057	359	18	crystal	crystal	NOUN
admet-2057	359	19	structure	structure	NOUN
admet-2057	359	20	.	.	PUNCT
admet-2057	360	1	the	the	DET
admet-2057	360	2	surface	surface	NOUN
admet-2057	360	3	modification	modification	NOUN
admet-2057	360	4	of	of	ADP
admet-2057	360	5	zif-8	zif-8	NUM
admet-2057	360	6	was	be	AUX
admet-2057	360	7	investigated	investigate	VERB
admet-2057	360	8	using	use	VERB
admet-2057	360	9	ftir	ftir	PROPN
admet-2057	360	10	spectroscopy	spectroscopy	NOUN
admet-2057	360	11	.	.	PUNCT
admet-2057	361	1	according	accord	VERB
admet-2057	361	2	to	to	ADP
admet-2057	361	3	the	the	DET
admet-2057	361	4	bet	bet	NOUN
admet-2057	361	5	analysis	analysis	NOUN
admet-2057	361	6	,	,	PUNCT
admet-2057	361	7	surface	surface	NOUN
admet-2057	361	8	modification	modification	NOUN
admet-2057	361	9	had	have	VERB
admet-2057	361	10	no	no	DET
admet-2057	361	11	effect	effect	NOUN
admet-2057	361	12	on	on	ADP
admet-2057	361	13	zif-8	zif-8	NOUN
admet-2057	361	14	's	's	PART
admet-2057	361	15	specific	specific	ADJ
admet-2057	361	16	surface	surface	NOUN
admet-2057	361	17	area	area	NOUN
admet-2057	361	18	and	and	CCONJ
admet-2057	361	19	pore	pore	ADJ
admet-2057	361	20	size	size	NOUN
admet-2057	361	21	distribution	distribution	NOUN
admet-2057	361	22	.	.	PUNCT
admet-2057	362	1	under	under	ADP
admet-2057	362	2	various	various	ADJ
admet-2057	362	3	ph	ph	ADJ
admet-2057	362	4	and	and	CCONJ
admet-2057	362	5	gsh	gsh	NOUN
admet-2057	362	6	concentrations	concentration	NOUN
admet-2057	362	7	,	,	PUNCT
admet-2057	362	8	the	the	DET
admet-2057	362	9	drug	drug	NOUN
admet-2057	362	10	release	release	NOUN
admet-2057	362	11	of	of	ADP
admet-2057	362	12	zif-8	zif-8	NUM
admet-2057	362	13	,	,	PUNCT
admet-2057	362	14	cystamine	cystamine	NOUN
admet-2057	362	15	,	,	PUNCT
admet-2057	362	16	and	and	CCONJ
admet-2057	362	17	ptx	ptx	NOUN
admet-2057	362	18	was	be	AUX
admet-2057	362	19	investigated	investigate	VERB
admet-2057	362	20	.	.	PUNCT
admet-2057	363	1	in	in	ADP
admet-2057	363	2	a	a	DET
admet-2057	363	3	different	different	ADJ
admet-2057	363	4	work	work	NOUN
admet-2057	363	5	,	,	PUNCT
admet-2057	363	6	bingqian	bingqian	NOUN
admet-2057	363	7	lei	lei	X
admet-2057	364	1	[	[	X
admet-2057	364	2	86	86	NUM
admet-2057	364	3	]	]	PUNCT
admet-2057	364	4	used	use	VERB
admet-2057	364	5	iron	iron	NOUN
admet-2057	364	6	,	,	PUNCT
admet-2057	364	7	aluminium	aluminium	NOUN
admet-2057	364	8	,	,	PUNCT
admet-2057	364	9	or	or	CCONJ
admet-2057	364	10	zirconium	zirconium	NOUN
admet-2057	364	11	as	as	ADP
admet-2057	364	12	the	the	DET
admet-2057	364	13	metal	metal	NOUN
admet-2057	364	14	nodes	node	NOUN
admet-2057	364	15	and	and	CCONJ
admet-2057	364	16	4,4′-dithiobisbenzoic	4,4′-dithiobisbenzoic	PROPN
admet-2057	364	17	acid	acid	NOUN
admet-2057	364	18	(	(	PUNCT
admet-2057	364	19	4,4′-dtba	4,4′-dtba	NOUN
admet-2057	364	20	)	)	PUNCT
admet-2057	364	21	as	as	ADP
admet-2057	364	22	the	the	DET
admet-2057	364	23	organic	organic	ADJ
admet-2057	364	24	ligand	ligand	NOUN
admet-2057	364	25	to	to	PART
admet-2057	364	26	construct	construct	VERB
admet-2057	364	27	a	a	DET
admet-2057	364	28	novel	novel	ADJ
admet-2057	364	29	intrinsic	intrinsic	ADJ
admet-2057	364	30	redoxresponsive	redoxresponsive	ADJ
admet-2057	364	31	mofs	mof	NOUN
admet-2057	364	32	carrier	carrier	NOUN
admet-2057	364	33	,	,	PUNCT
admet-2057	364	34	mofm(dtba	mofm(dtba	PROPN
admet-2057	364	35	)	)	PUNCT
admet-2057	364	36	(	(	PUNCT
admet-2057	364	37	m	m	NOUN
admet-2057	364	38	=	=	SYM
admet-2057	364	39	fe	fe	X
admet-2057	364	40	,	,	PUNCT
admet-2057	364	41	al	al	PROPN
admet-2057	364	42	or	or	CCONJ
admet-2057	364	43	zr	zr	PROPN
admet-2057	364	44	)	)	PUNCT
admet-2057	364	45	.	.	PUNCT
admet-2057	365	1	it	it	PRON
admet-2057	365	2	is	be	AUX
admet-2057	365	3	possible	possible	ADJ
admet-2057	365	4	for	for	ADP
admet-2057	365	5	gsh	gsh	PROPN
admet-2057	365	6	,	,	PUNCT
admet-2057	365	7	frequently	frequently	ADV
admet-2057	365	8	overexpressed	overexpresse	VERB
admet-2057	365	9	in	in	ADP
admet-2057	365	10	tumour	tumour	ADJ
admet-2057	365	11	cells	cell	NOUN
admet-2057	365	12	,	,	PUNCT
admet-2057	365	13	to	to	PART
admet-2057	365	14	break	break	VERB
admet-2057	365	15	the	the	DET
admet-2057	365	16	disulfide	disulfide	NOUN
admet-2057	365	17	link	link	NOUN
admet-2057	365	18	in	in	ADP
admet-2057	365	19	4,4′-dtba	4,4′-dtba	PROPN
admet-2057	365	20	.	.	PUNCT
admet-2057	366	1	it	it	PRON
admet-2057	366	2	was	be	AUX
admet-2057	366	3	discovered	discover	VERB
admet-2057	366	4	that	that	SCONJ
admet-2057	366	5	mof	mof	ADJ
admet-2057	366	6	-	-	ADJ
admet-2057	366	7	zr(dtba	zr(dtba	ADJ
admet-2057	366	8	)	)	PUNCT
admet-2057	366	9	produced	produce	VERB
admet-2057	366	10	at	at	ADP
admet-2057	366	11	40	40	NUM
admet-2057	366	12	°	°	NOUN
admet-2057	366	13	c	c	NOUN
admet-2057	366	14	has	have	VERB
admet-2057	366	15	the	the	DET
admet-2057	366	16	right	right	ADJ
admet-2057	366	17	shape	shape	NOUN
admet-2057	366	18	and	and	CCONJ
admet-2057	366	19	characteristics	characteristic	NOUN
admet-2057	366	20	for	for	ADP
admet-2057	366	21	a	a	DET
admet-2057	366	22	drug	drug	NOUN
admet-2057	366	23	carrier	carrier	NOUN
admet-2057	366	24	.	.	PUNCT
admet-2057	367	1	ccm	ccm	PROPN
admet-2057	367	2	was	be	AUX
admet-2057	367	3	added	add	VERB
admet-2057	367	4	to	to	ADP
admet-2057	367	5	mof	mof	ADJ
admet-2057	367	6	-	-	ADJ
admet-2057	367	7	zr(dtba	zr(dtba	ADJ
admet-2057	367	8	)	)	PUNCT
admet-2057	367	9	to	to	PART
admet-2057	367	10	create	create	VERB
admet-2057	367	11	ccm@mof	ccm@mof	NUM
admet-2057	367	12	-	-	ADJ
admet-2057	367	13	zr(dtba	zr(dtba	ADJ
admet-2057	367	14	)	)	PUNCT
admet-2057	367	15	nanoparticles	nanoparticle	NOUN
admet-2057	367	16	,	,	PUNCT
admet-2057	367	17	which	which	PRON
admet-2057	367	18	released	release	VERB
admet-2057	367	19	more	more	ADV
admet-2057	367	20	quickly	quickly	ADV
admet-2057	367	21	in	in	ADP
admet-2057	367	22	-	-	PUNCT
admet-2057	367	23	vitro	vitro	X
admet-2057	367	24	and	and	CCONJ
admet-2057	367	25	caused	cause	VERB
admet-2057	367	26	more	more	ADJ
admet-2057	367	27	cell	cell	NOUN
admet-2057	367	28	death	death	NOUN
admet-2057	367	29	than	than	ADP
admet-2057	367	30	free	free	ADJ
admet-2057	367	31	ccm	ccm	PROPN
admet-2057	367	32	.	.	PUNCT
admet-2057	368	1	according	accord	VERB
admet-2057	368	2	to	to	ADP
admet-2057	368	3	in	in	ADP
admet-2057	368	4	-	-	PUNCT
admet-2057	368	5	vivo	vivo	NOUN
admet-2057	368	6	anticancer	anticancer	NOUN
admet-2057	368	7	tests	test	NOUN
admet-2057	368	8	,	,	PUNCT
admet-2057	368	9	ccm@	ccm@	X
admet-2057	368	10	mof	mof	NOUN
admet-2057	368	11	-	-	ADJ
admet-2057	368	12	zr(dtba	zr(dtba	ADJ
admet-2057	368	13	)	)	PUNCT
admet-2057	368	14	has	have	VERB
admet-2057	368	15	much	much	ADV
admet-2057	368	16	better	well	ADJ
admet-2057	368	17	antitumor	antitumor	NOUN
admet-2057	368	18	activity	activity	NOUN
admet-2057	368	19	than	than	ADP
admet-2057	368	20	free	free	ADJ
admet-2057	368	21	ccm	ccm	NOUN
admet-2057	368	22	.	.	PUNCT
admet-2057	369	1	this	this	DET
admet-2057	369	2	method	method	NOUN
admet-2057	369	3	for	for	ADP
admet-2057	369	4	creating	create	VERB
admet-2057	369	5	responsive	responsive	ADJ
admet-2057	369	6	mof	mof	NOUN
admet-2057	369	7	-	-	PUNCT
admet-2057	369	8	based	base	VERB
admet-2057	369	9	nanocarriers	nanocarrier	NOUN
admet-2057	369	10	may	may	AUX
admet-2057	369	11	present	present	VERB
admet-2057	369	12	fresh	fresh	ADJ
admet-2057	369	13	opportunities	opportunity	NOUN
admet-2057	369	14	for	for	ADP
admet-2057	369	15	using	use	VERB
admet-2057	369	16	mofs	mof	NOUN
admet-2057	369	17	in	in	ADP
admet-2057	369	18	theranostics	theranostic	NOUN
admet-2057	369	19	,	,	PUNCT
admet-2057	369	20	molecular	molecular	ADJ
admet-2057	369	21	imaging	imaging	NOUN
admet-2057	369	22	,	,	PUNCT
admet-2057	369	23	and	and	CCONJ
admet-2057	369	24	drug	drug	NOUN
admet-2057	369	25	delivery	delivery	NOUN
admet-2057	369	26	.	.	PUNCT
admet-2057	370	1	in	in	ADP
admet-2057	370	2	a	a	DET
admet-2057	370	3	similar	similar	ADJ
admet-2057	370	4	line	line	NOUN
admet-2057	370	5	,	,	PUNCT
admet-2057	370	6	haozhe	haozhe	ADJ
admet-2057	370	7	he	he	PRON
admet-2057	370	8	[	[	X
admet-2057	370	9	87	87	NUM
admet-2057	370	10	]	]	PUNCT
admet-2057	370	11	demonstrated	demonstrate	VERB
admet-2057	370	12	that	that	SCONJ
admet-2057	370	13	a	a	DET
admet-2057	370	14	hybrid	hybrid	ADJ
admet-2057	370	15	pfp@fe	pfp@fe	NOUN
admet-2057	370	16	/	/	SYM
admet-2057	370	17	cu	cu	PROPN
admet-2057	370	18	-	-	PUNCT
admet-2057	370	19	ss	ss	PROPN
admet-2057	370	20	mof	mof	X
admet-2057	370	21	increased	increase	VERB
admet-2057	370	22	intratumoral	intratumoral	ADJ
admet-2057	370	23	lpo	lpo	PROPN
admet-2057	370	24	content	content	NOUN
admet-2057	370	25	by	by	ADP
admet-2057	370	26	redox	redox	ADJ
admet-2057	370	27	reactions	reaction	NOUN
admet-2057	370	28	producing	produce	VERB
admet-2057	370	29	oh	oh	INTJ
admet-2057	370	30	.	.	PUNCT
admet-2057	371	1	lpo	lpo	PROPN
admet-2057	371	2	level	level	NOUN
admet-2057	371	3	also	also	ADV
admet-2057	371	4	increased	increase	VERB
admet-2057	371	5	as	as	ADP
admet-2057	371	6	a	a	DET
admet-2057	371	7	result	result	NOUN
admet-2057	371	8	of	of	ADP
admet-2057	371	9	the	the	DET
admet-2057	371	10	inactivation	inactivation	NOUN
admet-2057	371	11	of	of	ADP
admet-2057	371	12	glutathione	glutathione	NOUN
admet-2057	371	13	peroxide	peroxide	NOUN
admet-2057	371	14	4	4	NUM
admet-2057	371	15	(	(	PUNCT
admet-2057	371	16	gpx4	gpx4	PROPN
admet-2057	371	17	)	)	PUNCT
admet-2057	371	18	caused	cause	VERB
admet-2057	371	19	by	by	ADP
admet-2057	371	20	the	the	DET
admet-2057	371	21	depletion	depletion	NOUN
admet-2057	371	22	of	of	ADP
admet-2057	371	23	gsh	gsh	NOUN
admet-2057	371	24	through	through	ADP
admet-2057	371	25	disulfide	disulfide	NOUN
admet-2057	371	26	-	-	PUNCT
admet-2057	371	27	thiol	thiol	NOUN
admet-2057	371	28	exchange	exchange	NOUN
admet-2057	371	29	.	.	PUNCT
admet-2057	372	1	this	this	DET
admet-2057	372	2	mof	mof	NOUN
admet-2057	372	3	significantly	significantly	ADV
admet-2057	372	4	slowed	slow	VERB
admet-2057	372	5	their	their	PRON
admet-2057	372	6	growth	growth	NOUN
admet-2057	372	7	when	when	SCONJ
admet-2057	372	8	huh-7	huh-7	VERB
admet-2057	372	9	tumours	tumour	NOUN
admet-2057	372	10	were	be	AUX
admet-2057	372	11	xenografted	xenografte	VERB
admet-2057	372	12	onto	onto	ADP
admet-2057	372	13	mice	mouse	NOUN
admet-2057	372	14	.	.	PUNCT
admet-2057	373	1	when	when	SCONJ
admet-2057	373	2	a	a	DET
admet-2057	373	3	ferroptosis	ferroptosis	NOUN
admet-2057	373	4	inhibitor	inhibitor	NOUN
admet-2057	373	5	is	be	AUX
admet-2057	373	6	also	also	ADV
admet-2057	373	7	administered	administer	VERB
admet-2057	373	8	,	,	PUNCT
admet-2057	373	9	the	the	DET
admet-2057	373	10	mof	mof	NOUN
admet-2057	373	11	's	's	PART
admet-2057	373	12	anticancer	anticancer	NOUN
admet-2057	373	13	action	action	NOUN
admet-2057	373	14	is	be	AUX
admet-2057	373	15	lessened	lessen	VERB
admet-2057	373	16	,	,	PUNCT
admet-2057	373	17	which	which	PRON
admet-2057	373	18	results	result	VERB
admet-2057	373	19	in	in	ADP
admet-2057	373	20	a	a	DET
admet-2057	373	21	recovery	recovery	NOUN
admet-2057	373	22	of	of	ADP
admet-2057	373	23	gpx4	gpx4	NOUN
admet-2057	373	24	activity	activity	NOUN
admet-2057	373	25	and	and	CCONJ
admet-2057	373	26	an	an	DET
admet-2057	373	27	acceleration	acceleration	NOUN
admet-2057	373	28	of	of	ADP
admet-2057	373	29	tumour	tumour	NOUN
admet-2057	373	30	growth	growth	NOUN
admet-2057	373	31	.	.	PUNCT
admet-2057	374	1	additionally	additionally	ADV
admet-2057	374	2	,	,	PUNCT
admet-2057	374	3	by	by	ADP
admet-2057	374	4	including	include	VERB
admet-2057	374	5	cu	cu	PROPN
admet-2057	374	6	in	in	ADP
admet-2057	374	7	mesoporous	mesoporous	ADJ
admet-2057	374	8	pfp@fe	pfp@fe	PROPN
admet-2057	374	9	/	/	SYM
admet-2057	374	10	cu	cu	PROPN
admet-2057	374	11	-	-	PUNCT
admet-2057	374	12	ss	ss	PROPN
admet-2057	374	13	,	,	PUNCT
admet-2057	374	14	the	the	DET
admet-2057	374	15	mof	mof	NOUN
admet-2057	374	16	was	be	AUX
admet-2057	374	17	able	able	ADJ
admet-2057	374	18	to	to	PART
admet-2057	374	19	retain	retain	VERB
admet-2057	374	20	its	its	PRON
admet-2057	374	21	photothermal	photothermal	ADJ
admet-2057	374	22	conversion	conversion	NOUN
admet-2057	374	23	capability	capability	NOUN
admet-2057	374	24	while	while	SCONJ
admet-2057	374	25	simultaneously	simultaneously	ADV
admet-2057	374	26	serving	serve	VERB
admet-2057	374	27	as	as	ADP
admet-2057	374	28	a	a	DET
admet-2057	374	29	contrast	contrast	NOUN
admet-2057	374	30	agent	agent	NOUN
admet-2057	374	31	for	for	ADP
admet-2057	374	32	t1	t1	NOUN
admet-2057	374	33	-	-	PUNCT
admet-2057	374	34	weighted	weight	VERB
admet-2057	374	35	magnetic	magnetic	ADJ
admet-2057	374	36	resonance	resonance	NOUN
admet-2057	374	37	imaging	imaging	NOUN
admet-2057	374	38	.	.	PUNCT
admet-2057	375	1	as	as	ADP
admet-2057	375	2	a	a	DET
admet-2057	375	3	result	result	NOUN
admet-2057	375	4	,	,	PUNCT
admet-2057	375	5	nearinfrared	nearinfrare	VERB
admet-2057	375	6	light	light	NOUN
admet-2057	375	7	caused	cause	VERB
admet-2057	375	8	photothermal	photothermal	ADJ
admet-2057	375	9	treatment	treatment	NOUN
admet-2057	375	10	and	and	CCONJ
admet-2057	375	11	turned	turn	VERB
admet-2057	375	12	the	the	DET
admet-2057	375	13	liquid	liquid	ADJ
admet-2057	375	14	perfluoropentane	perfluoropentane	NOUN
admet-2057	375	15	enclosed	enclose	VERB
admet-2057	375	16	into	into	ADP
admet-2057	375	17	microbubbles	microbubble	NOUN
admet-2057	375	18	for	for	ADP
admet-2057	375	19	ultrasound	ultrasound	ADJ
admet-2057	375	20	imaging	imaging	NOUN
admet-2057	375	21	.	.	PUNCT
admet-2057	376	1	e.	e.	PROPN
admet-2057	376	2	atp	atp	PROPN
admet-2057	376	3	responsive	responsive	ADJ
admet-2057	376	4	adenosine	adenosine	NOUN
admet-2057	376	5	triphosphate	triphosphate	NOUN
admet-2057	376	6	(	(	PUNCT
admet-2057	376	7	atp	atp	PROPN
admet-2057	376	8	)	)	PUNCT
admet-2057	376	9	,	,	PUNCT
admet-2057	376	10	a	a	DET
admet-2057	376	11	high	high	ADJ
admet-2057	376	12	-	-	PUNCT
admet-2057	376	13	energy	energy	NOUN
admet-2057	376	14	unstable	unstable	ADJ
admet-2057	376	15	compound	compound	NOUN
admet-2057	376	16	,	,	PUNCT
admet-2057	376	17	is	be	AUX
admet-2057	376	18	widely	widely	ADV
admet-2057	376	19	present	present	ADJ
admet-2057	376	20	throughout	throughout	ADP
admet-2057	376	21	all	all	DET
admet-2057	376	22	living	live	VERB
admet-2057	376	23	organisms	organism	NOUN
admet-2057	376	24	.	.	PUNCT
admet-2057	377	1	the	the	DET
admet-2057	377	2	mechanism	mechanism	NOUN
admet-2057	377	3	for	for	ADP
admet-2057	377	4	atp	atp	PROPN
admet-2057	377	5	responsiveness	responsiveness	NOUN
admet-2057	377	6	can	can	AUX
admet-2057	377	7	be	be	AUX
admet-2057	377	8	classified	classify	VERB
admet-2057	377	9	into	into	ADP
admet-2057	377	10	two	two	NUM
admet-2057	377	11	groups	group	NOUN
admet-2057	377	12	:	:	PUNCT
admet-2057	377	13	1	1	NUM
admet-2057	377	14	)	)	PUNCT
admet-2057	377	15	atp	atp	NOUN
admet-2057	377	16	-	-	PUNCT
admet-2057	377	17	aptamer	aptamer	NOUN
admet-2057	377	18	complex	complex	ADJ
admet-2057	377	19	formation	formation	NOUN
admet-2057	377	20	and	and	CCONJ
admet-2057	377	21	2	2	NUM
admet-2057	377	22	)	)	PUNCT
admet-2057	377	23	atp	atp	NOUN
admet-2057	377	24	-	-	PUNCT
admet-2057	377	25	ion	ion	NOUN
admet-2057	377	26	complex	complex	ADJ
admet-2057	377	27	formation	formation	NOUN
admet-2057	377	28	.	.	PUNCT
admet-2057	378	1	in	in	ADP
admet-2057	378	2	the	the	DET
admet-2057	378	3	first	first	ADJ
admet-2057	378	4	case	case	NOUN
admet-2057	378	5	,	,	PUNCT
admet-2057	378	6	a	a	DET
admet-2057	378	7	stable	stable	ADJ
admet-2057	378	8	atp	atp	NOUN
admet-2057	378	9	-	-	PUNCT
admet-2057	378	10	binding	bind	VERB
admet-2057	378	11	dna	dna	NOUN
admet-2057	378	12	structure	structure	NOUN
admet-2057	378	13	is	be	AUX
admet-2057	378	14	formed	form	VERB
admet-2057	378	15	by	by	ADP
admet-2057	378	16	binding	bind	VERB
admet-2057	378	17	dna	dna	NOUN
admet-2057	378	18	to	to	ADP
admet-2057	378	19	the	the	DET
admet-2057	378	20	agarose	agarose	NOUN
admet-2057	378	21	column	column	NOUN
admet-2057	378	22	with	with	ADP
admet-2057	378	23	two	two	NUM
admet-2057	378	24	piled	pile	VERB
admet-2057	378	25	g	g	NOUN
admet-2057	378	26	-	-	PUNCT
admet-2057	378	27	quartets	quartet	NOUN
admet-2057	378	28	.	.	PUNCT
admet-2057	379	1	the	the	DET
admet-2057	379	2	two	two	NUM
admet-2057	379	3	conserved	conserved	ADJ
admet-2057	379	4	adenosine	adenosine	NOUN
admet-2057	379	5	residues	residue	NOUN
admet-2057	379	6	can	can	AUX
admet-2057	379	7	stack	stack	VERB
admet-2057	379	8	between	between	ADP
admet-2057	379	9	the	the	DET
admet-2057	379	10	top	top	ADJ
admet-2057	379	11	g	g	NOUN
admet-2057	379	12	-	-	PUNCT
admet-2057	379	13	quartets	quartet	NOUN
admet-2057	379	14	and	and	CCONJ
admet-2057	379	15	the	the	DET
admet-2057	379	16	short	short	ADJ
admet-2057	379	17	stems	stem	NOUN
admet-2057	379	18	,	,	PUNCT
admet-2057	379	19	forming	form	VERB
admet-2057	379	20	a	a	DET
admet-2057	379	21	pocket	pocket	NOUN
admet-2057	379	22	structure	structure	NOUN
admet-2057	379	23	where	where	SCONJ
admet-2057	379	24	the	the	DET
admet-2057	379	25	adenosine	adenosine	NOUN
admet-2057	379	26	or	or	CCONJ
admet-2057	379	27	atp	atp	PROPN
admet-2057	379	28	ligand	ligand	NOUN
admet-2057	379	29	can	can	AUX
admet-2057	379	30	attach	attach	VERB
admet-2057	379	31	.	.	PUNCT
admet-2057	380	1	it	it	PRON
admet-2057	380	2	is	be	AUX
admet-2057	380	3	demonstrated	demonstrate	VERB
admet-2057	380	4	that	that	SCONJ
admet-2057	380	5	the	the	DET
admet-2057	380	6	synthesis	synthesis	NOUN
admet-2057	380	7	of	of	ADP
admet-2057	380	8	nucleic	nucleic	ADJ
admet-2057	380	9	acid	acid	NOUN
admet-2057	380	10	hairpins	hairpin	NOUN
admet-2057	380	11	or	or	CCONJ
admet-2057	380	12	the	the	DET
admet-2057	380	13	complexation	complexation	NOUN
admet-2057	380	14	of	of	ADP
admet-2057	380	15	sdna	sdna	ADV
admet-2057	380	16	with	with	ADP
admet-2057	380	17	complementary	complementary	ADJ
admet-2057	380	18	dna	dna	PROPN
admet-2057	380	19	might	might	AUX
admet-2057	380	20	lock	lock	VERB
admet-2057	380	21	cargos	cargo	NOUN
admet-2057	380	22	in	in	ADP
admet-2057	380	23	the	the	DET
admet-2057	380	24	pores	pore	NOUN
admet-2057	380	25	of	of	ADP
admet-2057	380	26	mofs	mof	NOUN
admet-2057	380	27	[	[	X
admet-2057	380	28	88	88	NUM
admet-2057	380	29	]	]	PUNCT
admet-2057	380	30	.	.	PUNCT
admet-2057	381	1	in	in	ADP
admet-2057	381	2	this	this	DET
admet-2057	381	3	regard	regard	NOUN
admet-2057	381	4	,	,	PUNCT
admet-2057	381	5	chen	chen	PROPN
admet-2057	381	6	and	and	CCONJ
admet-2057	381	7	co	co	NOUN
admet-2057	381	8	-	-	NOUN
admet-2057	381	9	workers	worker	NOUN
admet-2057	381	10	used	use	VERB
admet-2057	381	11	an	an	DET
admet-2057	381	12	nmof	nmof	NOUN
admet-2057	381	13	for	for	ADP
admet-2057	381	14	drug	drug	NOUN
admet-2057	381	15	delivery	delivery	NOUN
admet-2057	381	16	that	that	PRON
admet-2057	381	17	contained	contain	VERB
admet-2057	381	18	zr4	zr4	NOUN
admet-2057	381	19	+	+	NOUN
admet-2057	381	20	ions	ion	NOUN
admet-2057	381	21	,	,	PUNCT
admet-2057	381	22	amino	amino	NOUN
admet-2057	381	23	-	-	PUNCT
admet-2057	381	24	triphenyldicarboxylic	triphenyldicarboxylic	NOUN
admet-2057	381	25	acid	acid	NOUN
admet-2057	381	26	,	,	PUNCT
admet-2057	381	27	and	and	CCONJ
admet-2057	381	28	a	a	DET
admet-2057	381	29	complementary	complementary	ADJ
admet-2057	381	30	nucleic	nucleic	ADJ
admet-2057	381	31	acid	acid	NOUN
admet-2057	381	32	(	(	PUNCT
admet-2057	381	33	the	the	DET
admet-2057	381	34	atp	atp	PROPN
admet-2057	381	35	aptamer	aptamer	NOUN
admet-2057	381	36	sequence	sequence	NOUN
admet-2057	381	37	or	or	CCONJ
admet-2057	381	38	the	the	DET
admet-2057	381	39	atp	atp	NOUN
admet-2057	381	40	-	-	PUNCT
admet-2057	381	41	as1411	as1411	ADJ
admet-2057	381	42	hybrid	hybrid	NOUN
admet-2057	381	43	aptamer	aptamer	NOUN
admet-2057	381	44	sequence	sequence	NOUN
admet-2057	381	45	)	)	PUNCT
admet-2057	381	46	.	.	PUNCT
admet-2057	382	1	the	the	DET
admet-2057	382	2	release	release	NOUN
admet-2057	382	3	of	of	ADP
admet-2057	382	4	drugs	drug	NOUN
admet-2057	382	5	is	be	AUX
admet-2057	382	6	followed	follow	VERB
admet-2057	382	7	by	by	ADP
admet-2057	382	8	the	the	DET
admet-2057	382	9	unlocking	unlocking	NOUN
admet-2057	382	10	of	of	ADP
admet-2057	382	11	these	these	DET
admet-2057	382	12	frameworks	framework	NOUN
admet-2057	382	13	in	in	ADP
admet-2057	382	14	the	the	DET
admet-2057	382	15	atp	atp	NOUN
admet-2057	382	16	environment	environment	NOUN
admet-2057	382	17	by	by	ADP
admet-2057	382	18	the	the	DET
admet-2057	382	19	formation	formation	NOUN
admet-2057	382	20	of	of	ADP
admet-2057	382	21	an	an	DET
admet-2057	382	22	atp	atp	NOUN
admet-2057	382	23	-	-	PUNCT
admet-2057	382	24	aptamer	aptamer	NOUN
admet-2057	382	25	complex	complex	NOUN
admet-2057	382	26	.	.	PUNCT
admet-2057	383	1	only	only	ADV
admet-2057	383	2	10	10	NUM
admet-2057	383	3	%	%	NOUN
admet-2057	383	4	of	of	ADP
admet-2057	383	5	mcf-10a	mcf-10a	ADJ
admet-2057	383	6	epithelial	epithelial	ADJ
admet-2057	383	7	breast	breast	NOUN
admet-2057	383	8	cells	cell	NOUN
admet-2057	383	9	perished	perish	VERB
admet-2057	383	10	under	under	ADP
admet-2057	383	11	admet	admet	PROPN
admet-2057	383	12	&	&	CCONJ
admet-2057	383	13	dmpk	dmpk	PROPN
admet-2057	383	14	12(1	12(1	PROPN
admet-2057	383	15	)	)	PUNCT
admet-2057	383	16	(	(	PUNCT
admet-2057	383	17	2024	2024	NUM
admet-2057	383	18	)	)	PUNCT
admet-2057	383	19	27	27	NUM
admet-2057	383	20	-	-	SYM
admet-2057	383	21	62	62	NUM
admet-2057	383	22	drug	drug	NOUN
admet-2057	383	23	delivery	delivery	NOUN
admet-2057	383	24	applications	application	NOUN
admet-2057	383	25	of	of	ADP
admet-2057	383	26	metal	metal	NOUN
admet-2057	383	27	-	-	PUNCT
admet-2057	383	28	organic	organic	ADJ
admet-2057	383	29	framework	framework	NOUN
admet-2057	383	30	doi	doi	NOUN
admet-2057	383	31	:	:	PUNCT
admet-2057	383	32	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	383	33	41	41	NUM
admet-2057	383	34	comparable	comparable	ADJ
admet-2057	383	35	circumstances	circumstance	NOUN
admet-2057	383	36	when	when	SCONJ
admet-2057	383	37	dox	dox	NOUN
admet-2057	383	38	-	-	PUNCT
admet-2057	383	39	loaded	load	VERB
admet-2057	383	40	atp	atp	PROPN
admet-2057	383	41	aptamer	aptamer	NOUN
admet-2057	383	42	-	-	PUNCT
admet-2057	383	43	gated	gate	VERB
admet-2057	383	44	or	or	CCONJ
admet-2057	383	45	atp	atp	PROPN
admet-2057	383	46	as1411	as1411	PROPN
admet-2057	383	47	aptamer	aptamer	NOUN
admet-2057	383	48	-	-	PUNCT
admet-2057	383	49	gated	gate	VERB
admet-2057	383	50	nmofs	nmof	NOUN
admet-2057	383	51	were	be	AUX
admet-2057	383	52	used	use	VERB
admet-2057	383	53	to	to	PART
admet-2057	383	54	treat	treat	VERB
admet-2057	383	55	mda	mda	PROPN
admet-2057	383	56	-	-	PUNCT
admet-2057	383	57	mb-231	mb-231	PROPN
admet-2057	383	58	breast	breast	NOUN
admet-2057	383	59	cancer	cancer	NOUN
admet-2057	383	60	cells	cell	NOUN
admet-2057	383	61	.	.	PUNCT
admet-2057	384	1	the	the	DET
admet-2057	384	2	targeting	targeting	NOUN
admet-2057	384	3	and	and	CCONJ
admet-2057	384	4	efficient	efficient	ADJ
admet-2057	384	5	penetration	penetration	NOUN
admet-2057	384	6	of	of	ADP
admet-2057	384	7	the	the	DET
admet-2057	384	8	atp	atp	NOUN
admet-2057	384	9	-	-	PUNCT
admet-2057	384	10	responsive	responsive	ADJ
admet-2057	384	11	nmofs	nmof	NOUN
admet-2057	384	12	into	into	ADP
admet-2057	384	13	the	the	DET
admet-2057	384	14	cancer	cancer	NOUN
admet-2057	384	15	cells	cell	NOUN
admet-2057	384	16	increased	increase	VERB
admet-2057	384	17	the	the	DET
admet-2057	384	18	cytotoxicity	cytotoxicity	NOUN
admet-2057	384	19	because	because	SCONJ
admet-2057	384	20	atp	atp	PROPN
admet-2057	384	21	is	be	AUX
admet-2057	384	22	overexpressed	overexpresse	VERB
admet-2057	384	23	in	in	ADP
admet-2057	384	24	cancer	cancer	NOUN
admet-2057	384	25	cells	cell	NOUN
admet-2057	384	26	and	and	CCONJ
admet-2057	384	27	the	the	DET
admet-2057	384	28	as1411	as1411	ADJ
admet-2057	384	29	aptamer	aptamer	NOUN
admet-2057	384	30	recognises	recognise	VERB
admet-2057	384	31	the	the	DET
admet-2057	384	32	nucleolin	nucleolin	ADJ
admet-2057	384	33	receptor	receptor	NOUN
admet-2057	384	34	sites	site	NOUN
admet-2057	384	35	on	on	ADP
admet-2057	384	36	their	their	PRON
admet-2057	384	37	cell	cell	NOUN
admet-2057	384	38	membranes	membrane	NOUN
admet-2057	384	39	[	[	X
admet-2057	384	40	89	89	NUM
admet-2057	384	41	]	]	PUNCT
admet-2057	384	42	.	.	PUNCT
admet-2057	385	1	another	another	DET
admet-2057	385	2	facet	facet	NOUN
admet-2057	385	3	for	for	ADP
admet-2057	385	4	targeting	target	VERB
admet-2057	385	5	breast	breast	NOUN
admet-2057	385	6	cancer	cancer	NOUN
admet-2057	385	7	through	through	ADP
admet-2057	385	8	the	the	DET
admet-2057	385	9	atp	atp	NOUN
admet-2057	385	10	-	-	PUNCT
admet-2057	385	11	responsive	responsive	ADJ
admet-2057	385	12	coating	coating	NOUN
admet-2057	385	13	of	of	ADP
admet-2057	385	14	nucleic	nucleic	ADJ
admet-2057	385	15	acid	acid	NOUN
admet-2057	385	16	-	-	PUNCT
admet-2057	385	17	based	base	VERB
admet-2057	385	18	polyacrylamide	polyacrylamide	NOUN
admet-2057	385	19	hydrogel	hydrogel	NOUN
admet-2057	385	20	@dox	@dox	ADV
admet-2057	385	21	-	-	PUNCT
admet-2057	385	22	loaded	load	VERB
admet-2057	385	23	-	-	PUNCT
admet-2057	385	24	mof	mof	NOUN
admet-2057	385	25	was	be	AUX
admet-2057	385	26	introduced	introduce	VERB
admet-2057	385	27	by	by	ADP
admet-2057	385	28	wei	wei	PROPN
admet-2057	385	29	-	-	PROPN
admet-2057	385	30	hai	hai	PROPN
admet-2057	385	31	chen	chen	PROPN
admet-2057	385	32	and	and	CCONJ
admet-2057	385	33	colleagues	colleague	NOUN
admet-2057	386	1	[	[	X
admet-2057	386	2	90	90	NUM
admet-2057	386	3	]	]	PUNCT
admet-2057	386	4	.	.	PUNCT
admet-2057	387	1	the	the	DET
admet-2057	387	2	linkage	linkage	NOUN
admet-2057	387	3	of	of	ADP
admet-2057	387	4	a	a	DET
admet-2057	387	5	pair	pair	NOUN
admet-2057	387	6	of	of	ADP
admet-2057	387	7	polyacrylamide	polyacrylamide	NOUN
admet-2057	387	8	chains	chain	NOUN
admet-2057	387	9	,	,	PUNCT
admet-2057	387	10	pa	pa	PROPN
admet-2057	387	11	and	and	CCONJ
admet-2057	387	12	pb	pb	PROPN
admet-2057	387	13	,	,	PUNCT
admet-2057	387	14	which	which	PRON
admet-2057	387	15	are	be	AUX
admet-2057	387	16	modified	modify	VERB
admet-2057	387	17	with	with	ADP
admet-2057	387	18	two	two	NUM
admet-2057	387	19	nucleic	nucleic	ADJ
admet-2057	387	20	acid	acid	NOUN
admet-2057	387	21	hairpins	hairpin	NOUN
admet-2057	387	22	(	(	PUNCT
admet-2057	387	23	4	4	NUM
admet-2057	387	24	made	make	VERB
admet-2057	387	25	up	up	ADP
admet-2057	387	26	of	of	ADP
admet-2057	387	27	5′-acatccccttcctccgagctgacctgggggagtattgcggaggaaggtaccagatctagagc-3′	5′-acatccccttcctccgagctgacctgggggagtattgcggaggaaggtaccagatctagagc-3′	NUM
admet-2057	387	28	;	;	PUNCT
admet-2057	387	29	sequences	sequence	NOUN
admet-2057	387	30	of	of	ADP
admet-2057	387	31	dna	dna	PROPN
admet-2057	387	32	)	)	PUNCT
admet-2057	387	33	and	and	CCONJ
admet-2057	387	34	(	(	PUNCT
admet-2057	387	35	5	5	NUM
admet-2057	387	36	made	make	VERB
admet-2057	387	37	up	up	ADP
admet-2057	387	38	of	of	ADP
admet-2057	387	39	5′-acryd	5′-acryd	NUM
admet-2057	387	40	/	/	SYM
admet-2057	387	41	ttttttttcctgggggagtattgcggaggaaggggatgtctcccccaggtcagct-3′	ttttttttcctgggggagtattgcggaggaaggggatgtctcccccaggtcagct-3′	NOUN
admet-2057	387	42	sequences	sequence	NOUN
admet-2057	387	43	of	of	ADP
admet-2057	387	44	dna	dna	PROPN
admet-2057	387	45	)	)	PUNCT
admet-2057	387	46	utilising	utilise	VERB
admet-2057	387	47	the	the	DET
admet-2057	387	48	strand	strand	NOUN
admet-2057	387	49	-	-	PUNCT
admet-2057	387	50	induced	induce	VERB
admet-2057	387	51	hybridization	hybridization	NOUN
admet-2057	387	52	chain	chain	NOUN
admet-2057	387	53	reaction	reaction	NOUN
admet-2057	387	54	,	,	PUNCT
admet-2057	387	55	promotes	promote	VERB
admet-2057	387	56	the	the	DET
admet-2057	387	57	production	production	NOUN
admet-2057	387	58	of	of	ADP
admet-2057	387	59	the	the	DET
admet-2057	387	60	hydrogel	hydrogel	NOUN
admet-2057	387	61	.	.	PUNCT
admet-2057	388	1	the	the	DET
admet-2057	388	2	generated	generate	VERB
admet-2057	388	3	anti	anti	ADJ
admet-2057	388	4	-	-	ADJ
admet-2057	388	5	atp	atp	ADJ
admet-2057	388	6	aptamer	aptamer	NOUN
admet-2057	388	7	repeat	repeat	NOUN
admet-2057	388	8	is	be	AUX
admet-2057	388	9	enclosed	enclose	VERB
admet-2057	388	10	in	in	ADP
admet-2057	388	11	the	the	DET
admet-2057	388	12	polyacrylamide	polyacrylamide	NOUN
admet-2057	388	13	gel	gel	NOUN
admet-2057	388	14	with	with	ADP
admet-2057	388	15	duplex	duplex	NOUN
admet-2057	388	16	bridges	bridge	NOUN
admet-2057	388	17	.	.	PUNCT
admet-2057	389	1	the	the	DET
admet-2057	389	2	hydrogel	hydrogel	NOUN
admet-2057	389	3	shell	shell	NOUN
admet-2057	389	4	secures	secure	VERB
admet-2057	389	5	the	the	DET
admet-2057	389	6	drugs	drug	NOUN
admet-2057	389	7	contained	contain	VERB
admet-2057	389	8	in	in	ADP
admet-2057	389	9	the	the	DET
admet-2057	389	10	nmofs	nmof	NOUN
admet-2057	389	11	.	.	PUNCT
admet-2057	390	1	the	the	DET
admet-2057	390	2	hydrogel	hydrogel	NOUN
admet-2057	390	3	layer	layer	NOUN
admet-2057	390	4	is	be	AUX
admet-2057	390	5	broken	break	VERB
admet-2057	390	6	down	down	ADP
admet-2057	390	7	by	by	ADP
admet-2057	390	8	creating	create	VERB
admet-2057	390	9	the	the	DET
admet-2057	390	10	atp	atp	NOUN
admet-2057	390	11	-	-	PUNCT
admet-2057	390	12	aptamer	aptamer	NOUN
admet-2057	390	13	complex	complex	NOUN
admet-2057	390	14	in	in	ADP
admet-2057	390	15	the	the	DET
admet-2057	390	16	vicinity	vicinity	NOUN
admet-2057	390	17	of	of	ADP
admet-2057	390	18	atp	atp	PROPN
admet-2057	390	19	,	,	PUNCT
admet-2057	390	20	which	which	PRON
admet-2057	390	21	is	be	AUX
admet-2057	390	22	elevated	elevate	VERB
admet-2057	390	23	in	in	ADP
admet-2057	390	24	cancerous	cancerous	ADJ
admet-2057	390	25	cells	cell	NOUN
admet-2057	390	26	.	.	PUNCT
admet-2057	391	1	this	this	PRON
admet-2057	391	2	resulted	result	VERB
admet-2057	391	3	in	in	ADP
admet-2057	391	4	the	the	DET
admet-2057	391	5	release	release	NOUN
admet-2057	391	6	of	of	ADP
admet-2057	391	7	the	the	DET
admet-2057	391	8	dox	dox	NOUN
admet-2057	391	9	.	.	PUNCT
admet-2057	392	1	the	the	DET
admet-2057	392	2	modified	modify	VERB
admet-2057	392	3	nmofs	nmof	NOUN
admet-2057	392	4	address	address	VERB
admet-2057	392	5	important	important	ADJ
admet-2057	392	6	shortcomings	shortcoming	NOUN
admet-2057	392	7	of	of	ADP
admet-2057	392	8	the	the	DET
admet-2057	392	9	previously	previously	ADV
admet-2057	392	10	outlined	outline	VERB
admet-2057	392	11	nucleic	nucleic	ADJ
admet-2057	392	12	acid	acid	NOUN
admet-2057	392	13	-	-	PUNCT
admet-2057	392	14	gated	gate	VERB
admet-2057	392	15	drug	drug	NOUN
admet-2057	392	16	-	-	PUNCT
admet-2057	392	17	loaded	load	VERB
admet-2057	392	18	nmofs	nmof	NOUN
admet-2057	392	19	in	in	ADP
admet-2057	392	20	lieu	lieu	NOUN
admet-2057	392	21	of	of	ADP
admet-2057	392	22	providing	provide	VERB
admet-2057	392	23	an	an	DET
admet-2057	392	24	umbrella	umbrella	NOUN
admet-2057	392	25	approach	approach	NOUN
admet-2057	392	26	for	for	ADP
admet-2057	392	27	the	the	DET
admet-2057	392	28	synthesis	synthesis	NOUN
admet-2057	392	29	of	of	ADP
admet-2057	392	30	drug	drug	NOUN
admet-2057	392	31	-	-	PUNCT
admet-2057	392	32	loaded	load	VERB
admet-2057	392	33	atp	atp	NOUN
admet-2057	392	34	-	-	PUNCT
admet-2057	392	35	responsive	responsive	ADJ
admet-2057	392	36	polyacrylamide	polyacrylamide	NOUN
admet-2057	392	37	hydrogel	hydrogel	NOUN
admet-2057	392	38	-	-	PUNCT
admet-2057	392	39	coated	coat	VERB
admet-2057	392	40	nmofs	nmof	NOUN
admet-2057	392	41	.	.	PUNCT
admet-2057	393	1	the	the	DET
admet-2057	393	2	research	research	NOUN
admet-2057	393	3	clarifies	clarify	VERB
admet-2057	393	4	that	that	SCONJ
admet-2057	393	5	the	the	DET
admet-2057	393	6	hydrogel	hydrogel	NOUN
admet-2057	393	7	-	-	PUNCT
admet-2057	393	8	coated	coat	VERB
admet-2057	393	9	nmofs	nmof	NOUN
admet-2057	393	10	have	have	VERB
admet-2057	393	11	substantially	substantially	ADV
admet-2057	393	12	greater	great	ADJ
admet-2057	393	13	drug	drug	NOUN
admet-2057	393	14	loading	loading	NOUN
admet-2057	393	15	than	than	ADP
admet-2057	393	16	the	the	DET
admet-2057	393	17	nucleic	nucleic	ADJ
admet-2057	393	18	acid	acid	NOUN
admet-2057	393	19	-	-	PUNCT
admet-2057	393	20	gated	gate	VERB
admet-2057	393	21	nmofs	nmof	NOUN
admet-2057	393	22	,	,	PUNCT
admet-2057	393	23	preventing	prevent	VERB
admet-2057	393	24	off	off	ADP
admet-2057	393	25	-	-	PUNCT
admet-2057	393	26	target	target	NOUN
admet-2057	393	27	drug	drug	NOUN
admet-2057	393	28	leakage	leakage	NOUN
admet-2057	393	29	reported	report	VERB
admet-2057	393	30	with	with	ADP
admet-2057	393	31	the	the	DET
admet-2057	393	32	nucleic	nucleic	ADJ
admet-2057	393	33	acid	acid	NOUN
admet-2057	393	34	-	-	PUNCT
admet-2057	393	35	secured	secure	VERB
admet-2057	393	36	nmofs	nmof	NOUN
admet-2057	393	37	.	.	PUNCT
admet-2057	394	1	in	in	ADP
admet-2057	394	2	comparison	comparison	NOUN
admet-2057	394	3	with	with	ADP
admet-2057	394	4	healthy	healthy	ADJ
admet-2057	394	5	mcf-10a	mcf-10a	ADJ
admet-2057	394	6	breast	breast	NOUN
admet-2057	394	7	cells	cell	NOUN
admet-2057	394	8	,	,	PUNCT
admet-2057	394	9	the	the	DET
admet-2057	394	10	dox	dox	NOUN
admet-2057	394	11	-	-	PUNCT
admet-2057	394	12	encapsulated	encapsulate	VERB
admet-2057	394	13	,	,	PUNCT
admet-2057	394	14	atp	atp	NOUN
admet-2057	394	15	-	-	PUNCT
admet-2057	394	16	responsive	responsive	ADJ
admet-2057	394	17	,	,	PUNCT
admet-2057	394	18	hydrogel	hydrogel	NOUN
admet-2057	394	19	-	-	PUNCT
admet-2057	394	20	coated	coat	VERB
admet-2057	394	21	nmofs	nmof	NOUN
admet-2057	394	22	exhibit	exhibit	VERB
admet-2057	394	23	specific	specific	ADJ
admet-2057	394	24	and	and	CCONJ
admet-2057	394	25	potent	potent	ADJ
admet-2057	394	26	cytotoxicity	cytotoxicity	NOUN
admet-2057	394	27	towards	towards	ADP
admet-2057	394	28	mda	mda	PROPN
admet-2057	394	29	-	-	PUNCT
admet-2057	394	30	mb-231	mb-231	PROPN
admet-2057	394	31	breast	breast	NOUN
admet-2057	394	32	cancer	cancer	NOUN
admet-2057	394	33	cells	cell	NOUN
admet-2057	394	34	.	.	PUNCT
admet-2057	395	1	in	in	ADP
admet-2057	395	2	a	a	DET
admet-2057	395	3	similar	similar	ADJ
admet-2057	395	4	vein	vein	NOUN
admet-2057	395	5	,	,	PUNCT
admet-2057	395	6	xiaoti	xiaoti	PROPN
admet-2057	395	7	yang	yang	PROPN
admet-2057	395	8	et	et	PROPN
admet-2057	395	9	al	al	PROPN
admet-2057	395	10	.	.	PUNCT
admet-2057	396	1	[	[	X
admet-2057	396	2	91	91	NUM
admet-2057	396	3	]	]	PUNCT
admet-2057	396	4	reported	report	VERB
admet-2057	396	5	the	the	DET
admet-2057	396	6	zif-90	zif-90	NUM
admet-2057	396	7	nanoplatform	nanoplatform	NOUN
admet-2057	396	8	for	for	ADP
admet-2057	396	9	the	the	DET
admet-2057	396	10	delivery	delivery	NOUN
admet-2057	396	11	of	of	ADP
admet-2057	396	12	cytosolic	cytosolic	ADJ
admet-2057	396	13	protein	protein	NOUN
admet-2057	396	14	along	along	ADP
admet-2057	396	15	with	with	ADP
admet-2057	396	16	clustered	clustered	ADJ
admet-2057	396	17	regularly	regularly	ADV
admet-2057	396	18	interspaced	interspace	VERB
admet-2057	396	19	short	short	ADJ
admet-2057	396	20	palindromic	palindromic	ADJ
admet-2057	396	21	repeats	repeat	NOUN
admet-2057	396	22	(	(	PUNCT
admet-2057	396	23	crispr	crispr	NOUN
admet-2057	396	24	/	/	SYM
admet-2057	396	25	cas-9	cas-9	NOUN
admet-2057	396	26	)	)	PUNCT
admet-2057	396	27	genome	genome	NOUN
admet-2057	396	28	editing	editing	NOUN
admet-2057	396	29	.	.	PUNCT
admet-2057	397	1	imidazole-2	imidazole-2	NUM
admet-2057	397	2	-	-	PUNCT
admet-2057	397	3	carboxaldehyde	carboxaldehyde	PROPN
admet-2057	397	4	,	,	PUNCT
admet-2057	397	5	zn2	zn2	PROPN
admet-2057	397	6	+	+	NOUN
admet-2057	397	7	and	and	CCONJ
admet-2057	397	8	protein	protein	NOUN
admet-2057	397	9	self	self	NOUN
admet-2057	397	10	-	-	PUNCT
admet-2057	397	11	assemble	assemble	ADJ
admet-2057	397	12	to	to	PART
admet-2057	397	13	generate	generate	VERB
admet-2057	397	14	zif-90	zif-90	NUM
admet-2057	397	15	/	/	SYM
admet-2057	397	16	protein	protein	NOUN
admet-2057	397	17	nanoparticles	nanoparticle	NOUN
admet-2057	397	18	,	,	PUNCT
admet-2057	397	19	effectively	effectively	ADV
admet-2057	397	20	enclosing	enclose	VERB
admet-2057	397	21	protein	protein	NOUN
admet-2057	397	22	.	.	PUNCT
admet-2057	398	1	it	it	PRON
admet-2057	398	2	was	be	AUX
admet-2057	398	3	discovered	discover	VERB
admet-2057	398	4	that	that	SCONJ
admet-2057	398	5	the	the	DET
admet-2057	398	6	competitive	competitive	ADJ
admet-2057	398	7	coupling	coupling	NOUN
admet-2057	398	8	between	between	ADP
admet-2057	398	9	atp	atp	PROPN
admet-2057	398	10	and	and	CCONJ
admet-2057	398	11	the	the	DET
admet-2057	398	12	zn2	zn2	PROPN
admet-2057	398	13	+	+	PROPN
admet-2057	398	14	of	of	ADP
admet-2057	398	15	zif-90	zif-90	NUM
admet-2057	398	16	causes	cause	VERB
admet-2057	398	17	the	the	DET
admet-2057	398	18	degradation	degradation	NOUN
admet-2057	398	19	of	of	ADP
admet-2057	398	20	zif-90	zif-90	NUM
admet-2057	398	21	nps	nps	PROPN
admet-2057	398	22	in	in	ADP
admet-2057	398	23	the	the	DET
admet-2057	398	24	vicinity	vicinity	NOUN
admet-2057	398	25	of	of	ADP
admet-2057	398	26	atp	atp	PROPN
admet-2057	398	27	to	to	PART
admet-2057	398	28	liberate	liberate	VERB
admet-2057	398	29	protein	protein	NOUN
admet-2057	398	30	.	.	PUNCT
admet-2057	399	1	according	accord	VERB
admet-2057	399	2	to	to	ADP
admet-2057	399	3	intracellular	intracellular	ADJ
admet-2057	399	4	delivery	delivery	NOUN
admet-2057	399	5	research	research	NOUN
admet-2057	399	6	,	,	PUNCT
admet-2057	399	7	the	the	DET
admet-2057	399	8	zif-90	zif-90	NUM
admet-2057	399	9	nps	nps	PROPN
admet-2057	399	10	are	be	AUX
admet-2057	399	11	capable	capable	ADJ
admet-2057	399	12	of	of	ADP
admet-2057	399	13	delivering	deliver	VERB
admet-2057	399	14	a	a	DET
admet-2057	399	15	wide	wide	ADJ
admet-2057	399	16	range	range	NOUN
admet-2057	399	17	of	of	ADP
admet-2057	399	18	proteins	protein	NOUN
admet-2057	399	19	inside	inside	ADP
admet-2057	399	20	the	the	DET
admet-2057	399	21	cytosol	cytosol	NOUN
admet-2057	399	22	,	,	PUNCT
admet-2057	399	23	irrespective	irrespective	ADV
admet-2057	399	24	of	of	ADP
admet-2057	399	25	protein	protein	NOUN
admet-2057	399	26	size	size	NOUN
admet-2057	399	27	and	and	CCONJ
admet-2057	399	28	molecular	molecular	ADJ
admet-2057	399	29	mass	mass	NOUN
admet-2057	399	30	.	.	PUNCT
admet-2057	400	1	as	as	SCONJ
admet-2057	400	2	cytotoxic	cytotoxic	ADJ
admet-2057	400	3	rnase	rnase	NOUN
admet-2057	400	4	a	a	PRON
admet-2057	400	5	is	be	AUX
admet-2057	400	6	effectively	effectively	ADV
admet-2057	400	7	delivered	deliver	VERB
admet-2057	400	8	,	,	PUNCT
admet-2057	400	9	tumour	tumour	ADJ
admet-2057	400	10	cell	cell	NOUN
admet-2057	400	11	development	development	NOUN
admet-2057	400	12	is	be	AUX
admet-2057	400	13	inhibited	inhibit	VERB
admet-2057	400	14	,	,	PUNCT
admet-2057	400	15	and	and	CCONJ
admet-2057	400	16	while	while	SCONJ
admet-2057	400	17	the	the	DET
admet-2057	400	18	genome	genome	NOUN
admet-2057	400	19	-	-	PUNCT
admet-2057	400	20	editing	edit	VERB
admet-2057	400	21	protein	protein	NOUN
admet-2057	400	22	cas9	cas9	NOUN
admet-2057	400	23	is	be	AUX
admet-2057	400	24	successfully	successfully	ADV
admet-2057	400	25	delivered	deliver	VERB
admet-2057	400	26	,	,	PUNCT
admet-2057	400	27	hela	hela	PROPN
admet-2057	400	28	cells	cell	NOUN
admet-2057	400	29	'	'	PART
admet-2057	400	30	expression	expression	NOUN
admet-2057	400	31	of	of	ADP
admet-2057	400	32	the	the	DET
admet-2057	400	33	green	green	ADJ
admet-2057	400	34	fluorescent	fluorescent	NOUN
admet-2057	400	35	protein	protein	NOUN
admet-2057	400	36	(	(	PUNCT
admet-2057	400	37	gfp	gfp	PROPN
admet-2057	400	38	)	)	PUNCT
admet-2057	400	39	has	have	AUX
admet-2057	400	40	been	be	AUX
admet-2057	400	41	wiped	wipe	VERB
admet-2057	400	42	out	out	ADP
admet-2057	400	43	with	with	ADP
admet-2057	400	44	an	an	DET
admet-2057	400	45	effectiveness	effectiveness	NOUN
admet-2057	400	46	of	of	ADP
admet-2057	400	47	up	up	ADP
admet-2057	400	48	to	to	PART
admet-2057	400	49	35	35	NUM
admet-2057	400	50	%	%	NOUN
admet-2057	400	51	.	.	PUNCT
admet-2057	401	1	the	the	DET
admet-2057	401	2	levels	level	NOUN
admet-2057	401	3	of	of	ADP
admet-2057	401	4	atp	atp	PROPN
admet-2057	401	5	are	be	AUX
admet-2057	401	6	elevated	elevate	VERB
admet-2057	401	7	in	in	ADP
admet-2057	401	8	disease	disease	NOUN
admet-2057	401	9	cells	cell	NOUN
admet-2057	401	10	,	,	PUNCT
admet-2057	401	11	so	so	SCONJ
admet-2057	401	12	it	it	PRON
admet-2057	401	13	is	be	AUX
admet-2057	401	14	anticipated	anticipate	VERB
admet-2057	401	15	that	that	SCONJ
admet-2057	401	16	the	the	DET
admet-2057	401	17	administration	administration	NOUN
admet-2057	401	18	of	of	ADP
admet-2057	401	19	an	an	DET
admet-2057	401	20	atp	atp	NOUN
admet-2057	401	21	-	-	PUNCT
admet-2057	401	22	responsive	responsive	ADJ
admet-2057	401	23	protein	protein	NOUN
admet-2057	401	24	would	would	AUX
admet-2057	401	25	create	create	VERB
admet-2057	401	26	new	new	ADJ
admet-2057	401	27	possibilities	possibility	NOUN
admet-2057	401	28	for	for	ADP
admet-2057	401	29	enhanced	enhance	VERB
admet-2057	401	30	protein	protein	NOUN
admet-2057	401	31	delivery	delivery	NOUN
admet-2057	401	32	and	and	CCONJ
admet-2057	401	33	crispr	crispr	ADJ
admet-2057	401	34	/	/	SYM
admet-2057	401	35	cas9	cas9	NOUN
admet-2057	401	36	genome	genome	NOUN
admet-2057	401	37	editing	editing	NOUN
admet-2057	401	38	to	to	PART
admet-2057	401	39	treat	treat	VERB
admet-2057	401	40	target	target	NOUN
admet-2057	401	41	-	-	PUNCT
admet-2057	401	42	specific	specific	ADJ
admet-2057	401	43	ailments	ailment	NOUN
admet-2057	401	44	.	.	PUNCT
admet-2057	402	1	multi	multi	ADJ
admet-2057	402	2	-	-	VERB
admet-2057	402	3	stimuli	stimuli	VERB
admet-2057	402	4	responsive	responsive	ADJ
admet-2057	402	5	mof	mof	ADJ
admet-2057	402	6	a.	a.	NOUN
admet-2057	402	7	ph	ph	PROPN
admet-2057	402	8	and	and	CCONJ
admet-2057	402	9	temperature	temperature	NOUN
admet-2057	402	10	-	-	PUNCT
admet-2057	402	11	responsive	responsive	ADJ
admet-2057	402	12	cancerous	cancerous	ADJ
admet-2057	402	13	cells	cell	NOUN
admet-2057	402	14	have	have	VERB
admet-2057	402	15	certain	certain	ADJ
admet-2057	402	16	distinct	distinct	ADJ
admet-2057	402	17	features	feature	NOUN
admet-2057	402	18	,	,	PUNCT
admet-2057	402	19	such	such	ADJ
admet-2057	402	20	as	as	ADP
admet-2057	402	21	a	a	DET
admet-2057	402	22	lower	low	ADJ
admet-2057	402	23	ph	ph	ADJ
admet-2057	402	24	and	and	CCONJ
admet-2057	402	25	higher	high	ADJ
admet-2057	402	26	temperature	temperature	NOUN
admet-2057	402	27	.	.	PUNCT
admet-2057	403	1	these	these	DET
admet-2057	403	2	features	feature	NOUN
admet-2057	403	3	have	have	AUX
admet-2057	403	4	opened	open	VERB
admet-2057	403	5	the	the	DET
admet-2057	403	6	doors	door	NOUN
admet-2057	403	7	for	for	ADP
admet-2057	403	8	new	new	ADJ
admet-2057	403	9	ways	way	NOUN
admet-2057	403	10	of	of	ADP
admet-2057	403	11	controlling	control	VERB
admet-2057	403	12	and	and	CCONJ
admet-2057	403	13	treating	treat	VERB
admet-2057	403	14	cancer	cancer	NOUN
admet-2057	403	15	growth	growth	NOUN
admet-2057	403	16	.	.	PUNCT
admet-2057	404	1	owing	owe	VERB
admet-2057	404	2	to	to	ADP
admet-2057	404	3	the	the	DET
admet-2057	404	4	ph	ph	ADJ
admet-2057	404	5	and	and	CCONJ
admet-2057	404	6	temperature	temperature	NOUN
admet-2057	404	7	features	feature	NOUN
admet-2057	404	8	,	,	PUNCT
admet-2057	404	9	new	new	ADJ
admet-2057	404	10	gates	gate	NOUN
admet-2057	404	11	have	have	AUX
admet-2057	404	12	benefited	benefit	VERB
admet-2057	404	13	by	by	ADP
admet-2057	404	14	designing	design	VERB
admet-2057	404	15	a	a	DET
admet-2057	404	16	dual	dual	ADJ
admet-2057	404	17	ph	ph	ADJ
admet-2057	404	18	and	and	CCONJ
admet-2057	404	19	temperature	temperature	NOUN
admet-2057	404	20	-	-	PUNCT
admet-2057	404	21	responsive	responsive	ADJ
admet-2057	404	22	system	system	NOUN
admet-2057	404	23	.	.	PUNCT
admet-2057	405	1	certain	certain	ADJ
admet-2057	405	2	types	type	NOUN
admet-2057	405	3	of	of	ADP
admet-2057	405	4	amino	amino	ADJ
admet-2057	405	5	acids	acid	NOUN
admet-2057	405	6	have	have	VERB
admet-2057	405	7	a	a	DET
admet-2057	405	8	tendency	tendency	NOUN
admet-2057	405	9	to	to	PART
admet-2057	405	10	act	act	VERB
admet-2057	405	11	as	as	ADP
admet-2057	405	12	a	a	DET
admet-2057	405	13	ph	ph	ADJ
admet-2057	405	14	-	-	PUNCT
admet-2057	405	15	responsive	responsive	ADJ
admet-2057	405	16	ligand	ligand	NOUN
admet-2057	405	17	.	.	PUNCT
admet-2057	406	1	in	in	ADP
admet-2057	406	2	2018	2018	NUM
admet-2057	406	3	,	,	PUNCT
admet-2057	406	4	lin	lin	PROPN
admet-2057	406	5	and	and	CCONJ
admet-2057	406	6	his	his	PRON
admet-2057	406	7	colleagues	colleague	NOUN
admet-2057	407	1	[	[	X
admet-2057	407	2	92	92	NUM
admet-2057	407	3	]	]	PUNCT
admet-2057	407	4	created	create	VERB
admet-2057	407	5	the	the	DET
admet-2057	407	6	biocompatible	biocompatible	ADJ
admet-2057	407	7	mof	mof	X
admet-2057	407	8	(	(	PUNCT
admet-2057	407	9	zn	zn	PROPN
admet-2057	407	10	-	-	PUNCT
admet-2057	407	11	ga	ga	PROPN
admet-2057	407	12	)	)	PUNCT
admet-2057	407	13	by	by	ADP
admet-2057	407	14	combining	combine	VERB
admet-2057	407	15	l	l	ADJ
admet-2057	407	16	-	-	ADJ
admet-2057	407	17	glutamic	glutamic	ADJ
admet-2057	407	18	acid	acid	NOUN
admet-2057	407	19	with	with	ADP
admet-2057	407	20	zinc	zinc	NOUN
admet-2057	407	21	ions	ion	NOUN
admet-2057	407	22	.	.	PUNCT
admet-2057	408	1	the	the	DET
admet-2057	408	2	mofs	mof	NOUN
admet-2057	408	3	were	be	AUX
admet-2057	408	4	created	create	VERB
admet-2057	408	5	by	by	ADP
admet-2057	408	6	reacting	react	VERB
admet-2057	408	7	l	l	ADJ
admet-2057	408	8	-	-	ADJ
admet-2057	408	9	glutamic	glutamic	ADJ
admet-2057	408	10	acid	acid	NOUN
admet-2057	408	11	with	with	ADP
admet-2057	408	12	zn(no3)2x6h2o	zn(no3)2x6h2o	NOUN
admet-2057	408	13	and	and	CCONJ
admet-2057	408	14	adding	add	VERB
admet-2057	408	15	it	it	PRON
admet-2057	408	16	to	to	ADP
admet-2057	408	17	dmf	dmf	PROPN
admet-2057	408	18	/	/	SYM
admet-2057	408	19	h2o	h2o	PROPN
admet-2057	408	20	.	.	PUNCT
admet-2057	409	1	the	the	DET
admet-2057	409	2	resulting	result	VERB
admet-2057	409	3	zn	zn	PROPN
admet-2057	409	4	-	-	PUNCT
admet-2057	409	5	ga	ga	PROPN
admet-2057	409	6	has	have	AUX
admet-2057	409	7	been	be	AUX
admet-2057	409	8	separated	separate	VERB
admet-2057	409	9	and	and	CCONJ
admet-2057	409	10	mtx	mtx	NOUN
admet-2057	409	11	-	-	PUNCT
admet-2057	409	12	loaded	load	VERB
admet-2057	409	13	after	after	ADP
admet-2057	409	14	being	be	AUX
admet-2057	409	15	heated	heat	VERB
admet-2057	409	16	to	to	ADP
admet-2057	409	17	80	80	NUM
admet-2057	409	18	°	°	NOUN
admet-2057	409	19	c	c	NOUN
admet-2057	409	20	.	.	PUNCT
admet-2057	410	1	the	the	DET
admet-2057	410	2	nanocomposite	nanocomposite	NOUN
admet-2057	410	3	demonstrated	demonstrate	VERB
admet-2057	410	4	a	a	DET
admet-2057	410	5	suitable	suitable	ADJ
admet-2057	410	6	loading	loading	NOUN
admet-2057	410	7	capacity	capacity	NOUN
admet-2057	410	8	of	of	ADP
admet-2057	410	9	12.85	12.85	NUM
admet-2057	410	10	wt.%	wt.%	ADJ
admet-2057	410	11	and	and	CCONJ
admet-2057	410	12	the	the	DET
admet-2057	410	13	ability	ability	NOUN
admet-2057	410	14	to	to	PART
admet-2057	410	15	release	release	VERB
admet-2057	410	16	drugs	drug	NOUN
admet-2057	410	17	in	in	ADP
admet-2057	410	18	response	response	NOUN
admet-2057	410	19	to	to	PART
admet-2057	410	20	heat	heat	VERB
admet-2057	410	21	and	and	CCONJ
admet-2057	410	22	ph	ph	ADJ
admet-2057	410	23	stimuli	stimulus	NOUN
admet-2057	410	24	.	.	PUNCT
admet-2057	411	1	notably	notably	ADV
admet-2057	411	2	,	,	PUNCT
admet-2057	411	3	at	at	ADP
admet-2057	411	4	an	an	DET
admet-2057	411	5	acidic	acidic	ADJ
admet-2057	411	6	ph	ph	NOUN
admet-2057	411	7	of	of	ADP
admet-2057	411	8	5.0	5.0	NUM
admet-2057	411	9	,	,	PUNCT
admet-2057	411	10	only	only	ADV
admet-2057	411	11	43	43	NUM
admet-2057	411	12	%	%	NOUN
admet-2057	411	13	of	of	ADP
admet-2057	411	14	the	the	DET
admet-2057	411	15	medication	medication	NOUN
admet-2057	411	16	was	be	AUX
admet-2057	411	17	released	release	VERB
admet-2057	411	18	in	in	ADP
admet-2057	411	19	a	a	DET
admet-2057	411	20	normal	normal	ADJ
admet-2057	411	21	physiological	physiological	ADJ
admet-2057	411	22	fluid	fluid	NOUN
admet-2057	411	23	;	;	PUNCT
admet-2057	411	24	however	however	ADV
admet-2057	411	25	,	,	PUNCT
admet-2057	411	26	when	when	SCONJ
admet-2057	411	27	the	the	DET
admet-2057	411	28	temperature	temperature	NOUN
admet-2057	411	29	rose	rise	VERB
admet-2057	411	30	,	,	PUNCT
admet-2057	411	31	the	the	DET
admet-2057	411	32	drug	drug	NOUN
admet-2057	411	33	release	release	NOUN
admet-2057	411	34	rate	rate	NOUN
admet-2057	411	35	climbed	climb	VERB
admet-2057	411	36	to	to	ADP
admet-2057	411	37	68	68	NUM
admet-2057	411	38	%	%	NOUN
admet-2057	411	39	.	.	PUNCT
admet-2057	412	1	the	the	DET
admet-2057	412	2	drug	drug	NOUN
admet-2057	412	3	-	-	PUNCT
admet-2057	412	4	free	free	ADJ
admet-2057	412	5	nanocarriers	nanocarrier	NOUN
admet-2057	412	6	demonstrated	demonstrate	VERB
admet-2057	412	7	high	high	ADJ
admet-2057	412	8	biocompatibility	biocompatibility	NOUN
admet-2057	412	9	,	,	PUNCT
admet-2057	412	10	whereas	whereas	SCONJ
admet-2057	412	11	the	the	DET
admet-2057	412	12	pc12	pc12	PROPN
admet-2057	412	13	cell	cell	NOUN
admet-2057	412	14	viability	viability	NOUN
admet-2057	412	15	was	be	AUX
admet-2057	412	16	drastically	drastically	ADV
admet-2057	412	17	reduced	reduce	VERB
admet-2057	412	18	to	to	ADP
admet-2057	412	19	12	12	NUM
admet-2057	412	20	%	%	NOUN
admet-2057	412	21	following	follow	VERB
admet-2057	412	22	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	412	23	p.	p.	NOUN
admet-2057	412	24	mhettar	mhettar	NOUN
admet-2057	413	1	et	et	PROPN
admet-2057	413	2	al	al	PROPN
admet-2057	413	3	.	.	PROPN
admet-2057	413	4	admet	admet	PROPN
admet-2057	413	5	&	&	CCONJ
admet-2057	413	6	dmpk	dmpk	PROPN
admet-2057	413	7	12(1	12(1	PROPN
admet-2057	413	8	)	)	PUNCT
admet-2057	413	9	(	(	PUNCT
admet-2057	413	10	2024	2024	NUM
admet-2057	413	11	)	)	PUNCT
admet-2057	413	12	27	27	NUM
admet-2057	413	13	-	-	SYM
admet-2057	413	14	62	62	NUM
admet-2057	413	15	42	42	NUM
admet-2057	413	16	drug	drug	NOUN
admet-2057	413	17	loading	loading	NOUN
admet-2057	413	18	,	,	PUNCT
admet-2057	413	19	demonstrating	demonstrate	VERB
admet-2057	413	20	their	their	PRON
admet-2057	413	21	anticancer	anticancer	NOUN
admet-2057	413	22	potential	potential	NOUN
admet-2057	413	23	.	.	PUNCT
admet-2057	414	1	the	the	DET
admet-2057	414	2	outcomes	outcome	NOUN
admet-2057	414	3	confirmed	confirm	VERB
admet-2057	414	4	the	the	DET
admet-2057	414	5	possibility	possibility	NOUN
admet-2057	414	6	of	of	ADP
admet-2057	414	7	using	use	VERB
admet-2057	414	8	nanocarriers	nanocarrier	NOUN
admet-2057	414	9	for	for	ADP
admet-2057	414	10	cancer	cancer	NOUN
admet-2057	414	11	treatment	treatment	NOUN
admet-2057	414	12	.	.	PUNCT
admet-2057	415	1	a	a	DET
admet-2057	415	2	study	study	NOUN
admet-2057	415	3	by	by	ADP
admet-2057	415	4	li	li	PROPN
admet-2057	415	5	-	-	PUNCT
admet-2057	415	6	li	li	PROPN
admet-2057	415	7	tan	tan	PROPN
admet-2057	416	1	[	[	X
admet-2057	416	2	93	93	NUM
admet-2057	416	3	]	]	PUNCT
admet-2057	416	4	provided	provide	VERB
admet-2057	416	5	a	a	DET
admet-2057	416	6	novel	novel	ADJ
admet-2057	416	7	method	method	NOUN
admet-2057	416	8	for	for	ADP
admet-2057	416	9	creating	create	VERB
admet-2057	416	10	"	"	PUNCT
admet-2057	416	11	gated	gate	VERB
admet-2057	416	12	scaffolds	scaffold	NOUN
admet-2057	416	13	"	"	PUNCT
admet-2057	416	14	that	that	PRON
admet-2057	416	15	are	be	AUX
admet-2057	416	16	sensitive	sensitive	ADJ
admet-2057	416	17	to	to	ADP
admet-2057	416	18	multiple	multiple	ADJ
admet-2057	416	19	stimuli	stimulus	NOUN
admet-2057	416	20	,	,	PUNCT
admet-2057	416	21	combining	combine	VERB
admet-2057	416	22	capped	cap	VERB
admet-2057	416	23	mofs	mof	NOUN
admet-2057	416	24	with	with	ADP
admet-2057	416	25	supramolecular	supramolecular	ADJ
admet-2057	416	26	pseudorotaxanes	pseudorotaxane	NOUN
admet-2057	416	27	.	.	PUNCT
admet-2057	417	1	these	these	DET
admet-2057	417	2	mechanical	mechanical	ADJ
admet-2057	417	3	zr	zr	PROPN
admet-2057	417	4	-	-	NOUN
admet-2057	417	5	mofs	mof	NOUN
admet-2057	417	6	demonstrated	demonstrate	VERB
admet-2057	417	7	minimal	minimal	ADJ
admet-2057	417	8	cytotoxicity	cytotoxicity	NOUN
admet-2057	417	9	,	,	PUNCT
admet-2057	417	10	great	great	ADJ
admet-2057	417	11	drug	drug	NOUN
admet-2057	417	12	encapsulation	encapsulation	NOUN
admet-2057	417	13	,	,	PUNCT
admet-2057	417	14	minor	minor	ADJ
admet-2057	417	15	premature	premature	ADJ
admet-2057	417	16	release	release	NOUN
admet-2057	417	17	,	,	PUNCT
admet-2057	417	18	and	and	CCONJ
admet-2057	417	19	good	good	ADJ
admet-2057	417	20	biocompatibility	biocompatibility	NOUN
admet-2057	417	21	.	.	PUNCT
admet-2057	418	1	the	the	DET
admet-2057	418	2	ph	ph	ADJ
admet-2057	418	3	,	,	PUNCT
admet-2057	418	4	lysosomal	lysosomal	ADJ
admet-2057	418	5	ph	ph	NOUN
admet-2057	418	6	,	,	PUNCT
admet-2057	418	7	and	and	CCONJ
admet-2057	418	8	osteoclast	osteoclast	ADJ
admet-2057	418	9	ph	ph	NOUN
admet-2057	418	10	are	be	AUX
admet-2057	418	11	seen	see	VERB
admet-2057	418	12	to	to	PART
admet-2057	418	13	be	be	AUX
admet-2057	418	14	decreased	decrease	VERB
admet-2057	418	15	around	around	ADV
admet-2057	418	16	or	or	CCONJ
admet-2057	418	17	inside	inside	ADP
admet-2057	418	18	the	the	DET
admet-2057	418	19	bone	bone	NOUN
admet-2057	418	20	tumour	tumour	NOUN
admet-2057	418	21	cells	cell	NOUN
admet-2057	418	22	(	(	PUNCT
admet-2057	418	23	acidosis	acidosis	NOUN
admet-2057	418	24	)	)	PUNCT
admet-2057	418	25	,	,	PUNCT
admet-2057	418	26	and	and	CCONJ
admet-2057	418	27	the	the	DET
admet-2057	418	28	ensuing	ensue	VERB
admet-2057	418	29	osteolysis	osteolysis	NOUN
admet-2057	418	30	raises	raise	VERB
admet-2057	418	31	the	the	DET
admet-2057	418	32	ca2	ca2	PROPN
admet-2057	418	33	+	+	PROPN
admet-2057	418	34	concentration	concentration	NOUN
admet-2057	418	35	(	(	PUNCT
admet-2057	418	36	hypercalcemia	hypercalcemia	NOUN
admet-2057	418	37	)	)	PUNCT
admet-2057	418	38	.	.	PUNCT
admet-2057	419	1	the	the	DET
admet-2057	419	2	simultaneous	simultaneous	ADJ
admet-2057	419	3	changes	change	NOUN
admet-2057	419	4	in	in	ADP
admet-2057	419	5	ph	ph	NOUN
admet-2057	419	6	and	and	CCONJ
admet-2057	419	7	ca2	ca2	PROPN
admet-2057	419	8	+	+	PROPN
admet-2057	419	9	content	content	NOUN
admet-2057	419	10	in	in	ADP
admet-2057	419	11	bone	bone	NOUN
admet-2057	419	12	cancer	cancer	NOUN
admet-2057	419	13	cells	cell	NOUN
admet-2057	419	14	caused	cause	VERB
admet-2057	419	15	the	the	DET
admet-2057	419	16	mechanised	mechanised	ADJ
admet-2057	419	17	mofs	mof	NOUN
admet-2057	419	18	to	to	PART
admet-2057	419	19	release	release	VERB
admet-2057	419	20	their	their	PRON
admet-2057	419	21	drugs	drug	NOUN
admet-2057	419	22	.	.	PUNCT
admet-2057	420	1	as	as	ADP
admet-2057	420	2	a	a	DET
admet-2057	420	3	well	well	ADV
admet-2057	420	4	-	-	PUNCT
admet-2057	420	5	liked	like	VERB
admet-2057	420	6	method	method	NOUN
admet-2057	420	7	of	of	ADP
admet-2057	420	8	cancer	cancer	NOUN
admet-2057	420	9	treatment	treatment	NOUN
admet-2057	420	10	,	,	PUNCT
admet-2057	420	11	hyperthermia	hyperthermia	NOUN
admet-2057	420	12	,	,	PUNCT
admet-2057	420	13	also	also	ADV
admet-2057	420	14	known	know	VERB
admet-2057	420	15	as	as	ADP
admet-2057	420	16	thermal	thermal	ADJ
admet-2057	420	17	therapy	therapy	NOUN
admet-2057	420	18	or	or	CCONJ
admet-2057	420	19	thermotherapy	thermotherapy	NOUN
admet-2057	420	20	,	,	PUNCT
admet-2057	420	21	can	can	AUX
admet-2057	420	22	regulate	regulate	VERB
admet-2057	420	23	medication	medication	NOUN
admet-2057	420	24	release	release	NOUN
admet-2057	420	25	in	in	ADP
admet-2057	420	26	the	the	DET
admet-2057	420	27	aforementioned	aforementioned	ADJ
admet-2057	420	28	system	system	NOUN
admet-2057	420	29	.	.	PUNCT
admet-2057	421	1	the	the	DET
admet-2057	421	2	development	development	NOUN
admet-2057	421	3	of	of	ADP
admet-2057	421	4	intelligent	intelligent	ADJ
admet-2057	421	5	biomaterials	biomaterial	NOUN
admet-2057	421	6	for	for	ADP
admet-2057	421	7	cancer	cancer	NOUN
admet-2057	421	8	treatment	treatment	NOUN
admet-2057	421	9	and	and	CCONJ
admet-2057	421	10	bone	bone	NOUN
admet-2057	421	11	regeneration	regeneration	NOUN
admet-2057	421	12	is	be	AUX
admet-2057	421	13	now	now	ADV
admet-2057	421	14	possible	possible	ADJ
admet-2057	421	15	because	because	SCONJ
admet-2057	421	16	of	of	ADP
admet-2057	421	17	this	this	DET
admet-2057	421	18	design	design	NOUN
admet-2057	421	19	.	.	PUNCT
admet-2057	422	1	in	in	ADP
admet-2057	422	2	another	another	DET
admet-2057	422	3	study	study	NOUN
admet-2057	422	4	,	,	PUNCT
admet-2057	422	5	shunjiro	shunjiro	NOUN
admet-2057	422	6	nagata	nagata	PROPN
admet-2057	423	1	[	[	X
admet-2057	423	2	94	94	NUM
admet-2057	423	3	]	]	PUNCT
admet-2057	423	4	showed	show	VERB
admet-2057	423	5	that	that	SCONJ
admet-2057	423	6	an	an	DET
admet-2057	423	7	mof	mof	NOUN
admet-2057	423	8	may	may	AUX
admet-2057	423	9	release	release	VERB
admet-2057	423	10	a	a	DET
admet-2057	423	11	guest	guest	NOUN
admet-2057	423	12	molecule	molecule	NOUN
admet-2057	423	13	(	(	PUNCT
admet-2057	423	14	procainamide	procainamide	NOUN
admet-2057	423	15	)	)	PUNCT
admet-2057	423	16	under	under	ADP
admet-2057	423	17	regulated	regulated	ADJ
admet-2057	423	18	conditions	condition	NOUN
admet-2057	423	19	.	.	PUNCT
admet-2057	424	1	researchers	researcher	NOUN
admet-2057	424	2	coated	coat	VERB
admet-2057	424	3	the	the	DET
admet-2057	424	4	mof	mof	NOUN
admet-2057	424	5	in	in	ADP
admet-2057	424	6	post	post	ADJ
admet-2057	424	7	-	-	ADJ
admet-2057	424	8	synthetic	synthetic	ADJ
admet-2057	424	9	modification	modification	NOUN
admet-2057	424	10	coats	coat	NOUN
admet-2057	424	11	with	with	ADP
admet-2057	424	12	a	a	DET
admet-2057	424	13	copolymer	copolymer	NOUN
admet-2057	424	14	of	of	ADP
admet-2057	424	15	n	n	CCONJ
admet-2057	424	16	-	-	PUNCT
admet-2057	424	17	isopropyl	isopropyl	NOUN
admet-2057	424	18	acrylamide	acrylamide	NOUN
admet-2057	424	19	(	(	PUNCT
admet-2057	424	20	nipam	nipam	NOUN
admet-2057	424	21	)	)	PUNCT
admet-2057	424	22	and	and	CCONJ
admet-2057	424	23	acrylic	acrylic	NOUN
admet-2057	424	24	acid	acid	NOUN
admet-2057	424	25	(	(	PUNCT
admet-2057	424	26	aa	aa	NOUN
admet-2057	424	27	)	)	PUNCT
admet-2057	424	28	.	.	PUNCT
admet-2057	425	1	the	the	DET
admet-2057	425	2	hypothesis	hypothesis	NOUN
admet-2057	425	3	was	be	AUX
admet-2057	425	4	that	that	SCONJ
admet-2057	425	5	the	the	DET
admet-2057	425	6	guest	guest	NOUN
admet-2057	425	7	molecule	molecule	NOUN
admet-2057	425	8	may	may	AUX
admet-2057	425	9	be	be	AUX
admet-2057	425	10	released	release	VERB
admet-2057	425	11	from	from	ADP
admet-2057	425	12	the	the	DET
admet-2057	425	13	mof	mof	NOUN
admet-2057	425	14	in	in	ADP
admet-2057	425	15	an	an	DET
admet-2057	425	16	"	"	PUNCT
admet-2057	425	17	on	on	ADP
admet-2057	425	18	-	-	PUNCT
admet-2057	425	19	off	off	ADP
admet-2057	425	20	"	"	PUNCT
admet-2057	425	21	fashion	fashion	NOUN
admet-2057	425	22	thanks	thank	NOUN
admet-2057	425	23	to	to	ADP
admet-2057	425	24	the	the	DET
admet-2057	425	25	polymer	polymer	NOUN
admet-2057	425	26	's	's	PART
admet-2057	425	27	quick	quick	ADJ
admet-2057	425	28	and	and	CCONJ
admet-2057	425	29	reversible	reversible	ADJ
admet-2057	425	30	coil	coil	NOUN
admet-2057	425	31	-	-	PUNCT
admet-2057	425	32	globule	globule	NOUN
admet-2057	425	33	transition	transition	NOUN
admet-2057	425	34	,	,	PUNCT
admet-2057	425	35	which	which	PRON
admet-2057	425	36	is	be	AUX
admet-2057	425	37	phand	phand	NOUN
admet-2057	425	38	thermosresponsive	thermosresponsive	NOUN
admet-2057	425	39	.	.	PUNCT
admet-2057	426	1	the	the	DET
admet-2057	426	2	release	release	NOUN
admet-2057	426	3	of	of	ADP
admet-2057	426	4	the	the	DET
admet-2057	426	5	guest	guest	NOUN
admet-2057	426	6	molecule	molecule	NOUN
admet-2057	426	7	from	from	ADP
admet-2057	426	8	the	the	DET
admet-2057	426	9	mof	mof	NOUN
admet-2057	426	10	is	be	AUX
admet-2057	426	11	repressed	repress	VERB
admet-2057	426	12	at	at	ADP
admet-2057	426	13	low	low	ADJ
admet-2057	426	14	ph	ph	NOUN
admet-2057	426	15	(	(	PUNCT
admet-2057	426	16	4.01	4.01	NUM
admet-2057	426	17	)	)	PUNCT
admet-2057	426	18	and	and	CCONJ
admet-2057	426	19	high	high	ADJ
admet-2057	426	20	temperature	temperature	NOUN
admet-2057	426	21	(	(	PUNCT
admet-2057	426	22	>	>	X
admet-2057	426	23	40	40	NUM
admet-2057	426	24	°	°	NOUN
admet-2057	426	25	c	c	NOUN
admet-2057	426	26	)	)	PUNCT
admet-2057	426	27	,	,	PUNCT
admet-2057	426	28	where	where	SCONJ
admet-2057	426	29	it	it	PRON
admet-2057	426	30	was	be	AUX
admet-2057	426	31	rapidly	rapidly	ADV
admet-2057	426	32	released	release	VERB
admet-2057	426	33	at	at	ADP
admet-2057	426	34	high	high	ADJ
admet-2057	426	35	ph	ph	NOUN
admet-2057	426	36	(	(	PUNCT
admet-2057	426	37	6.86	6.86	NUM
admet-2057	426	38	)	)	PUNCT
admet-2057	426	39	and	and	CCONJ
admet-2057	426	40	low	low	ADJ
admet-2057	426	41	temperature	temperature	NOUN
admet-2057	426	42	(	(	PUNCT
admet-2057	426	43	25	25	NUM
admet-2057	426	44	°	°	NOUN
admet-2057	426	45	c	c	NOUN
admet-2057	426	46	)	)	PUNCT
admet-2057	426	47	,	,	PUNCT
admet-2057	426	48	respectively	respectively	ADV
admet-2057	426	49	,	,	PUNCT
admet-2057	426	50	when	when	SCONJ
admet-2057	426	51	the	the	DET
admet-2057	426	52	polymer	polymer	NOUN
admet-2057	426	53	adopts	adopt	VERB
admet-2057	426	54	a	a	DET
admet-2057	426	55	coil	coil	NOUN
admet-2057	426	56	conformation	conformation	NOUN
admet-2057	426	57	.	.	PUNCT
admet-2057	427	1	even	even	ADV
admet-2057	427	2	once	once	SCONJ
admet-2057	427	3	the	the	DET
admet-2057	427	4	release	release	NOUN
admet-2057	427	5	has	have	AUX
admet-2057	427	6	begun	begin	VERB
admet-2057	427	7	,	,	PUNCT
admet-2057	427	8	it	it	PRON
admet-2057	427	9	can	can	AUX
admet-2057	427	10	be	be	AUX
admet-2057	427	11	stopped	stop	VERB
admet-2057	427	12	by	by	ADP
admet-2057	427	13	adding	add	VERB
admet-2057	427	14	external	external	ADJ
admet-2057	427	15	stimulation	stimulation	NOUN
admet-2057	427	16	.	.	PUNCT
admet-2057	428	1	targeted	target	VERB
admet-2057	428	2	medication	medication	NOUN
admet-2057	428	3	distribution	distribution	NOUN
admet-2057	428	4	and	and	CCONJ
admet-2057	428	5	the	the	DET
admet-2057	428	6	regulated	regulated	ADJ
admet-2057	428	7	release	release	NOUN
admet-2057	428	8	of	of	ADP
admet-2057	428	9	therapeutic	therapeutic	ADJ
admet-2057	428	10	substances	substance	NOUN
admet-2057	428	11	will	will	AUX
admet-2057	428	12	be	be	AUX
admet-2057	428	13	made	make	VERB
admet-2057	428	14	easier	easy	ADJ
admet-2057	428	15	by	by	ADP
admet-2057	428	16	the	the	DET
admet-2057	428	17	controllable	controllable	ADJ
admet-2057	428	18	container	container	NOUN
admet-2057	428	19	generated	generate	VERB
admet-2057	428	20	from	from	ADP
admet-2057	428	21	mof	mof	PROPN
admet-2057	428	22	.	.	PUNCT
admet-2057	429	1	a	a	DET
admet-2057	429	2	multifunctional	multifunctional	ADJ
admet-2057	429	3	nanoplatforms	nanoplatform	NOUN
admet-2057	429	4	designed	design	VERB
admet-2057	429	5	to	to	PART
admet-2057	429	6	offer	offer	VERB
admet-2057	429	7	pdt	pdt	PROPN
admet-2057	429	8	,	,	PUNCT
admet-2057	429	9	ptt	ptt	PROPN
admet-2057	429	10	,	,	PUNCT
admet-2057	429	11	and	and	CCONJ
admet-2057	429	12	ct	ct	PROPN
admet-2057	429	13	was	be	AUX
admet-2057	429	14	described	describe	VERB
admet-2057	429	15	by	by	ADP
admet-2057	429	16	yao	yao	PROPN
admet-2057	429	17	et	et	PROPN
admet-2057	429	18	al	al	PROPN
admet-2057	429	19	.	.	PUNCT
admet-2057	430	1	[	[	X
admet-2057	430	2	95	95	NUM
admet-2057	430	3	]	]	PUNCT
admet-2057	430	4	.	.	PUNCT
admet-2057	431	1	initially	initially	ADV
admet-2057	431	2	,	,	PUNCT
admet-2057	431	3	a	a	DET
admet-2057	431	4	dispersion	dispersion	NOUN
admet-2057	431	5	of	of	ADP
admet-2057	431	6	zirconium	zirconium	NOUN
admet-2057	431	7	tetrachloride	tetrachloride	NOUN
admet-2057	431	8	in	in	ADP
admet-2057	431	9	dmf	dmf	PROPN
admet-2057	431	10	,	,	PUNCT
admet-2057	431	11	2	2	NUM
admet-2057	431	12	-	-	PUNCT
admet-2057	431	13	aminoterephthalic	aminoterephthalic	ADJ
admet-2057	431	14	acid	acid	NOUN
admet-2057	431	15	,	,	PUNCT
admet-2057	431	16	benzoic	benzoic	NOUN
admet-2057	431	17	acid	acid	NOUN
admet-2057	431	18	,	,	PUNCT
admet-2057	431	19	and	and	CCONJ
admet-2057	431	20	hydrochloric	hydrochloric	ADJ
admet-2057	431	21	acid	acid	NOUN
admet-2057	431	22	was	be	AUX
admet-2057	431	23	heated	heat	VERB
admet-2057	431	24	at	at	ADP
admet-2057	431	25	120	120	NUM
admet-2057	431	26	°	°	NOUN
admet-2057	431	27	c	c	NOUN
admet-2057	431	28	for	for	ADP
admet-2057	431	29	48	48	NUM
admet-2057	431	30	hours	hour	NOUN
admet-2057	431	31	to	to	PART
admet-2057	431	32	create	create	VERB
admet-2057	431	33	the	the	DET
admet-2057	431	34	zirconium	zirconium	NOUN
admet-2057	431	35	framework	framework	NOUN
admet-2057	431	36	(	(	PUNCT
admet-2057	431	37	uio-66	uio-66	NOUN
admet-2057	431	38	-	-	PUNCT
admet-2057	431	39	n3	n3	NOUN
admet-2057	431	40	)	)	PUNCT
admet-2057	431	41	.	.	PUNCT
admet-2057	432	1	in	in	ADP
admet-2057	432	2	order	order	NOUN
admet-2057	432	3	for	for	SCONJ
admet-2057	432	4	the	the	DET
admet-2057	432	5	framework	framework	NOUN
admet-2057	432	6	to	to	PART
admet-2057	432	7	function	function	VERB
admet-2057	432	8	as	as	ADP
admet-2057	432	9	a	a	DET
admet-2057	432	10	photosensitizer	photosensitizer	NOUN
admet-2057	432	11	,	,	PUNCT
admet-2057	432	12	it	it	PRON
admet-2057	432	13	has	have	AUX
admet-2057	432	14	been	be	AUX
admet-2057	432	15	conjugated	conjugate	VERB
admet-2057	432	16	with	with	ADP
admet-2057	432	17	a	a	DET
admet-2057	432	18	ru(ii	ru(ii	PROPN
admet-2057	432	19	)	)	PUNCT
admet-2057	432	20	polypyridyl	polypyridyl	ADJ
admet-2057	432	21	alkyne	alkyne	NOUN
admet-2057	432	22	group	group	NOUN
admet-2057	432	23	.	.	PUNCT
admet-2057	433	1	additionally	additionally	ADV
admet-2057	433	2	,	,	PUNCT
admet-2057	433	3	dox	dox	NOUN
admet-2057	433	4	has	have	AUX
admet-2057	433	5	been	be	AUX
admet-2057	433	6	loaded	load	VERB
admet-2057	433	7	as	as	ADP
admet-2057	433	8	a	a	DET
admet-2057	433	9	prototype	prototype	NOUN
admet-2057	433	10	chemotherapy	chemotherapy	NOUN
admet-2057	433	11	drug	drug	NOUN
admet-2057	433	12	.	.	PUNCT
admet-2057	434	1	after	after	ADP
admet-2057	434	2	that	that	PRON
admet-2057	434	3	,	,	PUNCT
admet-2057	434	4	cus	cus	ADJ
admet-2057	434	5	nanoparticles	nanoparticle	NOUN
admet-2057	434	6	were	be	AUX
admet-2057	434	7	physically	physically	ADV
admet-2057	434	8	adsorbed	adsorb	VERB
admet-2057	434	9	onto	onto	ADP
admet-2057	434	10	the	the	DET
admet-2057	434	11	nanoplatform	nanoplatform	NOUN
admet-2057	434	12	's	's	PART
admet-2057	434	13	surface	surface	NOUN
admet-2057	434	14	to	to	PART
admet-2057	434	15	serve	serve	VERB
admet-2057	434	16	as	as	ADP
admet-2057	434	17	a	a	DET
admet-2057	434	18	ptt	ptt	NOUN
admet-2057	434	19	agent	agent	NOUN
admet-2057	434	20	(	(	PUNCT
admet-2057	434	21	uio	uio	PROPN
admet-2057	434	22	-	-	PUNCT
admet-2057	434	23	ra	ra	PROPN
admet-2057	434	24	-	-	PUNCT
admet-2057	434	25	dox	dox	NOUN
admet-2057	434	26	-	-	PUNCT
admet-2057	434	27	cus	cus	NOUN
admet-2057	434	28	)	)	PUNCT
admet-2057	434	29	.	.	PUNCT
admet-2057	435	1	here	here	ADV
admet-2057	435	2	,	,	PUNCT
admet-2057	435	3	the	the	DET
admet-2057	435	4	conjugate	conjugate	NOUN
admet-2057	435	5	's	's	PART
admet-2057	435	6	ideal	ideal	ADJ
admet-2057	435	7	drug	drug	NOUN
admet-2057	435	8	loading	loading	NOUN
admet-2057	435	9	capacity	capacity	NOUN
admet-2057	435	10	(	(	PUNCT
admet-2057	435	11	13.5	13.5	NUM
admet-2057	435	12	%	%	NOUN
admet-2057	435	13	)	)	PUNCT
admet-2057	435	14	has	have	AUX
admet-2057	435	15	been	be	AUX
admet-2057	435	16	observed	observe	VERB
admet-2057	435	17	.	.	PUNCT
admet-2057	436	1	it	it	PRON
admet-2057	436	2	's	be	AUX
admet-2057	436	3	interesting	interesting	ADJ
admet-2057	436	4	to	to	PART
admet-2057	436	5	note	note	VERB
admet-2057	436	6	that	that	SCONJ
admet-2057	436	7	uio	uio	PROPN
admet-2057	436	8	-	-	PUNCT
admet-2057	436	9	ra	ra	PROPN
admet-2057	436	10	-	-	PUNCT
admet-2057	436	11	dox	dox	NOUN
admet-2057	436	12	-	-	PUNCT
admet-2057	436	13	cus	cus	NOUN
admet-2057	436	14	successfully	successfully	ADV
admet-2057	436	15	produced	produce	VERB
admet-2057	436	16	1o2	1o2	NUM
admet-2057	436	17	,	,	PUNCT
admet-2057	436	18	ensuring	ensure	VERB
admet-2057	436	19	its	its	PRON
admet-2057	436	20	potential	potential	NOUN
admet-2057	436	21	in	in	ADP
admet-2057	436	22	pdt	pdt	PROPN
admet-2057	436	23	.	.	PUNCT
admet-2057	437	1	notably	notably	ADV
admet-2057	437	2	,	,	PUNCT
admet-2057	437	3	the	the	DET
admet-2057	437	4	temperature	temperature	NOUN
admet-2057	437	5	has	have	AUX
admet-2057	437	6	linearly	linearly	ADV
admet-2057	437	7	increased	increase	VERB
admet-2057	437	8	as	as	SCONJ
admet-2057	437	9	the	the	DET
admet-2057	437	10	concentration	concentration	NOUN
admet-2057	437	11	of	of	ADP
admet-2057	437	12	nanoparticles	nanoparticle	NOUN
admet-2057	437	13	has	have	AUX
admet-2057	437	14	continuously	continuously	ADV
admet-2057	437	15	increased	increase	VERB
admet-2057	437	16	,	,	PUNCT
admet-2057	437	17	pointing	point	VERB
admet-2057	437	18	to	to	ADP
admet-2057	437	19	a	a	DET
admet-2057	437	20	photothermal	photothermal	ADJ
admet-2057	437	21	action	action	NOUN
admet-2057	437	22	.	.	PUNCT
admet-2057	438	1	approximately	approximately	ADV
admet-2057	438	2	30.5	30.5	NUM
admet-2057	438	3	%	%	NOUN
admet-2057	438	4	of	of	ADP
admet-2057	438	5	dox	dox	NOUN
admet-2057	438	6	was	be	AUX
admet-2057	438	7	released	release	VERB
admet-2057	438	8	at	at	ADP
admet-2057	438	9	physiological	physiological	ADJ
admet-2057	438	10	ph	ph	NOUN
admet-2057	438	11	,	,	PUNCT
admet-2057	438	12	whereas	whereas	SCONJ
admet-2057	438	13	48.5	48.5	NUM
admet-2057	438	14	%	%	NOUN
admet-2057	438	15	of	of	ADP
admet-2057	438	16	the	the	DET
admet-2057	438	17	medication	medication	NOUN
admet-2057	438	18	was	be	AUX
admet-2057	438	19	released	release	VERB
admet-2057	438	20	at	at	ADP
admet-2057	438	21	ph	ph	PROPN
admet-2057	438	22	5	5	NUM
admet-2057	438	23	.	.	PUNCT
admet-2057	438	24	importantly	importantly	ADV
admet-2057	438	25	,	,	PUNCT
admet-2057	438	26	after	after	ADP
admet-2057	438	27	nir	nir	ADJ
admet-2057	438	28	irradiation	irradiation	NOUN
admet-2057	438	29	,	,	PUNCT
admet-2057	438	30	drug	drug	NOUN
admet-2057	438	31	release	release	NOUN
admet-2057	438	32	was	be	AUX
admet-2057	438	33	significantly	significantly	ADV
admet-2057	438	34	encouraged	encourage	VERB
admet-2057	438	35	.	.	PUNCT
admet-2057	439	1	the	the	DET
admet-2057	439	2	uio	uio	PROPN
admet-2057	439	3	-	-	PUNCT
admet-2057	439	4	ra	ra	PROPN
admet-2057	439	5	-	-	PUNCT
admet-2057	439	6	dox	dox	ADJ
admet-2057	439	7	-	-	PUNCT
admet-2057	439	8	cus	cus	NOUN
admet-2057	439	9	treatment	treatment	NOUN
admet-2057	439	10	had	have	VERB
admet-2057	439	11	a	a	DET
admet-2057	439	12	greater	great	ADJ
admet-2057	439	13	synergistic	synergistic	ADJ
admet-2057	439	14	impact	impact	NOUN
admet-2057	439	15	(	(	PUNCT
admet-2057	439	16	almost	almost	ADV
admet-2057	439	17	100	100	NUM
admet-2057	439	18	%	%	NOUN
admet-2057	439	19	of	of	ADP
admet-2057	439	20	the	the	DET
admet-2057	439	21	cells	cell	NOUN
admet-2057	439	22	were	be	AUX
admet-2057	439	23	eliminated	eliminate	VERB
admet-2057	439	24	)	)	PUNCT
admet-2057	439	25	compared	compare	VERB
admet-2057	439	26	to	to	ADP
admet-2057	439	27	monotherapy	monotherapy	NOUN
admet-2057	439	28	ct-42	ct-42	NOUN
admet-2057	439	29	%	%	NOUN
admet-2057	439	30	and	and	CCONJ
admet-2057	439	31	laser	laser	NOUN
admet-2057	439	32	irradiation	irradiation	NOUN
admet-2057	439	33	(	(	PUNCT
admet-2057	439	34	59	59	NUM
admet-2057	439	35	%	%	NOUN
admet-2057	439	36	)	)	PUNCT
admet-2057	439	37	,	,	PUNCT
admet-2057	439	38	according	accord	VERB
admet-2057	439	39	to	to	ADP
admet-2057	439	40	the	the	DET
admet-2057	439	41	cell	cell	NOUN
admet-2057	439	42	line	line	NOUN
admet-2057	439	43	investigation	investigation	NOUN
admet-2057	439	44	on	on	ADP
admet-2057	439	45	mda	mda	PROPN
admet-2057	439	46	-	-	PUNCT
admet-2057	439	47	mb-231	mb-231	PROPN
admet-2057	439	48	.	.	PUNCT
admet-2057	440	1	b.	b.	PROPN
admet-2057	440	2	ph	ph	PROPN
admet-2057	440	3	and	and	CCONJ
admet-2057	440	4	magnetic	magnetic	ADJ
admet-2057	440	5	-	-	PUNCT
admet-2057	440	6	responsive	responsive	ADJ
admet-2057	440	7	under	under	ADP
admet-2057	440	8	the	the	DET
admet-2057	440	9	influence	influence	NOUN
admet-2057	440	10	of	of	ADP
admet-2057	440	11	alternating	alternate	VERB
admet-2057	440	12	magnetic	magnetic	ADJ
admet-2057	440	13	fields	field	NOUN
admet-2057	440	14	,	,	PUNCT
admet-2057	440	15	magnetic	magnetic	ADJ
admet-2057	440	16	materials	material	NOUN
admet-2057	440	17	tend	tend	VERB
admet-2057	440	18	to	to	PART
admet-2057	440	19	generate	generate	VERB
admet-2057	440	20	heat	heat	NOUN
admet-2057	440	21	through	through	ADP
admet-2057	440	22	hysteresis	hysteresis	NOUN
admet-2057	440	23	losses	loss	NOUN
admet-2057	440	24	caused	cause	VERB
admet-2057	440	25	by	by	ADP
admet-2057	440	26	magnetic	magnetic	ADJ
admet-2057	440	27	fields	field	NOUN
admet-2057	440	28	.	.	PUNCT
admet-2057	441	1	this	this	DET
admet-2057	441	2	phenomenon	phenomenon	NOUN
admet-2057	441	3	can	can	AUX
admet-2057	441	4	be	be	AUX
admet-2057	441	5	applied	apply	VERB
admet-2057	441	6	to	to	ADP
admet-2057	441	7	magnetic	magnetic	ADJ
admet-2057	441	8	hyperthermia	hyperthermia	NOUN
admet-2057	441	9	therapy	therapy	NOUN
admet-2057	441	10	(	(	PUNCT
admet-2057	441	11	mht	mht	PROPN
admet-2057	441	12	)	)	PUNCT
admet-2057	441	13	.	.	PUNCT
admet-2057	442	1	magnetic	magnetic	PROPN
admet-2057	442	2	stimuli	stimuli	VERB
admet-2057	442	3	mofs	mof	NOUN
admet-2057	442	4	are	be	AUX
admet-2057	442	5	the	the	DET
admet-2057	442	6	potential	potential	ADJ
admet-2057	442	7	candidates	candidate	NOUN
admet-2057	442	8	for	for	ADP
admet-2057	442	9	improving	improve	VERB
admet-2057	442	10	the	the	DET
admet-2057	442	11	therapeutic	therapeutic	ADJ
admet-2057	442	12	efficacy	efficacy	NOUN
admet-2057	442	13	of	of	ADP
admet-2057	442	14	mht	mht	PROPN
admet-2057	442	15	.	.	PUNCT
admet-2057	443	1	recently	recently	ADV
admet-2057	443	2	,	,	PUNCT
admet-2057	443	3	to	to	PART
admet-2057	443	4	understand	understand	VERB
admet-2057	443	5	the	the	DET
admet-2057	443	6	synergistic	synergistic	ADJ
admet-2057	443	7	activity	activity	NOUN
admet-2057	443	8	of	of	ADP
admet-2057	443	9	mht	mht	NOUN
admet-2057	443	10	along	along	ADP
admet-2057	443	11	with	with	ADP
admet-2057	443	12	chemotherapy	chemotherapy	NOUN
admet-2057	443	13	,	,	PUNCT
admet-2057	443	14	the	the	DET
admet-2057	443	15	fe3o4@pda@zif-90	fe3o4@pda@zif-90	NOUN
admet-2057	443	16	framework	framework	NOUN
admet-2057	443	17	has	have	AUX
admet-2057	443	18	been	be	AUX
admet-2057	443	19	synthesized	synthesize	VERB
admet-2057	443	20	.	.	PUNCT
admet-2057	444	1	the	the	DET
admet-2057	444	2	ph	ph	ADJ
admet-2057	444	3	-	-	ADJ
admet-2057	444	4	dependent	dependent	ADJ
admet-2057	444	5	release	release	NOUN
admet-2057	444	6	profile	profile	NOUN
admet-2057	444	7	has	have	AUX
admet-2057	444	8	been	be	AUX
admet-2057	444	9	studied	study	VERB
admet-2057	444	10	as	as	SCONJ
admet-2057	444	11	the	the	DET
admet-2057	444	12	system	system	NOUN
admet-2057	444	13	showed	show	VERB
admet-2057	444	14	the	the	DET
admet-2057	444	15	highest	high	ADJ
admet-2057	444	16	release	release	NOUN
admet-2057	444	17	of	of	ADP
admet-2057	444	18	88.7	88.7	NUM
admet-2057	444	19	%	%	NOUN
admet-2057	444	20	of	of	ADP
admet-2057	444	21	dox	dox	NOUN
admet-2057	444	22	at	at	ADP
admet-2057	444	23	ph	ph	PROPN
admet-2057	444	24	4.5[96	4.5[96	NOUN
admet-2057	444	25	]	]	PUNCT
admet-2057	444	26	.	.	PUNCT
admet-2057	445	1	a	a	DET
admet-2057	445	2	lot	lot	NOUN
admet-2057	445	3	of	of	ADP
admet-2057	445	4	consideration	consideration	NOUN
admet-2057	445	5	has	have	AUX
admet-2057	445	6	been	be	AUX
admet-2057	445	7	given	give	VERB
admet-2057	445	8	to	to	ADP
admet-2057	445	9	the	the	DET
admet-2057	445	10	cu	cu	PROPN
admet-2057	445	11	-	-	PUNCT
admet-2057	445	12	btc	btc	ADJ
admet-2057	445	13	framework	framework	NOUN
admet-2057	445	14	in	in	ADP
admet-2057	445	15	recent	recent	ADJ
admet-2057	445	16	years	year	NOUN
admet-2057	445	17	as	as	ADP
admet-2057	445	18	a	a	DET
admet-2057	445	19	potential	potential	ADJ
admet-2057	445	20	drug	drug	NOUN
admet-2057	445	21	carrier	carrier	NOUN
admet-2057	445	22	for	for	ADP
admet-2057	445	23	cancer	cancer	NOUN
admet-2057	445	24	treatment	treatment	NOUN
admet-2057	445	25	because	because	SCONJ
admet-2057	445	26	of	of	ADP
admet-2057	445	27	its	its	PRON
admet-2057	445	28	distinctive	distinctive	ADJ
admet-2057	445	29	structural	structural	ADJ
admet-2057	445	30	characteristics	characteristic	NOUN
admet-2057	445	31	and	and	CCONJ
admet-2057	445	32	prospective	prospective	ADJ
admet-2057	445	33	biocompatibility	biocompatibility	NOUN
admet-2057	445	34	.	.	PUNCT
admet-2057	446	1	a	a	DET
admet-2057	446	2	magnetic	magnetic	ADJ
admet-2057	446	3	nano	nano	NOUN
admet-2057	446	4	/	/	SYM
admet-2057	446	5	microscale	microscale	ADJ
admet-2057	446	6	mof	mof	NOUN
admet-2057	446	7	has	have	AUX
admet-2057	446	8	been	be	AUX
admet-2057	446	9	successfully	successfully	ADV
admet-2057	446	10	fabricated	fabricate	VERB
admet-2057	446	11	by	by	ADP
admet-2057	446	12	zahra	zahra	PROPN
admet-2057	446	13	gharehdagh	gharehdagh	PROPN
admet-2057	446	14	and	and	CCONJ
admet-2057	446	15	coworkers	coworker	NOUN
admet-2057	446	16	[	[	X
admet-2057	446	17	97	97	NUM
admet-2057	446	18	]	]	PUNCT
admet-2057	446	19	by	by	ADP
admet-2057	446	20	incorporating	incorporate	VERB
admet-2057	446	21	fe3o4	fe3o4	NOUN
admet-2057	446	22	nanoparticles	nanoparticle	NOUN
admet-2057	446	23	as	as	ADP
admet-2057	446	24	an	an	DET
admet-2057	446	25	imaging	imaging	NOUN
admet-2057	446	26	agent	agent	NOUN
admet-2057	446	27	into	into	ADP
admet-2057	446	28	the	the	DET
admet-2057	446	29	porous	porous	ADJ
admet-2057	446	30	isoreticular	isoreticular	ADJ
admet-2057	446	31	mof	mof	NOUN
admet-2057	446	32	[	[	X
admet-2057	446	33	cu3(btc)2	cu3(btc)2	NOUN
admet-2057	446	34	]	]	X
admet-2057	446	35	as	as	ADP
admet-2057	446	36	a	a	DET
admet-2057	446	37	drug	drug	NOUN
admet-2057	446	38	carrier	carrier	NOUN
admet-2057	446	39	.	.	PUNCT
admet-2057	447	1	however	however	ADV
admet-2057	447	2	,	,	PUNCT
admet-2057	447	3	this	this	DET
admet-2057	447	4	material	material	NOUN
admet-2057	447	5	's	's	PART
admet-2057	447	6	inherent	inherent	ADJ
admet-2057	447	7	incapacity	incapacity	NOUN
admet-2057	447	8	admet	admet	PROPN
admet-2057	447	9	&	&	CCONJ
admet-2057	447	10	dmpk	dmpk	PROPN
admet-2057	447	11	12(1	12(1	PROPN
admet-2057	447	12	)	)	PUNCT
admet-2057	447	13	(	(	PUNCT
admet-2057	447	14	2024	2024	NUM
admet-2057	447	15	)	)	PUNCT
admet-2057	447	16	27	27	NUM
admet-2057	447	17	-	-	SYM
admet-2057	447	18	62	62	NUM
admet-2057	447	19	drug	drug	NOUN
admet-2057	447	20	delivery	delivery	NOUN
admet-2057	447	21	applications	application	NOUN
admet-2057	447	22	of	of	ADP
admet-2057	447	23	metal	metal	NOUN
admet-2057	447	24	-	-	PUNCT
admet-2057	447	25	organic	organic	ADJ
admet-2057	447	26	framework	framework	NOUN
admet-2057	447	27	doi	doi	NOUN
admet-2057	447	28	:	:	PUNCT
admet-2057	447	29	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	447	30	43	43	NUM
admet-2057	447	31	for	for	ADP
admet-2057	447	32	medical	medical	ADJ
admet-2057	447	33	imaging	imaging	NOUN
admet-2057	447	34	may	may	AUX
admet-2057	447	35	limit	limit	VERB
admet-2057	447	36	its	its	PRON
admet-2057	447	37	bio	bio	NOUN
admet-2057	447	38	applications	application	NOUN
admet-2057	447	39	.	.	PUNCT
admet-2057	448	1	the	the	DET
admet-2057	448	2	synthetic	synthetic	ADJ
admet-2057	448	3	magnetic	magnetic	ADJ
admet-2057	448	4	mofs	mof	NOUN
admet-2057	448	5	display	display	VERB
admet-2057	448	6	an	an	DET
admet-2057	448	7	outstanding	outstanding	ADJ
admet-2057	448	8	phresponsive	phresponsive	ADJ
admet-2057	448	9	drug	drug	NOUN
admet-2057	448	10	release	release	NOUN
admet-2057	448	11	and	and	CCONJ
admet-2057	448	12	a	a	DET
admet-2057	448	13	high	high	ADJ
admet-2057	448	14	loading	loading	NOUN
admet-2057	448	15	capacity	capacity	NOUN
admet-2057	448	16	(	(	PUNCT
admet-2057	448	17	40.5	40.5	NUM
admet-2057	448	18	%	%	NOUN
admet-2057	448	19	)	)	PUNCT
admet-2057	448	20	towards	towards	ADP
admet-2057	448	21	the	the	DET
admet-2057	448	22	model	model	NOUN
admet-2057	448	23	anticancer	anticancer	NOUN
admet-2057	448	24	dox	dox	NOUN
admet-2057	448	25	.	.	PUNCT
admet-2057	449	1	the	the	DET
admet-2057	449	2	suggested	suggest	VERB
admet-2057	449	3	nanocomposite	nanocomposite	NOUN
admet-2057	449	4	not	not	PART
admet-2057	449	5	only	only	ADV
admet-2057	449	6	has	have	VERB
admet-2057	449	7	a	a	DET
admet-2057	449	8	lot	lot	NOUN
admet-2057	449	9	of	of	ADP
admet-2057	449	10	surface	surface	NOUN
admet-2057	449	11	area	area	NOUN
admet-2057	449	12	,	,	PUNCT
admet-2057	449	13	a	a	DET
admet-2057	449	14	lot	lot	NOUN
admet-2057	449	15	of	of	ADP
admet-2057	449	16	magnetic	magnetic	ADJ
admet-2057	449	17	response	response	NOUN
admet-2057	449	18	,	,	PUNCT
admet-2057	449	19	a	a	DET
admet-2057	449	20	lot	lot	NOUN
admet-2057	449	21	of	of	ADP
admet-2057	449	22	mesopore	mesopore	NOUN
admet-2057	449	23	volume	volume	NOUN
admet-2057	449	24	,	,	PUNCT
admet-2057	449	25	a	a	DET
admet-2057	449	26	lot	lot	NOUN
admet-2057	449	27	of	of	ADP
admet-2057	449	28	transverse	transverse	NOUN
admet-2057	449	29	relaxivity	relaxivity	NOUN
admet-2057	449	30	(	(	PUNCT
admet-2057	449	31	r2	r2	PROPN
admet-2057	449	32	)	)	PUNCT
admet-2057	449	33	,	,	PUNCT
admet-2057	449	34	and	and	CCONJ
admet-2057	449	35	good	good	ADJ
admet-2057	449	36	stability	stability	NOUN
admet-2057	449	37	,	,	PUNCT
admet-2057	449	38	but	but	CCONJ
admet-2057	449	39	it	it	PRON
admet-2057	449	40	also	also	ADV
admet-2057	449	41	has	have	VERB
admet-2057	449	42	a	a	DET
admet-2057	449	43	lot	lot	NOUN
admet-2057	449	44	of	of	ADP
admet-2057	449	45	tumor	tumor	NOUN
admet-2057	449	46	-	-	PUNCT
admet-2057	449	47	specific	specific	ADJ
admet-2057	449	48	cellular	cellular	ADJ
admet-2057	449	49	uptake	uptake	NOUN
admet-2057	449	50	and	and	CCONJ
admet-2057	449	51	significantly	significantly	ADV
admet-2057	449	52	inhibits	inhibit	VERB
admet-2057	449	53	cancer	cancer	NOUN
admet-2057	449	54	cell	cell	NOUN
admet-2057	449	55	viability	viability	NOUN
admet-2057	449	56	without	without	ADP
admet-2057	449	57	the	the	DET
admet-2057	449	58	use	use	NOUN
admet-2057	449	59	of	of	ADP
admet-2057	449	60	any	any	DET
admet-2057	449	61	targeting	target	VERB
admet-2057	449	62	agents	agent	NOUN
admet-2057	449	63	.	.	PUNCT
admet-2057	450	1	the	the	DET
admet-2057	450	2	synthesised	synthesise	VERB
admet-2057	450	3	magnetic	magnetic	ADJ
admet-2057	450	4	nano	nano	NOUN
admet-2057	450	5	/	/	SYM
admet-2057	450	6	microcomposite	microcomposite	NOUN
admet-2057	450	7	is	be	AUX
admet-2057	450	8	anticipated	anticipate	VERB
admet-2057	450	9	to	to	PART
admet-2057	450	10	be	be	AUX
admet-2057	450	11	useful	useful	ADJ
admet-2057	450	12	in	in	ADP
admet-2057	450	13	medicine	medicine	NOUN
admet-2057	450	14	and	and	CCONJ
admet-2057	450	15	to	to	PART
admet-2057	450	16	operate	operate	VERB
admet-2057	450	17	as	as	ADP
admet-2057	450	18	a	a	DET
admet-2057	450	19	platform	platform	NOUN
admet-2057	450	20	for	for	ADP
admet-2057	450	21	ph	ph	PROPN
admet-2057	450	22	/	/	SYM
admet-2057	450	23	gsh	gsh	NOUN
admet-2057	450	24	/	/	SYM
admet-2057	450	25	photo	photo	NOUN
admet-2057	450	26	-	-	PUNCT
admet-2057	450	27	triple	triple	ADJ
admet-2057	450	28	-	-	PUNCT
admet-2057	450	29	responsive	responsive	ADJ
admet-2057	450	30	nanocarriers	nanocarrier	NOUN
admet-2057	450	31	and	and	CCONJ
admet-2057	450	32	photoactive	photoactive	ADJ
admet-2057	450	33	antibacterial	antibacterial	ADJ
admet-2057	450	34	treatment	treatment	NOUN
admet-2057	450	35	.	.	PUNCT
admet-2057	451	1	in	in	ADP
admet-2057	451	2	another	another	DET
admet-2057	451	3	study	study	NOUN
admet-2057	451	4	,	,	PUNCT
admet-2057	451	5	rezvan	rezvan	PROPN
admet-2057	451	6	shahin	shahin	PROPN
admet-2057	451	7	et	et	PROPN
admet-2057	451	8	al	al	PROPN
admet-2057	451	9	.	.	PUNCT
admet-2057	452	1	[	[	X
admet-2057	452	2	98	98	NUM
admet-2057	452	3	]	]	PUNCT
admet-2057	452	4	designed	design	VERB
admet-2057	452	5	a	a	DET
admet-2057	452	6	nanocomposite	nanocomposite	NOUN
admet-2057	452	7	,	,	PUNCT
admet-2057	452	8	fe3o4@uio-66	fe3o4@uio-66	NOUN
admet-2057	452	9	-	-	PUNCT
admet-2057	452	10	nh2@pewith	nh2@pewith	NOUN
admet-2057	452	11	ph	ph	ADJ
admet-2057	452	12	-	-	PUNCT
admet-2057	452	13	responsive	responsive	ADJ
admet-2057	452	14	and	and	CCONJ
admet-2057	452	15	magnetic	magnetic	ADJ
admet-2057	452	16	responsive	responsive	ADJ
admet-2057	452	17	ability	ability	NOUN
admet-2057	452	18	for	for	ADP
admet-2057	452	19	drug	drug	NOUN
admet-2057	452	20	delivery	delivery	NOUN
admet-2057	452	21	.	.	PUNCT
admet-2057	453	1	after	after	ADP
admet-2057	453	2	being	be	AUX
admet-2057	453	3	artificially	artificially	ADV
admet-2057	453	4	modified	modify	VERB
admet-2057	453	5	via	via	ADP
admet-2057	453	6	the	the	DET
admet-2057	453	7	schiff	schiff	NOUN
admet-2057	453	8	base	base	NOUN
admet-2057	453	9	reaction	reaction	NOUN
admet-2057	453	10	between	between	ADP
admet-2057	453	11	the	the	DET
admet-2057	453	12	amino	amino	NOUN
admet-2057	453	13	groups	group	NOUN
admet-2057	453	14	in	in	ADP
admet-2057	453	15	uio-66	uio-66	NOUN
admet-2057	453	16	-	-	NOUN
admet-2057	453	17	nh2	nh2	NOUN
admet-2057	453	18	and	and	CCONJ
admet-2057	453	19	the	the	DET
admet-2057	453	20	aldehyde	aldehyde	NOUN
admet-2057	453	21	groups	group	NOUN
admet-2057	453	22	in	in	ADP
admet-2057	453	23	glutaraldehyde	glutaraldehyde	NOUN
admet-2057	453	24	,	,	PUNCT
admet-2057	453	25	a	a	DET
admet-2057	453	26	functional	functional	ADJ
admet-2057	453	27	mof	mof	NOUN
admet-2057	453	28	based	base	VERB
admet-2057	453	29	on	on	ADP
admet-2057	453	30	zirconium	zirconium	NOUN
admet-2057	453	31	was	be	AUX
admet-2057	453	32	created	create	VERB
admet-2057	453	33	:	:	PUNCT
admet-2057	453	34	fe3o4@uio-66	fe3o4@uio-66	NOUN
admet-2057	453	35	-	-	PUNCT
admet-2057	453	36	nh2	nh2	NOUN
admet-2057	453	37	.	.	PUNCT
admet-2057	454	1	analysis	analysis	NOUN
admet-2057	454	2	techniques	technique	NOUN
admet-2057	454	3	such	such	ADJ
admet-2057	454	4	as	as	ADP
admet-2057	454	5	ft	ft	NOUN
admet-2057	454	6	-	-	PUNCT
admet-2057	454	7	ir	ir	PROPN
admet-2057	454	8	,	,	PUNCT
admet-2057	454	9	xrd	xrd	PROPN
admet-2057	454	10	,	,	PUNCT
admet-2057	454	11	vsm	vsm	PROPN
admet-2057	454	12	,	,	PUNCT
admet-2057	454	13	tga	tga	PROPN
admet-2057	454	14	,	,	PUNCT
admet-2057	454	15	and	and	CCONJ
admet-2057	454	16	sem	sem	NOUN
admet-2057	454	17	were	be	AUX
admet-2057	454	18	used	use	VERB
admet-2057	454	19	to	to	PART
admet-2057	454	20	find	find	VERB
admet-2057	454	21	the	the	DET
admet-2057	454	22	synthesised	synthesise	VERB
admet-2057	454	23	carriers	carrier	NOUN
admet-2057	454	24	.	.	PUNCT
admet-2057	455	1	the	the	DET
admet-2057	455	2	encapsulation	encapsulation	NOUN
admet-2057	455	3	effectiveness	effectiveness	NOUN
admet-2057	455	4	of	of	ADP
admet-2057	455	5	core	core	ADJ
admet-2057	455	6	-	-	PUNCT
admet-2057	455	7	shell	shell	NOUN
admet-2057	455	8	nanocomposites	nanocomposite	NOUN
admet-2057	455	9	was	be	AUX
admet-2057	455	10	determined	determine	VERB
admet-2057	455	11	using	use	VERB
admet-2057	455	12	uv	uv	NOUN
admet-2057	455	13	spectrophotometry	spectrophotometry	NOUN
admet-2057	455	14	and	and	CCONJ
admet-2057	455	15	obtained	obtain	VERB
admet-2057	455	16	at	at	ADP
admet-2057	455	17	94	94	NUM
admet-2057	455	18	%	%	NOUN
admet-2057	455	19	due	due	ADP
admet-2057	455	20	to	to	ADP
admet-2057	455	21	the	the	DET
admet-2057	455	22	drug	drug	NOUN
admet-2057	455	23	's	's	PART
admet-2057	455	24	non	non	ADJ
admet-2057	455	25	-	-	ADJ
admet-2057	455	26	volatile	volatile	ADJ
admet-2057	455	27	nature	nature	NOUN
admet-2057	455	28	.	.	PUNCT
admet-2057	456	1	additionally	additionally	ADV
admet-2057	456	2	,	,	PUNCT
admet-2057	456	3	the	the	DET
admet-2057	456	4	drug	drug	NOUN
admet-2057	456	5	load	load	NOUN
admet-2057	456	6	efficiency	efficiency	NOUN
admet-2057	456	7	findings	finding	NOUN
admet-2057	456	8	and	and	CCONJ
admet-2057	456	9	the	the	DET
admet-2057	456	10	mtt	mtt	NOUN
admet-2057	456	11	technique	technique	NOUN
admet-2057	456	12	,	,	PUNCT
admet-2057	456	13	which	which	PRON
admet-2057	456	14	revealed	reveal	VERB
admet-2057	456	15	little	little	ADJ
admet-2057	456	16	cytotoxicity	cytotoxicity	NOUN
admet-2057	456	17	of	of	ADP
admet-2057	456	18	nanomaterials	nanomaterial	NOUN
admet-2057	456	19	even	even	ADV
admet-2057	456	20	after	after	ADP
admet-2057	456	21	that	that	PRON
admet-2057	456	22	,	,	PUNCT
admet-2057	456	23	are	be	AUX
admet-2057	456	24	in	in	ADP
admet-2057	456	25	excellent	excellent	ADJ
admet-2057	456	26	agreement	agreement	NOUN
admet-2057	456	27	.	.	PUNCT
admet-2057	457	1	the	the	DET
admet-2057	457	2	resultant	resultant	NOUN
admet-2057	457	3	nanomaterials	nanomaterial	NOUN
admet-2057	457	4	may	may	AUX
admet-2057	457	5	contain	contain	VERB
admet-2057	457	6	any	any	DET
admet-2057	457	7	tiny	tiny	ADJ
admet-2057	457	8	biological	biological	ADJ
admet-2057	457	9	molecule	molecule	NOUN
admet-2057	457	10	inside	inside	ADP
admet-2057	457	11	their	their	PRON
admet-2057	457	12	channels	channel	NOUN
admet-2057	457	13	and	and	CCONJ
admet-2057	457	14	porosity	porosity	NOUN
admet-2057	457	15	,	,	PUNCT
admet-2057	457	16	stabilise	stabilise	VERB
admet-2057	457	17	the	the	DET
admet-2057	457	18	environment	environment	NOUN
admet-2057	457	19	,	,	PUNCT
admet-2057	457	20	and	and	CCONJ
admet-2057	457	21	do	do	VERB
admet-2057	457	22	so	so	ADV
admet-2057	457	23	with	with	ADP
admet-2057	457	24	minimal	minimal	ADJ
admet-2057	457	25	cytotoxicity	cytotoxicity	NOUN
admet-2057	457	26	thanks	thank	NOUN
admet-2057	457	27	to	to	ADP
admet-2057	457	28	polymer	polymer	NOUN
admet-2057	457	29	coatings	coating	NOUN
admet-2057	457	30	.	.	PUNCT
admet-2057	458	1	however	however	ADV
admet-2057	458	2	,	,	PUNCT
admet-2057	458	3	the	the	DET
admet-2057	458	4	polymers	polymer	NOUN
admet-2057	458	5	gradually	gradually	ADV
admet-2057	458	6	broke	break	VERB
admet-2057	458	7	down	down	ADP
admet-2057	458	8	and	and	CCONJ
admet-2057	458	9	constantly	constantly	ADV
admet-2057	458	10	released	release	VERB
admet-2057	458	11	the	the	DET
admet-2057	458	12	drug	drug	NOUN
admet-2057	458	13	after	after	ADP
admet-2057	458	14	being	be	AUX
admet-2057	458	15	exposed	expose	VERB
admet-2057	458	16	to	to	ADP
admet-2057	458	17	various	various	ADJ
admet-2057	458	18	buffers	buffer	NOUN
admet-2057	458	19	and	and	CCONJ
admet-2057	458	20	time	time	NOUN
admet-2057	458	21	.	.	PUNCT
admet-2057	459	1	furthermore	furthermore	ADV
admet-2057	459	2	,	,	PUNCT
admet-2057	459	3	the	the	DET
admet-2057	459	4	nanocomposites	nanocomposite	NOUN
admet-2057	459	5	exhibited	exhibit	VERB
admet-2057	459	6	ph	ph	ADJ
admet-2057	459	7	-	-	ADJ
admet-2057	459	8	sensitive	sensitive	ADJ
admet-2057	459	9	behaviour	behaviour	NOUN
admet-2057	459	10	.	.	PUNCT
admet-2057	460	1	last	last	ADJ
admet-2057	460	2	but	but	CCONJ
admet-2057	460	3	not	not	PART
admet-2057	460	4	least	least	ADJ
admet-2057	460	5	,	,	PUNCT
admet-2057	460	6	the	the	DET
admet-2057	460	7	mtt	mtt	NOUN
admet-2057	460	8	test	test	NOUN
admet-2057	460	9	demonstrated	demonstrate	VERB
admet-2057	460	10	efficient	efficient	ADJ
admet-2057	460	11	cytotoxicity	cytotoxicity	NOUN
admet-2057	460	12	,	,	PUNCT
admet-2057	460	13	a	a	DET
admet-2057	460	14	positive	positive	ADJ
admet-2057	460	15	finding	finding	NOUN
admet-2057	460	16	for	for	ADP
admet-2057	460	17	future	future	ADJ
admet-2057	460	18	biological	biological	ADJ
admet-2057	460	19	applications	application	NOUN
admet-2057	460	20	[	[	X
admet-2057	460	21	98	98	NUM
admet-2057	460	22	]	]	PUNCT
admet-2057	460	23	.	.	PUNCT
admet-2057	461	1	by	by	ADP
admet-2057	461	2	grafting	graft	VERB
admet-2057	461	3	-cyclodextrin	-cyclodextrin	PROPN
admet-2057	461	4	onto	onto	ADP
admet-2057	461	5	the	the	DET
admet-2057	461	6	surface	surface	NOUN
admet-2057	461	7	of	of	ADP
admet-2057	461	8	fe3o4@silica@mil-100(fe	fe3o4@silica@mil-100(fe	NOUN
admet-2057	461	9	)	)	PUNCT
admet-2057	461	10	,	,	PUNCT
admet-2057	461	11	aseman	aseman	NOUN
admet-2057	461	12	lajevardi	lajevardi	PROPN
admet-2057	461	13	and	and	CCONJ
admet-2057	461	14	his	his	PRON
admet-2057	461	15	colleagues	colleague	NOUN
admet-2057	462	1	[	[	X
admet-2057	462	2	99	99	NUM
admet-2057	462	3	]	]	PUNCT
admet-2057	462	4	created	create	VERB
admet-2057	462	5	a	a	DET
admet-2057	462	6	new	new	ADJ
admet-2057	462	7	magnetic	magnetic	ADJ
admet-2057	462	8	and	and	CCONJ
admet-2057	462	9	phresponsive	phresponsive	ADJ
admet-2057	462	10	porous	porous	ADJ
admet-2057	462	11	nanocomposite	nanocomposite	NOUN
admet-2057	462	12	.	.	PUNCT
admet-2057	463	1	cephalexin	cephalexin	PROPN
admet-2057	463	2	's	's	PART
admet-2057	463	3	adsorption	adsorption	NOUN
admet-2057	463	4	on	on	ADP
admet-2057	463	5	the	the	DET
admet-2057	463	6	produced	produce	VERB
admet-2057	463	7	nanocomposite	nanocomposite	NOUN
admet-2057	463	8	and	and	CCONJ
admet-2057	463	9	its	its	PRON
admet-2057	463	10	release	release	NOUN
admet-2057	463	11	behaviour	behaviour	NOUN
admet-2057	463	12	were	be	AUX
admet-2057	463	13	examined	examine	VERB
admet-2057	463	14	in	in	ADP
admet-2057	463	15	relation	relation	NOUN
admet-2057	463	16	to	to	ADP
admet-2057	463	17	ph	ph	NOUN
admet-2057	463	18	and	and	CCONJ
admet-2057	463	19	temperature	temperature	NOUN
admet-2057	463	20	.	.	PUNCT
admet-2057	464	1	the	the	DET
admet-2057	464	2	highest	high	ADJ
admet-2057	464	3	adsorption	adsorption	NOUN
admet-2057	464	4	was	be	AUX
admet-2057	464	5	discovered	discover	VERB
admet-2057	464	6	to	to	PART
admet-2057	464	7	occur	occur	VERB
admet-2057	464	8	at	at	ADP
admet-2057	464	9	ambient	ambient	ADJ
admet-2057	464	10	temperature	temperature	NOUN
admet-2057	464	11	,	,	PUNCT
admet-2057	464	12	whereas	whereas	SCONJ
admet-2057	464	13	quick	quick	ADJ
admet-2057	464	14	release	release	NOUN
admet-2057	464	15	occurred	occur	VERB
admet-2057	464	16	at	at	ADP
admet-2057	464	17	higher	high	ADJ
admet-2057	464	18	temperatures	temperature	NOUN
admet-2057	464	19	.	.	PUNCT
admet-2057	465	1	according	accord	VERB
admet-2057	465	2	to	to	ADP
admet-2057	465	3	the	the	DET
admet-2057	465	4	data	datum	NOUN
admet-2057	465	5	,	,	PUNCT
admet-2057	465	6	the	the	DET
admet-2057	465	7	langmuir	langmuir	PROPN
admet-2057	465	8	isotherm	isotherm	PROPN
admet-2057	465	9	model	model	NOUN
admet-2057	465	10	outperformed	outperform	VERB
admet-2057	465	11	other	other	ADJ
admet-2057	465	12	two	two	NUM
admet-2057	465	13	-	-	PUNCT
admet-2057	465	14	parameter	parameter	NOUN
admet-2057	465	15	isotherm	isotherm	NOUN
admet-2057	465	16	models	model	NOUN
admet-2057	465	17	in	in	ADP
admet-2057	465	18	terms	term	NOUN
admet-2057	465	19	of	of	ADP
admet-2057	465	20	accurately	accurately	ADV
admet-2057	465	21	describing	describe	VERB
admet-2057	465	22	the	the	DET
admet-2057	465	23	drug	drug	NOUN
admet-2057	465	24	's	's	PART
admet-2057	465	25	adsorption	adsorption	NOUN
admet-2057	465	26	.	.	PUNCT
admet-2057	466	1	to	to	PART
admet-2057	466	2	examine	examine	VERB
admet-2057	466	3	the	the	DET
admet-2057	466	4	mechanism	mechanism	NOUN
admet-2057	466	5	of	of	ADP
admet-2057	466	6	adsorption	adsorption	NOUN
admet-2057	466	7	,	,	PUNCT
admet-2057	466	8	a	a	DET
admet-2057	466	9	variety	variety	NOUN
admet-2057	466	10	of	of	ADP
admet-2057	466	11	kinetic	kinetic	ADJ
admet-2057	466	12	models	model	NOUN
admet-2057	466	13	,	,	PUNCT
admet-2057	466	14	including	include	VERB
admet-2057	466	15	film	film	NOUN
admet-2057	466	16	transfer	transfer	NOUN
admet-2057	466	17	,	,	PUNCT
admet-2057	466	18	intra	intra	ADJ
admet-2057	466	19	-	-	ADJ
admet-2057	466	20	particle	particle	NOUN
admet-2057	466	21	diffusion	diffusion	NOUN
admet-2057	466	22	,	,	PUNCT
admet-2057	466	23	and	and	CCONJ
admet-2057	466	24	pseudo	pseudo	NOUN
admet-2057	466	25	-	-	ADJ
admet-2057	466	26	second	second	ADJ
admet-2057	466	27	-	-	PUNCT
admet-2057	466	28	order	order	NOUN
admet-2057	466	29	kinetic	kinetic	NOUN
admet-2057	466	30	models	model	NOUN
admet-2057	466	31	,	,	PUNCT
admet-2057	466	32	were	be	AUX
admet-2057	466	33	utilised	utilise	VERB
admet-2057	466	34	.	.	PUNCT
admet-2057	467	1	thermodynamic	thermodynamic	ADJ
admet-2057	467	2	analyses	analysis	NOUN
admet-2057	467	3	showed	show	VERB
admet-2057	467	4	the	the	DET
admet-2057	467	5	spontaneous	spontaneous	ADJ
admet-2057	467	6	and	and	CCONJ
admet-2057	467	7	exothermic	exothermic	ADJ
admet-2057	467	8	adsorption	adsorption	NOUN
admet-2057	467	9	of	of	ADP
admet-2057	467	10	cephalexin	cephalexin	PROPN
admet-2057	467	11	onto	onto	ADP
admet-2057	467	12	the	the	DET
admet-2057	467	13	nanocomposite	nanocomposite	NOUN
admet-2057	467	14	.	.	PUNCT
admet-2057	468	1	the	the	DET
admet-2057	468	2	nanocomposite	nanocomposite	PROPN
admet-2057	468	3	further	far	ADV
admet-2057	468	4	exhibited	exhibit	VERB
admet-2057	468	5	sensitive	sensitive	ADJ
admet-2057	468	6	ph	ph	ADJ
admet-2057	468	7	-	-	ADJ
admet-2057	468	8	dependent	dependent	ADJ
admet-2057	468	9	behaviour	behaviour	NOUN
admet-2057	468	10	.	.	PUNCT
admet-2057	469	1	the	the	DET
admet-2057	469	2	kinetics	kinetic	NOUN
admet-2057	469	3	of	of	ADP
admet-2057	469	4	release	release	NOUN
admet-2057	469	5	were	be	AUX
admet-2057	469	6	well	well	ADV
admet-2057	469	7	captured	capture	VERB
admet-2057	469	8	by	by	ADP
admet-2057	469	9	the	the	DET
admet-2057	469	10	higuchi	higuchi	PROPN
admet-2057	469	11	model	model	NOUN
admet-2057	469	12	,	,	PUNCT
admet-2057	469	13	which	which	PRON
admet-2057	469	14	was	be	AUX
admet-2057	469	15	researched	research	VERB
admet-2057	469	16	to	to	PART
admet-2057	469	17	explore	explore	VERB
admet-2057	469	18	the	the	DET
admet-2057	469	19	drug	drug	NOUN
admet-2057	469	20	release	release	NOUN
admet-2057	469	21	profile	profile	NOUN
admet-2057	469	22	.	.	PUNCT
admet-2057	470	1	other	other	ADJ
admet-2057	470	2	mathematical	mathematical	ADJ
admet-2057	470	3	kinetic	kinetic	NOUN
admet-2057	470	4	models	model	NOUN
admet-2057	470	5	studied	study	VERB
admet-2057	470	6	were	be	AUX
admet-2057	470	7	zero	zero	NUM
admet-2057	470	8	-	-	PUNCT
admet-2057	470	9	order	order	NOUN
admet-2057	470	10	,	,	PUNCT
admet-2057	470	11	first	first	ADJ
admet-2057	470	12	-	-	PUNCT
admet-2057	470	13	order	order	NOUN
admet-2057	470	14	,	,	PUNCT
admet-2057	470	15	korsmeyer	korsmeyer	NOUN
admet-2057	470	16	-	-	PUNCT
admet-2057	470	17	peppas	peppas	NOUN
admet-2057	470	18	,	,	PUNCT
admet-2057	470	19	and	and	CCONJ
admet-2057	470	20	higuchi	higuchi	PROPN
admet-2057	470	21	.	.	PUNCT
admet-2057	471	1	c.	c.	PROPN
admet-2057	471	2	thermal	thermal	PROPN
admet-2057	471	3	and	and	CCONJ
admet-2057	471	4	ion	ion	NOUN
admet-2057	471	5	-	-	PUNCT
admet-2057	471	6	responsive	responsive	ADJ
admet-2057	471	7	zn2	zn2	NOUN
admet-2057	471	8	+	+	PROPN
admet-2057	471	9	has	have	VERB
admet-2057	471	10	a	a	DET
admet-2057	471	11	crucial	crucial	ADJ
admet-2057	471	12	role	role	NOUN
admet-2057	471	13	in	in	ADP
admet-2057	471	14	the	the	DET
admet-2057	471	15	different	different	ADJ
admet-2057	471	16	organs	organ	NOUN
admet-2057	471	17	of	of	ADP
admet-2057	471	18	the	the	DET
admet-2057	471	19	body	body	NOUN
admet-2057	471	20	,	,	PUNCT
admet-2057	471	21	especially	especially	ADV
admet-2057	471	22	the	the	DET
admet-2057	471	23	nervous	nervous	ADJ
admet-2057	471	24	system	system	NOUN
admet-2057	471	25	.	.	PUNCT
admet-2057	472	1	by	by	ADP
admet-2057	472	2	considering	consider	VERB
admet-2057	472	3	this	this	PRON
admet-2057	472	4	,	,	PUNCT
admet-2057	472	5	the	the	DET
admet-2057	472	6	researcher	researcher	NOUN
admet-2057	472	7	has	have	AUX
admet-2057	472	8	investigated	investigate	VERB
admet-2057	472	9	zn2	zn2	PROPN
admet-2057	472	10	+	+	ADJ
admet-2057	472	11	-responsive	-responsive	ADJ
admet-2057	472	12	mofs	mof	NOUN
admet-2057	472	13	that	that	PRON
admet-2057	472	14	respond	respond	VERB
admet-2057	472	15	to	to	ADP
admet-2057	472	16	the	the	DET
admet-2057	472	17	zn2	zn2	PROPN
admet-2057	472	18	+	+	PROPN
admet-2057	472	19	imbalance	imbalance	NOUN
admet-2057	472	20	in	in	ADP
admet-2057	472	21	neurons	neuron	NOUN
admet-2057	472	22	and	and	CCONJ
admet-2057	472	23	can	can	AUX
admet-2057	472	24	effectively	effectively	ADV
admet-2057	472	25	treat	treat	VERB
admet-2057	472	26	nervous	nervous	ADJ
admet-2057	472	27	disorders	disorder	NOUN
admet-2057	472	28	.	.	PUNCT
admet-2057	473	1	tan	tan	PROPN
admet-2057	473	2	et	et	PROPN
admet-2057	474	1	al	al	PROPN
admet-2057	474	2	.	.	PROPN
admet-2057	474	3	used	use	VERB
admet-2057	474	4	quaternary	quaternary	ADJ
admet-2057	474	5	ammonium	ammonium	NOUN
admet-2057	474	6	salt	salt	NOUN
admet-2057	474	7	(	(	PUNCT
admet-2057	474	8	q	q	NOUN
admet-2057	474	9	)	)	PUNCT
admet-2057	474	10	to	to	PART
admet-2057	474	11	modify	modify	VERB
admet-2057	474	12	uio-66	uio-66	NOUN
admet-2057	474	13	-	-	NOUN
admet-2057	474	14	nh2	nh2	NOUN
admet-2057	474	15	and	and	CCONJ
admet-2057	474	16	cap	cap	VERB
admet-2057	474	17	it	it	PRON
admet-2057	474	18	with	with	ADP
admet-2057	474	19	cp5	cp5	NOUN
admet-2057	474	20	to	to	PART
admet-2057	474	21	assess	assess	VERB
admet-2057	474	22	the	the	DET
admet-2057	474	23	release	release	NOUN
admet-2057	474	24	of	of	ADP
admet-2057	474	25	5	5	NUM
admet-2057	474	26	-	-	PUNCT
admet-2057	474	27	fu	fu	NOUN
admet-2057	474	28	under	under	ADP
admet-2057	474	29	elevated	elevate	VERB
admet-2057	474	30	temperature	temperature	NOUN
admet-2057	474	31	and	and	CCONJ
admet-2057	474	32	increased	increase	VERB
admet-2057	474	33	zn2	zn2	PROPN
admet-2057	474	34	+	+	NOUN
admet-2057	474	35	concentrations	concentration	NOUN
admet-2057	474	36	.	.	PUNCT
admet-2057	475	1	when	when	SCONJ
admet-2057	475	2	zn2	zn2	PROPN
admet-2057	475	3	+	+	PRON
admet-2057	475	4	builds	build	VERB
admet-2057	475	5	up	up	ADP
admet-2057	475	6	in	in	ADP
admet-2057	475	7	the	the	DET
admet-2057	475	8	medium	medium	NOUN
admet-2057	475	9	,	,	PUNCT
admet-2057	475	10	the	the	DET
admet-2057	475	11	zn2+ions	zn2+ion	NOUN
admet-2057	475	12	have	have	VERB
admet-2057	475	13	a	a	DET
admet-2057	475	14	tendency	tendency	NOUN
admet-2057	475	15	to	to	PART
admet-2057	475	16	bind	bind	VERB
admet-2057	475	17	to	to	ADP
admet-2057	475	18	cp5	cp5	NOUN
admet-2057	475	19	and	and	CCONJ
admet-2057	475	20	open	open	VERB
admet-2057	475	21	the	the	DET
admet-2057	475	22	drug	drug	NOUN
admet-2057	475	23	-	-	PUNCT
admet-2057	475	24	loaded	load	VERB
admet-2057	475	25	pores	pore	NOUN
admet-2057	475	26	.	.	PUNCT
admet-2057	476	1	in	in	ADP
admet-2057	476	2	this	this	DET
admet-2057	476	3	investigation	investigation	NOUN
admet-2057	476	4	,	,	PUNCT
admet-2057	476	5	5	5	NUM
admet-2057	476	6	-	-	PUNCT
admet-2057	476	7	fu	fu	NOUN
admet-2057	476	8	released	release	VERB
admet-2057	476	9	less	less	ADJ
admet-2057	476	10	than	than	ADP
admet-2057	476	11	25	25	NUM
admet-2057	476	12	%	%	NOUN
admet-2057	476	13	in	in	ADP
admet-2057	476	14	zn2	zn2	PROPN
admet-2057	476	15	+	+	CCONJ
admet-2057	476	16	free	free	ADJ
admet-2057	476	17	medium	medium	NOUN
admet-2057	476	18	,	,	PUNCT
admet-2057	476	19	but	but	CCONJ
admet-2057	476	20	when	when	SCONJ
admet-2057	476	21	zn2	zn2	NOUN
admet-2057	476	22	+	+	CCONJ
admet-2057	476	23	concentration	concentration	NOUN
admet-2057	476	24	grew	grow	VERB
admet-2057	476	25	,	,	PUNCT
admet-2057	476	26	5	5	NUM
admet-2057	476	27	-	-	PUNCT
admet-2057	476	28	fu	fu	NOUN
admet-2057	476	29	release	release	NOUN
admet-2057	476	30	increased	increase	VERB
admet-2057	476	31	to	to	ADP
admet-2057	476	32	75	75	NUM
admet-2057	476	33	%	%	NOUN
admet-2057	476	34	in	in	ADP
admet-2057	476	35	10	10	NUM
admet-2057	476	36	mm	mm	PROPN
admet-2057	476	37	zn2	zn2	PROPN
admet-2057	476	38	+	+	NOUN
admet-2057	476	39	containing	contain	VERB
admet-2057	476	40	media	medium	NOUN
admet-2057	476	41	.	.	PUNCT
admet-2057	477	1	also	also	ADV
admet-2057	477	2	,	,	PUNCT
admet-2057	477	3	as	as	ADP
admet-2057	477	4	the	the	DET
admet-2057	477	5	release	release	NOUN
admet-2057	477	6	of	of	ADP
admet-2057	477	7	5	5	NUM
admet-2057	477	8	-	-	PUNCT
admet-2057	477	9	fu	fu	NOUN
admet-2057	477	10	at	at	ADP
admet-2057	477	11	60	60	NUM
admet-2057	477	12	°	°	NOUN
admet-2057	477	13	c	c	NOUN
admet-2057	477	14	has	have	AUX
admet-2057	477	15	risen	rise	VERB
admet-2057	477	16	to	to	ADP
admet-2057	477	17	approximately	approximately	ADV
admet-2057	477	18	70	70	NUM
admet-2057	477	19	%	%	NOUN
admet-2057	477	20	,	,	PUNCT
admet-2057	477	21	the	the	DET
admet-2057	477	22	interaction	interaction	NOUN
admet-2057	477	23	between	between	ADP
admet-2057	477	24	cp5	cp5	NOUN
admet-2057	477	25	and	and	CCONJ
admet-2057	477	26	q	q	NOUN
admet-2057	477	27	may	may	AUX
admet-2057	477	28	be	be	AUX
admet-2057	477	29	sensitive	sensitive	ADJ
admet-2057	477	30	to	to	ADP
admet-2057	477	31	temperature	temperature	NOUN
admet-2057	477	32	rise	rise	NOUN
admet-2057	478	1	[	[	X
admet-2057	478	2	100	100	NUM
admet-2057	478	3	]	]	PUNCT
admet-2057	478	4	.	.	PUNCT
admet-2057	479	1	routes	route	NOUN
admet-2057	479	2	of	of	ADP
admet-2057	479	3	administration	administration	NOUN
admet-2057	479	4	for	for	ADP
admet-2057	479	5	mof	mof	NUM
admet-2057	479	6	the	the	DET
admet-2057	479	7	drug	drug	NOUN
admet-2057	479	8	delivery	delivery	NOUN
admet-2057	479	9	applications	application	NOUN
admet-2057	479	10	of	of	ADP
admet-2057	479	11	mofs	mof	NOUN
admet-2057	479	12	have	have	AUX
admet-2057	479	13	greatly	greatly	ADV
admet-2057	479	14	drawn	draw	VERB
admet-2057	479	15	out	out	ADP
admet-2057	479	16	in	in	ADP
admet-2057	479	17	recent	recent	ADJ
admet-2057	479	18	years	year	NOUN
admet-2057	479	19	as	as	SCONJ
admet-2057	479	20	these	these	DET
admet-2057	479	21	systems	system	NOUN
admet-2057	479	22	can	can	AUX
admet-2057	479	23	deliver	deliver	VERB
admet-2057	479	24	therapeutics	therapeutic	NOUN
admet-2057	479	25	with	with	ADP
admet-2057	479	26	high	high	ADJ
admet-2057	479	27	precision	precision	NOUN
admet-2057	479	28	and	and	CCONJ
admet-2057	479	29	loading	loading	NOUN
admet-2057	479	30	due	due	ADP
admet-2057	479	31	to	to	ADP
admet-2057	479	32	their	their	PRON
admet-2057	479	33	large	large	ADJ
admet-2057	479	34	surface	surface	NOUN
admet-2057	479	35	area	area	NOUN
admet-2057	479	36	.	.	PUNCT
admet-2057	480	1	conventionally	conventionally	ADV
admet-2057	480	2	,	,	PUNCT
admet-2057	480	3	only	only	ADV
admet-2057	480	4	small	small	ADJ
admet-2057	480	5	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	480	6	p.	p.	NOUN
admet-2057	480	7	mhettar	mhettar	NOUN
admet-2057	480	8	et	et	PROPN
admet-2057	480	9	al	al	PROPN
admet-2057	480	10	.	.	PROPN
admet-2057	480	11	admet	admet	PROPN
admet-2057	480	12	&	&	CCONJ
admet-2057	480	13	dmpk	dmpk	PROPN
admet-2057	480	14	12(1	12(1	PROPN
admet-2057	480	15	)	)	PUNCT
admet-2057	480	16	(	(	PUNCT
admet-2057	480	17	2024	2024	NUM
admet-2057	480	18	)	)	PUNCT
admet-2057	480	19	27	27	NUM
admet-2057	480	20	-	-	SYM
admet-2057	480	21	62	62	NUM
admet-2057	480	22	44	44	NUM
admet-2057	480	23	molecular	molecular	ADJ
admet-2057	480	24	therapeutics	therapeutic	NOUN
admet-2057	480	25	were	be	AUX
admet-2057	480	26	thought	think	VERB
admet-2057	480	27	of	of	ADP
admet-2057	480	28	as	as	ADP
admet-2057	480	29	being	be	AUX
admet-2057	480	30	administered	administer	VERB
admet-2057	480	31	via	via	ADP
admet-2057	480	32	mof	mof	ADJ
admet-2057	480	33	delivery	delivery	NOUN
admet-2057	480	34	,	,	PUNCT
admet-2057	480	35	but	but	CCONJ
admet-2057	480	36	now	now	ADV
admet-2057	480	37	,	,	PUNCT
admet-2057	480	38	a	a	DET
admet-2057	480	39	large	large	ADJ
admet-2057	480	40	variety	variety	NOUN
admet-2057	480	41	of	of	ADP
admet-2057	480	42	macromolecular	macromolecular	ADJ
admet-2057	480	43	therapeutics	therapeutic	NOUN
admet-2057	480	44	like	like	ADP
admet-2057	480	45	nucleic	nucleic	ADJ
admet-2057	480	46	acids	acid	NOUN
admet-2057	480	47	and	and	CCONJ
admet-2057	480	48	proteins	protein	NOUN
admet-2057	480	49	are	be	AUX
admet-2057	480	50	being	be	AUX
admet-2057	480	51	administered	administer	VERB
admet-2057	480	52	via	via	ADP
admet-2057	480	53	mofs	mof	NOUN
admet-2057	480	54	.	.	PUNCT
admet-2057	481	1	in	in	ADP
admet-2057	481	2	this	this	DET
admet-2057	481	3	part	part	NOUN
admet-2057	481	4	of	of	ADP
admet-2057	481	5	the	the	DET
admet-2057	481	6	review	review	NOUN
admet-2057	481	7	,	,	PUNCT
admet-2057	481	8	we	we	PRON
admet-2057	481	9	discuss	discuss	VERB
admet-2057	481	10	the	the	DET
admet-2057	481	11	various	various	ADJ
admet-2057	481	12	routes	route	NOUN
admet-2057	481	13	of	of	ADP
admet-2057	481	14	administering	administer	VERB
admet-2057	481	15	mofs	mof	NOUN
admet-2057	481	16	,	,	PUNCT
admet-2057	481	17	as	as	SCONJ
admet-2057	481	18	portrayed	portray	VERB
admet-2057	481	19	in	in	ADP
admet-2057	481	20	figure	figure	NOUN
admet-2057	481	21	3	3	NUM
admet-2057	481	22	,	,	PUNCT
admet-2057	481	23	for	for	ADP
admet-2057	481	24	selective	selective	ADJ
admet-2057	481	25	and	and	CCONJ
admet-2057	481	26	non	non	ADJ
admet-2057	481	27	-	-	ADJ
admet-2057	481	28	selective	selective	ADJ
admet-2057	481	29	delivery	delivery	NOUN
admet-2057	481	30	.	.	PUNCT
admet-2057	482	1	figure	figure	NOUN
admet-2057	482	2	3	3	NUM
admet-2057	482	3	.	.	PUNCT
admet-2057	483	1	routes	route	NOUN
admet-2057	483	2	of	of	ADP
admet-2057	483	3	mof	mof	PROPN
admet-2057	483	4	administration	administration	PROPN
admet-2057	483	5	a.	a.	PROPN
admet-2057	483	6	oral	oral	PROPN
admet-2057	483	7	nanosized	nanosized	ADJ
admet-2057	483	8	biocompatible	biocompatible	ADJ
admet-2057	483	9	mofs	mof	NOUN
admet-2057	483	10	have	have	AUX
admet-2057	483	11	always	always	ADV
admet-2057	483	12	been	be	AUX
admet-2057	483	13	significantly	significantly	ADV
admet-2057	483	14	premeditated	premeditate	VERB
admet-2057	483	15	for	for	ADP
admet-2057	483	16	drug	drug	NOUN
admet-2057	483	17	delivery	delivery	NOUN
admet-2057	483	18	applications	application	NOUN
admet-2057	483	19	through	through	ADP
admet-2057	483	20	different	different	ADJ
admet-2057	483	21	routes	route	NOUN
admet-2057	483	22	of	of	ADP
admet-2057	483	23	administration	administration	NOUN
admet-2057	483	24	but	but	CCONJ
admet-2057	483	25	used	use	VERB
admet-2057	483	26	less	less	ADV
admet-2057	483	27	extensively	extensively	ADV
admet-2057	483	28	than	than	ADP
admet-2057	483	29	conventional	conventional	ADJ
admet-2057	483	30	oral	oral	ADJ
admet-2057	483	31	routes	route	NOUN
admet-2057	483	32	of	of	ADP
admet-2057	483	33	administration	administration	NOUN
admet-2057	483	34	as	as	ADP
admet-2057	483	35	,	,	PUNCT
admet-2057	483	36	until	until	ADP
admet-2057	483	37	now	now	ADV
admet-2057	483	38	,	,	PUNCT
admet-2057	483	39	the	the	DET
admet-2057	483	40	main	main	ADJ
admet-2057	483	41	focus	focus	NOUN
admet-2057	483	42	was	be	AUX
admet-2057	483	43	on	on	ADP
admet-2057	483	44	increasing	increase	VERB
admet-2057	483	45	the	the	DET
admet-2057	483	46	bioavailability	bioavailability	NOUN
admet-2057	483	47	of	of	ADP
admet-2057	483	48	the	the	DET
admet-2057	483	49	loaded	load	VERB
admet-2057	483	50	drug	drug	NOUN
admet-2057	483	51	without	without	ADP
admet-2057	483	52	taking	take	VERB
admet-2057	483	53	into	into	ADP
admet-2057	483	54	account	account	NOUN
admet-2057	483	55	the	the	DET
admet-2057	483	56	intestinal	intestinal	ADJ
admet-2057	483	57	permeability	permeability	NOUN
admet-2057	483	58	.	.	PUNCT
admet-2057	484	1	in	in	ADP
admet-2057	484	2	comparison	comparison	NOUN
admet-2057	484	3	with	with	ADP
admet-2057	484	4	fe(iron	fe(iron	NOUN
admet-2057	484	5	)	)	PUNCT
admet-2057	484	6	-based	-base	VERB
admet-2057	484	7	nano	nano	NOUN
admet-2057	484	8	mof	mof	NOUN
admet-2057	484	9	systems	system	NOUN
admet-2057	484	10	,	,	PUNCT
admet-2057	484	11	newly	newly	ADV
admet-2057	484	12	synthesized	synthesize	VERB
admet-2057	484	13	mll-127	mll-127	NOUN
admet-2057	484	14	has	have	VERB
admet-2057	484	15	a	a	DET
admet-2057	484	16	better	well	ADJ
admet-2057	484	17	permeation	permeation	NOUN
admet-2057	484	18	through	through	ADP
admet-2057	484	19	the	the	DET
admet-2057	484	20	intestine	intestine	NOUN
admet-2057	484	21	.	.	PUNCT
admet-2057	485	1	further	further	ADJ
admet-2057	485	2	intestinal	intestinal	ADJ
admet-2057	485	3	permeability	permeability	NOUN
admet-2057	485	4	was	be	AUX
admet-2057	485	5	improved	improve	VERB
admet-2057	485	6	by	by	ADP
admet-2057	485	7	surface	surface	NOUN
admet-2057	485	8	modification	modification	NOUN
admet-2057	485	9	through	through	ADP
admet-2057	485	10	chitosan	chitosan	NOUN
admet-2057	485	11	coating	coating	NOUN
admet-2057	485	12	.	.	PUNCT
admet-2057	486	1	the	the	DET
admet-2057	486	2	intestinal	intestinal	ADJ
admet-2057	486	3	permeability	permeability	NOUN
admet-2057	486	4	and	and	CCONJ
admet-2057	486	5	biocompatibility	biocompatibility	NOUN
admet-2057	486	6	were	be	AUX
admet-2057	486	7	confirmed	confirm	VERB
admet-2057	486	8	by	by	ADP
admet-2057	486	9	the	the	DET
admet-2057	486	10	caenorhabditis	caenorhabditis	PROPN
admet-2057	486	11	elegans	elegan	NOUN
admet-2057	486	12	in	in	ADP
admet-2057	486	13	vivo	vivo	NOUN
admet-2057	486	14	model	model	NOUN
admet-2057	486	15	.	.	PUNCT
admet-2057	487	1	caenorhabditis	caenorhabditis	PROPN
admet-2057	487	2	elegans	elegans	PROPN
admet-2057	487	3	are	be	AUX
admet-2057	487	4	worms	worm	NOUN
admet-2057	487	5	that	that	PRON
admet-2057	487	6	can	can	AUX
admet-2057	487	7	ingest	ingest	VERB
admet-2057	487	8	a	a	DET
admet-2057	487	9	large	large	ADJ
admet-2057	487	10	number	number	NOUN
admet-2057	487	11	of	of	ADP
admet-2057	487	12	nano	nano	NOUN
admet-2057	487	13	mofs	mof	NOUN
admet-2057	487	14	.	.	PUNCT
admet-2057	488	1	at	at	ADP
admet-2057	488	2	last	last	ADV
admet-2057	488	3	,	,	PUNCT
admet-2057	488	4	the	the	DET
admet-2057	488	5	ex	ex	X
admet-2057	488	6	vivo	vivo	ADJ
admet-2057	488	7	rat	rat	NOUN
admet-2057	488	8	intestinal	intestinal	ADJ
admet-2057	488	9	model	model	NOUN
admet-2057	488	10	confirmed	confirm	VERB
admet-2057	488	11	the	the	DET
admet-2057	488	12	system	system	NOUN
admet-2057	488	13	's	's	PART
admet-2057	488	14	passage	passage	NOUN
admet-2057	488	15	across	across	ADP
admet-2057	488	16	the	the	DET
admet-2057	488	17	intestinal	intestinal	ADJ
admet-2057	488	18	barrier	barrier	NOUN
admet-2057	488	19	for	for	ADP
admet-2057	488	20	only	only	ADV
admet-2057	488	21	2	2	NUM
admet-2057	488	22	hours	hour	NOUN
admet-2057	488	23	.	.	PUNCT
admet-2057	489	1	the	the	DET
admet-2057	489	2	study	study	NOUN
admet-2057	489	3	showed	show	VERB
admet-2057	489	4	that	that	SCONJ
admet-2057	489	5	mofs	mof	NOUN
admet-2057	489	6	can	can	AUX
admet-2057	489	7	act	act	VERB
admet-2057	489	8	as	as	ADP
admet-2057	489	9	a	a	DET
admet-2057	489	10	potential	potential	ADJ
admet-2057	489	11	system	system	NOUN
admet-2057	489	12	for	for	ADP
admet-2057	489	13	oral	oral	ADJ
admet-2057	489	14	administration	administration	NOUN
admet-2057	489	15	and	and	CCONJ
admet-2057	489	16	improve	improve	VERB
admet-2057	489	17	intestinal	intestinal	ADJ
admet-2057	489	18	permeability	permeability	NOUN
admet-2057	489	19	[	[	X
admet-2057	489	20	101	101	NUM
admet-2057	489	21	]	]	PUNCT
admet-2057	489	22	.	.	PUNCT
admet-2057	490	1	previously	previously	ADV
admet-2057	490	2	,	,	PUNCT
admet-2057	490	3	a	a	DET
admet-2057	490	4	similar	similar	ADJ
admet-2057	490	5	study	study	NOUN
admet-2057	490	6	was	be	AUX
admet-2057	490	7	carried	carry	VERB
admet-2057	490	8	out	out	ADP
admet-2057	490	9	by	by	ADP
admet-2057	490	10	yuhao	yuhao	PROPN
admet-2057	490	11	zhou	zhou	PROPN
admet-2057	490	12	and	and	CCONJ
admet-2057	490	13	his	his	PRON
admet-2057	490	14	research	research	NOUN
admet-2057	490	15	team	team	NOUN
admet-2057	490	16	[	[	X
admet-2057	490	17	102	102	NUM
admet-2057	490	18	]	]	PUNCT
admet-2057	490	19	.	.	PUNCT
admet-2057	491	1	the	the	DET
admet-2057	491	2	team	team	NOUN
admet-2057	491	3	developed	develop	VERB
admet-2057	491	4	a	a	DET
admet-2057	491	5	nanocomposite	nanocomposite	NOUN
admet-2057	491	6	-	-	PUNCT
admet-2057	491	7	based	base	VERB
admet-2057	491	8	mof	mof	ADJ
admet-2057	491	9	system	system	NOUN
admet-2057	491	10	for	for	ADP
admet-2057	491	11	the	the	DET
admet-2057	491	12	oral	oral	ADJ
admet-2057	491	13	delivery	delivery	NOUN
admet-2057	491	14	of	of	ADP
admet-2057	491	15	insulin	insulin	NOUN
admet-2057	491	16	to	to	PART
admet-2057	491	17	tackle	tackle	VERB
admet-2057	491	18	problems	problem	NOUN
admet-2057	491	19	of	of	ADP
admet-2057	491	20	low	low	ADJ
admet-2057	491	21	intestinal	intestinal	ADJ
admet-2057	491	22	permeability	permeability	NOUN
admet-2057	491	23	and	and	CCONJ
admet-2057	491	24	gastric	gastric	ADJ
admet-2057	491	25	degradation	degradation	NOUN
admet-2057	491	26	.	.	PUNCT
admet-2057	492	1	they	they	PRON
admet-2057	492	2	synthesized	synthesize	VERB
admet-2057	492	3	a	a	DET
admet-2057	492	4	nanocomposite	nanocomposite	NOUN
admet-2057	492	5	biodegradable	biodegradable	NOUN
admet-2057	492	6	microsphere	microsphere	NOUN
admet-2057	492	7	incorporating	incorporate	VERB
admet-2057	492	8	mof	mof	ADJ
admet-2057	492	9	nps	nps	PROPN
admet-2057	492	10	to	to	PART
admet-2057	492	11	overcome	overcome	VERB
admet-2057	492	12	these	these	DET
admet-2057	492	13	barriers	barrier	NOUN
admet-2057	492	14	.	.	PUNCT
admet-2057	493	1	a	a	DET
admet-2057	493	2	fe	fe	NOUN
admet-2057	493	3	-	-	PUNCT
admet-2057	493	4	based	base	VERB
admet-2057	493	5	mof	mof	NOUN
admet-2057	493	6	was	be	AUX
admet-2057	493	7	fabricated	fabricate	VERB
admet-2057	493	8	first	first	ADV
admet-2057	493	9	as	as	ADP
admet-2057	493	10	a	a	DET
admet-2057	493	11	carrier	carrier	NOUN
admet-2057	493	12	with	with	ADP
admet-2057	493	13	a	a	DET
admet-2057	493	14	loading	loading	NOUN
admet-2057	493	15	capacity	capacity	NOUN
admet-2057	493	16	of	of	ADP
admet-2057	493	17	35	35	NUM
admet-2057	493	18	%	%	NOUN
admet-2057	493	19	and	and	CCONJ
admet-2057	493	20	these	these	PRON
admet-2057	493	21	were	be	AUX
admet-2057	493	22	modified	modify	VERB
admet-2057	493	23	with	with	ADP
admet-2057	493	24	sodium	sodium	NOUN
admet-2057	493	25	dodecyl	dodecyl	NOUN
admet-2057	493	26	sulfate	sulfate	VERB
admet-2057	493	27	for	for	ADP
admet-2057	493	28	improving	improve	VERB
admet-2057	493	29	permeation	permeation	NOUN
admet-2057	493	30	across	across	ADP
admet-2057	493	31	the	the	DET
admet-2057	493	32	caco-2	caco-2	NUM
admet-2057	493	33	monolayer	monolayer	NOUN
admet-2057	493	34	invitro	invitro	ADJ
admet-2057	493	35	models	model	NOUN
admet-2057	493	36	.	.	PUNCT
admet-2057	494	1	further	far	ADV
admet-2057	494	2	,	,	PUNCT
admet-2057	494	3	these	these	DET
admet-2057	494	4	nps	nps	PROPN
admet-2057	494	5	were	be	AUX
admet-2057	494	6	incorporated	incorporate	VERB
admet-2057	494	7	into	into	ADP
admet-2057	494	8	biodegradable	biodegradable	ADJ
admet-2057	494	9	microspheres	microsphere	NOUN
admet-2057	494	10	to	to	PART
admet-2057	494	11	protect	protect	VERB
admet-2057	494	12	the	the	DET
admet-2057	494	13	system	system	NOUN
admet-2057	494	14	from	from	ADP
admet-2057	494	15	gastric	gastric	ADJ
admet-2057	494	16	degradation	degradation	NOUN
admet-2057	494	17	,	,	PUNCT
admet-2057	494	18	which	which	PRON
admet-2057	494	19	showed	show	VERB
admet-2057	494	20	better	well	ADJ
admet-2057	494	21	stability	stability	NOUN
admet-2057	494	22	in	in	ADP
admet-2057	494	23	acidic	acidic	ADJ
admet-2057	494	24	media	medium	NOUN
admet-2057	494	25	while	while	SCONJ
admet-2057	494	26	releasing	release	VERB
admet-2057	494	27	insulin	insulin	NOUN
admet-2057	494	28	in	in	ADP
admet-2057	494	29	simulated	simulated	ADJ
admet-2057	494	30	intestinal	intestinal	ADJ
admet-2057	494	31	fluid	fluid	NOUN
admet-2057	494	32	.	.	PUNCT
admet-2057	495	1	in	in	ADP
admet-2057	495	2	-	-	PUNCT
admet-2057	495	3	vitro	vitro	X
admet-2057	495	4	studies	study	NOUN
admet-2057	495	5	performed	perform	VERB
admet-2057	495	6	on	on	ADP
admet-2057	495	7	blab	blab	NOUN
admet-2057	495	8	/	/	SYM
admet-2057	495	9	c	c	PROPN
admet-2057	495	10	nude	nude	ADJ
admet-2057	495	11	mice	mouse	NOUN
admet-2057	495	12	showed	show	VERB
admet-2057	495	13	that	that	SCONJ
admet-2057	495	14	following	follow	VERB
admet-2057	495	15	oral	oral	ADJ
admet-2057	495	16	administration	administration	NOUN
admet-2057	495	17	,	,	PUNCT
admet-2057	495	18	this	this	DET
admet-2057	495	19	system	system	NOUN
admet-2057	495	20	showed	show	VERB
admet-2057	495	21	improved	improved	ADJ
admet-2057	495	22	insulin	insulin	NOUN
admet-2057	495	23	availability	availability	NOUN
admet-2057	495	24	compared	compare	VERB
admet-2057	495	25	to	to	ADP
admet-2057	495	26	free	free	ADJ
admet-2057	495	27	oral	oral	ADJ
admet-2057	495	28	insulin	insulin	NOUN
admet-2057	495	29	administration	administration	NOUN
admet-2057	495	30	and	and	CCONJ
admet-2057	495	31	showed	show	VERB
admet-2057	495	32	improved	improved	ADJ
admet-2057	495	33	plasma	plasma	NOUN
admet-2057	495	34	insulin	insulin	NOUN
admet-2057	495	35	levels	level	NOUN
admet-2057	495	36	for	for	ADP
admet-2057	495	37	more	more	ADJ
admet-2057	495	38	than	than	ADP
admet-2057	495	39	6	6	NUM
admet-2057	495	40	h	h	NOUN
admet-2057	495	41	in	in	ADP
admet-2057	495	42	diabetic	diabetic	ADJ
admet-2057	495	43	rats	rat	NOUN
admet-2057	495	44	,	,	PUNCT
admet-2057	495	45	proving	prove	VERB
admet-2057	495	46	that	that	SCONJ
admet-2057	495	47	these	these	DET
admet-2057	495	48	insulin	insulin	NOUN
admet-2057	495	49	containing	contain	VERB
admet-2057	495	50	mof	mof	X
admet-2057	495	51	admet	admet	PROPN
admet-2057	495	52	&	&	CCONJ
admet-2057	495	53	dmpk	dmpk	PROPN
admet-2057	495	54	12(1	12(1	PROPN
admet-2057	495	55	)	)	PUNCT
admet-2057	495	56	(	(	PUNCT
admet-2057	495	57	2024	2024	NUM
admet-2057	495	58	)	)	PUNCT
admet-2057	495	59	27	27	NUM
admet-2057	495	60	-	-	SYM
admet-2057	495	61	62	62	NUM
admet-2057	495	62	drug	drug	NOUN
admet-2057	495	63	delivery	delivery	NOUN
admet-2057	495	64	applications	application	NOUN
admet-2057	495	65	of	of	ADP
admet-2057	495	66	metal	metal	NOUN
admet-2057	495	67	-	-	PUNCT
admet-2057	495	68	organic	organic	ADJ
admet-2057	495	69	framework	framework	NOUN
admet-2057	495	70	doi	doi	NOUN
admet-2057	495	71	:	:	PUNCT
admet-2057	495	72	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	495	73	45	45	NUM
admet-2057	495	74	loaded	load	VERB
admet-2057	495	75	microspheres	microsphere	NOUN
admet-2057	495	76	can	can	AUX
admet-2057	495	77	act	act	VERB
admet-2057	495	78	as	as	ADP
admet-2057	495	79	an	an	DET
admet-2057	495	80	effective	effective	ADJ
admet-2057	495	81	means	mean	NOUN
admet-2057	495	82	of	of	ADP
admet-2057	495	83	oral	oral	ADJ
admet-2057	495	84	delivery	delivery	NOUN
admet-2057	495	85	.	.	PUNCT
admet-2057	496	1	in	in	ADP
admet-2057	496	2	2018	2018	NUM
admet-2057	496	3	,	,	PUNCT
admet-2057	496	4	siamak	siamak	PROPN
admet-2057	496	5	javanbakht	javanbakht	NOUN
admet-2057	497	1	[	[	X
admet-2057	497	2	103	103	NUM
admet-2057	497	3	]	]	PUNCT
admet-2057	497	4	used	use	VERB
admet-2057	497	5	cumof	cumof	ADJ
admet-2057	497	6	porous	porous	ADJ
admet-2057	497	7	blocks	block	NOUN
admet-2057	497	8	to	to	PART
admet-2057	497	9	be	be	AUX
admet-2057	497	10	immersed	immerse	VERB
admet-2057	497	11	in	in	ADP
admet-2057	497	12	a	a	DET
admet-2057	497	13	pharmacological	pharmacological	ADJ
admet-2057	497	14	solution	solution	NOUN
admet-2057	497	15	while	while	SCONJ
admet-2057	497	16	loading	load	VERB
admet-2057	497	17	ibu	ibu	PROPN
admet-2057	497	18	into	into	ADP
admet-2057	497	19	two	two	NUM
admet-2057	497	20	-	-	PUNCT
admet-2057	497	21	dimensionally	dimensionally	ADV
admet-2057	497	22	shaped	shape	VERB
admet-2057	497	23	tunnels	tunnel	NOUN
admet-2057	497	24	and	and	CCONJ
admet-2057	497	25	empty	empty	ADJ
admet-2057	497	26	face	face	NOUN
admet-2057	497	27	-	-	PUNCT
admet-2057	497	28	centered	center	VERB
admet-2057	497	29	cubic	cubic	ADJ
admet-2057	497	30	cubes	cube	NOUN
admet-2057	497	31	.	.	PUNCT
admet-2057	498	1	the	the	DET
admet-2057	498	2	ph	ph	ADJ
admet-2057	498	3	-	-	ADJ
admet-2057	498	4	sensitive	sensitive	ADJ
admet-2057	498	5	biopolymeric	biopolymeric	ADJ
admet-2057	498	6	gelatin	gelatin	NOUN
admet-2057	498	7	microspheres	microsphere	NOUN
admet-2057	498	8	were	be	AUX
admet-2057	498	9	used	use	VERB
admet-2057	498	10	to	to	PART
admet-2057	498	11	preserve	preserve	VERB
admet-2057	498	12	the	the	DET
admet-2057	498	13	cu	cu	PROPN
admet-2057	498	14	-	-	PUNCT
admet-2057	498	15	based	base	VERB
admet-2057	498	16	mofs	mof	NOUN
admet-2057	498	17	-	-	PUNCT
admet-2057	498	18	ibu	ibu	PROPN
admet-2057	498	19	nanohybrid	nanohybrid	PROPN
admet-2057	498	20	(	(	PUNCT
admet-2057	498	21	cu	cu	PROPN
admet-2057	498	22	-	-	PUNCT
admet-2057	498	23	mof	mof	VERB
admet-2057	498	24	/	/	SYM
admet-2057	498	25	ibu	ibu	PROPN
admet-2057	498	26	)	)	PUNCT
admet-2057	498	27	.	.	PUNCT
admet-2057	499	1	according	accord	VERB
admet-2057	499	2	to	to	ADP
admet-2057	499	3	the	the	DET
admet-2057	499	4	results	result	NOUN
admet-2057	499	5	,	,	PUNCT
admet-2057	499	6	the	the	DET
admet-2057	499	7	manufactured	manufacture	VERB
admet-2057	499	8	gelatin	gelatin	NOUN
admet-2057	499	9	microsphere	microsphere	NOUN
admet-2057	499	10	may	may	AUX
admet-2057	499	11	serve	serve	VERB
admet-2057	499	12	as	as	ADP
admet-2057	499	13	a	a	DET
admet-2057	499	14	suggested	suggest	VERB
admet-2057	499	15	capsule	capsule	NOUN
admet-2057	499	16	for	for	ADP
admet-2057	499	17	the	the	DET
admet-2057	499	18	medication	medication	NOUN
admet-2057	499	19	under	under	ADP
admet-2057	499	20	gastrointestinal	gastrointestinal	ADJ
admet-2057	499	21	tract	tract	NOUN
admet-2057	499	22	conditions	condition	NOUN
admet-2057	499	23	.	.	PUNCT
admet-2057	500	1	utilizing	utilize	VERB
admet-2057	500	2	ft	ft	PROPN
admet-2057	500	3	-	-	PUNCT
admet-2057	500	4	ir	ir	PROPN
admet-2057	500	5	,	,	PUNCT
admet-2057	500	6	xrd	xrd	NOUN
admet-2057	500	7	,	,	PUNCT
admet-2057	500	8	uv	uv	NOUN
admet-2057	500	9	-	-	PUNCT
admet-2057	500	10	vis	vis	X
admet-2057	500	11	,	,	PUNCT
admet-2057	500	12	and	and	CCONJ
admet-2057	500	13	sem	sem	NOUN
admet-2057	500	14	analyses	analysis	NOUN
admet-2057	500	15	,	,	PUNCT
admet-2057	500	16	the	the	DET
admet-2057	500	17	gelatin	gelatin	NOUN
admet-2057	500	18	-	-	PUNCT
admet-2057	500	19	encapsulated	encapsulate	VERB
admet-2057	500	20	cu	cu	PROPN
admet-2057	500	21	-	-	PUNCT
admet-2057	500	22	mof	mof	VERB
admet-2057	500	23	/	/	SYM
admet-2057	500	24	ibu	ibu	PROPN
admet-2057	500	25	microsphere	microsphere	PROPN
admet-2057	500	26	(	(	PUNCT
admet-2057	500	27	cu	cu	PROPN
admet-2057	500	28	-	-	PUNCT
admet-2057	500	29	mof	mof	VERB
admet-2057	500	30	/	/	SYM
admet-2057	500	31	ibu@gm	ibu@gm	NOUN
admet-2057	500	32	)	)	PUNCT
admet-2057	500	33	was	be	AUX
admet-2057	500	34	characterised	characterise	VERB
admet-2057	500	35	.	.	PUNCT
admet-2057	501	1	in	in	ADP
admet-2057	501	2	vitro	vitro	X
admet-2057	501	3	drug	drug	NOUN
admet-2057	501	4	delivery	delivery	NOUN
admet-2057	501	5	tests	test	NOUN
admet-2057	501	6	were	be	AUX
admet-2057	501	7	conducted	conduct	VERB
admet-2057	501	8	to	to	PART
admet-2057	501	9	demonstrate	demonstrate	VERB
admet-2057	501	10	the	the	DET
admet-2057	501	11	effectiveness	effectiveness	NOUN
admet-2057	501	12	of	of	ADP
admet-2057	501	13	the	the	DET
admet-2057	501	14	innovative	innovative	ADJ
admet-2057	501	15	microsphere	microsphere	NOUN
admet-2057	501	16	as	as	ADP
admet-2057	501	17	a	a	DET
admet-2057	501	18	controlled	control	VERB
admet-2057	501	19	drug	drug	NOUN
admet-2057	501	20	delivery	delivery	NOUN
admet-2057	501	21	device	device	NOUN
admet-2057	501	22	.	.	PUNCT
admet-2057	502	1	the	the	DET
admet-2057	502	2	mtt	mtt	NOUN
admet-2057	502	3	assay	assay	VERB
admet-2057	502	4	was	be	AUX
admet-2057	502	5	used	use	VERB
admet-2057	502	6	to	to	PART
admet-2057	502	7	determine	determine	VERB
admet-2057	502	8	the	the	DET
admet-2057	502	9	cytotoxicity	cytotoxicity	NOUN
admet-2057	502	10	of	of	ADP
admet-2057	502	11	the	the	DET
admet-2057	502	12	cu	cu	PROPN
admet-2057	502	13	-	-	PUNCT
admet-2057	502	14	mof	mof	PROPN
admet-2057	502	15	,	,	PUNCT
admet-2057	502	16	cu	cu	PROPN
admet-2057	502	17	-	-	PUNCT
admet-2057	502	18	mof	mof	PROPN
admet-2057	502	19	/	/	SYM
admet-2057	502	20	ibu	ibu	PROPN
admet-2057	502	21	,	,	PUNCT
admet-2057	502	22	and	and	CCONJ
admet-2057	502	23	cu	cu	PROPN
admet-2057	502	24	-	-	PUNCT
admet-2057	502	25	mof	mof	VERB
admet-2057	502	26	/	/	SYM
admet-2057	502	27	ibu@gm	ibu@gm	ADJ
admet-2057	502	28	compounds	compound	NOUN
admet-2057	502	29	.	.	PUNCT
admet-2057	503	1	cu	cu	NOUN
admet-2057	503	2	-	-	PUNCT
admet-2057	503	3	mof	mof	VERB
admet-2057	503	4	/	/	SYM
admet-2057	503	5	ibu@gm	ibu@gm	PROPN
admet-2057	503	6	showed	show	VERB
admet-2057	503	7	very	very	ADV
admet-2057	503	8	little	little	ADJ
admet-2057	503	9	cytotoxicity	cytotoxicity	NOUN
admet-2057	503	10	to	to	ADP
admet-2057	503	11	caco-2	caco-2	NUM
admet-2057	503	12	cells	cell	NOUN
admet-2057	503	13	after	after	ADP
admet-2057	503	14	being	be	AUX
admet-2057	503	15	incubated	incubate	VERB
admet-2057	503	16	at	at	ADP
admet-2057	503	17	various	various	ADJ
admet-2057	503	18	periods	period	NOUN
admet-2057	503	19	and	and	CCONJ
admet-2057	503	20	concentrations	concentration	NOUN
admet-2057	503	21	,	,	PUNCT
admet-2057	503	22	and	and	CCONJ
admet-2057	503	23	the	the	DET
admet-2057	503	24	cell	cell	NOUN
admet-2057	503	25	viability	viability	NOUN
admet-2057	503	26	remained	remain	VERB
admet-2057	503	27	over	over	ADP
admet-2057	503	28	60	60	NUM
admet-2057	503	29	%	%	NOUN
admet-2057	503	30	.	.	PUNCT
admet-2057	504	1	in	in	ADP
admet-2057	504	2	contrast	contrast	NOUN
admet-2057	504	3	,	,	PUNCT
admet-2057	504	4	cu	cu	PROPN
admet-2057	504	5	-	-	PUNCT
admet-2057	504	6	mof	mof	PROPN
admet-2057	504	7	and	and	CCONJ
admet-2057	504	8	ibu	ibu	PROPN
admet-2057	504	9	/	/	SYM
admet-2057	504	10	cu	cu	PROPN
admet-2057	504	11	-	-	PUNCT
admet-2057	504	12	mof	mof	PROPN
admet-2057	504	13	showed	show	VERB
admet-2057	504	14	substantial	substantial	ADJ
admet-2057	504	15	cytotoxicity	cytotoxicity	NOUN
admet-2057	504	16	to	to	ADP
admet-2057	504	17	caco-2	caco-2	NUM
admet-2057	504	18	cells	cell	NOUN
admet-2057	504	19	even	even	ADV
admet-2057	504	20	at	at	ADP
admet-2057	504	21	low	low	ADJ
admet-2057	504	22	doses	dose	NOUN
admet-2057	504	23	.	.	PUNCT
admet-2057	505	1	drug	drug	NOUN
admet-2057	505	2	release	release	NOUN
admet-2057	505	3	studies	study	NOUN
admet-2057	505	4	showed	show	VERB
admet-2057	505	5	that	that	SCONJ
admet-2057	505	6	cu	cu	PROPN
admet-2057	505	7	-	-	PUNCT
admet-2057	505	8	mof	mof	ADJ
admet-2057	505	9	decomposition	decomposition	NOUN
admet-2057	505	10	in	in	ADP
admet-2057	505	11	an	an	DET
admet-2057	505	12	acidic	acidic	ADJ
admet-2057	505	13	solution	solution	NOUN
admet-2057	505	14	caused	cause	VERB
admet-2057	505	15	fast	fast	ADJ
admet-2057	505	16	drug	drug	NOUN
admet-2057	505	17	release	release	NOUN
admet-2057	505	18	at	at	ADP
admet-2057	505	19	ph	ph	PROPN
admet-2057	505	20	1.2	1.2	NUM
admet-2057	505	21	(	(	PUNCT
admet-2057	505	22	95	95	NUM
admet-2057	505	23	%	%	NOUN
admet-2057	505	24	of	of	ADP
admet-2057	505	25	the	the	DET
admet-2057	505	26	drug	drug	NOUN
admet-2057	505	27	released	release	VERB
admet-2057	505	28	at	at	ADP
admet-2057	505	29	2	2	NUM
admet-2057	505	30	h	h	NOUN
admet-2057	505	31	)	)	PUNCT
admet-2057	505	32	for	for	ADP
admet-2057	505	33	cu	cu	PROPN
admet-2057	505	34	-	-	PUNCT
admet-2057	505	35	mof	mof	VERB
admet-2057	505	36	/	/	SYM
admet-2057	505	37	ibu	ibu	PROPN
admet-2057	505	38	while	while	SCONJ
admet-2057	505	39	cu	cu	PROPN
admet-2057	505	40	-	-	PUNCT
admet-2057	505	41	mof	mof	VERB
admet-2057	505	42	/	/	SYM
admet-2057	505	43	ibu@gm	ibu@gm	PROPN
admet-2057	505	44	released	release	VERB
admet-2057	505	45	the	the	DET
admet-2057	505	46	drug	drug	NOUN
admet-2057	505	47	in	in	ADP
admet-2057	505	48	a	a	DET
admet-2057	505	49	controlled	control	VERB
admet-2057	505	50	manner	manner	NOUN
admet-2057	505	51	(	(	PUNCT
admet-2057	505	52	ph	ph	NOUN
admet-2057	505	53	1.2	1.2	NUM
admet-2057	505	54	:	:	PUNCT
admet-2057	505	55	ph	ph	ADJ
admet-2057	505	56	6.8	6.8	NUM
admet-2057	505	57	:	:	PUNCT
admet-2057	505	58	ph	ph	ADJ
admet-2057	505	59	7.4	7.4	NUM
admet-2057	505	60	-	-	SYM
admet-2057	505	61	3:3:2	3:3:2	NUM
admet-2057	505	62	)	)	PUNCT
admet-2057	505	63	that	that	PRON
admet-2057	505	64	may	may	AUX
admet-2057	505	65	be	be	AUX
admet-2057	505	66	related	relate	VERB
admet-2057	505	67	to	to	ADP
admet-2057	505	68	the	the	DET
admet-2057	505	69	gelatin	gelatin	NOUN
admet-2057	505	70	polymer	polymer	NOUN
admet-2057	505	71	's	's	PART
admet-2057	505	72	ph	ph	NOUN
admet-2057	505	73	sensitivity	sensitivity	NOUN
admet-2057	505	74	and	and	CCONJ
admet-2057	505	75	the	the	DET
admet-2057	505	76	polymeric	polymeric	ADJ
admet-2057	505	77	network	network	NOUN
admet-2057	505	78	's	's	PART
admet-2057	505	79	diffusion	diffusion	NOUN
admet-2057	505	80	barrier	barrier	NOUN
admet-2057	505	81	.	.	PUNCT
admet-2057	506	1	a	a	DET
admet-2057	506	2	greater	great	ADJ
admet-2057	506	3	defense	defense	NOUN
admet-2057	506	4	against	against	ADP
admet-2057	506	5	drug	drug	NOUN
admet-2057	506	6	release	release	NOUN
admet-2057	506	7	at	at	ADP
admet-2057	506	8	low	low	ADJ
admet-2057	506	9	ph	ph	NOUN
admet-2057	506	10	and	and	CCONJ
admet-2057	506	11	a	a	DET
admet-2057	506	12	controlled	control	VERB
admet-2057	506	13	release	release	NOUN
admet-2057	506	14	in	in	ADP
admet-2057	506	15	alkaline	alkaline	NOUN
admet-2057	506	16	conditions	condition	NOUN
admet-2057	506	17	are	be	AUX
admet-2057	506	18	demonstrated	demonstrate	VERB
admet-2057	506	19	by	by	ADP
admet-2057	506	20	primary	primary	ADJ
admet-2057	506	21	drug	drug	NOUN
admet-2057	506	22	release	release	NOUN
admet-2057	506	23	tests	test	NOUN
admet-2057	506	24	of	of	ADP
admet-2057	506	25	ibu	ibu	PROPN
admet-2057	506	26	liberation	liberation	NOUN
admet-2057	506	27	from	from	ADP
admet-2057	506	28	the	the	DET
admet-2057	506	29	cu	cu	PROPN
admet-2057	506	30	-	-	PUNCT
admet-2057	506	31	mof	mof	VERB
admet-2057	506	32	/	/	SYM
admet-2057	506	33	ibu@gm	ibu@gm	ADJ
admet-2057	506	34	processes	process	NOUN
admet-2057	506	35	.	.	PUNCT
admet-2057	507	1	the	the	DET
admet-2057	507	2	results	result	NOUN
admet-2057	507	3	summarize	summarize	VERB
admet-2057	507	4	that	that	SCONJ
admet-2057	507	5	the	the	DET
admet-2057	507	6	system	system	NOUN
admet-2057	507	7	can	can	AUX
admet-2057	507	8	be	be	AUX
admet-2057	507	9	effectively	effectively	ADV
admet-2057	507	10	used	use	VERB
admet-2057	507	11	for	for	ADP
admet-2057	507	12	oral	oral	ADJ
admet-2057	507	13	delivery	delivery	NOUN
admet-2057	507	14	.	.	PUNCT
admet-2057	508	1	on	on	ADP
admet-2057	508	2	the	the	DET
admet-2057	508	3	other	other	ADJ
admet-2057	508	4	hand	hand	NOUN
admet-2057	508	5	,	,	PUNCT
admet-2057	508	6	although	although	SCONJ
admet-2057	508	7	oral	oral	ADJ
admet-2057	508	8	peptide	peptide	NOUN
admet-2057	508	9	or	or	CCONJ
admet-2057	508	10	protein	protein	NOUN
admet-2057	508	11	delivery	delivery	NOUN
admet-2057	508	12	is	be	AUX
admet-2057	508	13	regarded	regard	VERB
admet-2057	508	14	as	as	ADP
admet-2057	508	15	a	a	DET
admet-2057	508	16	ground	ground	NOUN
admet-2057	508	17	-	-	PUNCT
admet-2057	508	18	breaking	break	VERB
admet-2057	508	19	substitute	substitute	NOUN
admet-2057	508	20	for	for	ADP
admet-2057	508	21	daily	daily	ADJ
admet-2057	508	22	subcutaneous	subcutaneous	ADJ
admet-2057	508	23	injections	injection	NOUN
admet-2057	508	24	,	,	PUNCT
admet-2057	508	25	significant	significant	ADJ
admet-2057	508	26	obstacles	obstacle	NOUN
admet-2057	508	27	still	still	ADV
admet-2057	508	28	exist	exist	VERB
admet-2057	508	29	in	in	ADP
admet-2057	508	30	the	the	DET
admet-2057	508	31	stomach	stomach	NOUN
admet-2057	508	32	environment	environment	NOUN
admet-2057	508	33	and	and	CCONJ
admet-2057	508	34	the	the	DET
admet-2057	508	35	intestinal	intestinal	ADJ
admet-2057	508	36	epithelium	epithelium	NOUN
admet-2057	508	37	,	,	PUNCT
admet-2057	508	38	which	which	PRON
admet-2057	508	39	is	be	AUX
admet-2057	508	40	obstructed	obstruct	VERB
admet-2057	508	41	by	by	ADP
admet-2057	508	42	mucus	mucus	NOUN
admet-2057	508	43	and	and	CCONJ
admet-2057	508	44	the	the	DET
admet-2057	508	45	epithelial	epithelial	ADJ
admet-2057	508	46	cell	cell	NOUN
admet-2057	508	47	layer	layer	NOUN
admet-2057	508	48	and	and	CCONJ
admet-2057	508	49	results	result	NOUN
admet-2057	508	50	in	in	ADP
admet-2057	508	51	low	low	ADJ
admet-2057	508	52	bioavailability	bioavailability	NOUN
admet-2057	508	53	.	.	PUNCT
admet-2057	509	1	yuhao	yuhao	PROPN
admet-2057	509	2	zhou	zhou	PROPN
admet-2057	509	3	and	and	CCONJ
admet-2057	509	4	team	team	NOUN
admet-2057	510	1	[	[	X
admet-2057	510	2	104	104	X
admet-2057	510	3	]	]	PUNCT
admet-2057	510	4	created	create	VERB
admet-2057	510	5	a	a	DET
admet-2057	510	6	ph	ph	VERB
admet-2057	510	7	-	-	PUNCT
admet-2057	510	8	triggered	trigger	VERB
admet-2057	510	9	self	self	NOUN
admet-2057	510	10	-	-	PUNCT
admet-2057	510	11	unpacking	unpack	VERB
admet-2057	510	12	capsule	capsule	NOUN
admet-2057	510	13	containing	contain	VERB
admet-2057	510	14	zwitterionic	zwitterionic	ADJ
admet-2057	510	15	hydrogel	hydrogel	NOUN
admet-2057	510	16	-	-	PUNCT
admet-2057	510	17	mof	mof	VERB
admet-2057	510	18	nps	nps	PROPN
admet-2057	510	19	to	to	PART
admet-2057	510	20	prevent	prevent	VERB
admet-2057	510	21	gastrointestinal	gastrointestinal	ADJ
admet-2057	510	22	degradation	degradation	NOUN
admet-2057	510	23	and	and	CCONJ
admet-2057	510	24	encourage	encourage	VERB
admet-2057	510	25	penetration	penetration	NOUN
admet-2057	510	26	across	across	ADP
admet-2057	510	27	the	the	DET
admet-2057	510	28	intestinal	intestinal	ADJ
admet-2057	510	29	mucosa	mucosa	NOUN
admet-2057	510	30	.	.	PUNCT
admet-2057	511	1	the	the	DET
admet-2057	511	2	zwitterionic	zwitterionic	ADJ
admet-2057	511	3	hydrogel	hydrogel	NOUN
admet-2057	511	4	layer	layer	NOUN
admet-2057	511	5	gives	give	VERB
admet-2057	511	6	the	the	DET
admet-2057	511	7	nano	nano	NOUN
admet-2057	511	8	-	-	NOUN
admet-2057	511	9	vehicles	vehicle	NOUN
admet-2057	511	10	a	a	DET
admet-2057	511	11	special	special	ADJ
admet-2057	511	12	ability	ability	NOUN
admet-2057	511	13	to	to	PART
admet-2057	511	14	penetrate	penetrate	VERB
admet-2057	511	15	past	past	ADP
admet-2057	511	16	the	the	DET
admet-2057	511	17	mucus	mucus	NOUN
admet-2057	511	18	layer	layer	NOUN
admet-2057	511	19	and	and	CCONJ
admet-2057	511	20	effective	effective	ADJ
admet-2057	511	21	internalization	internalization	NOUN
admet-2057	511	22	by	by	ADP
admet-2057	511	23	epithelial	epithelial	ADJ
admet-2057	511	24	cells	cell	NOUN
admet-2057	511	25	.	.	PUNCT
admet-2057	512	1	the	the	DET
admet-2057	512	2	mof	mof	ADJ
admet-2057	512	3	nanoparticles	nanoparticle	NOUN
admet-2057	512	4	have	have	VERB
admet-2057	512	5	a	a	DET
admet-2057	512	6	high	high	ADJ
admet-2057	512	7	exendin-4	exendin-4	NUM
admet-2057	512	8	loading	loading	NOUN
admet-2057	512	9	capacity	capacity	NOUN
admet-2057	512	10	.	.	PUNCT
admet-2057	513	1	along	along	ADP
admet-2057	513	2	with	with	ADP
admet-2057	513	3	their	their	PRON
admet-2057	513	4	gastro	gastro	NOUN
admet-2057	513	5	-	-	PUNCT
admet-2057	513	6	resistance	resistance	NOUN
admet-2057	513	7	,	,	PUNCT
admet-2057	513	8	ph	ph	ADJ
admet-2057	513	9	-	-	ADJ
admet-2057	513	10	responsive	responsive	ADJ
admet-2057	513	11	capsules	capsule	NOUN
admet-2057	513	12	also	also	ADV
admet-2057	513	13	drastically	drastically	ADV
admet-2057	513	14	dissociate	dissociate	VERB
admet-2057	513	15	in	in	ADP
admet-2057	513	16	the	the	DET
admet-2057	513	17	intestinal	intestinal	ADJ
admet-2057	513	18	environment	environment	NOUN
admet-2057	513	19	due	due	ADP
admet-2057	513	20	to	to	ADP
admet-2057	513	21	the	the	DET
admet-2057	513	22	quick	quick	ADJ
admet-2057	513	23	formation	formation	NOUN
admet-2057	513	24	of	of	ADP
admet-2057	513	25	numerous	numerous	ADJ
admet-2057	513	26	co2	co2	NOUN
admet-2057	513	27	bubbles	bubble	NOUN
admet-2057	513	28	,	,	PUNCT
admet-2057	513	29	which	which	PRON
admet-2057	513	30	leads	lead	VERB
admet-2057	513	31	to	to	ADP
admet-2057	513	32	the	the	DET
admet-2057	513	33	abrupt	abrupt	ADJ
admet-2057	513	34	release	release	NOUN
admet-2057	513	35	of	of	ADP
admet-2057	513	36	the	the	DET
admet-2057	513	37	nanoparticles	nanoparticle	NOUN
admet-2057	513	38	.	.	PUNCT
admet-2057	514	1	in	in	ADP
admet-2057	514	2	a	a	DET
admet-2057	514	3	diabetes	diabetes	NOUN
admet-2057	514	4	rat	rat	NOUN
admet-2057	514	5	model	model	NOUN
admet-2057	514	6	,	,	PUNCT
admet-2057	514	7	orally	orally	ADV
admet-2057	514	8	administering	administer	VERB
admet-2057	514	9	the	the	DET
admet-2057	514	10	capsules	capsule	NOUN
admet-2057	514	11	containing	contain	VERB
admet-2057	514	12	exendin-4	exendin-4	ADV
admet-2057	514	13	-	-	PUNCT
admet-2057	514	14	loaded	load	VERB
admet-2057	514	15	nanoparticles	nanoparticle	NOUN
admet-2057	514	16	results	result	VERB
admet-2057	514	17	in	in	ADP
admet-2057	514	18	markedly	markedly	ADV
admet-2057	514	19	elevated	elevate	VERB
admet-2057	514	20	plasma	plasma	NOUN
admet-2057	514	21	exendin-4	exendin-4	NUM
admet-2057	514	22	levels	level	NOUN
admet-2057	514	23	for	for	ADP
admet-2057	514	24	over	over	ADP
admet-2057	514	25	8	8	NUM
admet-2057	514	26	hours	hour	NOUN
admet-2057	514	27	,	,	PUNCT
admet-2057	514	28	which	which	PRON
admet-2057	514	29	triggers	trigger	VERB
admet-2057	514	30	noticeably	noticeably	ADV
admet-2057	514	31	boosted	boost	VERB
admet-2057	514	32	endogenous	endogenous	ADJ
admet-2057	514	33	insulin	insulin	NOUN
admet-2057	514	34	release	release	NOUN
admet-2057	514	35	and	and	CCONJ
admet-2057	514	36	an	an	DET
admet-2057	514	37	outstanding	outstanding	ADJ
admet-2057	514	38	hypoglycemic	hypoglycemic	ADJ
admet-2057	514	39	effect	effect	NOUN
admet-2057	514	40	with	with	ADP
admet-2057	514	41	a	a	DET
admet-2057	514	42	relative	relative	ADJ
admet-2057	514	43	pharmacological	pharmacological	ADJ
admet-2057	514	44	availability	availability	NOUN
admet-2057	514	45	of	of	ADP
admet-2057	514	46	17.3	17.3	NUM
admet-2057	514	47	%	%	NOUN
admet-2057	514	48	.	.	PUNCT
admet-2057	515	1	this	this	DET
admet-2057	515	2	oral	oral	ADJ
admet-2057	515	3	exendin-4	exendin-4	NUM
admet-2057	515	4	method	method	NOUN
admet-2057	515	5	will	will	AUX
admet-2057	515	6	offer	offer	VERB
admet-2057	515	7	significant	significant	ADJ
admet-2057	515	8	potential	potential	NOUN
admet-2057	515	9	for	for	ADP
admet-2057	515	10	everyday	everyday	ADJ
admet-2057	515	11	and	and	CCONJ
admet-2057	515	12	simple	simple	ADJ
admet-2057	515	13	diabetic	diabetic	ADJ
admet-2057	515	14	therapy	therapy	NOUN
admet-2057	515	15	due	due	ADP
admet-2057	515	16	to	to	ADP
admet-2057	515	17	the	the	DET
admet-2057	515	18	reduced	reduce	VERB
admet-2057	515	19	risk	risk	NOUN
admet-2057	515	20	of	of	ADP
admet-2057	515	21	hypoglycemia	hypoglycemia	NOUN
admet-2057	515	22	.	.	PUNCT
admet-2057	516	1	in	in	ADP
admet-2057	516	2	2022	2022	NUM
admet-2057	516	3	,	,	PUNCT
admet-2057	516	4	meng	meng	PROPN
admet-2057	516	5	gao	gao	PROPN
admet-2057	516	6	and	and	CCONJ
admet-2057	516	7	coworkers	coworker	NOUN
admet-2057	516	8	[	[	X
admet-2057	516	9	105	105	NUM
admet-2057	516	10	]	]	PUNCT
admet-2057	516	11	developed	develop	VERB
admet-2057	516	12	a	a	DET
admet-2057	516	13	hybrid	hybrid	ADJ
admet-2057	516	14	hydrogel	hydrogel	NOUN
admet-2057	516	15	-	-	PUNCT
admet-2057	516	16	mof	mof	VERB
admet-2057	516	17	system	system	NOUN
admet-2057	516	18	for	for	ADP
admet-2057	516	19	the	the	DET
admet-2057	516	20	oral	oral	ADJ
admet-2057	516	21	delivery	delivery	NOUN
admet-2057	516	22	of	of	ADP
admet-2057	516	23	sirna	sirna	PROPN
admet-2057	516	24	for	for	ADP
admet-2057	516	25	the	the	DET
admet-2057	516	26	management	management	NOUN
admet-2057	516	27	of	of	ADP
admet-2057	516	28	ulcerative	ulcerative	ADJ
admet-2057	516	29	colitis	colitis	NOUN
admet-2057	516	30	.	.	PUNCT
admet-2057	517	1	small	small	ADJ
admet-2057	517	2	interfering	interfere	VERB
admet-2057	517	3	rnas	rna	NOUN
admet-2057	517	4	can	can	AUX
admet-2057	517	5	be	be	AUX
admet-2057	517	6	effective	effective	ADJ
admet-2057	517	7	means	mean	NOUN
admet-2057	517	8	of	of	ADP
admet-2057	517	9	treatment	treatment	NOUN
admet-2057	517	10	for	for	ADP
admet-2057	517	11	various	various	ADJ
admet-2057	517	12	inflammationrelated	inflammationrelated	ADJ
admet-2057	517	13	disorders	disorder	NOUN
admet-2057	517	14	.	.	PUNCT
admet-2057	518	1	even	even	ADV
admet-2057	518	2	though	though	SCONJ
admet-2057	518	3	the	the	DET
admet-2057	518	4	gastric	gastric	ADJ
admet-2057	518	5	degradation	degradation	NOUN
admet-2057	518	6	of	of	ADP
admet-2057	518	7	sirna	sirna	PROPN
admet-2057	518	8	limits	limit	VERB
admet-2057	518	9	its	its	PRON
admet-2057	518	10	use	use	NOUN
admet-2057	518	11	in	in	ADP
admet-2057	518	12	cases	case	NOUN
admet-2057	518	13	of	of	ADP
admet-2057	518	14	ulcerative	ulcerative	ADJ
admet-2057	518	15	colitis	colitis	NOUN
admet-2057	518	16	.	.	PUNCT
admet-2057	519	1	to	to	PART
admet-2057	519	2	overcome	overcome	VERB
admet-2057	519	3	this	this	PRON
admet-2057	519	4	,	,	PUNCT
admet-2057	519	5	the	the	DET
admet-2057	519	6	research	research	NOUN
admet-2057	519	7	team	team	NOUN
admet-2057	519	8	has	have	AUX
admet-2057	519	9	attempted	attempt	VERB
admet-2057	519	10	to	to	PART
admet-2057	519	11	load	load	VERB
admet-2057	519	12	sirna	sirna	PROPN
admet-2057	519	13	in	in	ADP
admet-2057	519	14	mof	mof	NUM
admet-2057	519	15	followed	follow	VERB
admet-2057	519	16	by	by	ADP
admet-2057	519	17	sodium	sodium	NOUN
admet-2057	519	18	alginate	alginate	NOUN
admet-2057	519	19	encapsulation	encapsulation	NOUN
admet-2057	519	20	(	(	PUNCT
admet-2057	519	21	sa@mof	sa@mof	NOUN
admet-2057	519	22	-	-	PUNCT
admet-2057	519	23	sirnatnfα	sirnatnfα	NOUN
admet-2057	519	24	)	)	PUNCT
admet-2057	519	25	to	to	PART
admet-2057	519	26	promote	promote	VERB
admet-2057	519	27	oral	oral	ADJ
admet-2057	519	28	absorption	absorption	NOUN
admet-2057	519	29	and	and	CCONJ
admet-2057	519	30	stability	stability	NOUN
admet-2057	519	31	.	.	PUNCT
admet-2057	520	1	these	these	DET
admet-2057	520	2	hybrid	hybrid	NOUN
admet-2057	520	3	platforms	platform	NOUN
admet-2057	520	4	not	not	PART
admet-2057	520	5	only	only	ADV
admet-2057	520	6	withstand	withstand	VERB
admet-2057	520	7	low	low	ADJ
admet-2057	520	8	gastric	gastric	ADJ
admet-2057	520	9	and	and	CCONJ
admet-2057	520	10	intestinal	intestinal	ADJ
admet-2057	520	11	ph	ph	NOUN
admet-2057	520	12	but	but	CCONJ
admet-2057	520	13	also	also	ADV
admet-2057	520	14	show	show	VERB
admet-2057	520	15	improved	improved	ADJ
admet-2057	520	16	intake	intake	NOUN
admet-2057	520	17	by	by	ADP
admet-2057	520	18	the	the	DET
admet-2057	520	19	inflammatory	inflammatory	ADJ
admet-2057	520	20	macrophages	macrophage	NOUN
admet-2057	520	21	,	,	PUNCT
admet-2057	520	22	resulting	result	VERB
admet-2057	520	23	in	in	ADP
admet-2057	520	24	a	a	DET
admet-2057	520	25	better	well	ADJ
admet-2057	520	26	release	release	NOUN
admet-2057	520	27	of	of	ADP
admet-2057	520	28	sa@mof	sa@mof	NOUN
admet-2057	520	29	-	-	PUNCT
admet-2057	520	30	sirnatnfα	sirnatnfα	NOUN
admet-2057	520	31	.	.	PUNCT
admet-2057	521	1	this	this	DET
admet-2057	521	2	results	result	VERB
admet-2057	521	3	in	in	ADP
admet-2057	521	4	better	well	ADJ
admet-2057	521	5	delivery	delivery	NOUN
admet-2057	521	6	of	of	ADP
admet-2057	521	7	sa@mof	sa@mof	NOUN
admet-2057	521	8	-	-	PUNCT
admet-2057	521	9	sirnatnfα	sirnatnfα	NOUN
admet-2057	521	10	into	into	ADP
admet-2057	521	11	local	local	ADJ
admet-2057	521	12	colon	colon	NOUN
admet-2057	521	13	tissues	tissue	NOUN
admet-2057	521	14	and	and	CCONJ
admet-2057	521	15	reduces	reduce	VERB
admet-2057	521	16	the	the	DET
admet-2057	521	17	progression	progression	NOUN
admet-2057	521	18	of	of	ADP
admet-2057	521	19	colitis	colitis	NOUN
admet-2057	521	20	,	,	PUNCT
admet-2057	521	21	which	which	PRON
admet-2057	521	22	was	be	AUX
admet-2057	521	23	confirmed	confirm	VERB
admet-2057	521	24	by	by	ADP
admet-2057	521	25	the	the	DET
admet-2057	521	26	in	in	ADP
admet-2057	521	27	vivo	vivo	ADJ
admet-2057	521	28	mice	mice	NOUN
admet-2057	521	29	model	model	NOUN
admet-2057	521	30	and	and	CCONJ
admet-2057	521	31	treated	treat	VERB
admet-2057	521	32	mice	mouse	NOUN
admet-2057	521	33	do	do	AUX
admet-2057	521	34	not	not	PART
admet-2057	521	35	exhibit	exhibit	VERB
admet-2057	521	36	any	any	DET
admet-2057	521	37	signs	sign	NOUN
admet-2057	521	38	of	of	ADP
admet-2057	521	39	weight	weight	NOUN
admet-2057	521	40	loss	loss	NOUN
admet-2057	521	41	,	,	PUNCT
admet-2057	521	42	diarrhea	diarrhea	NOUN
admet-2057	521	43	or	or	CCONJ
admet-2057	521	44	bloody	bloody	ADJ
admet-2057	521	45	stools	stool	NOUN
admet-2057	521	46	.	.	PUNCT
admet-2057	522	1	a	a	DET
admet-2057	522	2	conclusive	conclusive	ADJ
admet-2057	522	3	study	study	NOUN
admet-2057	522	4	has	have	AUX
admet-2057	522	5	long	long	ADV
admet-2057	522	6	-	-	PUNCT
admet-2057	522	7	established	establish	VERB
admet-2057	522	8	that	that	SCONJ
admet-2057	522	9	designing	design	VERB
admet-2057	522	10	hydrogel	hydrogel	NOUN
admet-2057	522	11	-	-	PUNCT
admet-2057	522	12	mofs	mof	NOUN
admet-2057	522	13	hybrids	hybrid	NOUN
admet-2057	522	14	can	can	AUX
admet-2057	522	15	act	act	VERB
admet-2057	522	16	as	as	ADP
admet-2057	522	17	an	an	DET
admet-2057	522	18	effective	effective	ADJ
admet-2057	522	19	means	mean	NOUN
admet-2057	522	20	of	of	ADP
admet-2057	522	21	delivery	delivery	NOUN
admet-2057	522	22	of	of	ADP
admet-2057	522	23	therapeutics	therapeutic	NOUN
admet-2057	522	24	that	that	PRON
admet-2057	522	25	tend	tend	VERB
admet-2057	522	26	to	to	PART
admet-2057	522	27	degrade	degrade	VERB
admet-2057	522	28	in	in	ADP
admet-2057	522	29	gastric	gastric	ADJ
admet-2057	522	30	media	medium	NOUN
admet-2057	522	31	and	and	CCONJ
admet-2057	522	32	can	can	AUX
admet-2057	522	33	be	be	AUX
admet-2057	522	34	a	a	DET
admet-2057	522	35	potential	potential	ADJ
admet-2057	522	36	means	mean	NOUN
admet-2057	522	37	of	of	ADP
admet-2057	522	38	the	the	DET
admet-2057	522	39	oral	oral	ADJ
admet-2057	522	40	delivery	delivery	NOUN
admet-2057	522	41	system	system	NOUN
admet-2057	522	42	for	for	ADP
admet-2057	522	43	the	the	DET
admet-2057	522	44	delivery	delivery	NOUN
admet-2057	522	45	of	of	ADP
admet-2057	522	46	sirna	sirna	PROPN
admet-2057	522	47	in	in	ADP
admet-2057	522	48	ulcerative	ulcerative	ADJ
admet-2057	522	49	colitis	colitis	NOUN
admet-2057	522	50	.	.	PUNCT
admet-2057	523	1	as	as	ADP
admet-2057	523	2	in	in	ADP
admet-2057	523	3	another	another	DET
admet-2057	523	4	case	case	NOUN
admet-2057	523	5	,	,	PUNCT
admet-2057	523	6	colon	colon	NOUN
admet-2057	523	7	cancer	cancer	NOUN
admet-2057	523	8	is	be	AUX
admet-2057	523	9	the	the	DET
admet-2057	523	10	fourth	fourth	ADJ
admet-2057	523	11	most	most	ADV
admet-2057	523	12	prevalent	prevalent	ADJ
admet-2057	523	13	type	type	NOUN
admet-2057	523	14	of	of	ADP
admet-2057	523	15	cancer	cancer	NOUN
admet-2057	523	16	overall	overall	NOUN
admet-2057	523	17	.	.	PUNCT
admet-2057	524	1	designing	design	VERB
admet-2057	524	2	effective	effective	ADJ
admet-2057	524	3	oral	oral	ADJ
admet-2057	524	4	delivery	delivery	NOUN
admet-2057	524	5	systems	system	NOUN
admet-2057	524	6	received	receive	VERB
admet-2057	524	7	increasing	increase	VERB
admet-2057	524	8	focus	focus	NOUN
admet-2057	524	9	in	in	ADP
admet-2057	524	10	the	the	DET
admet-2057	524	11	development	development	NOUN
admet-2057	524	12	of	of	ADP
admet-2057	524	13	novel	novel	ADJ
admet-2057	524	14	controlled	control	VERB
admet-2057	524	15	-	-	PUNCT
admet-2057	524	16	release	release	NOUN
admet-2057	524	17	approaches	approach	NOUN
admet-2057	524	18	.	.	PUNCT
admet-2057	525	1	to	to	PART
admet-2057	525	2	do	do	VERB
admet-2057	525	3	this	this	PRON
admet-2057	525	4	,	,	PUNCT
admet-2057	525	5	siamak	siamak	PROPN
admet-2057	525	6	javanbakht	javanbakht	NOUN
admet-2057	525	7	et	et	PROPN
admet-2057	525	8	al	al	PROPN
admet-2057	525	9	.	.	PUNCT
admet-2057	526	1	[	[	X
admet-2057	526	2	106	106	NUM
admet-2057	526	3	]	]	PUNCT
admet-2057	526	4	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	526	5	p.	p.	NOUN
admet-2057	526	6	mhettar	mhettar	NOUN
admet-2057	526	7	et	et	PROPN
admet-2057	526	8	al	al	PROPN
admet-2057	526	9	.	.	PROPN
admet-2057	526	10	admet	admet	PROPN
admet-2057	526	11	&	&	CCONJ
admet-2057	526	12	dmpk	dmpk	PROPN
admet-2057	526	13	12(1	12(1	PROPN
admet-2057	526	14	)	)	PUNCT
admet-2057	526	15	(	(	PUNCT
admet-2057	526	16	2024	2024	NUM
admet-2057	526	17	)	)	PUNCT
admet-2057	526	18	27	27	NUM
admet-2057	526	19	-	-	SYM
admet-2057	526	20	62	62	NUM
admet-2057	526	21	46	46	NUM
admet-2057	526	22	encapsulated	encapsulate	VERB
admet-2057	526	23	5	5	NUM
admet-2057	526	24	-	-	PUNCT
admet-2057	526	25	fu	fu	NOUN
admet-2057	526	26	within	within	ADP
admet-2057	526	27	the	the	DET
admet-2057	526	28	porous	porous	ADJ
admet-2057	526	29	mof-5	mof-5	PUNCT
admet-2057	526	30	made	make	VERB
admet-2057	526	31	of	of	ADP
admet-2057	526	32	zn	zn	PROPN
admet-2057	526	33	.	.	PUNCT
admet-2057	527	1	the	the	DET
admet-2057	527	2	5	5	NUM
admet-2057	527	3	-	-	PUNCT
admet-2057	527	4	fu	fu	NOUN
admet-2057	527	5	encapsulated	encapsulate	VERB
admet-2057	527	6	mof-5	mof-5	PUNCT
admet-2057	527	7	nano	nano	NOUN
admet-2057	527	8	-	-	PUNCT
admet-2057	527	9	hybrid	hybrid	NOUN
admet-2057	527	10	(	(	PUNCT
admet-2057	527	11	5fu@mof-5	5fu@mof-5	NUM
admet-2057	527	12	)	)	PUNCT
admet-2057	527	13	was	be	AUX
admet-2057	527	14	protected	protect	VERB
admet-2057	527	15	and	and	CCONJ
admet-2057	527	16	transported	transport	VERB
admet-2057	527	17	through	through	ADP
admet-2057	527	18	the	the	DET
admet-2057	527	19	digestive	digestive	ADJ
admet-2057	527	20	system	system	NOUN
admet-2057	527	21	using	use	VERB
admet-2057	527	22	a	a	DET
admet-2057	527	23	ph	ph	ADJ
admet-2057	527	24	-	-	ADJ
admet-2057	527	25	sensitive	sensitive	ADJ
admet-2057	527	26	carboxymethylcellulose	carboxymethylcellulose	PROPN
admet-2057	527	27	(	(	PUNCT
admet-2057	527	28	cmc	cmc	PROPN
admet-2057	527	29	)	)	PUNCT
admet-2057	527	30	biopolymer	biopolymer	NOUN
admet-2057	527	31	.	.	PUNCT
admet-2057	528	1	different	different	ADJ
admet-2057	528	2	methods	method	NOUN
admet-2057	528	3	were	be	AUX
admet-2057	528	4	used	use	VERB
admet-2057	528	5	to	to	PART
admet-2057	528	6	characterize	characterize	VERB
admet-2057	528	7	the	the	DET
admet-2057	528	8	cmc	cmc	NOUN
admet-2057	528	9	-	-	PUNCT
admet-2057	528	10	coated	coat	VERB
admet-2057	528	11	5fu@mof-5	5fu@mof-5	NUM
admet-2057	528	12	bio	bio	ADJ
admet-2057	528	13	-	-	ADJ
admet-2057	528	14	nanocomposite	nanocomposite	ADJ
admet-2057	528	15	hydrogel	hydrogel	NOUN
admet-2057	528	16	bead	bead	NOUN
admet-2057	528	17	(	(	PUNCT
admet-2057	528	18	cmc/5	cmc/5	NOUN
admet-2057	528	19	-	-	PUNCT
admet-2057	528	20	fu@mof-5	fu@mof-5	NOUN
admet-2057	528	21	)	)	PUNCT
admet-2057	528	22	.	.	PUNCT
admet-2057	529	1	ftir	ftir	PROPN
admet-2057	529	2	studies	study	NOUN
admet-2057	529	3	proved	prove	VERB
admet-2057	529	4	that	that	SCONJ
admet-2057	529	5	the	the	DET
admet-2057	529	6	ft	ft	PROPN
admet-2057	529	7	-	-	PUNCT
admet-2057	529	8	ir	ir	NOUN
admet-2057	529	9	spectrum	spectrum	NOUN
admet-2057	529	10	of	of	ADP
admet-2057	529	11	5	5	NUM
admet-2057	529	12	-	-	PUNCT
admet-2057	529	13	fu@mof-5	fu@mof-5	PROPN
admet-2057	529	14	is	be	AUX
admet-2057	529	15	a	a	DET
admet-2057	529	16	mixture	mixture	NOUN
admet-2057	529	17	of	of	ADP
admet-2057	529	18	the	the	DET
admet-2057	529	19	ft	ft	PROPN
admet-2057	529	20	-	-	PUNCT
admet-2057	529	21	ir	ir	NOUN
admet-2057	529	22	spectrum	spectrum	NOUN
admet-2057	529	23	of	of	ADP
admet-2057	529	24	mof-5	mof-5	PUNCT
admet-2057	529	25	and	and	CCONJ
admet-2057	529	26	5	5	NUM
admet-2057	529	27	-	-	PUNCT
admet-2057	529	28	fu	fu	NOUN
admet-2057	529	29	and	and	CCONJ
admet-2057	529	30	has	have	VERB
admet-2057	529	31	the	the	DET
admet-2057	529	32	characteristic	characteristic	ADJ
admet-2057	529	33	bands	band	NOUN
admet-2057	529	34	associated	associate	VERB
admet-2057	529	35	with	with	ADP
admet-2057	529	36	the	the	DET
admet-2057	529	37	mof-5	mof-5	ADV
admet-2057	529	38	and	and	CCONJ
admet-2057	529	39	5	5	NUM
admet-2057	529	40	-	-	PUNCT
admet-2057	529	41	fu	fu	NOUN
admet-2057	529	42	.	.	PUNCT
admet-2057	530	1	it	it	PRON
admet-2057	530	2	was	be	AUX
admet-2057	530	3	discovered	discover	VERB
admet-2057	530	4	that	that	SCONJ
admet-2057	530	5	there	there	PRON
admet-2057	530	6	was	be	VERB
admet-2057	530	7	a	a	DET
admet-2057	530	8	rise	rise	NOUN
admet-2057	530	9	in	in	ADP
admet-2057	530	10	the	the	DET
admet-2057	530	11	intensity	intensity	NOUN
admet-2057	530	12	of	of	ADP
admet-2057	530	13	a	a	DET
admet-2057	530	14	smaller	small	ADJ
admet-2057	530	15	band	band	NOUN
admet-2057	530	16	in	in	ADP
admet-2057	530	17	the	the	DET
admet-2057	530	18	400	400	NUM
admet-2057	530	19	-	-	SYM
admet-2057	530	20	800	800	NUM
admet-2057	530	21	cm1	cm1	NOUN
admet-2057	530	22	range	range	NOUN
admet-2057	530	23	associated	associate	VERB
admet-2057	530	24	with	with	ADP
admet-2057	530	25	the	the	DET
admet-2057	530	26	fe	fe	PROPN
admet-2057	530	27	-	-	PROPN
admet-2057	530	28	o	o	NOUN
admet-2057	530	29	band	band	NOUN
admet-2057	530	30	by	by	ADP
admet-2057	530	31	comparing	compare	VERB
admet-2057	530	32	the	the	DET
admet-2057	530	33	ft	ft	PROPN
admet-2057	530	34	-	-	PUNCT
admet-2057	530	35	ir	ir	NOUN
admet-2057	530	36	spectra	spectra	NOUN
admet-2057	530	37	of	of	ADP
admet-2057	530	38	pure	pure	ADJ
admet-2057	530	39	cmc	cmc	NOUN
admet-2057	530	40	and	and	CCONJ
admet-2057	530	41	cmc/5	cmc/5	PROPN
admet-2057	530	42	-	-	PUNCT
admet-2057	530	43	fu@mof-5	fu@mof-5	PROPN
admet-2057	530	44	beads	bead	NOUN
admet-2057	530	45	.	.	PUNCT
admet-2057	531	1	additionally	additionally	ADV
admet-2057	531	2	,	,	PUNCT
admet-2057	531	3	after	after	ADP
admet-2057	531	4	the	the	DET
admet-2057	531	5	production	production	NOUN
admet-2057	531	6	of	of	ADP
admet-2057	531	7	the	the	DET
admet-2057	531	8	cmc/5	cmc/5	PROPN
admet-2057	531	9	-	-	PUNCT
admet-2057	531	10	fu@mof-5	fu@mof-5	PROPN
admet-2057	531	11	hydrogel	hydrogel	NOUN
admet-2057	531	12	bead	bead	NOUN
admet-2057	531	13	,	,	PUNCT
admet-2057	531	14	the	the	DET
admet-2057	531	15	distinctive	distinctive	ADJ
admet-2057	531	16	cmc	cmc	NOUN
admet-2057	531	17	bands	band	NOUN
admet-2057	531	18	at	at	ADP
admet-2057	531	19	1322	1322	NUM
admet-2057	531	20	cm1	cm1	NOUN
admet-2057	531	21	were	be	AUX
admet-2057	531	22	reduced	reduce	VERB
admet-2057	531	23	.	.	PUNCT
admet-2057	532	1	the	the	DET
admet-2057	532	2	cmc/5	cmc/5	PROPN
admet-2057	532	3	-	-	PUNCT
admet-2057	532	4	fu@mof-5	fu@mof-5	PROPN
admet-2057	532	5	hydrogel	hydrogel	NOUN
admet-2057	532	6	bead	bead	NOUN
admet-2057	532	7	's	's	PART
admet-2057	532	8	cross	cross	ADJ
admet-2057	532	9	-	-	ADJ
admet-2057	532	10	linked	link	VERB
admet-2057	532	11	cmc	cmc	NOUN
admet-2057	532	12	polymeric	polymeric	ADJ
admet-2057	532	13	chains	chain	NOUN
admet-2057	532	14	with	with	ADP
admet-2057	532	15	fe3	fe3	NOUN
admet-2057	532	16	+	+	NUM
admet-2057	532	17	successfully	successfully	ADV
admet-2057	532	18	,	,	PUNCT
admet-2057	532	19	according	accord	VERB
admet-2057	532	20	to	to	ADP
admet-2057	532	21	the	the	DET
admet-2057	532	22	ft	ft	PROPN
admet-2057	532	23	-	-	PUNCT
admet-2057	532	24	ir	ir	PROPN
admet-2057	532	25	data	datum	NOUN
admet-2057	532	26	.	.	PUNCT
admet-2057	533	1	for	for	ADP
admet-2057	533	2	mof-5	mof-5	ADV
admet-2057	533	3	and	and	CCONJ
admet-2057	533	4	5	5	NUM
admet-2057	533	5	-	-	PUNCT
admet-2057	533	6	fu@mof-5	fu@mof-5	PROPN
admet-2057	533	7	,	,	PUNCT
admet-2057	533	8	the	the	DET
admet-2057	533	9	bet	bet	PROPN
admet-2057	533	10	surface	surface	NOUN
admet-2057	533	11	area	area	NOUN
admet-2057	533	12	measurements	measurement	NOUN
admet-2057	533	13	yielded	yield	VERB
admet-2057	533	14	147.8	147.8	NUM
admet-2057	533	15	and	and	CCONJ
admet-2057	533	16	106.4	106.4	NUM
admet-2057	533	17	m2	m2	PROPN
admet-2057	533	18	g-1	g-1	NOUN
admet-2057	533	19	,	,	PUNCT
admet-2057	533	20	respectively	respectively	ADV
admet-2057	533	21	.	.	PUNCT
admet-2057	534	1	the	the	PRON
admet-2057	534	2	mof-5	mof-5	PUNCT
admet-2057	534	3	showed	show	VERB
admet-2057	534	4	an	an	DET
admet-2057	534	5	entrapment	entrapment	ADJ
admet-2057	534	6	efficiency	efficiency	NOUN
admet-2057	534	7	of	of	ADP
admet-2057	534	8	84.1	84.1	NUM
admet-2057	534	9	%	%	NOUN
admet-2057	534	10	.	.	PUNCT
admet-2057	535	1	to	to	PART
admet-2057	535	2	determine	determine	VERB
admet-2057	535	3	the	the	DET
admet-2057	535	4	potential	potential	NOUN
admet-2057	535	5	of	of	ADP
admet-2057	535	6	the	the	DET
admet-2057	535	7	synthesised	synthesise	VERB
admet-2057	535	8	carrier	carrier	NOUN
admet-2057	535	9	as	as	ADP
admet-2057	535	10	an	an	DET
admet-2057	535	11	oral	oral	ADJ
admet-2057	535	12	5	5	NUM
admet-2057	535	13	-	-	PUNCT
admet-2057	535	14	fu	fu	NOUN
admet-2057	535	15	delivery	delivery	NOUN
admet-2057	535	16	method	method	NOUN
admet-2057	535	17	,	,	PUNCT
admet-2057	535	18	drug	drug	NOUN
admet-2057	535	19	release	release	NOUN
admet-2057	535	20	studies	study	NOUN
admet-2057	535	21	were	be	AUX
admet-2057	535	22	conducted	conduct	VERB
admet-2057	535	23	in	in	ADP
admet-2057	535	24	a	a	DET
admet-2057	535	25	simulated	simulated	ADJ
admet-2057	535	26	git	git	NOUN
admet-2057	535	27	.	.	PUNCT
admet-2057	536	1	all	all	DET
admet-2057	536	2	medicines	medicine	NOUN
admet-2057	536	3	were	be	AUX
admet-2057	536	4	released	release	VERB
admet-2057	536	5	from	from	ADP
admet-2057	536	6	the	the	DET
admet-2057	536	7	5fu@mof-5	5fu@mof-5	NUM
admet-2057	536	8	over	over	ADP
admet-2057	536	9	3.5	3.5	NUM
admet-2057	536	10	hours	hour	NOUN
admet-2057	536	11	due	due	ADP
admet-2057	536	12	to	to	ADP
admet-2057	536	13	mof-5	mof-5	PRON
admet-2057	536	14	's	's	PART
admet-2057	536	15	breakdown	breakdown	NOUN
admet-2057	536	16	at	at	ADP
admet-2057	536	17	an	an	DET
admet-2057	536	18	acidic	acidic	ADJ
admet-2057	536	19	ph	ph	NOUN
admet-2057	536	20	[	[	X
admet-2057	536	21	65	65	NUM
admet-2057	536	22	]	]	PUNCT
admet-2057	536	23	.	.	PUNCT
admet-2057	537	1	contrarily	contrarily	ADV
admet-2057	537	2	,	,	PUNCT
admet-2057	537	3	in	in	ADP
admet-2057	537	4	cmc/5fu@mof5	cmc/5fu@mof5	NOUN
admet-2057	537	5	,	,	PUNCT
admet-2057	537	6	the	the	DET
admet-2057	537	7	amount	amount	NOUN
admet-2057	537	8	of	of	ADP
admet-2057	537	9	medication	medication	NOUN
admet-2057	537	10	released	release	VERB
admet-2057	537	11	is	be	AUX
admet-2057	537	12	70	70	NUM
admet-2057	537	13	%	%	NOUN
admet-2057	537	14	at	at	ADP
admet-2057	537	15	8	8	NUM
admet-2057	537	16	hours	hour	NOUN
admet-2057	537	17	in	in	ADP
admet-2057	537	18	a	a	DET
admet-2057	537	19	regulated	regulated	ADJ
admet-2057	537	20	way	way	NOUN
admet-2057	537	21	(	(	PUNCT
admet-2057	537	22	ph	ph	NOUN
admet-2057	537	23	1.2	1.2	NUM
admet-2057	537	24	:	:	PUNCT
admet-2057	537	25	ph	ph	NOUN
admet-2057	537	26	6.8	6.8	NUM
admet-2057	537	27	:	:	PUNCT
admet-2057	537	28	ph	ph	PROPN
admet-2057	537	29	7.4	7.4	NUM
admet-2057	537	30	-	-	SYM
admet-2057	537	31	2:4:1	2:4:1	NUM
admet-2057	537	32	)	)	PUNCT
admet-2057	537	33	,	,	PUNCT
admet-2057	537	34	which	which	PRON
admet-2057	537	35	is	be	AUX
admet-2057	537	36	connected	connect	VERB
admet-2057	537	37	to	to	ADP
admet-2057	537	38	the	the	DET
admet-2057	537	39	ph	ph	ADJ
admet-2057	537	40	-	-	ADJ
admet-2057	537	41	sensitive	sensitive	ADJ
admet-2057	537	42	nature	nature	NOUN
admet-2057	537	43	of	of	ADP
admet-2057	537	44	cmc	cmc	PROPN
admet-2057	537	45	biopolymer	biopolymer	NOUN
admet-2057	537	46	and	and	CCONJ
admet-2057	537	47	the	the	DET
admet-2057	537	48	diffusion	diffusion	NOUN
admet-2057	537	49	barrier	barrier	NOUN
admet-2057	537	50	of	of	ADP
admet-2057	537	51	the	the	DET
admet-2057	537	52	hydrogel	hydrogel	NOUN
admet-2057	537	53	beads	bead	VERB
admet-2057	537	54	.	.	PUNCT
admet-2057	538	1	the	the	DET
admet-2057	538	2	5	5	NUM
admet-2057	538	3	-	-	PUNCT
admet-2057	538	4	fu@mof-5	fu@mof-5	NOUN
admet-2057	538	5	could	could	AUX
admet-2057	538	6	be	be	AUX
admet-2057	538	7	protected	protect	VERB
admet-2057	538	8	from	from	ADP
admet-2057	538	9	potential	potential	ADJ
admet-2057	538	10	degradation	degradation	NOUN
admet-2057	538	11	by	by	ADP
admet-2057	538	12	cmc	cmc	NOUN
admet-2057	538	13	with	with	ADP
admet-2057	538	14	shrinking	shrink	VERB
admet-2057	538	15	at	at	ADP
admet-2057	538	16	acidic	acidic	ADJ
admet-2057	538	17	ph	ph	NOUN
admet-2057	538	18	,	,	PUNCT
admet-2057	538	19	and	and	CCONJ
admet-2057	538	20	cmc	cmc	NOUN
admet-2057	538	21	with	with	ADP
admet-2057	538	22	time	time	NOUN
admet-2057	538	23	-	-	PUNCT
admet-2057	538	24	dependent	dependent	ADJ
admet-2057	538	25	swelling	swelling	NOUN
admet-2057	538	26	at	at	ADP
admet-2057	538	27	ph	ph	PROPN
admet-2057	538	28	6.8	6.8	NUM
admet-2057	538	29	and	and	CCONJ
admet-2057	538	30	7.4	7.4	NUM
admet-2057	538	31	demonstrated	demonstrate	VERB
admet-2057	538	32	sustained	sustained	ADJ
admet-2057	538	33	release	release	NOUN
admet-2057	538	34	of	of	ADP
admet-2057	538	35	5	5	NUM
admet-2057	538	36	-	-	PUNCT
admet-2057	538	37	fu	fu	NOUN
admet-2057	538	38	.	.	PUNCT
admet-2057	539	1	overall	overall	ADV
admet-2057	539	2	,	,	PUNCT
admet-2057	539	3	the	the	DET
admet-2057	539	4	produced	produce	VERB
admet-2057	539	5	bio	bio	NOUN
admet-2057	539	6	-	-	ADJ
admet-2057	539	7	nanocomposite	nanocomposite	ADJ
admet-2057	539	8	hydrogel	hydrogel	NOUN
admet-2057	539	9	beads	bead	NOUN
admet-2057	539	10	could	could	AUX
admet-2057	539	11	be	be	AUX
admet-2057	539	12	suggested	suggest	VERB
admet-2057	539	13	as	as	ADP
admet-2057	539	14	a	a	DET
admet-2057	539	15	possible	possible	ADJ
admet-2057	539	16	drug	drug	NOUN
admet-2057	539	17	delivery	delivery	NOUN
admet-2057	539	18	device	device	NOUN
admet-2057	539	19	for	for	ADP
admet-2057	539	20	the	the	DET
admet-2057	539	21	colonic	colonic	ADJ
admet-2057	539	22	administration	administration	NOUN
admet-2057	539	23	of	of	ADP
admet-2057	539	24	5	5	NUM
admet-2057	539	25	-	-	PUNCT
admet-2057	539	26	fu	fu	NOUN
admet-2057	539	27	in	in	ADP
admet-2057	539	28	light	light	NOUN
admet-2057	539	29	of	of	ADP
admet-2057	539	30	the	the	DET
admet-2057	539	31	results	result	NOUN
admet-2057	539	32	obtained	obtain	VERB
admet-2057	539	33	.	.	PUNCT
admet-2057	540	1	in	in	ADP
admet-2057	540	2	a	a	DET
admet-2057	540	3	different	different	ADJ
admet-2057	540	4	study	study	NOUN
admet-2057	540	5	,	,	PUNCT
admet-2057	540	6	ke	ke	PROPN
admet-2057	540	7	jiang	jiang	PROPN
admet-2057	540	8	and	and	CCONJ
admet-2057	540	9	colleagues	colleague	NOUN
admet-2057	540	10	[	[	X
admet-2057	540	11	107	107	NUM
admet-2057	540	12	]	]	PUNCT
admet-2057	540	13	created	create	VERB
admet-2057	540	14	and	and	CCONJ
admet-2057	540	15	synthesised	synthesise	VERB
admet-2057	540	16	zju-64	zju-64	PROPN
admet-2057	540	17	-	-	NOUN
admet-2057	540	18	nsn	nsn	PROPN
admet-2057	540	19	,	,	PUNCT
admet-2057	540	20	a	a	DET
admet-2057	540	21	novel	novel	ADJ
admet-2057	540	22	anionic	anionic	NOUN
admet-2057	540	23	mof	mof	NOUN
admet-2057	540	24	having	have	VERB
admet-2057	540	25	1d	1d	NUM
admet-2057	540	26	channels	channel	NOUN
admet-2057	540	27	adorned	adorn	VERB
admet-2057	540	28	with	with	ADP
admet-2057	540	29	highly	highly	ADV
admet-2057	540	30	polarized	polarize	VERB
admet-2057	540	31	thiadiazole	thiadiazole	NOUN
admet-2057	540	32	groups	group	NOUN
admet-2057	540	33	.	.	PUNCT
admet-2057	541	1	using	use	VERB
admet-2057	541	2	a	a	DET
admet-2057	541	3	straightforward	straightforward	ADJ
admet-2057	541	4	and	and	CCONJ
admet-2057	541	5	environmentally	environmentally	ADV
admet-2057	541	6	friendly	friendly	ADJ
admet-2057	541	7	method	method	NOUN
admet-2057	541	8	,	,	PUNCT
admet-2057	541	9	this	this	DET
admet-2057	541	10	mof	mof	NOUN
admet-2057	541	11	's	's	PART
admet-2057	541	12	crystal	crystal	NOUN
admet-2057	541	13	size	size	NOUN
admet-2057	541	14	could	could	AUX
admet-2057	541	15	be	be	AUX
admet-2057	541	16	systematically	systematically	ADV
admet-2057	541	17	adjusted	adjust	VERB
admet-2057	541	18	from	from	ADP
admet-2057	541	19	200	200	NUM
admet-2057	541	20	to	to	PART
admet-2057	541	21	300	300	NUM
admet-2057	541	22	nm	nm	NOUN
admet-2057	541	23	.	.	PUNCT
admet-2057	542	1	this	this	PRON
admet-2057	542	2	leads	lead	VERB
admet-2057	542	3	to	to	ADP
admet-2057	542	4	the	the	DET
admet-2057	542	5	discovery	discovery	NOUN
admet-2057	542	6	of	of	ADP
admet-2057	542	7	the	the	DET
admet-2057	542	8	ideal	ideal	ADJ
admet-2057	542	9	nanosized	nanosized	ADJ
admet-2057	542	10	zju64	zju64	PROPN
admet-2057	542	11	-	-	PUNCT
admet-2057	542	12	nsn	nsn	PROPN
admet-2057	542	13	,	,	PUNCT
admet-2057	542	14	which	which	PRON
admet-2057	542	15	enables	enable	VERB
admet-2057	542	16	very	very	ADV
admet-2057	542	17	quick	quick	ADJ
admet-2057	542	18	loading	loading	NOUN
admet-2057	542	19	of	of	ADP
admet-2057	542	20	the	the	DET
admet-2057	542	21	cationic	cationic	ADJ
admet-2057	542	22	api	api	NOUN
admet-2057	542	23	procainamide	procainamide	NOUN
admet-2057	542	24	(	(	PUNCT
admet-2057	542	25	pa	pa	PROPN
admet-2057	542	26	)	)	PUNCT
admet-2057	542	27	(	(	PUNCT
admet-2057	542	28	21.2	21.2	NUM
admet-2057	542	29	wt.%	wt.%	ADJ
admet-2057	542	30	in	in	ADP
admet-2057	542	31	1	1	NUM
admet-2057	542	32	min	min	NOUN
admet-2057	542	33	)	)	PUNCT
admet-2057	542	34	.	.	PUNCT
admet-2057	543	1	moreover	moreover	ADV
admet-2057	543	2	,	,	PUNCT
admet-2057	543	3	the	the	DET
admet-2057	543	4	surface	surface	NOUN
admet-2057	543	5	coating	coating	NOUN
admet-2057	543	6	of	of	ADP
admet-2057	543	7	polyethylene	polyethylene	NOUN
admet-2057	543	8	glycol	glycol	NOUN
admet-2057	543	9	(	(	PUNCT
admet-2057	543	10	peg	peg	NOUN
admet-2057	543	11	)	)	PUNCT
admet-2057	543	12	biopolymer	biopolymer	NOUN
admet-2057	543	13	significantly	significantly	ADV
admet-2057	543	14	increases	increase	VERB
admet-2057	543	15	the	the	DET
admet-2057	543	16	unfavorable	unfavorable	ADJ
admet-2057	543	17	chemical	chemical	NOUN
admet-2057	543	18	stability	stability	NOUN
admet-2057	543	19	of	of	ADP
admet-2057	543	20	pa@zju-64nsn	pa@zju-64nsn	PROPN
admet-2057	543	21	.	.	PUNCT
admet-2057	544	1	due	due	ADP
admet-2057	544	2	to	to	ADP
admet-2057	544	3	the	the	DET
admet-2057	544	4	intensive	intensive	ADJ
admet-2057	544	5	host	host	NOUN
admet-2057	544	6	-	-	PUNCT
admet-2057	544	7	guest	guest	NOUN
admet-2057	544	8	interaction	interaction	NOUN
admet-2057	544	9	,	,	PUNCT
admet-2057	544	10	the	the	DET
admet-2057	544	11	final	final	ADJ
admet-2057	544	12	drug	drug	NOUN
admet-2057	544	13	delivery	delivery	NOUN
admet-2057	544	14	system	system	NOUN
admet-2057	544	15	peg	peg	NOUN
admet-2057	544	16	/	/	SYM
admet-2057	544	17	pa@zju-64	pa@zju-64	PROPN
admet-2057	544	18	-	-	PUNCT
admet-2057	544	19	nsn	nsn	PROPN
admet-2057	544	20	successfully	successfully	ADV
admet-2057	544	21	blocks	block	VERB
admet-2057	544	22	pa	pa	PROPN
admet-2057	544	23	from	from	ADP
admet-2057	544	24	premature	premature	ADJ
admet-2057	544	25	release	release	NOUN
admet-2057	544	26	under	under	ADP
admet-2057	544	27	tough	tough	ADJ
admet-2057	544	28	stomach	stomach	NOUN
admet-2057	544	29	conditions	condition	NOUN
admet-2057	544	30	and	and	CCONJ
admet-2057	544	31	primarily	primarily	ADV
admet-2057	544	32	releases	release	VERB
admet-2057	544	33	pa	pa	PROPN
admet-2057	544	34	to	to	ADP
admet-2057	544	35	the	the	DET
admet-2057	544	36	targeted	target	VERB
admet-2057	544	37	intestinal	intestinal	ADJ
admet-2057	544	38	surroundings	surrounding	NOUN
admet-2057	544	39	.	.	PUNCT
admet-2057	545	1	the	the	DET
admet-2057	545	2	study	study	NOUN
admet-2057	545	3	on	on	ADP
admet-2057	545	4	the	the	DET
admet-2057	545	5	dynamic	dynamic	ADJ
admet-2057	545	6	behaviour	behaviour	NOUN
admet-2057	545	7	of	of	ADP
admet-2057	545	8	drug	drug	NOUN
admet-2057	545	9	release	release	NOUN
admet-2057	545	10	and	and	CCONJ
admet-2057	545	11	uv	uv	NOUN
admet-2057	545	12	-	-	PUNCT
admet-2057	545	13	vis	vis	X
admet-2057	545	14	absorption	absorption	NOUN
admet-2057	545	15	spectrum	spectrum	NOUN
admet-2057	545	16	clearly	clearly	ADV
admet-2057	545	17	demonstrates	demonstrate	VERB
admet-2057	545	18	that	that	SCONJ
admet-2057	545	19	such	such	ADJ
admet-2057	545	20	controlled	control	VERB
admet-2057	545	21	drug	drug	NOUN
admet-2057	545	22	delivery	delivery	NOUN
admet-2057	545	23	is	be	AUX
admet-2057	545	24	caused	cause	VERB
admet-2057	545	25	by	by	ADP
admet-2057	545	26	endogenic	endogenic	ADJ
admet-2057	545	27	na	na	ADP
admet-2057	545	28	ions	ion	NOUN
admet-2057	545	29	rather	rather	ADV
admet-2057	545	30	than	than	ADP
admet-2057	545	31	h	h	NOUN
admet-2057	545	32	ions	ion	NOUN
admet-2057	545	33	.	.	PUNCT
admet-2057	546	1	using	use	VERB
admet-2057	546	2	the	the	DET
admet-2057	546	3	mtt	mtt	NOUN
admet-2057	546	4	assay	assay	NOUN
admet-2057	546	5	and	and	CCONJ
admet-2057	546	6	confocal	confocal	ADJ
admet-2057	546	7	microscope	microscope	NOUN
admet-2057	546	8	imaging	imaging	NOUN
admet-2057	546	9	,	,	PUNCT
admet-2057	546	10	the	the	DET
admet-2057	546	11	good	good	ADJ
admet-2057	546	12	biocompatibility	biocompatibility	NOUN
admet-2057	546	13	of	of	ADP
admet-2057	546	14	zju-64	zju-64	PROPN
admet-2057	546	15	-	-	PROPN
admet-2057	546	16	nsn	nsn	PROPN
admet-2057	546	17	and	and	CCONJ
admet-2057	546	18	peg	peg	NOUN
admet-2057	546	19	-	-	PUNCT
admet-2057	546	20	coated	coat	VERB
admet-2057	546	21	zju-64	zju-64	PROPN
admet-2057	546	22	-	-	PROPN
admet-2057	546	23	nsn	nsn	PROPN
admet-2057	546	24	was	be	AUX
admet-2057	546	25	demonstrated	demonstrate	VERB
admet-2057	546	26	.	.	PUNCT
admet-2057	547	1	in	in	ADP
admet-2057	547	2	a	a	DET
admet-2057	547	3	different	different	ADJ
admet-2057	547	4	study	study	NOUN
admet-2057	547	5	,	,	PUNCT
admet-2057	547	6	jun	jun	PROPN
admet-2057	547	7	-	-	PUNCT
admet-2057	547	8	jie	jie	PROPN
admet-2057	547	9	zou	zou	PROPN
admet-2057	547	10	[	[	X
admet-2057	547	11	108	108	NUM
admet-2057	547	12	]	]	PUNCT
admet-2057	547	13	created	create	VERB
admet-2057	547	14	highly	highly	ADV
admet-2057	547	15	effective	effective	ADJ
admet-2057	547	16	oral	oral	ADJ
admet-2057	547	17	insulin	insulin	NOUN
admet-2057	547	18	administration	administration	NOUN
admet-2057	547	19	using	use	VERB
admet-2057	547	20	acid	acid	NOUN
admet-2057	547	21	-	-	PUNCT
admet-2057	547	22	resistant	resistant	ADJ
admet-2057	547	23	mof	mof	X
admet-2057	547	24	nps	nps	PROPN
admet-2057	547	25	(	(	PUNCT
admet-2057	547	26	uio-68	uio-68	PROPN
admet-2057	547	27	-	-	PUNCT
admet-2057	547	28	nh2	nh2	NOUN
admet-2057	547	29	)	)	PUNCT
admet-2057	547	30	that	that	PRON
admet-2057	547	31	were	be	AUX
admet-2057	547	32	coated	coat	VERB
admet-2057	547	33	with	with	ADP
admet-2057	547	34	targeting	target	VERB
admet-2057	547	35	proteins	protein	NOUN
admet-2057	547	36	(	(	PUNCT
admet-2057	547	37	transferrin	transferrin	NOUN
admet-2057	547	38	)	)	PUNCT
admet-2057	547	39	.	.	PUNCT
admet-2057	548	1	high	high	ADJ
admet-2057	548	2	insulin	insulin	NOUN
admet-2057	548	3	loading	loading	NOUN
admet-2057	548	4	was	be	AUX
admet-2057	548	5	made	make	VERB
admet-2057	548	6	possible	possible	ADJ
admet-2057	548	7	by	by	ADP
admet-2057	548	8	the	the	DET
admet-2057	548	9	uio-68	uio-68	PROPN
admet-2057	548	10	-	-	PUNCT
admet-2057	548	11	nh2	nh2	NOUN
admet-2057	548	12	nanocarrier	nanocarrier	NOUN
admet-2057	548	13	with	with	ADP
admet-2057	548	14	the	the	DET
admet-2057	548	15	right	right	ADJ
admet-2057	548	16	pore	pore	ADJ
admet-2057	548	17	size	size	NOUN
admet-2057	548	18	,	,	PUNCT
admet-2057	548	19	which	which	PRON
admet-2057	548	20	also	also	ADV
admet-2057	548	21	prevented	prevent	VERB
admet-2057	548	22	acid	acid	ADJ
admet-2057	548	23	and	and	CCONJ
admet-2057	548	24	enzymatic	enzymatic	ADJ
admet-2057	548	25	destruction	destruction	NOUN
admet-2057	548	26	of	of	ADP
admet-2057	548	27	the	the	DET
admet-2057	548	28	insulin	insulin	NOUN
admet-2057	548	29	.	.	PUNCT
admet-2057	549	1	the	the	DET
admet-2057	549	2	transferrin	transferrin	NOUN
admet-2057	549	3	-	-	PUNCT
admet-2057	549	4	coated	coat	VERB
admet-2057	549	5	nanoparticles	nanoparticle	NOUN
admet-2057	549	6	achieved	achieve	VERB
admet-2057	549	7	effective	effective	ADJ
admet-2057	549	8	transport	transport	NOUN
admet-2057	549	9	across	across	ADP
admet-2057	549	10	the	the	DET
admet-2057	549	11	intestinal	intestinal	ADJ
admet-2057	549	12	epithelium	epithelium	NOUN
admet-2057	549	13	and	and	CCONJ
admet-2057	549	14	controlled	control	VERB
admet-2057	549	15	insulin	insulin	NOUN
admet-2057	549	16	release	release	NOUN
admet-2057	549	17	under	under	ADP
admet-2057	549	18	physiological	physiological	ADJ
admet-2057	549	19	settings	setting	NOUN
admet-2057	549	20	,	,	PUNCT
admet-2057	549	21	resulting	result	VERB
admet-2057	549	22	in	in	ADP
admet-2057	549	23	a	a	DET
admet-2057	549	24	substantial	substantial	ADJ
admet-2057	549	25	hypoglycemic	hypoglycemic	ADJ
admet-2057	549	26	impact	impact	NOUN
admet-2057	549	27	and	and	CCONJ
admet-2057	549	28	a	a	DET
admet-2057	549	29	high	high	ADJ
admet-2057	549	30	oral	oral	ADJ
admet-2057	549	31	bioavailability	bioavailability	NOUN
admet-2057	549	32	of	of	ADP
admet-2057	549	33	29.6	29.6	NUM
admet-2057	549	34	%	%	NOUN
admet-2057	549	35	.	.	PUNCT
admet-2057	550	1	this	this	PRON
admet-2057	550	2	was	be	AUX
admet-2057	550	3	accomplished	accomplish	VERB
admet-2057	550	4	by	by	ADP
admet-2057	550	5	receptor	receptor	NOUN
admet-2057	550	6	-	-	PUNCT
admet-2057	550	7	mediated	mediate	VERB
admet-2057	550	8	transcellular	transcellular	NOUN
admet-2057	550	9	route	route	NOUN
admet-2057	550	10	.	.	PUNCT
admet-2057	551	1	the	the	DET
admet-2057	551	2	research	research	NOUN
admet-2057	551	3	showed	show	VERB
admet-2057	551	4	that	that	SCONJ
admet-2057	551	5	oral	oral	ADJ
admet-2057	551	6	biomacromolecule	biomacromolecule	NOUN
admet-2057	551	7	distribution	distribution	NOUN
admet-2057	551	8	is	be	AUX
admet-2057	551	9	possible	possible	ADJ
admet-2057	551	10	because	because	SCONJ
admet-2057	551	11	of	of	ADP
admet-2057	551	12	the	the	DET
admet-2057	551	13	ability	ability	NOUN
admet-2057	551	14	of	of	ADP
admet-2057	551	15	functional	functional	ADJ
admet-2057	551	16	mofs	mof	NOUN
admet-2057	551	17	to	to	PART
admet-2057	551	18	shield	shield	VERB
admet-2057	551	19	proteins	protein	NOUN
admet-2057	551	20	from	from	ADP
admet-2057	551	21	the	the	DET
admet-2057	551	22	gastric	gastric	ADJ
admet-2057	551	23	environment	environment	NOUN
admet-2057	551	24	and	and	CCONJ
admet-2057	551	25	cross	cross	VERB
admet-2057	551	26	the	the	DET
admet-2057	551	27	intestinal	intestinal	ADJ
admet-2057	551	28	barrier	barrier	NOUN
admet-2057	551	29	.	.	PUNCT
admet-2057	552	1	b.	b.	PROPN
admet-2057	552	2	parenteral	parenteral	ADJ
admet-2057	552	3	since	since	SCONJ
admet-2057	552	4	the	the	DET
admet-2057	552	5	discovery	discovery	NOUN
admet-2057	552	6	of	of	ADP
admet-2057	552	7	mofs	mof	NOUN
admet-2057	552	8	and	and	CCONJ
admet-2057	552	9	their	their	PRON
admet-2057	552	10	use	use	NOUN
admet-2057	552	11	in	in	ADP
admet-2057	552	12	drug	drug	NOUN
admet-2057	552	13	delivery	delivery	NOUN
admet-2057	552	14	applications	application	NOUN
admet-2057	552	15	,	,	PUNCT
admet-2057	552	16	the	the	DET
admet-2057	552	17	parenteral	parenteral	ADJ
admet-2057	552	18	route	route	NOUN
admet-2057	552	19	,	,	PUNCT
admet-2057	552	20	which	which	PRON
admet-2057	552	21	might	might	AUX
admet-2057	552	22	involve	involve	VERB
admet-2057	552	23	the	the	DET
admet-2057	552	24	intravenous	intravenous	ADJ
admet-2057	552	25	route	route	NOUN
admet-2057	552	26	,	,	PUNCT
admet-2057	552	27	intramuscular	intramuscular	ADJ
admet-2057	552	28	route	route	NOUN
admet-2057	552	29	,	,	PUNCT
admet-2057	552	30	subcutaneous	subcutaneous	ADJ
admet-2057	552	31	route	route	NOUN
admet-2057	552	32	and	and	CCONJ
admet-2057	552	33	many	many	ADJ
admet-2057	552	34	more	more	ADJ
admet-2057	552	35	,	,	PUNCT
admet-2057	552	36	is	be	AUX
admet-2057	552	37	a	a	DET
admet-2057	552	38	convenient	convenient	ADJ
admet-2057	552	39	route	route	NOUN
admet-2057	552	40	for	for	ADP
admet-2057	552	41	the	the	DET
admet-2057	552	42	rapid	rapid	ADJ
admet-2057	552	43	delivery	delivery	NOUN
admet-2057	552	44	of	of	ADP
admet-2057	552	45	cargo	cargo	NOUN
admet-2057	552	46	into	into	ADP
admet-2057	552	47	the	the	DET
admet-2057	552	48	systemic	systemic	ADJ
admet-2057	552	49	circulation	circulation	NOUN
admet-2057	552	50	.	.	PUNCT
admet-2057	553	1	in	in	ADP
admet-2057	553	2	this	this	DET
admet-2057	553	3	regard	regard	NOUN
admet-2057	553	4	,	,	PUNCT
admet-2057	553	5	gong	gong	PROPN
admet-2057	553	6	cheng	cheng	PROPN
admet-2057	553	7	and	and	CCONJ
admet-2057	553	8	his	his	PRON
admet-2057	553	9	team	team	NOUN
admet-2057	554	1	[	[	X
admet-2057	554	2	109	109	NUM
admet-2057	554	3	]	]	PUNCT
admet-2057	554	4	developed	develop	VERB
admet-2057	554	5	a	a	DET
admet-2057	554	6	biomimetic	biomimetic	ADJ
admet-2057	554	7	platform	platform	NOUN
admet-2057	554	8	based	base	VERB
admet-2057	554	9	on	on	ADP
admet-2057	554	10	mofs	mof	NOUN
admet-2057	554	11	for	for	ADP
admet-2057	554	12	the	the	DET
admet-2057	554	13	intracellular	intracellular	NOUN
admet-2057	554	14	and	and	CCONJ
admet-2057	554	15	systemic	systemic	ADJ
admet-2057	554	16	delivery	delivery	NOUN
admet-2057	554	17	of	of	ADP
admet-2057	554	18	admet	admet	PROPN
admet-2057	554	19	&	&	CCONJ
admet-2057	554	20	dmpk	dmpk	PROPN
admet-2057	554	21	12(1	12(1	PROPN
admet-2057	554	22	)	)	PUNCT
admet-2057	554	23	(	(	PUNCT
admet-2057	554	24	2024	2024	NUM
admet-2057	554	25	)	)	PUNCT
admet-2057	554	26	27	27	NUM
admet-2057	554	27	-	-	SYM
admet-2057	554	28	62	62	NUM
admet-2057	554	29	drug	drug	NOUN
admet-2057	554	30	delivery	delivery	NOUN
admet-2057	554	31	applications	application	NOUN
admet-2057	554	32	of	of	ADP
admet-2057	554	33	metal	metal	NOUN
admet-2057	554	34	-	-	PUNCT
admet-2057	554	35	organic	organic	ADJ
admet-2057	554	36	framework	framework	NOUN
admet-2057	554	37	doi	doi	NOUN
admet-2057	554	38	:	:	PUNCT
admet-2057	554	39	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	554	40	47	47	NUM
admet-2057	554	41	functional	functional	ADJ
admet-2057	554	42	therapeutic	therapeutic	ADJ
admet-2057	554	43	proteins	protein	NOUN
admet-2057	554	44	and	and	CCONJ
admet-2057	554	45	biofunctional	biofunctional	ADJ
admet-2057	554	46	enzymes	enzyme	NOUN
admet-2057	554	47	.	.	PUNCT
admet-2057	555	1	the	the	DET
admet-2057	555	2	mofs	mof	NOUN
admet-2057	555	3	showed	show	VERB
admet-2057	555	4	a	a	DET
admet-2057	555	5	high	high	ADJ
admet-2057	555	6	loading	loading	NOUN
admet-2057	555	7	capacity	capacity	NOUN
admet-2057	555	8	of	of	ADP
admet-2057	555	9	94	94	NUM
admet-2057	555	10	%	%	NOUN
admet-2057	555	11	of	of	ADP
admet-2057	555	12	proteins	protein	NOUN
admet-2057	555	13	,	,	PUNCT
admet-2057	555	14	50	50	NUM
admet-2057	555	15	times	time	NOUN
admet-2057	555	16	greater	great	ADJ
admet-2057	555	17	than	than	ADP
admet-2057	555	18	surface	surface	NOUN
admet-2057	555	19	conjugation	conjugation	NOUN
admet-2057	555	20	.	.	PUNCT
admet-2057	556	1	further	far	ADV
admet-2057	556	2	surface	surface	NOUN
admet-2057	556	3	modification	modification	NOUN
admet-2057	556	4	with	with	ADP
admet-2057	556	5	extracellular	extracellular	ADJ
admet-2057	556	6	vesicle	vesicle	NOUN
admet-2057	556	7	membrane	membrane	NOUN
admet-2057	556	8	was	be	AUX
admet-2057	556	9	done	do	VERB
admet-2057	556	10	.	.	PUNCT
admet-2057	557	1	the	the	DET
admet-2057	557	2	in	in	ADP
admet-2057	557	3	vitro	vitro	X
admet-2057	557	4	and	and	CCONJ
admet-2057	557	5	in	in	ADP
admet-2057	557	6	vivo	vivo	ADJ
admet-2057	557	7	studies	study	NOUN
admet-2057	557	8	proved	prove	VERB
admet-2057	557	9	that	that	SCONJ
admet-2057	557	10	the	the	DET
admet-2057	557	11	mofs	mof	NOUN
admet-2057	557	12	protected	protect	VERB
admet-2057	557	13	the	the	DET
admet-2057	557	14	proteins	protein	NOUN
admet-2057	557	15	against	against	ADP
admet-2057	557	16	degradation	degradation	NOUN
admet-2057	557	17	by	by	ADP
admet-2057	557	18	protease	protease	NOUN
admet-2057	557	19	enzymes	enzyme	NOUN
admet-2057	557	20	and	and	CCONJ
admet-2057	557	21	bypassed	bypass	VERB
admet-2057	557	22	immune	immune	ADJ
admet-2057	557	23	system	system	NOUN
admet-2057	557	24	clearance	clearance	NOUN
admet-2057	557	25	.	.	PUNCT
admet-2057	558	1	furthermore	furthermore	ADV
admet-2057	558	2	,	,	PUNCT
admet-2057	558	3	the	the	DET
admet-2057	558	4	system	system	NOUN
admet-2057	558	5	targeted	target	VERB
admet-2057	558	6	homotypic	homotypic	ADJ
admet-2057	558	7	tumor	tumor	NOUN
admet-2057	558	8	sites	site	NOUN
admet-2057	558	9	,	,	PUNCT
admet-2057	558	10	promoting	promote	VERB
admet-2057	558	11	the	the	DET
admet-2057	558	12	uptake	uptake	NOUN
admet-2057	558	13	of	of	ADP
admet-2057	558	14	mofs	mof	NOUN
admet-2057	558	15	by	by	ADP
admet-2057	558	16	tumor	tumor	NOUN
admet-2057	558	17	and	and	CCONJ
admet-2057	558	18	burst	burst	ADJ
admet-2057	558	19	release	release	NOUN
admet-2057	558	20	inside	inside	ADP
admet-2057	558	21	the	the	DET
admet-2057	558	22	tumor	tumor	NOUN
admet-2057	558	23	cells	cell	NOUN
admet-2057	558	24	and	and	CCONJ
admet-2057	558	25	inhibiting	inhibit	VERB
admet-2057	558	26	tumor	tumor	NOUN
admet-2057	558	27	growth	growth	NOUN
admet-2057	558	28	and	and	CCONJ
admet-2057	558	29	around	around	ADV
admet-2057	558	30	14	14	NUM
admet-2057	558	31	-	-	ADJ
admet-2057	558	32	fold	fold	ADJ
admet-2057	558	33	improving	improve	VERB
admet-2057	558	34	therapeutic	therapeutic	ADJ
admet-2057	558	35	activity	activity	NOUN
admet-2057	558	36	.	.	PUNCT
admet-2057	559	1	conclusively	conclusively	ADV
admet-2057	559	2	,	,	PUNCT
admet-2057	559	3	this	this	DET
admet-2057	559	4	work	work	NOUN
admet-2057	559	5	demonstrated	demonstrate	VERB
admet-2057	559	6	that	that	SCONJ
admet-2057	559	7	mofs	mof	NOUN
admet-2057	559	8	can	can	AUX
admet-2057	559	9	be	be	AUX
admet-2057	559	10	a	a	DET
admet-2057	559	11	potential	potential	ADJ
admet-2057	559	12	platform	platform	NOUN
admet-2057	559	13	for	for	ADP
admet-2057	559	14	intracellular	intracellular	ADJ
admet-2057	559	15	and	and	CCONJ
admet-2057	559	16	systemic	systemic	ADJ
admet-2057	559	17	delivery	delivery	NOUN
admet-2057	559	18	.	.	PUNCT
admet-2057	560	1	in	in	ADP
admet-2057	560	2	another	another	DET
admet-2057	560	3	study	study	NOUN
admet-2057	560	4	,	,	PUNCT
admet-2057	560	5	wenting	wente	VERB
admet-2057	560	6	shang	shang	PROPN
admet-2057	560	7	and	and	CCONJ
admet-2057	560	8	team	team	NOUN
admet-2057	561	1	[	[	X
admet-2057	561	2	110	110	NUM
admet-2057	561	3	]	]	PUNCT
admet-2057	561	4	demonstrated	demonstrate	VERB
admet-2057	561	5	a	a	DET
admet-2057	561	6	mof	mof	NOUN
admet-2057	561	7	that	that	PRON
admet-2057	561	8	,	,	PUNCT
admet-2057	561	9	after	after	ADP
admet-2057	561	10	labelling	label	VERB
admet-2057	561	11	the	the	DET
admet-2057	561	12	targeted	target	VERB
admet-2057	561	13	peptide	peptide	NOUN
admet-2057	561	14	irgd	irgd	NOUN
admet-2057	561	15	,	,	PUNCT
admet-2057	561	16	a	a	DET
admet-2057	561	17	theranostic	theranostic	ADJ
admet-2057	561	18	nanoplatform	nanoplatform	NOUN
admet-2057	561	19	would	would	AUX
admet-2057	561	20	combine	combine	VERB
admet-2057	561	21	medication	medication	NOUN
admet-2057	561	22	treatment	treatment	NOUN
admet-2057	561	23	with	with	ADP
admet-2057	561	24	phototherapy	phototherapy	NOUN
admet-2057	561	25	.	.	PUNCT
admet-2057	562	1	the	the	DET
admet-2057	562	2	micropore	micropore	PROPN
admet-2057	562	3	fe	fe	X
admet-2057	562	4	-	-	PUNCT
admet-2057	562	5	mof	mof	PROPN
admet-2057	562	6	was	be	AUX
admet-2057	562	7	employed	employ	VERB
admet-2057	562	8	as	as	ADP
admet-2057	562	9	a	a	DET
admet-2057	562	10	nanocarrier	nanocarrier	NOUN
admet-2057	562	11	to	to	PART
admet-2057	562	12	upload	upload	VERB
admet-2057	562	13	chemotherapy	chemotherapy	NOUN
admet-2057	562	14	medicines	medicine	NOUN
admet-2057	562	15	and	and	CCONJ
admet-2057	562	16	mri	mri	NOUN
admet-2057	562	17	agents	agent	NOUN
admet-2057	562	18	for	for	ADP
admet-2057	562	19	identifying	identify	VERB
admet-2057	562	20	tumours	tumour	NOUN
admet-2057	562	21	.	.	PUNCT
admet-2057	563	1	additionally	additionally	ADV
admet-2057	563	2	,	,	PUNCT
admet-2057	563	3	under	under	ADP
admet-2057	563	4	various	various	ADJ
admet-2057	563	5	delivery	delivery	NOUN
admet-2057	563	6	methods	method	NOUN
admet-2057	563	7	,	,	PUNCT
admet-2057	563	8	including	include	VERB
admet-2057	563	9	intravenous	intravenous	ADJ
admet-2057	563	10	injection	injection	NOUN
admet-2057	563	11	for	for	ADP
admet-2057	563	12	breast	breast	NOUN
admet-2057	563	13	cancer	cancer	NOUN
admet-2057	563	14	and	and	CCONJ
admet-2057	563	15	local	local	ADJ
admet-2057	563	16	instillation	instillation	NOUN
admet-2057	563	17	for	for	ADP
admet-2057	563	18	bladder	bladder	NOUN
admet-2057	563	19	cancer	cancer	NOUN
admet-2057	563	20	,	,	PUNCT
admet-2057	563	21	mof	mof	X
admet-2057	563	22	demonstrated	demonstrate	VERB
admet-2057	563	23	outstanding	outstanding	ADJ
admet-2057	563	24	targeting	targeting	NOUN
admet-2057	563	25	efficacy	efficacy	NOUN
admet-2057	563	26	.	.	PUNCT
admet-2057	564	1	in	in	ADP
admet-2057	564	2	particular	particular	ADJ
admet-2057	564	3	,	,	PUNCT
admet-2057	564	4	the	the	DET
admet-2057	564	5	agent	agent	NOUN
admet-2057	564	6	exhibits	exhibit	VERB
admet-2057	564	7	excellent	excellent	ADJ
admet-2057	564	8	photothermal	photothermal	ADJ
admet-2057	564	9	treatment	treatment	NOUN
admet-2057	564	10	effectiveness	effectiveness	NOUN
admet-2057	564	11	and	and	CCONJ
admet-2057	564	12	medication	medication	NOUN
admet-2057	564	13	heat	heat	NOUN
admet-2057	564	14	release	release	NOUN
admet-2057	564	15	efficiency	efficiency	NOUN
admet-2057	564	16	when	when	SCONJ
admet-2057	564	17	exposed	expose	VERB
admet-2057	564	18	to	to	ADP
admet-2057	564	19	an	an	DET
admet-2057	564	20	808	808	NUM
admet-2057	564	21	nm	nm	NOUN
admet-2057	564	22	laser	laser	NOUN
admet-2057	564	23	.	.	PUNCT
admet-2057	565	1	the	the	DET
admet-2057	565	2	agent	agent	NOUN
admet-2057	565	3	shows	show	VERB
admet-2057	565	4	the	the	DET
admet-2057	565	5	great	great	ADJ
admet-2057	565	6	efficacy	efficacy	NOUN
admet-2057	565	7	of	of	ADP
admet-2057	565	8	photothermal	photothermal	ADJ
admet-2057	565	9	therapy	therapy	NOUN
admet-2057	565	10	and	and	CCONJ
admet-2057	565	11	the	the	DET
admet-2057	565	12	effectiveness	effectiveness	NOUN
admet-2057	565	13	of	of	ADP
admet-2057	565	14	the	the	DET
admet-2057	565	15	medicine	medicine	NOUN
admet-2057	565	16	in	in	ADP
admet-2057	565	17	releasing	release	VERB
admet-2057	565	18	heat	heat	NOUN
admet-2057	565	19	from	from	ADP
admet-2057	565	20	the	the	DET
admet-2057	565	21	tumour	tumour	NOUN
admet-2057	565	22	location	location	NOUN
admet-2057	565	23	.	.	PUNCT
admet-2057	566	1	this	this	DET
admet-2057	566	2	combination	combination	NOUN
admet-2057	566	3	therapy	therapy	NOUN
admet-2057	566	4	offers	offer	VERB
admet-2057	566	5	a	a	DET
admet-2057	566	6	different	different	ADJ
admet-2057	566	7	way	way	NOUN
admet-2057	566	8	to	to	PART
admet-2057	566	9	administer	administer	VERB
admet-2057	566	10	medications	medication	NOUN
admet-2057	566	11	and	and	CCONJ
admet-2057	566	12	can	can	AUX
admet-2057	566	13	be	be	AUX
admet-2057	566	14	tailored	tailor	VERB
admet-2057	566	15	to	to	ADP
admet-2057	566	16	a	a	DET
admet-2057	566	17	variety	variety	NOUN
admet-2057	566	18	of	of	ADP
admet-2057	566	19	cancer	cancer	NOUN
admet-2057	566	20	cell	cell	NOUN
admet-2057	566	21	types	type	NOUN
admet-2057	566	22	and	and	CCONJ
admet-2057	566	23	molecular	molecular	ADJ
admet-2057	566	24	targets	target	NOUN
admet-2057	566	25	linked	link	VERB
admet-2057	566	26	to	to	ADP
admet-2057	566	27	the	the	DET
admet-2057	566	28	development	development	NOUN
admet-2057	566	29	of	of	ADP
admet-2057	566	30	the	the	DET
admet-2057	566	31	disease	disease	NOUN
admet-2057	566	32	.	.	PUNCT
admet-2057	567	1	in	in	ADP
admet-2057	567	2	a	a	DET
admet-2057	567	3	similar	similar	ADJ
admet-2057	567	4	vein	vein	NOUN
admet-2057	567	5	,	,	PUNCT
admet-2057	567	6	khaled	khaled	PROPN
admet-2057	567	7	abou	abou	PROPN
admet-2057	567	8	and	and	CCONJ
admet-2057	567	9	colleagues	colleague	NOUN
admet-2057	567	10	[	[	X
admet-2057	567	11	111	111	NUM
admet-2057	567	12	]	]	PUNCT
admet-2057	567	13	developed	develop	VERB
admet-2057	567	14	two	two	NUM
admet-2057	567	15	nanoformulations	nanoformulation	NOUN
admet-2057	567	16	consisting	consist	VERB
admet-2057	567	17	of	of	ADP
admet-2057	567	18	two	two	NUM
admet-2057	567	19	mofs	mof	NOUN
admet-2057	567	20	,	,	PUNCT
admet-2057	567	21	ti	ti	NOUN
admet-2057	567	22	-	-	ADJ
admet-2057	567	23	mof	mof	ADJ
admet-2057	567	24	and	and	CCONJ
admet-2057	567	25	zr	zr	VERB
admet-2057	567	26	-	-	PUNCT
admet-2057	567	27	mof	mof	ADJ
admet-2057	567	28	,	,	PUNCT
admet-2057	567	29	both	both	PRON
admet-2057	567	30	having	have	VERB
admet-2057	567	31	surface	surface	NOUN
admet-2057	567	32	changes	change	NOUN
admet-2057	567	33	,	,	PUNCT
admet-2057	567	34	and	and	CCONJ
admet-2057	567	35	each	each	DET
admet-2057	567	36	one	one	NOUN
admet-2057	567	37	filled	fill	VERB
admet-2057	567	38	with	with	ADP
admet-2057	567	39	rutin	rutin	NOUN
admet-2057	567	40	(	(	PUNCT
admet-2057	567	41	rut	rut	NOUN
admet-2057	567	42	)	)	PUNCT
admet-2057	567	43	and/or	and/or	CCONJ
admet-2057	567	44	piperine	piperine	PROPN
admet-2057	567	45	(	(	PUNCT
admet-2057	567	46	pip	pip	NOUN
admet-2057	567	47	)	)	PUNCT
admet-2057	567	48	.	.	PUNCT
admet-2057	568	1	in	in	ADP
admet-2057	568	2	vivo	vivo	ADJ
admet-2057	568	3	anti	anti	ADJ
admet-2057	568	4	-	-	ADJ
admet-2057	568	5	inflammatory	inflammatory	ADJ
admet-2057	568	6	and	and	CCONJ
admet-2057	568	7	antioxidant	antioxidant	ADJ
admet-2057	568	8	properties	property	NOUN
admet-2057	568	9	were	be	AUX
admet-2057	568	10	tested	test	VERB
admet-2057	568	11	on	on	ADP
admet-2057	568	12	mofs	mof	NOUN
admet-2057	568	13	and	and	CCONJ
admet-2057	568	14	nanoformulations	nanoformulation	NOUN
admet-2057	568	15	.	.	PUNCT
admet-2057	569	1	it	it	PRON
admet-2057	569	2	was	be	AUX
admet-2057	569	3	possible	possible	ADJ
admet-2057	569	4	to	to	PART
admet-2057	569	5	produce	produce	VERB
admet-2057	569	6	loadings	loading	NOUN
admet-2057	569	7	of	of	ADP
admet-2057	569	8	27	27	NUM
admet-2057	569	9	wt.%	wt.%	ADJ
admet-2057	569	10	for	for	ADP
admet-2057	569	11	dual	dual	ADJ
admet-2057	569	12	loading	loading	NOUN
admet-2057	569	13	and	and	CCONJ
admet-2057	569	14	17	17	NUM
admet-2057	569	15	wt.%	wt.%	ADJ
admet-2057	569	16	for	for	ADP
admet-2057	569	17	a	a	DET
admet-2057	569	18	single	single	ADJ
admet-2057	569	19	pro	pro	ADJ
admet-2057	569	20	-	-	ADJ
admet-2057	569	21	drug	drug	ADJ
admet-2057	569	22	.	.	PUNCT
admet-2057	570	1	for	for	ADP
admet-2057	570	2	the	the	DET
admet-2057	570	3	first	first	ADJ
admet-2057	570	4	12	12	NUM
admet-2057	570	5	-	-	PUNCT
admet-2057	570	6	hour	hour	NOUN
admet-2057	570	7	stage	stage	NOUN
admet-2057	570	8	,	,	PUNCT
admet-2057	570	9	the	the	DET
admet-2057	570	10	release	release	NOUN
admet-2057	570	11	patterns	pattern	NOUN
admet-2057	570	12	for	for	ADP
admet-2057	570	13	rut	rut	NOUN
admet-2057	570	14	and/or	and/or	CCONJ
admet-2057	570	15	pip	pip	PROPN
admet-2057	570	16	followed	follow	VERB
admet-2057	570	17	a	a	DET
admet-2057	570	18	zeroorder	zeroorder	NOUN
admet-2057	570	19	,	,	PUNCT
admet-2057	570	20	and	and	CCONJ
admet-2057	570	21	for	for	ADP
admet-2057	570	22	the	the	DET
admet-2057	570	23	second	second	ADJ
admet-2057	570	24	stage	stage	NOUN
admet-2057	570	25	,	,	PUNCT
admet-2057	570	26	a	a	DET
admet-2057	570	27	stable	stable	ADJ
admet-2057	570	28	,	,	PUNCT
admet-2057	570	29	sustained	sustained	ADJ
admet-2057	570	30	release	release	NOUN
admet-2057	570	31	.	.	PUNCT
admet-2057	571	1	the	the	DET
admet-2057	571	2	zero	zero	NUM
admet-2057	571	3	-	-	PUNCT
admet-2057	571	4	order	order	NOUN
admet-2057	571	5	and	and	CCONJ
admet-2057	571	6	korsmeyer	korsmeyer	NOUN
admet-2057	571	7	-	-	PUNCT
admet-2057	571	8	peppas	peppas	NOUN
admet-2057	571	9	kinetic	kinetic	NOUN
admet-2057	571	10	models	model	NOUN
admet-2057	571	11	best	well	ADV
admet-2057	571	12	fit	fit	VERB
admet-2057	571	13	the	the	DET
admet-2057	571	14	release	release	NOUN
admet-2057	571	15	patterns	pattern	NOUN
admet-2057	571	16	at	at	ADP
admet-2057	571	17	ph	ph	PROPN
admet-2057	571	18	7.4	7.4	NUM
admet-2057	571	19	.	.	PUNCT
admet-2057	572	1	the	the	DET
admet-2057	572	2	anti	anti	ADJ
admet-2057	572	3	-	-	ADJ
admet-2057	572	4	inflammatory	inflammatory	ADJ
admet-2057	572	5	and	and	CCONJ
admet-2057	572	6	antioxidant	antioxidant	ADJ
admet-2057	572	7	effects	effect	NOUN
admet-2057	572	8	of	of	ADP
admet-2057	572	9	the	the	DET
admet-2057	572	10	nanoformulations	nanoformulation	NOUN
admet-2057	572	11	were	be	AUX
admet-2057	572	12	greater	great	ADJ
admet-2057	572	13	than	than	ADP
admet-2057	572	14	those	those	PRON
admet-2057	572	15	of	of	ADP
admet-2057	572	16	either	either	PRON
admet-2057	572	17	of	of	ADP
admet-2057	572	18	their	their	PRON
admet-2057	572	19	constituents	constituent	NOUN
admet-2057	572	20	,	,	PUNCT
admet-2057	572	21	and	and	CCONJ
admet-2057	572	22	those	those	PRON
admet-2057	572	23	containing	contain	VERB
admet-2057	572	24	rut	rut	NOUN
admet-2057	572	25	or	or	CCONJ
admet-2057	572	26	pip	pip	NOUN
admet-2057	572	27	alone	alone	ADV
admet-2057	572	28	had	have	VERB
admet-2057	572	29	more	more	ADV
admet-2057	572	30	potent	potent	ADJ
admet-2057	572	31	effects	effect	NOUN
admet-2057	572	32	than	than	ADP
admet-2057	572	33	those	those	PRON
admet-2057	572	34	including	include	VERB
admet-2057	572	35	both	both	DET
admet-2057	572	36	agents	agent	NOUN
admet-2057	572	37	.	.	PUNCT
admet-2057	573	1	leukocyte	leukocyte	NOUN
admet-2057	573	2	migration	migration	NOUN
admet-2057	573	3	,	,	PUNCT
admet-2057	573	4	paw	paw	PROPN
admet-2057	573	5	edema	edema	PROPN
admet-2057	573	6	model	model	NOUN
admet-2057	573	7	,	,	PUNCT
admet-2057	573	8	and	and	CCONJ
admet-2057	573	9	plasma	plasma	NOUN
admet-2057	573	10	antioxidant	antioxidant	NOUN
admet-2057	573	11	capacity	capacity	NOUN
admet-2057	573	12	assay	assay	NOUN
admet-2057	573	13	results	result	NOUN
admet-2057	573	14	were	be	AUX
admet-2057	573	15	consistent	consistent	ADJ
admet-2057	573	16	.	.	PUNCT
admet-2057	574	1	the	the	DET
admet-2057	574	2	results	result	NOUN
admet-2057	574	3	showed	show	VERB
admet-2057	574	4	that	that	SCONJ
admet-2057	574	5	these	these	DET
admet-2057	574	6	drugs	drug	NOUN
admet-2057	574	7	'	'	PART
admet-2057	574	8	antiinflammatory	antiinflammatory	NOUN
admet-2057	574	9	and	and	CCONJ
admet-2057	574	10	antioxidant	antioxidant	ADJ
admet-2057	574	11	properties	property	NOUN
admet-2057	574	12	are	be	AUX
admet-2057	574	13	enhanced	enhance	VERB
admet-2057	574	14	in	in	ADP
admet-2057	574	15	nanoformulations	nanoformulation	NOUN
admet-2057	574	16	compared	compare	VERB
admet-2057	574	17	to	to	ADP
admet-2057	574	18	free	free	ADJ
admet-2057	574	19	form	form	NOUN
admet-2057	574	20	.	.	PUNCT
admet-2057	575	1	cheng	cheng	PROPN
admet-2057	575	2	zhang	zhang	PROPN
admet-2057	576	1	[	[	X
admet-2057	576	2	112	112	NUM
admet-2057	576	3	]	]	PUNCT
admet-2057	576	4	developed	develop	VERB
admet-2057	576	5	a	a	DET
admet-2057	576	6	new	new	ADJ
admet-2057	576	7	glucose	glucose	NOUN
admet-2057	576	8	-	-	PUNCT
admet-2057	576	9	responsive	responsive	ADJ
admet-2057	576	10	delivery	delivery	NOUN
admet-2057	576	11	system	system	NOUN
admet-2057	576	12	(	(	PUNCT
admet-2057	576	13	zif@ins&gox	zif@ins&gox	PROPN
admet-2057	576	14	)	)	PUNCT
admet-2057	576	15	for	for	ADP
admet-2057	576	16	self	self	NOUN
admet-2057	576	17	-	-	PUNCT
admet-2057	576	18	regulated	regulate	VERB
admet-2057	576	19	insulin	insulin	NOUN
admet-2057	576	20	release	release	NOUN
admet-2057	576	21	by	by	ADP
admet-2057	576	22	encapsulating	encapsulate	VERB
admet-2057	576	23	glucose	glucose	NOUN
admet-2057	576	24	oxidase	oxidase	NOUN
admet-2057	576	25	(	(	PUNCT
admet-2057	576	26	gox	gox	PROPN
admet-2057	576	27	)	)	PUNCT
admet-2057	576	28	and	and	CCONJ
admet-2057	576	29	insulin	insulin	NOUN
admet-2057	576	30	in	in	ADP
admet-2057	576	31	ph	ph	ADJ
admet-2057	576	32	-	-	ADJ
admet-2057	576	33	sensitive	sensitive	ADJ
admet-2057	576	34	zif-8	zif-8	NUM
admet-2057	576	35	nanocrystals	nanocrystal	NOUN
admet-2057	576	36	.	.	PUNCT
admet-2057	577	1	when	when	SCONJ
admet-2057	577	2	glucose	glucose	NOUN
admet-2057	577	3	enters	enter	VERB
admet-2057	577	4	the	the	DET
admet-2057	577	5	cavities	cavity	NOUN
admet-2057	577	6	of	of	ADP
admet-2057	577	7	zif-8	zif-8	NUM
admet-2057	577	8	,	,	PUNCT
admet-2057	577	9	gox	gox	PROPN
admet-2057	577	10	can	can	AUX
admet-2057	577	11	convert	convert	VERB
admet-2057	577	12	it	it	PRON
admet-2057	577	13	into	into	ADP
admet-2057	577	14	gluconic	gluconic	ADJ
admet-2057	577	15	acid	acid	NOUN
admet-2057	577	16	,	,	PUNCT
admet-2057	577	17	lowering	lower	VERB
admet-2057	577	18	the	the	DET
admet-2057	577	19	area	area	NOUN
admet-2057	577	20	's	's	PART
admet-2057	577	21	ph	ph	NOUN
admet-2057	577	22	.	.	PUNCT
admet-2057	578	1	the	the	DET
admet-2057	578	2	degradation	degradation	NOUN
admet-2057	578	3	of	of	ADP
admet-2057	578	4	zif-8	zif-8	NUM
admet-2057	578	5	nanocrystals	nanocrystal	NOUN
admet-2057	578	6	in	in	ADP
admet-2057	578	7	the	the	DET
admet-2057	578	8	presence	presence	NOUN
admet-2057	578	9	of	of	ADP
admet-2057	578	10	an	an	DET
admet-2057	578	11	acidic	acidic	ADJ
admet-2057	578	12	microenvironment	microenvironment	NOUN
admet-2057	578	13	would	would	AUX
admet-2057	578	14	thus	thus	ADV
admet-2057	578	15	result	result	VERB
admet-2057	578	16	in	in	ADP
admet-2057	578	17	insulin	insulin	NOUN
admet-2057	578	18	release	release	NOUN
admet-2057	578	19	in	in	ADP
admet-2057	578	20	a	a	DET
admet-2057	578	21	glucose	glucose	NOUN
admet-2057	578	22	-	-	PUNCT
admet-2057	578	23	responsive	responsive	ADJ
admet-2057	578	24	manner	manner	NOUN
admet-2057	578	25	.	.	PUNCT
admet-2057	579	1	studies	study	NOUN
admet-2057	579	2	conducted	conduct	VERB
admet-2057	579	3	in	in	ADP
admet-2057	579	4	vitro	vitro	X
admet-2057	579	5	suggested	suggest	VERB
admet-2057	579	6	that	that	SCONJ
admet-2057	579	7	zif-8	zif-8	NOUN
admet-2057	579	8	's	's	PART
admet-2057	579	9	stiff	stiff	ADJ
admet-2057	579	10	structure	structure	NOUN
admet-2057	579	11	might	might	AUX
admet-2057	579	12	shield	shield	VERB
admet-2057	579	13	insulin	insulin	NOUN
admet-2057	579	14	's	's	PART
admet-2057	579	15	biological	biological	ADJ
admet-2057	579	16	action	action	NOUN
admet-2057	579	17	and	and	CCONJ
admet-2057	579	18	that	that	PRON
admet-2057	579	19	insulin	insulin	NOUN
admet-2057	579	20	release	release	NOUN
admet-2057	579	21	might	might	AUX
admet-2057	579	22	be	be	AUX
admet-2057	579	23	adjusted	adjust	VERB
admet-2057	579	24	in	in	ADP
admet-2057	579	25	response	response	NOUN
admet-2057	579	26	to	to	ADP
admet-2057	579	27	glucose	glucose	NOUN
admet-2057	579	28	levels	level	NOUN
admet-2057	579	29	.	.	PUNCT
admet-2057	580	1	in	in	ADP
admet-2057	580	2	vivo	vivo	NOUN
admet-2057	580	3	tests	test	NOUN
admet-2057	580	4	showed	show	VERB
admet-2057	580	5	that	that	DET
admet-2057	580	6	type	type	NOUN
admet-2057	580	7	1	1	NUM
admet-2057	580	8	diabetes	diabetes	NOUN
admet-2057	580	9	(	(	PUNCT
admet-2057	580	10	t1d	t1d	NOUN
admet-2057	580	11	)	)	PUNCT
admet-2057	580	12	patients	patient	NOUN
admet-2057	580	13	could	could	AUX
admet-2057	580	14	stabilize	stabilize	VERB
admet-2057	580	15	their	their	PRON
admet-2057	580	16	blood	blood	NOUN
admet-2057	580	17	glucose	glucose	NOUN
admet-2057	580	18	level	level	NOUN
admet-2057	580	19	at	at	ADP
admet-2057	580	20	a	a	DET
admet-2057	580	21	normoglycemic	normoglycemic	ADJ
admet-2057	580	22	state	state	NOUN
admet-2057	580	23	for	for	ADP
admet-2057	580	24	up	up	ADP
admet-2057	580	25	to	to	PART
admet-2057	580	26	72	72	NUM
admet-2057	580	27	hours	hour	NOUN
admet-2057	580	28	after	after	ADP
admet-2057	580	29	receiving	receive	VERB
admet-2057	580	30	a	a	DET
admet-2057	580	31	single	single	ADJ
admet-2057	580	32	subcutaneous	subcutaneous	ADJ
admet-2057	580	33	injection	injection	NOUN
admet-2057	580	34	of	of	ADP
admet-2057	580	35	the	the	DET
admet-2057	580	36	zif@ins&gox	zif@ins&gox	PROPN
admet-2057	580	37	.	.	PUNCT
admet-2057	581	1	a	a	DET
admet-2057	581	2	new	new	ADJ
admet-2057	581	3	proof	proof	NOUN
admet-2057	581	4	-	-	PUNCT
admet-2057	581	5	ofconcept	ofconcept	ADJ
admet-2057	581	6	for	for	ADP
admet-2057	581	7	the	the	DET
admet-2057	581	8	treatment	treatment	NOUN
admet-2057	581	9	of	of	ADP
admet-2057	581	10	t1d	t1d	PROPN
admet-2057	581	11	is	be	AUX
admet-2057	581	12	demonstrated	demonstrate	VERB
admet-2057	581	13	by	by	ADP
admet-2057	581	14	the	the	DET
admet-2057	581	15	multifunctional	multifunctional	ADJ
admet-2057	581	16	insulin	insulin	NOUN
admet-2057	581	17	delivery	delivery	NOUN
admet-2057	581	18	system	system	NOUN
admet-2057	581	19	using	use	VERB
admet-2057	581	20	zif-8	zif-8	NUM
admet-2057	581	21	nanocrystals	nanocrystal	NOUN
admet-2057	581	22	loaded	load	VERB
admet-2057	581	23	with	with	ADP
admet-2057	581	24	an	an	DET
admet-2057	581	25	enzyme	enzyme	NOUN
admet-2057	581	26	and	and	CCONJ
admet-2057	581	27	insulin	insulin	NOUN
admet-2057	581	28	.	.	PUNCT
admet-2057	582	1	michael	michael	PROPN
admet-2057	582	2	a.	a.	PROPN
admet-2057	582	3	luzuriaga	luzuriaga	PROPN
admet-2057	583	1	[	[	X
admet-2057	583	2	113	113	NUM
admet-2057	583	3	]	]	PUNCT
admet-2057	583	4	published	publish	VERB
admet-2057	583	5	a	a	DET
admet-2057	583	6	thorough	thorough	ADJ
admet-2057	583	7	analysis	analysis	NOUN
admet-2057	583	8	of	of	ADP
admet-2057	583	9	zif-8	zif-8	NUM
admet-2057	583	10	and	and	CCONJ
admet-2057	583	11	its	its	PRON
admet-2057	583	12	capacity	capacity	NOUN
admet-2057	583	13	to	to	PART
admet-2057	583	14	shield	shield	VERB
admet-2057	583	15	a	a	DET
admet-2057	583	16	model	model	NOUN
admet-2057	583	17	viral	viral	ADJ
admet-2057	583	18	vector	vector	NOUN
admet-2057	583	19	from	from	ADP
admet-2057	583	20	denaturing	denature	VERB
admet-2057	583	21	circumstances	circumstance	NOUN
admet-2057	583	22	.	.	PUNCT
admet-2057	584	1	combined	combine	VERB
admet-2057	584	2	spectroscopy	spectroscopy	NOUN
admet-2057	584	3	and	and	CCONJ
admet-2057	584	4	immunoassay	immunoassay	ADJ
admet-2057	584	5	analysis	analysis	NOUN
admet-2057	584	6	showed	show	VERB
admet-2057	584	7	the	the	DET
admet-2057	584	8	improved	improved	ADJ
admet-2057	584	9	thermal	thermal	ADJ
admet-2057	584	10	and	and	CCONJ
admet-2057	584	11	chemical	chemical	NOUN
admet-2057	584	12	stability	stability	NOUN
admet-2057	584	13	conformational	conformational	ADJ
admet-2057	584	14	makeup	makeup	NOUN
admet-2057	584	15	of	of	ADP
admet-2057	584	16	the	the	DET
admet-2057	584	17	enclosed	enclose	VERB
admet-2057	584	18	viral	viral	ADJ
admet-2057	584	19	nanoparticle	nanoparticle	NOUN
admet-2057	584	20	.	.	PUNCT
admet-2057	585	1	the	the	DET
admet-2057	585	2	virus	virus	NOUN
admet-2057	585	3	-	-	PUNCT
admet-2057	585	4	zif	zif	NOUN
admet-2057	585	5	composite	composite	NOUN
admet-2057	585	6	's	's	PART
admet-2057	585	7	long	long	ADJ
admet-2057	585	8	-	-	PUNCT
admet-2057	585	9	term	term	NOUN
admet-2057	585	10	biological	biological	ADJ
admet-2057	585	11	activity	activity	NOUN
admet-2057	585	12	was	be	AUX
admet-2057	585	13	explored	explore	VERB
admet-2057	585	14	in	in	ADP
admet-2057	585	15	animal	animal	NOUN
admet-2057	585	16	models	model	NOUN
admet-2057	585	17	to	to	PART
admet-2057	585	18	clarify	clarify	VERB
admet-2057	585	19	the	the	DET
admet-2057	585	20	consistency	consistency	NOUN
admet-2057	585	21	of	of	ADP
admet-2057	585	22	the	the	DET
admet-2057	585	23	biosafety	biosafety	NOUN
admet-2057	585	24	,	,	PUNCT
admet-2057	585	25	immunogenicity	immunogenicity	NOUN
admet-2057	585	26	,	,	PUNCT
admet-2057	585	27	and	and	CCONJ
admet-2057	585	28	encapsulated	encapsulate	VERB
admet-2057	585	29	virus	virus	NOUN
admet-2057	585	30	of	of	ADP
admet-2057	585	31	the	the	DET
admet-2057	585	32	composite	composite	ADJ
admet-2057	585	33	overall	overall	NOUN
admet-2057	585	34	.	.	PUNCT
admet-2057	586	1	furthermore	furthermore	ADV
admet-2057	586	2	,	,	PUNCT
admet-2057	586	3	histological	histological	ADJ
admet-2057	586	4	examination	examination	NOUN
admet-2057	586	5	of	of	ADP
admet-2057	586	6	mice	mouse	NOUN
admet-2057	586	7	's	's	PART
admet-2057	586	8	skin	skin	NOUN
admet-2057	586	9	and	and	CCONJ
admet-2057	586	10	essential	essential	ADJ
admet-2057	586	11	organs	organ	NOUN
admet-2057	586	12	revealed	reveal	VERB
admet-2057	586	13	no	no	DET
admet-2057	586	14	discernible	discernible	ADJ
admet-2057	586	15	tissue	tissue	NOUN
admet-2057	586	16	damage	damage	NOUN
admet-2057	586	17	after	after	ADP
admet-2057	586	18	numerous	numerous	ADJ
admet-2057	586	19	subcutaneous	subcutaneous	ADJ
admet-2057	586	20	injections	injection	NOUN
admet-2057	586	21	.	.	PUNCT
admet-2057	587	1	this	this	DET
admet-2057	587	2	study	study	NOUN
admet-2057	587	3	demonstrates	demonstrate	VERB
admet-2057	587	4	that	that	SCONJ
admet-2057	587	5	zif	zif	NOUN
admet-2057	587	6	-	-	PUNCT
admet-2057	587	7	based	base	VERB
admet-2057	587	8	protein	protein	NOUN
admet-2057	587	9	composites	composite	NOUN
admet-2057	587	10	are	be	AUX
admet-2057	587	11	excellent	excellent	ADJ
admet-2057	587	12	candidates	candidate	NOUN
admet-2057	587	13	for	for	ADP
admet-2057	587	14	better	well	ADJ
admet-2057	587	15	proteinaceous	proteinaceous	ADJ
admet-2057	587	16	drug	drug	NOUN
admet-2057	587	17	storage	storage	NOUN
admet-2057	587	18	,	,	PUNCT
admet-2057	587	19	are	be	AUX
admet-2057	587	20	biocompatible	biocompatible	ADJ
admet-2057	587	21	and	and	CCONJ
admet-2057	587	22	can	can	AUX
admet-2057	587	23	regulate	regulate	VERB
admet-2057	587	24	drug	drug	NOUN
admet-2057	587	25	release	release	NOUN
admet-2057	587	26	and	and	CCONJ
admet-2057	587	27	adsorption	adsorption	NOUN
admet-2057	587	28	in	in	ADP
admet-2057	587	29	vivo	vivo	NOUN
admet-2057	587	30	.	.	PUNCT
admet-2057	588	1	in	in	ADP
admet-2057	588	2	2021	2021	NUM
admet-2057	588	3	,	,	PUNCT
admet-2057	588	4	mengyun	mengyun	ADV
admet-2057	588	5	he	he	PRON
admet-2057	588	6	and	and	CCONJ
admet-2057	588	7	team	team	NOUN
admet-2057	588	8	[	[	X
admet-2057	588	9	114	114	NUM
admet-2057	588	10	]	]	PUNCT
admet-2057	588	11	proposed	propose	VERB
admet-2057	588	12	a	a	DET
admet-2057	588	13	type	type	NOUN
admet-2057	588	14	of	of	ADP
admet-2057	588	15	"	"	PUNCT
admet-2057	588	16	corehttps://doi.org/10.5599/admet.2057	corehttps://doi.org/10.5599/admet.2057	NOUN
admet-2057	588	17	p.	p.	NOUN
admet-2057	588	18	mhettar	mhettar	NOUN
admet-2057	588	19	et	et	PROPN
admet-2057	588	20	al	al	PROPN
admet-2057	588	21	.	.	PROPN
admet-2057	588	22	admet	admet	PROPN
admet-2057	588	23	&	&	CCONJ
admet-2057	588	24	dmpk	dmpk	PROPN
admet-2057	588	25	12(1	12(1	PROPN
admet-2057	588	26	)	)	PUNCT
admet-2057	588	27	(	(	PUNCT
admet-2057	588	28	2024	2024	NUM
admet-2057	588	29	)	)	PUNCT
admet-2057	588	30	27	27	NUM
admet-2057	588	31	-	-	SYM
admet-2057	588	32	62	62	NUM
admet-2057	588	33	48	48	NUM
admet-2057	588	34	shell"-structured	shell"-structure	VERB
admet-2057	588	35	glucose	glucose	NOUN
admet-2057	588	36	-	-	PUNCT
admet-2057	588	37	responsive	responsive	ADJ
admet-2057	588	38	nanoplatform	nanoplatform	NOUN
admet-2057	588	39	for	for	ADP
admet-2057	588	40	intravenous	intravenous	ADJ
admet-2057	588	41	"	"	PUNCT
admet-2057	588	42	smart	smart	ADJ
admet-2057	588	43	"	"	PUNCT
admet-2057	588	44	insulin	insulin	NOUN
admet-2057	588	45	delivery	delivery	NOUN
admet-2057	588	46	.	.	PUNCT
admet-2057	589	1	the	the	DET
admet-2057	589	2	"	"	PUNCT
admet-2057	589	3	inner	inner	ADJ
admet-2057	589	4	core	core	NOUN
admet-2057	589	5	"	"	PUNCT
admet-2057	589	6	was	be	AUX
admet-2057	589	7	created	create	VERB
admet-2057	589	8	by	by	ADP
admet-2057	589	9	co	co	VERB
admet-2057	589	10	-	-	ADJ
admet-2057	589	11	encapsulating	encapsulate	VERB
admet-2057	589	12	insulin	insulin	NOUN
admet-2057	589	13	,	,	PUNCT
admet-2057	589	14	gox	gox	PROPN
admet-2057	589	15	,	,	PUNCT
admet-2057	589	16	and	and	CCONJ
admet-2057	589	17	catalase	catalase	NOUN
admet-2057	589	18	(	(	PUNCT
admet-2057	589	19	cat	cat	NOUN
admet-2057	589	20	)	)	PUNCT
admet-2057	589	21	into	into	ADP
admet-2057	589	22	zif-8	zif-8	ADJ
admet-2057	589	23	nanoparticles	nanoparticle	NOUN
admet-2057	589	24	using	use	VERB
admet-2057	589	25	a	a	DET
admet-2057	589	26	finely	finely	ADV
admet-2057	589	27	controlled	control	VERB
admet-2057	589	28	one	one	NUM
admet-2057	589	29	-	-	PUNCT
admet-2057	589	30	pot	pot	NOUN
admet-2057	589	31	biomimetic	biomimetic	ADJ
admet-2057	589	32	mineralization	mineralization	NOUN
admet-2057	589	33	technique	technique	NOUN
admet-2057	589	34	.	.	PUNCT
admet-2057	590	1	an	an	DET
admet-2057	590	2	effective	effective	ADJ
admet-2057	590	3	enzyme	enzyme	NOUN
admet-2057	590	4	cascade	cascade	NOUN
admet-2057	590	5	system	system	NOUN
admet-2057	590	6	(	(	PUNCT
admet-2057	590	7	gox	gox	PROPN
admet-2057	590	8	/	/	SYM
admet-2057	590	9	cat	cat	NOUN
admet-2057	590	10	group	group	NOUN
admet-2057	590	11	)	)	PUNCT
admet-2057	590	12	served	serve	VERB
admet-2057	590	13	as	as	ADP
admet-2057	590	14	an	an	DET
admet-2057	590	15	optimised	optimise	VERB
admet-2057	590	16	glucose	glucose	NOUN
admet-2057	590	17	-	-	PUNCT
admet-2057	590	18	responsive	responsive	ADJ
admet-2057	590	19	module	module	NOUN
admet-2057	590	20	that	that	PRON
admet-2057	590	21	could	could	AUX
admet-2057	590	22	quickly	quickly	ADV
admet-2057	590	23	catalyse	catalyse	VERB
admet-2057	590	24	glucose	glucose	NOUN
admet-2057	590	25	to	to	PART
admet-2057	590	26	yield	yield	VERB
admet-2057	590	27	gluconic	gluconic	ADJ
admet-2057	590	28	acid	acid	NOUN
admet-2057	590	29	to	to	PART
admet-2057	590	30	lower	lower	VERB
admet-2057	590	31	the	the	DET
admet-2057	590	32	local	local	ADJ
admet-2057	590	33	ph	ph	NOUN
admet-2057	590	34	and	and	CCONJ
admet-2057	590	35	effectively	effectively	ADV
admet-2057	590	36	consume	consume	VERB
admet-2057	590	37	the	the	DET
admet-2057	590	38	harmful	harmful	ADJ
admet-2057	590	39	byproduct	byproduct	NOUN
admet-2057	590	40	hydrogen	hydrogen	NOUN
admet-2057	590	41	peroxide	peroxide	NOUN
admet-2057	590	42	.	.	PUNCT
admet-2057	591	1	the	the	DET
admet-2057	591	2	"	"	PUNCT
admet-2057	591	3	outer	outer	ADJ
admet-2057	591	4	shell	shell	NOUN
admet-2057	591	5	"	"	PUNCT
admet-2057	591	6	of	of	ADP
admet-2057	591	7	the	the	DET
admet-2057	591	8	"	"	PUNCT
admet-2057	591	9	inner	inner	ADJ
admet-2057	591	10	core	core	NOUN
admet-2057	591	11	"	"	PUNCT
admet-2057	591	12	was	be	AUX
admet-2057	591	13	covered	cover	VERB
admet-2057	591	14	with	with	ADP
admet-2057	591	15	the	the	DET
admet-2057	591	16	erythrocyte	erythrocyte	NOUN
admet-2057	591	17	membrane	membrane	NOUN
admet-2057	591	18	,	,	PUNCT
admet-2057	591	19	a	a	DET
admet-2057	591	20	type	type	NOUN
admet-2057	591	21	of	of	ADP
admet-2057	591	22	naturally	naturally	ADV
admet-2057	591	23	occurring	occur	VERB
admet-2057	591	24	biologically	biologically	ADV
admet-2057	591	25	derived	derive	VERB
admet-2057	591	26	lipid	lipid	NOUN
admet-2057	591	27	bilayer	bilayer	NOUN
admet-2057	591	28	membrane	membrane	NOUN
admet-2057	591	29	with	with	ADP
admet-2057	591	30	intrinsic	intrinsic	ADJ
admet-2057	591	31	biocompatibility	biocompatibility	NOUN
admet-2057	591	32	,	,	PUNCT
admet-2057	591	33	making	make	VERB
admet-2057	591	34	the	the	DET
admet-2057	591	35	nps	nps	PROPN
admet-2057	591	36	injectable	injectable	NOUN
admet-2057	591	37	intravenously	intravenously	ADV
admet-2057	591	38	and	and	CCONJ
admet-2057	591	39	able	able	ADJ
admet-2057	591	40	to	to	PART
admet-2057	591	41	sustain	sustain	VERB
admet-2057	591	42	a	a	DET
admet-2057	591	43	long	long	ADJ
admet-2057	591	44	-	-	PUNCT
admet-2057	591	45	term	term	NOUN
admet-2057	591	46	existence	existence	NOUN
admet-2057	591	47	in	in	ADP
admet-2057	591	48	blood	blood	NOUN
admet-2057	591	49	circulation	circulation	NOUN
admet-2057	591	50	.	.	PUNCT
admet-2057	592	1	the	the	DET
admet-2057	592	2	in	in	ADP
admet-2057	592	3	vitro	vitro	X
admet-2057	592	4	and	and	CCONJ
admet-2057	592	5	in	in	ADP
admet-2057	592	6	vivo	vivo	NOUN
admet-2057	592	7	results	result	NOUN
admet-2057	592	8	show	show	VERB
admet-2057	592	9	that	that	SCONJ
admet-2057	592	10	our	our	PRON
admet-2057	592	11	expertly	expertly	ADV
admet-2057	592	12	designed	design	VERB
admet-2057	592	13	nanoplatform	nanoplatform	NOUN
admet-2057	592	14	has	have	VERB
admet-2057	592	15	excellent	excellent	ADJ
admet-2057	592	16	glucose	glucose	NOUN
admet-2057	592	17	-	-	PUNCT
admet-2057	592	18	responsive	responsive	ADJ
admet-2057	592	19	properties	property	NOUN
admet-2057	592	20	and	and	CCONJ
admet-2057	592	21	can	can	AUX
admet-2057	592	22	keep	keep	VERB
admet-2057	592	23	type	type	NOUN
admet-2057	592	24	1	1	NUM
admet-2057	592	25	diabetic	diabetic	ADJ
admet-2057	592	26	mice	mouse	NOUN
admet-2057	592	27	's	's	PART
admet-2057	592	28	blood	blood	NOUN
admet-2057	592	29	glucose	glucose	NOUN
admet-2057	592	30	levels	level	NOUN
admet-2057	592	31	at	at	ADP
admet-2057	592	32	the	the	DET
admet-2057	592	33	normoglycemic	normoglycemic	ADJ
admet-2057	592	34	state	state	NOUN
admet-2057	592	35	for	for	ADP
admet-2057	592	36	up	up	ADP
admet-2057	592	37	to	to	PART
admet-2057	592	38	24	24	NUM
admet-2057	592	39	hours	hour	NOUN
admet-2057	592	40	after	after	ADP
admet-2057	592	41	being	be	AUX
admet-2057	592	42	administered	administer	VERB
admet-2057	592	43	intravenously	intravenously	ADV
admet-2057	592	44	.	.	PUNCT
admet-2057	593	1	this	this	PRON
admet-2057	593	2	supports	support	VERB
admet-2057	593	3	the	the	DET
admet-2057	593	4	use	use	NOUN
admet-2057	593	5	of	of	ADP
admet-2057	593	6	an	an	DET
admet-2057	593	7	intravenous	intravenous	ADJ
admet-2057	593	8	insulin	insulin	NOUN
admet-2057	593	9	delivery	delivery	NOUN
admet-2057	593	10	strategy	strategy	NOUN
admet-2057	593	11	to	to	PART
admet-2057	593	12	make	make	VERB
admet-2057	593	13	up	up	ADP
admet-2057	593	14	for	for	ADP
admet-2057	593	15	the	the	DET
admet-2057	593	16	shortcomings	shortcoming	NOUN
admet-2057	593	17	of	of	ADP
admet-2057	593	18	daily	daily	ADJ
admet-2057	593	19	multiple	multiple	ADJ
admet-2057	593	20	subcutaneous	subcutaneous	ADJ
admet-2057	593	21	insulin	insulin	NOUN
admet-2057	593	22	administration	administration	NOUN
admet-2057	593	23	and	and	CCONJ
admet-2057	593	24	provides	provide	VERB
admet-2057	593	25	a	a	DET
admet-2057	593	26	promising	promising	ADJ
admet-2057	593	27	alternative	alternative	NOUN
admet-2057	593	28	.	.	PUNCT
admet-2057	594	1	c.	c.	NOUN
admet-2057	594	2	others	other	NOUN
admet-2057	594	3	even	even	ADV
admet-2057	594	4	though	though	SCONJ
admet-2057	594	5	nano	nano	NOUN
admet-2057	594	6	mofs	mof	NOUN
admet-2057	594	7	are	be	AUX
admet-2057	594	8	potential	potential	ADJ
admet-2057	594	9	drug	drug	NOUN
admet-2057	594	10	carriers	carrier	NOUN
admet-2057	594	11	,	,	PUNCT
admet-2057	594	12	different	different	ADJ
admet-2057	594	13	formulations	formulation	NOUN
admet-2057	594	14	are	be	AUX
admet-2057	594	15	the	the	DET
admet-2057	594	16	least	least	ADV
admet-2057	594	17	explored	explore	VERB
admet-2057	594	18	,	,	PUNCT
admet-2057	594	19	and	and	CCONJ
admet-2057	594	20	most	most	ADJ
admet-2057	594	21	of	of	ADP
admet-2057	594	22	their	their	PRON
admet-2057	594	23	formulations	formulation	NOUN
admet-2057	594	24	are	be	AUX
admet-2057	594	25	limited	limit	VERB
admet-2057	594	26	to	to	ADP
admet-2057	594	27	only	only	ADV
admet-2057	594	28	intravenous	intravenous	ADJ
admet-2057	594	29	routes	route	NOUN
admet-2057	594	30	.	.	PUNCT
admet-2057	595	1	on	on	ADP
admet-2057	595	2	the	the	DET
admet-2057	595	3	other	other	ADJ
admet-2057	595	4	hand	hand	NOUN
admet-2057	595	5	,	,	PUNCT
admet-2057	595	6	lungs	lung	NOUN
admet-2057	595	7	have	have	VERB
admet-2057	595	8	a	a	DET
admet-2057	595	9	vast	vast	ADJ
admet-2057	595	10	surface	surface	NOUN
admet-2057	595	11	area	area	NOUN
admet-2057	595	12	,	,	PUNCT
admet-2057	595	13	the	the	DET
admet-2057	595	14	least	least	ADJ
admet-2057	595	15	chances	chance	NOUN
admet-2057	595	16	of	of	ADP
admet-2057	595	17	enzymatic	enzymatic	ADJ
admet-2057	595	18	degradation	degradation	NOUN
admet-2057	595	19	,	,	PUNCT
admet-2057	595	20	and	and	CCONJ
admet-2057	595	21	can	can	AUX
admet-2057	595	22	target	target	VERB
admet-2057	595	23	both	both	CCONJ
admet-2057	595	24	local	local	ADJ
admet-2057	595	25	and	and	CCONJ
admet-2057	595	26	systemic	systemic	ADJ
admet-2057	595	27	delivery	delivery	NOUN
admet-2057	595	28	,	,	PUNCT
admet-2057	595	29	but	but	CCONJ
admet-2057	595	30	still	still	ADV
admet-2057	595	31	delivering	deliver	VERB
admet-2057	595	32	mofs	mof	NOUN
admet-2057	595	33	by	by	ADP
admet-2057	595	34	pulmonary	pulmonary	ADJ
admet-2057	595	35	route	route	NOUN
admet-2057	595	36	is	be	AUX
admet-2057	595	37	a	a	DET
admet-2057	595	38	less	less	ADV
admet-2057	595	39	explored	explore	VERB
admet-2057	595	40	area	area	NOUN
admet-2057	595	41	.	.	PUNCT
admet-2057	596	1	cristina	cristina	PROPN
admet-2057	596	2	fernández	fernández	PROPN
admet-2057	596	3	-	-	PUNCT
admet-2057	596	4	paz	paz	NOUN
admet-2057	596	5	and	and	CCONJ
admet-2057	596	6	team	team	NOUN
admet-2057	597	1	[	[	X
admet-2057	597	2	115	115	NUM
admet-2057	597	3	]	]	PUNCT
admet-2057	597	4	engineered	engineer	VERB
admet-2057	597	5	nano	nano	NOUN
admet-2057	597	6	mof	mof	NOUN
admet-2057	597	7	-	-	PUNCT
admet-2057	597	8	based	base	VERB
admet-2057	597	9	microspheres	microsphere	NOUN
admet-2057	597	10	for	for	ADP
admet-2057	597	11	pulmonary	pulmonary	ADJ
admet-2057	597	12	delivery	delivery	NOUN
admet-2057	597	13	.	.	PUNCT
admet-2057	598	1	the	the	DET
admet-2057	598	2	team	team	NOUN
admet-2057	598	3	reported	report	VERB
admet-2057	598	4	a	a	DET
admet-2057	598	5	simple	simple	ADJ
admet-2057	598	6	and	and	CCONJ
admet-2057	598	7	convenient	convenient	ADJ
admet-2057	598	8	method	method	NOUN
admet-2057	598	9	for	for	ADP
admet-2057	598	10	developing	develop	VERB
admet-2057	598	11	pulmonary	pulmonary	NOUN
admet-2057	598	12	-	-	PUNCT
admet-2057	598	13	targeted	target	VERB
admet-2057	598	14	composites	composite	NOUN
admet-2057	598	15	based	base	VERB
admet-2057	598	16	on	on	ADP
admet-2057	598	17	mil-100	mil-100	PROPN
admet-2057	598	18	.	.	PUNCT
admet-2057	599	1	for	for	ADP
admet-2057	599	2	deep	deep	ADJ
admet-2057	599	3	lung	lung	NOUN
admet-2057	599	4	deposition	deposition	NOUN
admet-2057	599	5	,	,	PUNCT
admet-2057	599	6	these	these	DET
admet-2057	599	7	mil-100	mil-100	ADJ
admet-2057	599	8	systems	system	NOUN
admet-2057	599	9	were	be	AUX
admet-2057	599	10	then	then	ADV
admet-2057	599	11	encapsulated	encapsulate	VERB
admet-2057	599	12	into	into	ADP
admet-2057	599	13	microspheres	microsphere	NOUN
admet-2057	599	14	with	with	ADP
admet-2057	599	15	a	a	DET
admet-2057	599	16	spray	spray	NOUN
admet-2057	599	17	drying	dry	VERB
admet-2057	599	18	technique	technique	NOUN
admet-2057	599	19	using	use	VERB
admet-2057	599	20	the	the	DET
admet-2057	599	21	negatively	negatively	ADV
admet-2057	599	22	charged	charge	VERB
admet-2057	599	23	polysaccharide	polysaccharide	NOUN
admet-2057	599	24	dextran	dextran	NOUN
admet-2057	599	25	,	,	PUNCT
admet-2057	599	26	the	the	DET
admet-2057	599	27	oligosaccharide	oligosaccharide	NOUN
admet-2057	599	28	α	α	NOUN
admet-2057	599	29	-	-	NOUN
admet-2057	599	30	cyclodextrin	cyclodextrin	NOUN
admet-2057	599	31	,	,	PUNCT
admet-2057	599	32	and	and	CCONJ
admet-2057	599	33	the	the	DET
admet-2057	599	34	polyol	polyol	NOUN
admet-2057	599	35	mannitol	mannitol	NOUN
admet-2057	599	36	.	.	PUNCT
admet-2057	600	1	the	the	DET
admet-2057	600	2	in	in	ADP
admet-2057	600	3	vivo	vivo	ADJ
admet-2057	600	4	studies	study	NOUN
admet-2057	600	5	done	do	VERB
admet-2057	600	6	on	on	ADP
admet-2057	600	7	rats	rat	NOUN
admet-2057	600	8	showed	show	VERB
admet-2057	600	9	that	that	SCONJ
admet-2057	600	10	upon	upon	SCONJ
admet-2057	600	11	intratracheal	intratracheal	NOUN
admet-2057	600	12	administration	administration	NOUN
admet-2057	600	13	,	,	PUNCT
admet-2057	600	14	the	the	DET
admet-2057	600	15	system	system	NOUN
admet-2057	600	16	showed	show	VERB
admet-2057	600	17	uniform	uniform	ADJ
admet-2057	600	18	release	release	NOUN
admet-2057	600	19	of	of	ADP
admet-2057	600	20	the	the	DET
admet-2057	600	21	nano	nano	NOUN
admet-2057	600	22	mil-100	mil-100	NOUN
admet-2057	600	23	carrier	carrier	NOUN
admet-2057	600	24	inside	inside	ADP
admet-2057	600	25	the	the	DET
admet-2057	600	26	lungs	lung	NOUN
admet-2057	600	27	,	,	PUNCT
admet-2057	600	28	reaching	reach	VERB
admet-2057	600	29	the	the	DET
admet-2057	600	30	bronchioles	bronchiole	NOUN
admet-2057	600	31	and	and	CCONJ
admet-2057	600	32	alveoli	alveolus	NOUN
admet-2057	600	33	,	,	PUNCT
admet-2057	600	34	proving	prove	VERB
admet-2057	600	35	that	that	SCONJ
admet-2057	600	36	the	the	DET
admet-2057	600	37	mof	mof	ADJ
admet-2057	600	38	system	system	NOUN
admet-2057	600	39	can	can	AUX
admet-2057	600	40	act	act	VERB
admet-2057	600	41	as	as	ADP
admet-2057	600	42	a	a	DET
admet-2057	600	43	potential	potential	ADJ
admet-2057	600	44	means	mean	NOUN
admet-2057	600	45	for	for	ADP
admet-2057	600	46	pulmonary	pulmonary	ADJ
admet-2057	600	47	delivery	delivery	NOUN
admet-2057	601	1	[	[	X
admet-2057	601	2	115	115	NUM
admet-2057	601	3	]	]	PUNCT
admet-2057	601	4	.	.	PUNCT
admet-2057	602	1	xiaoxiao	xiaoxiao	PROPN
admet-2057	602	2	hu	hu	PROPN
admet-2057	603	1	[	[	X
admet-2057	603	2	116	116	X
admet-2057	603	3	]	]	PUNCT
admet-2057	603	4	presented	present	VERB
admet-2057	603	5	a	a	DET
admet-2057	603	6	mof	mof	ADJ
admet-2057	603	7	platform	platform	NOUN
admet-2057	603	8	for	for	ADP
admet-2057	603	9	pulmonary	pulmonary	ADJ
admet-2057	603	10	delivery	delivery	NOUN
admet-2057	603	11	in	in	ADP
admet-2057	603	12	a	a	DET
admet-2057	603	13	study	study	NOUN
admet-2057	603	14	they	they	PRON
admet-2057	603	15	conducted	conduct	VERB
admet-2057	603	16	.	.	PUNCT
admet-2057	604	1	as	as	ADP
admet-2057	604	2	a	a	DET
admet-2057	604	3	dpi	dpi	NOUN
admet-2057	604	4	(	(	PUNCT
admet-2057	604	5	dry	dry	ADJ
admet-2057	604	6	powder	powder	NOUN
admet-2057	604	7	inhaler	inhaler	NOUN
admet-2057	604	8	)	)	PUNCT
admet-2057	604	9	carrier	carrier	NOUN
admet-2057	604	10	for	for	ADP
admet-2057	604	11	the	the	DET
admet-2057	604	12	drug	drug	NOUN
admet-2057	604	13	budesonide	budesonide	NOUN
admet-2057	604	14	(	(	PUNCT
admet-2057	604	15	bud	bud	NOUN
admet-2057	604	16	)	)	PUNCT
admet-2057	604	17	,	,	PUNCT
admet-2057	604	18	neutralized	neutralize	VERB
admet-2057	604	19	nanoporous	nanoporous	ADJ
admet-2057	604	20	cyclodextrin	cyclodextrin	NOUN
admet-2057	604	21	-	-	PUNCT
admet-2057	604	22	mof	mof	VERB
admet-2057	604	23	crystals	crystal	NOUN
admet-2057	604	24	with	with	ADP
admet-2057	604	25	cubic	cubic	ADJ
admet-2057	604	26	morphology	morphology	NOUN
admet-2057	604	27	and	and	CCONJ
admet-2057	604	28	uniform	uniform	ADJ
admet-2057	604	29	inhaling	inhaling	NOUN
admet-2057	604	30	size	size	NOUN
admet-2057	604	31	were	be	AUX
admet-2057	604	32	created	create	VERB
admet-2057	604	33	and	and	CCONJ
admet-2057	604	34	adjusted	adjust	VERB
admet-2057	604	35	.	.	PUNCT
admet-2057	605	1	to	to	PART
admet-2057	605	2	increase	increase	VERB
admet-2057	605	3	the	the	DET
admet-2057	605	4	flowability	flowability	NOUN
admet-2057	605	5	and	and	CCONJ
admet-2057	605	6	particle	particle	NOUN
admet-2057	605	7	aerodynamic	aerodynamic	ADJ
admet-2057	605	8	behaviour	behaviour	NOUN
admet-2057	605	9	of	of	ADP
admet-2057	605	10	the	the	DET
admet-2057	605	11	cd	cd	PROPN
admet-2057	605	12	-	-	PUNCT
admet-2057	605	13	mof	mof	VERB
admet-2057	605	14	powder	powder	NOUN
admet-2057	605	15	,	,	PUNCT
admet-2057	605	16	leucine	leucine	NOUN
admet-2057	605	17	(	(	PUNCT
admet-2057	605	18	leu)-poloxamer	leu)-poloxamer	PROPN
admet-2057	605	19	and	and	CCONJ
admet-2057	605	20	cholesterol	cholesterol	NOUN
admet-2057	605	21	(	(	PUNCT
admet-2057	605	22	cho	cho	NOUN
admet-2057	605	23	)	)	PUNCT
admet-2057	605	24	were	be	AUX
admet-2057	605	25	added	add	VERB
admet-2057	605	26	,	,	PUNCT
admet-2057	605	27	and	and	CCONJ
admet-2057	605	28	the	the	DET
admet-2057	605	29	particle	particle	NOUN
admet-2057	605	30	size	size	NOUN
admet-2057	605	31	distribution	distribution	NOUN
admet-2057	605	32	,	,	PUNCT
admet-2057	605	33	carr	carr	PROPN
admet-2057	605	34	's	's	PART
admet-2057	605	35	index	index	NOUN
admet-2057	605	36	,	,	PUNCT
admet-2057	605	37	and	and	CCONJ
admet-2057	605	38	in	in	ADP
admet-2057	605	39	vitro	vitro	X
admet-2057	605	40	pulmonary	pulmonary	ADJ
admet-2057	605	41	deposition	deposition	NOUN
admet-2057	605	42	were	be	AUX
admet-2057	605	43	measured	measure	VERB
admet-2057	605	44	as	as	ADP
admet-2057	605	45	a	a	DET
admet-2057	605	46	result	result	NOUN
admet-2057	605	47	.	.	PUNCT
admet-2057	606	1	cho	cho	PROPN
admet-2057	606	2	-	-	PUNCT
admet-2057	606	3	cd	cd	NOUN
admet-2057	606	4	-	-	PUNCT
admet-2057	606	5	mof	mof	VERB
admet-2057	606	6	outperformed	outperform	VERB
admet-2057	606	7	cd	cd	PROPN
admet-2057	606	8	-	-	PUNCT
admet-2057	606	9	mof	mof	PROPN
admet-2057	606	10	or	or	CCONJ
admet-2057	606	11	leu	leu	PROPN
admet-2057	606	12	-	-	PROPN
admet-2057	606	13	cd	cd	PROPN
admet-2057	606	14	-	-	PUNCT
admet-2057	606	15	mof	mof	NOUN
admet-2057	606	16	-	-	PUNCT
admet-2057	606	17	bud	bud	NOUN
admet-2057	606	18	in	in	ADP
admet-2057	606	19	terms	term	NOUN
admet-2057	606	20	of	of	ADP
admet-2057	606	21	mass	mass	ADJ
admet-2057	606	22	median	median	ADJ
admet-2057	606	23	aerodynamic	aerodynamic	ADJ
admet-2057	606	24	diameter	diameter	NOUN
admet-2057	606	25	(	(	PUNCT
admet-2057	606	26	4.35±0.04	4.35±0.04	NOUN
admet-2057	606	27	µm	µm	NOUN
admet-2057	606	28	)	)	PUNCT
admet-2057	606	29	and	and	CCONJ
admet-2057	606	30	inhalable	inhalable	ADJ
admet-2057	606	31	performance	performance	NOUN
admet-2057	606	32	(	(	PUNCT
admet-2057	606	33	30.60±0.76	30.60±0.76	NUM
admet-2057	606	34	%	%	NOUN
admet-2057	606	35	fine	fine	ADJ
admet-2057	606	36	particle	particle	NOUN
admet-2057	606	37	percentage	percentage	NOUN
admet-2057	606	38	)	)	PUNCT
admet-2057	606	39	,	,	PUNCT
admet-2057	606	40	both	both	PRON
admet-2057	606	41	of	of	ADP
admet-2057	606	42	which	which	PRON
admet-2057	606	43	persisted	persist	VERB
admet-2057	606	44	after	after	ADP
admet-2057	606	45	budesonide	budesonide	NOUN
admet-2057	606	46	loading	loading	NOUN
admet-2057	606	47	(	(	PUNCT
admet-2057	606	48	4.47±0.30	4.47±0.30	NOUN
admet-2057	606	49	µm	µm	NOUN
admet-2057	606	50	,	,	PUNCT
admet-2057	606	51	24.95±4.33	24.95±4.33	NUM
admet-2057	606	52	%	%	NOUN
admet-2057	606	53	)	)	PUNCT
admet-2057	607	1	.then	.then	X
admet-2057	607	2	,	,	PUNCT
admet-2057	607	3	powder	powder	NOUN
admet-2057	607	4	x	x	NOUN
admet-2057	607	5	-	-	NOUN
admet-2057	607	6	ray	ray	NOUN
admet-2057	607	7	diffraction	diffraction	NOUN
admet-2057	607	8	(	(	PUNCT
admet-2057	607	9	pxrd	pxrd	PROPN
admet-2057	607	10	)	)	PUNCT
admet-2057	607	11	,	,	PUNCT
admet-2057	607	12	cell	cell	NOUN
admet-2057	607	13	viability	viability	NOUN
admet-2057	607	14	analysis	analysis	NOUN
admet-2057	607	15	,	,	PUNCT
admet-2057	607	16	in	in	ADP
admet-2057	607	17	vivo	vivo	ADJ
admet-2057	607	18	fluorescence	fluorescence	NOUN
admet-2057	607	19	imaging	imaging	NOUN
admet-2057	607	20	,	,	PUNCT
admet-2057	607	21	and	and	CCONJ
admet-2057	607	22	pharmacokinetic	pharmacokinetic	ADJ
admet-2057	607	23	investigations	investigation	NOUN
admet-2057	607	24	in	in	ADP
admet-2057	607	25	rats	rat	NOUN
admet-2057	607	26	were	be	AUX
admet-2057	607	27	used	use	VERB
admet-2057	607	28	to	to	PART
admet-2057	607	29	assess	assess	VERB
admet-2057	607	30	the	the	DET
admet-2057	607	31	crystallinity	crystallinity	NOUN
admet-2057	607	32	,	,	PUNCT
admet-2057	607	33	cytotoxicity	cytotoxicity	NOUN
admet-2057	607	34	,	,	PUNCT
admet-2057	607	35	and	and	CCONJ
admet-2057	607	36	in	in	ADP
admet-2057	607	37	vivo	vivo	ADJ
admet-2057	607	38	deposition	deposition	NOUN
admet-2057	607	39	of	of	ADP
admet-2057	607	40	drug	drug	NOUN
admet-2057	607	41	-	-	PUNCT
admet-2057	607	42	loaded	load	VERB
admet-2057	607	43	materials	material	NOUN
admet-2057	607	44	(	(	PUNCT
admet-2057	607	45	cho	cho	NOUN
admet-2057	607	46	-	-	PUNCT
admet-2057	607	47	cd	cd	NOUN
admet-2057	607	48	-	-	PUNCT
admet-2057	607	49	mof	mof	VERB
admet-2057	607	50	-	-	PUNCT
admet-2057	607	51	bud	bud	NOUN
admet-2057	607	52	)	)	PUNCT
admet-2057	607	53	.	.	PUNCT
admet-2057	608	1	after	after	ADP
admet-2057	608	2	being	be	AUX
admet-2057	608	3	loaded	load	VERB
admet-2057	608	4	into	into	ADP
admet-2057	608	5	cho	cho	PROPN
admet-2057	608	6	-	-	PUNCT
admet-2057	608	7	cd	cd	NOUN
admet-2057	608	8	-	-	PUNCT
admet-2057	608	9	mof	mof	VERB
admet-2057	608	10	,	,	PUNCT
admet-2057	608	11	budesonide	budesonide	NOUN
admet-2057	608	12	's	's	PART
admet-2057	608	13	distinctive	distinctive	ADJ
admet-2057	608	14	pxrd	pxrd	NOUN
admet-2057	608	15	crystallinity	crystallinity	NOUN
admet-2057	608	16	peaks	peak	NOUN
admet-2057	608	17	vanished	vanish	VERB
admet-2057	608	18	,	,	PUNCT
admet-2057	608	19	possibly	possibly	ADV
admet-2057	608	20	indicating	indicate	VERB
admet-2057	608	21	that	that	SCONJ
admet-2057	608	22	budesonide	budesonide	NOUN
admet-2057	608	23	has	have	AUX
admet-2057	608	24	been	be	AUX
admet-2057	608	25	molecularly	molecularly	ADV
admet-2057	608	26	incorporated	incorporate	VERB
admet-2057	608	27	into	into	ADP
admet-2057	608	28	the	the	DET
admet-2057	608	29	pores	pore	NOUN
admet-2057	608	30	of	of	ADP
admet-2057	608	31	cd	cd	PROPN
admet-2057	608	32	-	-	PUNCT
admet-2057	608	33	mof	mof	NOUN
admet-2057	608	34	.	.	PUNCT
admet-2057	609	1	due	due	ADP
admet-2057	609	2	to	to	ADP
admet-2057	609	3	cd	cd	PROPN
admet-2057	609	4	-	-	PUNCT
admet-2057	609	5	mof	mof	NOUN
admet-2057	609	6	's	's	PART
admet-2057	609	7	excellent	excellent	ADJ
admet-2057	609	8	biocompatibility	biocompatibility	NOUN
admet-2057	609	9	,	,	PUNCT
admet-2057	609	10	the	the	DET
admet-2057	609	11	a549	a549	PROPN
admet-2057	609	12	cell	cell	NOUN
admet-2057	609	13	's	's	PART
admet-2057	609	14	viability	viability	NOUN
admet-2057	609	15	for	for	ADP
admet-2057	609	16	cho	cho	PROPN
admet-2057	609	17	-	-	PUNCT
admet-2057	609	18	cd	cd	NOUN
admet-2057	609	19	-	-	PUNCT
admet-2057	609	20	mof	mof	VERB
admet-2057	609	21	-	-	PUNCT
admet-2057	609	22	bud	bud	NOUN
admet-2057	609	23	was	be	AUX
admet-2057	609	24	greater	great	ADJ
admet-2057	609	25	than	than	ADP
admet-2057	609	26	90	90	NUM
admet-2057	609	27	%	%	NOUN
admet-2057	609	28	.	.	PUNCT
admet-2057	610	1	the	the	DET
admet-2057	610	2	fluorescent	fluorescent	ADJ
admet-2057	610	3	signal	signal	NOUN
admet-2057	610	4	at	at	ADP
admet-2057	610	5	the	the	DET
admet-2057	610	6	lung	lung	NOUN
admet-2057	610	7	tissue	tissue	NOUN
admet-2057	610	8	was	be	AUX
admet-2057	610	9	significantly	significantly	ADV
admet-2057	610	10	improved	improve	VERB
admet-2057	610	11	after	after	ADP
admet-2057	610	12	cholesterol	cholesterol	NOUN
admet-2057	610	13	modification	modification	NOUN
admet-2057	610	14	compared	compare	VERB
admet-2057	610	15	to	to	ADP
admet-2057	610	16	cd	cd	NOUN
admet-2057	610	17	-	-	PUNCT
admet-2057	610	18	mof	mof	PROPN
admet-2057	610	19	when	when	SCONJ
admet-2057	610	20	rhodamine	rhodamine	PROPN
admet-2057	610	21	b	b	PROPN
admet-2057	610	22	was	be	AUX
admet-2057	610	23	carried	carry	VERB
admet-2057	610	24	by	by	ADP
admet-2057	610	25	the	the	DET
admet-2057	610	26	dpi	dpi	NOUN
admet-2057	610	27	particles	particle	NOUN
admet-2057	610	28	,	,	PUNCT
admet-2057	610	29	and	and	CCONJ
admet-2057	610	30	the	the	DET
admet-2057	610	31	bioavailability	bioavailability	NOUN
admet-2057	610	32	of	of	ADP
admet-2057	610	33	cho	cho	PROPN
admet-2057	610	34	-	-	PUNCT
admet-2057	610	35	cd	cd	NOUN
admet-2057	610	36	-	-	PUNCT
admet-2057	610	37	mof	mof	NOUN
admet-2057	610	38	-	-	PUNCT
admet-2057	610	39	bud	bud	NOUN
admet-2057	610	40	in	in	ADP
admet-2057	610	41	rats	rat	NOUN
admet-2057	610	42	was	be	AUX
admet-2057	610	43	comparable	comparable	ADJ
admet-2057	610	44	to	to	ADP
admet-2057	610	45	that	that	PRON
admet-2057	610	46	of	of	ADP
admet-2057	610	47	pulmicort	pulmicort	NOUN
admet-2057	610	48	turbuhaler	turbuhaler	NOUN
admet-2057	610	49	,	,	PUNCT
admet-2057	610	50	a	a	DET
admet-2057	610	51	commercial	commercial	ADJ
admet-2057	610	52	product	product	NOUN
admet-2057	610	53	.	.	PUNCT
admet-2057	611	1	therefore	therefore	ADV
admet-2057	611	2	,	,	PUNCT
admet-2057	611	3	the	the	DET
admet-2057	611	4	cd	cd	PROPN
admet-2057	611	5	-	-	PUNCT
admet-2057	611	6	mof	mof	VERB
admet-2057	611	7	powders	powder	NOUN
admet-2057	611	8	modified	modify	VERB
admet-2057	611	9	by	by	ADP
admet-2057	611	10	cholesterol	cholesterol	NOUN
admet-2057	611	11	can	can	AUX
admet-2057	611	12	be	be	AUX
admet-2057	611	13	employed	employ	VERB
admet-2057	611	14	as	as	ADP
admet-2057	611	15	a	a	DET
admet-2057	611	16	promising	promising	ADJ
admet-2057	611	17	inhalable	inhalable	ADJ
admet-2057	611	18	carrier	carrier	NOUN
admet-2057	611	19	for	for	ADP
admet-2057	611	20	the	the	DET
admet-2057	611	21	pulmonary	pulmonary	ADJ
admet-2057	611	22	administration	administration	NOUN
admet-2057	611	23	of	of	ADP
admet-2057	611	24	medicines	medicine	NOUN
admet-2057	611	25	in	in	ADP
admet-2057	611	26	tiny	tiny	ADJ
admet-2057	611	27	doses	dose	NOUN
admet-2057	611	28	.	.	PUNCT
admet-2057	612	1	in	in	ADP
admet-2057	612	2	another	another	DET
admet-2057	612	3	study	study	NOUN
admet-2057	612	4	,	,	PUNCT
admet-2057	612	5	ccm	ccm	PROPN
admet-2057	612	6	was	be	AUX
admet-2057	612	7	loaded	load	VERB
admet-2057	612	8	onto	onto	ADP
admet-2057	612	9	cd	cd	NOUN
admet-2057	612	10	-	-	PUNCT
admet-2057	612	11	mofs	mof	NOUN
admet-2057	612	12	in	in	ADP
admet-2057	612	13	2019	2019	NUM
admet-2057	612	14	by	by	ADP
admet-2057	612	15	yixian	yixian	ADJ
admet-2057	612	16	zhou	zhou	PROPN
admet-2057	613	1	[	[	X
admet-2057	613	2	117	117	NUM
admet-2057	613	3	]	]	PUNCT
admet-2057	613	4	for	for	ADP
admet-2057	613	5	pulmonary	pulmonary	ADJ
admet-2057	613	6	administration	administration	NOUN
admet-2057	613	7	.	.	PUNCT
admet-2057	614	1	ccm	ccm	NOUN
admet-2057	614	2	-	-	PUNCT
admet-2057	614	3	loaded	load	VERB
admet-2057	614	4	cd	cd	NOUN
admet-2057	614	5	-	-	PUNCT
admet-2057	614	6	mofs	mof	NOUN
admet-2057	614	7	(	(	PUNCT
admet-2057	614	8	ccm	ccm	NOUN
admet-2057	614	9	-	-	PUNCT
admet-2057	614	10	cdmofs	cdmofs	NOUN
admet-2057	614	11	)	)	PUNCT
admet-2057	614	12	had	have	VERB
admet-2057	614	13	exceptional	exceptional	ADJ
admet-2057	614	14	aerodynamic	aerodynamic	ADJ
admet-2057	614	15	performance	performance	NOUN
admet-2057	614	16	in	in	ADP
admet-2057	614	17	comparison	comparison	NOUN
admet-2057	614	18	to	to	ADP
admet-2057	614	19	micronized	micronized	ADJ
admet-2057	614	20	ccm	ccm	NOUN
admet-2057	614	21	generated	generate	VERB
admet-2057	614	22	by	by	ADP
admet-2057	614	23	jet	jet	NOUN
admet-2057	614	24	milling	milling	NOUN
admet-2057	614	25	,	,	PUNCT
admet-2057	614	26	which	which	PRON
admet-2057	614	27	was	be	AUX
admet-2057	614	28	attributed	attribute	VERB
admet-2057	614	29	to	to	ADP
admet-2057	614	30	the	the	DET
admet-2057	614	31	special	special	ADJ
admet-2057	614	32	porous	porous	ADJ
admet-2057	614	33	structure	structure	NOUN
admet-2057	614	34	and	and	CCONJ
admet-2057	614	35	lower	low	ADJ
admet-2057	614	36	density	density	NOUN
admet-2057	614	37	admet	admet	PROPN
admet-2057	614	38	&	&	CCONJ
admet-2057	614	39	dmpk	dmpk	PROPN
admet-2057	614	40	12(1	12(1	PROPN
admet-2057	614	41	)	)	PUNCT
admet-2057	614	42	(	(	PUNCT
admet-2057	614	43	2024	2024	NUM
admet-2057	614	44	)	)	PUNCT
admet-2057	614	45	27	27	NUM
admet-2057	614	46	-	-	SYM
admet-2057	614	47	62	62	NUM
admet-2057	614	48	drug	drug	NOUN
admet-2057	614	49	delivery	delivery	NOUN
admet-2057	614	50	applications	application	NOUN
admet-2057	614	51	of	of	ADP
admet-2057	614	52	metal	metal	NOUN
admet-2057	614	53	-	-	PUNCT
admet-2057	614	54	organic	organic	ADJ
admet-2057	614	55	framework	framework	NOUN
admet-2057	614	56	doi	doi	NOUN
admet-2057	614	57	:	:	PUNCT
admet-2057	614	58	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	614	59	49	49	NUM
admet-2057	614	60	of	of	ADP
admet-2057	614	61	cd	cd	PROPN
admet-2057	614	62	-	-	PUNCT
admet-2057	614	63	mofs	mof	NOUN
admet-2057	614	64	.	.	PUNCT
admet-2057	615	1	the	the	DET
admet-2057	615	2	dissolution	dissolution	NOUN
admet-2057	615	3	test	test	NOUN
admet-2057	615	4	revealed	reveal	VERB
admet-2057	615	5	that	that	SCONJ
admet-2057	615	6	ccm	ccm	NOUN
admet-2057	615	7	-	-	PUNCT
admet-2057	615	8	cd	cd	NOUN
admet-2057	615	9	-	-	PUNCT
admet-2057	615	10	mofs	mof	NOUN
admet-2057	615	11	released	release	VERB
admet-2057	615	12	drugs	drug	NOUN
admet-2057	615	13	at	at	ADP
admet-2057	615	14	a	a	DET
admet-2057	615	15	rate	rate	NOUN
admet-2057	615	16	that	that	PRON
admet-2057	615	17	was	be	AUX
admet-2057	615	18	significantly	significantly	ADV
admet-2057	615	19	higher	high	ADJ
admet-2057	615	20	than	than	ADP
admet-2057	615	21	that	that	PRON
admet-2057	615	22	of	of	ADP
admet-2057	615	23	micronized	micronized	ADJ
admet-2057	615	24	ccm	ccm	NOUN
admet-2057	615	25	.	.	PUNCT
admet-2057	616	1	according	accord	VERB
admet-2057	616	2	to	to	ADP
admet-2057	616	3	the	the	DET
admet-2057	616	4	all	all	DET
admet-2057	616	5	-	-	PUNCT
admet-2057	616	6	atom	atom	NOUN
admet-2057	616	7	molecular	molecular	ADJ
admet-2057	616	8	dynamic	dynamic	ADJ
admet-2057	616	9	simulation	simulation	NOUN
admet-2057	616	10	,	,	PUNCT
admet-2057	616	11	ccm	ccm	NOUN
admet-2057	616	12	molecules	molecule	NOUN
admet-2057	616	13	were	be	AUX
admet-2057	616	14	found	find	VERB
admet-2057	616	15	to	to	PART
admet-2057	616	16	be	be	AUX
admet-2057	616	17	loaded	load	VERB
admet-2057	616	18	into	into	ADP
admet-2057	616	19	cd	cd	PROPN
admet-2057	616	20	-	-	PUNCT
admet-2057	616	21	mofs	mof	NOUN
admet-2057	616	22	'	'	PART
admet-2057	616	23	hydrophobic	hydrophobic	NOUN
admet-2057	616	24	cavities	cavity	NOUN
admet-2057	616	25	or	or	CCONJ
admet-2057	616	26	introduced	introduce	VERB
admet-2057	616	27	into	into	ADP
admet-2057	616	28	their	their	PRON
admet-2057	616	29	vast	vast	ADJ
admet-2057	616	30	hydrophilic	hydrophilic	ADJ
admet-2057	616	31	cavities	cavity	NOUN
admet-2057	616	32	to	to	PART
admet-2057	616	33	form	form	VERB
admet-2057	616	34	nanoclusters	nanocluster	NOUN
admet-2057	616	35	.	.	PUNCT
admet-2057	617	1	the	the	DET
admet-2057	617	2	improved	improve	VERB
admet-2057	617	3	dissolution	dissolution	NOUN
admet-2057	617	4	rate	rate	NOUN
admet-2057	617	5	may	may	AUX
admet-2057	617	6	be	be	AUX
admet-2057	617	7	facilitated	facilitate	VERB
admet-2057	617	8	by	by	ADP
admet-2057	617	9	the	the	DET
admet-2057	617	10	increased	increase	VERB
admet-2057	617	11	wettability	wettability	NOUN
admet-2057	617	12	of	of	ADP
admet-2057	617	13	ccmcd	ccmcd	NOUN
admet-2057	617	14	-	-	PUNCT
admet-2057	617	15	mofs	mof	NOUN
admet-2057	617	16	and	and	CCONJ
admet-2057	617	17	the	the	DET
admet-2057	617	18	distinctive	distinctive	ADJ
admet-2057	617	19	spatial	spatial	ADJ
admet-2057	617	20	distribution	distribution	NOUN
admet-2057	617	21	feature	feature	NOUN
admet-2057	617	22	of	of	ADP
admet-2057	617	23	ccm	ccm	NOUN
admet-2057	617	24	in	in	ADP
admet-2057	617	25	the	the	DET
admet-2057	617	26	porous	porous	ADJ
admet-2057	617	27	interior	interior	NOUN
admet-2057	617	28	of	of	ADP
admet-2057	617	29	cd	cd	PROPN
admet-2057	617	30	-	-	PUNCT
admet-2057	617	31	mofs	mof	NOUN
admet-2057	617	32	.	.	PUNCT
admet-2057	618	1	the	the	DET
admet-2057	618	2	dpph	dpph	PROPN
admet-2057	618	3	radical	radical	ADJ
admet-2057	618	4	scavenging	scavenging	NOUN
admet-2057	618	5	assay	assay	PROPN
admet-2057	618	6	demonstrated	demonstrate	VERB
admet-2057	618	7	ccm	ccm	PROPN
admet-2057	618	8	-	-	PUNCT
admet-2057	618	9	cd	cd	NOUN
admet-2057	618	10	-	-	PUNCT
admet-2057	618	11	mofs	mof	NOUN
admet-2057	618	12	'	'	PART
admet-2057	618	13	strong	strong	ADJ
admet-2057	618	14	antioxidant	antioxidant	ADJ
admet-2057	618	15	capacity	capacity	NOUN
admet-2057	618	16	.	.	PUNCT
admet-2057	619	1	consequently	consequently	ADV
admet-2057	619	2	,	,	PUNCT
admet-2057	619	3	it	it	PRON
admet-2057	619	4	was	be	AUX
admet-2057	619	5	anticipated	anticipate	VERB
admet-2057	619	6	that	that	SCONJ
admet-2057	619	7	cd	cd	NOUN
admet-2057	619	8	-	-	PUNCT
admet-2057	619	9	mofs	mof	NOUN
admet-2057	619	10	would	would	AUX
admet-2057	619	11	be	be	AUX
admet-2057	619	12	promising	promise	VERB
admet-2057	619	13	vehicles	vehicle	NOUN
admet-2057	619	14	for	for	ADP
admet-2057	619	15	the	the	DET
admet-2057	619	16	pulmonary	pulmonary	ADJ
admet-2057	619	17	administration	administration	NOUN
admet-2057	619	18	of	of	ADP
admet-2057	619	19	weakly	weakly	ADJ
admet-2057	619	20	watersoluble	watersoluble	ADJ
admet-2057	619	21	drugs	drug	NOUN
admet-2057	619	22	.	.	PUNCT
admet-2057	620	1	a	a	DET
admet-2057	620	2	series	series	NOUN
admet-2057	620	3	of	of	ADP
admet-2057	620	4	homogenous	homogenous	ADJ
admet-2057	620	5	nanopore	nanopore	ADV
admet-2057	620	6	-	-	PUNCT
admet-2057	620	7	containing	contain	VERB
admet-2057	620	8	cd	cd	NOUN
admet-2057	620	9	-	-	PUNCT
admet-2057	620	10	mof	mof	VERB
admet-2057	620	11	particles	particle	NOUN
admet-2057	620	12	were	be	AUX
admet-2057	620	13	expertly	expertly	ADV
admet-2057	620	14	crafted	craft	VERB
admet-2057	620	15	without	without	ADP
admet-2057	620	16	the	the	DET
admet-2057	620	17	use	use	NOUN
admet-2057	620	18	of	of	ADP
admet-2057	620	19	porogens	porogen	NOUN
admet-2057	620	20	in	in	ADP
admet-2057	620	21	a	a	DET
admet-2057	620	22	study	study	NOUN
admet-2057	620	23	by	by	ADP
admet-2057	620	24	yixian	yixian	ADJ
admet-2057	620	25	zhou	zhou	PROPN
admet-2057	621	1	[	[	X
admet-2057	621	2	118	118	NUM
admet-2057	621	3	]	]	PUNCT
admet-2057	621	4	.	.	PUNCT
admet-2057	622	1	due	due	ADP
admet-2057	622	2	to	to	ADP
admet-2057	622	3	its	its	PRON
admet-2057	622	4	uniform	uniform	ADJ
admet-2057	622	5	nanoporous	nanoporous	ADJ
admet-2057	622	6	structure	structure	NOUN
admet-2057	622	7	,	,	PUNCT
admet-2057	622	8	cd	cd	NOUN
admet-2057	622	9	-	-	PUNCT
admet-2057	622	10	mof	mof	PROPN
admet-2057	622	11	demonstrated	demonstrate	VERB
admet-2057	622	12	superior	superior	ADJ
admet-2057	622	13	aerosolization	aerosolization	NOUN
admet-2057	622	14	ability	ability	NOUN
admet-2057	622	15	compared	compare	VERB
admet-2057	622	16	to	to	ADP
admet-2057	622	17	commercial	commercial	ADJ
admet-2057	622	18	inhalation	inhalation	NOUN
admet-2057	622	19	carriers	carrier	NOUN
admet-2057	622	20	.	.	PUNCT
admet-2057	623	1	a	a	DET
admet-2057	623	2	number	number	NOUN
admet-2057	623	3	of	of	ADP
admet-2057	623	4	experiments	experiment	NOUN
admet-2057	623	5	,	,	PUNCT
admet-2057	623	6	including	include	VERB
admet-2057	623	7	cytotoxicity	cytotoxicity	NOUN
admet-2057	623	8	assays	assay	NOUN
admet-2057	623	9	,	,	PUNCT
admet-2057	623	10	hemolysis	hemolysis	NOUN
admet-2057	623	11	ratio	ratio	NOUN
admet-2057	623	12	tests	test	NOUN
admet-2057	623	13	,	,	PUNCT
admet-2057	623	14	lung	lung	NOUN
admet-2057	623	15	function	function	NOUN
admet-2057	623	16	assessments	assessment	NOUN
admet-2057	623	17	,	,	PUNCT
admet-2057	623	18	in	in	ADP
admet-2057	623	19	-	-	PUNCT
admet-2057	623	20	vivo	vivo	ADJ
admet-2057	623	21	lung	lung	NOUN
admet-2057	623	22	injury	injury	NOUN
admet-2057	623	23	indicators	indicator	NOUN
admet-2057	623	24	measurements	measurement	NOUN
admet-2057	623	25	,	,	PUNCT
admet-2057	623	26	and	and	CCONJ
admet-2057	623	27	histological	histological	ADJ
admet-2057	623	28	analyses	analysis	NOUN
admet-2057	623	29	,	,	PUNCT
admet-2057	623	30	further	far	ADV
admet-2057	623	31	supported	support	VERB
admet-2057	623	32	cd	cd	PROPN
admet-2057	623	33	-	-	PUNCT
admet-2057	623	34	mof	mof	NOUN
admet-2057	623	35	's	's	PART
admet-2057	623	36	excellent	excellent	ADJ
admet-2057	623	37	biocompatibility	biocompatibility	NOUN
admet-2057	623	38	in	in	ADP
admet-2057	623	39	pulmonary	pulmonary	ADJ
admet-2057	623	40	delivery	delivery	NOUN
admet-2057	623	41	.	.	PUNCT
admet-2057	624	1	the	the	DET
admet-2057	624	2	significant	significant	ADJ
admet-2057	624	3	rate	rate	NOUN
admet-2057	624	4	of	of	ADP
admet-2057	624	5	cd	cd	PROPN
admet-2057	624	6	-	-	PUNCT
admet-2057	624	7	mof	mof	ADJ
admet-2057	624	8	deposition	deposition	NOUN
admet-2057	624	9	in	in	ADP
admet-2057	624	10	the	the	DET
admet-2057	624	11	lungs	lung	NOUN
admet-2057	624	12	was	be	AUX
admet-2057	624	13	revealed	reveal	VERB
admet-2057	624	14	by	by	ADP
admet-2057	624	15	ex	ex	PRON
admet-2057	624	16	vivo	vivo	ADJ
admet-2057	624	17	fluorescence	fluorescence	NOUN
admet-2057	624	18	imaging	imaging	NOUN
admet-2057	624	19	data	datum	NOUN
admet-2057	624	20	.	.	PUNCT
admet-2057	625	1	in	in	ADP
admet-2057	625	2	light	light	NOUN
admet-2057	625	3	of	of	ADP
admet-2057	625	4	all	all	DET
admet-2057	625	5	the	the	DET
admet-2057	625	6	findings	finding	NOUN
admet-2057	625	7	,	,	PUNCT
admet-2057	625	8	cd	cd	PROPN
admet-2057	625	9	-	-	PUNCT
admet-2057	625	10	mof	mof	PROPN
admet-2057	625	11	was	be	AUX
admet-2057	625	12	shown	show	VERB
admet-2057	625	13	to	to	PART
admet-2057	625	14	be	be	AUX
admet-2057	625	15	a	a	DET
admet-2057	625	16	potential	potential	ADJ
admet-2057	625	17	carrier	carrier	NOUN
admet-2057	625	18	for	for	ADP
admet-2057	625	19	pulmonary	pulmonary	ADJ
admet-2057	625	20	medication	medication	NOUN
admet-2057	625	21	delivery	delivery	NOUN
admet-2057	625	22	.	.	PUNCT
admet-2057	626	1	the	the	DET
admet-2057	626	2	nanoporous	nanoporous	ADJ
admet-2057	626	3	particles	particle	NOUN
admet-2057	626	4	for	for	ADP
admet-2057	626	5	efficient	efficient	ADJ
admet-2057	626	6	pulmonary	pulmonary	ADJ
admet-2057	626	7	delivery	delivery	NOUN
admet-2057	626	8	may	may	AUX
admet-2057	626	9	be	be	AUX
admet-2057	626	10	clarified	clarify	VERB
admet-2057	626	11	by	by	ADP
admet-2057	626	12	this	this	DET
admet-2057	626	13	investigation	investigation	NOUN
admet-2057	626	14	.	.	PUNCT
admet-2057	627	1	in	in	ADP
admet-2057	627	2	a	a	DET
admet-2057	627	3	similar	similar	ADJ
admet-2057	627	4	line	line	NOUN
admet-2057	627	5	,	,	PUNCT
admet-2057	627	6	bader	bader	PROPN
admet-2057	627	7	m.	m.	PROPN
admet-2057	627	8	jarai	jarai	PROPN
admet-2057	627	9	and	and	CCONJ
admet-2057	627	10	colleagues	colleague	NOUN
admet-2057	628	1	[	[	X
admet-2057	628	2	119	119	NUM
admet-2057	628	3	]	]	PUNCT
admet-2057	628	4	examined	examine	VERB
admet-2057	628	5	the	the	DET
admet-2057	628	6	application	application	NOUN
admet-2057	628	7	of	of	ADP
admet-2057	628	8	the	the	DET
admet-2057	628	9	uio-66	uio-66	PROPN
admet-2057	628	10	nps	nps	PROPN
admet-2057	628	11	for	for	ADP
admet-2057	628	12	the	the	DET
admet-2057	628	13	targeted	target	VERB
admet-2057	628	14	pulmonary	pulmonary	ADJ
admet-2057	628	15	drug	drug	NOUN
admet-2057	628	16	delivery	delivery	NOUN
admet-2057	628	17	system	system	NOUN
admet-2057	628	18	.	.	PUNCT
admet-2057	629	1	they	they	PRON
admet-2057	629	2	evaluated	evaluate	VERB
admet-2057	629	3	the	the	DET
admet-2057	629	4	action	action	NOUN
admet-2057	629	5	of	of	ADP
admet-2057	629	6	missing	miss	VERB
admet-2057	629	7	linker	linker	NOUN
admet-2057	629	8	defects	defect	NOUN
admet-2057	629	9	in	in	ADP
admet-2057	629	10	pulmonary	pulmonary	ADJ
admet-2057	629	11	delivery	delivery	NOUN
admet-2057	629	12	.	.	PUNCT
admet-2057	630	1	they	they	PRON
admet-2057	630	2	determined	determine	VERB
admet-2057	630	3	that	that	SCONJ
admet-2057	630	4	the	the	DET
admet-2057	630	5	missing	miss	VERB
admet-2057	630	6	linker	linker	NOUN
admet-2057	630	7	defects	defect	NOUN
admet-2057	630	8	resulted	result	VERB
admet-2057	630	9	in	in	ADP
admet-2057	630	10	a	a	DET
admet-2057	630	11	contrast	contrast	NOUN
admet-2057	630	12	in	in	ADP
admet-2057	630	13	the	the	DET
admet-2057	630	14	aerodynamics	aerodynamic	NOUN
admet-2057	630	15	of	of	ADP
admet-2057	630	16	the	the	DET
admet-2057	630	17	nps	nps	PROPN
admet-2057	630	18	.	.	PUNCT
admet-2057	631	1	on	on	ADP
admet-2057	631	2	the	the	DET
admet-2057	631	3	other	other	ADJ
admet-2057	631	4	hand	hand	NOUN
admet-2057	631	5	,	,	PUNCT
admet-2057	631	6	it	it	PRON
admet-2057	631	7	has	have	VERB
admet-2057	631	8	a	a	DET
admet-2057	631	9	minimal	minimal	ADJ
admet-2057	631	10	effect	effect	NOUN
admet-2057	631	11	on	on	ADP
admet-2057	631	12	drug	drug	NOUN
admet-2057	631	13	loading	loading	NOUN
admet-2057	631	14	,	,	PUNCT
admet-2057	631	15	drug	drug	NOUN
admet-2057	631	16	release	release	NOUN
admet-2057	631	17	,	,	PUNCT
admet-2057	631	18	biocompatibility	biocompatibility	NOUN
admet-2057	631	19	and	and	CCONJ
admet-2057	631	20	biodistribution	biodistribution	NOUN
admet-2057	631	21	.	.	PUNCT
admet-2057	632	1	also	also	ADV
admet-2057	632	2	,	,	PUNCT
admet-2057	632	3	the	the	DET
admet-2057	632	4	uio-66	uio-66	ADV
admet-2057	632	5	-	-	PUNCT
admet-2057	632	6	based	base	VERB
admet-2057	632	7	system	system	NOUN
admet-2057	632	8	showed	show	VERB
admet-2057	632	9	better	well	ADJ
admet-2057	632	10	ph	ph	ADJ
admet-2057	632	11	-	-	ADJ
admet-2057	632	12	dependent	dependent	ADJ
admet-2057	632	13	stability	stability	NOUN
admet-2057	632	14	and	and	CCONJ
admet-2057	632	15	did	do	AUX
admet-2057	632	16	n’t	not	PART
admet-2057	632	17	undergo	undergo	VERB
admet-2057	632	18	degradation	degradation	NOUN
admet-2057	632	19	in	in	ADP
admet-2057	632	20	extracellular	extracellular	ADJ
admet-2057	632	21	conditions	condition	NOUN
admet-2057	632	22	or	or	CCONJ
admet-2057	632	23	breakdown	breakdown	NOUN
admet-2057	632	24	in	in	ADP
admet-2057	632	25	the	the	DET
admet-2057	632	26	intracellular	intracellular	ADJ
admet-2057	632	27	environment	environment	NOUN
admet-2057	632	28	.	.	PUNCT
admet-2057	633	1	further	far	ADV
admet-2057	633	2	,	,	PUNCT
admet-2057	633	3	the	the	DET
admet-2057	633	4	in	in	X
admet-2057	633	5	vitro	vitro	X
admet-2057	633	6	study	study	NOUN
admet-2057	633	7	suggested	suggest	VERB
admet-2057	633	8	that	that	SCONJ
admet-2057	633	9	it	it	PRON
admet-2057	633	10	showed	show	VERB
admet-2057	633	11	minimum	minimum	ADJ
admet-2057	633	12	toxicity	toxicity	NOUN
admet-2057	633	13	and	and	CCONJ
admet-2057	633	14	better	well	ADJ
admet-2057	633	15	biocompatibility	biocompatibility	NOUN
admet-2057	633	16	,	,	PUNCT
admet-2057	633	17	while	while	SCONJ
admet-2057	633	18	the	the	PRON
admet-2057	633	19	in	in	ADP
admet-2057	633	20	vivo	vivo	NOUN
admet-2057	633	21	study	study	NOUN
admet-2057	633	22	showed	show	VERB
admet-2057	633	23	good	good	ADJ
admet-2057	633	24	tolerance	tolerance	NOUN
admet-2057	633	25	in	in	ADP
admet-2057	633	26	murine	murine	ADJ
admet-2057	633	27	evaluations	evaluation	NOUN
admet-2057	633	28	after	after	SCONJ
admet-2057	633	29	orotracheally	orotracheally	ADV
admet-2057	633	30	administered	administer	VERB
admet-2057	633	31	nps	nps	PROPN
admet-2057	633	32	.	.	PUNCT
admet-2057	634	1	the	the	DET
admet-2057	634	2	uio-66	uio-66	PROPN
admet-2057	634	3	nps	nps	PROPN
admet-2057	634	4	remained	remain	VERB
admet-2057	634	5	in	in	ADP
admet-2057	634	6	the	the	DET
admet-2057	634	7	lungs	lung	NOUN
admet-2057	634	8	for	for	ADP
admet-2057	634	9	seven	seven	NUM
admet-2057	634	10	days	day	NOUN
admet-2057	634	11	and	and	CCONJ
admet-2057	634	12	showed	show	VERB
admet-2057	634	13	localized	localized	ADJ
admet-2057	634	14	action	action	NOUN
admet-2057	634	15	before	before	ADP
admet-2057	634	16	clearance	clearance	NOUN
admet-2057	634	17	.	.	PUNCT
admet-2057	635	1	overall	overall	ADJ
admet-2057	635	2	results	result	NOUN
admet-2057	635	3	showed	show	VERB
admet-2057	635	4	that	that	SCONJ
admet-2057	635	5	uio-66	uio-66	PRON
admet-2057	635	6	could	could	AUX
admet-2057	635	7	act	act	VERB
admet-2057	635	8	as	as	ADP
admet-2057	635	9	a	a	DET
admet-2057	635	10	potential	potential	ADJ
admet-2057	635	11	platform	platform	NOUN
admet-2057	635	12	for	for	ADP
admet-2057	635	13	pulmonary	pulmonary	ADJ
admet-2057	635	14	delivery	delivery	NOUN
admet-2057	635	15	owning	own	VERB
admet-2057	635	16	to	to	ADP
admet-2057	635	17	the	the	DET
admet-2057	635	18	localization	localization	NOUN
admet-2057	635	19	,	,	PUNCT
admet-2057	635	20	better	well	ADJ
admet-2057	635	21	release	release	NOUN
admet-2057	635	22	and	and	CCONJ
admet-2057	635	23	biocompatibility	biocompatibility	NOUN
admet-2057	635	24	.	.	PUNCT
admet-2057	636	1	the	the	DET
admet-2057	636	2	volatile	volatile	ADJ
admet-2057	636	3	oil	oil	NOUN
admet-2057	636	4	d	d	NOUN
admet-2057	636	5	-	-	PUNCT
admet-2057	636	6	limonene	limonene	ADJ
admet-2057	636	7	(	(	PUNCT
admet-2057	636	8	d	d	NOUN
admet-2057	636	9	-	-	PUNCT
admet-2057	636	10	lim	lim	NOUN
admet-2057	636	11	)	)	PUNCT
admet-2057	636	12	,	,	PUNCT
admet-2057	636	13	derived	derive	VERB
admet-2057	636	14	from	from	ADP
admet-2057	636	15	citrus	citrus	NOUN
admet-2057	636	16	fruits	fruit	NOUN
admet-2057	636	17	,	,	PUNCT
admet-2057	636	18	has	have	VERB
admet-2057	636	19	antiinflammatory	antiinflammatory	NOUN
admet-2057	636	20	and	and	CCONJ
admet-2057	636	21	anti	anti	ADJ
admet-2057	636	22	-	-	ADJ
admet-2057	636	23	cancer	cancer	ADJ
admet-2057	636	24	properties	property	NOUN
admet-2057	636	25	,	,	PUNCT
admet-2057	636	26	but	but	CCONJ
admet-2057	636	27	its	its	PRON
admet-2057	636	28	physical	physical	ADJ
admet-2057	636	29	instability	instability	NOUN
admet-2057	636	30	makes	make	VERB
admet-2057	636	31	deep	deep	ADJ
admet-2057	636	32	delivery	delivery	NOUN
admet-2057	636	33	difficult	difficult	ADJ
admet-2057	636	34	.	.	PUNCT
admet-2057	637	1	d	d	X
admet-2057	637	2	-	-	PUNCT
admet-2057	637	3	lim	lim	PROPN
admet-2057	637	4	was	be	AUX
admet-2057	637	5	loaded	load	VERB
admet-2057	637	6	into	into	ADP
admet-2057	637	7	a	a	DET
admet-2057	637	8	biodegradable	biodegradable	ADJ
admet-2057	637	9	cd	cd	NOUN
admet-2057	637	10	-	-	PUNCT
admet-2057	637	11	mof	mof	NOUN
admet-2057	637	12	with	with	ADP
admet-2057	637	13	an	an	DET
admet-2057	637	14	optimal	optimal	ADJ
admet-2057	637	15	loading	loading	NOUN
admet-2057	637	16	efficiency	efficiency	NOUN
admet-2057	637	17	of	of	ADP
admet-2057	637	18	13.79±0.01	13.79±0.01	NUM
admet-2057	637	19	%	%	NOUN
admet-2057	637	20	(	(	PUNCT
admet-2057	637	21	the	the	DET
admet-2057	637	22	molar	molar	ADJ
admet-2057	637	23	ratio	ratio	NOUN
admet-2057	637	24	of	of	ADP
admet-2057	637	25	d	d	PROPN
admet-2057	637	26	-	-	PUNCT
admet-2057	637	27	lim	lim	PROPN
admet-2057	637	28	and	and	CCONJ
admet-2057	637	29	-cd	-cd	NOUN
admet-2057	637	30	-	-	PUNCT
admet-2057	637	31	mof	mof	NOUN
admet-2057	637	32	was	be	AUX
admet-2057	637	33	1.6:1	1.6:1	NUM
admet-2057	637	34	)	)	PUNCT
admet-2057	637	35	,	,	PUNCT
admet-2057	637	36	which	which	PRON
admet-2057	637	37	had	have	VERB
admet-2057	637	38	cubic	cubic	ADJ
admet-2057	637	39	shape	shape	NOUN
admet-2057	637	40	and	and	CCONJ
admet-2057	637	41	controllable	controllable	ADJ
admet-2057	637	42	particle	particle	NOUN
admet-2057	637	43	size	size	NOUN
admet-2057	637	44	(	(	PUNCT
admet-2057	637	45	1	1	NUM
admet-2057	637	46	-	-	SYM
admet-2057	637	47	5	5	NUM
admet-2057	637	48	m	m	NOUN
admet-2057	637	49	)	)	PUNCT
admet-2057	637	50	in	in	ADP
admet-2057	637	51	order	order	NOUN
admet-2057	637	52	to	to	PART
admet-2057	637	53	prevent	prevent	VERB
admet-2057	637	54	the	the	DET
admet-2057	637	55	volatilization	volatilization	NOUN
admet-2057	637	56	of	of	ADP
admet-2057	637	57	d	d	PROPN
admet-2057	637	58	-	-	PUNCT
admet-2057	637	59	lim	lim	NOUN
admet-2057	637	60	and	and	CCONJ
admet-2057	637	61	achieve	achieve	VERB
admet-2057	637	62	effective	effective	ADJ
admet-2057	637	63	pulmonary	pulmonary	ADJ
admet-2057	637	64	delivery	delivery	NOUN
admet-2057	637	65	.	.	PUNCT
admet-2057	638	1	according	accord	VERB
admet-2057	638	2	to	to	ADP
admet-2057	638	3	the	the	DET
admet-2057	638	4	experimental	experimental	ADJ
admet-2057	638	5	findings	finding	NOUN
admet-2057	638	6	,	,	PUNCT
admet-2057	638	7	-cd	-cd	NOUN
admet-2057	638	8	-	-	PUNCT
admet-2057	638	9	mof	mof	NOUN
admet-2057	638	10	could	could	AUX
admet-2057	638	11	increase	increase	VERB
admet-2057	638	12	d	d	PROPN
admet-2057	638	13	-	-	PUNCT
admet-2057	638	14	lim	lim	NOUN
admet-2057	638	15	's	's	PART
admet-2057	638	16	stability	stability	NOUN
admet-2057	638	17	.	.	PUNCT
admet-2057	639	1	the	the	DET
admet-2057	639	2	interaction	interaction	NOUN
admet-2057	639	3	between	between	ADP
admet-2057	639	4	d	d	PROPN
admet-2057	639	5	-	-	PUNCT
admet-2057	639	6	lim	lim	PROPN
admet-2057	639	7	and	and	CCONJ
admet-2057	639	8	-cd	-cd	NOUN
admet-2057	639	9	-	-	PUNCT
admet-2057	639	10	mof	mof	NOUN
admet-2057	639	11	was	be	AUX
admet-2057	639	12	discovered	discover	VERB
admet-2057	639	13	using	use	VERB
admet-2057	639	14	several	several	ADJ
admet-2057	639	15	characterizations	characterization	NOUN
admet-2057	639	16	and	and	CCONJ
admet-2057	639	17	molecular	molecular	ADJ
admet-2057	639	18	docking	docking	NOUN
admet-2057	639	19	.	.	PUNCT
admet-2057	640	1	the	the	DET
admet-2057	640	2	utilisation	utilisation	NOUN
admet-2057	640	3	of	of	ADP
admet-2057	640	4	d	d	PROPN
admet-2057	640	5	-	-	PUNCT
admet-2057	640	6	lim	lim	PROPN
admet-2057	640	7	's	's	PART
admet-2057	640	8	inhalable	inhalable	ADJ
admet-2057	640	9	dose	dose	NOUN
admet-2057	640	10	form	form	NOUN
admet-2057	640	11	,	,	PUNCT
admet-2057	640	12	dry	dry	ADJ
admet-2057	640	13	powder	powder	NOUN
admet-2057	640	14	inhaler	inhaler	NOUN
admet-2057	640	15	(	(	PUNCT
admet-2057	640	16	dpi	dpi	PROPN
admet-2057	640	17	)	)	PUNCT
admet-2057	640	18	,	,	PUNCT
admet-2057	640	19	was	be	AUX
admet-2057	640	20	greatly	greatly	ADV
admet-2057	640	21	aided	aid	VERB
admet-2057	640	22	by	by	ADP
admet-2057	640	23	the	the	DET
admet-2057	640	24	solidification	solidification	NOUN
admet-2057	640	25	of	of	ADP
admet-2057	640	26	d	d	PROPN
admet-2057	640	27	-	-	PUNCT
admet-2057	640	28	lim	lim	NOUN
admet-2057	640	29	by	by	ADP
admet-2057	640	30	-cd	-cd	NOUN
admet-2057	640	31	-	-	PUNCT
admet-2057	640	32	mof	mof	NOUN
admet-2057	640	33	.	.	PUNCT
admet-2057	641	1	d	d	X
admet-2057	641	2	-	-	ADJ
admet-2057	641	3	lim@-cd	lim@-cd	ADV
admet-2057	641	4	-	-	PUNCT
admet-2057	641	5	mof	mof	NOUN
admet-2057	641	6	was	be	AUX
admet-2057	641	7	successfully	successfully	ADV
admet-2057	641	8	aerosolized	aerosolize	VERB
admet-2057	641	9	for	for	ADP
admet-2057	641	10	inhalation	inhalation	NOUN
admet-2057	641	11	with	with	ADP
admet-2057	641	12	a	a	DET
admet-2057	641	13	fine	fine	ADJ
admet-2057	641	14	particle	particle	NOUN
admet-2057	641	15	fraction	fraction	NOUN
admet-2057	641	16	(	(	PUNCT
admet-2057	641	17	fpf	fpf	NOUN
admet-2057	641	18	)	)	PUNCT
admet-2057	641	19	of	of	ADP
admet-2057	641	20	33.12	33.12	NUM
admet-2057	641	21	±	±	NUM
admet-2057	641	22	1.50	1.50	NUM
admet-2057	641	23	%	%	NOUN
admet-2057	641	24	at	at	ADP
admet-2057	641	25	a	a	DET
admet-2057	641	26	flow	flow	NOUN
admet-2057	641	27	rate	rate	NOUN
admet-2057	641	28	of	of	ADP
admet-2057	641	29	65	65	NUM
admet-2057	641	30	l	l	NOUN
admet-2057	641	31	min-1	min-1	PROPN
admet-2057	641	32	.	.	PUNCT
admet-2057	642	1	additionally	additionally	ADV
admet-2057	642	2	,	,	PUNCT
admet-2057	642	3	an	an	DET
admet-2057	642	4	in	in	ADP
admet-2057	642	5	vivo	vivo	NOUN
admet-2057	642	6	investigation	investigation	NOUN
admet-2057	642	7	revealed	reveal	VERB
admet-2057	642	8	that	that	SCONJ
admet-2057	642	9	d	d	X
admet-2057	642	10	-	-	PUNCT
admet-2057	642	11	lim	lim	NOUN
admet-2057	642	12	solidified	solidify	VERB
admet-2057	642	13	by	by	ADP
admet-2057	642	14	-cd	-cd	NOUN
admet-2057	642	15	-	-	PUNCT
admet-2057	642	16	mof	mof	NOUN
admet-2057	642	17	for	for	ADP
admet-2057	642	18	inhalation	inhalation	NOUN
admet-2057	642	19	had	have	VERB
admet-2057	642	20	a	a	DET
admet-2057	642	21	2.23	2.23	NUM
admet-2057	642	22	-	-	ADJ
admet-2057	642	23	fold	fold	ADJ
admet-2057	642	24	higher	high	ADJ
admet-2057	642	25	bioavailability	bioavailability	NOUN
admet-2057	642	26	than	than	ADP
admet-2057	642	27	d	d	NOUN
admet-2057	642	28	-	-	PUNCT
admet-2057	642	29	lim	lim	NOUN
admet-2057	642	30	for	for	ADP
admet-2057	642	31	oral	oral	ADJ
admet-2057	642	32	delivery	delivery	NOUN
admet-2057	642	33	.	.	PUNCT
admet-2057	643	1	as	as	ADP
admet-2057	643	2	a	a	DET
admet-2057	643	3	result	result	NOUN
admet-2057	643	4	,	,	PUNCT
admet-2057	643	5	it	it	PRON
admet-2057	643	6	is	be	AUX
admet-2057	643	7	thought	think	VERB
admet-2057	643	8	that	that	SCONJ
admet-2057	643	9	-cd	-cd	NOUN
admet-2057	643	10	-	-	PUNCT
admet-2057	643	11	mof	mof	NOUN
admet-2057	643	12	could	could	AUX
admet-2057	643	13	be	be	AUX
admet-2057	643	14	a	a	DET
admet-2057	643	15	great	great	ADJ
admet-2057	643	16	drug	drug	NOUN
admet-2057	643	17	delivery	delivery	NOUN
admet-2057	643	18	system	system	NOUN
admet-2057	643	19	for	for	ADP
admet-2057	643	20	the	the	DET
admet-2057	643	21	lungs	lung	NOUN
admet-2057	643	22	to	to	PART
admet-2057	643	23	achieve	achieve	VERB
admet-2057	643	24	the	the	DET
admet-2057	643	25	solidification	solidification	NOUN
admet-2057	643	26	and	and	CCONJ
admet-2057	643	27	therapeutic	therapeutic	ADJ
admet-2057	643	28	benefits	benefit	NOUN
admet-2057	643	29	of	of	ADP
admet-2057	643	30	volatile	volatile	ADJ
admet-2057	643	31	oils	oil	NOUN
admet-2057	643	32	[	[	X
admet-2057	643	33	120	120	NUM
admet-2057	643	34	]	]	PUNCT
admet-2057	643	35	.	.	PUNCT
admet-2057	644	1	while	while	SCONJ
admet-2057	644	2	exploring	explore	VERB
admet-2057	644	3	the	the	DET
admet-2057	644	4	different	different	ADJ
admet-2057	644	5	means	mean	NOUN
admet-2057	644	6	of	of	ADP
admet-2057	644	7	administering	administer	VERB
admet-2057	644	8	mof	mof	NOUN
admet-2057	644	9	and	and	CCONJ
admet-2057	644	10	its	its	PRON
admet-2057	644	11	use	use	NOUN
admet-2057	644	12	in	in	ADP
admet-2057	644	13	the	the	DET
admet-2057	644	14	arena	arena	NOUN
admet-2057	644	15	of	of	ADP
admet-2057	644	16	cosmetics	cosmetic	NOUN
admet-2057	644	17	,	,	PUNCT
admet-2057	644	18	alfonso	alfonso	PROPN
admet-2057	644	19	garcía	garcía	PROPN
admet-2057	644	20	márqueza	márqueza	PROPN
admet-2057	644	21	et	et	PROPN
admet-2057	644	22	al	al	PROPN
admet-2057	644	23	.	.	PUNCT
admet-2057	645	1	[	[	X
admet-2057	645	2	121	121	NUM
admet-2057	645	3	]	]	PUNCT
admet-2057	645	4	proposed	propose	VERB
admet-2057	645	5	a	a	DET
admet-2057	645	6	convenient	convenient	ADJ
admet-2057	645	7	and	and	CCONJ
admet-2057	645	8	eco	eco	NOUN
admet-2057	645	9	-	-	PUNCT
admet-2057	645	10	friendly	friendly	ADJ
admet-2057	645	11	method	method	NOUN
admet-2057	645	12	for	for	ADP
admet-2057	645	13	the	the	DET
admet-2057	645	14	preparation	preparation	NOUN
admet-2057	645	15	of	of	ADP
admet-2057	645	16	cutaneous	cutaneous	ADJ
admet-2057	645	17	patches	patch	NOUN
admet-2057	645	18	comprising	comprising	NOUN
admet-2057	645	19	of	of	ADP
admet-2057	645	20	drug	drug	NOUN
admet-2057	645	21	nanocarrier	nanocarrier	PROPN
admet-2057	645	22	mil-100(fe	mil-100(fe	PROPN
admet-2057	645	23	)	)	PUNCT
admet-2057	645	24	and	and	CCONJ
admet-2057	645	25	biopolymers	biopolymer	NOUN
admet-2057	645	26	for	for	ADP
admet-2057	645	27	cosmetic	cosmetic	ADJ
admet-2057	645	28	applications	application	NOUN
admet-2057	645	29	.	.	PUNCT
admet-2057	646	1	the	the	DET
admet-2057	646	2	ex	ex	NOUN
admet-2057	646	3	-	-	NOUN
admet-2057	646	4	vivo	vivo	ADJ
admet-2057	646	5	and	and	CCONJ
admet-2057	646	6	in	in	ADP
admet-2057	646	7	-	-	PUNCT
admet-2057	646	8	vitro	vitro	X
admet-2057	646	9	models	model	NOUN
admet-2057	646	10	showed	show	VERB
admet-2057	646	11	better	well	ADJ
admet-2057	646	12	release	release	NOUN
admet-2057	646	13	capabilities	capability	NOUN
admet-2057	646	14	and	and	CCONJ
admet-2057	646	15	encapsulation	encapsulation	NOUN
admet-2057	646	16	due	due	ADP
admet-2057	646	17	to	to	ADP
admet-2057	646	18	better	well	ADJ
admet-2057	646	19	physicochemical	physicochemical	ADJ
admet-2057	646	20	properties	property	NOUN
admet-2057	646	21	like	like	ADP
admet-2057	646	22	swelling	swell	VERB
admet-2057	646	23	properties	property	NOUN
admet-2057	646	24	,	,	PUNCT
admet-2057	646	25	structure	structure	NOUN
admet-2057	646	26	,	,	PUNCT
admet-2057	646	27	bio	bio	NOUN
admet-2057	646	28	-	-	NOUN
admet-2057	646	29	adhesion	adhesion	NOUN
admet-2057	646	30	,	,	PUNCT
admet-2057	646	31	and	and	CCONJ
admet-2057	646	32	hydration	hydration	NOUN
admet-2057	646	33	.	.	PUNCT
admet-2057	647	1	these	these	PRON
admet-2057	647	2	were	be	AUX
admet-2057	647	3	evaluated	evaluate	VERB
admet-2057	647	4	using	use	VERB
admet-2057	647	5	active	active	ADJ
admet-2057	647	6	pharmaceutical	pharmaceutical	ADJ
admet-2057	647	7	ingredients	ingredient	NOUN
admet-2057	647	8	(	(	PUNCT
admet-2057	647	9	apis	apis	ADJ
admet-2057	647	10	)	)	PUNCT
admet-2057	647	11	like	like	ADP
admet-2057	647	12	caffeine	caffeine	NOUN
admet-2057	647	13	and	and	CCONJ
admet-2057	647	14	ibu	ibu	PROPN
admet-2057	647	15	.	.	PUNCT
admet-2057	648	1	particularly	particularly	ADV
admet-2057	648	2	,	,	PUNCT
admet-2057	648	3	very	very	ADV
admet-2057	648	4	large	large	ADJ
admet-2057	648	5	caffeine	caffeine	NOUN
admet-2057	648	6	loadings	loading	NOUN
admet-2057	648	7	were	be	AUX
admet-2057	648	8	held	hold	VERB
admet-2057	648	9	within	within	ADP
admet-2057	648	10	these	these	DET
admet-2057	648	11	cutaneous	cutaneous	ADJ
admet-2057	648	12	devices	device	NOUN
admet-2057	648	13	,	,	PUNCT
admet-2057	648	14	with	with	ADP
admet-2057	648	15	gradual	gradual	ADJ
admet-2057	648	16	releases	release	NOUN
admet-2057	648	17	occurring	occur	VERB
admet-2057	648	18	as	as	ADP
admet-2057	648	19	a	a	DET
admet-2057	648	20	result	result	NOUN
admet-2057	648	21	of	of	ADP
admet-2057	648	22	the	the	DET
admet-2057	648	23	hydrophilic	hydrophilic	ADJ
admet-2057	648	24	patches	patch	NOUN
admet-2057	648	25	expanding	expand	VERB
admet-2057	648	26	in	in	ADP
admet-2057	648	27	simulated	simulated	ADJ
admet-2057	648	28	cutaneous	cutaneous	ADJ
admet-2057	648	29	physiological	physiological	ADJ
admet-2057	648	30	circumstances	circumstance	NOUN
admet-2057	648	31	.	.	PUNCT
admet-2057	649	1	these	these	DET
admet-2057	649	2	patches	patch	NOUN
admet-2057	649	3	offered	offer	VERB
admet-2057	649	4	a	a	DET
admet-2057	649	5	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	649	6	p.	p.	NOUN
admet-2057	649	7	mhettar	mhettar	NOUN
admet-2057	649	8	et	et	PROPN
admet-2057	649	9	al	al	PROPN
admet-2057	649	10	.	.	PROPN
admet-2057	649	11	admet	admet	PROPN
admet-2057	649	12	&	&	CCONJ
admet-2057	649	13	dmpk	dmpk	PROPN
admet-2057	649	14	12(1	12(1	PROPN
admet-2057	649	15	)	)	PUNCT
admet-2057	649	16	(	(	PUNCT
admet-2057	649	17	2024	2024	NUM
admet-2057	649	18	)	)	PUNCT
admet-2057	649	19	27	27	NUM
admet-2057	649	20	-	-	SYM
admet-2057	649	21	62	62	NUM
admet-2057	649	22	50	50	NUM
admet-2057	649	23	gradual	gradual	ADJ
admet-2057	649	24	and	and	CCONJ
admet-2057	649	25	appropriate	appropriate	ADJ
admet-2057	649	26	penetration	penetration	NOUN
admet-2057	649	27	of	of	ADP
admet-2057	649	28	their	their	PRON
admet-2057	649	29	aesthetic	aesthetic	ADJ
admet-2057	649	30	payload	payload	NOUN
admet-2057	649	31	through	through	ADP
admet-2057	649	32	the	the	DET
admet-2057	649	33	skin	skin	NOUN
admet-2057	649	34	,	,	PUNCT
admet-2057	649	35	curiously	curiously	ADV
admet-2057	649	36	reaching	reach	VERB
admet-2057	649	37	the	the	DET
admet-2057	649	38	targeted	target	VERB
admet-2057	649	39	adipose	adipose	ADJ
admet-2057	649	40	tissue	tissue	NOUN
admet-2057	649	41	despite	despite	SCONJ
admet-2057	649	42	lacking	lack	VERB
admet-2057	649	43	any	any	DET
admet-2057	649	44	cutaneous	cutaneous	ADJ
admet-2057	649	45	bio	bio	ADJ
admet-2057	649	46	-	-	ADJ
admet-2057	649	47	adhesive	adhesive	ADJ
admet-2057	649	48	character	character	NOUN
admet-2057	649	49	.	.	PUNCT
admet-2057	650	1	this	this	PRON
admet-2057	650	2	makes	make	VERB
admet-2057	650	3	these	these	DET
admet-2057	650	4	composite	composite	ADJ
admet-2057	650	5	mof	mof	NOUN
admet-2057	650	6	-	-	PUNCT
admet-2057	650	7	based	base	VERB
admet-2057	650	8	patches	patch	NOUN
admet-2057	650	9	for	for	ADP
admet-2057	650	10	aesthetic	aesthetic	ADJ
admet-2057	650	11	applications	application	NOUN
admet-2057	650	12	,	,	PUNCT
admet-2057	650	13	which	which	PRON
admet-2057	650	14	include	include	VERB
admet-2057	650	15	cosmetics	cosmetic	NOUN
admet-2057	650	16	,	,	PUNCT
admet-2057	650	17	promising	promising	ADJ
admet-2057	650	18	possibilities	possibility	NOUN
admet-2057	650	19	.	.	PUNCT
admet-2057	651	1	in	in	ADP
admet-2057	651	2	another	another	DET
admet-2057	651	3	similar	similar	ADJ
admet-2057	651	4	work	work	NOUN
admet-2057	651	5	by	by	ADP
admet-2057	651	6	sara	sara	PROPN
admet-2057	651	7	rojas	rojas	PROPN
admet-2057	651	8	[	[	X
admet-2057	651	9	122	122	NUM
admet-2057	651	10	]	]	PUNCT
admet-2057	651	11	on	on	ADP
admet-2057	651	12	understanding	understand	VERB
admet-2057	651	13	the	the	DET
admet-2057	651	14	cutaneous	cutaneous	ADJ
admet-2057	651	15	administration	administration	NOUN
admet-2057	651	16	and	and	CCONJ
admet-2057	651	17	release	release	NOUN
admet-2057	651	18	of	of	ADP
admet-2057	651	19	mofs	mof	NOUN
admet-2057	651	20	,	,	PUNCT
admet-2057	651	21	a	a	DET
admet-2057	651	22	mixture	mixture	NOUN
admet-2057	651	23	of	of	ADP
admet-2057	651	24	experimental	experimental	ADJ
admet-2057	651	25	and	and	CCONJ
admet-2057	651	26	computational	computational	ADJ
admet-2057	651	27	examinations	examination	NOUN
admet-2057	651	28	was	be	AUX
admet-2057	651	29	carried	carry	VERB
admet-2057	651	30	out	out	ADP
admet-2057	651	31	to	to	PART
admet-2057	651	32	investigate	investigate	VERB
admet-2057	651	33	the	the	DET
admet-2057	651	34	main	main	ADJ
admet-2057	651	35	physicochemical	physicochemical	ADJ
admet-2057	651	36	and	and	CCONJ
admet-2057	651	37	structural	structural	ADJ
admet-2057	651	38	parameters	parameter	NOUN
admet-2057	651	39	involved	involve	VERB
admet-2057	651	40	in	in	ADP
admet-2057	651	41	the	the	DET
admet-2057	651	42	drug	drug	NOUN
admet-2057	651	43	abortion	abortion	NOUN
admet-2057	651	44	kinetics	kinetic	NOUN
admet-2057	651	45	of	of	ADP
admet-2057	651	46	ibu	ibu	PROPN
admet-2057	651	47	and	and	CCONJ
admet-2057	651	48	aspirin	aspirin	NOUN
admet-2057	651	49	.	.	PUNCT
admet-2057	652	1	for	for	ADP
admet-2057	652	2	obtaining	obtain	VERB
admet-2057	652	3	a	a	DET
admet-2057	652	4	variety	variety	NOUN
admet-2057	652	5	of	of	ADP
admet-2057	652	6	drug	drug	NOUN
admet-2057	652	7	-	-	PUNCT
admet-2057	652	8	matrix	matrix	NOUN
admet-2057	652	9	complexes	complex	NOUN
admet-2057	652	10	with	with	ADP
admet-2057	652	11	varying	vary	VERB
admet-2057	652	12	structural	structural	ADJ
admet-2057	652	13	and	and	CCONJ
admet-2057	652	14	physicochemical	physicochemical	ADJ
admet-2057	652	15	characteristics	characteristic	NOUN
admet-2057	652	16	along	along	ADP
admet-2057	652	17	with	with	ADP
admet-2057	652	18	these	these	DET
admet-2057	652	19	two	two	NUM
admet-2057	652	20	drugs	drug	NOUN
admet-2057	652	21	,	,	PUNCT
admet-2057	652	22	three	three	NUM
admet-2057	652	23	model	model	NOUN
admet-2057	652	24	mof	mof	NOUN
admet-2057	652	25	systems	system	NOUN
admet-2057	652	26	were	be	AUX
admet-2057	652	27	selected	select	VERB
admet-2057	652	28	viz	viz	PROPN
admet-2057	652	29	mil-100(fe	mil-100(fe	NOUN
admet-2057	652	30	)	)	PUNCT
admet-2057	652	31	,	,	PUNCT
admet-2057	652	32	uio-66(zr	uio-66(zr	ADJ
admet-2057	652	33	)	)	PUNCT
admet-2057	652	34	,	,	PUNCT
admet-2057	652	35	and	and	CCONJ
admet-2057	652	36	mil-127(fe	mil-127(fe	PROPN
admet-2057	652	37	)	)	PUNCT
admet-2057	652	38	.	.	PUNCT
admet-2057	653	1	this	this	DET
admet-2057	653	2	study	study	NOUN
admet-2057	653	3	proved	prove	VERB
admet-2057	653	4	that	that	SCONJ
admet-2057	653	5	structural	structural	ADJ
admet-2057	653	6	parameters	parameter	NOUN
admet-2057	653	7	and	and	CCONJ
admet-2057	653	8	mof	mof	ADJ
admet-2057	653	9	/	/	SYM
admet-2057	653	10	drug	drug	NOUN
admet-2057	653	11	hydrophobic	hydrophobic	NOUN
admet-2057	653	12	/	/	SYM
admet-2057	653	13	hydrophilic	hydrophilic	ADJ
admet-2057	653	14	balance	balance	NOUN
admet-2057	653	15	are	be	AUX
admet-2057	653	16	the	the	DET
admet-2057	653	17	key	key	ADJ
admet-2057	653	18	mechanisms	mechanism	NOUN
admet-2057	653	19	governing	govern	VERB
admet-2057	653	20	drug	drug	NOUN
admet-2057	653	21	loading	loading	NOUN
admet-2057	653	22	and	and	CCONJ
admet-2057	653	23	release	release	NOUN
admet-2057	653	24	.	.	PUNCT
admet-2057	654	1	these	these	DET
admet-2057	654	2	devices	device	NOUN
admet-2057	654	3	were	be	AUX
admet-2057	654	4	shown	show	VERB
admet-2057	654	5	to	to	PART
admet-2057	654	6	meet	meet	VERB
admet-2057	654	7	the	the	DET
admet-2057	654	8	criteria	criterion	NOUN
admet-2057	654	9	for	for	ADP
admet-2057	654	10	usage	usage	NOUN
admet-2057	654	11	as	as	ADP
admet-2057	654	12	topical	topical	ADJ
admet-2057	654	13	drugdelivery	drugdelivery	NOUN
admet-2057	654	14	systems	system	NOUN
admet-2057	654	15	,	,	PUNCT
admet-2057	654	16	such	such	ADJ
admet-2057	654	17	as	as	ADP
admet-2057	654	18	releasing	release	VERB
admet-2057	654	19	the	the	DET
admet-2057	654	20	payload	payload	NOUN
admet-2057	654	21	between	between	ADP
admet-2057	654	22	1	1	NUM
admet-2057	654	23	and	and	CCONJ
admet-2057	654	24	7	7	NUM
admet-2057	654	25	days	day	NOUN
admet-2057	654	26	by	by	ADP
admet-2057	654	27	delivering	deliver	VERB
admet-2057	654	28	the	the	DET
admet-2057	654	29	drug	drug	NOUN
admet-2057	654	30	under	under	ADP
admet-2057	654	31	simulated	simulated	ADJ
admet-2057	654	32	cutaneous	cutaneous	ADJ
admet-2057	654	33	conditions	condition	NOUN
admet-2057	654	34	(	(	PUNCT
admet-2057	654	35	aqueous	aqueous	ADJ
admet-2057	654	36	medium	medium	NOUN
admet-2057	654	37	at	at	ADP
admet-2057	654	38	37	37	NUM
admet-2057	654	39	°	°	NOUN
admet-2057	654	40	c	c	NOUN
admet-2057	654	41	)	)	PUNCT
admet-2057	654	42	.	.	PUNCT
admet-2057	655	1	these	these	DET
admet-2057	655	2	findings	finding	NOUN
admet-2057	655	3	demonstrate	demonstrate	VERB
admet-2057	655	4	the	the	DET
admet-2057	655	5	significance	significance	NOUN
admet-2057	655	6	of	of	ADP
admet-2057	655	7	selecting	select	VERB
admet-2057	655	8	mofs	mof	NOUN
admet-2057	655	9	carefully	carefully	ADV
admet-2057	655	10	by	by	ADP
admet-2057	655	11	demonstrating	demonstrate	VERB
admet-2057	655	12	how	how	SCONJ
admet-2057	655	13	the	the	DET
admet-2057	655	14	geometrical	geometrical	ADJ
admet-2057	655	15	and	and	CCONJ
admet-2057	655	16	chemical	chemical	NOUN
admet-2057	655	17	properties	property	NOUN
admet-2057	655	18	of	of	ADP
admet-2057	655	19	both	both	CCONJ
admet-2057	655	20	the	the	DET
admet-2057	655	21	mof	mof	NOUN
admet-2057	655	22	and	and	CCONJ
admet-2057	655	23	the	the	DET
admet-2057	655	24	drug	drug	NOUN
admet-2057	655	25	affect	affect	VERB
admet-2057	655	26	the	the	DET
admet-2057	655	27	adsorption	adsorption	NOUN
admet-2057	655	28	and	and	CCONJ
admet-2057	655	29	release	release	NOUN
admet-2057	655	30	of	of	ADP
admet-2057	655	31	the	the	DET
admet-2057	655	32	drug	drug	NOUN
admet-2057	655	33	.	.	PUNCT
admet-2057	656	1	in	in	ADP
admet-2057	656	2	another	another	DET
admet-2057	656	3	study	study	NOUN
admet-2057	656	4	,	,	PUNCT
admet-2057	656	5	sara	sara	PROPN
admet-2057	656	6	rojas	rojas	PROPN
admet-2057	656	7	and	and	CCONJ
admet-2057	656	8	patricia	patricia	PROPN
admet-2057	656	9	horcajada	horcajada	PROPN
admet-2057	656	10	[	[	X
admet-2057	656	11	123	123	NUM
admet-2057	656	12	]	]	PUNCT
admet-2057	656	13	synthesized	synthesize	VERB
admet-2057	656	14	eight	eight	NUM
admet-2057	656	15	different	different	ADJ
admet-2057	656	16	mof	mof	ADJ
admet-2057	656	17	platforms	platform	NOUN
admet-2057	656	18	for	for	ADP
admet-2057	656	19	the	the	DET
admet-2057	656	20	topical	topical	ADJ
admet-2057	656	21	delivery	delivery	NOUN
admet-2057	656	22	of	of	ADP
admet-2057	656	23	salicylic	salicylic	ADJ
admet-2057	656	24	acid	acid	NOUN
admet-2057	656	25	to	to	PART
admet-2057	656	26	tackle	tackle	VERB
admet-2057	656	27	the	the	DET
admet-2057	656	28	stability	stability	NOUN
admet-2057	656	29	issue	issue	NOUN
admet-2057	656	30	.	.	PUNCT
admet-2057	657	1	among	among	ADP
admet-2057	657	2	the	the	DET
admet-2057	657	3	different	different	ADJ
admet-2057	657	4	structures	structure	NOUN
admet-2057	657	5	,	,	PUNCT
admet-2057	657	6	the	the	DET
admet-2057	657	7	microporous	microporous	ADJ
admet-2057	657	8	zr	zr	PROPN
admet-2057	657	9	amino	amino	PROPN
admet-2057	657	10	terephthalate	terephthalate	ADJ
admet-2057	657	11	uio-66	uio-66	PROPN
admet-2057	657	12	-	-	PUNCT
admet-2057	657	13	nh2	nh2	NOUN
admet-2057	657	14	demonstrated	demonstrate	VERB
admet-2057	657	15	the	the	DET
admet-2057	657	16	most	most	ADV
admet-2057	657	17	promising	promising	ADJ
admet-2057	657	18	results	result	NOUN
admet-2057	657	19	for	for	ADP
admet-2057	657	20	the	the	DET
admet-2057	657	21	loading	loading	NOUN
admet-2057	657	22	of	of	ADP
admet-2057	657	23	salicylic	salicylic	ADJ
admet-2057	657	24	acid	acid	NOUN
admet-2057	657	25	.	.	PUNCT
admet-2057	658	1	when	when	SCONJ
admet-2057	658	2	the	the	DET
admet-2057	658	3	delivery	delivery	NOUN
admet-2057	658	4	procedure	procedure	NOUN
admet-2057	658	5	was	be	AUX
admet-2057	658	6	examined	examine	VERB
admet-2057	658	7	in	in	ADP
admet-2057	658	8	a	a	DET
admet-2057	658	9	simulated	simulate	VERB
admet-2057	658	10	cutaneous	cutaneous	ADJ
admet-2057	658	11	condition	condition	NOUN
admet-2057	658	12	comprising	comprise	VERB
admet-2057	658	13	aqueous	aqueous	ADJ
admet-2057	658	14	media	medium	NOUN
admet-2057	658	15	at	at	ADP
admet-2057	658	16	37	37	NUM
admet-2057	658	17	°	°	NOUN
admet-2057	658	18	c	c	NOUN
admet-2057	658	19	,	,	PUNCT
admet-2057	658	20	the	the	DET
admet-2057	658	21	maximum	maximum	ADJ
admet-2057	658	22	plasma	plasma	NOUN
admet-2057	658	23	concentration	concentration	NOUN
admet-2057	658	24	was	be	AUX
admet-2057	658	25	reached	reach	VERB
admet-2057	658	26	in	in	ADP
admet-2057	658	27	6	6	NUM
admet-2057	658	28	h	h	NOUN
admet-2057	658	29	with	with	ADP
admet-2057	658	30	a	a	DET
admet-2057	658	31	64	64	NUM
admet-2057	658	32	%	%	NOUN
admet-2057	658	33	release	release	NOUN
admet-2057	658	34	.	.	PUNCT
admet-2057	659	1	these	these	DET
admet-2057	659	2	findings	finding	NOUN
admet-2057	659	3	show	show	VERB
admet-2057	659	4	that	that	SCONJ
admet-2057	659	5	uio-66	uio-66	NOUN
admet-2057	659	6	-	-	PUNCT
admet-2057	659	7	nh2	nh2	NOUN
admet-2057	659	8	is	be	AUX
admet-2057	659	9	a	a	DET
admet-2057	659	10	viable	viable	ADJ
admet-2057	659	11	option	option	NOUN
admet-2057	659	12	for	for	ADP
admet-2057	659	13	the	the	DET
admet-2057	659	14	development	development	NOUN
admet-2057	659	15	of	of	ADP
admet-2057	659	16	novel	novel	ADJ
admet-2057	659	17	skin	skin	NOUN
admet-2057	659	18	-	-	PUNCT
admet-2057	659	19	treatment	treatment	NOUN
admet-2057	659	20	devices	device	NOUN
admet-2057	659	21	since	since	SCONJ
admet-2057	659	22	it	it	PRON
admet-2057	659	23	is	be	AUX
admet-2057	659	24	suitable	suitable	ADJ
admet-2057	659	25	for	for	ADP
admet-2057	659	26	the	the	DET
admet-2057	659	27	topical	topical	ADJ
admet-2057	659	28	controlled	control	VERB
admet-2057	659	29	release	release	NOUN
admet-2057	659	30	of	of	ADP
admet-2057	659	31	sa	sa	PROPN
admet-2057	659	32	.	.	PUNCT
admet-2057	660	1	in	in	ADP
admet-2057	660	2	another	another	DET
admet-2057	660	3	study	study	NOUN
admet-2057	660	4	,	,	PUNCT
admet-2057	660	5	mubarak	mubarak	PROPN
admet-2057	660	6	g.	g.	PROPN
admet-2057	660	7	bello	bello	PROPN
admet-2057	661	1	[	[	X
admet-2057	661	2	124	124	NUM
admet-2057	661	3	]	]	PUNCT
admet-2057	661	4	used	use	VERB
admet-2057	661	5	an	an	DET
admet-2057	661	6	easy	easy	ADJ
admet-2057	661	7	green	green	ADJ
admet-2057	661	8	chemistry	chemistry	NOUN
admet-2057	661	9	method	method	NOUN
admet-2057	661	10	to	to	PART
admet-2057	661	11	create	create	VERB
admet-2057	661	12	a	a	DET
admet-2057	661	13	2d	2d	NUM
admet-2057	661	14	nanosheet	nanosheet	NOUN
admet-2057	661	15	(	(	PUNCT
admet-2057	661	16	ns	ns	PROPN
admet-2057	661	17	)	)	PUNCT
admet-2057	661	18	of	of	ADP
admet-2057	661	19	cd	cd	PROPN
admet-2057	661	20	-	-	PUNCT
admet-2057	661	21	mofs	mof	NOUN
admet-2057	661	22	.	.	PUNCT
admet-2057	662	1	the	the	DET
admet-2057	662	2	water	water	NOUN
admet-2057	662	3	system	system	NOUN
admet-2057	662	4	was	be	AUX
admet-2057	662	5	used	use	VERB
admet-2057	662	6	to	to	PART
admet-2057	662	7	create	create	VERB
admet-2057	662	8	the	the	DET
admet-2057	662	9	ns	n	VERB
admet-2057	662	10	-	-	PUNCT
admet-2057	662	11	mof	mof	ADJ
admet-2057	662	12	carrier	carrier	NOUN
admet-2057	662	13	in	in	ADP
admet-2057	662	14	a	a	DET
admet-2057	662	15	straightforward	straightforward	ADJ
admet-2057	662	16	one	one	NUM
admet-2057	662	17	-	-	PUNCT
admet-2057	662	18	pot	pot	NOUN
admet-2057	662	19	synthesis	synthesis	NOUN
admet-2057	662	20	combining	combine	VERB
admet-2057	662	21	cd	cd	NOUN
admet-2057	662	22	and	and	CCONJ
admet-2057	662	23	potassium	potassium	NOUN
admet-2057	662	24	carbonate	carbonate	NOUN
admet-2057	662	25	.	.	PUNCT
admet-2057	663	1	by	by	ADP
admet-2057	663	2	changing	change	VERB
admet-2057	663	3	the	the	DET
admet-2057	663	4	reaction	reaction	NOUN
admet-2057	663	5	temperature	temperature	NOUN
admet-2057	663	6	and	and	CCONJ
admet-2057	663	7	adding	add	VERB
admet-2057	663	8	a	a	DET
admet-2057	663	9	crystal	crystal	NOUN
admet-2057	663	10	growth	growth	NOUN
admet-2057	663	11	inhibitor	inhibitor	NOUN
admet-2057	663	12	(	(	PUNCT
admet-2057	663	13	the	the	DET
admet-2057	663	14	proper	proper	ADJ
admet-2057	663	15	amount	amount	NOUN
admet-2057	663	16	of	of	ADP
admet-2057	663	17	acetone	acetone	NOUN
admet-2057	663	18	)	)	PUNCT
admet-2057	663	19	,	,	PUNCT
admet-2057	663	20	particle	particle	NOUN
admet-2057	663	21	size	size	NOUN
admet-2057	663	22	optimisation	optimisation	NOUN
admet-2057	663	23	is	be	AUX
admet-2057	663	24	accomplished	accomplish	VERB
admet-2057	663	25	.	.	PUNCT
admet-2057	664	1	the	the	DET
admet-2057	664	2	crosslinked	crosslinked	ADJ
admet-2057	664	3	cd	cd	PROPN
admet-2057	664	4	-	-	PUNCT
admet-2057	664	5	mof	mof	ADJ
admet-2057	664	6	(	(	PUNCT
admet-2057	664	7	cl	cl	NOUN
admet-2057	664	8	-	-	PUNCT
admet-2057	664	9	cd	cd	NOUN
admet-2057	664	10	-	-	PUNCT
admet-2057	664	11	mof	mof	ADJ
admet-2057	664	12	)	)	PUNCT
admet-2057	664	13	polymerization	polymerization	NOUN
admet-2057	664	14	procedure	procedure	NOUN
admet-2057	664	15	increases	increase	VERB
admet-2057	664	16	the	the	DET
admet-2057	664	17	stability	stability	NOUN
admet-2057	664	18	of	of	ADP
admet-2057	664	19	ns	ns	NOUN
admet-2057	664	20	-	-	PUNCT
admet-2057	664	21	mof	mof	NOUN
admet-2057	664	22	in	in	ADP
admet-2057	664	23	aqueous	aqueous	ADJ
admet-2057	664	24	medium	medium	NOUN
admet-2057	664	25	without	without	ADP
admet-2057	664	26	obstructing	obstruct	VERB
admet-2057	664	27	the	the	DET
admet-2057	664	28	cavity	cavity	NOUN
admet-2057	664	29	for	for	ADP
admet-2057	664	30	drug	drug	NOUN
admet-2057	664	31	loading	loading	NOUN
admet-2057	664	32	.	.	PUNCT
admet-2057	665	1	in	in	ADP
admet-2057	665	2	order	order	NOUN
admet-2057	665	3	to	to	PART
admet-2057	665	4	assess	assess	VERB
admet-2057	665	5	the	the	DET
admet-2057	665	6	impact	impact	NOUN
admet-2057	665	7	of	of	ADP
admet-2057	665	8	particle	particle	NOUN
admet-2057	665	9	geometry	geometry	NOUN
admet-2057	665	10	and	and	CCONJ
admet-2057	665	11	size	size	NOUN
admet-2057	665	12	on	on	ADP
admet-2057	665	13	the	the	DET
admet-2057	665	14	pharmacokinetics	pharmacokinetic	NOUN
admet-2057	665	15	of	of	ADP
admet-2057	665	16	nanoporous	nanoporous	ADJ
admet-2057	665	17	materials	material	NOUN
admet-2057	665	18	during	during	ADP
admet-2057	665	19	drug	drug	NOUN
admet-2057	665	20	delivery	delivery	NOUN
admet-2057	665	21	,	,	PUNCT
admet-2057	665	22	the	the	DET
admet-2057	665	23	same	same	ADJ
admet-2057	665	24	amount	amount	NOUN
admet-2057	665	25	of	of	ADP
admet-2057	665	26	dexamethasone	dexamethasone	NOUN
admet-2057	665	27	(	(	PUNCT
admet-2057	665	28	dxm	dxm	NOUN
admet-2057	665	29	)	)	PUNCT
admet-2057	665	30	was	be	AUX
admet-2057	665	31	loaded	load	VERB
admet-2057	665	32	into	into	ADP
admet-2057	665	33	both	both	PRON
admet-2057	665	34	the	the	DET
admet-2057	665	35	sheetlike	sheetlike	ADJ
admet-2057	665	36	dxm@cl	dxm@cl	NOUN
admet-2057	665	37	-	-	PUNCT
admet-2057	665	38	ns	n	VERB
admet-2057	665	39	-	-	PUNCT
admet-2057	665	40	mof	mof	NOUN
admet-2057	665	41	and	and	CCONJ
admet-2057	665	42	the	the	DET
admet-2057	665	43	3d	3d	NUM
admet-2057	665	44	-	-	PUNCT
admet-2057	665	45	cubic	cubic	ADV
admet-2057	665	46	-	-	PUNCT
admet-2057	665	47	shaped	shape	VERB
admet-2057	665	48	dxm@cl	dxm@cl	NOUN
admet-2057	665	49	-	-	PUNCT
admet-2057	665	50	cd	cd	NOUN
admet-2057	665	51	-	-	PUNCT
admet-2057	665	52	mof	mof	NOUN
admet-2057	665	53	.	.	PUNCT
admet-2057	666	1	in	in	ADP
admet-2057	666	2	vivo	vivo	ADJ
admet-2057	666	3	research	research	NOUN
admet-2057	666	4	is	be	AUX
admet-2057	666	5	done	do	VERB
admet-2057	666	6	to	to	PART
admet-2057	666	7	determine	determine	VERB
admet-2057	666	8	how	how	SCONJ
admet-2057	666	9	well	well	ADV
admet-2057	666	10	these	these	DET
admet-2057	666	11	carriers	carrier	NOUN
admet-2057	666	12	transport	transport	VERB
admet-2057	666	13	dxm	dxm	NOUN
admet-2057	666	14	through	through	ADP
admet-2057	666	15	the	the	DET
admet-2057	666	16	tear	tear	ADJ
admet-2057	666	17	and	and	CCONJ
admet-2057	666	18	aqueous	aqueous	ADJ
admet-2057	666	19	humours	humour	NOUN
admet-2057	666	20	.	.	PUNCT
admet-2057	667	1	the	the	DET
admet-2057	667	2	outcomes	outcome	NOUN
admet-2057	667	3	show	show	VERB
admet-2057	667	4	that	that	SCONJ
admet-2057	667	5	the	the	DET
admet-2057	667	6	2d	2d	NUM
admet-2057	667	7	-	-	PUNCT
admet-2057	667	8	nanosheet	nanosheet	NOUN
admet-2057	667	9	particles	particle	NOUN
admet-2057	667	10	greatly	greatly	ADV
admet-2057	667	11	outperform	outperform	VERB
admet-2057	667	12	the	the	DET
admet-2057	667	13	commercial	commercial	ADJ
admet-2057	667	14	maxidex	maxidex	NOUN
admet-2057	667	15	(	(	PUNCT
admet-2057	667	16	0.1	0.1	NUM
admet-2057	667	17	%	%	NOUN
admet-2057	667	18	dexamethasone	dexamethasone	NOUN
admet-2057	667	19	)	)	PUNCT
admet-2057	667	20	and	and	CCONJ
admet-2057	667	21	its	its	PRON
admet-2057	667	22	3d	3d	NUM
admet-2057	667	23	-	-	PUNCT
admet-2057	667	24	cube	cube	NOUN
admet-2057	667	25	counterparts	counterpart	NOUN
admet-2057	667	26	of	of	ADP
admet-2057	667	27	similar	similar	ADJ
admet-2057	667	28	chemical	chemical	NOUN
admet-2057	667	29	composition	composition	NOUN
admet-2057	667	30	in	in	ADP
admet-2057	667	31	terms	term	NOUN
admet-2057	667	32	of	of	ADP
admet-2057	667	33	precorneal	precorneal	NOUN
admet-2057	667	34	residence	residence	NOUN
admet-2057	667	35	duration	duration	NOUN
admet-2057	667	36	and	and	CCONJ
admet-2057	667	37	intraocular	intraocular	ADJ
admet-2057	667	38	bioavailability	bioavailability	NOUN
admet-2057	667	39	.	.	PUNCT
admet-2057	668	1	it	it	PRON
admet-2057	668	2	implies	imply	VERB
admet-2057	668	3	that	that	SCONJ
admet-2057	668	4	a	a	DET
admet-2057	668	5	carrier	carrier	NOUN
admet-2057	668	6	's	's	PART
admet-2057	668	7	geometry	geometry	NOUN
admet-2057	668	8	affects	affect	VERB
admet-2057	668	9	biodistribution	biodistribution	NOUN
admet-2057	668	10	significantly	significantly	ADV
admet-2057	668	11	,	,	PUNCT
admet-2057	668	12	and	and	CCONJ
admet-2057	668	13	the	the	DET
admet-2057	668	14	cl	cl	NOUN
admet-2057	668	15	-	-	PUNCT
admet-2057	668	16	ns	ns	ADJ
admet-2057	668	17	-	-	PUNCT
admet-2057	668	18	mof	mof	ADJ
admet-2057	668	19	carrier	carrier	NOUN
admet-2057	668	20	is	be	AUX
admet-2057	668	21	an	an	DET
admet-2057	668	22	excellent	excellent	ADJ
admet-2057	668	23	choice	choice	NOUN
admet-2057	668	24	for	for	ADP
admet-2057	668	25	ocular	ocular	ADJ
admet-2057	668	26	drug	drug	NOUN
admet-2057	668	27	administration	administration	NOUN
admet-2057	668	28	.	.	PUNCT
admet-2057	669	1	similar	similar	ADJ
admet-2057	669	2	research	research	NOUN
admet-2057	669	3	was	be	AUX
admet-2057	669	4	done	do	VERB
admet-2057	669	5	by	by	ADP
admet-2057	669	6	gandara	gandara	PROPN
admet-2057	669	7	-	-	PUNCT
admet-2057	669	8	loe	loe	NOUN
admet-2057	669	9	and	and	CCONJ
admet-2057	669	10	colleagues	colleague	NOUN
admet-2057	669	11	[	[	X
admet-2057	669	12	125	125	NUM
admet-2057	669	13	]	]	PUNCT
admet-2057	669	14	.	.	PUNCT
admet-2057	670	1	zr	zr	VERB
admet-2057	670	2	-	-	PUNCT
admet-2057	670	3	based	base	VERB
admet-2057	670	4	uio-67	uio-67	NOUN
admet-2057	670	5	as	as	ADP
admet-2057	670	6	a	a	DET
admet-2057	670	7	mof	mof	NOUN
admet-2057	670	8	and	and	CCONJ
admet-2057	670	9	polyurethane	polyurethane	NOUN
admet-2057	670	10	(	(	PUNCT
admet-2057	670	11	pu	pu	PROPN
admet-2057	670	12	)	)	PUNCT
admet-2057	670	13	as	as	ADP
admet-2057	670	14	a	a	DET
admet-2057	670	15	polymeric	polymeric	ADJ
admet-2057	670	16	matrix	matrix	NOUN
admet-2057	670	17	was	be	AUX
admet-2057	670	18	used	use	VERB
admet-2057	670	19	to	to	PART
admet-2057	670	20	successfully	successfully	ADV
admet-2057	670	21	construct	construct	VERB
admet-2057	670	22	novel	novel	ADJ
admet-2057	670	23	mof	mof	ADV
admet-2057	670	24	-	-	PUNCT
admet-2057	670	25	based	base	VERB
admet-2057	670	26	polymer	polymer	NOUN
admet-2057	670	27	nanocomposite	nanocomposite	NOUN
admet-2057	670	28	films	film	NOUN
admet-2057	670	29	.	.	PUNCT
admet-2057	671	1	the	the	DET
admet-2057	671	2	enhanced	enhanced	ADJ
admet-2057	671	3	stability	stability	NOUN
admet-2057	671	4	of	of	ADP
admet-2057	671	5	the	the	DET
admet-2057	671	6	uio-67	uio-67	ADV
admet-2057	671	7	implanted	implant	VERB
admet-2057	671	8	nanocrystals	nanocrystal	NOUN
admet-2057	671	9	is	be	AUX
admet-2057	671	10	confirmed	confirm	VERB
admet-2057	671	11	by	by	ADP
admet-2057	671	12	synchrotron	synchrotron	NOUN
admet-2057	671	13	x	x	NOUN
admet-2057	671	14	-	-	NOUN
admet-2057	671	15	ray	ray	NOUN
admet-2057	671	16	powder	powder	NOUN
admet-2057	671	17	diffraction	diffraction	NOUN
admet-2057	671	18	(	(	PUNCT
admet-2057	671	19	sxrpd	sxrpd	ADJ
admet-2057	671	20	)	)	PUNCT
admet-2057	671	21	analysis	analysis	NOUN
admet-2057	671	22	,	,	PUNCT
admet-2057	671	23	and	and	CCONJ
admet-2057	671	24	their	their	PRON
admet-2057	671	25	homogeneous	homogeneous	ADJ
admet-2057	671	26	distribution	distribution	NOUN
admet-2057	671	27	(	(	PUNCT
admet-2057	671	28	average	average	ADJ
admet-2057	671	29	crystal	crystal	NOUN
admet-2057	671	30	size	size	NOUN
admet-2057	671	31	of	of	ADP
admet-2057	671	32	100	100	NUM
admet-2057	671	33	-	-	SYM
admet-2057	671	34	200	200	NUM
admet-2057	671	35	nm	nm	NOUN
admet-2057	671	36	)	)	PUNCT
admet-2057	671	37	inside	inside	ADP
admet-2057	671	38	the	the	DET
admet-2057	671	39	50	50	NUM
admet-2057	671	40	µm	µm	ADP
admet-2057	671	41	thick	thick	ADJ
admet-2057	671	42	film	film	NOUN
admet-2057	671	43	is	be	AUX
admet-2057	671	44	confirmed	confirm	VERB
admet-2057	671	45	by	by	ADP
admet-2057	671	46	sem	sem	NOUN
admet-2057	671	47	images	image	NOUN
admet-2057	671	48	.	.	PUNCT
admet-2057	672	1	for	for	ADP
admet-2057	672	2	n2	n2	NOUN
admet-2057	672	3	at	at	ADP
admet-2057	672	4	cryogenic	cryogenic	ADJ
admet-2057	672	5	temperatures	temperature	NOUN
admet-2057	672	6	,	,	PUNCT
admet-2057	672	7	access	access	NOUN
admet-2057	672	8	to	to	ADP
admet-2057	672	9	the	the	DET
admet-2057	672	10	implanted	implant	VERB
admet-2057	672	11	mofs	mof	NOUN
admet-2057	672	12	'	'	PART
admet-2057	672	13	internal	internal	ADJ
admet-2057	672	14	porous	porous	ADJ
admet-2057	672	15	structure	structure	NOUN
admet-2057	672	16	was	be	AUX
admet-2057	672	17	prevented	prevent	VERB
admet-2057	672	18	.	.	PUNCT
admet-2057	673	1	at	at	ADP
admet-2057	673	2	least	least	ADV
admet-2057	673	3	45	45	NUM
admet-2057	673	4	%	%	NOUN
admet-2057	673	5	of	of	ADP
admet-2057	673	6	the	the	DET
admet-2057	673	7	mof	mof	ADJ
admet-2057	673	8	crystals	crystal	NOUN
admet-2057	673	9	are	be	AUX
admet-2057	673	10	fully	fully	ADV
admet-2057	673	11	accessible	accessible	ADJ
admet-2057	673	12	for	for	ADP
admet-2057	673	13	the	the	DET
admet-2057	673	14	gas	gas	NOUN
admet-2057	673	15	phase	phase	NOUN
admet-2057	673	16	adsorption	adsorption	NOUN
admet-2057	673	17	of	of	ADP
admet-2057	673	18	non	non	ADJ
admet-2057	673	19	-	-	ADJ
admet-2057	673	20	polar	polar	ADJ
admet-2057	673	21	molecules	molecule	NOUN
admet-2057	673	22	,	,	PUNCT
admet-2057	673	23	according	accord	VERB
admet-2057	673	24	to	to	ADP
admet-2057	673	25	ethylene	ethylene	NOUN
admet-2057	673	26	adsorption	adsorption	NOUN
admet-2057	673	27	studies	study	NOUN
admet-2057	673	28	at	at	ADP
admet-2057	673	29	25	25	NUM
admet-2057	673	30	°	°	NOUN
admet-2057	673	31	c	c	NOUN
admet-2057	673	32	.	.	PUNCT
admet-2057	674	1	although	although	SCONJ
admet-2057	674	2	this	this	DET
admet-2057	674	3	partial	partial	ADJ
admet-2057	674	4	blocking	blocking	NOUN
admet-2057	674	5	hinders	hinder	VERB
admet-2057	674	6	the	the	DET
admet-2057	674	7	embedded	embed	VERB
admet-2057	674	8	mofs	mof	NOUN
admet-2057	674	9	'	'	PART
admet-2057	674	10	ability	ability	NOUN
admet-2057	674	11	to	to	PART
admet-2057	674	12	adsorb	adsorb	VERB
admet-2057	674	13	ocular	ocular	ADJ
admet-2057	674	14	medications	medication	NOUN
admet-2057	674	15	(	(	PUNCT
admet-2057	674	16	such	such	ADJ
admet-2057	674	17	as	as	ADP
admet-2057	674	18	brimonidine	brimonidine	NOUN
admet-2057	674	19	tartrate	tartrate	NOUN
admet-2057	674	20	)	)	PUNCT
admet-2057	674	21	as	as	SCONJ
admet-2057	674	22	compared	compare	VERB
admet-2057	674	23	to	to	ADP
admet-2057	674	24	the	the	DET
admet-2057	674	25	pure	pure	ADJ
admet-2057	674	26	mof	mof	NOUN
admet-2057	674	27	,	,	PUNCT
admet-2057	674	28	the	the	DET
admet-2057	674	29	integration	integration	NOUN
admet-2057	674	30	of	of	ADP
admet-2057	674	31	uio-67	uio-67	DET
admet-2057	674	32	nanocrystals	nanocrystal	NOUN
admet-2057	674	33	increased	increase	VERB
admet-2057	674	34	the	the	DET
admet-2057	674	35	pu	pu	PROPN
admet-2057	674	36	matrix	matrix	NOUN
admet-2057	674	37	's	's	PART
admet-2057	674	38	adsorption	adsorption	NOUN
admet-2057	674	39	capacity	capacity	NOUN
admet-2057	674	40	by	by	ADP
admet-2057	674	41	about	about	ADV
admet-2057	674	42	60	60	NUM
admet-2057	674	43	times	time	NOUN
admet-2057	674	44	.	.	PUNCT
admet-2057	675	1	brimonidine	brimonidine	PROPN
admet-2057	675	2	is	be	AUX
admet-2057	675	3	released	release	VERB
admet-2057	675	4	from	from	ADP
admet-2057	675	5	uio-67@pu	uio-67@pu	PROPN
admet-2057	675	6	nanocomposite	nanocomposite	PROPN
admet-2057	675	7	over	over	ADP
admet-2057	675	8	an	an	DET
admet-2057	675	9	extended	extended	ADJ
admet-2057	675	10	time	time	NOUN
admet-2057	675	11	(	(	PUNCT
admet-2057	675	12	up	up	ADP
admet-2057	675	13	to	to	PART
admet-2057	675	14	14	14	NUM
admet-2057	675	15	days	day	NOUN
admet-2057	675	16	were	be	AUX
admet-2057	675	17	measured	measure	VERB
admet-2057	675	18	)	)	PUNCT
admet-2057	675	19	.	.	PUNCT
admet-2057	676	1	the	the	DET
admet-2057	676	2	presence	presence	NOUN
admet-2057	676	3	of	of	ADP
admet-2057	676	4	the	the	DET
admet-2057	676	5	drug	drug	NOUN
admet-2057	676	6	in	in	ADP
admet-2057	676	7	the	the	DET
admet-2057	676	8	nanocomposite	nanocomposite	NOUN
admet-2057	676	9	film	film	NOUN
admet-2057	676	10	,	,	PUNCT
admet-2057	676	11	the	the	DET
admet-2057	676	12	stability	stability	NOUN
admet-2057	676	13	of	of	ADP
admet-2057	676	14	the	the	DET
admet-2057	676	15	mof	mof	ADJ
admet-2057	676	16	framework	framework	NOUN
admet-2057	676	17	and	and	CCONJ
admet-2057	676	18	the	the	DET
admet-2057	676	19	drug	drug	NOUN
admet-2057	676	20	upon	upon	SCONJ
admet-2057	676	21	loading	loading	NOUN
admet-2057	676	22	,	,	PUNCT
admet-2057	676	23	and	and	CCONJ
admet-2057	676	24	the	the	DET
admet-2057	676	25	existence	existence	NOUN
admet-2057	676	26	of	of	ADP
admet-2057	676	27	brimonidine	brimonidine	NOUN
admet-2057	676	28	in	in	ADP
admet-2057	676	29	an	an	DET
admet-2057	676	30	amorphous	amorphous	ADJ
admet-2057	676	31	admet	admet	NOUN
admet-2057	676	32	&	&	CCONJ
admet-2057	676	33	dmpk	dmpk	PROPN
admet-2057	676	34	12(1	12(1	PROPN
admet-2057	676	35	)	)	PUNCT
admet-2057	676	36	(	(	PUNCT
admet-2057	676	37	2024	2024	NUM
admet-2057	676	38	)	)	PUNCT
admet-2057	676	39	27	27	NUM
admet-2057	676	40	-	-	SYM
admet-2057	676	41	62	62	NUM
admet-2057	676	42	drug	drug	NOUN
admet-2057	676	43	delivery	delivery	NOUN
admet-2057	676	44	applications	application	NOUN
admet-2057	676	45	of	of	ADP
admet-2057	676	46	metal	metal	NOUN
admet-2057	676	47	-	-	PUNCT
admet-2057	676	48	organic	organic	ADJ
admet-2057	676	49	framework	framework	NOUN
admet-2057	676	50	doi	doi	NOUN
admet-2057	676	51	:	:	PUNCT
admet-2057	676	52	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	676	53	51	51	NUM
admet-2057	676	54	phase	phase	NOUN
admet-2057	676	55	after	after	SCONJ
admet-2057	676	56	adsorbed	adsorb	VERB
admet-2057	676	57	were	be	AUX
admet-2057	676	58	all	all	PRON
admet-2057	676	59	validated	validate	VERB
admet-2057	676	60	by	by	ADP
admet-2057	676	61	the	the	DET
admet-2057	676	62	combined	combine	VERB
admet-2057	676	63	use	use	NOUN
admet-2057	676	64	of	of	ADP
admet-2057	676	65	sxrpd	sxrpd	ADJ
admet-2057	676	66	,	,	PUNCT
admet-2057	676	67	tga	tga	NOUN
admet-2057	676	68	,	,	PUNCT
admet-2057	676	69	and	and	CCONJ
admet-2057	676	70	ftir	ftir	VERB
admet-2057	676	71	analysis	analysis	NOUN
admet-2057	676	72	.	.	PUNCT
admet-2057	677	1	these	these	DET
admet-2057	677	2	findings	finding	NOUN
admet-2057	677	3	pave	pave	VERB
admet-2057	677	4	the	the	DET
admet-2057	677	5	way	way	NOUN
admet-2057	677	6	for	for	ADP
admet-2057	677	7	the	the	DET
admet-2057	677	8	use	use	NOUN
admet-2057	677	9	of	of	ADP
admet-2057	677	10	these	these	DET
admet-2057	677	11	polymeric	polymeric	ADJ
admet-2057	677	12	nanocomposite	nanocomposite	NOUN
admet-2057	677	13	films	film	NOUN
admet-2057	677	14	for	for	ADP
admet-2057	677	15	drug	drug	NOUN
admet-2057	677	16	administration	administration	NOUN
admet-2057	677	17	in	in	ADP
admet-2057	677	18	optical	optical	ADJ
admet-2057	677	19	treatments	treatment	NOUN
admet-2057	677	20	,	,	PUNCT
admet-2057	677	21	whether	whether	SCONJ
admet-2057	677	22	as	as	ADP
admet-2057	677	23	an	an	DET
admet-2057	677	24	element	element	NOUN
admet-2057	677	25	of	of	ADP
admet-2057	677	26	contact	contact	NOUN
admet-2057	677	27	lenses	lense	NOUN
admet-2057	677	28	,	,	PUNCT
admet-2057	677	29	a	a	DET
admet-2057	677	30	component	component	NOUN
admet-2057	677	31	of	of	ADP
admet-2057	677	32	lacrimal	lacrimal	ADJ
admet-2057	677	33	stoppers	stopper	NOUN
admet-2057	677	34	(	(	PUNCT
admet-2057	677	35	such	such	ADJ
admet-2057	677	36	as	as	ADP
admet-2057	677	37	punctal	punctal	ADJ
admet-2057	677	38	plugs	plug	NOUN
admet-2057	677	39	)	)	PUNCT
admet-2057	677	40	,	,	PUNCT
admet-2057	677	41	or	or	CCONJ
admet-2057	677	42	as	as	ADP
admet-2057	677	43	sub	sub	ADJ
admet-2057	677	44	-	-	ADJ
admet-2057	677	45	tenon	tenon	ADJ
admet-2057	677	46	inserts	insert	NOUN
admet-2057	677	47	.	.	PUNCT
admet-2057	677	48	drug	drug	NOUN
admet-2057	677	49	release	release	NOUN
admet-2057	677	50	mechanism	mechanism	NOUN
admet-2057	677	51	conventional	conventional	ADJ
admet-2057	677	52	release	release	NOUN
admet-2057	677	53	it	it	PRON
admet-2057	677	54	's	be	AUX
admet-2057	677	55	important	important	ADJ
admet-2057	677	56	to	to	PART
admet-2057	677	57	note	note	VERB
admet-2057	677	58	that	that	SCONJ
admet-2057	677	59	the	the	DET
admet-2057	677	60	drug	drug	NOUN
admet-2057	677	61	release	release	NOUN
admet-2057	677	62	mechanism	mechanism	NOUN
admet-2057	677	63	from	from	ADP
admet-2057	677	64	mofs	mof	NOUN
admet-2057	677	65	can	can	AUX
admet-2057	677	66	be	be	AUX
admet-2057	677	67	influenced	influence	VERB
admet-2057	677	68	by	by	ADP
admet-2057	677	69	various	various	ADJ
admet-2057	677	70	factors	factor	NOUN
admet-2057	677	71	,	,	PUNCT
admet-2057	677	72	including	include	VERB
admet-2057	677	73	the	the	DET
admet-2057	677	74	specific	specific	ADJ
admet-2057	677	75	mof	mof	ADJ
admet-2057	677	76	structure	structure	NOUN
admet-2057	677	77	,	,	PUNCT
admet-2057	677	78	pore	pore	ADJ
admet-2057	677	79	size	size	NOUN
admet-2057	677	80	,	,	PUNCT
admet-2057	677	81	drug	drug	NOUN
admet-2057	677	82	loading	loading	NOUN
admet-2057	677	83	method	method	NOUN
admet-2057	677	84	,	,	PUNCT
admet-2057	677	85	and	and	CCONJ
admet-2057	677	86	the	the	DET
admet-2057	677	87	physicochemical	physicochemical	ADJ
admet-2057	677	88	properties	property	NOUN
admet-2057	677	89	of	of	ADP
admet-2057	677	90	the	the	DET
admet-2057	677	91	drug	drug	NOUN
admet-2057	677	92	molecules	molecule	NOUN
admet-2057	677	93	.	.	PUNCT
admet-2057	678	1	therefore	therefore	ADV
admet-2057	678	2	,	,	PUNCT
admet-2057	678	3	it	it	PRON
admet-2057	678	4	's	be	AUX
admet-2057	678	5	crucial	crucial	ADJ
admet-2057	678	6	to	to	PART
admet-2057	678	7	consider	consider	VERB
admet-2057	678	8	these	these	DET
admet-2057	678	9	factors	factor	NOUN
admet-2057	678	10	and	and	CCONJ
admet-2057	678	11	conduct	conduct	VERB
admet-2057	678	12	experimental	experimental	ADJ
admet-2057	678	13	studies	study	NOUN
admet-2057	678	14	to	to	PART
admet-2057	678	15	understand	understand	VERB
admet-2057	678	16	and	and	CCONJ
admet-2057	678	17	optimize	optimize	VERB
admet-2057	678	18	the	the	DET
admet-2057	678	19	drug	drug	NOUN
admet-2057	678	20	release	release	NOUN
admet-2057	678	21	behaviour	behaviour	NOUN
admet-2057	678	22	of	of	ADP
admet-2057	678	23	mofs	mof	NOUN
admet-2057	678	24	for	for	ADP
admet-2057	678	25	specific	specific	ADJ
admet-2057	678	26	applications	application	NOUN
admet-2057	678	27	[	[	X
admet-2057	678	28	126	126	NUM
admet-2057	678	29	]	]	PUNCT
admet-2057	678	30	.	.	PUNCT
admet-2057	679	1	drugs	drug	NOUN
admet-2057	679	2	are	be	AUX
admet-2057	679	3	essentially	essentially	ADV
admet-2057	679	4	released	release	VERB
admet-2057	679	5	from	from	ADP
admet-2057	679	6	the	the	DET
admet-2057	679	7	mof	mof	NOUN
admet-2057	679	8	by	by	ADP
admet-2057	679	9	breaking	break	VERB
admet-2057	679	10	the	the	DET
admet-2057	679	11	bonds	bond	NOUN
admet-2057	679	12	between	between	ADP
admet-2057	679	13	metal	metal	NOUN
admet-2057	679	14	ions	ion	NOUN
admet-2057	679	15	and	and	CCONJ
admet-2057	679	16	linkers	linker	NOUN
admet-2057	679	17	,	,	PUNCT
admet-2057	679	18	which	which	PRON
admet-2057	679	19	causes	cause	VERB
admet-2057	679	20	the	the	DET
admet-2057	679	21	coordination	coordination	NOUN
admet-2057	679	22	structure	structure	NOUN
admet-2057	679	23	to	to	PART
admet-2057	679	24	collapse	collapse	VERB
admet-2057	679	25	and	and	CCONJ
admet-2057	679	26	further	far	ADV
admet-2057	679	27	releases	release	VERB
admet-2057	679	28	the	the	DET
admet-2057	679	29	drug	drug	NOUN
admet-2057	679	30	molecules	molecule	NOUN
admet-2057	679	31	at	at	ADP
admet-2057	679	32	the	the	DET
admet-2057	679	33	precise	precise	ADJ
admet-2057	679	34	location	location	NOUN
admet-2057	679	35	.	.	PUNCT
admet-2057	680	1	the	the	DET
admet-2057	680	2	conventional	conventional	ADJ
admet-2057	680	3	drug	drug	NOUN
admet-2057	680	4	release	release	NOUN
admet-2057	680	5	is	be	AUX
admet-2057	680	6	independent	independent	ADJ
admet-2057	680	7	or	or	CCONJ
admet-2057	680	8	lacks	lack	VERB
admet-2057	680	9	target	target	NOUN
admet-2057	680	10	-	-	PUNCT
admet-2057	680	11	specific	specific	ADJ
admet-2057	680	12	drug	drug	NOUN
admet-2057	680	13	delivery	delivery	NOUN
admet-2057	680	14	because	because	SCONJ
admet-2057	680	15	it	it	PRON
admet-2057	680	16	is	be	AUX
admet-2057	680	17	not	not	PART
admet-2057	680	18	predicated	predicate	VERB
admet-2057	680	19	on	on	ADP
admet-2057	680	20	any	any	DET
admet-2057	680	21	particular	particular	ADJ
admet-2057	680	22	stimuli	stimulus	NOUN
admet-2057	680	23	[	[	PUNCT
admet-2057	680	24	127	127	NUM
admet-2057	680	25	]	]	PUNCT
admet-2057	680	26	.	.	PUNCT
admet-2057	681	1	drug	drug	NOUN
admet-2057	681	2	release	release	NOUN
admet-2057	681	3	kinetic	kinetic	NOUN
admet-2057	681	4	models	model	NOUN
admet-2057	681	5	the	the	DET
admet-2057	681	6	drug	drug	NOUN
admet-2057	681	7	release	release	NOUN
admet-2057	681	8	from	from	ADP
admet-2057	681	9	any	any	DET
admet-2057	681	10	drug	drug	NOUN
admet-2057	681	11	delivery	delivery	NOUN
admet-2057	681	12	carrier	carrier	NOUN
admet-2057	681	13	is	be	AUX
admet-2057	681	14	crucial	crucial	ADJ
admet-2057	681	15	,	,	PUNCT
admet-2057	681	16	as	as	SCONJ
admet-2057	681	17	it	it	PRON
admet-2057	681	18	determines	determine	VERB
admet-2057	681	19	the	the	DET
admet-2057	681	20	efficacy	efficacy	NOUN
admet-2057	681	21	of	of	ADP
admet-2057	681	22	the	the	DET
admet-2057	681	23	dosage	dosage	NOUN
admet-2057	681	24	form	form	NOUN
admet-2057	681	25	.	.	PUNCT
admet-2057	682	1	to	to	PART
admet-2057	682	2	study	study	VERB
admet-2057	682	3	the	the	DET
admet-2057	682	4	pattern	pattern	NOUN
admet-2057	682	5	of	of	ADP
admet-2057	682	6	drug	drug	NOUN
admet-2057	682	7	release	release	NOUN
admet-2057	682	8	,	,	PUNCT
admet-2057	682	9	researchers	researcher	NOUN
admet-2057	682	10	used	use	VERB
admet-2057	682	11	different	different	ADJ
admet-2057	682	12	types	type	NOUN
admet-2057	682	13	of	of	ADP
admet-2057	682	14	drug	drug	NOUN
admet-2057	682	15	release	release	NOUN
admet-2057	682	16	kinetic	kinetic	NOUN
admet-2057	682	17	models	model	NOUN
admet-2057	682	18	such	such	ADJ
admet-2057	682	19	as	as	ADP
admet-2057	682	20	first	first	ADJ
admet-2057	682	21	order	order	NOUN
admet-2057	682	22	,	,	PUNCT
admet-2057	682	23	zero	zero	NUM
admet-2057	682	24	order	order	NOUN
admet-2057	682	25	,	,	PUNCT
admet-2057	682	26	hixon	hixon	NOUN
admet-2057	682	27	-	-	PUNCT
admet-2057	682	28	crowell	crowell	NOUN
admet-2057	682	29	,	,	PUNCT
admet-2057	682	30	higuchi	higuchi	ADJ
admet-2057	682	31	matrix	matrix	NOUN
admet-2057	682	32	,	,	PUNCT
admet-2057	682	33	korsmeyer	korsmeyer	NOUN
admet-2057	682	34	-	-	PUNCT
admet-2057	682	35	peppas	peppas	NOUN
admet-2057	682	36	,	,	PUNCT
admet-2057	682	37	peppas	peppas	NOUN
admet-2057	682	38	-	-	PUNCT
admet-2057	682	39	sahlin	sahlin	PROPN
admet-2057	682	40	,	,	PUNCT
admet-2057	682	41	baker	baker	NOUN
admet-2057	682	42	-	-	PUNCT
admet-2057	682	43	lonsdale	lonsdale	PROPN
admet-2057	682	44	,	,	PUNCT
admet-2057	682	45	etc	etc	X
admet-2057	682	46	.	.	X
admet-2057	683	1	[	[	X
admet-2057	683	2	128	128	NUM
admet-2057	683	3	]	]	PUNCT
admet-2057	683	4	.	.	PUNCT
admet-2057	684	1	as	as	SCONJ
admet-2057	684	2	porous	porous	ADJ
admet-2057	684	3	mofs	mof	NOUN
admet-2057	684	4	are	be	AUX
admet-2057	684	5	used	use	VERB
admet-2057	684	6	for	for	ADP
admet-2057	684	7	drug	drug	NOUN
admet-2057	684	8	delivery	delivery	NOUN
admet-2057	684	9	purposes	purpose	NOUN
admet-2057	684	10	,	,	PUNCT
admet-2057	684	11	their	their	PRON
admet-2057	684	12	developed	develop	VERB
admet-2057	684	13	formulations	formulation	NOUN
admet-2057	684	14	are	be	AUX
admet-2057	684	15	also	also	ADV
admet-2057	684	16	evaluated	evaluate	VERB
admet-2057	684	17	for	for	ADP
admet-2057	684	18	their	their	PRON
admet-2057	684	19	drug	drug	NOUN
admet-2057	684	20	release	release	NOUN
admet-2057	684	21	pattern	pattern	NOUN
admet-2057	684	22	.	.	PUNCT
admet-2057	685	1	for	for	ADP
admet-2057	685	2	example	example	NOUN
admet-2057	685	3	,	,	PUNCT
admet-2057	685	4	horcajada	horcajada	PROPN
admet-2057	685	5	et	et	PROPN
admet-2057	685	6	al	al	PROPN
admet-2057	685	7	.	.	PUNCT
admet-2057	686	1	[	[	X
admet-2057	686	2	129	129	NUM
admet-2057	686	3	]	]	PUNCT
admet-2057	686	4	developed	develop	VERB
admet-2057	686	5	the	the	DET
admet-2057	686	6	nanoporous	nanoporous	PROPN
admet-2057	686	7	mil-53	mil-53	PROPN
admet-2057	686	8	(	(	PUNCT
admet-2057	686	9	fe	fe	X
admet-2057	686	10	,	,	PUNCT
admet-2057	686	11	cr	cr	PROPN
admet-2057	686	12	)	)	PUNCT
admet-2057	686	13	for	for	ADP
admet-2057	686	14	the	the	DET
admet-2057	686	15	delivery	delivery	NOUN
admet-2057	686	16	of	of	ADP
admet-2057	686	17	ibu	ibu	PROPN
admet-2057	686	18	.	.	PUNCT
admet-2057	687	1	the	the	DET
admet-2057	687	2	delivery	delivery	NOUN
admet-2057	687	3	of	of	ADP
admet-2057	687	4	ibu	ibu	PROPN
admet-2057	687	5	was	be	AUX
admet-2057	687	6	demonstrated	demonstrate	VERB
admet-2057	687	7	using	use	VERB
admet-2057	687	8	simulated	simulated	ADJ
admet-2057	687	9	body	body	NOUN
admet-2057	687	10	fluid	fluid	NOUN
admet-2057	687	11	(	(	PUNCT
admet-2057	687	12	sbf	sbf	NOUN
admet-2057	687	13	)	)	PUNCT
admet-2057	687	14	at	at	ADP
admet-2057	687	15	37	37	NUM
admet-2057	687	16	°	°	NOUN
admet-2057	687	17	c	c	NOUN
admet-2057	687	18	under	under	ADP
admet-2057	687	19	continuous	continuous	ADJ
admet-2057	687	20	stirring	stirring	NOUN
admet-2057	687	21	,	,	PUNCT
admet-2057	687	22	which	which	PRON
admet-2057	687	23	was	be	AUX
admet-2057	687	24	further	far	ADV
admet-2057	687	25	analysed	analyse	VERB
admet-2057	687	26	using	use	VERB
admet-2057	687	27	hplc	hplc	NOUN
admet-2057	687	28	.	.	PUNCT
admet-2057	688	1	unexpectedly	unexpectedly	ADV
admet-2057	688	2	,	,	PUNCT
admet-2057	688	3	a	a	DET
admet-2057	688	4	very	very	ADV
admet-2057	688	5	slow	slow	ADJ
admet-2057	688	6	delivery	delivery	NOUN
admet-2057	688	7	that	that	PRON
admet-2057	688	8	takes	take	VERB
admet-2057	688	9	three	three	NUM
admet-2057	688	10	weeks	week	NOUN
admet-2057	688	11	to	to	PART
admet-2057	688	12	finish	finish	NOUN
admet-2057	688	13	is	be	AUX
admet-2057	688	14	seen	see	VERB
admet-2057	688	15	.	.	PUNCT
admet-2057	689	1	there	there	PRON
admet-2057	689	2	are	be	VERB
admet-2057	689	3	clearly	clearly	ADV
admet-2057	689	4	two	two	NUM
admet-2057	689	5	processes	process	NOUN
admet-2057	689	6	involved	involve	VERB
admet-2057	689	7	.	.	PUNCT
admet-2057	690	1	the	the	DET
admet-2057	690	2	data	datum	NOUN
admet-2057	690	3	were	be	AUX
admet-2057	690	4	treated	treat	VERB
admet-2057	690	5	as	as	ADP
admet-2057	690	6	a	a	DET
admet-2057	690	7	first	first	ADJ
admet-2057	690	8	approximation	approximation	NOUN
admet-2057	690	9	and	and	CCONJ
admet-2057	690	10	as	as	ADP
admet-2057	690	11	having	have	VERB
admet-2057	690	12	zero	zero	NUM
admet-2057	690	13	-	-	PUNCT
admet-2057	690	14	order	order	NOUN
admet-2057	690	15	kinetics	kinetic	NOUN
admet-2057	690	16	,	,	PUNCT
admet-2057	690	17	as	as	SCONJ
admet-2057	690	18	reported	report	VERB
admet-2057	690	19	(	(	PUNCT
admet-2057	690	20	r2	r2	PROPN
admet-2057	690	21	=	=	NOUN
admet-2057	690	22	0.99	0.99	NUM
admet-2057	690	23	)	)	PUNCT
admet-2057	690	24	,	,	PUNCT
admet-2057	690	25	regardless	regardless	ADV
admet-2057	690	26	of	of	ADP
admet-2057	690	27	minor	minor	ADJ
admet-2057	690	28	changes	change	NOUN
admet-2057	690	29	in	in	ADP
admet-2057	690	30	slope	slope	NOUN
admet-2057	690	31	.	.	PUNCT
admet-2057	691	1	in	in	ADP
admet-2057	691	2	another	another	DET
admet-2057	691	3	study	study	NOUN
admet-2057	691	4	,	,	PUNCT
admet-2057	691	5	maryam	maryam	PROPN
admet-2057	691	6	esfahanian	esfahanian	PROPN
admet-2057	691	7	et	et	PROPN
admet-2057	691	8	al	al	PROPN
admet-2057	691	9	.	.	PUNCT
admet-2057	692	1	[	[	X
admet-2057	692	2	130	130	NUM
admet-2057	692	3	]	]	PUNCT
admet-2057	692	4	reported	report	VERB
admet-2057	692	5	a	a	DET
admet-2057	692	6	fe3o4@paa@zif-8	fe3o4@paa@zif-8	NOUN
admet-2057	692	7	nanocarrier	nanocarrier	NOUN
admet-2057	692	8	for	for	ADP
admet-2057	692	9	the	the	DET
admet-2057	692	10	effective	effective	ADJ
admet-2057	692	11	delivery	delivery	NOUN
admet-2057	692	12	of	of	ADP
admet-2057	692	13	ciprofloxacin	ciprofloxacin	PROPN
admet-2057	692	14	(	(	PUNCT
admet-2057	692	15	cip	cip	NOUN
admet-2057	692	16	)	)	PUNCT
admet-2057	692	17	for	for	ADP
admet-2057	692	18	antibacterial	antibacterial	ADJ
admet-2057	692	19	activity	activity	NOUN
admet-2057	692	20	against	against	ADP
admet-2057	692	21	staphylococcus	staphylococcus	NOUN
admet-2057	692	22	aureus	aureus	PROPN
admet-2057	692	23	(	(	PUNCT
admet-2057	692	24	s.	s.	PROPN
admet-2057	692	25	aureus	aureus	PROPN
admet-2057	692	26	)	)	PUNCT
admet-2057	692	27	and	and	CCONJ
admet-2057	692	28	escherichia	escherichia	NOUN
admet-2057	692	29	coli	coli	NOUN
admet-2057	692	30	(	(	PUNCT
admet-2057	692	31	e.	e.	NOUN
admet-2057	692	32	coli	coli	PROPN
admet-2057	692	33	)	)	PUNCT
admet-2057	692	34	.	.	PUNCT
admet-2057	693	1	the	the	DET
admet-2057	693	2	cip	cip	NOUN
admet-2057	693	3	release	release	NOUN
admet-2057	693	4	from	from	ADP
admet-2057	693	5	nanocomposite	nanocomposite	NOUN
admet-2057	693	6	was	be	AUX
admet-2057	693	7	carried	carry	VERB
admet-2057	693	8	out	out	ADP
admet-2057	693	9	in	in	ADP
admet-2057	693	10	buffers	buffer	NOUN
admet-2057	693	11	ph	ph	VERB
admet-2057	693	12	5	5	NUM
admet-2057	693	13	and	and	CCONJ
admet-2057	693	14	7.4	7.4	NUM
admet-2057	693	15	.	.	PUNCT
admet-2057	694	1	the	the	DET
admet-2057	694	2	developed	develop	VERB
admet-2057	694	3	nanocomposite	nanocomposite	NOUN
admet-2057	694	4	was	be	AUX
admet-2057	694	5	evaluated	evaluate	VERB
admet-2057	694	6	for	for	ADP
admet-2057	694	7	different	different	ADJ
admet-2057	694	8	kinetic	kinetic	ADJ
admet-2057	694	9	models	model	NOUN
admet-2057	694	10	such	such	ADJ
admet-2057	694	11	as	as	ADP
admet-2057	694	12	zero	zero	NUM
admet-2057	694	13	-	-	PUNCT
admet-2057	694	14	order	order	NOUN
admet-2057	694	15	,	,	PUNCT
admet-2057	694	16	first	first	ADJ
admet-2057	694	17	-	-	PUNCT
admet-2057	694	18	order	order	NOUN
admet-2057	694	19	,	,	PUNCT
admet-2057	694	20	the	the	DET
admet-2057	694	21	higuchi	higuchi	ADJ
admet-2057	694	22	equation	equation	NOUN
admet-2057	694	23	,	,	PUNCT
admet-2057	694	24	and	and	CCONJ
admet-2057	694	25	the	the	DET
admet-2057	694	26	korsmeyer	korsmeyer	NOUN
admet-2057	694	27	-	-	PUNCT
admet-2057	694	28	peppas	peppa	NOUN
admet-2057	694	29	equation	equation	NOUN
admet-2057	694	30	.	.	PUNCT
admet-2057	695	1	as	as	ADV
admet-2057	695	2	far	far	ADV
admet-2057	695	3	as	as	SCONJ
admet-2057	695	4	results	result	NOUN
admet-2057	695	5	are	be	AUX
admet-2057	695	6	concerned	concern	VERB
admet-2057	695	7	,	,	PUNCT
admet-2057	695	8	the	the	DET
admet-2057	695	9	higuchi	higuchi	ADJ
admet-2057	695	10	and	and	CCONJ
admet-2057	695	11	peppas	peppa	NOUN
admet-2057	695	12	models	model	NOUN
admet-2057	695	13	are	be	AUX
admet-2057	695	14	the	the	DET
admet-2057	695	15	best	well	ADV
admet-2057	695	16	-	-	PUNCT
admet-2057	695	17	fitted	fit	VERB
admet-2057	695	18	kinetic	kinetic	NOUN
admet-2057	695	19	models	model	NOUN
admet-2057	695	20	.	.	PUNCT
admet-2057	696	1	in	in	ADP
admet-2057	696	2	a	a	DET
admet-2057	696	3	similar	similar	ADJ
admet-2057	696	4	vein	vein	NOUN
admet-2057	696	5	of	of	ADP
admet-2057	696	6	work	work	NOUN
admet-2057	696	7	,	,	PUNCT
admet-2057	696	8	mohaddeseh	mohaddeseh	ADJ
admet-2057	696	9	nasrabadi	nasrabadi	NOUN
admet-2057	696	10	and	and	CCONJ
admet-2057	696	11	his	his	PRON
admet-2057	696	12	team	team	NOUN
admet-2057	697	1	[	[	X
admet-2057	697	2	131	131	NUM
admet-2057	697	3	]	]	PUNCT
admet-2057	697	4	reported	report	VERB
admet-2057	697	5	a	a	DET
admet-2057	697	6	cip	cip	NOUN
admet-2057	697	7	-	-	PUNCT
admet-2057	697	8	uio-66	uio-66	NOUN
admet-2057	697	9	nanoframework	nanoframework	NOUN
admet-2057	697	10	for	for	ADP
admet-2057	697	11	the	the	DET
admet-2057	697	12	effective	effective	ADJ
admet-2057	697	13	delivery	delivery	NOUN
admet-2057	697	14	of	of	ADP
admet-2057	697	15	cip	cip	NOUN
admet-2057	697	16	for	for	ADP
admet-2057	697	17	anti	anti	ADJ
admet-2057	697	18	-	-	ADJ
admet-2057	697	19	bacterial	bacterial	ADJ
admet-2057	697	20	activity	activity	NOUN
admet-2057	697	21	.	.	PUNCT
admet-2057	698	1	the	the	DET
admet-2057	698	2	drug	drug	NOUN
admet-2057	698	3	release	release	NOUN
admet-2057	698	4	studies	study	NOUN
admet-2057	698	5	were	be	AUX
admet-2057	698	6	performed	perform	VERB
admet-2057	698	7	in	in	ADP
admet-2057	698	8	phosphate	phosphate	ADJ
admet-2057	698	9	buffer	buffer	NOUN
admet-2057	698	10	ph	ph	VERB
admet-2057	698	11	7.4	7.4	NUM
admet-2057	698	12	and	and	CCONJ
admet-2057	698	13	acetate	acetate	NOUN
admet-2057	698	14	buffer	buffer	NOUN
admet-2057	698	15	ph	ph	VERB
admet-2057	698	16	5.0	5.0	NUM
admet-2057	698	17	.	.	PUNCT
admet-2057	699	1	furthermore	furthermore	ADV
admet-2057	699	2	,	,	PUNCT
admet-2057	699	3	the	the	DET
admet-2057	699	4	data	datum	NOUN
admet-2057	699	5	obtained	obtain	VERB
admet-2057	699	6	from	from	ADP
admet-2057	699	7	the	the	DET
admet-2057	699	8	cip	cip	NOUN
admet-2057	699	9	release	release	NOUN
admet-2057	699	10	was	be	AUX
admet-2057	699	11	further	far	ADV
admet-2057	699	12	evaluated	evaluate	VERB
admet-2057	699	13	for	for	ADP
admet-2057	699	14	zero	zero	NUM
admet-2057	699	15	order	order	NOUN
admet-2057	699	16	,	,	PUNCT
admet-2057	699	17	first	first	ADJ
admet-2057	699	18	order	order	NOUN
admet-2057	699	19	,	,	PUNCT
admet-2057	699	20	higuchi	higuchi	PROPN
admet-2057	699	21	,	,	PUNCT
admet-2057	699	22	hixson	hixson	PROPN
admet-2057	699	23	,	,	PUNCT
admet-2057	699	24	and	and	CCONJ
admet-2057	699	25	kor	kor	PROPN
admet-2057	699	26	's	's	PART
admet-2057	699	27	peppas	peppas	NOUN
admet-2057	699	28	kinetic	kinetic	NOUN
admet-2057	699	29	models	model	NOUN
admet-2057	699	30	.	.	PUNCT
admet-2057	700	1	on	on	ADP
admet-2057	700	2	the	the	DET
admet-2057	700	3	basis	basis	NOUN
admet-2057	700	4	of	of	ADP
admet-2057	700	5	the	the	DET
admet-2057	700	6	findings	finding	NOUN
admet-2057	700	7	,	,	PUNCT
admet-2057	700	8	the	the	DET
admet-2057	700	9	release	release	NOUN
admet-2057	700	10	kinetic	kinetic	NOUN
admet-2057	700	11	process	process	NOUN
admet-2057	700	12	of	of	ADP
admet-2057	700	13	cip	cip	NOUN
admet-2057	700	14	from	from	ADP
admet-2057	700	15	uio-66	uio-66	PROPN
admet-2057	700	16	follows	follow	VERB
admet-2057	700	17	the	the	DET
admet-2057	700	18	higuchi	higuchi	ADJ
admet-2057	700	19	model	model	NOUN
admet-2057	700	20	and	and	CCONJ
admet-2057	700	21	kor	kor	PROPN
admet-2057	700	22	's	's	PART
admet-2057	700	23	peppas	peppa	NOUN
admet-2057	700	24	at	at	ADP
admet-2057	700	25	ph	ph	PROPN
admet-2057	700	26	7.4	7.4	NUM
admet-2057	700	27	and	and	CCONJ
admet-2057	700	28	5.0	5.0	NUM
admet-2057	700	29	.	.	PUNCT
admet-2057	701	1	khaled	khale	VERB
admet-2057	701	2	abouaitah	abouaitah	PROPN
admet-2057	701	3	and	and	CCONJ
admet-2057	701	4	co	co	NOUN
admet-2057	701	5	-	-	NOUN
admet-2057	701	6	workers	worker	NOUN
admet-2057	701	7	[	[	X
admet-2057	701	8	111	111	NUM
admet-2057	701	9	]	]	PUNCT
admet-2057	701	10	fabricated	fabricate	VERB
admet-2057	701	11	zr	zr	X
admet-2057	701	12	-	-	ADJ
admet-2057	701	13	mof	mof	ADJ
admet-2057	701	14	(	(	PUNCT
admet-2057	701	15	uio-66	uio-66	NOUN
admet-2057	701	16	-	-	PUNCT
admet-2057	701	17	cooh	cooh	NOUN
admet-2057	701	18	)	)	PUNCT
admet-2057	701	19	and	and	CCONJ
admet-2057	701	20	titanium	titanium	NOUN
admet-2057	701	21	-	-	PUNCT
admet-2057	701	22	based	base	VERB
admet-2057	701	23	mof	mof	NOUN
admet-2057	701	24	(	(	PUNCT
admet-2057	701	25	timof	timof	NOUN
admet-2057	701	26	)	)	PUNCT
admet-2057	701	27	(	(	PUNCT
admet-2057	701	28	mil-125	mil-125	NOUN
admet-2057	701	29	-	-	PUNCT
admet-2057	701	30	nh2	nh2	NOUN
admet-2057	701	31	)	)	PUNCT
admet-2057	701	32	.	.	PUNCT
admet-2057	702	1	they	they	PRON
admet-2057	702	2	developed	develop	VERB
admet-2057	702	3	nanocarriers	nanocarrier	NOUN
admet-2057	702	4	used	use	VERB
admet-2057	702	5	for	for	ADP
admet-2057	702	6	plant	plant	NOUN
admet-2057	702	7	-	-	PUNCT
admet-2057	702	8	based	base	VERB
admet-2057	702	9	medicine	medicine	NOUN
admet-2057	702	10	delivery	delivery	NOUN
admet-2057	702	11	:	:	PUNCT
admet-2057	702	12	ru	ru	PROPN
admet-2057	702	13	-	-	PUNCT
admet-2057	702	14	flavonoid	flavonoid	NOUN
admet-2057	702	15	and	and	CCONJ
admet-2057	702	16	pip	pip	PROPN
admet-2057	702	17	-	-	PUNCT
admet-2057	702	18	alkaloid	alkaloid	PROPN
admet-2057	702	19	,	,	PUNCT
admet-2057	702	20	which	which	PRON
admet-2057	702	21	exhibit	exhibit	VERB
admet-2057	702	22	antioxidant	antioxidant	NOUN
admet-2057	702	23	and	and	CCONJ
admet-2057	702	24	anti	anti	ADJ
admet-2057	702	25	-	-	ADJ
admet-2057	702	26	inflammatory	inflammatory	ADJ
admet-2057	702	27	effects	effect	NOUN
admet-2057	702	28	.	.	PUNCT
admet-2057	703	1	ru	ru	PROPN
admet-2057	703	2	and	and	CCONJ
admet-2057	703	3	pip	pip	PROPN
admet-2057	703	4	exhibited	exhibit	VERB
admet-2057	703	5	a	a	DET
admet-2057	703	6	zero	zero	NUM
admet-2057	703	7	-	-	PUNCT
admet-2057	703	8	order	order	NOUN
admet-2057	703	9	release	release	NOUN
admet-2057	703	10	pattern	pattern	NOUN
admet-2057	703	11	for	for	ADP
admet-2057	703	12	the	the	DET
admet-2057	703	13	initial	initial	ADJ
admet-2057	703	14	12	12	NUM
admet-2057	703	15	hours	hour	NOUN
admet-2057	703	16	and	and	CCONJ
admet-2057	703	17	further	far	ADV
admet-2057	703	18	continued	continue	VERB
admet-2057	703	19	to	to	PART
admet-2057	703	20	follow	follow	VERB
admet-2057	703	21	the	the	DET
admet-2057	703	22	stable	stable	ADJ
admet-2057	703	23	,	,	PUNCT
admet-2057	703	24	sustained	sustained	ADJ
admet-2057	703	25	release	release	NOUN
admet-2057	703	26	.	.	PUNCT
admet-2057	704	1	at	at	ADP
admet-2057	704	2	ph	ph	PROPN
admet-2057	704	3	7.4	7.4	NUM
admet-2057	704	4	,	,	PUNCT
admet-2057	704	5	zero	zero	NUM
admet-2057	704	6	-	-	PUNCT
admet-2057	704	7	order	order	NOUN
admet-2057	704	8	and	and	CCONJ
admet-2057	704	9	korsmeyerpeppas	korsmeyerpeppas	NOUN
admet-2057	704	10	kinetic	kinetic	NOUN
admet-2057	704	11	models	model	NOUN
admet-2057	704	12	are	be	AUX
admet-2057	704	13	the	the	DET
admet-2057	704	14	best	good	ADJ
admet-2057	704	15	fits	fit	NOUN
admet-2057	704	16	for	for	ADP
admet-2057	704	17	the	the	DET
admet-2057	704	18	release	release	NOUN
admet-2057	704	19	patterns	pattern	NOUN
admet-2057	704	20	.	.	PUNCT
admet-2057	705	1	a.	a.	NOUN
admet-2057	705	2	bazzazzadeh	bazzazzadeh	NOUN
admet-2057	705	3	and	and	CCONJ
admet-2057	705	4	his	his	PRON
admet-2057	705	5	research	research	NOUN
admet-2057	705	6	team	team	NOUN
admet-2057	706	1	[	[	X
admet-2057	706	2	132	132	NUM
admet-2057	706	3	]	]	PUNCT
admet-2057	706	4	developed	develop	VERB
admet-2057	706	5	a	a	DET
admet-2057	706	6	magnetically	magnetically	ADV
admet-2057	706	7	responsive	responsive	ADJ
admet-2057	706	8	mil-53	mil-53	NUM
admet-2057	706	9	nanocarrier	nanocarrier	NOUN
admet-2057	706	10	into	into	ADP
admet-2057	706	11	core	core	NOUN
admet-2057	706	12	-	-	PUNCT
admet-2057	706	13	shell	shell	NOUN
admet-2057	706	14	nanofibers	nanofiber	NOUN
admet-2057	706	15	composed	compose	VERB
admet-2057	706	16	of	of	ADP
admet-2057	706	17	polyacrylic	polyacrylic	ADJ
admet-2057	706	18	acid	acid	NOUN
admet-2057	706	19	-	-	PUNCT
admet-2057	706	20	grafted	graft	VERB
admet-2057	706	21	chitosan	chitosan	NOUN
admet-2057	706	22	and	and	CCONJ
admet-2057	706	23	polyurethane	polyurethane	NOUN
admet-2057	706	24	(	(	PUNCT
admet-2057	706	25	pa	pa	NOUN
admet-2057	706	26	-	-	PUNCT
admet-2057	706	27	g	g	PROPN
admet-2057	706	28	-	-	PUNCT
admet-2057	706	29	cs	cs	PROPN
admet-2057	706	30	/	/	SYM
admet-2057	706	31	pu	pu	PROPN
admet-2057	706	32	)	)	PUNCT
admet-2057	706	33	.	.	PUNCT
admet-2057	707	1	for	for	ADP
admet-2057	707	2	the	the	DET
admet-2057	707	3	controlled	control	VERB
admet-2057	707	4	release	release	NOUN
admet-2057	707	5	delivery	delivery	NOUN
admet-2057	707	6	of	of	ADP
admet-2057	707	7	temozolomide	temozolomide	NOUN
admet-2057	707	8	(	(	PUNCT
admet-2057	707	9	tmz	tmz	NOUN
admet-2057	707	10	)	)	PUNCT
admet-2057	707	11	and	and	CCONJ
admet-2057	707	12	ptx	ptx	VERB
admet-2057	707	13	against	against	ADP
admet-2057	707	14	u-87	u-87	PROPN
admet-2057	707	15	mg	mg	PROPN
admet-2057	707	16	glioblastoma	glioblastoma	NOUN
admet-2057	707	17	cells	cell	NOUN
admet-2057	707	18	during	during	ADP
admet-2057	707	19	the	the	DET
admet-2057	707	20	chemotherapy	chemotherapy	NOUN
admet-2057	707	21	/	/	SYM
admet-2057	707	22	hyperthermia	hyperthermia	NOUN
admet-2057	707	23	combined	combine	VERB
admet-2057	707	24	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	707	25	p.	p.	NOUN
admet-2057	707	26	mhettar	mhettar	NOUN
admet-2057	707	27	et	et	PROPN
admet-2057	707	28	al	al	PROPN
admet-2057	707	29	.	.	PROPN
admet-2057	707	30	admet	admet	PROPN
admet-2057	707	31	&	&	CCONJ
admet-2057	707	32	dmpk	dmpk	PROPN
admet-2057	707	33	12(1	12(1	PROPN
admet-2057	707	34	)	)	PUNCT
admet-2057	707	35	(	(	PUNCT
admet-2057	707	36	2024	2024	NUM
admet-2057	707	37	)	)	PUNCT
admet-2057	707	38	27	27	NUM
admet-2057	707	39	-	-	SYM
admet-2057	707	40	62	62	NUM
admet-2057	707	41	52	52	NUM
admet-2057	707	42	approach	approach	NOUN
admet-2057	707	43	.	.	PUNCT
admet-2057	708	1	researchers	researcher	NOUN
admet-2057	708	2	investigated	investigate	VERB
admet-2057	708	3	the	the	DET
admet-2057	708	4	effect	effect	NOUN
admet-2057	708	5	of	of	ADP
admet-2057	708	6	the	the	DET
admet-2057	708	7	hyperthermia	hyperthermia	NOUN
admet-2057	708	8	phenomenon	phenomenon	NOUN
admet-2057	708	9	on	on	ADP
admet-2057	708	10	the	the	DET
admet-2057	708	11	drug	drug	NOUN
admet-2057	708	12	release	release	NOUN
admet-2057	708	13	pattern	pattern	NOUN
admet-2057	708	14	of	of	ADP
admet-2057	708	15	loaded	load	VERB
admet-2057	708	16	drugs	drug	NOUN
admet-2057	708	17	.	.	PUNCT
admet-2057	709	1	the	the	DET
admet-2057	709	2	non	non	ADJ
admet-2057	709	3	-	-	ADJ
admet-2057	709	4	fickian	fickian	ADJ
admet-2057	709	5	diffusion	diffusion	NOUN
admet-2057	709	6	of	of	ADP
admet-2057	709	7	the	the	DET
admet-2057	709	8	korsmeyer	korsmeyer	NOUN
admet-2057	709	9	-	-	PUNCT
admet-2057	709	10	peppas	peppa	NOUN
admet-2057	709	11	equation	equation	NOUN
admet-2057	709	12	provided	provide	VERB
admet-2057	709	13	the	the	DET
admet-2057	709	14	best	good	ADJ
admet-2057	709	15	explanation	explanation	NOUN
admet-2057	709	16	for	for	ADP
admet-2057	709	17	the	the	DET
admet-2057	709	18	release	release	NOUN
admet-2057	709	19	data	datum	NOUN
admet-2057	709	20	.	.	PUNCT
admet-2057	710	1	in	in	ADP
admet-2057	710	2	another	another	DET
admet-2057	710	3	work	work	NOUN
admet-2057	710	4	,	,	PUNCT
admet-2057	710	5	xin	xin	PROPN
admet-2057	710	6	leng	leng	PROPN
admet-2057	710	7	and	and	CCONJ
admet-2057	710	8	co	co	NOUN
admet-2057	710	9	-	-	NOUN
admet-2057	710	10	workers	worker	NOUN
admet-2057	710	11	[	[	X
admet-2057	710	12	133	133	NUM
admet-2057	710	13	]	]	PUNCT
admet-2057	710	14	developed	develop	VERB
admet-2057	710	15	a	a	DET
admet-2057	710	16	nanocarrier	nanocarrier	NOUN
admet-2057	710	17	for	for	ADP
admet-2057	710	18	efficient	efficient	ADJ
admet-2057	710	19	delivery	delivery	NOUN
admet-2057	710	20	of	of	ADP
admet-2057	710	21	oridon	oridon	NOUN
admet-2057	710	22	(	(	PUNCT
admet-2057	710	23	ori)-mil-53	ori)-mil-53	PROPN
admet-2057	710	24	(	(	PUNCT
admet-2057	710	25	fe	fe	NOUN
admet-2057	710	26	)	)	PUNCT
admet-2057	710	27	against	against	ADP
admet-2057	710	28	liver	liver	NOUN
admet-2057	710	29	cancer	cancer	NOUN
admet-2057	710	30	therapy	therapy	NOUN
admet-2057	710	31	.	.	PUNCT
admet-2057	711	1	the	the	DET
admet-2057	711	2	research	research	NOUN
admet-2057	711	3	work	work	NOUN
admet-2057	711	4	comprised	comprise	VERB
admet-2057	711	5	the	the	DET
admet-2057	711	6	synthesis	synthesis	NOUN
admet-2057	711	7	and	and	CCONJ
admet-2057	711	8	fabrication	fabrication	NOUN
admet-2057	711	9	of	of	ADP
admet-2057	711	10	mil-53(fe	mil-53(fe	NOUN
admet-2057	711	11	)	)	PUNCT
admet-2057	711	12	nanocarriers	nanocarrier	NOUN
admet-2057	711	13	along	along	ADP
admet-2057	711	14	with	with	ADP
admet-2057	711	15	different	different	ADJ
admet-2057	711	16	characterizations	characterization	NOUN
admet-2057	711	17	to	to	PART
admet-2057	711	18	evaluate	evaluate	VERB
admet-2057	711	19	their	their	PRON
admet-2057	711	20	efficiency	efficiency	NOUN
admet-2057	711	21	in	in	ADP
admet-2057	711	22	carrying	carry	VERB
admet-2057	711	23	ori	ori	NOUN
admet-2057	711	24	selectively	selectively	ADV
admet-2057	711	25	to	to	ADP
admet-2057	711	26	liver	liver	NOUN
admet-2057	711	27	cancer	cancer	NOUN
admet-2057	711	28	cells	cell	NOUN
admet-2057	711	29	.	.	PUNCT
admet-2057	712	1	the	the	DET
admet-2057	712	2	nanosystem	nanosystem	NOUN
admet-2057	712	3	was	be	AUX
admet-2057	712	4	further	far	ADV
admet-2057	712	5	evaluated	evaluate	VERB
admet-2057	712	6	for	for	ADP
admet-2057	712	7	the	the	DET
admet-2057	712	8	drug	drug	NOUN
admet-2057	712	9	release	release	NOUN
admet-2057	712	10	performance	performance	NOUN
admet-2057	712	11	test	test	NOUN
admet-2057	712	12	;	;	PUNCT
admet-2057	712	13	the	the	DET
admet-2057	712	14	evaluation	evaluation	NOUN
admet-2057	712	15	was	be	AUX
admet-2057	712	16	carried	carry	VERB
admet-2057	712	17	out	out	ADP
admet-2057	712	18	in	in	ADP
admet-2057	712	19	phosphate	phosphate	NOUN
admet-2057	712	20	-	-	PUNCT
admet-2057	712	21	buffered	buffer	VERB
admet-2057	712	22	saline	saline	NOUN
admet-2057	712	23	at	at	ADP
admet-2057	712	24	ph	ph	PROPN
admet-2057	712	25	7.2	7.2	NUM
admet-2057	712	26	and	and	CCONJ
admet-2057	712	27	5.5	5.5	NUM
admet-2057	712	28	,	,	PUNCT
admet-2057	712	29	and	and	CCONJ
admet-2057	712	30	findings	finding	NOUN
admet-2057	712	31	revealed	reveal	VERB
admet-2057	712	32	that	that	SCONJ
admet-2057	712	33	the	the	DET
admet-2057	712	34	ori	ori	PROPN
admet-2057	712	35	release	release	NOUN
admet-2057	712	36	lasted	last	VERB
admet-2057	712	37	for	for	ADP
admet-2057	712	38	seven	seven	NUM
admet-2057	712	39	days	day	NOUN
admet-2057	712	40	.	.	PUNCT
admet-2057	713	1	ori	ori	PROPN
admet-2057	713	2	-	-	PROPN
admet-2057	713	3	mil-53	mil-53	NUM
admet-2057	713	4	(	(	PUNCT
admet-2057	713	5	fe	fe	NOUN
admet-2057	713	6	)	)	PUNCT
admet-2057	713	7	followed	follow	VERB
admet-2057	713	8	the	the	DET
admet-2057	713	9	sustained	sustain	VERB
admet-2057	713	10	release	release	NOUN
admet-2057	713	11	kinetic	kinetic	NOUN
admet-2057	713	12	model	model	NOUN
admet-2057	713	13	for	for	ADP
admet-2057	713	14	drug	drug	NOUN
admet-2057	713	15	release	release	NOUN
admet-2057	713	16	;	;	PUNCT
admet-2057	713	17	thus	thus	ADV
admet-2057	713	18	,	,	PUNCT
admet-2057	713	19	it	it	PRON
admet-2057	713	20	could	could	AUX
admet-2057	713	21	be	be	AUX
admet-2057	713	22	a	a	DET
admet-2057	713	23	promising	promising	ADJ
admet-2057	713	24	candidate	candidate	NOUN
admet-2057	713	25	for	for	ADP
admet-2057	713	26	sustained	sustained	ADJ
admet-2057	713	27	release	release	NOUN
admet-2057	713	28	drug	drug	NOUN
admet-2057	713	29	delivery	delivery	NOUN
admet-2057	713	30	for	for	ADP
admet-2057	713	31	anticancer	anticancer	NOUN
admet-2057	713	32	applications	application	NOUN
admet-2057	713	33	.	.	PUNCT
admet-2057	714	1	current	current	ADJ
admet-2057	714	2	challenges	challenge	NOUN
admet-2057	714	3	and	and	CCONJ
admet-2057	714	4	future	future	ADJ
admet-2057	714	5	prospects	prospect	NOUN
admet-2057	714	6	in	in	ADP
admet-2057	714	7	the	the	DET
admet-2057	714	8	present	present	ADJ
admet-2057	714	9	review	review	NOUN
admet-2057	714	10	,	,	PUNCT
admet-2057	714	11	the	the	DET
admet-2057	714	12	mofs	mof	NOUN
admet-2057	714	13	'	'	PART
admet-2057	714	14	potential	potential	NOUN
admet-2057	714	15	as	as	ADP
admet-2057	714	16	intelligent	intelligent	ADJ
admet-2057	714	17	theranostic	theranostic	ADJ
admet-2057	714	18	nanosystems	nanosystem	NOUN
admet-2057	714	19	has	have	AUX
admet-2057	714	20	been	be	AUX
admet-2057	714	21	highlighted	highlight	VERB
admet-2057	714	22	.	.	PUNCT
admet-2057	715	1	these	these	DET
admet-2057	715	2	systems	system	NOUN
admet-2057	715	3	have	have	VERB
admet-2057	715	4	excellent	excellent	ADJ
admet-2057	715	5	features	feature	NOUN
admet-2057	715	6	such	such	ADJ
admet-2057	715	7	as	as	ADP
admet-2057	715	8	high	high	ADJ
admet-2057	715	9	drug	drug	NOUN
admet-2057	715	10	loading	loading	NOUN
admet-2057	715	11	,	,	PUNCT
admet-2057	715	12	controlled	control	VERB
admet-2057	715	13	cargo	cargo	NOUN
admet-2057	715	14	release	release	NOUN
admet-2057	715	15	,	,	PUNCT
admet-2057	715	16	surface	surface	NOUN
admet-2057	715	17	modification	modification	NOUN
admet-2057	715	18	,	,	PUNCT
admet-2057	715	19	and	and	CCONJ
admet-2057	715	20	stimulus	stimulus	ADJ
admet-2057	715	21	responsiveness	responsiveness	NOUN
admet-2057	715	22	.	.	PUNCT
admet-2057	716	1	the	the	DET
admet-2057	716	2	article	article	NOUN
admet-2057	716	3	also	also	ADV
admet-2057	716	4	highlighted	highlight	VERB
admet-2057	716	5	the	the	DET
admet-2057	716	6	synthesis	synthesis	NOUN
admet-2057	716	7	and	and	CCONJ
admet-2057	716	8	characterization	characterization	NOUN
admet-2057	716	9	techniques	technique	NOUN
admet-2057	716	10	,	,	PUNCT
admet-2057	716	11	cargo	cargo	NOUN
admet-2057	716	12	loading	loading	NOUN
admet-2057	716	13	methodologies	methodology	NOUN
admet-2057	716	14	,	,	PUNCT
admet-2057	716	15	formulation	formulation	NOUN
admet-2057	716	16	development	development	NOUN
admet-2057	716	17	aspects	aspect	NOUN
admet-2057	716	18	,	,	PUNCT
admet-2057	716	19	non	non	ADJ
admet-2057	716	20	-	-	ADJ
admet-2057	716	21	stimuli	stimulus	NOUN
admet-2057	716	22	and	and	CCONJ
admet-2057	716	23	stimuli	stimulus	NOUN
admet-2057	716	24	-	-	PUNCT
admet-2057	716	25	responsive	responsive	ADJ
admet-2057	716	26	mofs	mof	NOUN
admet-2057	716	27	,	,	PUNCT
admet-2057	716	28	drug	drug	NOUN
admet-2057	716	29	release	release	NOUN
admet-2057	716	30	mechanism	mechanism	NOUN
admet-2057	716	31	,	,	PUNCT
admet-2057	716	32	and	and	CCONJ
admet-2057	716	33	routes	route	NOUN
admet-2057	716	34	for	for	ADP
admet-2057	716	35	delivering	deliver	VERB
admet-2057	716	36	the	the	DET
admet-2057	716	37	mofs	mof	NOUN
admet-2057	716	38	[	[	X
admet-2057	716	39	134	134	NUM
admet-2057	716	40	]	]	PUNCT
admet-2057	716	41	.	.	PUNCT
admet-2057	717	1	the	the	DET
admet-2057	717	2	mofs	mof	NOUN
admet-2057	717	3	have	have	VERB
admet-2057	717	4	a	a	DET
admet-2057	717	5	tunable	tunable	ADJ
admet-2057	717	6	surface	surface	NOUN
admet-2057	717	7	architecture	architecture	NOUN
admet-2057	717	8	,	,	PUNCT
admet-2057	717	9	which	which	PRON
admet-2057	717	10	makes	make	VERB
admet-2057	717	11	them	they	PRON
admet-2057	717	12	promising	promise	VERB
admet-2057	717	13	carriers	carrier	NOUN
admet-2057	717	14	for	for	ADP
admet-2057	717	15	targeted	target	VERB
admet-2057	717	16	delivery	delivery	NOUN
admet-2057	717	17	,	,	PUNCT
admet-2057	717	18	gene	gene	NOUN
admet-2057	717	19	therapy	therapy	NOUN
admet-2057	717	20	,	,	PUNCT
admet-2057	717	21	antibiotic	antibiotic	ADJ
admet-2057	717	22	delivery	delivery	NOUN
admet-2057	717	23	,	,	PUNCT
admet-2057	717	24	and	and	CCONJ
admet-2057	717	25	especially	especially	ADV
admet-2057	717	26	cancer	cancer	NOUN
admet-2057	717	27	targeting	targeting	NOUN
admet-2057	717	28	.	.	PUNCT
admet-2057	718	1	even	even	ADV
admet-2057	718	2	though	though	SCONJ
admet-2057	718	3	the	the	DET
admet-2057	718	4	study	study	NOUN
admet-2057	718	5	of	of	ADP
admet-2057	718	6	mof	mof	NOUN
admet-2057	718	7	-	-	PUNCT
admet-2057	718	8	based	base	VERB
admet-2057	718	9	dds	dds	PROPN
admet-2057	718	10	has	have	AUX
admet-2057	718	11	advanced	advance	VERB
admet-2057	718	12	quickly	quickly	ADV
admet-2057	718	13	,	,	PUNCT
admet-2057	718	14	numerous	numerous	ADJ
admet-2057	718	15	problems	problem	NOUN
admet-2057	718	16	still	still	ADV
admet-2057	718	17	need	need	VERB
admet-2057	718	18	to	to	PART
admet-2057	718	19	be	be	AUX
admet-2057	718	20	resolved	resolve	VERB
admet-2057	718	21	before	before	SCONJ
admet-2057	718	22	they	they	PRON
admet-2057	718	23	can	can	AUX
admet-2057	718	24	be	be	AUX
admet-2057	718	25	used	use	VERB
admet-2057	718	26	in	in	ADP
admet-2057	718	27	clinical	clinical	ADJ
admet-2057	718	28	settings	setting	NOUN
admet-2057	718	29	[	[	X
admet-2057	718	30	135	135	NUM
admet-2057	718	31	]	]	PUNCT
admet-2057	718	32	.	.	PUNCT
admet-2057	719	1	the	the	DET
admet-2057	719	2	biostability	biostability	NOUN
admet-2057	719	3	of	of	ADP
admet-2057	719	4	mofs	mof	NOUN
admet-2057	719	5	is	be	AUX
admet-2057	719	6	an	an	DET
admet-2057	719	7	important	important	ADJ
admet-2057	719	8	concern	concern	NOUN
admet-2057	719	9	,	,	PUNCT
admet-2057	719	10	as	as	SCONJ
admet-2057	719	11	they	they	PRON
admet-2057	719	12	need	need	VERB
admet-2057	719	13	to	to	PART
admet-2057	719	14	be	be	AUX
admet-2057	719	15	stable	stable	ADJ
admet-2057	719	16	in	in	ADP
admet-2057	719	17	the	the	DET
admet-2057	719	18	body	body	NOUN
admet-2057	719	19	so	so	SCONJ
admet-2057	719	20	that	that	SCONJ
admet-2057	719	21	they	they	PRON
admet-2057	719	22	do	do	AUX
admet-2057	719	23	not	not	PART
admet-2057	719	24	degrade	degrade	VERB
admet-2057	719	25	before	before	SCONJ
admet-2057	719	26	they	they	PRON
admet-2057	719	27	release	release	VERB
admet-2057	719	28	the	the	DET
admet-2057	719	29	drug	drug	NOUN
admet-2057	719	30	.	.	PUNCT
admet-2057	720	1	toxicity	toxicity	NOUN
admet-2057	720	2	-	-	PUNCT
admet-2057	720	3	wise	wise	ADJ
admet-2057	720	4	,	,	PUNCT
admet-2057	720	5	mofs	mof	NOUN
admet-2057	720	6	need	need	VERB
admet-2057	720	7	to	to	PART
admet-2057	720	8	be	be	AUX
admet-2057	720	9	non	non	ADJ
admet-2057	720	10	-	-	ADJ
admet-2057	720	11	toxic	toxic	ADJ
admet-2057	720	12	to	to	ADP
admet-2057	720	13	cells	cell	NOUN
admet-2057	720	14	and	and	CCONJ
admet-2057	720	15	tissues	tissue	NOUN
admet-2057	720	16	.	.	PUNCT
admet-2057	721	1	from	from	ADP
admet-2057	721	2	a	a	DET
admet-2057	721	3	manufacturing	manufacturing	NOUN
admet-2057	721	4	viewpoint	viewpoint	NOUN
admet-2057	721	5	,	,	PUNCT
admet-2057	721	6	mofs	mof	NOUN
admet-2057	721	7	should	should	AUX
admet-2057	721	8	be	be	AUX
admet-2057	721	9	inexpensive	inexpensive	ADJ
admet-2057	721	10	to	to	PART
admet-2057	721	11	be	be	AUX
admet-2057	721	12	used	use	VERB
admet-2057	721	13	for	for	ADP
admet-2057	721	14	wider	wide	ADJ
admet-2057	721	15	clinical	clinical	ADJ
admet-2057	721	16	applications	application	NOUN
admet-2057	721	17	.	.	PUNCT
admet-2057	722	1	these	these	DET
admet-2057	722	2	aforementioned	aforementione	VERB
admet-2057	722	3	hurdles	hurdle	NOUN
admet-2057	722	4	need	need	VERB
admet-2057	722	5	to	to	PART
admet-2057	722	6	be	be	AUX
admet-2057	722	7	addressed	address	VERB
admet-2057	722	8	before	before	ADP
admet-2057	722	9	the	the	DET
admet-2057	722	10	successful	successful	ADJ
admet-2057	722	11	stabilisation	stabilisation	NOUN
admet-2057	722	12	of	of	ADP
admet-2057	722	13	mofs	mof	NOUN
admet-2057	722	14	in	in	ADP
admet-2057	722	15	clinical	clinical	ADJ
admet-2057	722	16	implementation	implementation	NOUN
admet-2057	723	1	[	[	X
admet-2057	723	2	136	136	NUM
admet-2057	723	3	]	]	PUNCT
admet-2057	723	4	.	.	PUNCT
admet-2057	724	1	concluding	conclude	VERB
admet-2057	724	2	remarks	remark	NOUN
admet-2057	724	3	in	in	ADP
admet-2057	724	4	recent	recent	ADJ
admet-2057	724	5	years	year	NOUN
admet-2057	724	6	,	,	PUNCT
admet-2057	724	7	mofs	mof	NOUN
admet-2057	724	8	have	have	AUX
admet-2057	724	9	secured	secure	VERB
admet-2057	724	10	a	a	DET
admet-2057	724	11	prime	prime	ADJ
admet-2057	724	12	position	position	NOUN
admet-2057	724	13	as	as	ADP
admet-2057	724	14	drug	drug	NOUN
admet-2057	724	15	delivery	delivery	NOUN
admet-2057	724	16	carriers	carrier	NOUN
admet-2057	724	17	.	.	PUNCT
admet-2057	725	1	the	the	DET
admet-2057	725	2	galoric	galoric	ADJ
admet-2057	725	3	mof	mof	ADJ
admet-2057	725	4	developments	development	NOUN
admet-2057	725	5	can	can	AUX
admet-2057	725	6	be	be	AUX
admet-2057	725	7	attributed	attribute	VERB
admet-2057	725	8	to	to	ADP
admet-2057	725	9	their	their	PRON
admet-2057	725	10	high	high	ADJ
admet-2057	725	11	porosity	porosity	NOUN
admet-2057	725	12	and	and	CCONJ
admet-2057	725	13	surface	surface	NOUN
admet-2057	725	14	area	area	NOUN
admet-2057	725	15	,	,	PUNCT
admet-2057	725	16	structural	structural	ADJ
admet-2057	725	17	flexibility	flexibility	NOUN
admet-2057	725	18	,	,	PUNCT
admet-2057	725	19	and	and	CCONJ
admet-2057	725	20	diverse	diverse	ADJ
admet-2057	725	21	functionality	functionality	NOUN
admet-2057	725	22	,	,	PUNCT
admet-2057	725	23	leading	lead	VERB
admet-2057	725	24	to	to	ADP
admet-2057	725	25	high	high	ADJ
admet-2057	725	26	drug	drug	NOUN
admet-2057	725	27	loading	loading	NOUN
admet-2057	725	28	and	and	CCONJ
admet-2057	725	29	efficient	efficient	ADJ
admet-2057	725	30	drug	drug	NOUN
admet-2057	725	31	release	release	NOUN
admet-2057	725	32	.	.	PUNCT
admet-2057	726	1	considering	consider	VERB
admet-2057	726	2	the	the	DET
admet-2057	726	3	potential	potential	NOUN
admet-2057	726	4	of	of	ADP
admet-2057	726	5	mofs	mof	NOUN
admet-2057	726	6	,	,	PUNCT
admet-2057	726	7	the	the	DET
admet-2057	726	8	current	current	ADJ
admet-2057	726	9	review	review	NOUN
admet-2057	726	10	provides	provide	VERB
admet-2057	726	11	insights	insight	NOUN
admet-2057	726	12	into	into	ADP
admet-2057	726	13	structural	structural	ADJ
admet-2057	726	14	composition	composition	NOUN
admet-2057	726	15	,	,	PUNCT
admet-2057	726	16	conventional	conventional	ADJ
admet-2057	726	17	and	and	CCONJ
admet-2057	726	18	novel	novel	ADJ
admet-2057	726	19	synthesis	synthesis	NOUN
admet-2057	726	20	methods	method	NOUN
admet-2057	726	21	,	,	PUNCT
admet-2057	726	22	characterization	characterization	NOUN
admet-2057	726	23	techniques	technique	NOUN
admet-2057	726	24	,	,	PUNCT
admet-2057	726	25	drug	drug	NOUN
admet-2057	726	26	loading	loading	NOUN
admet-2057	726	27	approaches	approach	NOUN
admet-2057	726	28	,	,	PUNCT
admet-2057	726	29	and	and	CCONJ
admet-2057	726	30	formulation	formulation	NOUN
admet-2057	726	31	development	development	NOUN
admet-2057	726	32	strategies	strategy	NOUN
admet-2057	726	33	.	.	PUNCT
admet-2057	727	1	also	also	ADV
admet-2057	727	2	,	,	PUNCT
admet-2057	727	3	the	the	DET
admet-2057	727	4	distinction	distinction	NOUN
admet-2057	727	5	between	between	ADP
admet-2057	727	6	non	non	ADJ
admet-2057	727	7	-	-	ADJ
admet-2057	727	8	responsive	responsive	ADJ
admet-2057	727	9	and	and	CCONJ
admet-2057	727	10	stimuli	stimuli	VERB
admet-2057	727	11	-	-	PUNCT
admet-2057	727	12	responsive	responsive	ADJ
admet-2057	727	13	mofs	mof	NOUN
admet-2057	727	14	and	and	CCONJ
admet-2057	727	15	their	their	PRON
admet-2057	727	16	role	role	NOUN
admet-2057	727	17	in	in	ADP
admet-2057	727	18	drug	drug	NOUN
admet-2057	727	19	delivery	delivery	NOUN
admet-2057	727	20	has	have	AUX
admet-2057	727	21	been	be	AUX
admet-2057	727	22	exhaustively	exhaustively	ADV
admet-2057	727	23	discussed	discuss	VERB
admet-2057	727	24	.	.	PUNCT
admet-2057	728	1	considering	consider	VERB
admet-2057	728	2	the	the	DET
admet-2057	728	3	distinct	distinct	ADJ
admet-2057	728	4	merits	merit	NOUN
admet-2057	728	5	of	of	ADP
admet-2057	728	6	mofs	mof	NOUN
admet-2057	728	7	,	,	PUNCT
admet-2057	728	8	several	several	ADJ
admet-2057	728	9	routes	route	NOUN
admet-2057	728	10	,	,	PUNCT
admet-2057	728	11	viz	viz	NOUN
admet-2057	728	12	.	.	PUNCT
admet-2057	728	13	oral	oral	ADJ
admet-2057	728	14	,	,	PUNCT
admet-2057	728	15	parenteral	parenteral	ADJ
admet-2057	728	16	,	,	PUNCT
admet-2057	728	17	etc	etc	X
admet-2057	728	18	.	.	X
admet-2057	728	19	,	,	PUNCT
admet-2057	728	20	have	have	AUX
admet-2057	728	21	been	be	AUX
admet-2057	728	22	explored	explore	VERB
admet-2057	728	23	for	for	ADP
admet-2057	728	24	the	the	DET
admet-2057	728	25	administration	administration	NOUN
admet-2057	728	26	of	of	ADP
admet-2057	728	27	mofs	mof	NOUN
admet-2057	728	28	.	.	PUNCT
admet-2057	729	1	moreover	moreover	ADV
admet-2057	729	2	,	,	PUNCT
admet-2057	729	3	the	the	DET
admet-2057	729	4	favourable	favourable	ADJ
admet-2057	729	5	routes	route	NOUN
admet-2057	729	6	for	for	ADP
admet-2057	729	7	mof	mof	ADJ
admet-2057	729	8	administration	administration	NOUN
admet-2057	729	9	and	and	CCONJ
admet-2057	729	10	drug	drug	NOUN
admet-2057	729	11	release	release	NOUN
admet-2057	729	12	kinetics	kinetic	NOUN
admet-2057	729	13	have	have	AUX
admet-2057	729	14	been	be	AUX
admet-2057	729	15	discussed	discuss	VERB
admet-2057	729	16	in	in	ADP
admet-2057	729	17	detail	detail	NOUN
admet-2057	729	18	,	,	PUNCT
admet-2057	729	19	providing	provide	VERB
admet-2057	729	20	in	in	ADP
admet-2057	729	21	-	-	PUNCT
admet-2057	729	22	depth	depth	NOUN
admet-2057	729	23	peculiarities	peculiarity	NOUN
admet-2057	729	24	to	to	PART
admet-2057	729	25	serve	serve	VERB
admet-2057	729	26	as	as	ADP
admet-2057	729	27	a	a	DET
admet-2057	729	28	potential	potential	ADJ
admet-2057	729	29	candidate	candidate	NOUN
admet-2057	729	30	in	in	ADP
admet-2057	729	31	the	the	DET
admet-2057	729	32	upcoming	upcoming	ADJ
admet-2057	729	33	years	year	NOUN
admet-2057	729	34	of	of	ADP
admet-2057	729	35	drug	drug	NOUN
admet-2057	729	36	delivery	delivery	NOUN
admet-2057	729	37	.	.	PUNCT
admet-2057	730	1	additionally	additionally	ADV
admet-2057	730	2	,	,	PUNCT
admet-2057	730	3	mof	mof	ADJ
admet-2057	730	4	-	-	PUNCT
admet-2057	730	5	based	base	VERB
admet-2057	730	6	formulation	formulation	NOUN
admet-2057	730	7	development	development	NOUN
admet-2057	730	8	and	and	CCONJ
admet-2057	730	9	optimisation	optimisation	NOUN
admet-2057	730	10	considering	consider	VERB
admet-2057	730	11	doe	doe	NOUN
admet-2057	730	12	have	have	AUX
admet-2057	730	13	been	be	AUX
admet-2057	730	14	discussed	discuss	VERB
admet-2057	730	15	thoroughly	thoroughly	ADV
admet-2057	730	16	,	,	PUNCT
admet-2057	730	17	which	which	PRON
admet-2057	730	18	provides	provide	VERB
admet-2057	730	19	a	a	DET
admet-2057	730	20	platform	platform	NOUN
admet-2057	730	21	for	for	ADP
admet-2057	730	22	future	future	ADJ
admet-2057	730	23	considerations	consideration	NOUN
admet-2057	730	24	for	for	ADP
admet-2057	730	25	formulation	formulation	NOUN
admet-2057	730	26	development	development	NOUN
admet-2057	730	27	.	.	PUNCT
admet-2057	731	1	in	in	ADP
admet-2057	731	2	brief	brief	NOUN
admet-2057	731	3	,	,	PUNCT
admet-2057	731	4	the	the	DET
admet-2057	731	5	growing	grow	VERB
admet-2057	731	6	interest	interest	NOUN
admet-2057	731	7	in	in	ADP
admet-2057	731	8	the	the	DET
admet-2057	731	9	scientific	scientific	ADJ
admet-2057	731	10	fraternity	fraternity	NOUN
admet-2057	731	11	for	for	ADP
admet-2057	731	12	mof	mof	ADJ
admet-2057	731	13	application	application	NOUN
admet-2057	731	14	in	in	ADP
admet-2057	731	15	the	the	DET
admet-2057	731	16	biomedical	biomedical	ADJ
admet-2057	731	17	field	field	NOUN
admet-2057	731	18	has	have	AUX
admet-2057	731	19	provided	provide	VERB
admet-2057	731	20	many	many	ADJ
admet-2057	731	21	economical	economical	ADJ
admet-2057	731	22	and	and	CCONJ
admet-2057	731	23	green	green	ADJ
admet-2057	731	24	techniques	technique	NOUN
admet-2057	731	25	for	for	ADP
admet-2057	731	26	constructing	construct	VERB
admet-2057	731	27	mofs	mof	NOUN
admet-2057	731	28	.	.	PUNCT
admet-2057	732	1	also	also	ADV
admet-2057	732	2	,	,	PUNCT
admet-2057	732	3	by	by	ADP
admet-2057	732	4	employing	employ	VERB
admet-2057	732	5	analytical	analytical	ADJ
admet-2057	732	6	techniques	technique	NOUN
admet-2057	732	7	,	,	PUNCT
admet-2057	732	8	the	the	DET
admet-2057	732	9	structural	structural	ADJ
admet-2057	732	10	and	and	CCONJ
admet-2057	732	11	morphological	morphological	ADJ
admet-2057	732	12	peculiarities	peculiarity	NOUN
admet-2057	732	13	of	of	ADP
admet-2057	732	14	mofs	mof	NOUN
admet-2057	732	15	can	can	AUX
admet-2057	732	16	be	be	AUX
admet-2057	732	17	revealed	reveal	VERB
admet-2057	732	18	and	and	CCONJ
admet-2057	732	19	modified	modify	VERB
admet-2057	732	20	accordingly	accordingly	ADV
admet-2057	732	21	.	.	PUNCT
admet-2057	733	1	the	the	DET
admet-2057	733	2	distinct	distinct	ADJ
admet-2057	733	3	analytical	analytical	ADJ
admet-2057	733	4	techniques	technique	NOUN
admet-2057	733	5	give	give	VERB
admet-2057	733	6	an	an	DET
admet-2057	733	7	idea	idea	NOUN
admet-2057	733	8	of	of	ADP
admet-2057	733	9	the	the	DET
admet-2057	733	10	versatility	versatility	NOUN
admet-2057	733	11	of	of	ADP
admet-2057	733	12	mofs	mof	NOUN
admet-2057	733	13	in	in	ADP
admet-2057	733	14	a	a	DET
admet-2057	733	15	series	series	NOUN
admet-2057	733	16	of	of	ADP
admet-2057	733	17	applications	application	NOUN
admet-2057	733	18	,	,	PUNCT
admet-2057	733	19	which	which	PRON
admet-2057	733	20	primarily	primarily	ADV
admet-2057	733	21	include	include	VERB
admet-2057	733	22	drug	drug	NOUN
admet-2057	733	23	delivery	delivery	NOUN
admet-2057	733	24	aspects	aspect	NOUN
admet-2057	733	25	.	.	PUNCT
admet-2057	734	1	in	in	ADP
admet-2057	734	2	terms	term	NOUN
admet-2057	734	3	of	of	ADP
admet-2057	734	4	drug	drug	NOUN
admet-2057	734	5	loading	loading	NOUN
admet-2057	734	6	,	,	PUNCT
admet-2057	734	7	several	several	ADJ
admet-2057	734	8	strategies	strategy	NOUN
admet-2057	734	9	have	have	AUX
admet-2057	734	10	been	be	AUX
admet-2057	734	11	offered	offer	VERB
admet-2057	734	12	to	to	PART
admet-2057	734	13	ensure	ensure	VERB
admet-2057	734	14	uniform	uniform	ADJ
admet-2057	734	15	drug	drug	NOUN
admet-2057	734	16	distribution	distribution	NOUN
admet-2057	734	17	.	.	PUNCT
admet-2057	735	1	these	these	DET
admet-2057	735	2	strategies	strategy	NOUN
admet-2057	735	3	furnish	furnish	VERB
admet-2057	735	4	the	the	DET
admet-2057	735	5	suitability	suitability	NOUN
admet-2057	735	6	of	of	ADP
admet-2057	735	7	methods	method	NOUN
admet-2057	735	8	according	accord	VERB
admet-2057	735	9	to	to	ADP
admet-2057	735	10	the	the	DET
admet-2057	735	11	type	type	NOUN
admet-2057	735	12	of	of	ADP
admet-2057	735	13	material	material	NOUN
admet-2057	735	14	used	use	VERB
admet-2057	735	15	for	for	ADP
admet-2057	735	16	the	the	DET
admet-2057	735	17	entrapment	entrapment	NOUN
admet-2057	735	18	.	.	PUNCT
admet-2057	736	1	furthermore	furthermore	ADV
admet-2057	736	2	,	,	PUNCT
admet-2057	736	3	the	the	DET
admet-2057	736	4	stimuliresponsive	stimuliresponsive	ADJ
admet-2057	736	5	potential	potential	NOUN
admet-2057	736	6	of	of	ADP
admet-2057	736	7	mofs	mof	NOUN
admet-2057	736	8	can	can	AUX
admet-2057	736	9	efficiently	efficiently	ADV
admet-2057	736	10	provide	provide	VERB
admet-2057	736	11	site	site	NOUN
admet-2057	736	12	-	-	PUNCT
admet-2057	736	13	specific	specific	ADJ
admet-2057	736	14	drug	drug	NOUN
admet-2057	736	15	delivery	delivery	NOUN
admet-2057	736	16	.	.	PUNCT
admet-2057	737	1	stimuli	stimuli	VERB
admet-2057	737	2	-	-	PUNCT
admet-2057	737	3	responsive	responsive	ADJ
admet-2057	737	4	mofs	mof	NOUN
admet-2057	737	5	have	have	VERB
admet-2057	737	6	admet	admet	PROPN
admet-2057	737	7	&	&	CCONJ
admet-2057	737	8	dmpk	dmpk	PROPN
admet-2057	737	9	12(1	12(1	PROPN
admet-2057	737	10	)	)	PUNCT
admet-2057	737	11	(	(	PUNCT
admet-2057	737	12	2024	2024	NUM
admet-2057	737	13	)	)	PUNCT
admet-2057	737	14	27	27	NUM
admet-2057	737	15	-	-	SYM
admet-2057	737	16	62	62	NUM
admet-2057	737	17	drug	drug	NOUN
admet-2057	737	18	delivery	delivery	NOUN
admet-2057	737	19	applications	application	NOUN
admet-2057	737	20	of	of	ADP
admet-2057	737	21	metal	metal	NOUN
admet-2057	737	22	-	-	PUNCT
admet-2057	737	23	organic	organic	ADJ
admet-2057	737	24	framework	framework	NOUN
admet-2057	737	25	doi	doi	NOUN
admet-2057	737	26	:	:	PUNCT
admet-2057	737	27	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	737	28	53	53	NUM
admet-2057	737	29	several	several	ADJ
admet-2057	737	30	benefits	benefit	NOUN
admet-2057	737	31	,	,	PUNCT
admet-2057	737	32	such	such	ADJ
admet-2057	737	33	as	as	ADP
admet-2057	737	34	precise	precise	ADJ
admet-2057	737	35	targeting	targeting	NOUN
admet-2057	737	36	of	of	ADP
admet-2057	737	37	actives	active	NOUN
admet-2057	737	38	,	,	PUNCT
admet-2057	737	39	controlled	control	VERB
admet-2057	737	40	drug	drug	NOUN
admet-2057	737	41	release	release	NOUN
admet-2057	737	42	,	,	PUNCT
admet-2057	737	43	high	high	ADJ
admet-2057	737	44	drug	drug	NOUN
admet-2057	737	45	loading	loading	NOUN
admet-2057	737	46	ability	ability	NOUN
admet-2057	737	47	,	,	PUNCT
admet-2057	737	48	and	and	CCONJ
admet-2057	737	49	the	the	DET
admet-2057	737	50	utilisation	utilisation	NOUN
admet-2057	737	51	of	of	ADP
admet-2057	737	52	altered	altered	ADJ
admet-2057	737	53	physiological	physiological	ADJ
admet-2057	737	54	changes	change	NOUN
admet-2057	737	55	to	to	PART
admet-2057	737	56	target	target	VERB
admet-2057	737	57	relatable	relatable	ADJ
admet-2057	737	58	diseases	disease	NOUN
admet-2057	737	59	.	.	PUNCT
admet-2057	738	1	along	along	ADP
admet-2057	738	2	with	with	ADP
admet-2057	738	3	the	the	DET
admet-2057	738	4	insights	insight	NOUN
admet-2057	738	5	of	of	ADP
admet-2057	738	6	stimuliresponsive	stimuliresponsive	ADJ
admet-2057	738	7	mofs	mof	NOUN
admet-2057	738	8	,	,	PUNCT
admet-2057	738	9	the	the	DET
admet-2057	738	10	multiples	multiple	NOUN
admet-2057	738	11	of	of	ADP
admet-2057	738	12	diseases	disease	NOUN
admet-2057	738	13	with	with	ADP
admet-2057	738	14	their	their	PRON
admet-2057	738	15	background	background	NOUN
admet-2057	738	16	for	for	ADP
admet-2057	738	17	development	development	NOUN
admet-2057	738	18	,	,	PUNCT
admet-2057	738	19	targetability	targetability	NOUN
admet-2057	738	20	,	,	PUNCT
admet-2057	738	21	and	and	CCONJ
admet-2057	738	22	future	future	ADJ
admet-2057	738	23	propensity	propensity	NOUN
admet-2057	738	24	in	in	ADP
admet-2057	738	25	clinical	clinical	ADJ
admet-2057	738	26	applications	application	NOUN
admet-2057	738	27	were	be	AUX
admet-2057	738	28	elaborated	elaborate	VERB
admet-2057	738	29	thoroughly	thoroughly	ADV
admet-2057	738	30	.	.	PUNCT
admet-2057	739	1	the	the	DET
admet-2057	739	2	routes	route	NOUN
admet-2057	739	3	of	of	ADP
admet-2057	739	4	administration	administration	NOUN
admet-2057	739	5	offer	offer	VERB
admet-2057	739	6	a	a	DET
admet-2057	739	7	comprehensive	comprehensive	ADJ
admet-2057	739	8	aspect	aspect	NOUN
admet-2057	739	9	of	of	ADP
admet-2057	739	10	several	several	ADJ
admet-2057	739	11	routes	route	NOUN
admet-2057	739	12	in	in	ADP
admet-2057	739	13	alliance	alliance	NOUN
admet-2057	739	14	with	with	ADP
admet-2057	739	15	different	different	ADJ
admet-2057	739	16	experimental	experimental	ADJ
admet-2057	739	17	research	research	NOUN
admet-2057	739	18	,	,	PUNCT
admet-2057	739	19	which	which	PRON
admet-2057	739	20	would	would	AUX
admet-2057	739	21	be	be	AUX
admet-2057	739	22	beneficial	beneficial	ADJ
admet-2057	739	23	while	while	SCONJ
admet-2057	739	24	ensuring	ensure	VERB
admet-2057	739	25	the	the	DET
admet-2057	739	26	safe	safe	ADJ
admet-2057	739	27	targeting	targeting	NOUN
admet-2057	739	28	of	of	ADP
admet-2057	739	29	actives	active	NOUN
admet-2057	739	30	via	via	ADP
admet-2057	739	31	mofs	mof	NOUN
admet-2057	739	32	.	.	PUNCT
admet-2057	740	1	as	as	ADP
admet-2057	740	2	a	a	DET
admet-2057	740	3	result	result	NOUN
admet-2057	740	4	,	,	PUNCT
admet-2057	740	5	the	the	DET
admet-2057	740	6	multifunctional	multifunctional	ADJ
admet-2057	740	7	potential	potential	NOUN
admet-2057	740	8	of	of	ADP
admet-2057	740	9	mofs	mof	NOUN
admet-2057	740	10	can	can	AUX
admet-2057	740	11	potentially	potentially	ADV
admet-2057	740	12	offer	offer	VERB
admet-2057	740	13	a	a	DET
admet-2057	740	14	great	great	ADJ
admet-2057	740	15	avenue	avenue	NOUN
admet-2057	740	16	for	for	ADP
admet-2057	740	17	drug	drug	NOUN
admet-2057	740	18	delivery	delivery	NOUN
admet-2057	740	19	applications	application	NOUN
admet-2057	740	20	.	.	PUNCT
admet-2057	741	1	even	even	ADV
admet-2057	741	2	though	though	SCONJ
admet-2057	741	3	some	some	DET
admet-2057	741	4	important	important	ADJ
admet-2057	741	5	aspects	aspect	NOUN
admet-2057	741	6	related	relate	VERB
admet-2057	741	7	to	to	ADP
admet-2057	741	8	their	their	PRON
admet-2057	741	9	biosafety	biosafety	NOUN
admet-2057	741	10	,	,	PUNCT
admet-2057	741	11	off	off	ADP
admet-2057	741	12	-	-	PUNCT
admet-2057	741	13	target	target	NOUN
admet-2057	741	14	accumulation	accumulation	NOUN
admet-2057	741	15	and	and	CCONJ
admet-2057	741	16	manufacturing	manufacturing	NOUN
admet-2057	741	17	setting	setting	NOUN
admet-2057	741	18	should	should	AUX
admet-2057	741	19	be	be	AUX
admet-2057	741	20	critical	critical	ADJ
admet-2057	741	21	considerations	consideration	NOUN
admet-2057	741	22	.	.	PUNCT
admet-2057	742	1	acknowledgements	acknowledgement	NOUN
admet-2057	742	2	:	:	PUNCT
admet-2057	742	3	the	the	DET
admet-2057	742	4	authors	author	NOUN
admet-2057	742	5	are	be	AUX
admet-2057	742	6	thankful	thankful	ADJ
admet-2057	742	7	to	to	ADP
admet-2057	742	8	the	the	DET
admet-2057	742	9	principal	principal	PROPN
admet-2057	742	10	dr	dr	PROPN
admet-2057	742	11	.	.	PROPN
admet-2057	742	12	h.	h.	PROPN
admet-2057	742	13	n.	n.	PROPN
admet-2057	743	1	more	more	ADV
admet-2057	743	2	,	,	PUNCT
admet-2057	743	3	bharati	bharati	PROPN
admet-2057	743	4	vidyapeeth	vidyapeeth	PROPN
admet-2057	743	5	college	college	PROPN
admet-2057	743	6	of	of	ADP
admet-2057	743	7	pharmacy	pharmacy	NOUN
admet-2057	743	8	,	,	PUNCT
admet-2057	743	9	kolhapur	kolhapur	NOUN
admet-2057	743	10	for	for	ADP
admet-2057	743	11	providing	provide	VERB
admet-2057	743	12	the	the	DET
admet-2057	743	13	required	require	VERB
admet-2057	743	14	facility	facility	NOUN
admet-2057	743	15	to	to	PART
admet-2057	743	16	complete	complete	VERB
admet-2057	743	17	the	the	DET
admet-2057	743	18	present	present	ADJ
admet-2057	743	19	review	review	NOUN
admet-2057	743	20	article	article	NOUN
admet-2057	743	21	.	.	PUNCT
admet-2057	744	1	sopan	sopan	NOUN
admet-2057	744	2	nangare	nangare	ADV
admet-2057	744	3	would	would	AUX
admet-2057	744	4	like	like	VERB
admet-2057	744	5	to	to	PART
admet-2057	744	6	acknowledge	acknowledge	VERB
admet-2057	744	7	the	the	DET
admet-2057	744	8	indian	indian	ADJ
admet-2057	744	9	council	council	PROPN
admet-2057	744	10	of	of	ADP
admet-2057	744	11	medical	medical	ADJ
admet-2057	744	12	research	research	NOUN
admet-2057	744	13	(	(	PUNCT
admet-2057	744	14	icmr	icmr	PROPN
admet-2057	744	15	)	)	PUNCT
admet-2057	744	16	,	,	PUNCT
admet-2057	744	17	new	new	ADJ
admet-2057	744	18	delhi	delhi	PROPN
admet-2057	744	19	for	for	ADP
admet-2057	744	20	providing	provide	VERB
admet-2057	744	21	research	research	NOUN
admet-2057	744	22	associate	associate	NOUN
admet-2057	744	23	(	(	PUNCT
admet-2057	744	24	ra	ra	NOUN
admet-2057	744	25	)	)	PUNCT
admet-2057	744	26	fellowship	fellowship	NOUN
admet-2057	744	27	.	.	PUNCT
admet-2057	745	1	the	the	DET
admet-2057	745	2	authors	author	NOUN
admet-2057	745	3	acknowledge	acknowledge	VERB
admet-2057	745	4	vecteezy	vecteezy	PROPN
admet-2057	745	5	(	(	PUNCT
admet-2057	745	6	https://www.vecteezy.com/free-vector/person	https://www.vecteezy.com/free-vector/person	PROPN
admet-2057	745	7	)	)	PUNCT
admet-2057	745	8	,	,	PUNCT
admet-2057	745	9	freepik	freepik	PROPN
admet-2057	745	10	(	(	PUNCT
admet-2057	745	11	www.freepik.com	www.freepik.com	NOUN
admet-2057	745	12	)	)	PUNCT
admet-2057	745	13	,	,	PUNCT
admet-2057	745	14	pixabay	pixabay	VERB
admet-2057	745	15	(	(	PUNCT
admet-2057	745	16	www.pixabay.com	www.pixabay.com	NOUN
admet-2057	745	17	)	)	PUNCT
admet-2057	745	18	for	for	ADP
admet-2057	745	19	providing	provide	VERB
admet-2057	745	20	a	a	DET
admet-2057	745	21	free	free	ADJ
admet-2057	745	22	platform	platform	NOUN
admet-2057	745	23	to	to	PART
admet-2057	745	24	create	create	VERB
admet-2057	745	25	images	image	NOUN
admet-2057	745	26	..	..	PUNCT
admet-2057	745	27	conflict	conflict	NOUN
admet-2057	745	28	of	of	ADP
admet-2057	745	29	interest	interest	NOUN
admet-2057	745	30	and	and	CCONJ
admet-2057	745	31	funding	funding	NOUN
admet-2057	745	32	:	:	PUNCT
admet-2057	745	33	there	there	PRON
admet-2057	745	34	is	be	VERB
admet-2057	745	35	no	no	DET
admet-2057	745	36	conflict	conflict	NOUN
admet-2057	745	37	of	of	ADP
admet-2057	745	38	interest	interest	NOUN
admet-2057	745	39	and	and	CCONJ
admet-2057	745	40	funding	funding	NOUN
admet-2057	745	41	to	to	PART
admet-2057	745	42	declare	declare	VERB
admet-2057	745	43	.	.	PUNCT
admet-2057	746	1	author	author	NOUN
admet-2057	746	2	contributions	contribution	NOUN
admet-2057	746	3	:	:	PUNCT
admet-2057	746	4	prachi	prachi	PROPN
admet-2057	746	5	mhettar	mhettar	PROPN
admet-2057	746	6	and	and	CCONJ
admet-2057	746	7	niraj	niraj	VERB
admet-2057	746	8	kale	kale	PROPN
admet-2057	746	9	contributed	contribute	VERB
admet-2057	746	10	equally	equally	ADV
admet-2057	746	11	as	as	ADP
admet-2057	746	12	the	the	DET
admet-2057	746	13	first	first	ADJ
admet-2057	746	14	author	author	NOUN
admet-2057	746	15	.	.	PUNCT
admet-2057	747	1	references	reference	NOUN
admet-2057	747	2	[	[	X
admet-2057	747	3	1	1	X
admet-2057	747	4	]	]	PUNCT
admet-2057	747	5	s.	s.	PROPN
admet-2057	747	6	adepu	adepu	PROPN
admet-2057	747	7	,	,	PUNCT
admet-2057	747	8	s.	s.	PROPN
admet-2057	747	9	ramakrishna	ramakrishna	PROPN
admet-2057	747	10	.	.	PUNCT
admet-2057	748	1	controlled	control	VERB
admet-2057	748	2	drug	drug	NOUN
admet-2057	748	3	delivery	delivery	NOUN
admet-2057	748	4	systems	system	NOUN
admet-2057	748	5	:	:	PUNCT
admet-2057	748	6	current	current	ADJ
admet-2057	748	7	status	status	NOUN
admet-2057	748	8	and	and	CCONJ
admet-2057	748	9	future	future	ADJ
admet-2057	748	10	directions	direction	NOUN
admet-2057	748	11	.	.	PUNCT
admet-2057	749	1	molecules	molecule	NOUN
admet-2057	749	2	26	26	NUM
admet-2057	749	3	(	(	PUNCT
admet-2057	749	4	2021	2021	NUM
admet-2057	749	5	)	)	PUNCT
admet-2057	749	6	5905	5905	NUM
admet-2057	749	7	.	.	PUNCT
admet-2057	750	1	https://doi.org/10.3390/molecules26195905	https://doi.org/10.3390/molecules26195905	VERB
admet-2057	751	1	[	[	X
admet-2057	751	2	2	2	X
admet-2057	751	3	]	]	X
admet-2057	751	4	y.	y.	PROPN
admet-2057	751	5	wang	wang	PROPN
admet-2057	751	6	,	,	PUNCT
admet-2057	751	7	j.	j.	PROPN
admet-2057	751	8	yan	yan	PROPN
admet-2057	751	9	,	,	PUNCT
admet-2057	751	10	n.	n.	PROPN
admet-2057	751	11	wen	wen	PROPN
admet-2057	751	12	,	,	PUNCT
admet-2057	751	13	h.	h.	PROPN
admet-2057	751	14	xiong	xiong	PROPN
admet-2057	751	15	,	,	PUNCT
admet-2057	751	16	s.	s.	PROPN
admet-2057	751	17	cai	cai	PROPN
admet-2057	751	18	,	,	PUNCT
admet-2057	751	19	q.	q.	PROPN
admet-2057	751	20	he	he	PRON
admet-2057	751	21	,	,	PUNCT
admet-2057	751	22	y.	y.	PROPN
admet-2057	751	23	hu	hu	PROPN
admet-2057	751	24	,	,	PUNCT
admet-2057	751	25	d.	d.	PROPN
admet-2057	751	26	peng	peng	PROPN
admet-2057	751	27	,	,	PUNCT
admet-2057	751	28	z.	z.	PROPN
admet-2057	751	29	liu	liu	PROPN
admet-2057	751	30	,	,	PUNCT
admet-2057	751	31	y.	y.	PROPN
admet-2057	751	32	liu	liu	PROPN
admet-2057	751	33	.	.	PUNCT
admet-2057	752	1	metal	metal	NOUN
admet-2057	752	2	-	-	PUNCT
admet-2057	752	3	organic	organic	ADJ
admet-2057	752	4	frameworks	framework	NOUN
admet-2057	752	5	for	for	ADP
admet-2057	752	6	stimuli	stimulus	NOUN
admet-2057	752	7	-	-	PUNCT
admet-2057	752	8	responsive	responsive	ADJ
admet-2057	752	9	drug	drug	NOUN
admet-2057	752	10	delivery	delivery	NOUN
admet-2057	752	11	.	.	PUNCT
admet-2057	753	1	biomaterials	biomaterial	NOUN
admet-2057	753	2	230	230	NUM
admet-2057	753	3	(	(	PUNCT
admet-2057	753	4	2020	2020	NUM
admet-2057	753	5	)	)	PUNCT
admet-2057	753	6	119619	119619	NUM
admet-2057	753	7	.	.	PUNCT
admet-2057	754	1	https://doi.org/10.1016/j.biomaterials.2019.119619	https://doi.org/10.1016/j.biomaterials.2019.119619	PROPN
admet-2057	754	2	[	[	X
admet-2057	754	3	3	3	X
admet-2057	754	4	]	]	X
admet-2057	754	5	i.	i.	NOUN
admet-2057	754	6	tibbetts	tibbetts	PROPN
admet-2057	754	7	,	,	PUNCT
admet-2057	754	8	g.e	g.e	PROPN
admet-2057	754	9	.	.	PUNCT
admet-2057	754	10	kostakis	kostakis	PROPN
admet-2057	754	11	.	.	PUNCT
admet-2057	755	1	recent	recent	ADJ
admet-2057	755	2	bio	bio	NOUN
admet-2057	755	3	-	-	NOUN
admet-2057	755	4	advances	advance	NOUN
admet-2057	755	5	in	in	ADP
admet-2057	755	6	metal	metal	NOUN
admet-2057	755	7	-	-	PUNCT
admet-2057	755	8	organic	organic	ADJ
admet-2057	755	9	frameworks	framework	NOUN
admet-2057	755	10	.	.	PUNCT
admet-2057	756	1	molecules	molecule	NOUN
admet-2057	756	2	25	25	NUM
admet-2057	756	3	(	(	PUNCT
admet-2057	756	4	2020	2020	NUM
admet-2057	756	5	)	)	PUNCT
admet-2057	756	6	1291	1291	NUM
admet-2057	756	7	.	.	PUNCT
admet-2057	757	1	https://doi.org/10.3390/molecules25061291	https://doi.org/10.3390/molecules25061291	PROPN
admet-2057	758	1	[	[	X
admet-2057	758	2	4	4	X
admet-2057	758	3	]	]	PUNCT
admet-2057	758	4	s.	s.	PROPN
admet-2057	758	5	zhang	zhang	PROPN
admet-2057	758	6	,	,	PUNCT
admet-2057	758	7	x.	x.	PROPN
admet-2057	758	8	pei	pei	PROPN
admet-2057	758	9	,	,	PUNCT
admet-2057	758	10	h.	h.	PROPN
admet-2057	758	11	gao	gao	PROPN
admet-2057	758	12	,	,	PUNCT
admet-2057	758	13	s.	s.	PROPN
admet-2057	758	14	chen	chen	PROPN
admet-2057	758	15	,	,	PUNCT
admet-2057	758	16	j.	j.	PROPN
admet-2057	758	17	wang	wang	PROPN
admet-2057	758	18	.	.	PUNCT
admet-2057	759	1	metal	metal	NOUN
admet-2057	759	2	-	-	PUNCT
admet-2057	759	3	organic	organic	ADJ
admet-2057	759	4	framework	framework	NOUN
admet-2057	759	5	-	-	PUNCT
admet-2057	759	6	based	base	VERB
admet-2057	759	7	nanomaterials	nanomaterial	NOUN
admet-2057	759	8	for	for	ADP
admet-2057	759	9	biomedical	biomedical	ADJ
admet-2057	759	10	applications	application	NOUN
admet-2057	759	11	.	.	PUNCT
admet-2057	760	1	chinese	chinese	ADJ
admet-2057	760	2	chemical	chemical	PROPN
admet-2057	760	3	letters	letter	NOUN
admet-2057	760	4	31	31	NUM
admet-2057	760	5	(	(	PUNCT
admet-2057	760	6	2020	2020	NUM
admet-2057	760	7	)	)	PUNCT
admet-2057	760	8	1060	1060	NUM
admet-2057	760	9	-	-	SYM
admet-2057	760	10	1070	1070	NUM
admet-2057	760	11	.	.	PUNCT
admet-2057	761	1	https://doi.org/10.1016/j.cclet.2019.11.036	https://doi.org/10.1016/j.cclet.2019.11.036	NOUN
admet-2057	762	1	[	[	X
admet-2057	762	2	5	5	X
admet-2057	762	3	]	]	PUNCT
admet-2057	762	4	s.	s.	PROPN
admet-2057	762	5	z.	z.	PROPN
admet-2057	762	6	mohammadi	mohammadi	PROPN
admet-2057	762	7	,	,	PUNCT
admet-2057	762	8	f.	f.	PROPN
admet-2057	762	9	mousazadeh	mousazadeh	PROPN
admet-2057	762	10	,	,	PUNCT
admet-2057	762	11	m.	m.	NOUN
admet-2057	762	12	mohammadhasani	mohammadhasani	PROPN
admet-2057	762	13	-	-	PUNCT
admet-2057	762	14	pour	pour	PROPN
admet-2057	762	15	.	.	PUNCT
admet-2057	763	1	electrochemical	electrochemical	ADJ
admet-2057	763	2	detection	detection	NOUN
admet-2057	763	3	of	of	ADP
admet-2057	763	4	folic	folic	ADJ
admet-2057	763	5	acid	acid	NOUN
admet-2057	763	6	using	use	VERB
admet-2057	763	7	a	a	DET
admet-2057	763	8	modified	modify	VERB
admet-2057	763	9	screen	screen	NOUN
admet-2057	763	10	printed	print	VERB
admet-2057	763	11	electrode	electrode	PROPN
admet-2057	763	12	.	.	PUNCT
admet-2057	764	1	journal	journal	PROPN
admet-2057	764	2	of	of	ADP
admet-2057	764	3	electrochemical	electrochemical	ADJ
admet-2057	764	4	science	science	NOUN
admet-2057	764	5	and	and	CCONJ
admet-2057	764	6	engineering	engineering	NOUN
admet-2057	764	7	12	12	NUM
admet-2057	764	8	(	(	PUNCT
admet-2057	764	9	2022	2022	NUM
admet-2057	764	10	)	)	PUNCT
admet-2057	764	11	1111	1111	NUM
admet-2057	764	12	-	-	SYM
admet-2057	764	13	1120	1120	NUM
admet-2057	764	14	.	.	PUNCT
admet-2057	765	1	https://doi.org/10.5599/jese.1360	https://doi.org/10.5599/jese.1360	NOUN
admet-2057	766	1	[	[	X
admet-2057	766	2	6	6	NUM
admet-2057	766	3	]	]	PUNCT
admet-2057	766	4	j.	j.	PROPN
admet-2057	766	5	pantwalawalkar	pantwalawalkar	PROPN
admet-2057	766	6	,	,	PUNCT
admet-2057	766	7	p.	p.	NOUN
admet-2057	766	8	mhettar	mhettar	NOUN
admet-2057	766	9	,	,	PUNCT
admet-2057	766	10	s.	s.	PROPN
admet-2057	766	11	nangare	nangare	PROPN
admet-2057	766	12	,	,	PUNCT
admet-2057	766	13	r.	r.	PROPN
admet-2057	766	14	mali	mali	PROPN
admet-2057	766	15	,	,	PUNCT
admet-2057	766	16	a.	a.	NOUN
admet-2057	766	17	ghule	ghule	PROPN
admet-2057	766	18	,	,	PUNCT
admet-2057	766	19	p.	p.	PROPN
admet-2057	766	20	patil	patil	PROPN
admet-2057	766	21	,	,	PUNCT
admet-2057	766	22	s.	s.	PROPN
admet-2057	766	23	mohite	mohite	PROPN
admet-2057	766	24	,	,	PUNCT
admet-2057	766	25	h.	h.	PROPN
admet-2057	766	26	more	more	ADV
admet-2057	766	27	,	,	PUNCT
admet-2057	766	28	n.	n.	PROPN
admet-2057	766	29	jadhav	jadhav	PROPN
admet-2057	766	30	.	.	PUNCT
admet-2057	767	1	stimuli	stimuli	VERB
admet-2057	767	2	-	-	PUNCT
admet-2057	767	3	responsive	responsive	ADJ
admet-2057	767	4	design	design	NOUN
admet-2057	767	5	of	of	ADP
admet-2057	767	6	metal	metal	NOUN
admet-2057	767	7	-	-	PUNCT
admet-2057	767	8	organic	organic	ADJ
admet-2057	767	9	frameworks	framework	NOUN
admet-2057	767	10	for	for	ADP
admet-2057	767	11	cancer	cancer	NOUN
admet-2057	767	12	theranostics	theranostic	NOUN
admet-2057	767	13	:	:	PUNCT
admet-2057	767	14	current	current	ADJ
admet-2057	767	15	challenges	challenge	NOUN
admet-2057	767	16	and	and	CCONJ
admet-2057	767	17	future	future	ADJ
admet-2057	767	18	perspective	perspective	NOUN
admet-2057	767	19	.	.	PUNCT
admet-2057	768	1	acs	acs	PROPN
admet-2057	768	2	biomaterial	biomaterial	PROPN
admet-2057	768	3	science	science	PROPN
admet-2057	768	4	&	&	CCONJ
admet-2057	768	5	engineering	engineering	PROPN
admet-2057	768	6	9(8	9(8	NUM
admet-2057	768	7	)	)	PUNCT
admet-2057	768	8	(	(	PUNCT
admet-2057	768	9	2023	2023	NUM
admet-2057	768	10	)	)	PUNCT
admet-2057	768	11	4497	4497	NUM
admet-2057	768	12	-	-	SYM
admet-2057	768	13	4626	4626	NUM
admet-2057	768	14	.	.	PUNCT
admet-2057	769	1	https://doi.org/10.1021/acsbiomaterials.3c00507	https://doi.org/10.1021/acsbiomaterials.3c00507	NOUN
admet-2057	770	1	[	[	X
admet-2057	770	2	7	7	NUM
admet-2057	770	3	]	]	PUNCT
admet-2057	770	4	a.	a.	NOUN
admet-2057	770	5	anumah	anumah	PROPN
admet-2057	770	6	,	,	PUNCT
admet-2057	770	7	h.	h.	PROPN
admet-2057	770	8	louis	louis	PROPN
admet-2057	770	9	,	,	PUNCT
admet-2057	770	10	a.t	a.t	PROPN
admet-2057	770	11	.	.	PROPN
admet-2057	770	12	hamzat	hamzat	PROPN
admet-2057	770	13	,	,	PUNCT
admet-2057	770	14	o.o	o.o	PROPN
admet-2057	770	15	.	.	PROPN
admet-2057	770	16	amusan	amusan	PROPN
admet-2057	770	17	,	,	PUNCT
admet-2057	770	18	a.i	a.i	PROPN
admet-2057	770	19	.	.	PROPN
admet-2057	770	20	pigweh	pigweh	PROPN
admet-2057	770	21	,	,	PUNCT
admet-2057	770	22	o.u	o.u	PROPN
admet-2057	770	23	.	.	PROPN
admet-2057	770	24	akakuru	akakuru	PROPN
admet-2057	770	25	,	,	PUNCT
admet-2057	770	26	a.t	a.t	PROPN
admet-2057	770	27	.	.	PROPN
admet-2057	770	28	adeleye	adeleye	PROPN
admet-2057	770	29	,	,	PUNCT
admet-2057	770	30	t.o	t.o	PROPN
admet-2057	770	31	.	.	PROPN
admet-2057	770	32	magu	magu	PROPN
admet-2057	770	33	,	,	PUNCT
admet-2057	770	34	chemical	chemical	NOUN
admet-2057	770	35	methodologies	methodology	NOUN
admet-2057	770	36	metal	metal	NOUN
admet-2057	770	37	-	-	PUNCT
admet-2057	770	38	organic	organic	ADJ
admet-2057	770	39	frameworks	framework	NOUN
admet-2057	770	40	(	(	PUNCT
admet-2057	770	41	mofs	mof	NOUN
admet-2057	770	42	):	):	PUNCT
admet-2057	770	43	recent	recent	ADJ
admet-2057	770	44	advances	advance	NOUN
admet-2057	770	45	in	in	ADP
admet-2057	770	46	synthetic	synthetic	ADJ
admet-2057	770	47	methodologies	methodology	NOUN
admet-2057	770	48	and	and	CCONJ
admet-2057	770	49	some	some	DET
admet-2057	770	50	applications	application	NOUN
admet-2057	770	51	.	.	PUNCT
admet-2057	771	1	chemical	chemical	ADJ
admet-2057	771	2	methodologies	methodology	NOUN
admet-2057	771	3	3	3	NUM
admet-2057	771	4	(	(	PUNCT
admet-2057	771	5	2019	2019	NUM
admet-2057	771	6	)	)	PUNCT
admet-2057	771	7	283	283	NUM
admet-2057	771	8	-	-	SYM
admet-2057	771	9	305	305	NUM
admet-2057	771	10	.	.	PUNCT
admet-2057	772	1	http://dx.doi.org/10.22034/chemm.2018.139807.1067	http://dx.doi.org/10.22034/chemm.2018.139807.1067	NOUN
admet-2057	772	2	[	[	X
admet-2057	772	3	8	8	NUM
admet-2057	772	4	]	]	X
admet-2057	772	5	b.	b.	PROPN
admet-2057	772	6	maranescu	maranescu	PROPN
admet-2057	772	7	,	,	PUNCT
admet-2057	772	8	a.	a.	NOUN
admet-2057	772	9	visa	visa	NOUN
admet-2057	772	10	.	.	PUNCT
admet-2057	773	1	applications	application	NOUN
admet-2057	773	2	of	of	ADP
admet-2057	773	3	metal	metal	NOUN
admet-2057	773	4	-	-	PUNCT
admet-2057	773	5	organic	organic	ADJ
admet-2057	773	6	frameworks	framework	NOUN
admet-2057	773	7	as	as	ADP
admet-2057	773	8	drug	drug	NOUN
admet-2057	773	9	delivery	delivery	NOUN
admet-2057	773	10	systems	system	NOUN
admet-2057	773	11	.	.	PUNCT
admet-2057	774	1	international	international	ADJ
admet-2057	774	2	journal	journal	NOUN
admet-2057	774	3	of	of	ADP
admet-2057	774	4	molecular	molecular	ADJ
admet-2057	774	5	sciences	science	NOUN
admet-2057	774	6	23(8	23(8	NUM
admet-2057	774	7	)	)	PUNCT
admet-2057	774	8	(	(	PUNCT
admet-2057	774	9	2022	2022	NUM
admet-2057	774	10	)	)	PUNCT
admet-2057	774	11	1	1	NUM
admet-2057	774	12	-	-	SYM
admet-2057	774	13	19	19	NUM
admet-2057	774	14	.	.	PUNCT
admet-2057	775	1	https://doi.org/10.3390/ijms23084458	https://doi.org/10.3390/ijms23084458	PROPN
admet-2057	775	2	[	[	X
admet-2057	775	3	9	9	NUM
admet-2057	775	4	]	]	PUNCT
admet-2057	775	5	m.	m.	NOUN
admet-2057	775	6	al	al	PROPN
admet-2057	775	7	sharabati	sharabati	PROPN
admet-2057	775	8	,	,	PUNCT
admet-2057	775	9	r.	r.	PROPN
admet-2057	775	10	sabouni	sabouni	PROPN
admet-2057	775	11	,	,	PUNCT
admet-2057	775	12	g.a	g.a	PROPN
admet-2057	775	13	.	.	PROPN
admet-2057	775	14	husseini	husseini	PROPN
admet-2057	775	15	.	.	PROPN
admet-2057	775	16	biomedical	biomedical	ADJ
admet-2057	775	17	applications	application	NOUN
admet-2057	775	18	of	of	ADP
admet-2057	775	19	metal−organic	metal−organic	ADJ
admet-2057	775	20	frameworks	framework	NOUN
admet-2057	775	21	for	for	ADP
admet-2057	775	22	disease	disease	NOUN
admet-2057	775	23	diagnosis	diagnosis	NOUN
admet-2057	775	24	and	and	CCONJ
admet-2057	775	25	drug	drug	NOUN
admet-2057	775	26	delivery	delivery	NOUN
admet-2057	775	27	:	:	PUNCT
admet-2057	775	28	a	a	DET
admet-2057	775	29	review	review	NOUN
admet-2057	775	30	.	.	PUNCT
admet-2057	776	1	nanomaterials	nanomaterial	NOUN
admet-2057	776	2	12(2	12(2	NUM
admet-2057	776	3	)	)	PUNCT
admet-2057	776	4	(	(	PUNCT
admet-2057	776	5	2022	2022	NUM
admet-2057	776	6	)	)	PUNCT
admet-2057	776	7	277	277	NUM
admet-2057	776	8	.	.	PUNCT
admet-2057	777	1	https://doi.org/10.3390/nano12020277	https://doi.org/10.3390/nano12020277	NOUN
admet-2057	777	2	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	PROPN
admet-2057	777	3	https://www.vecteezy.com/free-vector/person	https://www.vecteezy.com/free-vector/person	PROPN
admet-2057	777	4	http://www.freepik.com/	http://www.freepik.com/	NOUN
admet-2057	777	5	http://www.pixabay.com/	http://www.pixabay.com/	PROPN
admet-2057	777	6	https://doi.org/10.3390/molecules26195905	https://doi.org/10.3390/molecules26195905	PROPN
admet-2057	777	7	https://doi.org/10.1016/j.biomaterials.2019.119619	https://doi.org/10.1016/j.biomaterials.2019.119619	PROPN
admet-2057	777	8	https://doi.org/10.3390/molecules25061291	https://doi.org/10.3390/molecules25061291	PROPN
admet-2057	777	9	https://doi.org/10.1016/j.cclet.2019.11.036	https://doi.org/10.1016/j.cclet.2019.11.036	PROPN
admet-2057	777	10	https://doi.org/10.5599/jese.1360	https://doi.org/10.5599/jese.1360	NOUN
admet-2057	777	11	https://doi.org/10.1021/acsbiomaterials.3c00507	https://doi.org/10.1021/acsbiomaterials.3c00507	NOUN
admet-2057	777	12	http://dx.doi.org/10.22034/chemm.2018.139807.1067	http://dx.doi.org/10.22034/chemm.2018.139807.1067	PROPN
admet-2057	777	13	https://doi.org/10.3390/ijms23084458	https://doi.org/10.3390/ijms23084458	VERB
admet-2057	777	14	https://doi.org/10.3390/nano12020277	https://doi.org/10.3390/nano12020277	NOUN
admet-2057	777	15	p.	p.	NOUN
admet-2057	777	16	mhettar	mhettar	NOUN
admet-2057	777	17	et	et	PROPN
admet-2057	777	18	al	al	PROPN
admet-2057	777	19	.	.	PROPN
admet-2057	777	20	admet	admet	PROPN
admet-2057	777	21	&	&	CCONJ
admet-2057	777	22	dmpk	dmpk	PROPN
admet-2057	777	23	12(1	12(1	PROPN
admet-2057	777	24	)	)	PUNCT
admet-2057	777	25	(	(	PUNCT
admet-2057	777	26	2024	2024	NUM
admet-2057	777	27	)	)	PUNCT
admet-2057	777	28	27	27	NUM
admet-2057	777	29	-	-	SYM
admet-2057	777	30	62	62	NUM
admet-2057	777	31	54	54	NUM
admet-2057	778	1	[	[	SYM
admet-2057	778	2	10	10	NUM
admet-2057	778	3	]	]	X
admet-2057	778	4	j.w.m	j.w.m	PROPN
admet-2057	778	5	.	.	PUNCT
admet-2057	778	6	osterrieth	osterrieth	PROPN
admet-2057	778	7	,	,	PUNCT
admet-2057	778	8	d.	d.	PROPN
admet-2057	778	9	fairen	fairen	PROPN
admet-2057	778	10	-	-	PUNCT
admet-2057	778	11	jimenez	jimenez	PROPN
admet-2057	778	12	.	.	PUNCT
admet-2057	779	1	metal	metal	NOUN
admet-2057	779	2	-	-	PUNCT
admet-2057	779	3	organic	organic	ADJ
admet-2057	779	4	framework	framework	NOUN
admet-2057	779	5	composites	composite	NOUN
admet-2057	779	6	for	for	ADP
admet-2057	779	7	theragnostics	theragnostic	NOUN
admet-2057	779	8	and	and	CCONJ
admet-2057	779	9	drug	drug	NOUN
admet-2057	779	10	delivery	delivery	NOUN
admet-2057	779	11	applications	application	NOUN
admet-2057	779	12	.	.	PUNCT
admet-2057	780	1	biotechnology	biotechnology	NOUN
admet-2057	780	2	journal	journal	PROPN
admet-2057	780	3	16(2	16(2	NUM
admet-2057	780	4	)	)	PUNCT
admet-2057	780	5	(	(	PUNCT
admet-2057	780	6	2021	2021	NUM
admet-2057	780	7	)	)	PUNCT
admet-2057	780	8	2000005	2000005	NUM
admet-2057	780	9	.	.	PUNCT
admet-2057	781	1	https://doi.org/10.1002/biot.202000005	https://doi.org/10.1002/biot.202000005	X
admet-2057	782	1	[	[	X
admet-2057	782	2	11	11	NUM
admet-2057	782	3	]	]	X
admet-2057	782	4	s.j	s.j	PROPN
admet-2057	782	5	.	.	PROPN
admet-2057	782	6	rahaman	rahaman	PROPN
admet-2057	782	7	,	,	PUNCT
admet-2057	782	8	a.	a.	PROPN
admet-2057	782	9	samanta	samanta	PROPN
admet-2057	782	10	,	,	PUNCT
admet-2057	782	11	m.h	m.h	PROPN
admet-2057	782	12	.	.	PROPN
admet-2057	782	13	mir	mir	PROPN
admet-2057	782	14	,	,	PUNCT
admet-2057	782	15	b.	b.	PROPN
admet-2057	782	16	dutta	dutta	PROPN
admet-2057	782	17	.	.	PUNCT
admet-2057	783	1	metal	metal	NOUN
admet-2057	783	2	-	-	PUNCT
admet-2057	783	3	organic	organic	ADJ
admet-2057	783	4	frameworks	framework	NOUN
admet-2057	783	5	(	(	PUNCT
admet-2057	783	6	mofs	mof	NOUN
admet-2057	783	7	):	):	PUNCT
admet-2057	783	8	a	a	DET
admet-2057	783	9	promising	promising	ADJ
admet-2057	783	10	candidate	candidate	NOUN
admet-2057	783	11	for	for	ADP
admet-2057	783	12	stimuli	stimulus	NOUN
admet-2057	783	13	-	-	PUNCT
admet-2057	783	14	responsive	responsive	ADJ
admet-2057	783	15	drug	drug	NOUN
admet-2057	783	16	delivery	delivery	NOUN
admet-2057	783	17	.	.	PUNCT
admet-2057	784	1	es	es	X
admet-2057	784	2	materials	material	NOUN
admet-2057	784	3	and	and	CCONJ
admet-2057	784	4	manufacturing	manufacture	VERB
admet-2057	784	5	19	19	NUM
admet-2057	784	6	(	(	PUNCT
admet-2057	784	7	2023	2023	NUM
admet-2057	784	8	)	)	PUNCT
admet-2057	784	9	792	792	NUM
admet-2057	784	10	.	.	PUNCT
admet-2057	785	1	https://doi.org/10.30919/esmm5f792	https://doi.org/10.30919/esmm5f792	PROPN
admet-2057	785	2	[	[	X
admet-2057	785	3	12	12	NUM
admet-2057	785	4	]	]	X
admet-2057	785	5	c.p	c.p	PROPN
admet-2057	785	6	.	.	PROPN
admet-2057	785	7	raptopoulou	raptopoulou	PROPN
admet-2057	785	8	.	.	PUNCT
admet-2057	786	1	metal	metal	NOUN
admet-2057	786	2	-	-	PUNCT
admet-2057	786	3	organic	organic	ADJ
admet-2057	786	4	frameworks	framework	NOUN
admet-2057	786	5	:	:	PUNCT
admet-2057	786	6	synthetic	synthetic	ADJ
admet-2057	786	7	methods	method	NOUN
admet-2057	786	8	and	and	CCONJ
admet-2057	786	9	potential	potential	ADJ
admet-2057	786	10	applications	application	NOUN
admet-2057	786	11	.	.	PUNCT
admet-2057	787	1	materials	material	NOUN
admet-2057	787	2	14(2	14(2	NUM
admet-2057	787	3	)	)	PUNCT
admet-2057	787	4	(	(	PUNCT
admet-2057	787	5	2021	2021	NUM
admet-2057	787	6	)	)	PUNCT
admet-2057	787	7	310	310	NUM
admet-2057	787	8	.	.	PUNCT
admet-2057	788	1	https://doi.org/10.3390/ma14020310	https://doi.org/10.3390/ma14020310	PRON
admet-2057	789	1	[	[	X
admet-2057	789	2	13	13	NUM
admet-2057	789	3	]	]	X
admet-2057	789	4	v.f	v.f	PROPN
admet-2057	789	5	.	.	PROPN
admet-2057	789	6	yusuf	yusuf	PROPN
admet-2057	789	7	,	,	PUNCT
admet-2057	789	8	n.i	n.i	PROPN
admet-2057	789	9	.	.	PROPN
admet-2057	789	10	malek	malek	PROPN
admet-2057	789	11	,	,	PUNCT
admet-2057	789	12	s.k	s.k	PROPN
admet-2057	789	13	.	.	PROPN
admet-2057	789	14	kailasa	kailasa	PROPN
admet-2057	789	15	.	.	PUNCT
admet-2057	790	1	review	review	NOUN
admet-2057	790	2	on	on	ADP
admet-2057	790	3	metal	metal	NOUN
admet-2057	790	4	-	-	PUNCT
admet-2057	790	5	organic	organic	ADJ
admet-2057	790	6	framework	framework	NOUN
admet-2057	790	7	classification	classification	NOUN
admet-2057	790	8	,	,	PUNCT
admet-2057	790	9	synthetic	synthetic	ADJ
admet-2057	790	10	approaches	approach	NOUN
admet-2057	790	11	,	,	PUNCT
admet-2057	790	12	and	and	CCONJ
admet-2057	790	13	influencing	influence	VERB
admet-2057	790	14	factors	factor	NOUN
admet-2057	790	15	:	:	PUNCT
admet-2057	790	16	applications	application	NOUN
admet-2057	790	17	in	in	ADP
admet-2057	790	18	energy	energy	NOUN
admet-2057	790	19	,	,	PUNCT
admet-2057	790	20	drug	drug	NOUN
admet-2057	790	21	delivery	delivery	NOUN
admet-2057	790	22	,	,	PUNCT
admet-2057	790	23	and	and	CCONJ
admet-2057	790	24	wastewater	wastewater	NOUN
admet-2057	790	25	treatment	treatment	NOUN
admet-2057	790	26	.	.	PUNCT
admet-2057	791	1	acs	acs	PROPN
admet-2057	791	2	omega	omega	NOUN
admet-2057	791	3	7(49	7(49	NUM
admet-2057	791	4	)	)	PUNCT
admet-2057	791	5	(	(	PUNCT
admet-2057	791	6	2022	2022	NUM
admet-2057	791	7	)	)	PUNCT
admet-2057	791	8	44507	44507	NUM
admet-2057	791	9	-	-	SYM
admet-2057	791	10	44531	44531	NUM
admet-2057	791	11	.	.	PUNCT
admet-2057	792	1	https://doi.org/10.1021/acsomega.2c05310	https://doi.org/10.1021/acsomega.2c05310	X
admet-2057	793	1	[	[	X
admet-2057	793	2	14	14	NUM
admet-2057	793	3	]	]	PUNCT
admet-2057	793	4	t.	t.	PROPN
admet-2057	793	5	hidalgo	hidalgo	PROPN
admet-2057	793	6	,	,	PUNCT
admet-2057	793	7	c.	c.	PROPN
admet-2057	793	8	serre	serre	PROPN
admet-2057	793	9	,	,	PUNCT
admet-2057	793	10	p.	p.	PROPN
admet-2057	793	11	horcajada	horcajada	PROPN
admet-2057	793	12	.	.	PUNCT
admet-2057	794	1	applications	application	NOUN
admet-2057	794	2	.	.	PUNCT
admet-2057	795	1	nanostructured	nanostructure	VERB
admet-2057	795	2	metal	metal	NOUN
admet-2057	795	3	-	-	PUNCT
admet-2057	795	4	organic	organic	ADJ
admet-2057	795	5	frameworks	framework	NOUN
admet-2057	795	6	and	and	CCONJ
admet-2057	795	7	their	their	PRON
admet-2057	795	8	bio	bio	ADJ
admet-2057	795	9	-	-	PUNCT
admet-2057	795	10	related	relate	VERB
admet-2057	795	11	applications	application	NOUN
admet-2057	795	12	.	.	PUNCT
admet-2057	796	1	coordination	coordination	NOUN
admet-2057	796	2	chemistry	chemistry	NOUN
admet-2057	796	3	review	review	NOUN
admet-2057	796	4	307	307	NUM
admet-2057	796	5	(	(	PUNCT
admet-2057	796	6	2015	2015	NUM
admet-2057	796	7	)	)	PUNCT
admet-2057	796	8	342	342	NUM
admet-2057	796	9	-	-	SYM
admet-2057	796	10	360	360	NUM
admet-2057	796	11	.	.	PUNCT
admet-2057	797	1	https://doi.org/10.1016/j.ccr.2015.08.008	https://doi.org/10.1016/j.ccr.2015.08.008	NOUN
admet-2057	798	1	[	[	X
admet-2057	798	2	15	15	NUM
admet-2057	798	3	]	]	X
admet-2057	798	4	h.	h.	PROPN
admet-2057	798	5	sohrabi	sohrabi	PROPN
admet-2057	798	6	,	,	PUNCT
admet-2057	798	7	s.	s.	PROPN
admet-2057	798	8	javanbakht	javanbakht	PROPN
admet-2057	798	9	,	,	PUNCT
admet-2057	798	10	f.	f.	PROPN
admet-2057	798	11	oroojalian	oroojalian	PROPN
admet-2057	798	12	,	,	PUNCT
admet-2057	798	13	f.	f.	PROPN
admet-2057	798	14	rouhani	rouhani	PROPN
admet-2057	798	15	,	,	PUNCT
admet-2057	798	16	a.	a.	NOUN
admet-2057	798	17	shaabani	shaabani	PROPN
admet-2057	798	18	,	,	PUNCT
admet-2057	798	19	m.r	m.r	PROPN
admet-2057	798	20	.	.	PROPN
admet-2057	798	21	majidi	majidi	PROPN
admet-2057	798	22	,	,	PUNCT
admet-2057	798	23	m.	m.	NOUN
admet-2057	798	24	hashemzaei	hashemzaei	NOUN
admet-2057	798	25	,	,	PUNCT
admet-2057	798	26	y.	y.	PROPN
admet-2057	798	27	hanifehpour	hanifehpour	PROPN
admet-2057	798	28	,	,	PUNCT
admet-2057	798	29	a.	a.	NOUN
admet-2057	798	30	mokhtarzadeh	mokhtarzadeh	PROPN
admet-2057	798	31	,	,	PUNCT
admet-2057	798	32	a.	a.	PROPN
admet-2057	798	33	morsali	morsali	VERB
admet-2057	798	34	.	.	PROPN
admet-2057	799	1	nanoscale	nanoscale	NOUN
admet-2057	799	2	metal	metal	NOUN
admet-2057	799	3	-	-	PUNCT
admet-2057	799	4	organic	organic	ADJ
admet-2057	799	5	frameworks	framework	NOUN
admet-2057	799	6	:	:	PUNCT
admet-2057	799	7	recent	recent	ADJ
admet-2057	799	8	developments	development	NOUN
admet-2057	799	9	in	in	ADP
admet-2057	799	10	synthesis	synthesis	NOUN
admet-2057	799	11	,	,	PUNCT
admet-2057	799	12	modifications	modification	NOUN
admet-2057	799	13	and	and	CCONJ
admet-2057	799	14	bioimaging	bioimaging	NOUN
admet-2057	799	15	applications	application	NOUN
admet-2057	799	16	.	.	PUNCT
admet-2057	800	1	chemosphere	chemosphere	PROPN
admet-2057	800	2	281	281	NUM
admet-2057	800	3	(	(	PUNCT
admet-2057	800	4	2021	2021	NUM
admet-2057	800	5	)	)	PUNCT
admet-2057	800	6	130717	130717	NUM
admet-2057	801	1	https://doi.org/10.1016/j.chemosphere.2021.130717	https://doi.org/10.1016/j.chemosphere.2021.130717	NOUN
admet-2057	801	2	[	[	X
admet-2057	801	3	16	16	NUM
admet-2057	801	4	]	]	X
admet-2057	801	5	v.r	v.r	PROPN
admet-2057	801	6	.	.	PROPN
admet-2057	801	7	remya	remya	PROPN
admet-2057	801	8	,	,	PUNCT
admet-2057	801	9	m.	m.	NOUN
admet-2057	801	10	kurian	kurian	NOUN
admet-2057	801	11	.	.	PUNCT
admet-2057	802	1	synthesis	synthesis	NOUN
admet-2057	802	2	and	and	CCONJ
admet-2057	802	3	catalytic	catalytic	ADJ
admet-2057	802	4	applications	application	NOUN
admet-2057	802	5	of	of	ADP
admet-2057	802	6	metal	metal	NOUN
admet-2057	802	7	-	-	PUNCT
admet-2057	802	8	organic	organic	ADJ
admet-2057	802	9	frameworks	framework	NOUN
admet-2057	802	10	:	:	PUNCT
admet-2057	802	11	a	a	DET
admet-2057	802	12	review	review	NOUN
admet-2057	802	13	on	on	ADP
admet-2057	802	14	recent	recent	ADJ
admet-2057	802	15	literature	literature	NOUN
admet-2057	802	16	.	.	PUNCT
admet-2057	803	1	international	international	ADJ
admet-2057	803	2	nano	nano	NOUN
admet-2057	803	3	letters	letter	NOUN
admet-2057	803	4	9	9	NUM
admet-2057	803	5	(	(	PUNCT
admet-2057	803	6	2019	2019	NUM
admet-2057	803	7	)	)	PUNCT
admet-2057	803	8	17	17	NUM
admet-2057	803	9	-	-	SYM
admet-2057	803	10	29	29	NUM
admet-2057	803	11	.	.	PUNCT
admet-2057	803	12	https://doi.org/10.1007/s40089-018-0255-1	https://doi.org/10.1007/s40089-018-0255-1	PUNCT
admet-2057	804	1	[	[	X
admet-2057	804	2	17	17	NUM
admet-2057	804	3	]	]	PUNCT
admet-2057	804	4	l.	l.	PROPN
admet-2057	804	5	liu	liu	PROPN
admet-2057	804	6	,	,	PUNCT
admet-2057	804	7	h.	h.	PROPN
admet-2057	804	8	wei	wei	PROPN
admet-2057	804	9	,	,	PUNCT
admet-2057	804	10	l.	l.	PROPN
admet-2057	804	11	zhang	zhang	PROPN
admet-2057	804	12	,	,	PUNCT
admet-2057	804	13	j.	j.	PROPN
admet-2057	804	14	li	li	PROPN
admet-2057	804	15	,	,	PUNCT
admet-2057	804	16	j.	j.	PROPN
admet-2057	804	17	dong	dong	PROPN
admet-2057	804	18	.	.	PUNCT
admet-2057	805	1	ionothermal	ionothermal	ADJ
admet-2057	805	2	synthesis	synthesis	NOUN
admet-2057	805	3	of	of	ADP
admet-2057	805	4	the	the	DET
admet-2057	805	5	metal	metal	NOUN
admet-2057	805	6	-	-	PUNCT
admet-2057	805	7	organic	organic	ADJ
admet-2057	805	8	framework	framework	NOUN
admet-2057	805	9	compound	compound	NOUN
admet-2057	805	10	cu3(btc)2	cu3(btc)2	NOUN
admet-2057	805	11	.	.	PUNCT
admet-2057	806	1	studies	study	NOUN
admet-2057	806	2	in	in	ADP
admet-2057	806	3	surface	surface	NOUN
admet-2057	806	4	science	science	NOUN
admet-2057	806	5	and	and	CCONJ
admet-2057	806	6	catalysis	catalysis	NOUN
admet-2057	806	7	14	14	NUM
admet-2057	806	8	(	(	PUNCT
admet-2057	806	9	2008	2008	NUM
admet-2057	806	10	)	)	PUNCT
admet-2057	806	11	459	459	NUM
admet-2057	806	12	-	-	SYM
admet-2057	806	13	462	462	NUM
admet-2057	806	14	.	.	PUNCT
admet-2057	807	1	https://doi.org/10.1016/s0167-2991(08)80240-6	https://doi.org/10.1016/s0167-2991(08)80240-6	PROPN
admet-2057	808	1	[	[	X
admet-2057	808	2	18	18	NUM
admet-2057	808	3	]	]	X
admet-2057	808	4	p.s	p.s	PROPN
admet-2057	808	5	.	.	PROPN
admet-2057	808	6	sharanyakanth	sharanyakanth	PROPN
admet-2057	808	7	,	,	PUNCT
admet-2057	808	8	m.	m.	PROPN
admet-2057	808	9	radhakrishnan	radhakrishnan	PROPN
admet-2057	808	10	.	.	PUNCT
admet-2057	809	1	synthesis	synthesis	NOUN
admet-2057	809	2	of	of	ADP
admet-2057	809	3	metal	metal	NOUN
admet-2057	809	4	-	-	PUNCT
admet-2057	809	5	organic	organic	ADJ
admet-2057	809	6	frameworks	framework	NOUN
admet-2057	809	7	(	(	PUNCT
admet-2057	809	8	mofs	mof	NOUN
admet-2057	809	9	)	)	PUNCT
admet-2057	809	10	and	and	CCONJ
admet-2057	809	11	its	its	PRON
admet-2057	809	12	application	application	NOUN
admet-2057	809	13	in	in	ADP
admet-2057	809	14	food	food	NOUN
admet-2057	809	15	packaging	packaging	NOUN
admet-2057	809	16	:	:	PUNCT
admet-2057	809	17	a	a	DET
admet-2057	809	18	critical	critical	ADJ
admet-2057	809	19	review	review	NOUN
admet-2057	809	20	.	.	PUNCT
admet-2057	810	1	trends	trend	NOUN
admet-2057	810	2	food	food	NOUN
admet-2057	810	3	science	science	NOUN
admet-2057	810	4	technology	technology	NOUN
admet-2057	810	5	104	104	NUM
admet-2057	810	6	(	(	PUNCT
admet-2057	810	7	2020	2020	NUM
admet-2057	810	8	)	)	PUNCT
admet-2057	810	9	102116	102116	NUM
admet-2057	810	10	.	.	PUNCT
admet-2057	811	1	https://doi.org/10.1016/j.tifs.2020.08.004	https://doi.org/10.1016/j.tifs.2020.08.004	PUNCT
admet-2057	811	2	[	[	X
admet-2057	811	3	19	19	NUM
admet-2057	811	4	]	]	PUNCT
admet-2057	811	5	j.	j.	PROPN
admet-2057	811	6	bedia	bedia	PROPN
admet-2057	811	7	,	,	PUNCT
admet-2057	811	8	v.	v.	ADP
admet-2057	811	9	muelas	muelas	PROPN
admet-2057	811	10	-	-	PUNCT
admet-2057	811	11	ramos	ramos	PROPN
admet-2057	811	12	,	,	PUNCT
admet-2057	811	13	m.	m.	PROPN
admet-2057	811	14	peñas	peñas	PROPN
admet-2057	811	15	-	-	PUNCT
admet-2057	811	16	garzón	garzón	PROPN
admet-2057	811	17	,	,	PUNCT
admet-2057	811	18	a.	a.	NOUN
admet-2057	811	19	gómez	gómez	NOUN
admet-2057	811	20	-	-	PUNCT
admet-2057	811	21	avilés	avilés	PROPN
admet-2057	811	22	,	,	PUNCT
admet-2057	811	23	j.j	j.j	PROPN
admet-2057	811	24	.	.	PROPN
admet-2057	811	25	rodríguez	rodríguez	PROPN
admet-2057	811	26	,	,	PUNCT
admet-2057	811	27	c.	c.	PROPN
admet-2057	811	28	belver	belver	PROPN
admet-2057	811	29	.	.	PUNCT
admet-2057	812	1	a	a	DET
admet-2057	812	2	review	review	NOUN
admet-2057	812	3	on	on	ADP
admet-2057	812	4	the	the	DET
admet-2057	812	5	synthesis	synthesis	NOUN
admet-2057	812	6	and	and	CCONJ
admet-2057	812	7	characterization	characterization	NOUN
admet-2057	812	8	of	of	ADP
admet-2057	812	9	metal	metal	NOUN
admet-2057	812	10	organic	organic	ADJ
admet-2057	812	11	frameworks	framework	NOUN
admet-2057	812	12	for	for	ADP
admet-2057	812	13	photocatalytic	photocatalytic	ADJ
admet-2057	812	14	water	water	NOUN
admet-2057	812	15	purification	purification	NOUN
admet-2057	812	16	.	.	PUNCT
admet-2057	813	1	catalysts	catalyst	NOUN
admet-2057	813	2	9(1	9(1	NUM
admet-2057	813	3	)	)	PUNCT
admet-2057	813	4	(	(	PUNCT
admet-2057	813	5	2019	2019	NUM
admet-2057	813	6	)	)	PUNCT
admet-2057	813	7	52	52	NUM
admet-2057	813	8	.	.	PUNCT
admet-2057	814	1	https://doi.org/10.3390/catal9010052	https://doi.org/10.3390/catal9010052	PROPN
admet-2057	815	1	[	[	X
admet-2057	815	2	20	20	NUM
admet-2057	815	3	]	]	X
admet-2057	815	4	y.r	y.r	PROPN
admet-2057	815	5	.	.	PROPN
admet-2057	815	6	lee	lee	PROPN
admet-2057	815	7	,	,	PUNCT
admet-2057	815	8	j.	j.	PROPN
admet-2057	815	9	kim	kim	PROPN
admet-2057	815	10	,	,	PUNCT
admet-2057	815	11	w.s	w.s	PROPN
admet-2057	815	12	.	.	PROPN
admet-2057	815	13	ahn	ahn	PROPN
admet-2057	815	14	.	.	PUNCT
admet-2057	816	1	synthesis	synthesis	NOUN
admet-2057	816	2	of	of	ADP
admet-2057	816	3	metal	metal	NOUN
admet-2057	816	4	-	-	PUNCT
admet-2057	816	5	organic	organic	ADJ
admet-2057	816	6	frameworks	framework	NOUN
admet-2057	816	7	:	:	PUNCT
admet-2057	816	8	a	a	DET
admet-2057	816	9	mini	mini	ADJ
admet-2057	816	10	review	review	NOUN
admet-2057	816	11	.	.	PUNCT
admet-2057	817	1	korean	korean	ADJ
admet-2057	817	2	journal	journal	PROPN
admet-2057	817	3	of	of	ADP
admet-2057	817	4	chemical	chemical	PROPN
admet-2057	817	5	engineering	engineering	NOUN
admet-2057	817	6	.	.	PUNCT
admet-2057	818	1	30(9	30(9	NUM
admet-2057	818	2	)	)	PUNCT
admet-2057	818	3	(	(	PUNCT
admet-2057	818	4	2013	2013	NUM
admet-2057	818	5	)	)	PUNCT
admet-2057	818	6	1667	1667	NUM
admet-2057	818	7	-	-	SYM
admet-2057	818	8	1680	1680	NUM
admet-2057	818	9	.	.	PUNCT
admet-2057	819	1	https://doi.org/10.1007/s11814-013-0140-6	https://doi.org/10.1007/s11814-013-0140-6	NUM
admet-2057	820	1	[	[	X
admet-2057	820	2	21	21	NUM
admet-2057	820	3	]	]	X
admet-2057	820	4	c.	c.	PROPN
admet-2057	820	5	echaide	echaide	NOUN
admet-2057	820	6	-	-	PUNCT
admet-2057	820	7	górriz	górriz	NOUN
admet-2057	820	8	,	,	PUNCT
admet-2057	820	9	c.	c.	PROPN
admet-2057	820	10	clément	clément	PROPN
admet-2057	820	11	,	,	PUNCT
admet-2057	820	12	f.	f.	PROPN
admet-2057	820	13	cacho	cacho	PROPN
admet-2057	820	14	-	-	PUNCT
admet-2057	820	15	bailo	bailo	NOUN
admet-2057	820	16	,	,	PUNCT
admet-2057	820	17	c.	c.	PROPN
admet-2057	820	18	téllez	téllez	PROPN
admet-2057	820	19	,	,	PUNCT
admet-2057	820	20	j.	j.	PROPN
admet-2057	820	21	coronas	coronas	PROPN
admet-2057	820	22	.	.	PUNCT
admet-2057	821	1	new	new	ADJ
admet-2057	821	2	strategies	strategy	NOUN
admet-2057	821	3	based	base	VERB
admet-2057	821	4	on	on	ADP
admet-2057	821	5	microfluidics	microfluidic	NOUN
admet-2057	821	6	for	for	ADP
admet-2057	821	7	the	the	DET
admet-2057	821	8	synthesis	synthesis	NOUN
admet-2057	821	9	of	of	ADP
admet-2057	821	10	metal	metal	NOUN
admet-2057	821	11	organic	organic	ADJ
admet-2057	821	12	frameworks	framework	NOUN
admet-2057	821	13	.	.	PUNCT
admet-2057	822	1	journal	journal	NOUN
admet-2057	822	2	of	of	ADP
admet-2057	822	3	material	material	NOUN
admet-2057	822	4	chemistry	chemistry	NOUN
admet-2057	822	5	a	a	DET
admet-2057	822	6	6(14	6(14	NOUN
admet-2057	822	7	)	)	PUNCT
admet-2057	822	8	(	(	PUNCT
admet-2057	822	9	2018	2018	NUM
admet-2057	822	10	)	)	PUNCT
admet-2057	822	11	5485	5485	NUM
admet-2057	822	12	-	-	SYM
admet-2057	822	13	5506	5506	NUM
admet-2057	822	14	.	.	PUNCT
admet-2057	823	1	https://doi.org/10.1039/c8ta01232f	https://doi.org/10.1039/c8ta01232f	PROPN
admet-2057	824	1	[	[	X
admet-2057	824	2	22	22	NUM
admet-2057	824	3	]	]	X
admet-2057	824	4	n.	n.	NOUN
admet-2057	824	5	stock	stock	NOUN
admet-2057	824	6	,	,	PUNCT
admet-2057	824	7	s.	s.	PROPN
admet-2057	824	8	biswas	biswas	PROPN
admet-2057	824	9	.	.	PUNCT
admet-2057	825	1	synthesis	synthesis	NOUN
admet-2057	825	2	of	of	ADP
admet-2057	825	3	metal	metal	NOUN
admet-2057	825	4	-	-	PUNCT
admet-2057	825	5	organic	organic	ADJ
admet-2057	825	6	frameworks	framework	NOUN
admet-2057	825	7	(	(	PUNCT
admet-2057	825	8	mofs	mof	NOUN
admet-2057	825	9	):	):	PUNCT
admet-2057	825	10	routes	route	NOUN
admet-2057	825	11	to	to	ADP
admet-2057	825	12	various	various	ADJ
admet-2057	825	13	mof	mof	ADJ
admet-2057	825	14	topologies	topology	NOUN
admet-2057	825	15	,	,	PUNCT
admet-2057	825	16	morphologies	morphology	NOUN
admet-2057	825	17	,	,	PUNCT
admet-2057	825	18	and	and	CCONJ
admet-2057	825	19	composites	composite	NOUN
admet-2057	825	20	.	.	PUNCT
admet-2057	826	1	chemical	chemical	ADJ
admet-2057	826	2	reviews	review	NOUN
admet-2057	826	3	112(2	112(2	NUM
admet-2057	826	4	)	)	PUNCT
admet-2057	826	5	(	(	PUNCT
admet-2057	826	6	2012	2012	NUM
admet-2057	826	7	)	)	PUNCT
admet-2057	826	8	933	933	NUM
admet-2057	826	9	-	-	SYM
admet-2057	826	10	969	969	NUM
admet-2057	826	11	.	.	PUNCT
admet-2057	827	1	https://doi.org/10.1021/cr200304e	https://doi.org/10.1021/cr200304e	PROPN
admet-2057	828	1	[	[	X
admet-2057	828	2	23	23	NUM
admet-2057	828	3	]	]	X
admet-2057	828	4	v.m	v.m	PROPN
admet-2057	828	5	.	.	PUNCT
admet-2057	828	6	varsha	varsha	PROPN
admet-2057	828	7	,	,	PUNCT
admet-2057	828	8	g.	g.	PROPN
admet-2057	828	9	nageswaran	nageswaran	PROPN
admet-2057	828	10	.	.	PUNCT
admet-2057	829	1	review	review	NOUN
admet-2057	829	2	—	—	PUNCT
admet-2057	829	3	direct	direct	ADJ
admet-2057	829	4	electrochemical	electrochemical	ADJ
admet-2057	829	5	synthesis	synthesis	NOUN
admet-2057	829	6	of	of	ADP
admet-2057	829	7	metal	metal	NOUN
admet-2057	829	8	organic	organic	ADJ
admet-2057	829	9	frameworks	framework	NOUN
admet-2057	829	10	.	.	PUNCT
admet-2057	830	1	journal	journal	NOUN
admet-2057	830	2	of	of	ADP
admet-2057	830	3	electrochemical	electrochemical	ADJ
admet-2057	830	4	society	society	NOUN
admet-2057	830	5	167	167	NUM
admet-2057	830	6	(	(	PUNCT
admet-2057	830	7	2020	2020	NUM
admet-2057	830	8	)	)	PUNCT
admet-2057	830	9	155527	155527	NUM
admet-2057	830	10	.	.	PUNCT
admet-2057	831	1	https://doi.org/10.1149/19457111/abc6c6	https://doi.org/10.1149/19457111/abc6c6	PUNCT
admet-2057	832	1	[	[	X
admet-2057	832	2	24	24	NUM
admet-2057	832	3	]	]	SYM
admet-2057	832	4	p.p	p.p	PROPN
admet-2057	832	5	.	.	PROPN
admet-2057	832	6	bag	bag	PROPN
admet-2057	832	7	,	,	PUNCT
admet-2057	832	8	g.p	g.p	PROPN
admet-2057	832	9	.	.	PROPN
admet-2057	832	10	singh	singh	PROPN
admet-2057	832	11	,	,	PUNCT
admet-2057	832	12	s.	s.	PROPN
admet-2057	832	13	singha	singha	PROPN
admet-2057	832	14	,	,	PUNCT
admet-2057	832	15	g.	g.	PROPN
admet-2057	832	16	roymahapatra	roymahapatra	PROPN
admet-2057	832	17	.	.	PUNCT
admet-2057	833	1	synthesis	synthesis	NOUN
admet-2057	833	2	of	of	ADP
admet-2057	833	3	metal	metal	NOUN
admet-2057	833	4	-	-	PUNCT
admet-2057	833	5	organic	organic	ADJ
admet-2057	833	6	frameworks	framework	NOUN
admet-2057	833	7	(	(	PUNCT
admet-2057	833	8	mofs	mof	NOUN
admet-2057	833	9	)	)	PUNCT
admet-2057	833	10	and	and	CCONJ
admet-2057	833	11	their	their	PRON
admet-2057	833	12	biological	biological	ADJ
admet-2057	833	13	,	,	PUNCT
admet-2057	833	14	catalytic	catalytic	ADJ
admet-2057	833	15	and	and	CCONJ
admet-2057	833	16	energetic	energetic	ADJ
admet-2057	833	17	applications	application	NOUN
admet-2057	833	18	.	.	PUNCT
admet-2057	834	1	engineered	engineer	VERB
admet-2057	834	2	science	science	NOUN
admet-2057	834	3	13	13	NUM
admet-2057	834	4	(	(	PUNCT
admet-2057	834	5	2021	2021	NUM
admet-2057	834	6	)	)	PUNCT
admet-2057	834	7	1	1	NUM
admet-2057	834	8	-	-	SYM
admet-2057	834	9	10	10	NUM
admet-2057	834	10	.	.	PUNCT
admet-2057	835	1	https://doi.org/10.30919/es8d1166	https://doi.org/10.30919/es8d1166	PROPN
admet-2057	835	2	[	[	X
admet-2057	835	3	25	25	NUM
admet-2057	835	4	]	]	X
admet-2057	835	5	y.	y.	PROPN
admet-2057	835	6	sun	sun	PROPN
admet-2057	835	7	,	,	PUNCT
admet-2057	835	8	l.	l.	PROPN
admet-2057	835	9	zheng	zheng	PROPN
admet-2057	835	10	,	,	PUNCT
admet-2057	835	11	y.	y.	PROPN
admet-2057	835	12	yang	yang	PROPN
admet-2057	835	13	,	,	PUNCT
admet-2057	835	14	x.	x.	PROPN
admet-2057	835	15	qian	qian	PROPN
admet-2057	835	16	,	,	PUNCT
admet-2057	835	17	t.	t.	PROPN
admet-2057	835	18	fu	fu	PROPN
admet-2057	835	19	,	,	PUNCT
admet-2057	835	20	x.	x.	PROPN
admet-2057	835	21	li	li	PROPN
admet-2057	835	22	,	,	PUNCT
admet-2057	835	23	z.	z.	PROPN
admet-2057	835	24	yang	yang	PROPN
admet-2057	835	25	,	,	PUNCT
admet-2057	835	26	h.	h.	PROPN
admet-2057	835	27	yan	yan	PROPN
admet-2057	835	28	,	,	PUNCT
admet-2057	835	29	c.	c.	PROPN
admet-2057	835	30	cui	cui	PROPN
admet-2057	835	31	,	,	PUNCT
admet-2057	835	32	w.	w.	PROPN
admet-2057	835	33	tan	tan	PROPN
admet-2057	835	34	.	.	PUNCT
admet-2057	836	1	metal	metal	NOUN
admet-2057	836	2	-	-	PUNCT
admet-2057	836	3	organic	organic	ADJ
admet-2057	836	4	framework	framework	NOUN
admet-2057	836	5	nanocarriers	nanocarrier	NOUN
admet-2057	836	6	for	for	ADP
admet-2057	836	7	drug	drug	NOUN
admet-2057	836	8	delivery	delivery	NOUN
admet-2057	836	9	in	in	ADP
admet-2057	836	10	biomedical	biomedical	ADJ
admet-2057	836	11	applications	application	NOUN
admet-2057	836	12	.	.	PUNCT
admet-2057	837	1	nano	nano	NOUN
admet-2057	837	2	-	-	PUNCT
admet-2057	837	3	micro	micro	NOUN
admet-2057	837	4	letters	letter	NOUN
admet-2057	837	5	12(1	12(1	NUM
admet-2057	837	6	)	)	PUNCT
admet-2057	837	7	(	(	PUNCT
admet-2057	837	8	2020	2020	NUM
admet-2057	837	9	)	)	PUNCT
admet-2057	837	10	1	1	NUM
admet-2057	837	11	-	-	SYM
admet-2057	837	12	29	29	NUM
admet-2057	837	13	.	.	PUNCT
admet-2057	838	1	https://doi.org/10.1007/s40820-020-00423-3	https://doi.org/10.1007/s40820-020-00423-3	X
admet-2057	839	1	[	[	X
admet-2057	839	2	26	26	NUM
admet-2057	839	3	]	]	X
admet-2057	839	4	a.a	a.a	PROPN
admet-2057	839	5	.	.	PROPN
admet-2057	839	6	vodyashkin	vodyashkin	PROPN
admet-2057	839	7	,	,	PUNCT
admet-2057	839	8	a.v	a.v	PROPN
admet-2057	839	9	.	.	PROPN
admet-2057	839	10	ergorodceva	ergorodceva	PROPN
admet-2057	839	11	,	,	PUNCT
admet-2057	839	12	p.	p.	PROPN
admet-2057	839	13	kezimana	kezimana	PROPN
admet-2057	839	14	,	,	PUNCT
admet-2057	839	15	y.m	y.m	PROPN
admet-2057	839	16	.	.	PROPN
admet-2057	839	17	stanishevskiy	stanishevskiy	PROPN
admet-2057	839	18	.	.	PUNCT
admet-2057	840	1	metal	metal	NOUN
admet-2057	840	2	-	-	PUNCT
admet-2057	840	3	organic	organic	ADJ
admet-2057	840	4	framework	framework	NOUN
admet-2057	840	5	(	(	PUNCT
admet-2057	840	6	mof)—a	mof)—a	CCONJ
admet-2057	840	7	universal	universal	ADJ
admet-2057	840	8	material	material	NOUN
admet-2057	840	9	for	for	ADP
admet-2057	840	10	biomedicine	biomedicine	NOUN
admet-2057	840	11	.	.	PUNCT
admet-2057	841	1	international	international	ADJ
admet-2057	841	2	journal	journal	NOUN
admet-2057	841	3	of	of	ADP
admet-2057	841	4	molecular	molecular	ADJ
admet-2057	841	5	sciences	science	NOUN
admet-2057	841	6	24(9	24(9	NUM
admet-2057	841	7	)	)	PUNCT
admet-2057	841	8	(	(	PUNCT
admet-2057	841	9	2023	2023	NUM
admet-2057	841	10	)	)	PUNCT
admet-2057	841	11	7819	7819	NUM
admet-2057	841	12	.	.	PUNCT
admet-2057	842	1	https://doi.org/10.3390/ijms24097819	https://doi.org/10.3390/ijms24097819	NOUN
admet-2057	842	2	https://doi.org/10.1002/biot.202000005	https://doi.org/10.1002/biot.202000005	X
admet-2057	843	1	https://doi.org/10.30919/esmm5f792	https://doi.org/10.30919/esmm5f792	PROPN
admet-2057	843	2	https://doi.org/10.3390/ma14020310	https://doi.org/10.3390/ma14020310	CCONJ
admet-2057	843	3	https://doi.org/10.1021/acsomega.2c05310	https://doi.org/10.1021/acsomega.2c05310	PROPN
admet-2057	843	4	https://doi.org/10.1016/j.ccr.2015.08.008	https://doi.org/10.1016/j.ccr.2015.08.008	NOUN
admet-2057	843	5	https://doi.org/10.1016/j.chemosphere.2021.130717	https://doi.org/10.1016/j.chemosphere.2021.130717	PROPN
admet-2057	843	6	https://doi.org/10.1007/s40089-018-0255-1	https://doi.org/10.1007/s40089-018-0255-1	PROPN
admet-2057	843	7	https://doi.org/10.1016/s0167-2991(08)80240-6	https://doi.org/10.1016/s0167-2991(08)80240-6	PROPN
admet-2057	843	8	https://doi.org/10.1016/j.tifs.2020.08.004	https://doi.org/10.1016/j.tifs.2020.08.004	PROPN
admet-2057	843	9	https://doi.org/10.3390/catal9010052	https://doi.org/10.3390/catal9010052	PROPN
admet-2057	843	10	https://doi.org/10.1007/s11814-013-0140-6	https://doi.org/10.1007/s11814-013-0140-6	PROPN
admet-2057	843	11	https://doi.org/10.1039/c8ta01232f	https://doi.org/10.1039/c8ta01232f	PROPN
admet-2057	843	12	https://doi.org/10.1021/cr200304e	https://doi.org/10.1021/cr200304e	PROPN
admet-2057	843	13	https://doi.org/10.1149/1945-7111/abc6c6	https://doi.org/10.1149/1945-7111/abc6c6	ADJ
admet-2057	843	14	https://doi.org/10.1149/1945-7111/abc6c6	https://doi.org/10.1149/1945-7111/abc6c6	NOUN
admet-2057	843	15	https://doi.org/10.30919/es8d1166	https://doi.org/10.30919/es8d1166	PROPN
admet-2057	843	16	https://doi.org/10.1007/s40820-020-00423-3	https://doi.org/10.1007/s40820-020-00423-3	NUM
admet-2057	843	17	https://doi.org/10.3390/ijms24097819	https://doi.org/10.3390/ijms24097819	PROPN
admet-2057	843	18	admet	admet	PROPN
admet-2057	843	19	&	&	CCONJ
admet-2057	843	20	dmpk	dmpk	PROPN
admet-2057	843	21	12(1	12(1	PROPN
admet-2057	843	22	)	)	PUNCT
admet-2057	843	23	(	(	PUNCT
admet-2057	843	24	2024	2024	NUM
admet-2057	843	25	)	)	PUNCT
admet-2057	843	26	27	27	NUM
admet-2057	843	27	-	-	SYM
admet-2057	843	28	62	62	NUM
admet-2057	843	29	drug	drug	NOUN
admet-2057	843	30	delivery	delivery	NOUN
admet-2057	843	31	applications	application	NOUN
admet-2057	843	32	of	of	ADP
admet-2057	843	33	metal	metal	NOUN
admet-2057	843	34	-	-	PUNCT
admet-2057	843	35	organic	organic	ADJ
admet-2057	843	36	framework	framework	NOUN
admet-2057	843	37	doi	doi	NOUN
admet-2057	843	38	:	:	PUNCT
admet-2057	843	39	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	843	40	55	55	NUM
admet-2057	843	41	[	[	SYM
admet-2057	843	42	27	27	NUM
admet-2057	843	43	]	]	PUNCT
admet-2057	843	44	m.	m.	NOUN
admet-2057	843	45	kalaj	kalaj	PROPN
admet-2057	843	46	,	,	PUNCT
admet-2057	843	47	s.m	s.m	PROPN
admet-2057	843	48	.	.	PROPN
admet-2057	843	49	cohen	cohen	PROPN
admet-2057	843	50	.	.	PUNCT
admet-2057	844	1	postsynthetic	postsynthetic	ADJ
admet-2057	844	2	modification	modification	NOUN
admet-2057	844	3	:	:	PUNCT
admet-2057	844	4	an	an	DET
admet-2057	844	5	enabling	enable	VERB
admet-2057	844	6	technology	technology	NOUN
admet-2057	844	7	for	for	ADP
admet-2057	844	8	the	the	DET
admet-2057	844	9	advancement	advancement	NOUN
admet-2057	844	10	of	of	ADP
admet-2057	844	11	metal	metal	NOUN
admet-2057	844	12	-	-	PUNCT
admet-2057	844	13	organic	organic	ADJ
admet-2057	844	14	frameworks	framework	NOUN
admet-2057	844	15	.	.	PUNCT
admet-2057	845	1	acs	acs	PROPN
admet-2057	845	2	central	central	ADJ
admet-2057	845	3	science	science	PROPN
admet-2057	845	4	7	7	NUM
admet-2057	845	5	(	(	PUNCT
admet-2057	845	6	2020	2020	NUM
admet-2057	845	7	)	)	PUNCT
admet-2057	845	8	1046	1046	NUM
admet-2057	845	9	-	-	SYM
admet-2057	845	10	1057	1057	NUM
admet-2057	845	11	.	.	PUNCT
admet-2057	846	1	https://doi.org/10.1021/acscentsci.0c00690	https://doi.org/10.1021/acscentsci.0c00690	NOUN
admet-2057	847	1	[	[	X
admet-2057	847	2	28	28	NUM
admet-2057	847	3	]	]	X
admet-2057	847	4	m.	m.	NOUN
admet-2057	847	5	rivera	rivera	PROPN
admet-2057	847	6	-	-	PUNCT
admet-2057	847	7	torrente	torrente	PROPN
admet-2057	847	8	,	,	PUNCT
admet-2057	847	9	l.d.b	l.d.b	NOUN
admet-2057	847	10	.	.	PUNCT
admet-2057	848	1	mandemaker	mandemaker	PROPN
admet-2057	848	2	,	,	PUNCT
admet-2057	848	3	m.	m.	NOUN
admet-2057	848	4	filez	filez	PROPN
admet-2057	848	5	,	,	PUNCT
admet-2057	848	6	g.	g.	PROPN
admet-2057	848	7	delen	delen	PROPN
admet-2057	848	8	,	,	PUNCT
admet-2057	848	9	b.	b.	PROPN
admet-2057	848	10	seoane	seoane	PROPN
admet-2057	848	11	,	,	PUNCT
admet-2057	848	12	f.	f.	PROPN
admet-2057	848	13	meirer	meirer	PROPN
admet-2057	848	14	,	,	PUNCT
admet-2057	848	15	b.m	b.m	PROPN
admet-2057	848	16	.	.	PROPN
admet-2057	848	17	weckhuysen	weckhuysen	PROPN
admet-2057	848	18	.	.	PUNCT
admet-2057	849	1	spectroscopy	spectroscopy	NOUN
admet-2057	849	2	,	,	PUNCT
admet-2057	849	3	microscopy	microscopy	NOUN
admet-2057	849	4	,	,	PUNCT
admet-2057	849	5	diffraction	diffraction	NOUN
admet-2057	849	6	and	and	CCONJ
admet-2057	849	7	scattering	scattering	NOUN
admet-2057	849	8	of	of	ADP
admet-2057	849	9	archetypal	archetypal	ADJ
admet-2057	849	10	mofs	mof	NOUN
admet-2057	849	11	:	:	PUNCT
admet-2057	849	12	formation	formation	NOUN
admet-2057	849	13	,	,	PUNCT
admet-2057	849	14	metal	metal	NOUN
admet-2057	849	15	sites	site	NOUN
admet-2057	849	16	in	in	ADP
admet-2057	849	17	catalysis	catalysis	NOUN
admet-2057	849	18	and	and	CCONJ
admet-2057	849	19	thin	thin	ADJ
admet-2057	849	20	films	film	NOUN
admet-2057	849	21	.	.	PUNCT
admet-2057	850	1	chemical	chemical	ADJ
admet-2057	850	2	society	society	PROPN
admet-2057	850	3	reviews	review	VERB
admet-2057	850	4	49	49	NUM
admet-2057	850	5	(	(	PUNCT
admet-2057	850	6	2020	2020	NUM
admet-2057	850	7	)	)	PUNCT
admet-2057	850	8	6694	6694	NUM
admet-2057	850	9	-	-	SYM
admet-2057	850	10	6732	6732	NUM
admet-2057	850	11	.	.	PUNCT
admet-2057	851	1	https://doi.org/10.1039/d0cs00635a	https://doi.org/10.1039/d0cs00635a	PROPN
admet-2057	851	2	[	[	SYM
admet-2057	851	3	29	29	NUM
admet-2057	851	4	]	]	X
admet-2057	851	5	v.v	v.v	PROPN
admet-2057	851	6	butova	butova	PROPN
admet-2057	851	7	,	,	PUNCT
admet-2057	851	8	m.a	m.a	PROPN
admet-2057	851	9	.	.	PROPN
admet-2057	851	10	soldatov	soldatov	PROPN
admet-2057	851	11	,	,	PUNCT
admet-2057	851	12	a.a	a.a	PROPN
admet-2057	851	13	.	.	PROPN
admet-2057	851	14	guda	guda	PROPN
admet-2057	851	15	,	,	PUNCT
admet-2057	851	16	k.a	k.a	PROPN
admet-2057	851	17	.	.	PROPN
admet-2057	851	18	lomachenko	lomachenko	PROPN
admet-2057	851	19	,	,	PUNCT
admet-2057	851	20	c.	c.	PROPN
admet-2057	851	21	lamberti	lamberti	PROPN
admet-2057	851	22	.	.	PUNCT
admet-2057	852	1	metal	metal	NOUN
admet-2057	852	2	-	-	PUNCT
admet-2057	852	3	organic	organic	ADJ
admet-2057	852	4	frameworks	framework	NOUN
admet-2057	852	5	:	:	PUNCT
admet-2057	852	6	structure	structure	NOUN
admet-2057	852	7	,	,	PUNCT
admet-2057	852	8	properties	property	NOUN
admet-2057	852	9	,	,	PUNCT
admet-2057	852	10	methods	method	NOUN
admet-2057	852	11	of	of	ADP
admet-2057	852	12	synthesis	synthesis	NOUN
admet-2057	852	13	and	and	CCONJ
admet-2057	852	14	characterization	characterization	NOUN
admet-2057	852	15	.	.	PUNCT
admet-2057	853	1	russian	russian	ADJ
admet-2057	853	2	chemical	chemical	NOUN
admet-2057	853	3	reviews	review	NOUN
admet-2057	853	4	3	3	NUM
admet-2057	853	5	(	(	PUNCT
admet-2057	853	6	2016	2016	NUM
admet-2057	853	7	)	)	PUNCT
admet-2057	853	8	280	280	NUM
admet-2057	853	9	-	-	SYM
admet-2057	853	10	307	307	NUM
admet-2057	853	11	.	.	PUNCT
admet-2057	854	1	https://doi.org/10.1070/rcr4554	https://doi.org/10.1070/rcr4554	X
admet-2057	855	1	[	[	X
admet-2057	855	2	30	30	NUM
admet-2057	855	3	]	]	X
admet-2057	855	4	i.a	i.a	PROPN
admet-2057	855	5	.	.	PROPN
admet-2057	855	6	lázaro	lázaro	PROPN
admet-2057	855	7	.	.	PUNCT
admet-2057	856	1	a	a	DET
admet-2057	856	2	comprehensive	comprehensive	ADJ
admet-2057	856	3	thermogravimetric	thermogravimetric	ADJ
admet-2057	856	4	analysis	analysis	NOUN
admet-2057	856	5	multifaceted	multifaceted	ADJ
admet-2057	856	6	method	method	NOUN
admet-2057	856	7	for	for	ADP
admet-2057	856	8	the	the	DET
admet-2057	856	9	exact	exact	ADJ
admet-2057	856	10	determination	determination	NOUN
admet-2057	856	11	of	of	ADP
admet-2057	856	12	the	the	DET
admet-2057	856	13	composition	composition	NOUN
admet-2057	856	14	of	of	ADP
admet-2057	856	15	multifunctional	multifunctional	ADJ
admet-2057	856	16	metal	metal	NOUN
admet-2057	856	17	-	-	PUNCT
admet-2057	856	18	organic	organic	ADJ
admet-2057	856	19	framework	framework	NOUN
admet-2057	856	20	materials	material	NOUN
admet-2057	856	21	.	.	PUNCT
admet-2057	857	1	european	european	PROPN
admet-2057	857	2	journal	journal	PROPN
admet-2057	857	3	of	of	ADP
admet-2057	857	4	inorganic	inorganic	ADJ
admet-2057	857	5	chemistry	chemistry	NOUN
admet-2057	857	6	45	45	NUM
admet-2057	857	7	(	(	PUNCT
admet-2057	857	8	2020	2020	NUM
admet-2057	857	9	)	)	PUNCT
admet-2057	857	10	4284	4284	NUM
admet-2057	857	11	-	-	SYM
admet-2057	857	12	4294	4294	NUM
admet-2057	857	13	.	.	PUNCT
admet-2057	858	1	https://doi.org/10.1002/ejic.202000656	https://doi.org/10.1002/ejic.202000656	PROPN
admet-2057	858	2	[	[	X
admet-2057	858	3	31	31	NUM
admet-2057	858	4	]	]	X
admet-2057	858	5	a.j	a.j	PROPN
admet-2057	858	6	.	.	PROPN
admet-2057	858	7	howarth	howarth	PROPN
admet-2057	858	8	,	,	PUNCT
admet-2057	858	9	a.w	a.w	PROPN
admet-2057	858	10	.	.	PROPN
admet-2057	858	11	peters	peters	PROPN
admet-2057	858	12	,	,	PUNCT
admet-2057	858	13	n.a	n.a	PROPN
admet-2057	858	14	.	.	PROPN
admet-2057	858	15	vermeulen	vermeulen	PROPN
admet-2057	858	16	,	,	PUNCT
admet-2057	858	17	t.c	t.c	PROPN
admet-2057	858	18	.	.	PROPN
admet-2057	858	19	wang	wang	PROPN
admet-2057	858	20	,	,	PUNCT
admet-2057	858	21	j.t	j.t	PROPN
admet-2057	858	22	.	.	PROPN
admet-2057	858	23	hupp	hupp	PROPN
admet-2057	858	24	,	,	PUNCT
admet-2057	858	25	o.k	o.k	PROPN
admet-2057	858	26	.	.	PROPN
admet-2057	858	27	farha	farha	PROPN
admet-2057	858	28	.	.	PUNCT
admet-2057	859	1	best	good	ADJ
admet-2057	859	2	practices	practice	NOUN
admet-2057	859	3	for	for	ADP
admet-2057	859	4	the	the	DET
admet-2057	859	5	synthesis	synthesis	NOUN
admet-2057	859	6	,	,	PUNCT
admet-2057	859	7	activation	activation	NOUN
admet-2057	859	8	,	,	PUNCT
admet-2057	859	9	and	and	CCONJ
admet-2057	859	10	characterization	characterization	NOUN
admet-2057	859	11	of	of	ADP
admet-2057	859	12	metal−organic	metal−organic	ADJ
admet-2057	859	13	frameworks	framework	NOUN
admet-2057	859	14	.	.	PUNCT
admet-2057	860	1	chemistry	chemistry	NOUN
admet-2057	860	2	of	of	ADP
admet-2057	860	3	materials	material	NOUN
admet-2057	860	4	29(1	29(1	NUM
admet-2057	860	5	)	)	PUNCT
admet-2057	860	6	(	(	PUNCT
admet-2057	860	7	2017	2017	NUM
admet-2057	860	8	)	)	PUNCT
admet-2057	860	9	26	26	NUM
admet-2057	860	10	-	-	SYM
admet-2057	860	11	39	39	NUM
admet-2057	860	12	.	.	PUNCT
admet-2057	861	1	https://doi.org/10.1021/acs.chemmater.6b02626	https://doi.org/10.1021/acs.chemmater.6b02626	PRON
admet-2057	861	2	[	[	X
admet-2057	861	3	32	32	NUM
admet-2057	861	4	]	]	PUNCT
admet-2057	861	5	p.	p.	NOUN
admet-2057	861	6	hirschle	hirschle	PROPN
admet-2057	861	7	,	,	PUNCT
admet-2057	861	8	t.	t.	PROPN
admet-2057	861	9	preiß	preiß	PROPN
admet-2057	861	10	,	,	PUNCT
admet-2057	861	11	f.	f.	PROPN
admet-2057	861	12	auras	auras	PROPN
admet-2057	861	13	,	,	PUNCT
admet-2057	861	14	a.	a.	NOUN
admet-2057	861	15	pick	pick	PROPN
admet-2057	861	16	,	,	PUNCT
admet-2057	861	17	j.	j.	PROPN
admet-2057	861	18	völkner	völkner	PROPN
admet-2057	861	19	,	,	PUNCT
admet-2057	861	20	d.	d.	PROPN
admet-2057	861	21	valdepérez	valdepérez	PROPN
admet-2057	861	22	,	,	PUNCT
admet-2057	861	23	g.	g.	PROPN
admet-2057	861	24	witte	witte	PROPN
admet-2057	861	25	,	,	PUNCT
admet-2057	861	26	w.j	w.j	PROPN
admet-2057	861	27	.	.	PROPN
admet-2057	861	28	parak	parak	PROPN
admet-2057	861	29	,	,	PUNCT
admet-2057	861	30	j.o	j.o	PROPN
admet-2057	861	31	.	.	PROPN
admet-2057	861	32	rädler	rädler	PROPN
admet-2057	861	33	,	,	PUNCT
admet-2057	861	34	s.	s.	PROPN
admet-2057	861	35	wuttke	wuttke	PROPN
admet-2057	861	36	.	.	PUNCT
admet-2057	861	37	.	.	PUNCT
admet-2057	862	1	exploration	exploration	NOUN
admet-2057	862	2	of	of	ADP
admet-2057	862	3	mof	mof	X
admet-2057	862	4	nanoparticle	nanoparticle	NOUN
admet-2057	862	5	sizes	size	NOUN
admet-2057	862	6	using	use	VERB
admet-2057	862	7	various	various	ADJ
admet-2057	862	8	physical	physical	ADJ
admet-2057	862	9	characterization	characterization	NOUN
admet-2057	862	10	methods	method	NOUN
admet-2057	862	11	-	-	PUNCT
admet-2057	862	12	is	be	AUX
admet-2057	862	13	what	what	PRON
admet-2057	862	14	you	you	PRON
admet-2057	862	15	measure	measure	VERB
admet-2057	862	16	what	what	PRON
admet-2057	862	17	you	you	PRON
admet-2057	862	18	get	get	VERB
admet-2057	862	19	?	?	PUNCT
admet-2057	863	1	crystengcomm	crystengcomm	NOUN
admet-2057	863	2	23	23	NUM
admet-2057	863	3	(	(	PUNCT
admet-2057	863	4	2016	2016	NUM
admet-2057	863	5	)	)	PUNCT
admet-2057	863	6	4359	4359	NUM
admet-2057	863	7	-	-	SYM
admet-2057	863	8	4368	4368	NUM
admet-2057	863	9	.	.	PUNCT
admet-2057	864	1	https://doi.org/10.1039/c6ce00198j	https://doi.org/10.1039/c6ce00198j	PROPN
admet-2057	865	1	[	[	X
admet-2057	865	2	33	33	NUM
admet-2057	865	3	]	]	PUNCT
admet-2057	865	4	c.	c.	PROPN
admet-2057	865	5	marsh	marsh	PROPN
admet-2057	865	6	,	,	PUNCT
admet-2057	865	7	g.c	g.c	PROPN
admet-2057	865	8	.	.	PROPN
admet-2057	865	9	shearer	shearer	PROPN
admet-2057	865	10	,	,	PUNCT
admet-2057	865	11	b.t	b.t	PROPN
admet-2057	865	12	.	.	PROPN
admet-2057	865	13	knight	knight	PROPN
admet-2057	865	14	,	,	PUNCT
admet-2057	865	15	j.	j.	PROPN
admet-2057	865	16	paul	paul	PROPN
admet-2057	865	17	-	-	PUNCT
admet-2057	865	18	taylor	taylor	PROPN
admet-2057	865	19	,	,	PUNCT
admet-2057	865	20	a.d	a.d	PROPN
admet-2057	865	21	.	.	PROPN
admet-2057	865	22	burrows	burrow	NOUN
admet-2057	865	23	.	.	PUNCT
admet-2057	866	1	supramolecular	supramolecular	ADJ
admet-2057	866	2	aspects	aspect	NOUN
admet-2057	866	3	of	of	ADP
admet-2057	866	4	biomolecule	biomolecule	NOUN
admet-2057	866	5	interactions	interaction	NOUN
admet-2057	866	6	in	in	ADP
admet-2057	866	7	metal	metal	NOUN
admet-2057	866	8	-	-	PUNCT
admet-2057	866	9	organic	organic	ADJ
admet-2057	866	10	frameworks	framework	NOUN
admet-2057	866	11	.	.	PUNCT
admet-2057	867	1	coordination	coordination	NOUN
admet-2057	867	2	chemistry	chemistry	NOUN
admet-2057	867	3	reviews	review	VERB
admet-2057	867	4	439	439	NUM
admet-2057	867	5	(	(	PUNCT
admet-2057	867	6	2021	2021	NUM
admet-2057	867	7	)	)	PUNCT
admet-2057	867	8	213928	213928	NUM
admet-2057	867	9	.	.	PUNCT
admet-2057	868	1	https://doi.org/10.1016/j.ccr.2021.213928	https://doi.org/10.1016/j.ccr.2021.213928	PUNCT
admet-2057	869	1	[	[	X
admet-2057	869	2	34	34	NUM
admet-2057	869	3	]	]	X
admet-2057	869	4	b.e.g	b.e.g	PROPN
admet-2057	869	5	.	.	PROPN
admet-2057	869	6	lucier	lucier	PROPN
admet-2057	869	7	,	,	PUNCT
admet-2057	869	8	s.	s.	PROPN
admet-2057	869	9	chen	chen	PROPN
admet-2057	869	10	,	,	PUNCT
admet-2057	869	11	y.	y.	PROPN
admet-2057	869	12	huang	huang	PROPN
admet-2057	869	13	.	.	PUNCT
admet-2057	869	14	characterization	characterization	NOUN
admet-2057	869	15	of	of	ADP
admet-2057	869	16	metal	metal	NOUN
admet-2057	869	17	-	-	PUNCT
admet-2057	869	18	organic	organic	ADJ
admet-2057	869	19	frameworks	framework	NOUN
admet-2057	869	20	:	:	PUNCT
admet-2057	869	21	unlocking	unlock	VERB
admet-2057	869	22	the	the	DET
admet-2057	869	23	potential	potential	NOUN
admet-2057	869	24	of	of	ADP
admet-2057	869	25	solid	solid	ADJ
admet-2057	869	26	-	-	PUNCT
admet-2057	869	27	state	state	NOUN
admet-2057	869	28	nmr	nmr	NOUN
admet-2057	869	29	.	.	PUNCT
admet-2057	870	1	accounts	account	NOUN
admet-2057	870	2	of	of	ADP
admet-2057	870	3	chemical	chemical	ADJ
admet-2057	870	4	research	research	NOUN
admet-2057	870	5	2	2	NUM
admet-2057	870	6	(	(	PUNCT
admet-2057	870	7	2018	2018	NUM
admet-2057	870	8	)	)	PUNCT
admet-2057	870	9	319	319	NUM
admet-2057	870	10	-	-	SYM
admet-2057	870	11	330	330	NUM
admet-2057	870	12	.	.	PUNCT
admet-2057	871	1	https://doi.org/10.1021/acs.accounts.7b00357	https://doi.org/10.1021/acs.accounts.7b00357	NOUN
admet-2057	872	1	[	[	X
admet-2057	872	2	35	35	NUM
admet-2057	872	3	]	]	X
admet-2057	872	4	y.s	y.s	PROPN
admet-2057	872	5	.	.	PROPN
admet-2057	872	6	wei	wei	PROPN
admet-2057	872	7	,	,	PUNCT
admet-2057	872	8	m.	m.	PROPN
admet-2057	872	9	zhang	zhang	PROPN
admet-2057	872	10	,	,	PUNCT
admet-2057	872	11	r.	r.	PROPN
admet-2057	872	12	zou	zou	PROPN
admet-2057	872	13	,	,	PUNCT
admet-2057	872	14	q.	q.	PROPN
admet-2057	872	15	xu	xu	PROPN
admet-2057	872	16	.	.	PUNCT
admet-2057	873	1	metal	metal	NOUN
admet-2057	873	2	-	-	PUNCT
admet-2057	873	3	organic	organic	ADJ
admet-2057	873	4	framework	framework	NOUN
admet-2057	873	5	-	-	PUNCT
admet-2057	873	6	based	base	VERB
admet-2057	873	7	catalysts	catalyst	NOUN
admet-2057	873	8	with	with	ADP
admet-2057	873	9	single	single	ADJ
admet-2057	873	10	metal	metal	NOUN
admet-2057	873	11	sites	site	NOUN
admet-2057	873	12	.	.	PUNCT
admet-2057	874	1	chemical	chemical	ADJ
admet-2057	874	2	reviews	review	NOUN
admet-2057	874	3	121(21	121(21	NUM
admet-2057	874	4	)	)	PUNCT
admet-2057	874	5	(	(	PUNCT
admet-2057	874	6	2020	2020	NUM
admet-2057	874	7	)	)	PUNCT
admet-2057	874	8	12089	12089	NUM
admet-2057	874	9	-	-	SYM
admet-2057	874	10	12174	12174	NUM
admet-2057	874	11	.	.	PUNCT
admet-2057	875	1	https://doi.org/10.1021/acs.chemrev.9b00757	https://doi.org/10.1021/acs.chemrev.9b00757	X
admet-2057	876	1	[	[	X
admet-2057	876	2	36	36	NUM
admet-2057	876	3	]	]	X
admet-2057	876	4	k.i	k.i	PROPN
admet-2057	876	5	.	.	PUNCT
admet-2057	876	6	hadjiivanov	hadjiivanov	PROPN
admet-2057	876	7	,	,	PUNCT
admet-2057	876	8	d.a	d.a	PROPN
admet-2057	876	9	.	.	PROPN
admet-2057	876	10	panayotov	panayotov	PROPN
admet-2057	876	11	,	,	PUNCT
admet-2057	876	12	m.y	m.y	PROPN
admet-2057	876	13	.	.	PROPN
admet-2057	876	14	mihaylov	mihaylov	PROPN
admet-2057	876	15	,	,	PUNCT
admet-2057	876	16	e.z	e.z	PROPN
admet-2057	876	17	.	.	PROPN
admet-2057	876	18	ivanova	ivanova	PROPN
admet-2057	876	19	,	,	PUNCT
admet-2057	876	20	k.k	k.k	PROPN
admet-2057	876	21	.	.	PROPN
admet-2057	876	22	chakarova	chakarova	PROPN
admet-2057	876	23	,	,	PUNCT
admet-2057	876	24	s.m	s.m	PROPN
admet-2057	876	25	.	.	PROPN
admet-2057	876	26	andonova	andonova	PROPN
admet-2057	876	27	,	,	PUNCT
admet-2057	876	28	n.l	n.l	PROPN
admet-2057	876	29	.	.	PUNCT
admet-2057	876	30	drenchev	drenchev	PROPN
admet-2057	876	31	.	.	PUNCT
admet-2057	877	1	power	power	NOUN
admet-2057	877	2	of	of	ADP
admet-2057	877	3	infrared	infrared	NOUN
admet-2057	877	4	and	and	CCONJ
admet-2057	877	5	raman	raman	NOUN
admet-2057	877	6	spectroscopies	spectroscopy	NOUN
admet-2057	877	7	to	to	PART
admet-2057	877	8	characterize	characterize	VERB
admet-2057	877	9	metal	metal	NOUN
admet-2057	877	10	-	-	PUNCT
admet-2057	877	11	organic	organic	ADJ
admet-2057	877	12	frameworks	framework	NOUN
admet-2057	877	13	and	and	CCONJ
admet-2057	877	14	investigate	investigate	VERB
admet-2057	877	15	their	their	PRON
admet-2057	877	16	interaction	interaction	NOUN
admet-2057	877	17	with	with	ADP
admet-2057	877	18	guest	guest	NOUN
admet-2057	877	19	molecules	molecule	NOUN
admet-2057	877	20	.	.	PUNCT
admet-2057	878	1	chemical	chemical	ADJ
admet-2057	878	2	reviews	review	NOUN
admet-2057	878	3	121(3	121(3	NUM
admet-2057	878	4	)	)	PUNCT
admet-2057	878	5	(	(	PUNCT
admet-2057	878	6	2021	2021	NUM
admet-2057	878	7	)	)	PUNCT
admet-2057	878	8	1286	1286	NUM
admet-2057	878	9	-	-	SYM
admet-2057	878	10	1424	1424	NUM
admet-2057	878	11	.	.	PUNCT
admet-2057	879	1	https://doi.org/10.1021/acs.chemrev.0c00487	https://doi.org/10.1021/acs.chemrev.0c00487	PRON
admet-2057	880	1	[	[	X
admet-2057	880	2	37	37	NUM
admet-2057	880	3	]	]	PUNCT
admet-2057	880	4	s.	s.	PROPN
admet-2057	880	5	he	he	PRON
admet-2057	880	6	,	,	PUNCT
admet-2057	880	7	l.	l.	PROPN
admet-2057	880	8	wu	wu	PROPN
admet-2057	880	9	,	,	PUNCT
admet-2057	880	10	x.	x.	PROPN
admet-2057	880	11	li	li	PROPN
admet-2057	880	12	,	,	PUNCT
admet-2057	880	13	h.	h.	PROPN
admet-2057	880	14	sun	sun	PROPN
admet-2057	880	15	,	,	PUNCT
admet-2057	880	16	t.	t.	PROPN
admet-2057	880	17	xiong	xiong	PROPN
admet-2057	880	18	,	,	PUNCT
admet-2057	880	19	j.	j.	PROPN
admet-2057	880	20	liu	liu	PROPN
admet-2057	880	21	,	,	PUNCT
admet-2057	880	22	c.	c.	PROPN
admet-2057	880	23	huang	huang	PROPN
admet-2057	880	24	,	,	PUNCT
admet-2057	880	25	h.	h.	PROPN
admet-2057	880	26	xu	xu	PROPN
admet-2057	880	27	,	,	PUNCT
admet-2057	880	28	h.	h.	PROPN
admet-2057	880	29	sun	sun	PROPN
admet-2057	880	30	,	,	PUNCT
admet-2057	880	31	w.	w.	PROPN
admet-2057	880	32	chen	chen	PROPN
admet-2057	880	33	,	,	PUNCT
admet-2057	880	34	r.	r.	PROPN
admet-2057	880	35	gref	gref	PROPN
admet-2057	880	36	,	,	PUNCT
admet-2057	880	37	j.	j.	PROPN
admet-2057	880	38	zhang	zhang	PROPN
admet-2057	880	39	.	.	PROPN
admet-2057	880	40	metalorganic	metalorganic	ADJ
admet-2057	880	41	frameworks	framework	NOUN
admet-2057	880	42	for	for	ADP
admet-2057	880	43	advanced	advanced	ADJ
admet-2057	880	44	drug	drug	NOUN
admet-2057	880	45	delivery	delivery	NOUN
admet-2057	880	46	.	.	PUNCT
admet-2057	881	1	acta	acta	PROPN
admet-2057	881	2	pharmaceutica	pharmaceutica	PROPN
admet-2057	881	3	sinica	sinica	PROPN
admet-2057	881	4	b	b	PROPN
admet-2057	881	5	11(8	11(8	PROPN
admet-2057	881	6	)	)	PUNCT
admet-2057	881	7	(	(	PUNCT
admet-2057	881	8	2021	2021	NUM
admet-2057	881	9	)	)	PUNCT
admet-2057	881	10	23622395	23622395	NUM
admet-2057	881	11	.	.	PUNCT
admet-2057	882	1	https://doi.org/10.1016/j.apsb.2021.03.019	https://doi.org/10.1016/j.apsb.2021.03.019	X
admet-2057	883	1	[	[	X
admet-2057	883	2	38	38	NUM
admet-2057	883	3	]	]	PUNCT
admet-2057	883	4	t.	t.	PROPN
admet-2057	883	5	wen	wen	PROPN
admet-2057	883	6	,	,	PUNCT
admet-2057	883	7	g.	g.	PROPN
admet-2057	883	8	quan	quan	PROPN
admet-2057	883	9	,	,	PUNCT
admet-2057	883	10	b.	b.	PROPN
admet-2057	883	11	niu	niu	PROPN
admet-2057	883	12	,	,	PUNCT
admet-2057	883	13	y.	y.	PROPN
admet-2057	883	14	zhou	zhou	PROPN
admet-2057	883	15	,	,	PUNCT
admet-2057	883	16	y.	y.	PROPN
admet-2057	883	17	zhao	zhao	PROPN
admet-2057	883	18	,	,	PUNCT
admet-2057	883	19	c.	c.	PROPN
admet-2057	883	20	lu	lu	PROPN
admet-2057	883	21	,	,	PUNCT
admet-2057	883	22	x.	x.	PROPN
admet-2057	883	23	pan	pan	PROPN
admet-2057	883	24	,	,	PUNCT
admet-2057	883	25	c.	c.	PROPN
admet-2057	883	26	wu	wu	PROPN
admet-2057	883	27	.	.	PUNCT
admet-2057	884	1	versatile	versatile	ADJ
admet-2057	884	2	nanoscale	nanoscale	NOUN
admet-2057	884	3	metal	metal	NOUN
admet-2057	884	4	-	-	PUNCT
admet-2057	884	5	organic	organic	ADJ
admet-2057	884	6	frameworks	framework	NOUN
admet-2057	884	7	(	(	PUNCT
admet-2057	884	8	nmofs	nmof	NOUN
admet-2057	884	9	):	):	PUNCT
admet-2057	884	10	an	an	DET
admet-2057	884	11	emerging	emerge	VERB
admet-2057	884	12	3d	3d	NUM
admet-2057	884	13	nanoplatform	nanoplatform	NOUN
admet-2057	884	14	for	for	ADP
admet-2057	884	15	drug	drug	NOUN
admet-2057	884	16	delivery	delivery	NOUN
admet-2057	884	17	and	and	CCONJ
admet-2057	884	18	therapeutic	therapeutic	ADJ
admet-2057	884	19	applications	application	NOUN
admet-2057	884	20	.	.	PUNCT
admet-2057	885	1	small	small	ADJ
admet-2057	885	2	17(8	17(8	NOUN
admet-2057	885	3	)	)	PUNCT
admet-2057	885	4	(	(	PUNCT
admet-2057	885	5	2021	2021	NUM
admet-2057	885	6	)	)	PUNCT
admet-2057	885	7	2005064	2005064	NUM
admet-2057	885	8	.	.	PUNCT
admet-2057	886	1	https://doi.org/10.1002/smll.202005064	https://doi.org/10.1002/smll.202005064	NOUN
admet-2057	886	2	[	[	X
admet-2057	886	3	39	39	NUM
admet-2057	886	4	]	]	X
admet-2057	886	5	h.d	h.d	PROPN
admet-2057	886	6	.	.	PROPN
admet-2057	886	7	lawson	lawson	PROPN
admet-2057	886	8	,	,	PUNCT
admet-2057	886	9	s.p	s.p	PROPN
admet-2057	886	10	.	.	PROPN
admet-2057	886	11	walton	walton	PROPN
admet-2057	886	12	,	,	PUNCT
admet-2057	886	13	c.	c.	PROPN
admet-2057	886	14	chan	chan	PROPN
admet-2057	886	15	.	.	PUNCT
admet-2057	887	1	metal	metal	NOUN
admet-2057	887	2	-	-	PUNCT
admet-2057	887	3	organic	organic	ADJ
admet-2057	887	4	frameworks	framework	NOUN
admet-2057	887	5	for	for	ADP
admet-2057	887	6	drug	drug	NOUN
admet-2057	887	7	delivery	delivery	NOUN
admet-2057	887	8	:	:	PUNCT
admet-2057	887	9	a	a	DET
admet-2057	887	10	design	design	NOUN
admet-2057	887	11	perspective	perspective	NOUN
admet-2057	887	12	.	.	PUNCT
admet-2057	888	1	acs	acs	PROPN
admet-2057	888	2	applied	apply	VERB
admet-2057	888	3	materials	material	NOUN
admet-2057	888	4	&	&	CCONJ
admet-2057	888	5	interfaces	interface	NOUN
admet-2057	888	6	6	6	NUM
admet-2057	888	7	(	(	PUNCT
admet-2057	888	8	2021	2021	NUM
admet-2057	888	9	)	)	PUNCT
admet-2057	888	10	7004	7004	NUM
admet-2057	888	11	-	-	SYM
admet-2057	888	12	7020	7020	NUM
admet-2057	888	13	.	.	PUNCT
admet-2057	889	1	https://doi.org/10.1021/acsami.1c01089	https://doi.org/10.1021/acsami.1c01089	ADJ
admet-2057	889	2	[	[	X
admet-2057	889	3	40	40	NUM
admet-2057	889	4	]	]	PUNCT
admet-2057	889	5	h.	h.	PROPN
admet-2057	889	6	zheng	zheng	PROPN
admet-2057	889	7	,	,	PUNCT
admet-2057	889	8	y.	y.	PROPN
admet-2057	889	9	zhang	zhang	PROPN
admet-2057	889	10	,	,	PUNCT
admet-2057	889	11	l.	l.	PROPN
admet-2057	889	12	liu	liu	PROPN
admet-2057	889	13	,	,	PUNCT
admet-2057	889	14	w.	w.	PROPN
admet-2057	889	15	wan	wan	PROPN
admet-2057	889	16	,	,	PUNCT
admet-2057	889	17	p.	p.	PROPN
admet-2057	889	18	guo	guo	PROPN
admet-2057	889	19	,	,	PUNCT
admet-2057	889	20	a.m.	a.m.	PROPN
admet-2057	889	21	nyström	nyström	PROPN
admet-2057	889	22	,	,	PUNCT
admet-2057	889	23	x.	x.	PROPN
admet-2057	889	24	zou	zou	PROPN
admet-2057	889	25	.	.	PUNCT
admet-2057	890	1	one	one	NUM
admet-2057	890	2	-	-	PUNCT
admet-2057	890	3	pot	pot	NOUN
admet-2057	890	4	synthesis	synthesis	NOUN
admet-2057	890	5	of	of	ADP
admet-2057	890	6	metalorganic	metalorganic	ADJ
admet-2057	890	7	frameworks	framework	NOUN
admet-2057	890	8	with	with	ADP
admet-2057	890	9	encapsulated	encapsulate	VERB
admet-2057	890	10	target	target	NOUN
admet-2057	890	11	molecules	molecule	NOUN
admet-2057	890	12	and	and	CCONJ
admet-2057	890	13	their	their	PRON
admet-2057	890	14	applications	application	NOUN
admet-2057	890	15	for	for	ADP
admet-2057	890	16	controlled	control	VERB
admet-2057	890	17	drug	drug	NOUN
admet-2057	890	18	delivery	delivery	NOUN
admet-2057	890	19	.	.	PUNCT
admet-2057	891	1	journal	journal	NOUN
admet-2057	891	2	of	of	ADP
admet-2057	891	3	the	the	DET
admet-2057	891	4	american	american	PROPN
admet-2057	891	5	chemical	chemical	PROPN
admet-2057	891	6	society	society	PROPN
admet-2057	891	7	3	3	NUM
admet-2057	891	8	(	(	PUNCT
admet-2057	891	9	2016	2016	NUM
admet-2057	891	10	)	)	PUNCT
admet-2057	891	11	962	962	NUM
admet-2057	891	12	-	-	SYM
admet-2057	891	13	968	968	NUM
admet-2057	891	14	.	.	PUNCT
admet-2057	892	1	https://doi.org/10.1021/jacs.5b11720	https://doi.org/10.1021/jacs.5b11720	PRON
admet-2057	892	2	[	[	X
admet-2057	892	3	41	41	NUM
admet-2057	892	4	]	]	PUNCT
admet-2057	892	5	i.	i.	NOUN
admet-2057	892	6	kritskiy	kritskiy	PROPN
admet-2057	892	7	,	,	PUNCT
admet-2057	892	8	t.	t.	PROPN
admet-2057	892	9	volkova	volkova	PROPN
admet-2057	892	10	,	,	PUNCT
admet-2057	892	11	a.	a.	NOUN
admet-2057	892	12	surov	surov	PROPN
admet-2057	892	13	,	,	PUNCT
admet-2057	892	14	i.	i.	PROPN
admet-2057	892	15	terekhova	terekhova	PROPN
admet-2057	892	16	.	.	PUNCT
admet-2057	893	1	γ	γ	PROPN
admet-2057	893	2	-	-	PUNCT
admet-2057	893	3	cyclodextrin	cyclodextrin	NOUN
admet-2057	893	4	-	-	PUNCT
admet-2057	893	5	metal	metal	NOUN
admet-2057	893	6	organic	organic	ADJ
admet-2057	893	7	frameworks	framework	NOUN
admet-2057	893	8	as	as	ADP
admet-2057	893	9	efficient	efficient	ADJ
admet-2057	893	10	microcontainers	microcontainer	NOUN
admet-2057	893	11	for	for	ADP
admet-2057	893	12	encapsulation	encapsulation	NOUN
admet-2057	893	13	of	of	ADP
admet-2057	893	14	leflunomide	leflunomide	NOUN
admet-2057	893	15	and	and	CCONJ
admet-2057	893	16	acceleration	acceleration	NOUN
admet-2057	893	17	of	of	ADP
admet-2057	893	18	its	its	PRON
admet-2057	893	19	transformation	transformation	NOUN
admet-2057	893	20	into	into	ADP
admet-2057	893	21	teriflunomide	teriflunomide	NOUN
admet-2057	893	22	.	.	PUNCT
admet-2057	894	1	carbohydrate	carbohydrate	NOUN
admet-2057	894	2	polymers	polymer	NOUN
admet-2057	894	3	216	216	NUM
admet-2057	894	4	(	(	PUNCT
admet-2057	894	5	2019	2019	NUM
admet-2057	894	6	)	)	PUNCT
admet-2057	894	7	224	224	NUM
admet-2057	894	8	-	-	SYM
admet-2057	894	9	230	230	NUM
admet-2057	894	10	.	.	PUNCT
admet-2057	895	1	https://doi.org/10.1016/j.carbpol.2019.04.037	https://doi.org/10.1016/j.carbpol.2019.04.037	NUM
admet-2057	895	2	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	895	3	https://doi.org/10.1021/acscentsci.0c00690	https://doi.org/10.1021/acscentsci.0c00690	ADJ
admet-2057	895	4	https://doi.org/10.1039/d0cs00635a	https://doi.org/10.1039/d0cs00635a	PROPN
admet-2057	895	5	https://doi.org/10.1070/rcr4554	https://doi.org/10.1070/rcr4554	NOUN
admet-2057	895	6	https://doi.org/10.1002/ejic.202000656	https://doi.org/10.1002/ejic.202000656	VERB
admet-2057	895	7	https://doi.org/10.1021/acs.chemmater.6b02626	https://doi.org/10.1021/acs.chemmater.6b02626	ADJ
admet-2057	895	8	https://doi.org/10.1039/c6ce00198j	https://doi.org/10.1039/c6ce00198j	PROPN
admet-2057	895	9	https://doi.org/10.1016/j.ccr.2021.213928	https://doi.org/10.1016/j.ccr.2021.213928	PUNCT
admet-2057	895	10	https://doi.org/10.1021/acs.accounts.7b00357	https://doi.org/10.1021/acs.accounts.7b00357	VERB
admet-2057	895	11	https://doi.org/10.1021/acs.chemrev.9b00757	https://doi.org/10.1021/acs.chemrev.9b00757	ADP
admet-2057	895	12	https://doi.org/10.1021/acs.chemrev.0c00487	https://doi.org/10.1021/acs.chemrev.0c00487	NOUN
admet-2057	895	13	https://doi.org/10.1016/j.apsb.2021.03.019	https://doi.org/10.1016/j.apsb.2021.03.019	VERB
admet-2057	895	14	https://doi.org/10.1002/smll.202005064	https://doi.org/10.1002/smll.202005064	NOUN
admet-2057	896	1	https://doi.org/10.1021/acsami.1c01089	https://doi.org/10.1021/acsami.1c01089	SCONJ
admet-2057	896	2	https://doi.org/10.1021/jacs.5b11720	https://doi.org/10.1021/jacs.5b11720	PROPN
admet-2057	896	3	https://doi.org/10.1016/j.carbpol.2019.04.037	https://doi.org/10.1016/j.carbpol.2019.04.037	PROPN
admet-2057	896	4	p.	p.	NOUN
admet-2057	896	5	mhettar	mhettar	NOUN
admet-2057	896	6	et	et	PROPN
admet-2057	896	7	al	al	PROPN
admet-2057	896	8	.	.	PROPN
admet-2057	896	9	admet	admet	PROPN
admet-2057	896	10	&	&	CCONJ
admet-2057	896	11	dmpk	dmpk	PROPN
admet-2057	896	12	12(1	12(1	PROPN
admet-2057	896	13	)	)	PUNCT
admet-2057	896	14	(	(	PUNCT
admet-2057	896	15	2024	2024	NUM
admet-2057	896	16	)	)	PUNCT
admet-2057	896	17	27	27	NUM
admet-2057	896	18	-	-	SYM
admet-2057	896	19	62	62	NUM
admet-2057	896	20	56	56	NUM
admet-2057	896	21	[	[	X
admet-2057	896	22	42	42	NUM
admet-2057	896	23	]	]	PUNCT
admet-2057	896	24	m.	m.	NOUN
admet-2057	896	25	vassaki	vassaki	PROPN
admet-2057	896	26	,	,	PUNCT
admet-2057	896	27	k.e	k.e	PROPN
admet-2057	896	28	.	.	PROPN
admet-2057	896	29	papathanasiou	papathanasiou	PROPN
admet-2057	896	30	,	,	PUNCT
admet-2057	896	31	c.	c.	PROPN
admet-2057	896	32	hadjicharalambous	hadjicharalambous	PROPN
admet-2057	896	33	,	,	PUNCT
admet-2057	896	34	d.	d.	PROPN
admet-2057	896	35	chandrinou	chandrinou	PROPN
admet-2057	896	36	,	,	PUNCT
admet-2057	896	37	p.	p.	PROPN
admet-2057	896	38	turhanen	turhanen	PROPN
admet-2057	896	39	,	,	PUNCT
admet-2057	896	40	d.	d.	PROPN
admet-2057	896	41	choquesillolazarte	choquesillolazarte	PROPN
admet-2057	896	42	,	,	PUNCT
admet-2057	896	43	k.d	k.d	PROPN
admet-2057	896	44	.	.	PROPN
admet-2057	896	45	demadis	demadis	PROPN
admet-2057	896	46	.	.	PUNCT
admet-2057	897	1	self	self	NOUN
admet-2057	897	2	-	-	PUNCT
admet-2057	897	3	sacrificial	sacrificial	ADJ
admet-2057	897	4	mofs	mof	NOUN
admet-2057	897	5	for	for	ADP
admet-2057	897	6	ultra	ultra	ADJ
admet-2057	897	7	-	-	ADJ
admet-2057	897	8	long	long	ADJ
admet-2057	897	9	controlled	control	VERB
admet-2057	897	10	release	release	NOUN
admet-2057	897	11	of	of	ADP
admet-2057	897	12	bisphosphonate	bisphosphonate	ADJ
admet-2057	897	13	anti	anti	ADJ
admet-2057	897	14	-	-	ADJ
admet-2057	897	15	osteoporotic	osteoporotic	ADJ
admet-2057	897	16	drugs	drug	NOUN
admet-2057	897	17	.	.	PUNCT
admet-2057	898	1	chemical	chemical	NOUN
admet-2057	898	2	communications	communication	NOUN
admet-2057	898	3	238	238	NUM
admet-2057	898	4	(	(	PUNCT
admet-2057	898	5	2020	2020	NUM
admet-2057	898	6	)	)	PUNCT
admet-2057	898	7	5166	5166	NUM
admet-2057	898	8	-	-	SYM
admet-2057	898	9	5169	5169	NUM
admet-2057	898	10	.	.	PUNCT
admet-2057	899	1	https://doi.org/10.1039/d0cc00439a	https://doi.org/10.1039/d0cc00439a	X
admet-2057	900	1	[	[	X
admet-2057	900	2	43	43	NUM
admet-2057	900	3	]	]	PUNCT
admet-2057	900	4	s.	s.	PROPN
admet-2057	900	5	li	li	PROPN
admet-2057	900	6	,	,	PUNCT
admet-2057	900	7	f.	f.	PROPN
admet-2057	900	8	huo	huo	PROPN
admet-2057	900	9	.	.	PUNCT
admet-2057	901	1	metal	metal	NOUN
admet-2057	901	2	-	-	PUNCT
admet-2057	901	3	organic	organic	ADJ
admet-2057	901	4	framework	framework	NOUN
admet-2057	901	5	composites	composite	NOUN
admet-2057	901	6	:	:	PUNCT
admet-2057	901	7	from	from	ADP
admet-2057	901	8	fundamentals	fundamental	NOUN
admet-2057	901	9	to	to	ADP
admet-2057	901	10	applications	application	NOUN
admet-2057	901	11	.	.	PUNCT
admet-2057	902	1	nanoscale	nanoscale	PROPN
admet-2057	902	2	7(17	7(17	NUM
admet-2057	902	3	)	)	PUNCT
admet-2057	902	4	(	(	PUNCT
admet-2057	902	5	2015	2015	NUM
admet-2057	902	6	)	)	PUNCT
admet-2057	902	7	7482	7482	NUM
admet-2057	902	8	-	-	SYM
admet-2057	902	9	7501	7501	NUM
admet-2057	902	10	.	.	PUNCT
admet-2057	903	1	https://doi.org/10.1039/c5nr00518c	https://doi.org/10.1039/c5nr00518c	PUNCT
admet-2057	904	1	[	[	X
admet-2057	904	2	44	44	NUM
admet-2057	904	3	]	]	PUNCT
admet-2057	904	4	s.	s.	PROPN
admet-2057	904	5	devautour	devautour	PROPN
admet-2057	904	6	-	-	PUNCT
admet-2057	904	7	vinot	vinot	PROPN
admet-2057	904	8	,	,	PUNCT
admet-2057	904	9	c.	c.	PROPN
admet-2057	904	10	martineau	martineau	PROPN
admet-2057	904	11	,	,	PUNCT
admet-2057	904	12	s.	s.	PROPN
admet-2057	904	13	diaby	diaby	PROPN
admet-2057	904	14	,	,	PUNCT
admet-2057	904	15	m.	m.	PROPN
admet-2057	904	16	ben	ben	PROPN
admet-2057	904	17	-	-	PROPN
admet-2057	904	18	yahia	yahia	PROPN
admet-2057	904	19	,	,	PUNCT
admet-2057	904	20	s.	s.	PROPN
admet-2057	904	21	miller	miller	PROPN
admet-2057	904	22	,	,	PUNCT
admet-2057	904	23	c.	c.	PROPN
admet-2057	904	24	serre	serre	PROPN
admet-2057	904	25	,	,	PUNCT
admet-2057	904	26	p.	p.	PROPN
admet-2057	904	27	horcajada	horcajada	PROPN
admet-2057	904	28	,	,	PUNCT
admet-2057	904	29	d.	d.	PROPN
admet-2057	904	30	cunha	cunha	PROPN
admet-2057	904	31	,	,	PUNCT
admet-2057	904	32	f.	f.	PROPN
admet-2057	904	33	taulelle	taulelle	PROPN
admet-2057	904	34	,	,	PUNCT
admet-2057	904	35	g.	g.	PROPN
admet-2057	904	36	maurin	maurin	NOUN
admet-2057	904	37	.	.	PUNCT
admet-2057	905	1	caffeine	caffeine	NOUN
admet-2057	905	2	confinement	confinement	NOUN
admet-2057	905	3	into	into	ADP
admet-2057	905	4	a	a	DET
admet-2057	905	5	series	series	NOUN
admet-2057	905	6	of	of	ADP
admet-2057	905	7	functionalized	functionalized	ADJ
admet-2057	905	8	porous	porous	ADJ
admet-2057	905	9	zirconium	zirconium	NOUN
admet-2057	905	10	mofs	mof	NOUN
admet-2057	905	11	:	:	PUNCT
admet-2057	905	12	a	a	DET
admet-2057	905	13	joint	joint	ADJ
admet-2057	905	14	experimental	experimental	ADJ
admet-2057	905	15	/	/	SYM
admet-2057	905	16	modeling	model	VERB
admet-2057	905	17	exploration	exploration	NOUN
admet-2057	905	18	.	.	PUNCT
admet-2057	906	1	journal	journal	PROPN
admet-2057	906	2	of	of	ADP
admet-2057	906	3	physical	physical	ADJ
admet-2057	906	4	chemistry	chemistry	NOUN
admet-2057	906	5	c	c	PROPN
admet-2057	906	6	22	22	NUM
admet-2057	906	7	(	(	PUNCT
admet-2057	906	8	2013	2013	NUM
admet-2057	906	9	)	)	PUNCT
admet-2057	906	10	1169411704	1169411704	NUM
admet-2057	906	11	.	.	PUNCT
admet-2057	907	1	https://doi.org/10.1021/jp402916y	https://doi.org/10.1021/jp402916y	X
admet-2057	908	1	[	[	X
admet-2057	908	2	45	45	NUM
admet-2057	908	3	]	]	PUNCT
admet-2057	908	4	z.	z.	PROPN
admet-2057	908	5	nadizadeh	nadizadeh	PROPN
admet-2057	908	6	,	,	PUNCT
admet-2057	908	7	m.r	m.r	PROPN
admet-2057	908	8	.	.	PROPN
admet-2057	908	9	naimi	naimi	PROPN
admet-2057	908	10	-	-	PUNCT
admet-2057	908	11	jamal	jamal	PROPN
admet-2057	908	12	,	,	PUNCT
admet-2057	908	13	l.	l.	PROPN
admet-2057	908	14	panahi	panahi	PROPN
admet-2057	908	15	.	.	PUNCT
admet-2057	909	1	mechanochemical	mechanochemical	ADJ
admet-2057	909	2	solvent	solvent	NOUN
admet-2057	909	3	-	-	PUNCT
admet-2057	909	4	free	free	ADJ
admet-2057	909	5	in	in	ADP
admet-2057	909	6	situ	situ	ADJ
admet-2057	909	7	synthesis	synthesis	NOUN
admet-2057	909	8	of	of	ADP
admet-2057	909	9	drugloaded	drugloade	VERB
admet-2057	909	10	{	{	PUNCT
admet-2057	909	11	cu2(1,4	cu2(1,4	ADJ
admet-2057	909	12	-	-	PUNCT
admet-2057	909	13	bdc)2(dabco)}n	bdc)2(dabco)}n	NOUN
admet-2057	909	14	mofs	mof	NOUN
admet-2057	909	15	for	for	ADP
admet-2057	909	16	controlled	control	VERB
admet-2057	909	17	drug	drug	NOUN
admet-2057	909	18	delivery	delivery	NOUN
admet-2057	909	19	.	.	PUNCT
admet-2057	910	1	journal	journal	NOUN
admet-2057	910	2	of	of	ADP
admet-2057	910	3	solid	solid	ADJ
admet-2057	910	4	state	state	NOUN
admet-2057	910	5	chemistry	chemistry	NOUN
admet-2057	910	6	259	259	NUM
admet-2057	910	7	(	(	PUNCT
admet-2057	910	8	2018	2018	NUM
admet-2057	910	9	)	)	PUNCT
admet-2057	910	10	35	35	NUM
admet-2057	910	11	-	-	SYM
admet-2057	910	12	42	42	NUM
admet-2057	910	13	.	.	PUNCT
admet-2057	911	1	https://doi.org/10.1016/j.jssc.2017.12.027	https://doi.org/10.1016/j.jssc.2017.12.027	PROPN
admet-2057	912	1	[	[	X
admet-2057	912	2	46	46	NUM
admet-2057	912	3	]	]	X
admet-2057	912	4	s.a	s.a	PROPN
admet-2057	912	5	.	.	PROPN
admet-2057	912	6	noorian	noorian	PROPN
admet-2057	912	7	,	,	PUNCT
admet-2057	912	8	n.	n.	PROPN
admet-2057	912	9	hemmatinejad	hemmatinejad	PROPN
admet-2057	912	10	,	,	PUNCT
admet-2057	912	11	j.a.r	j.a.r	PROPN
admet-2057	912	12	.	.	PUNCT
admet-2057	913	1	navarro	navarro	PROPN
admet-2057	913	2	.	.	PUNCT
admet-2057	914	1	bioactive	bioactive	VERB
admet-2057	914	2	molecule	molecule	NOUN
admet-2057	914	3	encapsulation	encapsulation	NOUN
admet-2057	914	4	on	on	ADP
admet-2057	914	5	metal	metal	NOUN
admet-2057	914	6	-	-	PUNCT
admet-2057	914	7	organic	organic	ADJ
admet-2057	914	8	framework	framework	NOUN
admet-2057	914	9	via	via	ADP
admet-2057	914	10	simple	simple	ADJ
admet-2057	914	11	mechanochemical	mechanochemical	ADJ
admet-2057	914	12	method	method	NOUN
admet-2057	914	13	for	for	ADP
admet-2057	914	14	controlled	control	VERB
admet-2057	914	15	topical	topical	ADJ
admet-2057	914	16	drug	drug	NOUN
admet-2057	914	17	delivery	delivery	NOUN
admet-2057	914	18	systems	system	NOUN
admet-2057	914	19	.	.	PUNCT
admet-2057	915	1	microporous	microporous	ADJ
admet-2057	915	2	&	&	CCONJ
admet-2057	915	3	mesoporous	mesoporous	ADJ
admet-2057	915	4	materials	material	NOUN
admet-2057	915	5	302	302	NUM
admet-2057	915	6	(	(	PUNCT
admet-2057	915	7	2020	2020	NUM
admet-2057	915	8	)	)	PUNCT
admet-2057	915	9	110199	110199	NUM
admet-2057	915	10	.	.	PUNCT
admet-2057	916	1	https://doi.org/10.1016/j.micromeso.2020.110199	https://doi.org/10.1016/j.micromeso.2020.110199	NOUN
admet-2057	916	2	[	[	X
admet-2057	916	3	47	47	NUM
admet-2057	916	4	]	]	PUNCT
admet-2057	916	5	w.	w.	PROPN
admet-2057	916	6	morris	morris	PROPN
admet-2057	916	7	,	,	PUNCT
admet-2057	916	8	w.e	w.e	PROPN
admet-2057	916	9	.	.	PROPN
admet-2057	916	10	briley	briley	PROPN
admet-2057	916	11	,	,	PUNCT
admet-2057	916	12	e.	e.	PROPN
admet-2057	916	13	auyeung	auyeung	PROPN
admet-2057	916	14	,	,	PUNCT
admet-2057	916	15	m.d	m.d	PROPN
admet-2057	916	16	.	.	PROPN
admet-2057	916	17	cabezas	cabezas	PROPN
admet-2057	916	18	,	,	PUNCT
admet-2057	917	1	c.a	c.a	PROPN
admet-2057	917	2	.	.	PROPN
admet-2057	917	3	mirkin	mirkin	PROPN
admet-2057	917	4	.	.	PUNCT
admet-2057	918	1	nucleic	nucleic	ADJ
admet-2057	918	2	acid	acid	NOUN
admet-2057	918	3	-	-	PUNCT
admet-2057	918	4	metal	metal	NOUN
admet-2057	918	5	organic	organic	ADJ
admet-2057	918	6	framework	framework	NOUN
admet-2057	918	7	(	(	PUNCT
admet-2057	918	8	mof	mof	NOUN
admet-2057	918	9	)	)	PUNCT
admet-2057	918	10	nanoparticle	nanoparticle	NOUN
admet-2057	918	11	conjugates	conjugate	NOUN
admet-2057	918	12	.	.	PUNCT
admet-2057	919	1	journal	journal	PROPN
admet-2057	919	2	of	of	ADP
admet-2057	919	3	american	american	PROPN
admet-2057	919	4	chemical	chemical	PROPN
admet-2057	919	5	society	society	NOUN
admet-2057	919	6	20	20	NUM
admet-2057	919	7	(	(	PUNCT
admet-2057	919	8	2014	2014	NUM
admet-2057	919	9	)	)	PUNCT
admet-2057	919	10	72617264	72617264	NUM
admet-2057	919	11	.	.	PUNCT
admet-2057	920	1	https://doi.org/10.1021/ja503215w	https://doi.org/10.1021/ja503215w	NOUN
admet-2057	920	2	[	[	X
admet-2057	920	3	48	48	NUM
admet-2057	920	4	]	]	PUNCT
admet-2057	920	5	m.	m.	NOUN
admet-2057	920	6	giménez	giménez	PROPN
admet-2057	920	7	-	-	PUNCT
admet-2057	920	8	marqués	marqués	PROPN
admet-2057	920	9	,	,	PUNCT
admet-2057	920	10	t.	t.	PROPN
admet-2057	920	11	hidalgo	hidalgo	PROPN
admet-2057	920	12	,	,	PUNCT
admet-2057	920	13	c.	c.	PROPN
admet-2057	920	14	serre	serre	PROPN
admet-2057	920	15	,	,	PUNCT
admet-2057	920	16	p.	p.	PROPN
admet-2057	920	17	horcajada	horcajada	PROPN
admet-2057	920	18	.	.	PUNCT
admet-2057	921	1	nanostructured	nanostructure	VERB
admet-2057	921	2	metal	metal	NOUN
admet-2057	921	3	-	-	PUNCT
admet-2057	921	4	organic	organic	ADJ
admet-2057	921	5	frameworks	framework	NOUN
admet-2057	921	6	and	and	CCONJ
admet-2057	921	7	their	their	PRON
admet-2057	921	8	bio	bio	ADJ
admet-2057	921	9	-	-	PUNCT
admet-2057	921	10	related	relate	VERB
admet-2057	921	11	applications	application	NOUN
admet-2057	921	12	.	.	PUNCT
admet-2057	922	1	coordination	coordination	NOUN
admet-2057	922	2	chemistry	chemistry	NOUN
admet-2057	922	3	reviews	review	VERB
admet-2057	922	4	307	307	NUM
admet-2057	922	5	(	(	PUNCT
admet-2057	922	6	2016	2016	NUM
admet-2057	922	7	)	)	PUNCT
admet-2057	922	8	342360	342360	NUM
admet-2057	922	9	.	.	PUNCT
admet-2057	923	1	https://doi.org/10.1016/j.ccr.2015.08.008	https://doi.org/10.1016/j.ccr.2015.08.008	NOUN
admet-2057	924	1	[	[	X
admet-2057	924	2	49	49	NUM
admet-2057	924	3	]	]	PUNCT
admet-2057	924	4	s.	s.	PROPN
admet-2057	924	5	h.	h.	PROPN
admet-2057	924	6	anastasiadis	anastasiadis	PROPN
admet-2057	924	7	,	,	PUNCT
admet-2057	924	8	k.	k.	PROPN
admet-2057	924	9	chrissopoulou	chrissopoulou	PROPN
admet-2057	924	10	,	,	PUNCT
admet-2057	924	11	e.	e.	PROPN
admet-2057	924	12	stratakis	stratakis	PROPN
admet-2057	924	13	,	,	PUNCT
admet-2057	924	14	p.	p.	NOUN
admet-2057	924	15	kavatzikidou	kavatzikidou	NOUN
admet-2057	924	16	,	,	PUNCT
admet-2057	924	17	g.	g.	PROPN
admet-2057	924	18	kaklamani	kaklamani	PROPN
admet-2057	924	19	,	,	PUNCT
admet-2057	924	20	a.	a.	NOUN
admet-2057	924	21	ranella	ranella	NOUN
admet-2057	924	22	.	.	PUNCT
admet-2057	925	1	how	how	SCONJ
admet-2057	925	2	the	the	DET
admet-2057	925	3	physicochemical	physicochemical	ADJ
admet-2057	925	4	properties	property	NOUN
admet-2057	925	5	of	of	ADP
admet-2057	925	6	manufactured	manufacture	VERB
admet-2057	925	7	nanomaterials	nanomaterial	NOUN
admet-2057	925	8	affect	affect	VERB
admet-2057	925	9	their	their	PRON
admet-2057	925	10	performance	performance	NOUN
admet-2057	925	11	in	in	ADP
admet-2057	925	12	dispersion	dispersion	NOUN
admet-2057	925	13	and	and	CCONJ
admet-2057	925	14	their	their	PRON
admet-2057	925	15	applications	application	NOUN
admet-2057	925	16	in	in	ADP
admet-2057	925	17	biomedicine	biomedicine	NOUN
admet-2057	925	18	:	:	PUNCT
admet-2057	925	19	a	a	DET
admet-2057	925	20	review	review	NOUN
admet-2057	925	21	.	.	PUNCT
admet-2057	926	1	nanomaterials	nanomaterial	NOUN
admet-2057	926	2	12(3	12(3	PROPN
admet-2057	926	3	)	)	PUNCT
admet-2057	926	4	(	(	PUNCT
admet-2057	926	5	2022	2022	NUM
admet-2057	926	6	)	)	PUNCT
admet-2057	926	7	552	552	NUM
admet-2057	926	8	.	.	PUNCT
admet-2057	927	1	https://doi.org/10.3390/nano12030552	https://doi.org/10.3390/nano12030552	PROPN
admet-2057	928	1	[	[	X
admet-2057	928	2	50	50	NUM
admet-2057	928	3	]	]	X
admet-2057	928	4	a.c	a.c	PROPN
admet-2057	928	5	.	.	PROPN
admet-2057	928	6	mckinlay	mckinlay	PROPN
admet-2057	928	7	,	,	PUNCT
admet-2057	928	8	r.e	r.e	PROPN
admet-2057	928	9	.	.	PROPN
admet-2057	928	10	morris	morris	PROPN
admet-2057	928	11	,	,	PUNCT
admet-2057	928	12	p.	p.	PROPN
admet-2057	928	13	horcajada	horcajada	PROPN
admet-2057	928	14	,	,	PUNCT
admet-2057	928	15	g.	g.	PROPN
admet-2057	928	16	férey	férey	PROPN
admet-2057	928	17	,	,	PUNCT
admet-2057	928	18	r.	r.	PROPN
admet-2057	928	19	gref	gref	PROPN
admet-2057	928	20	,	,	PUNCT
admet-2057	928	21	p.	p.	PROPN
admet-2057	928	22	couvreur	couvreur	PROPN
admet-2057	928	23	,	,	PUNCT
admet-2057	928	24	c.	c.	PROPN
admet-2057	928	25	serre	serre	PROPN
admet-2057	928	26	.	.	PUNCT
admet-2057	929	1	biomofs	biomof	NOUN
admet-2057	929	2	:	:	PUNCT
admet-2057	929	3	metalorganic	metalorganic	ADJ
admet-2057	929	4	frameworks	framework	NOUN
admet-2057	929	5	for	for	ADP
admet-2057	929	6	biological	biological	ADJ
admet-2057	929	7	and	and	CCONJ
admet-2057	929	8	medical	medical	ADJ
admet-2057	929	9	applications	application	NOUN
admet-2057	929	10	.	.	PUNCT
admet-2057	930	1	angewandtechemie	angewandtechemie	PROPN
admet-2057	930	2	international	international	PROPN
admet-2057	930	3	edition	edition	NOUN
admet-2057	930	4	49(36	49(36	PROPN
admet-2057	930	5	)	)	PUNCT
admet-2057	930	6	(	(	PUNCT
admet-2057	930	7	2010	2010	NUM
admet-2057	930	8	)	)	PUNCT
admet-2057	930	9	6260	6260	NUM
admet-2057	930	10	-	-	SYM
admet-2057	930	11	6266	6266	NUM
admet-2057	930	12	.	.	PUNCT
admet-2057	931	1	https://doi.org/10.1002/anie.201000048	https://doi.org/10.1002/anie.201000048	NOUN
admet-2057	932	1	[	[	X
admet-2057	932	2	51	51	NUM
admet-2057	932	3	]	]	X
admet-2057	932	4	f.	f.	PROPN
admet-2057	932	5	lamberti	lamberti	PROPN
admet-2057	932	6	,	,	PUNCT
admet-2057	932	7	c.	c.	PROPN
admet-2057	932	8	mazzariol	mazzariol	PROPN
admet-2057	932	9	,	,	PUNCT
admet-2057	932	10	f.	f.	PROPN
admet-2057	932	11	spolaore	spolaore	PROPN
admet-2057	932	12	,	,	PUNCT
admet-2057	932	13	r.	r.	PROPN
admet-2057	932	14	ceccato	ceccato	PROPN
admet-2057	932	15	,	,	PUNCT
admet-2057	932	16	l.	l.	PROPN
admet-2057	932	17	salmaso	salmaso	PROPN
admet-2057	932	18	,	,	PUNCT
admet-2057	932	19	s.	s.	PROPN
admet-2057	932	20	gross	gross	PROPN
admet-2057	932	21	.	.	PUNCT
admet-2057	933	1	design	design	NOUN
admet-2057	933	2	of	of	ADP
admet-2057	933	3	experiment	experiment	NOUN
admet-2057	933	4	:	:	PUNCT
admet-2057	933	5	a	a	DET
admet-2057	933	6	rational	rational	ADJ
admet-2057	933	7	and	and	CCONJ
admet-2057	933	8	still	still	ADV
admet-2057	933	9	unexplored	unexplored	ADJ
admet-2057	933	10	approach	approach	NOUN
admet-2057	933	11	to	to	ADP
admet-2057	933	12	inorganic	inorganic	ADJ
admet-2057	933	13	materials	material	NOUN
admet-2057	933	14	’	'	PUNCT
admet-2057	933	15	synthesis	synthesis	NOUN
admet-2057	933	16	.	.	PUNCT
admet-2057	934	1	sustainable	sustainable	ADJ
admet-2057	934	2	chemistry	chemistry	NOUN
admet-2057	934	3	1	1	NUM
admet-2057	934	4	(	(	PUNCT
admet-2057	934	5	2022	2022	NUM
admet-2057	934	6	)	)	PUNCT
admet-2057	934	7	114	114	NUM
admet-2057	934	8	-	-	SYM
admet-2057	934	9	130	130	NUM
admet-2057	934	10	.	.	PUNCT
admet-2057	934	11	https://doi.org/10.3390/suschem3010009	https://doi.org/10.3390/suschem3010009	NOUN
admet-2057	935	1	[	[	X
admet-2057	935	2	52	52	NUM
admet-2057	935	3	]	]	PUNCT
admet-2057	935	4	m.	m.	NOUN
admet-2057	935	5	tavares	tavare	NOUN
admet-2057	935	6	luiz	luiz	PROPN
admet-2057	935	7	,	,	PUNCT
admet-2057	935	8	j.	j.	PROPN
admet-2057	935	9	santos	santos	PROPN
admet-2057	935	10	rosa	rosa	PROPN
admet-2057	935	11	viegas	viegas	PROPN
admet-2057	935	12	,	,	PUNCT
admet-2057	935	13	j.	j.	PROPN
admet-2057	935	14	palma	palma	PROPN
admet-2057	935	15	abriata	abriata	PROPN
admet-2057	935	16	,	,	PUNCT
admet-2057	935	17	f.	f.	PROPN
admet-2057	935	18	viegas	viegas	PROPN
admet-2057	935	19	,	,	PUNCT
admet-2057	935	20	f.	f.	PROPN
admet-2057	935	21	testa	testa	PROPN
admet-2057	935	22	moura	moura	PROPN
admet-2057	935	23	de	de	PROPN
admet-2057	935	24	carvalho	carvalho	PROPN
admet-2057	935	25	vicentini	vicentini	PROPN
admet-2057	935	26	,	,	PUNCT
admet-2057	935	27	m.v	m.v	PROPN
admet-2057	935	28	.	.	PROPN
admet-2057	935	29	lopes	lopes	PROPN
admet-2057	935	30	badra	badra	PROPN
admet-2057	935	31	bentley	bentley	PROPN
admet-2057	935	32	,	,	PUNCT
admet-2057	935	33	m.	m.	PROPN
admet-2057	935	34	chorilli	chorilli	PROPN
admet-2057	935	35	,	,	PUNCT
admet-2057	935	36	j.	j.	PROPN
admet-2057	935	37	maldonado	maldonado	PROPN
admet-2057	935	38	marchetti	marchetti	PROPN
admet-2057	935	39	,	,	PUNCT
admet-2057	935	40	d.r	d.r	PROPN
admet-2057	935	41	.	.	PROPN
admet-2057	935	42	tapia	tapia	PROPN
admet-2057	935	43	-	-	PUNCT
admet-2057	935	44	blácido	blácido	PROPN
admet-2057	935	45	.	.	PUNCT
admet-2057	936	1	design	design	NOUN
admet-2057	936	2	of	of	ADP
admet-2057	936	3	experiments	experiment	NOUN
admet-2057	936	4	(	(	PUNCT
admet-2057	936	5	doe	doe	NOUN
admet-2057	936	6	)	)	PUNCT
admet-2057	936	7	to	to	PART
admet-2057	936	8	develop	develop	VERB
admet-2057	936	9	and	and	CCONJ
admet-2057	936	10	to	to	PART
admet-2057	936	11	optimize	optimize	VERB
admet-2057	936	12	nanoparticles	nanoparticle	NOUN
admet-2057	936	13	as	as	ADP
admet-2057	936	14	drug	drug	NOUN
admet-2057	936	15	delivery	delivery	NOUN
admet-2057	936	16	systems	system	NOUN
admet-2057	936	17	.	.	PUNCT
admet-2057	937	1	european	european	ADJ
admet-2057	937	2	journal	journal	PROPN
admet-2057	937	3	of	of	ADP
admet-2057	937	4	pharmaceutics	pharmaceutic	NOUN
admet-2057	937	5	and	and	CCONJ
admet-2057	937	6	biopharmaceutics	biopharmaceutic	NOUN
admet-2057	937	7	165	165	NUM
admet-2057	937	8	(	(	PUNCT
admet-2057	937	9	2021	2021	NUM
admet-2057	937	10	)	)	PUNCT
admet-2057	937	11	127	127	NUM
admet-2057	937	12	-	-	SYM
admet-2057	937	13	148	148	NUM
admet-2057	937	14	.	.	PUNCT
admet-2057	938	1	https://doi.org/10.1016/j.ejpb.2021.05.011	https://doi.org/10.1016/j.ejpb.2021.05.011	NUM
admet-2057	939	1	[	[	X
admet-2057	939	2	53	53	NUM
admet-2057	939	3	]	]	X
admet-2057	939	4	y.	y.	PROPN
admet-2057	939	5	li	li	PROPN
admet-2057	939	6	,	,	PUNCT
admet-2057	939	7	x.	x.	PROPN
admet-2057	939	8	li	li	PROPN
admet-2057	939	9	,	,	PUNCT
admet-2057	939	10	q.	q.	PROPN
admet-2057	939	11	guan	guan	PROPN
admet-2057	939	12	,	,	PUNCT
admet-2057	939	13	c.	c.	PROPN
admet-2057	939	14	zhang	zhang	PROPN
admet-2057	939	15	,	,	PUNCT
admet-2057	939	16	t.	t.	PROPN
admet-2057	939	17	xu	xu	PROPN
admet-2057	939	18	,	,	PUNCT
admet-2057	939	19	y.	y.	PROPN
admet-2057	939	20	dong	dong	PROPN
admet-2057	939	21	,	,	PUNCT
admet-2057	939	22	x.	x.	PROPN
admet-2057	939	23	bai	bai	PROPN
admet-2057	939	24	,	,	PUNCT
admet-2057	939	25	w.	w.	PROPN
admet-2057	939	26	zhang	zhang	PROPN
admet-2057	939	27	.	.	PUNCT
admet-2057	940	1	strategy	strategy	NOUN
admet-2057	940	2	for	for	ADP
admet-2057	940	3	chemotherapeutic	chemotherapeutic	ADJ
admet-2057	940	4	delivery	delivery	NOUN
admet-2057	940	5	using	use	VERB
admet-2057	940	6	a	a	DET
admet-2057	940	7	nanosized	nanosized	ADJ
admet-2057	940	8	porous	porous	ADJ
admet-2057	940	9	metal	metal	NOUN
admet-2057	940	10	-	-	PUNCT
admet-2057	940	11	organic	organic	ADJ
admet-2057	940	12	framework	framework	NOUN
admet-2057	940	13	with	with	ADP
admet-2057	940	14	a	a	DET
admet-2057	940	15	central	central	ADJ
admet-2057	940	16	composite	composite	ADJ
admet-2057	940	17	design	design	NOUN
admet-2057	940	18	.	.	PUNCT
admet-2057	941	1	international	international	ADJ
admet-2057	941	2	journal	journal	PROPN
admet-2057	941	3	of	of	ADP
admet-2057	941	4	nanomedicine	nanomedicine	NOUN
admet-2057	941	5	12	12	NUM
admet-2057	941	6	(	(	PUNCT
admet-2057	941	7	2017	2017	NUM
admet-2057	941	8	)	)	PUNCT
admet-2057	941	9	1465	1465	NUM
admet-2057	941	10	-	-	SYM
admet-2057	941	11	1474	1474	NUM
admet-2057	941	12	.	.	PUNCT
admet-2057	942	1	https://doi.org/10.2147/ijn.s119115	https://doi.org/10.2147/ijn.s119115	X
admet-2057	943	1	[	[	X
admet-2057	943	2	54	54	NUM
admet-2057	943	3	]	]	PUNCT
admet-2057	943	4	p.	p.	NOUN
admet-2057	943	5	kush	kush	NOUN
admet-2057	943	6	,	,	PUNCT
admet-2057	943	7	j.	j.	PROPN
admet-2057	943	8	madan	madan	PROPN
admet-2057	943	9	,	,	PUNCT
admet-2057	943	10	p.	p.	PROPN
admet-2057	943	11	kumar	kumar	PROPN
admet-2057	943	12	.	.	PUNCT
admet-2057	944	1	application	application	NOUN
admet-2057	944	2	of	of	ADP
admet-2057	944	3	central	central	ADJ
admet-2057	944	4	composite	composite	ADJ
admet-2057	944	5	design	design	NOUN
admet-2057	944	6	and	and	CCONJ
admet-2057	944	7	response	response	NOUN
admet-2057	944	8	surface	surface	NOUN
admet-2057	944	9	methodology	methodology	NOUN
admet-2057	944	10	for	for	ADP
admet-2057	944	11	optimization	optimization	NOUN
admet-2057	944	12	of	of	ADP
admet-2057	944	13	metal	metal	NOUN
admet-2057	944	14	organic	organic	ADJ
admet-2057	944	15	framework	framework	NOUN
admet-2057	944	16	:	:	PUNCT
admet-2057	944	17	novel	novel	ADJ
admet-2057	944	18	carrier	carrier	NOUN
admet-2057	944	19	for	for	ADP
admet-2057	944	20	drug	drug	NOUN
admet-2057	944	21	delivery	delivery	NOUN
admet-2057	944	22	.	.	PUNCT
admet-2057	945	1	asian	asian	ADJ
admet-2057	945	2	journal	journal	PROPN
admet-2057	945	3	of	of	ADP
admet-2057	945	4	pharmaceutical	pharmaceutical	NOUN
admet-2057	945	5	and	and	CCONJ
admet-2057	945	6	clinical	clinical	ADJ
admet-2057	945	7	research	research	NOUN
admet-2057	945	8	12(8	12(8	NUM
admet-2057	945	9	)	)	PUNCT
admet-2057	945	10	(	(	PUNCT
admet-2057	945	11	2019	2019	NUM
admet-2057	945	12	)	)	PUNCT
admet-2057	945	13	121	121	NUM
admet-2057	945	14	-	-	SYM
admet-2057	945	15	127	127	NUM
admet-2057	945	16	.	.	PUNCT
admet-2057	946	1	https://doi.org/10.22159/ajpcr.2019.v12i8.34299	https://doi.org/10.22159/ajpcr.2019.v12i8.34299	PUNCT
admet-2057	947	1	[	[	X
admet-2057	947	2	55	55	NUM
admet-2057	947	3	]	]	PUNCT
admet-2057	947	4	s.	s.	PROPN
admet-2057	947	5	he	he	PRON
admet-2057	947	6	,	,	PUNCT
admet-2057	947	7	l.	l.	PROPN
admet-2057	947	8	wu	wu	PROPN
admet-2057	947	9	,	,	PUNCT
admet-2057	947	10	x.	x.	PROPN
admet-2057	947	11	li	li	PROPN
admet-2057	947	12	,	,	PUNCT
admet-2057	947	13	h.	h.	PROPN
admet-2057	947	14	sun	sun	PROPN
admet-2057	947	15	,	,	PUNCT
admet-2057	947	16	t.	t.	PROPN
admet-2057	947	17	xiong	xiong	PROPN
admet-2057	947	18	,	,	PUNCT
admet-2057	947	19	j.	j.	PROPN
admet-2057	947	20	liu	liu	PROPN
admet-2057	947	21	,	,	PUNCT
admet-2057	947	22	c.	c.	PROPN
admet-2057	947	23	huang	huang	PROPN
admet-2057	947	24	,	,	PUNCT
admet-2057	947	25	h.	h.	PROPN
admet-2057	947	26	xu	xu	PROPN
admet-2057	947	27	,	,	PUNCT
admet-2057	947	28	h.	h.	PROPN
admet-2057	947	29	sun	sun	PROPN
admet-2057	947	30	,	,	PUNCT
admet-2057	947	31	w.	w.	PROPN
admet-2057	947	32	chen	chen	PROPN
admet-2057	947	33	,	,	PUNCT
admet-2057	947	34	r.	r.	PROPN
admet-2057	947	35	gref	gref	PROPN
admet-2057	947	36	,	,	PUNCT
admet-2057	947	37	j.	j.	PROPN
admet-2057	947	38	zhang	zhang	PROPN
admet-2057	947	39	.	.	PROPN
admet-2057	947	40	metalorganic	metalorganic	ADJ
admet-2057	947	41	frameworks	framework	NOUN
admet-2057	947	42	for	for	ADP
admet-2057	947	43	advanced	advanced	ADJ
admet-2057	947	44	drug	drug	NOUN
admet-2057	947	45	delivery	delivery	NOUN
admet-2057	947	46	.	.	PUNCT
admet-2057	948	1	acta	acta	PROPN
admet-2057	948	2	pharmaceutica	pharmaceutica	PROPN
admet-2057	948	3	sinica	sinica	PROPN
admet-2057	948	4	b	b	PROPN
admet-2057	948	5	11(8	11(8	PROPN
admet-2057	948	6	)	)	PUNCT
admet-2057	948	7	(	(	PUNCT
admet-2057	948	8	2021	2021	NUM
admet-2057	948	9	)	)	PUNCT
admet-2057	948	10	23622395	23622395	NUM
admet-2057	948	11	.	.	PUNCT
admet-2057	949	1	https://doi.org/10.1016/j.apsb.2021.03.019	https://doi.org/10.1016/j.apsb.2021.03.019	X
admet-2057	950	1	[	[	X
admet-2057	950	2	56	56	NUM
admet-2057	950	3	]	]	X
admet-2057	950	4	c.	c.	PROPN
admet-2057	950	5	tamames	tamames	PROPN
admet-2057	950	6	-	-	PUNCT
admet-2057	950	7	tabar	tabar	PROPN
admet-2057	950	8	,	,	PUNCT
admet-2057	950	9	a.	a.	NOUN
admet-2057	950	10	garcía	garcía	NOUN
admet-2057	950	11	-	-	PUNCT
admet-2057	950	12	márquez	márquez	NOUN
admet-2057	950	13	,	,	PUNCT
admet-2057	950	14	m.	m.	NOUN
admet-2057	950	15	j.	j.	PROPN
admet-2057	950	16	blanco	blanco	PROPN
admet-2057	950	17	-	-	PUNCT
admet-2057	950	18	prieto	prieto	PROPN
admet-2057	950	19	,	,	PUNCT
admet-2057	950	20	c.	c.	PROPN
admet-2057	950	21	serre	serre	PROPN
admet-2057	950	22	,	,	PUNCT
admet-2057	950	23	p.	p.	PROPN
admet-2057	950	24	horcajada	horcajada	PROPN
admet-2057	950	25	,	,	PUNCT
admet-2057	950	26	d.	d.	PROPN
admet-2057	950	27	ruiz	ruiz	PROPN
admet-2057	950	28	-	-	PUNCT
admet-2057	950	29	molina	molina	PROPN
admet-2057	950	30	,	,	PUNCT
admet-2057	950	31	f.	f.	PROPN
admet-2057	950	32	novio	novio	PROPN
admet-2057	950	33	,	,	PUNCT
admet-2057	950	34	c.	c.	PROPN
admet-2057	950	35	roscini	roscini	PROPN
admet-2057	950	36	.	.	PUNCT
admet-2057	951	1	mofs	mof	NOUN
admet-2057	951	2	in	in	ADP
admet-2057	951	3	pharmaceutical	pharmaceutical	ADJ
admet-2057	951	4	technology	technology	NOUN
admet-2057	951	5	.	.	PUNCT
admet-2057	952	1	bio	bio	PROPN
admet-2057	952	2	and	and	CCONJ
admet-2057	952	3	bioinspired	bioinspired	ADJ
admet-2057	952	4	nanomaterials	nanomaterial	NOUN
admet-2057	952	5	(	(	PUNCT
admet-2057	952	6	2014	2014	NUM
admet-2057	952	7	)	)	PUNCT
admet-2057	952	8	83	83	NUM
admet-2057	952	9	-	-	SYM
admet-2057	952	10	112	112	NUM
admet-2057	952	11	.	.	PUNCT
admet-2057	953	1	http://dx.doi.org/10.1002/9783527675821.ch04	http://dx.doi.org/10.1002/9783527675821.ch04	PROPN
admet-2057	953	2	https://doi.org/10.1039/d0cc00439a	https://doi.org/10.1039/d0cc00439a	PROPN
admet-2057	953	3	https://doi.org/10.1039/c5nr00518c	https://doi.org/10.1039/c5nr00518c	PROPN
admet-2057	953	4	https://doi.org/10.1021/jp402916y	https://doi.org/10.1021/jp402916y	NOUN
admet-2057	953	5	https://doi.org/10.1016/j.jssc.2017.12.027	https://doi.org/10.1016/j.jssc.2017.12.027	PROPN
admet-2057	953	6	https://doi.org/10.1016/j.micromeso.2020.110199	https://doi.org/10.1016/j.micromeso.2020.110199	ADJ
admet-2057	953	7	https://doi.org/10.1021/ja503215w	https://doi.org/10.1021/ja503215w	NOUN
admet-2057	953	8	https://doi.org/10.1016/j.ccr.2015.08.008	https://doi.org/10.1016/j.ccr.2015.08.008	NOUN
admet-2057	953	9	https://doi.org/10.3390/nano12030552	https://doi.org/10.3390/nano12030552	NOUN
admet-2057	953	10	https://doi.org/10.1002/anie.201000048	https://doi.org/10.1002/anie.201000048	NOUN
admet-2057	953	11	https://doi.org/10.3390/suschem3010009	https://doi.org/10.3390/suschem3010009	NOUN
admet-2057	953	12	https://doi.org/10.1016/j.ejpb.2021.05.011	https://doi.org/10.1016/j.ejpb.2021.05.011	X
admet-2057	953	13	https://doi.org/10.2147/ijn.s119115	https://doi.org/10.2147/ijn.s119115	X
admet-2057	954	1	https://doi.org/10.22159/ajpcr.2019.v12i8.34299	https://doi.org/10.22159/ajpcr.2019.v12i8.34299	NOUN
admet-2057	954	2	https://doi.org/10.1016/j.apsb.2021.03.019	https://doi.org/10.1016/j.apsb.2021.03.019	VERB
admet-2057	954	3	http://dx.doi.org/10.1002/9783527675821.ch04	http://dx.doi.org/10.1002/9783527675821.ch04	PROPN
admet-2057	954	4	admet	admet	PROPN
admet-2057	954	5	&	&	CCONJ
admet-2057	954	6	dmpk	dmpk	PROPN
admet-2057	954	7	12(1	12(1	PROPN
admet-2057	954	8	)	)	PUNCT
admet-2057	954	9	(	(	PUNCT
admet-2057	954	10	2024	2024	NUM
admet-2057	954	11	)	)	PUNCT
admet-2057	954	12	27	27	NUM
admet-2057	954	13	-	-	SYM
admet-2057	954	14	62	62	NUM
admet-2057	954	15	drug	drug	NOUN
admet-2057	954	16	delivery	delivery	NOUN
admet-2057	954	17	applications	application	NOUN
admet-2057	954	18	of	of	ADP
admet-2057	954	19	metal	metal	NOUN
admet-2057	954	20	-	-	PUNCT
admet-2057	954	21	organic	organic	ADJ
admet-2057	954	22	framework	framework	NOUN
admet-2057	954	23	doi	doi	NOUN
admet-2057	954	24	:	:	PUNCT
admet-2057	954	25	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	954	26	57	57	NUM
admet-2057	954	27	[	[	SYM
admet-2057	954	28	57	57	NUM
admet-2057	954	29	]	]	PUNCT
admet-2057	954	30	s.	s.	PROPN
admet-2057	954	31	karimzadeh	karimzadeh	PROPN
admet-2057	954	32	,	,	PUNCT
admet-2057	954	33	s.	s.	PROPN
admet-2057	954	34	javanbakht	javanbakht	PROPN
admet-2057	954	35	,	,	PUNCT
admet-2057	954	36	b.	b.	PROPN
admet-2057	954	37	baradaran	baradaran	PROPN
admet-2057	954	38	,	,	PUNCT
admet-2057	954	39	m.a	m.a	PROPN
admet-2057	954	40	.	.	PROPN
admet-2057	954	41	shahbazi	shahbazi	PROPN
admet-2057	954	42	,	,	PUNCT
admet-2057	954	43	m.	m.	NOUN
admet-2057	954	44	hashemzaei	hashemzaei	NOUN
admet-2057	954	45	,	,	PUNCT
admet-2057	954	46	a.	a.	NOUN
admet-2057	954	47	mokhtarzadeh	mokhtarzadeh	PROPN
admet-2057	954	48	,	,	PUNCT
admet-2057	954	49	h.a	h.a	PROPN
admet-2057	954	50	.	.	PROPN
admet-2057	954	51	santos	santos	PROPN
admet-2057	954	52	.	.	PUNCT
admet-2057	955	1	synthesis	synthesis	NOUN
admet-2057	955	2	and	and	CCONJ
admet-2057	955	3	therapeutic	therapeutic	ADJ
admet-2057	955	4	potential	potential	NOUN
admet-2057	955	5	of	of	ADP
admet-2057	955	6	stimuli	stimulus	NOUN
admet-2057	955	7	-	-	PUNCT
admet-2057	955	8	responsive	responsive	ADJ
admet-2057	955	9	metal	metal	NOUN
admet-2057	955	10	-	-	PUNCT
admet-2057	955	11	organic	organic	ADJ
admet-2057	955	12	frameworks	framework	NOUN
admet-2057	955	13	.	.	PUNCT
admet-2057	956	1	chemical	chemical	NOUN
admet-2057	956	2	engineering	engineering	PROPN
admet-2057	956	3	journal	journal	PROPN
admet-2057	956	4	408	408	NUM
admet-2057	956	5	(	(	PUNCT
admet-2057	956	6	2021	2021	NUM
admet-2057	956	7	)	)	PUNCT
admet-2057	956	8	127233	127233	NUM
admet-2057	956	9	.	.	PUNCT
admet-2057	957	1	https://doi.org/10.1016/j.cej.2020.127233	https://doi.org/10.1016/j.cej.2020.127233	PUNCT
admet-2057	958	1	[	[	X
admet-2057	958	2	58	58	NUM
admet-2057	958	3	]	]	X
admet-2057	958	4	c.	c.	PROPN
admet-2057	958	5	carrillo	carrillo	PROPN
admet-2057	958	6	-	-	PUNCT
admet-2057	958	7	carrión	carrión	PROPN
admet-2057	958	8	.	.	PUNCT
admet-2057	959	1	nanoscale	nanoscale	NOUN
admet-2057	959	2	metal	metal	NOUN
admet-2057	959	3	-	-	PUNCT
admet-2057	959	4	organic	organic	ADJ
admet-2057	959	5	frameworks	framework	NOUN
admet-2057	959	6	as	as	ADP
admet-2057	959	7	key	key	ADJ
admet-2057	959	8	players	player	NOUN
admet-2057	959	9	in	in	ADP
admet-2057	959	10	the	the	DET
admet-2057	959	11	context	context	NOUN
admet-2057	959	12	of	of	ADP
admet-2057	959	13	drug	drug	NOUN
admet-2057	959	14	delivery	delivery	NOUN
admet-2057	959	15	:	:	PUNCT
admet-2057	959	16	evolution	evolution	NOUN
admet-2057	959	17	toward	toward	ADP
admet-2057	959	18	theranostic	theranostic	ADJ
admet-2057	959	19	platforms	platform	NOUN
admet-2057	959	20	.	.	PUNCT
admet-2057	960	1	analytical	analytical	ADJ
admet-2057	960	2	and	and	CCONJ
admet-2057	960	3	bioanalytical	bioanalytical	ADJ
admet-2057	960	4	chemistry	chemistry	NOUN
admet-2057	960	5	412	412	NUM
admet-2057	960	6	(	(	PUNCT
admet-2057	960	7	2020	2020	NUM
admet-2057	960	8	)	)	PUNCT
admet-2057	960	9	37	37	NUM
admet-2057	960	10	-	-	SYM
admet-2057	960	11	54	54	NUM
admet-2057	960	12	.	.	PUNCT
admet-2057	961	1	https://doi.org/10.1007/s00216-019-02217-y	https://doi.org/10.1007/s00216-019-02217-y	NOUN
admet-2057	962	1	[	[	X
admet-2057	962	2	59	59	NUM
admet-2057	962	3	]	]	X
admet-2057	962	4	y.	y.	PROPN
admet-2057	962	5	liu	liu	PROPN
admet-2057	962	6	,	,	PUNCT
admet-2057	962	7	y.	y.	PROPN
admet-2057	962	8	zhao	zhao	PROPN
admet-2057	962	9	,	,	PUNCT
admet-2057	962	10	x.	x.	PROPN
admet-2057	962	11	chen	chen	PROPN
admet-2057	962	12	.	.	PUNCT
admet-2057	963	1	bioengineering	bioengineere	VERB
admet-2057	963	2	of	of	ADP
admet-2057	963	3	metal	metal	NOUN
admet-2057	963	4	-	-	PUNCT
admet-2057	963	5	organic	organic	ADJ
admet-2057	963	6	frameworks	framework	NOUN
admet-2057	963	7	for	for	ADP
admet-2057	963	8	nanomedicine	nanomedicine	NOUN
admet-2057	963	9	.	.	PUNCT
admet-2057	964	1	theranostics	theranostic	NOUN
admet-2057	964	2	9(11	9(11	NUM
admet-2057	964	3	)	)	PUNCT
admet-2057	964	4	(	(	PUNCT
admet-2057	964	5	2019	2019	NUM
admet-2057	964	6	)	)	PUNCT
admet-2057	964	7	3122	3122	NUM
admet-2057	964	8	-	-	SYM
admet-2057	964	9	3133	3133	NUM
admet-2057	964	10	.	.	PUNCT
admet-2057	965	1	https://doi.org/10.7150/thno.31918	https://doi.org/10.7150/thno.31918	X
admet-2057	966	1	[	[	X
admet-2057	966	2	60	60	NUM
admet-2057	966	3	]	]	X
admet-2057	966	4	f.	f.	PROPN
admet-2057	966	5	duan	duan	PROPN
admet-2057	966	6	,	,	PUNCT
admet-2057	966	7	x.	x.	PROPN
admet-2057	966	8	feng	feng	PROPN
admet-2057	966	9	,	,	PUNCT
admet-2057	966	10	x.	x.	PROPN
admet-2057	966	11	yang	yang	PROPN
admet-2057	966	12	,	,	PUNCT
admet-2057	966	13	w.	w.	PROPN
admet-2057	966	14	sun	sun	PROPN
admet-2057	966	15	,	,	PUNCT
admet-2057	966	16	y.	y.	PROPN
admet-2057	966	17	jin	jin	PROPN
admet-2057	966	18	,	,	PUNCT
admet-2057	966	19	h.	h.	PROPN
admet-2057	966	20	liu	liu	PROPN
admet-2057	966	21	,	,	PUNCT
admet-2057	966	22	k.	k.	PROPN
admet-2057	966	23	ge	ge	PROPN
admet-2057	966	24	,	,	PUNCT
admet-2057	966	25	z.	z.	PROPN
admet-2057	966	26	li	li	PROPN
admet-2057	966	27	,	,	PUNCT
admet-2057	966	28	j.	j.	PROPN
admet-2057	966	29	zhang.a	zhang.a	PROPN
admet-2057	966	30	simple	simple	ADJ
admet-2057	966	31	and	and	CCONJ
admet-2057	966	32	powerful	powerful	ADJ
admet-2057	966	33	codelivery	codelivery	NOUN
admet-2057	966	34	system	system	NOUN
admet-2057	966	35	based	base	VERB
admet-2057	966	36	on	on	ADP
admet-2057	966	37	ph	ph	ADJ
admet-2057	966	38	-	-	PUNCT
admet-2057	966	39	responsive	responsive	ADJ
admet-2057	966	40	metal	metal	NOUN
admet-2057	966	41	-	-	PUNCT
admet-2057	966	42	organic	organic	ADJ
admet-2057	966	43	frameworks	framework	NOUN
admet-2057	966	44	for	for	ADP
admet-2057	966	45	enhanced	enhanced	ADJ
admet-2057	966	46	cancer	cancer	NOUN
admet-2057	966	47	immunotherapy	immunotherapy	NOUN
admet-2057	966	48	.	.	PUNCT
admet-2057	967	1	biomaterials	biomaterial	NOUN
admet-2057	967	2	122	122	NUM
admet-2057	967	3	(	(	PUNCT
admet-2057	967	4	2017	2017	NUM
admet-2057	967	5	)	)	PUNCT
admet-2057	967	6	23	23	NUM
admet-2057	967	7	-	-	SYM
admet-2057	967	8	33	33	NUM
admet-2057	967	9	.	.	PUNCT
admet-2057	968	1	https://doi.org/10.1016/j.biomaterials.2017.01.017	https://doi.org/10.1016/j.biomaterials.2017.01.017	NOUN
admet-2057	968	2	[	[	SYM
admet-2057	968	3	61	61	NUM
admet-2057	968	4	]	]	X
admet-2057	968	5	f.m	f.m	PROPN
admet-2057	968	6	.	.	PROPN
admet-2057	968	7	zhang	zhang	PROPN
admet-2057	968	8	,	,	PUNCT
admet-2057	968	9	h.	h.	PROPN
admet-2057	968	10	dong	dong	PROPN
admet-2057	968	11	,	,	PUNCT
admet-2057	968	12	x.	x.	PROPN
admet-2057	968	13	zhang	zhang	PROPN
admet-2057	968	14	,	,	PUNCT
admet-2057	968	15	x.j	x.j	PROPN
admet-2057	968	16	.	.	PROPN
admet-2057	968	17	sun	sun	PROPN
admet-2057	968	18	,	,	PUNCT
admet-2057	968	19	m.	m.	NOUN
admet-2057	968	20	liu	liu	PROPN
admet-2057	968	21	,	,	PUNCT
admet-2057	968	22	d.d	d.d	PROPN
admet-2057	968	23	.	.	PROPN
admet-2057	968	24	yang	yang	PROPN
admet-2057	968	25	,	,	PUNCT
admet-2057	968	26	x.	x.	PROPN
admet-2057	968	27	liu	liu	PROPN
admet-2057	968	28	,	,	PUNCT
admet-2057	968	29	j.z	j.z	PROPN
admet-2057	968	30	.	.	PROPN
admet-2057	968	31	wei	wei	PROPN
admet-2057	968	32	.	.	PUNCT
admet-2057	969	1	postsynthetic	postsynthetic	ADJ
admet-2057	969	2	modification	modification	NOUN
admet-2057	969	3	of	of	ADP
admet-2057	969	4	zif-90	zif-90	NUM
admet-2057	969	5	for	for	ADP
admet-2057	969	6	potential	potential	ADJ
admet-2057	969	7	targeted	target	VERB
admet-2057	969	8	codelivery	codelivery	NOUN
admet-2057	969	9	of	of	ADP
admet-2057	969	10	two	two	NUM
admet-2057	969	11	anticancer	anticancer	NOUN
admet-2057	969	12	drugs	drug	NOUN
admet-2057	969	13	.	.	PUNCT
admet-2057	970	1	acs	acs	PROPN
admet-2057	970	2	applied	apply	VERB
admet-2057	970	3	material	material	NOUN
admet-2057	970	4	interfaces	interface	NOUN
admet-2057	970	5	32	32	NUM
admet-2057	970	6	(	(	PUNCT
admet-2057	970	7	2017	2017	NUM
admet-2057	970	8	)	)	PUNCT
admet-2057	970	9	27332	27332	NUM
admet-2057	970	10	-	-	SYM
admet-2057	970	11	27337	27337	NUM
admet-2057	970	12	.	.	PUNCT
admet-2057	971	1	https://doi.org/10.1021/acsami.7b08451	https://doi.org/10.1021/acsami.7b08451	PROPN
admet-2057	972	1	[	[	X
admet-2057	972	2	62	62	NUM
admet-2057	972	3	]	]	X
admet-2057	972	4	c.y	c.y	PROPN
admet-2057	972	5	.	.	PROPN
admet-2057	972	6	sun	sun	PROPN
admet-2057	972	7	,	,	PUNCT
admet-2057	972	8	c.	c.	PROPN
admet-2057	972	9	qin	qin	PROPN
admet-2057	972	10	,	,	PUNCT
admet-2057	972	11	x.l	x.l	PROPN
admet-2057	972	12	.	.	PROPN
admet-2057	972	13	wang	wang	PROPN
admet-2057	972	14	,	,	PUNCT
admet-2057	972	15	g.s	g.s	PROPN
admet-2057	972	16	.	.	PROPN
admet-2057	972	17	yang	yang	PROPN
admet-2057	972	18	,	,	PUNCT
admet-2057	972	19	k.z	k.z	PROPN
admet-2057	972	20	.	.	PROPN
admet-2057	972	21	shao	shao	PROPN
admet-2057	972	22	,	,	PUNCT
admet-2057	972	23	y.q	y.q	PROPN
admet-2057	972	24	.	.	PROPN
admet-2057	972	25	lan	lan	PROPN
admet-2057	972	26	,	,	PUNCT
admet-2057	972	27	z.m	z.m	PROPN
admet-2057	972	28	.	.	PROPN
admet-2057	972	29	su	su	PROPN
admet-2057	972	30	,	,	PUNCT
admet-2057	972	31	p.	p.	PROPN
admet-2057	972	32	huang	huang	PROPN
admet-2057	972	33	,	,	PUNCT
admet-2057	972	34	c.g	c.g	PROPN
admet-2057	972	35	.	.	PROPN
admet-2057	972	36	wang	wang	PROPN
admet-2057	972	37	,	,	PUNCT
admet-2057	972	38	e.b	e.b	PROPN
admet-2057	972	39	.	.	PROPN
admet-2057	972	40	wang	wang	PROPN
admet-2057	972	41	.	.	PUNCT
admet-2057	973	1	zeolitic	zeolitic	ADJ
admet-2057	973	2	imidazolate	imidazolate	NOUN
admet-2057	973	3	framework-8	framework-8	NUM
admet-2057	973	4	as	as	ADP
admet-2057	973	5	efficient	efficient	ADJ
admet-2057	973	6	ph	ph	ADJ
admet-2057	973	7	-	-	ADJ
admet-2057	973	8	sensitive	sensitive	ADJ
admet-2057	973	9	drug	drug	NOUN
admet-2057	973	10	delivery	delivery	NOUN
admet-2057	973	11	vehicle	vehicle	NOUN
admet-2057	973	12	.	.	PUNCT
admet-2057	974	1	dalton	dalton	PROPN
admet-2057	974	2	transactions	transactions	PROPN
admet-2057	974	3	41(23	41(23	NOUN
admet-2057	974	4	)	)	PUNCT
admet-2057	974	5	(	(	PUNCT
admet-2057	974	6	2012	2012	NUM
admet-2057	974	7	)	)	PUNCT
admet-2057	974	8	6906	6906	NUM
admet-2057	974	9	-	-	SYM
admet-2057	974	10	6909	6909	NUM
admet-2057	974	11	.	.	PUNCT
admet-2057	975	1	https://doi.org/10.1039/c2dt30357d	https://doi.org/10.1039/c2dt30357d	PUNCT
admet-2057	975	2	[	[	X
admet-2057	975	3	63	63	NUM
admet-2057	975	4	]	]	X
admet-2057	975	5	s.g	s.g	PROPN
admet-2057	975	6	.	.	PROPN
admet-2057	975	7	guillen	guillen	PROPN
admet-2057	975	8	,	,	PUNCT
admet-2057	975	9	j.	j.	PROPN
admet-2057	975	10	parres	parres	PROPN
admet-2057	975	11	-	-	PUNCT
admet-2057	975	12	gold	gold	NOUN
admet-2057	975	13	,	,	PUNCT
admet-2057	975	14	a.	a.	NOUN
admet-2057	975	15	ruiz	ruiz	PROPN
admet-2057	975	16	,	,	PUNCT
admet-2057	975	17	e.	e.	PROPN
admet-2057	975	18	lucsik	lucsik	PROPN
admet-2057	975	19	,	,	PUNCT
admet-2057	975	20	b.	b.	PROPN
admet-2057	975	21	dao	dao	PROPN
admet-2057	975	22	,	,	PUNCT
admet-2057	975	23	t.k.l	t.k.l	NOUN
admet-2057	975	24	.	.	PUNCT
admet-2057	976	1	hang	hang	PROPN
admet-2057	976	2	,	,	PUNCT
admet-2057	976	3	m.	m.	PROPN
admet-2057	976	4	chang	chang	PROPN
admet-2057	976	5	,	,	PUNCT
admet-2057	976	6	a.o	a.o	PROPN
admet-2057	976	7	.	.	PROPN
admet-2057	976	8	garcia	garcia	PROPN
admet-2057	976	9	,	,	PUNCT
admet-2057	976	10	y.	y.	PROPN
admet-2057	976	11	wang	wang	PROPN
admet-2057	976	12	,	,	PUNCT
admet-2057	976	13	f.	f.	PROPN
admet-2057	976	14	tian	tian	PROPN
admet-2057	976	15	.	.	PUNCT
admet-2057	977	1	ph	ph	ADJ
admet-2057	977	2	-	-	PUNCT
admet-2057	977	3	responsive	responsive	ADJ
admet-2057	977	4	metal	metal	NOUN
admet-2057	977	5	-	-	PUNCT
admet-2057	977	6	organic	organic	ADJ
admet-2057	977	7	framework	framework	NOUN
admet-2057	977	8	thin	thin	ADJ
admet-2057	977	9	film	film	NOUN
admet-2057	977	10	for	for	ADP
admet-2057	977	11	drug	drug	NOUN
admet-2057	977	12	delivery	delivery	NOUN
admet-2057	977	13	.	.	PUNCT
admet-2057	978	1	langmuir	langmuir	PROPN
admet-2057	978	2	38(51	38(51	NUM
admet-2057	978	3	)	)	PUNCT
admet-2057	978	4	(	(	PUNCT
admet-2057	978	5	2022	2022	NUM
admet-2057	978	6	)	)	PUNCT
admet-2057	978	7	16014	16014	NUM
admet-2057	978	8	-	-	SYM
admet-2057	978	9	16023	16023	NUM
admet-2057	978	10	.	.	PUNCT
admet-2057	979	1	https://doi.org/10.1021/acs.langmuir.2c02497	https://doi.org/10.1021/acs.langmuir.2c02497	PROPN
admet-2057	980	1	[	[	X
admet-2057	980	2	64	64	NUM
admet-2057	980	3	]	]	X
admet-2057	981	1	z.j	z.j	PROPN
admet-2057	981	2	.	.	PROPN
admet-2057	981	3	zhang	zhang	PROPN
admet-2057	981	4	,	,	PUNCT
admet-2057	981	5	y.k	y.k	PROPN
admet-2057	981	6	.	.	PROPN
admet-2057	981	7	hou	hou	PROPN
admet-2057	981	8	,	,	PUNCT
admet-2057	981	9	m.w	m.w	PROPN
admet-2057	981	10	.	.	PROPN
admet-2057	981	11	chen	chen	PROPN
admet-2057	981	12	,	,	PUNCT
admet-2057	981	13	x.z	x.z	PROPN
admet-2057	981	14	.	.	PROPN
admet-2057	981	15	yu	yu	PROPN
admet-2057	981	16	,	,	PUNCT
admet-2057	982	1	s.y	s.y	PROPN
admet-2057	982	2	.	.	PROPN
admet-2057	982	3	chen	chen	PROPN
admet-2057	982	4	,	,	PUNCT
admet-2057	982	5	y.r	y.r	PROPN
admet-2057	982	6	.	.	PROPN
admet-2057	982	7	yue	yue	PROPN
admet-2057	982	8	,	,	PUNCT
admet-2057	982	9	x.t	x.t	PROPN
admet-2057	982	10	.	.	PROPN
admet-2057	982	11	guo	guo	PROPN
admet-2057	982	12	,	,	PUNCT
admet-2057	982	13	j.x	j.x	PROPN
admet-2057	982	14	.	.	PROPN
admet-2057	982	15	chen	chen	PROPN
admet-2057	982	16	,	,	PUNCT
admet-2057	982	17	q.a	q.a	PROPN
admet-2057	982	18	.	.	PROPN
admet-2057	982	19	zhou	zhou	PROPN
admet-2057	982	20	.	.	PUNCT
admet-2057	983	1	phresponsive	phresponsive	ADJ
admet-2057	983	2	metal	metal	NOUN
admet-2057	983	3	-	-	PUNCT
admet-2057	983	4	organic	organic	ADJ
admet-2057	983	5	framework	framework	NOUN
admet-2057	983	6	for	for	ADP
admet-2057	983	7	the	the	DET
admet-2057	983	8	co	co	NOUN
admet-2057	983	9	-	-	NOUN
admet-2057	983	10	delivery	delivery	NOUN
admet-2057	983	11	of	of	ADP
admet-2057	983	12	hif-2α	hif-2α	PROPN
admet-2057	983	13	sirna	sirna	PROPN
admet-2057	983	14	and	and	CCONJ
admet-2057	983	15	curcumin	curcumin	NOUN
admet-2057	983	16	for	for	ADP
admet-2057	983	17	enhanced	enhanced	ADJ
admet-2057	983	18	therapy	therapy	NOUN
admet-2057	983	19	of	of	ADP
admet-2057	983	20	osteoarthritis	osteoarthritis	PROPN
admet-2057	983	21	.	.	PUNCT
admet-2057	984	1	journal	journal	PROPN
admet-2057	984	2	of	of	ADP
admet-2057	984	3	nanobiotechnology	nanobiotechnology	NOUN
admet-2057	984	4	21(1	21(1	NUM
admet-2057	984	5	)	)	PUNCT
admet-2057	984	6	(	(	PUNCT
admet-2057	984	7	2021	2021	NUM
admet-2057	984	8	)	)	PUNCT
admet-2057	984	9	18	18	NUM
admet-2057	984	10	.	.	X
admet-2057	985	1	https://doi.org/10.1186/s12951-022-01758-2	https://doi.org/10.1186/s12951-022-01758-2	NUM
admet-2057	985	2	[	[	X
admet-2057	985	3	65	65	NUM
admet-2057	985	4	]	]	X
admet-2057	985	5	x.	x.	NOUN
admet-2057	985	6	ai	ai	PROPN
admet-2057	985	7	,	,	PUNCT
admet-2057	985	8	j.	j.	PROPN
admet-2057	985	9	mu	mu	PROPN
admet-2057	985	10	,	,	PUNCT
admet-2057	985	11	b.	b.	PROPN
admet-2057	985	12	xing	xing	PROPN
admet-2057	985	13	.	.	PUNCT
admet-2057	986	1	recent	recent	ADJ
admet-2057	986	2	advances	advance	NOUN
admet-2057	986	3	of	of	ADP
admet-2057	986	4	light	light	ADJ
admet-2057	986	5	-	-	PUNCT
admet-2057	986	6	mediated	mediate	VERB
admet-2057	986	7	theranostics	theranostic	NOUN
admet-2057	986	8	.	.	PUNCT
admet-2057	987	1	theranostics	theranostic	NOUN
admet-2057	987	2	.	.	PUNCT
admet-2057	988	1	6(13	6(13	NUM
admet-2057	988	2	)	)	PUNCT
admet-2057	988	3	(	(	PUNCT
admet-2057	988	4	2016	2016	NUM
admet-2057	988	5	)	)	PUNCT
admet-2057	988	6	2439	2439	NUM
admet-2057	988	7	-	-	SYM
admet-2057	988	8	2457	2457	NUM
admet-2057	988	9	.	.	PUNCT
admet-2057	989	1	https://doi.org/10.7150/thno.16088	https://doi.org/10.7150/thno.16088	X
admet-2057	990	1	[	[	X
admet-2057	990	2	66	66	NUM
admet-2057	990	3	]	]	PUNCT
admet-2057	990	4	a.m.	a.m.	PROPN
admet-2057	991	1	rice	rice	PROPN
admet-2057	991	2	,	,	PUNCT
admet-2057	991	3	c.r	c.r	PROPN
admet-2057	991	4	.	.	PROPN
admet-2057	991	5	martin	martin	PROPN
admet-2057	991	6	,	,	PUNCT
admet-2057	991	7	v.a	v.a	PROPN
admet-2057	991	8	.	.	PROPN
admet-2057	991	9	galitskiy	galitskiy	PROPN
admet-2057	991	10	,	,	PUNCT
admet-2057	991	11	a.a	a.a	PROPN
admet-2057	991	12	.	.	PROPN
admet-2057	991	13	berseneva	berseneva	PROPN
admet-2057	991	14	,	,	PUNCT
admet-2057	991	15	g.a	g.a	PROPN
admet-2057	991	16	.	.	PROPN
admet-2057	991	17	leith	leith	PROPN
admet-2057	991	18	,	,	PUNCT
admet-2057	991	19	n.b	n.b	PROPN
admet-2057	991	20	.	.	PROPN
admet-2057	991	21	shustova	shustova	PROPN
admet-2057	991	22	.	.	PUNCT
admet-2057	992	1	photophysics	photophysic	NOUN
admet-2057	992	2	modulation	modulation	NOUN
admet-2057	992	3	in	in	ADP
admet-2057	992	4	photoswitchable	photoswitchable	ADJ
admet-2057	992	5	metal	metal	NOUN
admet-2057	992	6	-	-	PUNCT
admet-2057	992	7	organic	organic	ADJ
admet-2057	992	8	frameworks	framework	NOUN
admet-2057	992	9	.	.	PUNCT
admet-2057	993	1	chemical	chemical	ADJ
admet-2057	993	2	reviews	review	NOUN
admet-2057	993	3	120(16	120(16	NUM
admet-2057	993	4	)	)	PUNCT
admet-2057	993	5	(	(	PUNCT
admet-2057	993	6	2020	2020	NUM
admet-2057	993	7	)	)	PUNCT
admet-2057	993	8	87908813	87908813	NUM
admet-2057	993	9	.	.	PUNCT
admet-2057	994	1	https://doi.org/10.1021/acs.chemrev.9b00350	https://doi.org/10.1021/acs.chemrev.9b00350	PRON
admet-2057	995	1	[	[	X
admet-2057	995	2	67	67	NUM
admet-2057	995	3	]	]	PUNCT
admet-2057	995	4	k.	k.	PROPN
admet-2057	995	5	roth	roth	PROPN
admet-2057	995	6	stefaniak	stefaniak	PROPN
admet-2057	995	7	,	,	PUNCT
admet-2057	995	8	c.c	c.c	PROPN
admet-2057	995	9	.	.	PROPN
admet-2057	995	10	epley	epley	PROPN
admet-2057	995	11	,	,	PUNCT
admet-2057	995	12	j.j	j.j	PROPN
admet-2057	995	13	.	.	PROPN
admet-2057	995	14	novak	novak	PROPN
admet-2057	995	15	,	,	PUNCT
admet-2057	995	16	m.l	m.l	PROPN
admet-2057	995	17	.	.	PROPN
admet-2057	995	18	mcandrew	mcandrew	PROPN
admet-2057	995	19	,	,	PUNCT
admet-2057	995	20	h.d	h.d	PROPN
admet-2057	995	21	.	.	PROPN
admet-2057	995	22	cornell	cornell	PROPN
admet-2057	995	23	,	,	PUNCT
admet-2057	995	24	j.	j.	PROPN
admet-2057	995	25	zhu	zhu	PROPN
admet-2057	995	26	,	,	PUNCT
admet-2057	995	27	d.k	d.k	PROPN
admet-2057	995	28	.	.	PROPN
admet-2057	995	29	mcdaniel	mcdaniel	PROPN
admet-2057	995	30	,	,	PUNCT
admet-2057	995	31	j.l	j.l	PROPN
admet-2057	995	32	.	.	PROPN
admet-2057	995	33	davis	davis	PROPN
admet-2057	995	34	,	,	PUNCT
admet-2057	995	35	i.c	i.c	PROPN
admet-2057	995	36	.	.	PROPN
admet-2057	995	37	allen	allen	PROPN
admet-2057	995	38	,	,	PUNCT
admet-2057	995	39	a.j	a.j	PROPN
admet-2057	995	40	.	.	PROPN
admet-2057	995	41	morris	morris	PROPN
admet-2057	995	42	,	,	PUNCT
admet-2057	995	43	t.z	t.z	PROPN
admet-2057	995	44	.	.	PROPN
admet-2057	995	45	grove	grove	PROPN
admet-2057	995	46	.	.	PUNCT
admet-2057	996	1	photo	photo	NOUN
admet-2057	996	2	-	-	PUNCT
admet-2057	996	3	triggered	trigger	VERB
admet-2057	996	4	release	release	NOUN
admet-2057	996	5	of	of	ADP
admet-2057	996	6	5	5	NUM
admet-2057	996	7	-	-	PUNCT
admet-2057	996	8	fluorouracil	fluorouracil	NOUN
admet-2057	996	9	from	from	ADP
admet-2057	996	10	a	a	DET
admet-2057	996	11	mof	mof	ADJ
admet-2057	996	12	drug	drug	NOUN
admet-2057	996	13	delivery	delivery	NOUN
admet-2057	996	14	vehicle	vehicle	NOUN
admet-2057	996	15	.	.	PUNCT
admet-2057	997	1	chemical	chemical	NOUN
admet-2057	997	2	communications	communication	NOUN
admet-2057	997	3	55	55	NUM
admet-2057	997	4	(	(	PUNCT
admet-2057	997	5	2018	2018	NUM
admet-2057	997	6	)	)	PUNCT
admet-2057	997	7	7617	7617	NUM
admet-2057	997	8	-	-	SYM
admet-2057	997	9	7620	7620	NUM
admet-2057	997	10	.	.	PUNCT
admet-2057	998	1	https://doi.org/10.1039/c8cc01601a	https://doi.org/10.1039/c8cc01601a	VERB
admet-2057	999	1	[	[	X
admet-2057	999	2	68	68	NUM
admet-2057	999	3	]	]	X
admet-2057	999	4	h.d	h.d	PROPN
admet-2057	999	5	.	.	PROPN
admet-2057	999	6	cornell	cornell	PROPN
admet-2057	999	7	,	,	PUNCT
admet-2057	999	8	a.	a.	PROPN
admet-2057	999	9	morris	morris	PROPN
admet-2057	999	10	,	,	PUNCT
admet-2057	999	11	r.d	r.d	PROPN
admet-2057	999	12	.	.	PROPN
admet-2057	999	13	gandour	gandour	PROPN
admet-2057	999	14	,	,	PUNCT
admet-2057	999	15	j.	j.	PROPN
admet-2057	999	16	matson	matson	PROPN
admet-2057	999	17	,	,	PUNCT
admet-2057	999	18	j.m	j.m	PROPN
admet-2057	999	19	.	.	PROPN
admet-2057	999	20	tanko	tanko	PROPN
admet-2057	999	21	.	.	PUNCT
admet-2057	1000	1	a	a	DET
admet-2057	1000	2	green	green	ADJ
admet-2057	1000	3	light	light	NOUN
admet-2057	1000	4	at	at	ADP
admet-2057	1000	5	the	the	DET
admet-2057	1000	6	intersection	intersection	NOUN
admet-2057	1000	7	of	of	ADP
admet-2057	1000	8	metal	metal	NOUN
admet-2057	1000	9	-	-	PUNCT
admet-2057	1000	10	organic	organic	ADJ
admet-2057	1000	11	frameworks	framework	NOUN
admet-2057	1000	12	and	and	CCONJ
admet-2057	1000	13	drug	drug	NOUN
admet-2057	1000	14	delivery	delivery	NOUN
admet-2057	1000	15	.	.	PUNCT
admet-2057	1001	1	chemical	chemical	NOUN
admet-2057	1001	2	communications	communication	NOUN
admet-2057	1001	3	58	58	NUM
admet-2057	1001	4	(	(	PUNCT
admet-2057	1001	5	2022	2022	NUM
admet-2057	1001	6	)	)	PUNCT
admet-2057	1001	7	5225	5225	NUM
admet-2057	1001	8	-	-	SYM
admet-2057	1001	9	5228	5228	NUM
admet-2057	1001	10	.	.	PUNCT
admet-2057	1002	1	https://doi.org/10.1039/d2cc00591c	https://doi.org/10.1039/d2cc00591c	NOUN
admet-2057	1003	1	[	[	X
admet-2057	1003	2	69	69	NUM
admet-2057	1003	3	]	]	PUNCT
admet-2057	1003	4	j.	j.	PROPN
admet-2057	1003	5	park	park	PROPN
admet-2057	1003	6	,	,	PUNCT
admet-2057	1003	7	q.	q.	PROPN
admet-2057	1003	8	jiang	jiang	PROPN
admet-2057	1003	9	,	,	PUNCT
admet-2057	1003	10	d.	d.	PROPN
admet-2057	1003	11	feng	feng	PROPN
admet-2057	1003	12	,	,	PUNCT
admet-2057	1003	13	l.	l.	PROPN
admet-2057	1003	14	mao	mao	PROPN
admet-2057	1003	15	,	,	PUNCT
admet-2057	1004	1	h.c	h.c	PROPN
admet-2057	1004	2	.	.	PUNCT
admet-2057	1005	1	zhou	zhou	PROPN
admet-2057	1005	2	.	.	PUNCT
admet-2057	1005	3	size	size	NOUN
admet-2057	1005	4	-	-	PUNCT
admet-2057	1005	5	controlled	control	VERB
admet-2057	1005	6	synthesis	synthesis	NOUN
admet-2057	1005	7	of	of	ADP
admet-2057	1005	8	porphyrinic	porphyrinic	ADJ
admet-2057	1005	9	metal	metal	NOUN
admet-2057	1005	10	-	-	PUNCT
admet-2057	1005	11	organic	organic	ADJ
admet-2057	1005	12	framework	framework	NOUN
admet-2057	1005	13	and	and	CCONJ
admet-2057	1005	14	functionalization	functionalization	NOUN
admet-2057	1005	15	for	for	ADP
admet-2057	1005	16	targeted	target	VERB
admet-2057	1005	17	photodynamic	photodynamic	ADJ
admet-2057	1005	18	therapy	therapy	NOUN
admet-2057	1005	19	.	.	PUNCT
admet-2057	1006	1	journal	journal	PROPN
admet-2057	1006	2	of	of	ADP
admet-2057	1006	3	american	american	PROPN
admet-2057	1006	4	chemical	chemical	PROPN
admet-2057	1006	5	society	society	NOUN
admet-2057	1006	6	10	10	NUM
admet-2057	1006	7	(	(	PUNCT
admet-2057	1006	8	2016	2016	NUM
admet-2057	1006	9	)	)	PUNCT
admet-2057	1006	10	3518	3518	NUM
admet-2057	1006	11	-	-	SYM
admet-2057	1006	12	3525	3525	NUM
admet-2057	1006	13	.	.	PUNCT
admet-2057	1007	1	https://doi.org/10.1021/jacs.6b00007	https://doi.org/10.1021/jacs.6b00007	PROPN
admet-2057	1008	1	[	[	X
admet-2057	1008	2	70	70	NUM
admet-2057	1008	3	]	]	X
admet-2057	1008	4	y.	y.	PROPN
admet-2057	1008	5	liu	liu	PROPN
admet-2057	1008	6	,	,	PUNCT
admet-2057	1008	7	y.	y.	PROPN
admet-2057	1008	8	liu	liu	PROPN
admet-2057	1008	9	,	,	PUNCT
admet-2057	1008	10	w.	w.	PROPN
admet-2057	1008	11	bu	bu	PROPN
admet-2057	1008	12	,	,	PUNCT
admet-2057	1008	13	c.	c.	PROPN
admet-2057	1008	14	cheng	cheng	PROPN
admet-2057	1008	15	,	,	PUNCT
admet-2057	1008	16	c.	c.	PROPN
admet-2057	1008	17	zuo	zuo	PROPN
admet-2057	1008	18	,	,	PUNCT
admet-2057	1008	19	q.	q.	PROPN
admet-2057	1008	20	xiao	xiao	PROPN
admet-2057	1008	21	,	,	PUNCT
admet-2057	1008	22	y.	y.	PROPN
admet-2057	1008	23	sun	sun	PROPN
admet-2057	1008	24	,	,	PUNCT
admet-2057	1008	25	d.	d.	PROPN
admet-2057	1008	26	ni	ni	PROPN
admet-2057	1008	27	,	,	PUNCT
admet-2057	1008	28	c.	c.	PROPN
admet-2057	1008	29	zhang	zhang	PROPN
admet-2057	1008	30	,	,	PUNCT
admet-2057	1008	31	j.	j.	PROPN
admet-2057	1008	32	liu	liu	PROPN
admet-2057	1008	33	,	,	PUNCT
admet-2057	1008	34	j.	j.	PROPN
admet-2057	1008	35	shi.hypoxia	shi.hypoxia	PROPN
admet-2057	1008	36	induced	induce	VERB
admet-2057	1008	37	by	by	ADP
admet-2057	1008	38	upconversion	upconversion	NOUN
admet-2057	1008	39	-	-	PUNCT
admet-2057	1008	40	based	base	VERB
admet-2057	1008	41	photodynamic	photodynamic	ADJ
admet-2057	1008	42	therapy	therapy	NOUN
admet-2057	1008	43	:	:	PUNCT
admet-2057	1008	44	towards	towards	ADP
admet-2057	1008	45	highly	highly	ADV
admet-2057	1008	46	effective	effective	ADJ
admet-2057	1008	47	synergistic	synergistic	ADJ
admet-2057	1008	48	bioreductive	bioreductive	ADJ
admet-2057	1008	49	therapy	therapy	NOUN
admet-2057	1008	50	in	in	ADP
admet-2057	1008	51	tumors	tumor	NOUN
admet-2057	1008	52	.	.	PUNCT
admet-2057	1009	1	angewandte	angewandte	PROPN
admet-2057	1009	2	chemie	chemie	PROPN
admet-2057	1009	3	international	international	PROPN
admet-2057	1009	4	edition	edition	PROPN
admet-2057	1009	5	28	28	NUM
admet-2057	1009	6	(	(	PUNCT
admet-2057	1009	7	2015	2015	NUM
admet-2057	1009	8	)	)	PUNCT
admet-2057	1009	9	8105	8105	NUM
admet-2057	1009	10	-	-	SYM
admet-2057	1009	11	8109	8109	NUM
admet-2057	1009	12	.	.	PUNCT
admet-2057	1010	1	https://doi.org/10.1002/anie.201500478	https://doi.org/10.1002/anie.201500478	NOUN
admet-2057	1011	1	[	[	X
admet-2057	1011	2	71	71	NUM
admet-2057	1011	3	]	]	X
admet-2057	1011	4	d.	d.	PROPN
admet-2057	1011	5	xu	xu	PROPN
admet-2057	1011	6	,	,	PUNCT
admet-2057	1011	7	y.	y.	PROPN
admet-2057	1011	8	you	you	PRON
admet-2057	1011	9	,	,	PUNCT
admet-2057	1011	10	f.	f.	PROPN
admet-2057	1011	11	zeng	zeng	PROPN
admet-2057	1011	12	,	,	PUNCT
admet-2057	1011	13	y.	y.	PROPN
admet-2057	1011	14	wang	wang	PROPN
admet-2057	1011	15	,	,	PUNCT
admet-2057	1011	16	c.	c.	PROPN
admet-2057	1011	17	liang	liang	PROPN
admet-2057	1011	18	,	,	PUNCT
admet-2057	1011	19	h.	h.	PROPN
admet-2057	1011	20	feng	feng	PROPN
admet-2057	1011	21	,	,	PUNCT
admet-2057	1011	22	x.	x.	PROPN
admet-2057	1011	23	ma	ma	PROPN
admet-2057	1011	24	.	.	PROPN
admet-2057	1011	25	disassembly	disassembly	NOUN
admet-2057	1011	26	of	of	ADP
admet-2057	1011	27	hydrophobic	hydrophobic	NOUN
admet-2057	1011	28	photosensitizer	photosensitizer	NOUN
admet-2057	1011	29	by	by	ADP
admet-2057	1011	30	biodegradable	biodegradable	ADJ
admet-2057	1011	31	zeolitic	zeolitic	ADJ
admet-2057	1011	32	imidazolate	imidazolate	NOUN
admet-2057	1011	33	framework-8	framework-8	NUM
admet-2057	1011	34	for	for	ADP
admet-2057	1011	35	photodynamic	photodynamic	ADJ
admet-2057	1011	36	cancer	cancer	NOUN
admet-2057	1011	37	therapy	therapy	NOUN
admet-2057	1011	38	.	.	PUNCT
admet-2057	1012	1	acs	acs	PROPN
admet-2057	1012	2	applied	apply	VERB
admet-2057	1012	3	material	material	NOUN
admet-2057	1012	4	&	&	CCONJ
admet-2057	1012	5	interfaces	interface	NOUN
admet-2057	1012	6	10(18	10(18	NUM
admet-2057	1012	7	)	)	PUNCT
admet-2057	1012	8	(	(	PUNCT
admet-2057	1012	9	2018	2018	NUM
admet-2057	1012	10	)	)	PUNCT
admet-2057	1012	11	,	,	PUNCT
admet-2057	1012	12	15517	15517	NUM
admet-2057	1012	13	-	-	SYM
admet-2057	1012	14	15523	15523	NUM
admet-2057	1012	15	.	.	PUNCT
admet-2057	1013	1	https://doi.org/10.1021/acsami.8b03831	https://doi.org/10.1021/acsami.8b03831	X
admet-2057	1014	1	[	[	X
admet-2057	1014	2	72	72	NUM
admet-2057	1014	3	]	]	PUNCT
admet-2057	1014	4	a.	a.	NOUN
admet-2057	1014	5	sharsheeva	sharsheeva	PROPN
admet-2057	1014	6	,	,	PUNCT
admet-2057	1014	7	v.a	v.a	PROPN
admet-2057	1014	8	.	.	PROPN
admet-2057	1014	9	iglin	iglin	PROPN
admet-2057	1014	10	,	,	PUNCT
admet-2057	1014	11	p.v	p.v	PROPN
admet-2057	1014	12	.	.	PROPN
admet-2057	1014	13	nesterov	nesterov	PROPN
admet-2057	1014	14	,	,	PUNCT
admet-2057	1014	15	o.a	o.a	PROPN
admet-2057	1014	16	.	.	PROPN
admet-2057	1014	17	kuchur	kuchur	PROPN
admet-2057	1014	18	,	,	PUNCT
admet-2057	1014	19	e.	e.	PROPN
admet-2057	1014	20	garifullina	garifullina	PROPN
admet-2057	1014	21	,	,	PUNCT
admet-2057	1014	22	e.	e.	PROPN
admet-2057	1014	23	hey	hey	PROPN
admet-2057	1014	24	-	-	PUNCT
admet-2057	1014	25	hawkins	hawkins	PROPN
admet-2057	1014	26	,	,	PUNCT
admet-2057	1014	27	s.a	s.a	PROPN
admet-2057	1014	28	.	.	PROPN
admet-2057	1014	29	ulasevich	ulasevich	PROPN
admet-2057	1014	30	,	,	PUNCT
admet-2057	1014	31	e.v	e.v	PROPN
admet-2057	1014	32	.	.	PROPN
admet-2057	1014	33	skorb	skorb	PROPN
admet-2057	1014	34	,	,	PUNCT
admet-2057	1014	35	a.v	a.v	PROPN
admet-2057	1014	36	.	.	PROPN
admet-2057	1014	37	vinogradov	vinogradov	PROPN
admet-2057	1014	38	,	,	PUNCT
admet-2057	1014	39	m.i	m.i	PROPN
admet-2057	1014	40	.	.	PROPN
admet-2057	1014	41	morozov	morozov	PROPN
admet-2057	1014	42	.	.	PUNCT
admet-2057	1015	1	light	light	ADJ
admet-2057	1015	2	-	-	PUNCT
admet-2057	1015	3	controllable	controllable	ADJ
admet-2057	1015	4	systems	system	NOUN
admet-2057	1015	5	based	base	VERB
admet-2057	1015	6	on	on	ADP
admet-2057	1015	7	tio2	tio2	NOUN
admet-2057	1015	8	-	-	PUNCT
admet-2057	1015	9	zif-8	zif-8	PRON
admet-2057	1015	10	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	1015	11	https://doi.org/10.1016/j.cej.2020.127233	https://doi.org/10.1016/j.cej.2020.127233	X
admet-2057	1015	12	https://doi.org/10.1007/s00216-019-02217-y	https://doi.org/10.1007/s00216-019-02217-y	NOUN
admet-2057	1015	13	https://doi.org/10.7150/thno.31918	https://doi.org/10.7150/thno.31918	NOUN
admet-2057	1015	14	https://doi.org/10.1016/j.biomaterials.2017.01.017	https://doi.org/10.1016/j.biomaterials.2017.01.017	NOUN
admet-2057	1015	15	https://doi.org/10.1021/acsami.7b08451	https://doi.org/10.1021/acsami.7b08451	PROPN
admet-2057	1015	16	https://doi.org/10.1039/c2dt30357d	https://doi.org/10.1039/c2dt30357d	PROPN
admet-2057	1016	1	https://doi.org/10.1021/acs.langmuir.2c02497	https://doi.org/10.1021/acs.langmuir.2c02497	PROPN
admet-2057	1016	2	https://doi.org/10.1186/s12951-022-01758-2	https://doi.org/10.1186/s12951-022-01758-2	NUM
admet-2057	1016	3	https://doi.org/10.7150/thno.16088	https://doi.org/10.7150/thno.16088	NOUN
admet-2057	1016	4	https://doi.org/10.1021/acs.chemrev.9b00350	https://doi.org/10.1021/acs.chemrev.9b00350	PRON
admet-2057	1016	5	https://doi.org/10.1039/c8cc01601a	https://doi.org/10.1039/c8cc01601a	VERB
admet-2057	1016	6	https://doi.org/10.1039/d2cc00591c	https://doi.org/10.1039/d2cc00591c	NUM
admet-2057	1016	7	https://doi.org/10.1021/jacs.6b00007	https://doi.org/10.1021/jacs.6b00007	PROPN
admet-2057	1016	8	https://doi.org/10.1002/anie.201500478	https://doi.org/10.1002/anie.201500478	NOUN
admet-2057	1017	1	https://doi.org/10.1021/acsami.8b03831	https://doi.org/10.1021/acsami.8b03831	PROPN
admet-2057	1017	2	p.	p.	PROPN
admet-2057	1017	3	mhettar	mhettar	PROPN
admet-2057	1017	4	et	et	PROPN
admet-2057	1017	5	al	al	PROPN
admet-2057	1017	6	.	.	PROPN
admet-2057	1017	7	admet	admet	PROPN
admet-2057	1017	8	&	&	CCONJ
admet-2057	1017	9	dmpk	dmpk	PROPN
admet-2057	1017	10	12(1	12(1	PROPN
admet-2057	1017	11	)	)	PUNCT
admet-2057	1017	12	(	(	PUNCT
admet-2057	1017	13	2024	2024	NUM
admet-2057	1017	14	)	)	PUNCT
admet-2057	1017	15	27	27	NUM
admet-2057	1017	16	-	-	SYM
admet-2057	1017	17	62	62	NUM
admet-2057	1017	18	58	58	NUM
admet-2057	1017	19	composites	composite	NOUN
admet-2057	1017	20	for	for	ADP
admet-2057	1017	21	targeted	target	VERB
admet-2057	1017	22	drug	drug	NOUN
admet-2057	1017	23	release	release	NOUN
admet-2057	1017	24	:	:	PUNCT
admet-2057	1017	25	communicating	communicate	VERB
admet-2057	1017	26	with	with	ADP
admet-2057	1017	27	tumour	tumour	ADJ
admet-2057	1017	28	cells	cell	NOUN
admet-2057	1017	29	.	.	PUNCT
admet-2057	1018	1	journal	journal	NOUN
admet-2057	1018	2	of	of	ADP
admet-2057	1018	3	material	material	NOUN
admet-2057	1018	4	chemistry	chemistry	NOUN
admet-2057	1018	5	b7	b7	PROPN
admet-2057	1018	6	43	43	NUM
admet-2057	1018	7	(	(	PUNCT
admet-2057	1018	8	2019	2019	NUM
admet-2057	1018	9	)	)	PUNCT
admet-2057	1018	10	6810	6810	NUM
admet-2057	1018	11	-	-	SYM
admet-2057	1018	12	6821	6821	NUM
admet-2057	1018	13	.	.	PUNCT
admet-2057	1019	1	https://doi.org/10.1039/c9tb01377f	https://doi.org/10.1039/c9tb01377f	PROPN
admet-2057	1020	1	[	[	X
admet-2057	1020	2	73	73	NUM
admet-2057	1020	3	]	]	PUNCT
admet-2057	1020	4	z.	z.	PROPN
admet-2057	1020	5	fan	fan	PROPN
admet-2057	1020	6	,	,	PUNCT
admet-2057	1020	7	h.	h.	PROPN
admet-2057	1020	8	liu	liu	PROPN
admet-2057	1020	9	,	,	PUNCT
admet-2057	1020	10	y.	y.	PROPN
admet-2057	1020	11	xue	xue	PROPN
admet-2057	1020	12	,	,	PUNCT
admet-2057	1020	13	j.	j.	PROPN
admet-2057	1020	14	lin	lin	PROPN
admet-2057	1020	15	,	,	PUNCT
admet-2057	1020	16	y.	y.	PROPN
admet-2057	1020	17	fu	fu	PROPN
admet-2057	1020	18	,	,	PUNCT
admet-2057	1020	19	z.	z.	PROPN
admet-2057	1020	20	xia	xia	PROPN
admet-2057	1020	21	,	,	PUNCT
admet-2057	1020	22	d.	d.	PROPN
admet-2057	1020	23	pan	pan	PROPN
admet-2057	1020	24	,	,	PUNCT
admet-2057	1020	25	j.	j.	PROPN
admet-2057	1020	26	zhang	zhang	PROPN
admet-2057	1020	27	,	,	PUNCT
admet-2057	1020	28	k.	k.	PROPN
admet-2057	1020	29	qiao	qiao	PROPN
admet-2057	1020	30	,	,	PUNCT
admet-2057	1020	31	z.	z.	PROPN
admet-2057	1020	32	zhang	zhang	PROPN
admet-2057	1020	33	,	,	PUNCT
admet-2057	1020	34	y.	y.	PROPN
admet-2057	1020	35	liao	liao	PROPN
admet-2057	1020	36	.	.	PUNCT
admet-2057	1020	37	reversing	reverse	VERB
admet-2057	1020	38	cold	cold	ADJ
admet-2057	1020	39	tumors	tumor	NOUN
admet-2057	1020	40	to	to	PART
admet-2057	1020	41	hot	hot	VERB
admet-2057	1020	42	:	:	PUNCT
admet-2057	1020	43	an	an	DET
admet-2057	1020	44	immunoadjuvant	immunoadjuvant	NOUN
admet-2057	1020	45	-	-	PUNCT
admet-2057	1020	46	functionalized	functionalize	VERB
admet-2057	1020	47	metal	metal	NOUN
admet-2057	1020	48	-	-	PUNCT
admet-2057	1020	49	organic	organic	ADJ
admet-2057	1020	50	framework	framework	NOUN
admet-2057	1020	51	for	for	ADP
admet-2057	1020	52	multimodal	multimodal	ADJ
admet-2057	1020	53	imaging	imaging	NOUN
admet-2057	1020	54	-	-	PUNCT
admet-2057	1020	55	guided	guide	VERB
admet-2057	1020	56	synergistic	synergistic	ADJ
admet-2057	1020	57	photo	photo	NOUN
admet-2057	1020	58	-	-	PUNCT
admet-2057	1020	59	immunotherapy	immunotherapy	NOUN
admet-2057	1020	60	.	.	PUNCT
admet-2057	1021	1	bioactive	bioactive	ADJ
admet-2057	1021	2	materials	material	NOUN
admet-2057	1021	3	6(2	6(2	NUM
admet-2057	1021	4	)	)	PUNCT
admet-2057	1021	5	(	(	PUNCT
admet-2057	1021	6	2021	2021	NUM
admet-2057	1021	7	)	)	PUNCT
admet-2057	1021	8	312	312	NUM
admet-2057	1021	9	-	-	SYM
admet-2057	1021	10	325	325	NUM
admet-2057	1021	11	.	.	PUNCT
admet-2057	1022	1	https://doi.org/10.1016/j.bioactmat.2020.08.005	https://doi.org/10.1016/j.bioactmat.2020.08.005	PROPN
admet-2057	1022	2	[	[	X
admet-2057	1023	1	74	74	NUM
admet-2057	1023	2	]	]	PUNCT
admet-2057	1023	3	k.	k.	PROPN
admet-2057	1023	4	jiang	jiang	PROPN
admet-2057	1023	5	,	,	PUNCT
admet-2057	1023	6	l.	l.	PROPN
admet-2057	1023	7	zhang	zhang	PROPN
admet-2057	1023	8	,	,	PUNCT
admet-2057	1023	9	q.	q.	PROPN
admet-2057	1023	10	hu	hu	PROPN
admet-2057	1023	11	,	,	PUNCT
admet-2057	1023	12	q.	q.	PROPN
admet-2057	1023	13	zhang	zhang	PROPN
admet-2057	1023	14	,	,	PUNCT
admet-2057	1023	15	w.	w.	PROPN
admet-2057	1023	16	lin	lin	PROPN
admet-2057	1023	17	,	,	PUNCT
admet-2057	1023	18	y.	y.	PROPN
admet-2057	1023	19	cui	cui	PROPN
admet-2057	1023	20	,	,	PUNCT
admet-2057	1023	21	y.	y.	PROPN
admet-2057	1023	22	yang	yang	PROPN
admet-2057	1023	23	,	,	PUNCT
admet-2057	1023	24	g.	g.	PROPN
admet-2057	1023	25	qian	qian	PROPN
admet-2057	1023	26	.	.	PUNCT
admet-2057	1024	1	thermal	thermal	ADJ
admet-2057	1024	2	stimuli	stimulus	NOUN
admet-2057	1024	3	-	-	PUNCT
admet-2057	1024	4	triggered	trigger	VERB
admet-2057	1024	5	drug	drug	NOUN
admet-2057	1024	6	release	release	NOUN
admet-2057	1024	7	from	from	ADP
admet-2057	1024	8	a	a	DET
admet-2057	1024	9	biocompatible	biocompatible	ADJ
admet-2057	1024	10	porous	porous	ADJ
admet-2057	1024	11	metal	metal	NOUN
admet-2057	1024	12	-	-	PUNCT
admet-2057	1024	13	organic	organic	ADJ
admet-2057	1024	14	framework	framework	NOUN
admet-2057	1024	15	.	.	PUNCT
admet-2057	1025	1	chemistry	chemistry	NOUN
admet-2057	1025	2	a	a	DET
admet-2057	1025	3	european	european	PROPN
admet-2057	1025	4	journal	journal	NOUN
admet-2057	1025	5	42	42	NUM
admet-2057	1025	6	(	(	PUNCT
admet-2057	1025	7	2017	2017	NUM
admet-2057	1025	8	)	)	PUNCT
admet-2057	1025	9	10215	10215	NUM
admet-2057	1025	10	-	-	SYM
admet-2057	1025	11	10221	10221	NUM
admet-2057	1025	12	.	.	PUNCT
admet-2057	1026	1	https://doi.org/10.1002/chem.201701904	https://doi.org/10.1002/chem.201701904	ADJ
admet-2057	1026	2	[	[	X
admet-2057	1026	3	75	75	NUM
admet-2057	1026	4	]	]	X
admet-2057	1026	5	y.q	y.q	PROPN
admet-2057	1026	6	.	.	PROPN
admet-2057	1026	7	tian	tian	PROPN
admet-2057	1026	8	,	,	PUNCT
admet-2057	1026	9	z.x	z.x	PROPN
admet-2057	1026	10	.	.	PROPN
admet-2057	1026	11	chen	chen	PROPN
admet-2057	1026	12	,	,	PUNCT
admet-2057	1026	13	l.h	l.h	PROPN
admet-2057	1026	14	.	.	PROPN
admet-2057	1026	15	weng	weng	PROPN
admet-2057	1026	16	,	,	PUNCT
admet-2057	1026	17	h.	h.	PROPN
admet-2057	1026	18	bin	bin	PROPN
admet-2057	1026	19	guo	guo	PROPN
admet-2057	1026	20	,	,	PUNCT
admet-2057	1026	21	s.	s.	PROPN
admet-2057	1026	22	gao	gao	PROPN
admet-2057	1026	23	,	,	PUNCT
admet-2057	1026	24	d.y	d.y	PROPN
admet-2057	1026	25	.	.	PUNCT
admet-2057	1027	1	zhao.two	zhao.two	NUM
admet-2057	1027	2	polymorphs	polymorph	NOUN
admet-2057	1027	3	of	of	ADP
admet-2057	1027	4	cobalt(ii	cobalt(ii	ADJ
admet-2057	1027	5	)	)	PUNCT
admet-2057	1027	6	imidazolate	imidazolate	NOUN
admet-2057	1027	7	polymers	polymer	NOUN
admet-2057	1027	8	synthesized	synthesize	VERB
admet-2057	1027	9	solvothermally	solvothermally	ADV
admet-2057	1027	10	by	by	ADP
admet-2057	1027	11	using	use	VERB
admet-2057	1027	12	one	one	NUM
admet-2057	1027	13	organic	organic	ADJ
admet-2057	1027	14	template	template	NOUN
admet-2057	1027	15	n	n	CCONJ
admet-2057	1027	16	,	,	PUNCT
admet-2057	1027	17	ndimethylacetamide	ndimethylacetamide	NOUN
admet-2057	1027	18	.	.	PUNCT
admet-2057	1028	1	inorganic	inorganic	ADJ
admet-2057	1028	2	chemistry	chemistry	NOUN
admet-2057	1028	3	15	15	NUM
admet-2057	1028	4	(	(	PUNCT
admet-2057	1028	5	2004	2004	NUM
admet-2057	1028	6	)	)	PUNCT
admet-2057	1028	7	4631	4631	NUM
admet-2057	1028	8	-	-	SYM
admet-2057	1028	9	4635	4635	NUM
admet-2057	1028	10	.	.	PUNCT
admet-2057	1029	1	https://doi.org/10.1021/ic049713z	https://doi.org/10.1021/ic049713z	PROPN
admet-2057	1030	1	[	[	X
admet-2057	1030	2	76	76	NUM
admet-2057	1030	3	]	]	X
admet-2057	1030	4	s.	s.	PROPN
admet-2057	1030	5	nagata	nagata	PROPN
admet-2057	1030	6	,	,	PUNCT
admet-2057	1030	7	k.	k.	PROPN
admet-2057	1030	8	kokado	kokado	PROPN
admet-2057	1030	9	,	,	PUNCT
admet-2057	1030	10	k.	k.	PROPN
admet-2057	1030	11	sada	sada	PROPN
admet-2057	1030	12	.	.	PUNCT
admet-2057	1031	1	metal	metal	NOUN
admet-2057	1031	2	-	-	PUNCT
admet-2057	1031	3	organic	organic	ADJ
admet-2057	1031	4	framework	framework	NOUN
admet-2057	1031	5	tethering	tethering	NOUN
admet-2057	1031	6	pnipam	pnipam	NOUN
admet-2057	1031	7	for	for	ADP
admet-2057	1031	8	on	on	ADP
admet-2057	1031	9	-	-	PUNCT
admet-2057	1031	10	off	off	ADP
admet-2057	1031	11	controlled	control	VERB
admet-2057	1031	12	release	release	NOUN
admet-2057	1031	13	in	in	ADP
admet-2057	1031	14	solution	solution	NOUN
admet-2057	1031	15	.	.	PUNCT
admet-2057	1032	1	chemical	chemical	NOUN
admet-2057	1032	2	communications	communication	NOUN
admet-2057	1032	3	51(41	51(41	NUM
admet-2057	1032	4	)	)	PUNCT
admet-2057	1032	5	(	(	PUNCT
admet-2057	1032	6	2015	2015	NUM
admet-2057	1032	7	)	)	PUNCT
admet-2057	1032	8	8614	8614	NUM
admet-2057	1032	9	-	-	SYM
admet-2057	1032	10	8617	8617	NUM
admet-2057	1032	11	.	.	PUNCT
admet-2057	1033	1	https://doi.org/10.1039/c5cc02339d	https://doi.org/10.1039/c5cc02339d	PROPN
admet-2057	1034	1	[	[	X
admet-2057	1034	2	77	77	X
admet-2057	1034	3	]	]	X
admet-2057	1034	4	s.	s.	PROPN
admet-2057	1034	5	mura	mura	PROPN
admet-2057	1034	6	,	,	PUNCT
admet-2057	1034	7	j.	j.	PROPN
admet-2057	1034	8	nicolas	nicolas	PROPN
admet-2057	1034	9	,	,	PUNCT
admet-2057	1034	10	p.	p.	PROPN
admet-2057	1034	11	couvreur	couvreur	PROPN
admet-2057	1034	12	.	.	PUNCT
admet-2057	1035	1	stimuli	stimuli	VERB
admet-2057	1035	2	-	-	PUNCT
admet-2057	1035	3	responsive	responsive	ADJ
admet-2057	1035	4	nanocarriers	nanocarrier	NOUN
admet-2057	1035	5	for	for	ADP
admet-2057	1035	6	drug	drug	NOUN
admet-2057	1035	7	delivery	delivery	NOUN
admet-2057	1035	8	.	.	PUNCT
admet-2057	1036	1	nature	nature	NOUN
admet-2057	1036	2	materials	material	NOUN
admet-2057	1036	3	12(11	12(11	NUM
admet-2057	1036	4	)	)	PUNCT
admet-2057	1036	5	(	(	PUNCT
admet-2057	1036	6	2013	2013	NUM
admet-2057	1036	7	)	)	PUNCT
admet-2057	1036	8	991	991	NUM
admet-2057	1036	9	-	-	SYM
admet-2057	1036	10	1003	1003	NUM
admet-2057	1036	11	.	.	PUNCT
admet-2057	1037	1	https://doi.org/10.1038/nmat3776	https://doi.org/10.1038/nmat3776	NOUN
admet-2057	1038	1	[	[	X
admet-2057	1038	2	78	78	NUM
admet-2057	1038	3	]	]	PUNCT
admet-2057	1038	4	w.	w.	PROPN
admet-2057	1038	5	lin	lin	PROPN
admet-2057	1038	6	,	,	PUNCT
admet-2057	1038	7	q.	q.	PROPN
admet-2057	1038	8	hu	hu	PROPN
admet-2057	1038	9	,	,	PUNCT
admet-2057	1038	10	j.	j.	PROPN
admet-2057	1038	11	yu	yu	PROPN
admet-2057	1038	12	,	,	PUNCT
admet-2057	1038	13	k.	k.	PROPN
admet-2057	1038	14	jiang	jiang	PROPN
admet-2057	1038	15	,	,	PUNCT
admet-2057	1038	16	y.	y.	PROPN
admet-2057	1038	17	yang	yang	PROPN
admet-2057	1038	18	,	,	PUNCT
admet-2057	1038	19	s.	s.	PROPN
admet-2057	1038	20	xiang	xiang	PROPN
admet-2057	1038	21	,	,	PUNCT
admet-2057	1038	22	y.	y.	PROPN
admet-2057	1038	23	cui	cui	PROPN
admet-2057	1038	24	,	,	PUNCT
admet-2057	1038	25	y.	y.	PROPN
admet-2057	1038	26	yang	yang	PROPN
admet-2057	1038	27	,	,	PUNCT
admet-2057	1038	28	z.	z.	PROPN
admet-2057	1038	29	wang	wang	PROPN
admet-2057	1038	30	,	,	PUNCT
admet-2057	1038	31	g.	g.	PROPN
admet-2057	1038	32	qian	qian	PROPN
admet-2057	1038	33	.	.	PUNCT
admet-2057	1039	1	low	low	ADJ
admet-2057	1039	2	cytotoxic	cytotoxic	ADJ
admet-2057	1039	3	metal	metal	NOUN
admet-2057	1039	4	-	-	PUNCT
admet-2057	1039	5	organic	organic	ADJ
admet-2057	1039	6	frameworks	framework	NOUN
admet-2057	1039	7	as	as	ADP
admet-2057	1039	8	temperature	temperature	NOUN
admet-2057	1039	9	-	-	PUNCT
admet-2057	1039	10	responsive	responsive	ADJ
admet-2057	1039	11	drug	drug	NOUN
admet-2057	1039	12	carriers	carrier	NOUN
admet-2057	1039	13	.	.	PUNCT
admet-2057	1040	1	chempluschem	chempluschem	PROPN
admet-2057	1040	2	81(8	81(8	NUM
admet-2057	1040	3	)	)	PUNCT
admet-2057	1040	4	(	(	PUNCT
admet-2057	1040	5	2016	2016	NUM
admet-2057	1040	6	)	)	PUNCT
admet-2057	1040	7	,	,	PUNCT
admet-2057	1040	8	804	804	NUM
admet-2057	1040	9	-	-	SYM
admet-2057	1040	10	810	810	NUM
admet-2057	1040	11	.	.	PUNCT
admet-2057	1041	1	https://doi.org/10.1002/cplu.201600142	https://doi.org/10.1002/cplu.201600142	PROPN
admet-2057	1041	2	[	[	X
admet-2057	1041	3	79	79	NUM
admet-2057	1041	4	]	]	X
admet-2057	1041	5	j.y.r	j.y.r	PROPN
admet-2057	1041	6	.	.	PROPN
admet-2057	1041	7	silva	silva	PROPN
admet-2057	1041	8	,	,	PUNCT
admet-2057	1041	9	y.g	y.g	PROPN
admet-2057	1041	10	.	.	PROPN
admet-2057	1041	11	proenza	proenza	PROPN
admet-2057	1041	12	,	,	PUNCT
admet-2057	1041	13	l.l	l.l	PROPN
admet-2057	1041	14	.	.	PROPN
admet-2057	1041	15	da	da	PROPN
admet-2057	1041	16	luz	luz	PROPN
admet-2057	1041	17	,	,	PUNCT
admet-2057	1041	18	s.	s.	PROPN
admet-2057	1041	19	de	de	PROPN
admet-2057	1041	20	sousa	sousa	PROPN
admet-2057	1041	21	araújo	araújo	PROPN
admet-2057	1041	22	,	,	PUNCT
admet-2057	1041	23	m.a.g	m.a.g	ADJ
admet-2057	1041	24	.	.	PUNCT
admet-2057	1041	25	filho	filho	PROPN
admet-2057	1041	26	,	,	PUNCT
admet-2057	1041	27	m.s.a	m.s.a	X
admet-2057	1041	28	.	.	PUNCT
admet-2057	1041	29	junior	junior	PROPN
admet-2057	1041	30	,	,	PUNCT
admet-2057	1041	31	t.a	t.a	PROPN
admet-2057	1041	32	.	.	PROPN
admet-2057	1041	33	soares	soares	PROPN
admet-2057	1041	34	,	,	PUNCT
admet-2057	1041	35	r.l	r.l	PROPN
admet-2057	1041	36	.	.	PROPN
admet-2057	1041	37	longo	longo	PROPN
admet-2057	1041	38	.	.	PUNCT
admet-2057	1042	1	a	a	DET
admet-2057	1042	2	thermo	thermo	NOUN
admet-2057	1042	3	-	-	PUNCT
admet-2057	1042	4	responsive	responsive	ADJ
admet-2057	1042	5	adsorbent	adsorbent	NOUN
admet-2057	1042	6	-	-	PUNCT
admet-2057	1042	7	heater	heater	NOUN
admet-2057	1042	8	-	-	PUNCT
admet-2057	1042	9	thermometer	thermometer	NOUN
admet-2057	1042	10	nanomaterial	nanomaterial	NOUN
admet-2057	1042	11	for	for	ADP
admet-2057	1042	12	controlled	control	VERB
admet-2057	1042	13	drug	drug	NOUN
admet-2057	1042	14	release	release	NOUN
admet-2057	1042	15	:	:	PUNCT
admet-2057	1042	16	(	(	PUNCT
admet-2057	1042	17	zif-8,euxtby)@aunp	zif-8,euxtby)@aunp	NOUN
admet-2057	1042	18	core	core	NOUN
admet-2057	1042	19	-	-	PUNCT
admet-2057	1042	20	shell	shell	NOUN
admet-2057	1042	21	.	.	PUNCT
admet-2057	1043	1	materials	material	NOUN
admet-2057	1043	2	science	science	NOUN
admet-2057	1043	3	and	and	CCONJ
admet-2057	1043	4	engineering	engineering	NOUN
admet-2057	1043	5	c	c	PROPN
admet-2057	1043	6	102	102	NUM
admet-2057	1043	7	(	(	PUNCT
admet-2057	1043	8	2019	2019	NUM
admet-2057	1043	9	)	)	PUNCT
admet-2057	1043	10	578	578	NUM
admet-2057	1043	11	-	-	SYM
admet-2057	1043	12	588	588	NUM
admet-2057	1043	13	.	.	PUNCT
admet-2057	1044	1	https://doi.org/10.1016/j.msec.2019.04.078	https://doi.org/10.1016/j.msec.2019.04.078	PROPN
admet-2057	1044	2	[	[	X
admet-2057	1044	3	80	80	NUM
admet-2057	1044	4	]	]	X
admet-2057	1044	5	w.	w.	PROPN
admet-2057	1044	6	wu	wu	PROPN
admet-2057	1044	7	,	,	PUNCT
admet-2057	1044	8	j.	j.	PROPN
admet-2057	1044	9	liu	liu	PROPN
admet-2057	1044	10	,	,	PUNCT
admet-2057	1044	11	p.	p.	PROPN
admet-2057	1044	12	gong	gong	PROPN
admet-2057	1044	13	,	,	PUNCT
admet-2057	1044	14	z.	z.	PROPN
admet-2057	1044	15	li	li	PROPN
admet-2057	1044	16	,	,	PUNCT
admet-2057	1044	17	c.	c.	PROPN
admet-2057	1044	18	ke	ke	PROPN
admet-2057	1044	19	,	,	PUNCT
admet-2057	1044	20	y.	y.	PROPN
admet-2057	1044	21	qian	qian	PROPN
admet-2057	1044	22	,	,	PUNCT
admet-2057	1044	23	h.	h.	PROPN
admet-2057	1044	24	luo	luo	PROPN
admet-2057	1044	25	,	,	PUNCT
admet-2057	1044	26	l.	l.	PROPN
admet-2057	1044	27	xiao	xiao	PROPN
admet-2057	1044	28	,	,	PUNCT
admet-2057	1044	29	f.	f.	PROPN
admet-2057	1044	30	zhou	zhou	PROPN
admet-2057	1044	31	,	,	PUNCT
admet-2057	1044	32	w.	w.	PROPN
admet-2057	1044	33	liu	liu	PROPN
admet-2057	1044	34	.	.	PUNCT
admet-2057	1045	1	construction	construction	NOUN
admet-2057	1045	2	of	of	ADP
admet-2057	1045	3	core	core	NOUN
admet-2057	1045	4	-	-	PUNCT
admet-2057	1045	5	shell	shell	NOUN
admet-2057	1045	6	nanomofs@microgel	nanomofs@microgel	NOUN
admet-2057	1045	7	for	for	ADP
admet-2057	1045	8	aqueous	aqueous	ADJ
admet-2057	1045	9	lubrication	lubrication	NOUN
admet-2057	1045	10	and	and	CCONJ
admet-2057	1045	11	thermal	thermal	ADJ
admet-2057	1045	12	-	-	PUNCT
admet-2057	1045	13	responsive	responsive	ADJ
admet-2057	1045	14	drug	drug	NOUN
admet-2057	1045	15	release	release	NOUN
admet-2057	1045	16	.	.	PUNCT
admet-2057	1046	1	small	small	ADJ
admet-2057	1046	2	18(28	18(28	NUM
admet-2057	1046	3	)	)	PUNCT
admet-2057	1046	4	(	(	PUNCT
admet-2057	1046	5	2022	2022	NUM
admet-2057	1046	6	)	)	PUNCT
admet-2057	1046	7	2202510	2202510	NUM
admet-2057	1046	8	.	.	PUNCT
admet-2057	1047	1	https://doi.org/10.1002/smll.202202510	https://doi.org/10.1002/smll.202202510	PROPN
admet-2057	1047	2	[	[	X
admet-2057	1047	3	81	81	NUM
admet-2057	1047	4	]	]	PUNCT
admet-2057	1047	5	x.y	x.y	PROPN
admet-2057	1047	6	.	.	PROPN
admet-2057	1047	7	li	li	PROPN
admet-2057	1047	8	,	,	PUNCT
admet-2057	1047	9	q.x	q.x	PROPN
admet-2057	1047	10	.	.	PROPN
admet-2057	1047	11	guan	guan	PROPN
admet-2057	1047	12	,	,	PUNCT
admet-2057	1047	13	y.z	y.z	PROPN
admet-2057	1047	14	.	.	PROPN
admet-2057	1047	15	shang	shang	PROPN
admet-2057	1047	16	,	,	PUNCT
admet-2057	1047	17	y.h	y.h	PROPN
admet-2057	1047	18	.	.	PROPN
admet-2057	1047	19	wang	wang	PROPN
admet-2057	1047	20	,	,	PUNCT
admet-2057	1047	21	s.w	s.w	PROPN
admet-2057	1047	22	.	.	PROPN
admet-2057	1047	23	lv	lv	PROPN
admet-2057	1047	24	,	,	PUNCT
admet-2057	1047	25	z.x	z.x	PROPN
admet-2057	1047	26	.	.	PROPN
admet-2057	1047	27	yang	yang	PROPN
admet-2057	1047	28	,	,	PUNCT
admet-2057	1047	29	r.	r.	PROPN
admet-2057	1047	30	wang	wang	PROPN
admet-2057	1047	31	,	,	PUNCT
admet-2057	1047	32	y.f	y.f	PROPN
admet-2057	1047	33	.	.	PUNCT
admet-2057	1048	1	feng	feng	PROPN
admet-2057	1048	2	,	,	PUNCT
admet-2057	1048	3	w.n	w.n	PROPN
admet-2057	1048	4	.	.	PROPN
admet-2057	1048	5	li	li	PROPN
admet-2057	1048	6	,	,	PUNCT
admet-2057	1048	7	y.j	y.j	PROPN
admet-2057	1048	8	.	.	PUNCT
admet-2057	1049	1	li	li	PROPN
admet-2057	1049	2	.	.	PUNCT
admet-2057	1049	3	metal	metal	NOUN
admet-2057	1049	4	-	-	PUNCT
admet-2057	1049	5	organic	organic	ADJ
admet-2057	1049	6	framework	framework	NOUN
admet-2057	1049	7	irmofs	irmof	NOUN
admet-2057	1049	8	coated	coat	VERB
admet-2057	1049	9	with	with	ADP
admet-2057	1049	10	a	a	DET
admet-2057	1049	11	temperature	temperature	NOUN
admet-2057	1049	12	-	-	PUNCT
admet-2057	1049	13	sensitive	sensitive	ADJ
admet-2057	1049	14	gel	gel	NOUN
admet-2057	1049	15	delivering	deliver	VERB
admet-2057	1049	16	norcantharidin	norcantharidin	ADV
admet-2057	1049	17	to	to	PART
admet-2057	1049	18	treat	treat	VERB
admet-2057	1049	19	liver	liver	NOUN
admet-2057	1049	20	cancer	cancer	NOUN
admet-2057	1049	21	.	.	PUNCT
admet-2057	1050	1	world	world	PROPN
admet-2057	1050	2	j	j	PROPN
admet-2057	1050	3	gastroenterology	gastroenterology	NOUN
admet-2057	1050	4	27(26	27(26	NUM
admet-2057	1050	5	)	)	PUNCT
admet-2057	1050	6	(	(	PUNCT
admet-2057	1050	7	2021	2021	NUM
admet-2057	1050	8	)	)	PUNCT
admet-2057	1050	9	4208	4208	NUM
admet-2057	1050	10	-	-	SYM
admet-2057	1050	11	4220	4220	NUM
admet-2057	1050	12	.	.	PUNCT
admet-2057	1051	1	https://doi.org/10.3748/wjg.v27.i26.4208	https://doi.org/10.3748/wjg.v27.i26.4208	NOUN
admet-2057	1052	1	[	[	X
admet-2057	1052	2	82	82	NUM
admet-2057	1052	3	]	]	X
admet-2057	1052	4	j.	j.	PROPN
admet-2057	1052	5	li	li	PROPN
admet-2057	1052	6	,	,	PUNCT
admet-2057	1052	7	m.	m.	NOUN
admet-2057	1052	8	huo	huo	PROPN
admet-2057	1052	9	,	,	PUNCT
admet-2057	1052	10	j.	j.	PROPN
admet-2057	1052	11	wang	wang	PROPN
admet-2057	1052	12	,	,	PUNCT
admet-2057	1052	13	j.	j.	PROPN
admet-2057	1052	14	zhou	zhou	PROPN
admet-2057	1052	15	,	,	PUNCT
admet-2057	1052	16	j.m	j.m	PROPN
admet-2057	1052	17	.	.	PROPN
admet-2057	1052	18	mohammad	mohammad	PROPN
admet-2057	1052	19	,	,	PUNCT
admet-2057	1052	20	y.	y.	PROPN
admet-2057	1052	21	zhang	zhang	PROPN
admet-2057	1052	22	,	,	PUNCT
admet-2057	1052	23	q.	q.	PROPN
admet-2057	1052	24	zhu	zhu	PROPN
admet-2057	1052	25	,	,	PUNCT
admet-2057	1052	26	a.y	a.y	PROPN
admet-2057	1052	27	.	.	PROPN
admet-2057	1052	28	waddad	waddad	PROPN
admet-2057	1052	29	,	,	PUNCT
admet-2057	1052	30	q.	q.	PROPN
admet-2057	1052	31	zhang	zhang	PROPN
admet-2057	1052	32	.	.	PUNCT
admet-2057	1053	1	redoxsensitive	redoxsensitive	ADJ
admet-2057	1053	2	micelles	micelle	NOUN
admet-2057	1053	3	self	self	NOUN
admet-2057	1053	4	-	-	PUNCT
admet-2057	1053	5	assembled	assemble	VERB
admet-2057	1053	6	from	from	ADP
admet-2057	1053	7	amphiphilic	amphiphilic	ADJ
admet-2057	1053	8	hyaluronic	hyaluronic	ADJ
admet-2057	1053	9	acid	acid	NOUN
admet-2057	1053	10	-	-	PUNCT
admet-2057	1053	11	deoxycholic	deoxycholic	ADJ
admet-2057	1053	12	acid	acid	NOUN
admet-2057	1053	13	conjugates	conjugate	NOUN
admet-2057	1053	14	for	for	ADP
admet-2057	1053	15	targeted	target	VERB
admet-2057	1053	16	intracellular	intracellular	ADJ
admet-2057	1053	17	delivery	delivery	NOUN
admet-2057	1053	18	of	of	ADP
admet-2057	1053	19	paclitaxel	paclitaxel	PROPN
admet-2057	1053	20	.	.	PUNCT
admet-2057	1054	1	biomaterials	biomaterial	NOUN
admet-2057	1054	2	7	7	NUM
admet-2057	1054	3	(	(	PUNCT
admet-2057	1054	4	2012	2012	NUM
admet-2057	1054	5	)	)	PUNCT
admet-2057	1054	6	2310	2310	NUM
admet-2057	1054	7	-	-	SYM
admet-2057	1054	8	2320	2320	NUM
admet-2057	1054	9	.	.	PUNCT
admet-2057	1055	1	https://doi.org/10.1016/j.biomaterials.2011.11.022	https://doi.org/10.1016/j.biomaterials.2011.11.022	PRON
admet-2057	1056	1	[	[	X
admet-2057	1056	2	83	83	NUM
admet-2057	1056	3	]	]	PUNCT
admet-2057	1056	4	j.	j.	PROPN
admet-2057	1056	5	zhao	zhao	PROPN
admet-2057	1056	6	,	,	PUNCT
admet-2057	1056	7	y.	y.	PROPN
admet-2057	1056	8	yang	yang	PROPN
admet-2057	1056	9	,	,	PUNCT
admet-2057	1056	10	x.	x.	PROPN
admet-2057	1056	11	han	han	PROPN
admet-2057	1056	12	,	,	PUNCT
admet-2057	1056	13	c.	c.	PROPN
admet-2057	1056	14	liang	liang	PROPN
admet-2057	1056	15	,	,	PUNCT
admet-2057	1056	16	j.	j.	PROPN
admet-2057	1056	17	liu	liu	PROPN
admet-2057	1056	18	,	,	PUNCT
admet-2057	1056	19	x.	x.	NOUN
admet-2057	1056	20	song	song	PROPN
admet-2057	1056	21	,	,	PUNCT
admet-2057	1056	22	z.	z.	PROPN
admet-2057	1056	23	ge	ge	PROPN
admet-2057	1056	24	,	,	PUNCT
admet-2057	1056	25	z.	z.	PROPN
admet-2057	1056	26	liu	liu	PROPN
admet-2057	1056	27	.	.	PUNCT
admet-2057	1057	1	redox	redox	NOUN
admet-2057	1057	2	-	-	PUNCT
admet-2057	1057	3	sensitive	sensitive	ADJ
admet-2057	1057	4	nanoscale	nanoscale	NOUN
admet-2057	1057	5	coordination	coordination	NOUN
admet-2057	1057	6	polymers	polymer	NOUN
admet-2057	1057	7	for	for	ADP
admet-2057	1057	8	drug	drug	NOUN
admet-2057	1057	9	delivery	delivery	NOUN
admet-2057	1057	10	and	and	CCONJ
admet-2057	1057	11	cancer	cancer	NOUN
admet-2057	1057	12	theranostics	theranostic	NOUN
admet-2057	1057	13	.	.	PUNCT
admet-2057	1058	1	acs	acs	PROPN
admet-2057	1058	2	applied	apply	VERB
admet-2057	1058	3	material	material	NOUN
admet-2057	1058	4	&	&	CCONJ
admet-2057	1058	5	interfaces	interface	NOUN
admet-2057	1058	6	28	28	NUM
admet-2057	1058	7	(	(	PUNCT
admet-2057	1058	8	2017	2017	NUM
admet-2057	1058	9	)	)	PUNCT
admet-2057	1058	10	23555	23555	NUM
admet-2057	1058	11	-	-	SYM
admet-2057	1058	12	23563	23563	NUM
admet-2057	1058	13	.	.	PUNCT
admet-2057	1059	1	https://doi.org/10.1021/acsami.7b07535	https://doi.org/10.1021/acsami.7b07535	VERB
admet-2057	1060	1	[	[	X
admet-2057	1060	2	84	84	NUM
admet-2057	1060	3	]	]	PUNCT
admet-2057	1060	4	t.	t.	NOUN
admet-2057	1060	5	fukino	fukino	PROPN
admet-2057	1060	6	,	,	PUNCT
admet-2057	1060	7	h.	h.	PROPN
admet-2057	1060	8	yamagishi	yamagishi	PROPN
admet-2057	1060	9	,	,	PUNCT
admet-2057	1060	10	t.	t.	PROPN
admet-2057	1060	11	aida	aida	PROPN
admet-2057	1060	12	.	.	PUNCT
admet-2057	1061	1	redox	redox	NOUN
admet-2057	1061	2	-	-	PUNCT
admet-2057	1061	3	responsive	responsive	ADJ
admet-2057	1061	4	molecular	molecular	ADJ
admet-2057	1061	5	systems	system	NOUN
admet-2057	1061	6	and	and	CCONJ
admet-2057	1061	7	materials	material	NOUN
admet-2057	1061	8	.	.	PUNCT
admet-2057	1062	1	advanced	advanced	ADJ
admet-2057	1062	2	materials	material	NOUN
admet-2057	1062	3	29(25	29(25	NOUN
admet-2057	1062	4	)	)	PUNCT
admet-2057	1062	5	(	(	PUNCT
admet-2057	1062	6	2017	2017	NUM
admet-2057	1062	7	)	)	PUNCT
admet-2057	1062	8	1603888	1603888	NUM
admet-2057	1062	9	.	.	PUNCT
admet-2057	1063	1	https://doi.org/10.1002/adma.201603888	https://doi.org/10.1002/adma.201603888	X
admet-2057	1064	1	[	[	X
admet-2057	1064	2	85	85	NUM
admet-2057	1064	3	]	]	PUNCT
admet-2057	1064	4	a.	a.	NOUN
admet-2057	1064	5	ma	ma	PROPN
admet-2057	1064	6	,	,	PUNCT
admet-2057	1064	7	r.	r.	PROPN
admet-2057	1064	8	zhang	zhang	PROPN
admet-2057	1064	9	.	.	PUNCT
admet-2057	1064	10	facile	facile	ADJ
admet-2057	1064	11	synthesis	synthesis	NOUN
admet-2057	1064	12	of	of	ADP
admet-2057	1064	13	redox	redox	NOUN
admet-2057	1064	14	-	-	PUNCT
admet-2057	1064	15	responsive	responsive	ADJ
admet-2057	1064	16	paclitaxel	paclitaxel	ADJ
admet-2057	1064	17	drug	drug	NOUN
admet-2057	1064	18	release	release	NOUN
admet-2057	1064	19	platform	platform	NOUN
admet-2057	1064	20	using	use	VERB
admet-2057	1064	21	metal	metal	NOUN
admet-2057	1064	22	-	-	PUNCT
admet-2057	1064	23	organic	organic	ADJ
admet-2057	1064	24	frameworks	framework	NOUN
admet-2057	1064	25	(	(	PUNCT
admet-2057	1064	26	zif-8	zif-8	NUM
admet-2057	1064	27	)	)	PUNCT
admet-2057	1064	28	for	for	ADP
admet-2057	1064	29	gastric	gastric	ADJ
admet-2057	1064	30	cancer	cancer	NOUN
admet-2057	1064	31	treatment	treatment	NOUN
admet-2057	1064	32	.	.	PUNCT
admet-2057	1065	1	material	material	NOUN
admet-2057	1065	2	research	research	NOUN
admet-2057	1065	3	express	express	VERB
admet-2057	1065	4	7(9	7(9	NUM
admet-2057	1065	5	)	)	PUNCT
admet-2057	1065	6	(	(	PUNCT
admet-2057	1065	7	2020	2020	NUM
admet-2057	1065	8	)	)	PUNCT
admet-2057	1065	9	095402	095402	NUM
admet-2057	1065	10	.	.	PUNCT
admet-2057	1066	1	https://doi.org/10.1088/2053-1591/abb2ce	https://doi.org/10.1088/2053-1591/abb2ce	PROPN
admet-2057	1067	1	[	[	X
admet-2057	1067	2	86	86	NUM
admet-2057	1067	3	]	]	X
admet-2057	1067	4	b.	b.	PROPN
admet-2057	1067	5	lei	lei	PROPN
admet-2057	1067	6	,	,	PUNCT
admet-2057	1067	7	m.	m.	PROPN
admet-2057	1067	8	wang	wang	PROPN
admet-2057	1067	9	,	,	PUNCT
admet-2057	1067	10	z.	z.	PROPN
admet-2057	1067	11	jiang	jiang	PROPN
admet-2057	1067	12	,	,	PUNCT
admet-2057	1067	13	w.	w.	PROPN
admet-2057	1067	14	qi	qi	PROPN
admet-2057	1067	15	,	,	PUNCT
admet-2057	1067	16	r.	r.	PROPN
admet-2057	1067	17	su	su	PROPN
admet-2057	1067	18	,	,	PUNCT
admet-2057	1067	19	z.	z.	PROPN
admet-2057	1067	20	he	he	PRON
admet-2057	1067	21	.	.	PUNCT
admet-2057	1068	1	constructing	construct	VERB
admet-2057	1068	2	redox	redox	NOUN
admet-2057	1068	3	-	-	PUNCT
admet-2057	1068	4	responsive	responsive	ADJ
admet-2057	1068	5	metal	metal	NOUN
admet-2057	1068	6	-	-	PUNCT
admet-2057	1068	7	organic	organic	ADJ
admet-2057	1068	8	framework	framework	NOUN
admet-2057	1068	9	nanocarriers	nanocarrier	NOUN
admet-2057	1068	10	for	for	ADP
admet-2057	1068	11	anticancer	anticancer	NOUN
admet-2057	1068	12	drug	drug	NOUN
admet-2057	1068	13	delivery	delivery	NOUN
admet-2057	1068	14	.	.	PUNCT
admet-2057	1069	1	acs	acs	PROPN
admet-2057	1069	2	applied	apply	VERB
admet-2057	1069	3	material	material	NOUN
admet-2057	1069	4	&	&	CCONJ
admet-2057	1069	5	interfaces	interface	NOUN
admet-2057	1069	6	10(19	10(19	NUM
admet-2057	1069	7	)	)	PUNCT
admet-2057	1069	8	(	(	PUNCT
admet-2057	1069	9	2018	2018	NUM
admet-2057	1069	10	)	)	PUNCT
admet-2057	1069	11	16698	16698	NUM
admet-2057	1069	12	-	-	SYM
admet-2057	1069	13	16706	16706	NUM
admet-2057	1069	14	.	.	PUNCT
admet-2057	1070	1	https://doi.org/10.1021/acsami.7b19693	https://doi.org/10.1021/acsami.7b19693	PROPN
admet-2057	1070	2	[	[	X
admet-2057	1070	3	87	87	NUM
admet-2057	1070	4	]	]	PUNCT
admet-2057	1070	5	h.	h.	PROPN
admet-2057	1070	6	he	he	PROPN
admet-2057	1070	7	,	,	PUNCT
admet-2057	1070	8	l.	l.	PROPN
admet-2057	1070	9	du	du	PROPN
admet-2057	1070	10	,	,	PUNCT
admet-2057	1070	11	h.	h.	PROPN
admet-2057	1070	12	guo	guo	PROPN
admet-2057	1070	13	,	,	PUNCT
admet-2057	1070	14	y.	y.	PROPN
admet-2057	1070	15	an	an	PROPN
admet-2057	1070	16	,	,	PUNCT
admet-2057	1070	17	l.	l.	PROPN
admet-2057	1070	18	lu	lu	PROPN
admet-2057	1070	19	,	,	PUNCT
admet-2057	1070	20	y.	y.	PROPN
admet-2057	1070	21	chen	chen	PROPN
admet-2057	1070	22	,	,	PUNCT
admet-2057	1070	23	y.	y.	PROPN
admet-2057	1070	24	wang	wang	PROPN
admet-2057	1070	25	,	,	PUNCT
admet-2057	1070	26	h.	h.	PROPN
admet-2057	1070	27	zhong	zhong	PROPN
admet-2057	1070	28	,	,	PUNCT
admet-2057	1070	29	j.	j.	PROPN
admet-2057	1070	30	shen	shen	PROPN
admet-2057	1070	31	,	,	PUNCT
admet-2057	1070	32	j.	j.	PROPN
admet-2057	1070	33	wu	wu	PROPN
admet-2057	1070	34	,	,	PUNCT
admet-2057	1070	35	x.	x.	PROPN
admet-2057	1070	36	shuai	shuai	PROPN
admet-2057	1070	37	.	.	PUNCT
admet-2057	1071	1	redox	redox	ADJ
admet-2057	1071	2	responsive	responsive	ADJ
admet-2057	1071	3	metal	metal	NOUN
admet-2057	1071	4	organic	organic	ADJ
admet-2057	1071	5	framework	framework	NOUN
admet-2057	1071	6	nanoparticles	nanoparticle	NOUN
admet-2057	1071	7	induces	induce	VERB
admet-2057	1071	8	ferroptosis	ferroptosis	NOUN
admet-2057	1071	9	for	for	ADP
admet-2057	1071	10	cancer	cancer	NOUN
admet-2057	1071	11	therapy	therapy	NOUN
admet-2057	1071	12	.	.	PUNCT
admet-2057	1072	1	small	small	ADJ
admet-2057	1072	2	16(33	16(33	NUM
admet-2057	1072	3	)	)	PUNCT
admet-2057	1072	4	(	(	PUNCT
admet-2057	1072	5	2020	2020	NUM
admet-2057	1072	6	)	)	PUNCT
admet-2057	1072	7	2001251	2001251	NUM
admet-2057	1072	8	.	.	PUNCT
admet-2057	1073	1	https://doi.org/10.1002/smll.202001251	https://doi.org/10.1002/smll.202001251	PROPN
admet-2057	1074	1	https://doi.org/10.1039/c9tb01377f	https://doi.org/10.1039/c9tb01377f	PROPN
admet-2057	1074	2	https://doi.org/10.1016/j.bioactmat.2020.08.005	https://doi.org/10.1016/j.bioactmat.2020.08.005	PROPN
admet-2057	1074	3	https://doi.org/10.1002/chem.201701904	https://doi.org/10.1002/chem.201701904	ADJ
admet-2057	1074	4	https://doi.org/10.1021/ic049713z	https://doi.org/10.1021/ic049713z	PROPN
admet-2057	1074	5	https://doi.org/10.1039/c5cc02339d	https://doi.org/10.1039/c5cc02339d	PROPN
admet-2057	1074	6	https://doi.org/10.1038/nmat3776	https://doi.org/10.1038/nmat3776	NOUN
admet-2057	1074	7	https://doi.org/10.1002/cplu.201600142	https://doi.org/10.1002/cplu.201600142	ADJ
admet-2057	1074	8	https://doi.org/10.1016/j.msec.2019.04.078	https://doi.org/10.1016/j.msec.2019.04.078	PROPN
admet-2057	1074	9	https://doi.org/10.1002/smll.202202510	https://doi.org/10.1002/smll.202202510	PROPN
admet-2057	1074	10	https://doi.org/10.3748/wjg.v27.i26.4208	https://doi.org/10.3748/wjg.v27.i26.4208	PROPN
admet-2057	1074	11	https://doi.org/10.1016/j.biomaterials.2011.11.022	https://doi.org/10.1016/j.biomaterials.2011.11.022	PROPN
admet-2057	1074	12	https://doi.org/10.1021/acsami.7b07535	https://doi.org/10.1021/acsami.7b07535	NOUN
admet-2057	1074	13	https://doi.org/10.1002/adma.201603888	https://doi.org/10.1002/adma.201603888	NOUN
admet-2057	1074	14	https://doi.org/10.1088/2053-1591/abb2ce	https://doi.org/10.1088/2053-1591/abb2ce	PROPN
admet-2057	1074	15	https://doi.org/10.1021/acsami.7b19693	https://doi.org/10.1021/acsami.7b19693	PROPN
admet-2057	1074	16	https://doi.org/10.1002/smll.202001251	https://doi.org/10.1002/smll.202001251	PROPN
admet-2057	1074	17	admet	admet	PROPN
admet-2057	1074	18	&	&	CCONJ
admet-2057	1074	19	dmpk	dmpk	PROPN
admet-2057	1074	20	12(1	12(1	PROPN
admet-2057	1074	21	)	)	PUNCT
admet-2057	1074	22	(	(	PUNCT
admet-2057	1074	23	2024	2024	NUM
admet-2057	1074	24	)	)	PUNCT
admet-2057	1074	25	27	27	NUM
admet-2057	1074	26	-	-	SYM
admet-2057	1074	27	62	62	NUM
admet-2057	1074	28	drug	drug	NOUN
admet-2057	1074	29	delivery	delivery	NOUN
admet-2057	1074	30	applications	application	NOUN
admet-2057	1074	31	of	of	ADP
admet-2057	1074	32	metal	metal	NOUN
admet-2057	1074	33	-	-	PUNCT
admet-2057	1074	34	organic	organic	ADJ
admet-2057	1074	35	framework	framework	NOUN
admet-2057	1074	36	doi	doi	NOUN
admet-2057	1074	37	:	:	PUNCT
admet-2057	1074	38	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	1074	39	59	59	NUM
admet-2057	1074	40	[	[	X
admet-2057	1074	41	88	88	NUM
admet-2057	1074	42	]	]	X
admet-2057	1074	43	d.e	d.e	PROPN
admet-2057	1074	44	.	.	PROPN
admet-2057	1074	45	huizenga	huizenga	PROPN
admet-2057	1074	46	,	,	PUNCT
admet-2057	1074	47	j.w	j.w	PROPN
admet-2057	1074	48	.	.	PROPN
admet-2057	1074	49	szostak	szostak	PROPN
admet-2057	1074	50	.	.	PUNCT
admet-2057	1075	1	a	a	DET
admet-2057	1075	2	dna	dna	PROPN
admet-2057	1075	3	aptamer	aptamer	NOUN
admet-2057	1075	4	that	that	PRON
admet-2057	1075	5	binds	bind	VERB
admet-2057	1075	6	adenosine	adenosine	NOUN
admet-2057	1075	7	and	and	CCONJ
admet-2057	1075	8	atp	atp	PROPN
admet-2057	1075	9	.	.	PROPN
admet-2057	1076	1	biochemistry	biochemistry	PROPN
admet-2057	1076	2	34(2	34(2	PROPN
admet-2057	1076	3	)	)	PUNCT
admet-2057	1076	4	(	(	PUNCT
admet-2057	1076	5	1995	1995	NUM
admet-2057	1076	6	)	)	PUNCT
admet-2057	1076	7	656	656	NUM
admet-2057	1076	8	-	-	SYM
admet-2057	1076	9	665	665	NUM
admet-2057	1076	10	.	.	PUNCT
admet-2057	1077	1	https://doi.org/10.1021/bi00002a033	https://doi.org/10.1021/bi00002a033	PROPN
admet-2057	1077	2	[	[	PUNCT
admet-2057	1077	3	89	89	NUM
admet-2057	1077	4	]	]	X
admet-2057	1077	5	w.h	w.h	PROPN
admet-2057	1077	6	.	.	PROPN
admet-2057	1077	7	chen	chen	PROPN
admet-2057	1077	8	,	,	PUNCT
admet-2057	1077	9	x.	x.	PROPN
admet-2057	1077	10	yu	yu	PROPN
admet-2057	1077	11	,	,	PUNCT
admet-2057	1077	12	w.c	w.c	PROPN
admet-2057	1077	13	.	.	PROPN
admet-2057	1077	14	liao	liao	PROPN
admet-2057	1077	15	,	,	PUNCT
admet-2057	1077	16	y.s	y.s	PROPN
admet-2057	1077	17	.	.	PROPN
admet-2057	1077	18	sohn	sohn	PROPN
admet-2057	1077	19	,	,	PUNCT
admet-2057	1077	20	a.	a.	PROPN
admet-2057	1077	21	cecconello	cecconello	PROPN
admet-2057	1077	22	,	,	PUNCT
admet-2057	1077	23	a.	a.	NOUN
admet-2057	1077	24	kozell	kozell	PROPN
admet-2057	1077	25	,	,	PUNCT
admet-2057	1077	26	r.	r.	PROPN
admet-2057	1077	27	nechushtai	nechushtai	PROPN
admet-2057	1077	28	,	,	PUNCT
admet-2057	1077	29	i.	i.	PROPN
admet-2057	1077	30	willner	willner	PROPN
admet-2057	1077	31	.	.	PUNCT
admet-2057	1078	1	atpresponsive	atpresponsive	ADJ
admet-2057	1078	2	aptamer	aptamer	NOUN
admet-2057	1078	3	-	-	PUNCT
admet-2057	1078	4	based	base	VERB
admet-2057	1078	5	metal	metal	NOUN
admet-2057	1078	6	-	-	PUNCT
admet-2057	1078	7	organic	organic	ADJ
admet-2057	1078	8	framework	framework	NOUN
admet-2057	1078	9	nanoparticles	nanoparticle	NOUN
admet-2057	1078	10	(	(	PUNCT
admet-2057	1078	11	nmofs	nmof	NOUN
admet-2057	1078	12	)	)	PUNCT
admet-2057	1078	13	for	for	ADP
admet-2057	1078	14	the	the	DET
admet-2057	1078	15	controlled	control	VERB
admet-2057	1078	16	release	release	NOUN
admet-2057	1078	17	of	of	ADP
admet-2057	1078	18	loads	load	NOUN
admet-2057	1078	19	and	and	CCONJ
admet-2057	1078	20	drugs	drug	NOUN
admet-2057	1078	21	.	.	PUNCT
admet-2057	1079	1	advanced	advanced	ADJ
admet-2057	1079	2	functional	functional	ADJ
admet-2057	1079	3	materials	material	NOUN
admet-2057	1079	4	27(37	27(37	NUM
admet-2057	1079	5	)	)	PUNCT
admet-2057	1079	6	(	(	PUNCT
admet-2057	1079	7	2017	2017	NUM
admet-2057	1079	8	)	)	PUNCT
admet-2057	1079	9	1702102	1702102	NUM
admet-2057	1079	10	.	.	PUNCT
admet-2057	1080	1	https://doi.org/10.1002/adfm.201702102	https://doi.org/10.1002/adfm.201702102	PUNCT
admet-2057	1081	1	[	[	X
admet-2057	1081	2	90	90	NUM
admet-2057	1081	3	]	]	X
admet-2057	1081	4	w.h	w.h	PROPN
admet-2057	1081	5	.	.	PROPN
admet-2057	1081	6	chen	chen	PROPN
admet-2057	1081	7	,	,	PUNCT
admet-2057	1081	8	w.c	w.c	PROPN
admet-2057	1081	9	.	.	PROPN
admet-2057	1081	10	liao	liao	PROPN
admet-2057	1081	11	,	,	PUNCT
admet-2057	1081	12	y.s	y.s	PROPN
admet-2057	1081	13	.	.	PROPN
admet-2057	1081	14	sohn	sohn	PROPN
admet-2057	1081	15	,	,	PUNCT
admet-2057	1081	16	m.	m.	NOUN
admet-2057	1081	17	fadeev	fadeev	NOUN
admet-2057	1081	18	,	,	PUNCT
admet-2057	1081	19	a.	a.	PROPN
admet-2057	1081	20	cecconello	cecconello	PROPN
admet-2057	1081	21	,	,	PUNCT
admet-2057	1081	22	r.	r.	PROPN
admet-2057	1081	23	nechushtai	nechushtai	PROPN
admet-2057	1081	24	,	,	PUNCT
admet-2057	1081	25	i.	i.	PROPN
admet-2057	1081	26	willner	willner	PROPN
admet-2057	1081	27	.	.	PUNCT
admet-2057	1082	1	stimuliresponsive	stimuliresponsive	ADJ
admet-2057	1082	2	nucleic	nucleic	ADJ
admet-2057	1082	3	acid	acid	NOUN
admet-2057	1082	4	-	-	PUNCT
admet-2057	1082	5	based	base	VERB
admet-2057	1082	6	polyacrylamide	polyacrylamide	NOUN
admet-2057	1082	7	hydrogel	hydrogel	NOUN
admet-2057	1082	8	-	-	PUNCT
admet-2057	1082	9	coated	coat	VERB
admet-2057	1082	10	metal	metal	NOUN
admet-2057	1082	11	-	-	PUNCT
admet-2057	1082	12	organic	organic	ADJ
admet-2057	1082	13	framework	framework	NOUN
admet-2057	1082	14	nanoparticles	nanoparticle	NOUN
admet-2057	1082	15	for	for	ADP
admet-2057	1082	16	controlled	control	VERB
admet-2057	1082	17	drug	drug	NOUN
admet-2057	1082	18	release	release	NOUN
admet-2057	1082	19	.	.	PUNCT
admet-2057	1083	1	advanced	advanced	ADJ
admet-2057	1083	2	functional	functional	ADJ
admet-2057	1083	3	material	material	NOUN
admet-2057	1083	4	28(8	28(8	NUM
admet-2057	1083	5	)	)	PUNCT
admet-2057	1083	6	(	(	PUNCT
admet-2057	1083	7	2018	2018	NUM
admet-2057	1083	8	)	)	PUNCT
admet-2057	1083	9	1705137	1705137	NUM
admet-2057	1083	10	.	.	PUNCT
admet-2057	1084	1	https://doi.org/10.1002/adfm.201705137	https://doi.org/10.1002/adfm.201705137	X
admet-2057	1085	1	[	[	X
admet-2057	1085	2	91	91	NUM
admet-2057	1085	3	]	]	PUNCT
admet-2057	1085	4	x.	x.	PROPN
admet-2057	1085	5	yang	yang	PROPN
admet-2057	1085	6	,	,	PUNCT
admet-2057	1085	7	q.	q.	PROPN
admet-2057	1085	8	tang	tang	PROPN
admet-2057	1085	9	,	,	PUNCT
admet-2057	1085	10	y.	y.	PROPN
admet-2057	1085	11	jiang	jiang	PROPN
admet-2057	1085	12	,	,	PUNCT
admet-2057	1085	13	m.	m.	PROPN
admet-2057	1085	14	zhang	zhang	PROPN
admet-2057	1085	15	,	,	PUNCT
admet-2057	1085	16	m.	m.	PROPN
admet-2057	1085	17	wang	wang	PROPN
admet-2057	1085	18	,	,	PUNCT
admet-2057	1085	19	l.	l.	PROPN
admet-2057	1085	20	mao	mao	PROPN
admet-2057	1085	21	.	.	PUNCT
admet-2057	1086	1	nanoscale	nanoscale	PROPN
admet-2057	1086	2	atp	atp	PROPN
admet-2057	1086	3	-	-	PUNCT
admet-2057	1086	4	responsive	responsive	ADJ
admet-2057	1086	5	zeolitic	zeolitic	ADJ
admet-2057	1086	6	imidazole	imidazole	NOUN
admet-2057	1086	7	framework-90	framework-90	PROPN
admet-2057	1086	8	as	as	ADP
admet-2057	1086	9	a	a	DET
admet-2057	1086	10	general	general	ADJ
admet-2057	1086	11	platform	platform	NOUN
admet-2057	1086	12	for	for	ADP
admet-2057	1086	13	cytosolic	cytosolic	ADJ
admet-2057	1086	14	protein	protein	NOUN
admet-2057	1086	15	delivery	delivery	NOUN
admet-2057	1086	16	and	and	CCONJ
admet-2057	1086	17	genome	genome	NOUN
admet-2057	1086	18	editing	editing	NOUN
admet-2057	1086	19	.	.	PUNCT
admet-2057	1087	1	journal	journal	PROPN
admet-2057	1087	2	of	of	ADP
admet-2057	1087	3	american	american	PROPN
admet-2057	1087	4	chemical	chemical	PROPN
admet-2057	1087	5	society	society	PROPN
admet-2057	1087	6	141(9	141(9	NUM
admet-2057	1087	7	)	)	PUNCT
admet-2057	1087	8	(	(	PUNCT
admet-2057	1087	9	2019	2019	NUM
admet-2057	1087	10	)	)	PUNCT
admet-2057	1087	11	3782	3782	NUM
admet-2057	1087	12	-	-	SYM
admet-2057	1087	13	3786	3786	NUM
admet-2057	1087	14	.	.	PUNCT
admet-2057	1088	1	https://doi.org/10.1021/jacs.8b11996	https://doi.org/10.1021/jacs.8b11996	NOUN
admet-2057	1088	2	[	[	X
admet-2057	1088	3	92	92	NUM
admet-2057	1088	4	]	]	PUNCT
admet-2057	1088	5	w.	w.	PROPN
admet-2057	1088	6	lin	lin	PROPN
admet-2057	1088	7	,	,	PUNCT
admet-2057	1088	8	y.	y.	PROPN
admet-2057	1088	9	cui	cui	PROPN
admet-2057	1088	10	,	,	PUNCT
admet-2057	1088	11	y.	y.	PROPN
admet-2057	1088	12	yang	yang	PROPN
admet-2057	1088	13	,	,	PUNCT
admet-2057	1088	14	q.	q.	PROPN
admet-2057	1088	15	hu	hu	PROPN
admet-2057	1088	16	,	,	PUNCT
admet-2057	1088	17	g.	g.	PROPN
admet-2057	1088	18	qian	qian	PROPN
admet-2057	1088	19	.	.	PUNCT
admet-2057	1089	1	a	a	DET
admet-2057	1089	2	biocompatible	biocompatible	ADJ
admet-2057	1089	3	metal	metal	NOUN
admet-2057	1089	4	-	-	PUNCT
admet-2057	1089	5	organic	organic	ADJ
admet-2057	1089	6	framework	framework	NOUN
admet-2057	1089	7	as	as	ADP
admet-2057	1089	8	a	a	DET
admet-2057	1089	9	ph	ph	ADJ
admet-2057	1089	10	and	and	CCONJ
admet-2057	1089	11	temperature	temperature	NOUN
admet-2057	1089	12	dual	dual	ADJ
admet-2057	1089	13	-	-	PUNCT
admet-2057	1089	14	responsive	responsive	ADJ
admet-2057	1089	15	drug	drug	NOUN
admet-2057	1089	16	carrier	carrier	NOUN
admet-2057	1089	17	.	.	PUNCT
admet-2057	1090	1	dalton	dalton	PROPN
admet-2057	1090	2	transactions	transaction	NOUN
admet-2057	1090	3	47	47	NUM
admet-2057	1090	4	(	(	PUNCT
admet-2057	1090	5	2018	2018	NUM
admet-2057	1090	6	)	)	PUNCT
admet-2057	1090	7	15882	15882	NUM
admet-2057	1090	8	-	-	SYM
admet-2057	1090	9	15887	15887	NUM
admet-2057	1090	10	.	.	PUNCT
admet-2057	1091	1	https://doi.org/10.1039/c8dt03202e	https://doi.org/10.1039/c8dt03202e	PUNCT
admet-2057	1092	1	[	[	X
admet-2057	1092	2	93	93	NUM
admet-2057	1092	3	]	]	X
admet-2057	1092	4	l.l	l.l	PROPN
admet-2057	1092	5	.	.	PROPN
admet-2057	1092	6	tan	tan	PROPN
admet-2057	1092	7	,	,	PUNCT
admet-2057	1092	8	n.	n.	NOUN
admet-2057	1092	9	song	song	NOUN
admet-2057	1092	10	,	,	PUNCT
admet-2057	1092	11	s.x.a	s.x.a	PROPN
admet-2057	1092	12	.	.	PROPN
admet-2057	1092	13	zhang	zhang	PROPN
admet-2057	1092	14	,	,	PUNCT
admet-2057	1092	15	h.	h.	PROPN
admet-2057	1092	16	li	li	PROPN
admet-2057	1092	17	,	,	PUNCT
admet-2057	1092	18	b.	b.	PROPN
admet-2057	1092	19	wang	wang	PROPN
admet-2057	1092	20	,	,	PUNCT
admet-2057	1092	21	y.w	y.w	PROPN
admet-2057	1092	22	.	.	PROPN
admet-2057	1092	23	yang	yang	PROPN
admet-2057	1092	24	.	.	PUNCT
admet-2057	1093	1	ca2	ca2	PROPN
admet-2057	1093	2	+	+	PROPN
admet-2057	1093	3	,	,	PUNCT
admet-2057	1093	4	ph	ph	ADJ
admet-2057	1093	5	and	and	CCONJ
admet-2057	1093	6	thermo	thermo	NOUN
admet-2057	1093	7	triple	triple	ADJ
admet-2057	1093	8	-	-	PUNCT
admet-2057	1093	9	responsive	responsive	ADJ
admet-2057	1093	10	mechanized	mechanized	ADJ
admet-2057	1093	11	zr	zr	NOUN
admet-2057	1093	12	-	-	PUNCT
admet-2057	1093	13	based	base	VERB
admet-2057	1093	14	mofs	mof	NOUN
admet-2057	1093	15	for	for	ADP
admet-2057	1093	16	on	on	ADP
admet-2057	1093	17	-	-	PUNCT
admet-2057	1093	18	command	command	NOUN
admet-2057	1093	19	drug	drug	NOUN
admet-2057	1093	20	release	release	NOUN
admet-2057	1093	21	in	in	ADP
admet-2057	1093	22	bone	bone	NOUN
admet-2057	1093	23	diseases	disease	NOUN
admet-2057	1093	24	.	.	PUNCT
admet-2057	1094	1	journal	journal	NOUN
admet-2057	1094	2	of	of	ADP
admet-2057	1094	3	material	material	NOUN
admet-2057	1094	4	chemistry	chemistry	NOUN
admet-2057	1094	5	b	b	NOUN
admet-2057	1094	6	4(1	4(1	NOUN
admet-2057	1094	7	)	)	PUNCT
admet-2057	1094	8	(	(	PUNCT
admet-2057	1094	9	2016	2016	NUM
admet-2057	1094	10	)	)	PUNCT
admet-2057	1094	11	135	135	NUM
admet-2057	1094	12	-	-	SYM
admet-2057	1094	13	140	140	NUM
admet-2057	1094	14	.	.	PUNCT
admet-2057	1095	1	https://doi.org/10.1039/c5tb01789k	https://doi.org/10.1039/c5tb01789k	NOUN
admet-2057	1095	2	[	[	X
admet-2057	1095	3	94	94	NUM
admet-2057	1095	4	]	]	PUNCT
admet-2057	1095	5	s.	s.	PROPN
admet-2057	1095	6	nagata	nagata	PROPN
admet-2057	1095	7	,	,	PUNCT
admet-2057	1095	8	k.	k.	PROPN
admet-2057	1095	9	kokado	kokado	PROPN
admet-2057	1095	10	,	,	PUNCT
admet-2057	1095	11	k.	k.	PROPN
admet-2057	1095	12	sada	sada	PROPN
admet-2057	1095	13	.	.	PUNCT
admet-2057	1096	1	metal	metal	NOUN
admet-2057	1096	2	-	-	PUNCT
admet-2057	1096	3	organic	organic	ADJ
admet-2057	1096	4	framework	framework	NOUN
admet-2057	1096	5	tethering	tether	VERB
admet-2057	1096	6	phand	phand	PROPN
admet-2057	1096	7	thermo	thermo	NOUN
admet-2057	1096	8	-	-	PUNCT
admet-2057	1096	9	responsive	responsive	ADJ
admet-2057	1096	10	polymer	polymer	NOUN
admet-2057	1096	11	for	for	ADP
admet-2057	1096	12	on	on	ADP
admet-2057	1096	13	-	-	PUNCT
admet-2057	1096	14	off	off	ADP
admet-2057	1096	15	controlled	control	VERB
admet-2057	1096	16	release	release	NOUN
admet-2057	1096	17	of	of	ADP
admet-2057	1096	18	guest	guest	NOUN
admet-2057	1096	19	molecules	molecule	NOUN
admet-2057	1096	20	.	.	PUNCT
admet-2057	1097	1	crystengcomm	crystengcomm	NOUN
admet-2057	1097	2	22(6	22(6	NUM
admet-2057	1097	3	)	)	PUNCT
admet-2057	1097	4	(	(	PUNCT
admet-2057	1097	5	2020	2020	NUM
admet-2057	1097	6	)	)	PUNCT
admet-2057	1097	7	11061111	11061111	NUM
admet-2057	1097	8	.	.	PUNCT
admet-2057	1098	1	https://doi.org/10.1039/c9ce01731c	https://doi.org/10.1039/c9ce01731c	PROPN
admet-2057	1099	1	[	[	X
admet-2057	1099	2	95	95	NUM
admet-2057	1099	3	]	]	PUNCT
admet-2057	1099	4	x.	x.	NOUN
admet-2057	1099	5	hu	hu	PROPN
admet-2057	1099	6	,	,	PUNCT
admet-2057	1099	7	y.	y.	PROPN
admet-2057	1099	8	lu	lu	PROPN
admet-2057	1099	9	,	,	PUNCT
admet-2057	1099	10	c.	c.	PROPN
admet-2057	1099	11	dong	dong	PROPN
admet-2057	1099	12	,	,	PUNCT
admet-2057	1099	13	w.	w.	PROPN
admet-2057	1099	14	zhao	zhao	PROPN
admet-2057	1099	15	,	,	PUNCT
admet-2057	1099	16	x.	x.	PROPN
admet-2057	1099	17	wu	wu	PROPN
admet-2057	1099	18	,	,	PUNCT
admet-2057	1099	19	l.	l.	PROPN
admet-2057	1099	20	zhou	zhou	PROPN
admet-2057	1099	21	,	,	PUNCT
admet-2057	1099	22	l.	l.	PROPN
admet-2057	1099	23	chen	chen	PROPN
admet-2057	1099	24	,	,	PUNCT
admet-2057	1099	25	t.	t.	PROPN
admet-2057	1099	26	yao	yao	PROPN
admet-2057	1099	27	,	,	PUNCT
admet-2057	1099	28	s.	s.	PROPN
admet-2057	1099	29	shi	shi	PROPN
admet-2057	1099	30	.	.	PUNCT
admet-2057	1100	1	a	a	DET
admet-2057	1100	2	ruii	ruii	ADJ
admet-2057	1100	3	polypyridyl	polypyridyl	ADJ
admet-2057	1100	4	alkyne	alkyne	NOUN
admet-2057	1100	5	complex	complex	NOUN
admet-2057	1100	6	based	base	VERB
admet-2057	1100	7	metal	metal	NOUN
admet-2057	1100	8	-	-	PUNCT
admet-2057	1100	9	organic	organic	ADJ
admet-2057	1100	10	frameworks	framework	NOUN
admet-2057	1100	11	for	for	ADP
admet-2057	1100	12	combined	combine	VERB
admet-2057	1100	13	photodynamic	photodynamic	ADJ
admet-2057	1100	14	/	/	SYM
admet-2057	1100	15	photothermal	photothermal	ADJ
admet-2057	1100	16	/	/	SYM
admet-2057	1100	17	chemotherapy	chemotherapy	NOUN
admet-2057	1100	18	.	.	PUNCT
admet-2057	1101	1	chemistrya	chemistrya	ADJ
admet-2057	1101	2	,	,	PUNCT
admet-2057	1101	3	european	european	PROPN
admet-2057	1101	4	journal	journal	PROPN
admet-2057	1101	5	26(7	26(7	PROPN
admet-2057	1101	6	)	)	PUNCT
admet-2057	1101	7	(	(	PUNCT
admet-2057	1101	8	2020	2020	NUM
admet-2057	1101	9	)	)	PUNCT
admet-2057	1101	10	1668	1668	NUM
admet-2057	1101	11	-	-	SYM
admet-2057	1101	12	1675	1675	NUM
admet-2057	1101	13	.	.	PUNCT
admet-2057	1102	1	https://doi.org/10.1002/chem.201904704	https://doi.org/10.1002/chem.201904704	NOUN
admet-2057	1102	2	[	[	X
admet-2057	1102	3	96	96	NUM
admet-2057	1102	4	]	]	PUNCT
admet-2057	1102	5	j.	j.	PROPN
admet-2057	1102	6	chen	chen	PROPN
admet-2057	1102	7	,	,	PUNCT
admet-2057	1102	8	j.	j.	PROPN
admet-2057	1102	9	liu	liu	PROPN
admet-2057	1102	10	,	,	PUNCT
admet-2057	1102	11	y.	y.	PROPN
admet-2057	1102	12	hu	hu	PROPN
admet-2057	1102	13	,	,	PUNCT
admet-2057	1102	14	z.	z.	PROPN
admet-2057	1102	15	tian	tian	PROPN
admet-2057	1102	16	,	,	PUNCT
admet-2057	1102	17	y.	y.	PROPN
admet-2057	1102	18	zhu	zhu	PROPN
admet-2057	1102	19	.	.	PUNCT
admet-2057	1103	1	metal	metal	NOUN
admet-2057	1103	2	-	-	PUNCT
admet-2057	1103	3	organic	organic	ADJ
admet-2057	1103	4	framework	framework	NOUN
admet-2057	1103	5	-	-	PUNCT
admet-2057	1103	6	coated	coat	VERB
admet-2057	1103	7	magnetite	magnetite	NOUN
admet-2057	1103	8	nanoparticles	nanoparticle	NOUN
admet-2057	1103	9	for	for	ADP
admet-2057	1103	10	synergistic	synergistic	ADJ
admet-2057	1103	11	magnetic	magnetic	ADJ
admet-2057	1103	12	hyperthermia	hyperthermia	NOUN
admet-2057	1103	13	and	and	CCONJ
admet-2057	1103	14	chemotherapy	chemotherapy	NOUN
admet-2057	1103	15	with	with	ADP
admet-2057	1103	16	ph	ph	VERB
admet-2057	1103	17	-	-	PUNCT
admet-2057	1103	18	triggered	triggered	ADJ
admet-2057	1103	19	drug	drug	NOUN
admet-2057	1103	20	release	release	NOUN
admet-2057	1103	21	.	.	PUNCT
admet-2057	1104	1	science	science	NOUN
admet-2057	1104	2	and	and	CCONJ
admet-2057	1104	3	technology	technology	NOUN
admet-2057	1104	4	of	of	ADP
admet-2057	1104	5	advanced	advanced	ADJ
admet-2057	1104	6	material	material	NOUN
admet-2057	1104	7	20	20	NUM
admet-2057	1104	8	(	(	PUNCT
admet-2057	1104	9	2019	2019	NUM
admet-2057	1104	10	)	)	PUNCT
admet-2057	1104	11	1043	1043	NUM
admet-2057	1104	12	-	-	SYM
admet-2057	1104	13	1054	1054	NUM
admet-2057	1104	14	.	.	PUNCT
admet-2057	1105	1	https://doi.org/10.1080/14686996.2019.1682467	https://doi.org/10.1080/14686996.2019.1682467	PUNCT
admet-2057	1106	1	[	[	X
admet-2057	1106	2	97	97	NUM
admet-2057	1106	3	]	]	PUNCT
admet-2057	1106	4	z.	z.	PROPN
admet-2057	1106	5	gharehdaghi	gharehdaghi	PROPN
admet-2057	1106	6	,	,	PUNCT
admet-2057	1106	7	s.m	s.m	PROPN
admet-2057	1106	8	.	.	PROPN
admet-2057	1106	9	naghib	naghib	NOUN
admet-2057	1106	10	,	,	PUNCT
admet-2057	1106	11	r.	r.	PROPN
admet-2057	1106	12	rahimi	rahimi	NOUN
admet-2057	1106	13	,	,	PUNCT
admet-2057	1106	14	a.	a.	NOUN
admet-2057	1106	15	bakhshi	bakhshi	PROPN
admet-2057	1106	16	,	,	PUNCT
admet-2057	1106	17	a.	a.	PROPN
admet-2057	1106	18	kefayat	kefayat	PROPN
admet-2057	1106	19	,	,	PUNCT
admet-2057	1106	20	a.	a.	PROPN
admet-2057	1106	21	shamaeizadeh	shamaeizadeh	PROPN
admet-2057	1106	22	,	,	PUNCT
admet-2057	1106	23	f.	f.	PROPN
admet-2057	1106	24	molaabasi	molaabasi	PROPN
admet-2057	1106	25	.	.	PUNCT
admet-2057	1107	1	highly	highly	ADV
admet-2057	1107	2	improved	improve	VERB
admet-2057	1107	3	ph	ph	ADJ
admet-2057	1107	4	-	-	ADJ
admet-2057	1107	5	responsive	responsive	ADJ
admet-2057	1107	6	anticancer	anticancer	NOUN
admet-2057	1107	7	drug	drug	NOUN
admet-2057	1107	8	delivery	delivery	NOUN
admet-2057	1107	9	and	and	CCONJ
admet-2057	1107	10	t2	t2	NOUN
admet-2057	1107	11	-	-	PUNCT
admet-2057	1107	12	weighted	weight	VERB
admet-2057	1107	13	mri	mri	NOUN
admet-2057	1107	14	imaging	imaging	NOUN
admet-2057	1107	15	by	by	ADP
admet-2057	1107	16	magnetic	magnetic	ADJ
admet-2057	1107	17	mof	mof	VERB
admet-2057	1107	18	cubtc	cubtc	PROPN
admet-2057	1107	19	-	-	PUNCT
admet-2057	1107	20	based	base	VERB
admet-2057	1107	21	nano	nano	NOUN
admet-2057	1107	22	/	/	SYM
admet-2057	1107	23	microcomposite	microcomposite	ADJ
admet-2057	1107	24	.	.	PUNCT
admet-2057	1108	1	frontiers	frontier	NOUN
admet-2057	1108	2	in	in	ADP
admet-2057	1108	3	molecular	molecular	ADJ
admet-2057	1108	4	biosciences	bioscience	NOUN
admet-2057	1108	5	10	10	NUM
admet-2057	1108	6	(	(	PUNCT
admet-2057	1108	7	2023	2023	NUM
admet-2057	1108	8	)	)	PUNCT
admet-2057	1108	9	1071376	1071376	NUM
admet-2057	1108	10	.	.	PUNCT
admet-2057	1109	1	https://doi.org/10.3389/fmolb.2023.1071376	https://doi.org/10.3389/fmolb.2023.1071376	PROPN
admet-2057	1109	2	[	[	X
admet-2057	1109	3	98	98	NUM
admet-2057	1109	4	]	]	X
admet-2057	1109	5	r.	r.	PROPN
admet-2057	1109	6	shahin	shahin	PROPN
admet-2057	1109	7	,	,	PUNCT
admet-2057	1109	8	m.	m.	NOUN
admet-2057	1109	9	yousefi	yousefi	PROPN
admet-2057	1109	10	,	,	PUNCT
admet-2057	1109	11	h.	h.	PROPN
admet-2057	1109	12	ziyadi	ziyadi	PROPN
admet-2057	1109	13	,	,	PUNCT
admet-2057	1109	14	m.	m.	NOUN
admet-2057	1109	15	bikhof	bikhof	PROPN
admet-2057	1109	16	,	,	PUNCT
admet-2057	1109	17	m.	m.	NOUN
admet-2057	1109	18	hekmati	hekmati	PROPN
admet-2057	1109	19	.	.	PUNCT
admet-2057	1110	1	ph	ph	VERB
admet-2057	1110	2	-	-	PUNCT
admet-2057	1110	3	responsive	responsive	ADJ
admet-2057	1110	4	and	and	CCONJ
admet-2057	1110	5	magnetic	magnetic	ADJ
admet-2057	1110	6	fe3o4@uio66	fe3o4@uio66	PROPN
admet-2057	1110	7	-	-	PUNCT
admet-2057	1110	8	nh2@pei	nh2@pei	PROPN
admet-2057	1110	9	nanocomposite	nanocomposite	PROPN
admet-2057	1110	10	as	as	ADP
admet-2057	1110	11	drug	drug	NOUN
admet-2057	1110	12	nanocarrier	nanocarrier	NOUN
admet-2057	1110	13	:	:	PUNCT
admet-2057	1110	14	loading	loading	NOUN
admet-2057	1110	15	and	and	CCONJ
admet-2057	1110	16	release	release	NOUN
admet-2057	1110	17	study	study	NOUN
admet-2057	1110	18	of	of	ADP
admet-2057	1110	19	imatinib	imatinib	NOUN
admet-2057	1110	20	.	.	PUNCT
admet-2057	1111	1	inorganic	inorganic	ADJ
admet-2057	1111	2	chemistry	chemistry	NOUN
admet-2057	1111	3	communication	communication	NOUN
admet-2057	1111	4	147	147	NUM
admet-2057	1111	5	(	(	PUNCT
admet-2057	1111	6	2023	2023	NUM
admet-2057	1111	7	)	)	PUNCT
admet-2057	1111	8	110186	110186	NUM
admet-2057	1111	9	.	.	PUNCT
admet-2057	1112	1	https://doi.org/10.1016/j.inoche.2022.110186	https://doi.org/10.1016/j.inoche.2022.110186	VERB
admet-2057	1112	2	[	[	X
admet-2057	1112	3	99	99	NUM
admet-2057	1112	4	]	]	PUNCT
admet-2057	1112	5	a.	a.	NOUN
admet-2057	1112	6	lajevardi	lajevardi	PROPN
admet-2057	1112	7	,	,	PUNCT
admet-2057	1112	8	m.	m.	NOUN
admet-2057	1112	9	hossaini	hossaini	PROPN
admet-2057	1112	10	sadr	sadr	PROPN
admet-2057	1112	11	,	,	PUNCT
admet-2057	1112	12	m.	m.	NOUN
admet-2057	1112	13	tavakkoli	tavakkoli	PROPN
admet-2057	1112	14	yaraki	yaraki	PROPN
admet-2057	1112	15	,	,	PUNCT
admet-2057	1112	16	a.	a.	PROPN
admet-2057	1112	17	badiei	badiei	PROPN
admet-2057	1112	18	,	,	PUNCT
admet-2057	1112	19	m.	m.	NOUN
admet-2057	1112	20	armaghan	armaghan	NOUN
admet-2057	1112	21	.	.	PUNCT
admet-2057	1113	1	a	a	DET
admet-2057	1113	2	ph	ph	VERB
admet-2057	1113	3	-	-	PUNCT
admet-2057	1113	4	responsive	responsive	ADJ
admet-2057	1113	5	and	and	CCONJ
admet-2057	1113	6	magnetic	magnetic	ADJ
admet-2057	1113	7	fe3o4@silica@mil-100(fe)/β	fe3o4@silica@mil-100(fe)/β	PROPN
admet-2057	1113	8	-	-	PUNCT
admet-2057	1113	9	cd	cd	PROPN
admet-2057	1113	10	nanocomposite	nanocomposite	NOUN
admet-2057	1113	11	as	as	ADP
admet-2057	1113	12	a	a	DET
admet-2057	1113	13	drug	drug	NOUN
admet-2057	1113	14	nanocarrier	nanocarrier	NOUN
admet-2057	1113	15	:	:	PUNCT
admet-2057	1113	16	loading	loading	NOUN
admet-2057	1113	17	and	and	CCONJ
admet-2057	1113	18	release	release	NOUN
admet-2057	1113	19	study	study	NOUN
admet-2057	1113	20	of	of	ADP
admet-2057	1113	21	cephalexin	cephalexin	PROPN
admet-2057	1113	22	.	.	PUNCT
admet-2057	1114	1	new	new	ADJ
admet-2057	1114	2	journal	journal	NOUN
admet-2057	1114	3	of	of	ADP
admet-2057	1114	4	chemistry	chemistry	NOUN
admet-2057	1114	5	42(12	42(12	NUM
admet-2057	1114	6	)	)	PUNCT
admet-2057	1114	7	(	(	PUNCT
admet-2057	1114	8	2018	2018	NUM
admet-2057	1114	9	)	)	PUNCT
admet-2057	1114	10	9690	9690	NUM
admet-2057	1114	11	-	-	SYM
admet-2057	1114	12	9701	9701	NUM
admet-2057	1114	13	.	.	PUNCT
admet-2057	1115	1	https://doi.org/10.1039/c8nj01375f	https://doi.org/10.1039/c8nj01375f	NOUN
admet-2057	1115	2	[	[	X
admet-2057	1115	3	100	100	NUM
admet-2057	1115	4	]	]	X
admet-2057	1115	5	l.l	l.l	PROPN
admet-2057	1115	6	.	.	PROPN
admet-2057	1115	7	tan	tan	PROPN
admet-2057	1115	8	,	,	PUNCT
admet-2057	1115	9	h.	h.	PROPN
admet-2057	1115	10	li	li	PROPN
admet-2057	1115	11	,	,	PUNCT
admet-2057	1115	12	y.	y.	PROPN
admet-2057	1115	13	zhou	zhou	PROPN
admet-2057	1115	14	,	,	PUNCT
admet-2057	1115	15	y.	y.	PROPN
admet-2057	1115	16	zhang	zhang	PROPN
admet-2057	1115	17	,	,	PUNCT
admet-2057	1115	18	x.	x.	PROPN
admet-2057	1115	19	feng	feng	PROPN
admet-2057	1115	20	,	,	PUNCT
admet-2057	1115	21	b.	b.	PROPN
admet-2057	1115	22	wang	wang	PROPN
admet-2057	1115	23	,	,	PUNCT
admet-2057	1115	24	y.w	y.w	PROPN
admet-2057	1115	25	.	.	PROPN
admet-2057	1115	26	yang	yang	PROPN
admet-2057	1115	27	.	.	PUNCT
admet-2057	1116	1	zn2	zn2	PROPN
admet-2057	1116	2	+	+	ADJ
admet-2057	1116	3	-triggered	-triggered	ADJ
admet-2057	1116	4	drug	drug	NOUN
admet-2057	1116	5	release	release	NOUN
admet-2057	1116	6	from	from	ADP
admet-2057	1116	7	biocompatible	biocompatible	ADJ
admet-2057	1116	8	zirconium	zirconium	NOUN
admet-2057	1116	9	mofs	mof	NOUN
admet-2057	1116	10	equipped	equip	VERB
admet-2057	1116	11	with	with	ADP
admet-2057	1116	12	supramolecular	supramolecular	ADJ
admet-2057	1116	13	gates	gate	NOUN
admet-2057	1116	14	.	.	PUNCT
admet-2057	1117	1	small	small	ADJ
admet-2057	1117	2	11(31	11(31	NUM
admet-2057	1117	3	)	)	PUNCT
admet-2057	1117	4	(	(	PUNCT
admet-2057	1117	5	2015	2015	NUM
admet-2057	1117	6	)	)	PUNCT
admet-2057	1117	7	38073813	38073813	NUM
admet-2057	1117	8	.	.	PUNCT
admet-2057	1118	1	https://doi.org/10.1002/smll.201500155	https://doi.org/10.1002/smll.201500155	X
admet-2057	1119	1	[	[	X
admet-2057	1119	2	101	101	NUM
admet-2057	1119	3	]	]	PUNCT
admet-2057	1119	4	s.	s.	PROPN
admet-2057	1119	5	rojas	rojas	PROPN
admet-2057	1119	6	,	,	PUNCT
admet-2057	1119	7	t.	t.	PROPN
admet-2057	1119	8	hidalgo	hidalgo	PROPN
admet-2057	1119	9	,	,	PUNCT
admet-2057	1119	10	z.	z.	PROPN
admet-2057	1119	11	luo	luo	PROPN
admet-2057	1119	12	,	,	PUNCT
admet-2057	1119	13	d.	d.	PROPN
admet-2057	1119	14	ávila	ávila	PROPN
admet-2057	1119	15	,	,	PUNCT
admet-2057	1119	16	a.	a.	NOUN
admet-2057	1119	17	laromaine	laromaine	PROPN
admet-2057	1119	18	,	,	PUNCT
admet-2057	1119	19	p.	p.	PROPN
admet-2057	1119	20	horcajada	horcajada	PROPN
admet-2057	1119	21	.	.	PUNCT
admet-2057	1120	1	pushing	push	VERB
admet-2057	1120	2	the	the	DET
admet-2057	1120	3	limits	limit	NOUN
admet-2057	1120	4	on	on	ADP
admet-2057	1120	5	the	the	DET
admet-2057	1120	6	intestinal	intestinal	ADJ
admet-2057	1120	7	crossing	crossing	NOUN
admet-2057	1120	8	of	of	ADP
admet-2057	1120	9	metal	metal	NOUN
admet-2057	1120	10	-	-	PUNCT
admet-2057	1120	11	organic	organic	ADJ
admet-2057	1120	12	frameworks	framework	NOUN
admet-2057	1120	13	:	:	PUNCT
admet-2057	1120	14	an	an	DET
admet-2057	1120	15	ex	ex	NOUN
admet-2057	1120	16	vivo	vivo	NOUN
admet-2057	1120	17	and	and	CCONJ
admet-2057	1120	18	in	in	ADP
admet-2057	1120	19	vivo	vivo	ADJ
admet-2057	1120	20	detailed	detailed	ADJ
admet-2057	1120	21	study	study	NOUN
admet-2057	1120	22	.	.	PUNCT
admet-2057	1121	1	acs	acs	PROPN
admet-2057	1121	2	nano	nano	VERB
admet-2057	1121	3	16	16	NUM
admet-2057	1121	4	(	(	PUNCT
admet-2057	1121	5	2022	2022	NUM
admet-2057	1121	6	)	)	PUNCT
admet-2057	1121	7	5830	5830	NUM
admet-2057	1121	8	-	-	SYM
admet-2057	1121	9	5838	5838	NUM
admet-2057	1121	10	.	.	PUNCT
admet-2057	1122	1	https://doi.org/10.1021/acsnano.1c10942	https://doi.org/10.1021/acsnano.1c10942	PROPN
admet-2057	1123	1	[	[	X
admet-2057	1123	2	102	102	NUM
admet-2057	1123	3	]	]	X
admet-2057	1123	4	y.	y.	PROPN
admet-2057	1123	5	zhou	zhou	PROPN
admet-2057	1123	6	,	,	PUNCT
admet-2057	1123	7	l.	l.	PROPN
admet-2057	1123	8	liu	liu	PROPN
admet-2057	1123	9	,	,	PUNCT
admet-2057	1123	10	y.	y.	PROPN
admet-2057	1123	11	cao	cao	PROPN
admet-2057	1123	12	,	,	PUNCT
admet-2057	1123	13	s.	s.	PROPN
admet-2057	1123	14	yu	yu	PROPN
admet-2057	1123	15	,	,	PUNCT
admet-2057	1123	16	c.	c.	PROPN
admet-2057	1123	17	he	he	PRON
admet-2057	1123	18	,	,	PUNCT
admet-2057	1123	19	x.	x.	PROPN
admet-2057	1123	20	chen	chen	PROPN
admet-2057	1123	21	.	.	PUNCT
admet-2057	1124	1	a	a	DET
admet-2057	1124	2	nanocomposite	nanocomposite	NOUN
admet-2057	1124	3	vehicle	vehicle	NOUN
admet-2057	1124	4	based	base	VERB
admet-2057	1124	5	on	on	ADP
admet-2057	1124	6	metal	metal	NOUN
admet-2057	1124	7	-	-	PUNCT
admet-2057	1124	8	organic	organic	ADJ
admet-2057	1124	9	framework	framework	NOUN
admet-2057	1124	10	nanoparticle	nanoparticle	NOUN
admet-2057	1124	11	incorporated	incorporate	VERB
admet-2057	1124	12	biodegradable	biodegradable	ADJ
admet-2057	1124	13	microspheres	microsphere	NOUN
admet-2057	1124	14	for	for	ADP
admet-2057	1124	15	enhanced	enhanced	ADJ
admet-2057	1124	16	oral	oral	ADJ
admet-2057	1124	17	insulin	insulin	NOUN
admet-2057	1124	18	delivery	delivery	NOUN
admet-2057	1124	19	.	.	PUNCT
admet-2057	1125	1	acs	acs	PROPN
admet-2057	1125	2	applied	apply	VERB
admet-2057	1125	3	material	material	NOUN
admet-2057	1125	4	&	&	CCONJ
admet-2057	1125	5	interfaces	interface	NOUN
admet-2057	1125	6	12	12	NUM
admet-2057	1125	7	(	(	PUNCT
admet-2057	1125	8	2020	2020	NUM
admet-2057	1125	9	)	)	PUNCT
admet-2057	1125	10	22581	22581	NUM
admet-2057	1125	11	-	-	SYM
admet-2057	1125	12	22592	22592	NUM
admet-2057	1125	13	.	.	PUNCT
admet-2057	1126	1	https://doi.org/10.1021/acsami.0c04303	https://doi.org/10.1021/acsami.0c04303	PROPN
admet-2057	1126	2	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	VERB
admet-2057	1126	3	https://doi.org/10.1021/bi00002a033	https://doi.org/10.1021/bi00002a033	PROPN
admet-2057	1126	4	https://doi.org/10.1002/adfm.201702102	https://doi.org/10.1002/adfm.201702102	NOUN
admet-2057	1126	5	https://doi.org/10.1002/adfm.201705137	https://doi.org/10.1002/adfm.201705137	ADJ
admet-2057	1126	6	https://doi.org/10.1021/jacs.8b11996	https://doi.org/10.1021/jacs.8b11996	NOUN
admet-2057	1126	7	https://doi.org/10.1039/c8dt03202e	https://doi.org/10.1039/c8dt03202e	PROPN
admet-2057	1126	8	https://doi.org/10.1039/c5tb01789k	https://doi.org/10.1039/c5tb01789k	NOUN
admet-2057	1126	9	https://doi.org/10.1039/c9ce01731c	https://doi.org/10.1039/c9ce01731c	PROPN
admet-2057	1126	10	https://doi.org/10.1002/chem.201904704	https://doi.org/10.1002/chem.201904704	NOUN
admet-2057	1126	11	https://doi.org/10.1080/14686996.2019.1682467	https://doi.org/10.1080/14686996.2019.1682467	ADJ
admet-2057	1126	12	https://doi.org/10.3389/fmolb.2023.1071376	https://doi.org/10.3389/fmolb.2023.1071376	PROPN
admet-2057	1126	13	https://doi.org/10.1016/j.inoche.2022.110186	https://doi.org/10.1016/j.inoche.2022.110186	VERB
admet-2057	1126	14	https://doi.org/10.1039/c8nj01375f	https://doi.org/10.1039/c8nj01375f	PROPN
admet-2057	1126	15	https://doi.org/10.1002/smll.201500155	https://doi.org/10.1002/smll.201500155	NOUN
admet-2057	1126	16	https://doi.org/10.1021/acsnano.1c10942	https://doi.org/10.1021/acsnano.1c10942	PROPN
admet-2057	1126	17	https://doi.org/10.1021/acsami.0c04303	https://doi.org/10.1021/acsami.0c04303	PROPN
admet-2057	1126	18	p.	p.	PROPN
admet-2057	1126	19	mhettar	mhettar	PROPN
admet-2057	1126	20	et	et	PROPN
admet-2057	1126	21	al	al	PROPN
admet-2057	1126	22	.	.	PROPN
admet-2057	1126	23	admet	admet	PROPN
admet-2057	1126	24	&	&	CCONJ
admet-2057	1126	25	dmpk	dmpk	PROPN
admet-2057	1126	26	12(1	12(1	PROPN
admet-2057	1126	27	)	)	PUNCT
admet-2057	1126	28	(	(	PUNCT
admet-2057	1126	29	2024	2024	NUM
admet-2057	1126	30	)	)	PUNCT
admet-2057	1126	31	27	27	NUM
admet-2057	1126	32	-	-	SYM
admet-2057	1126	33	62	62	NUM
admet-2057	1126	34	60	60	NUM
admet-2057	1127	1	[	[	X
admet-2057	1127	2	103	103	NUM
admet-2057	1127	3	]	]	PUNCT
admet-2057	1127	4	s.	s.	PROPN
admet-2057	1127	5	javanbakht	javanbakht	PROPN
admet-2057	1127	6	,	,	PUNCT
admet-2057	1127	7	p.	p.	PROPN
admet-2057	1127	8	nezhad	nezhad	PROPN
admet-2057	1127	9	-	-	PUNCT
admet-2057	1127	10	mokhtari	mokhtari	NOUN
admet-2057	1127	11	,	,	PUNCT
admet-2057	1127	12	a.	a.	NOUN
admet-2057	1127	13	shaabani	shaabani	PROPN
admet-2057	1127	14	,	,	PUNCT
admet-2057	1127	15	n.	n.	PROPN
admet-2057	1127	16	arsalani	arsalani	PROPN
admet-2057	1127	17	,	,	PUNCT
admet-2057	1127	18	m.	m.	NOUN
admet-2057	1127	19	ghorbani	ghorbani	NOUN
admet-2057	1127	20	.	.	PUNCT
admet-2057	1128	1	incorporating	incorporate	VERB
admet-2057	1128	2	cu	cu	PROPN
admet-2057	1128	3	-	-	PUNCT
admet-2057	1128	4	based	base	VERB
admet-2057	1128	5	metal	metal	NOUN
admet-2057	1128	6	-	-	PUNCT
admet-2057	1128	7	organic	organic	ADJ
admet-2057	1128	8	framework	framework	NOUN
admet-2057	1128	9	/	/	SYM
admet-2057	1128	10	drug	drug	NOUN
admet-2057	1128	11	nanohybrids	nanohybrid	NOUN
admet-2057	1128	12	into	into	ADP
admet-2057	1128	13	gelatin	gelatin	NOUN
admet-2057	1128	14	microsphere	microsphere	NOUN
admet-2057	1128	15	for	for	ADP
admet-2057	1128	16	ibuprofen	ibuprofen	PROPN
admet-2057	1128	17	oral	oral	ADJ
admet-2057	1128	18	delivery	delivery	NOUN
admet-2057	1128	19	.	.	PUNCT
admet-2057	1129	1	materials	material	NOUN
admet-2057	1129	2	science	science	NOUN
admet-2057	1129	3	and	and	CCONJ
admet-2057	1129	4	engineering	engineering	NOUN
admet-2057	1129	5	c	c	PROPN
admet-2057	1129	6	96	96	NUM
admet-2057	1129	7	(	(	PUNCT
admet-2057	1129	8	2019	2019	NUM
admet-2057	1129	9	)	)	PUNCT
admet-2057	1129	10	302	302	NUM
admet-2057	1129	11	-	-	SYM
admet-2057	1129	12	309	309	NUM
admet-2057	1129	13	.	.	PUNCT
admet-2057	1130	1	https://doi.org/10.1016/j.msec.2018.11.028	https://doi.org/10.1016/j.msec.2018.11.028	NOUN
admet-2057	1130	2	[	[	X
admet-2057	1130	3	104	104	NUM
admet-2057	1130	4	]	]	PUNCT
admet-2057	1130	5	y.	y.	PROPN
admet-2057	1130	6	zhou	zhou	PROPN
admet-2057	1130	7	,	,	PUNCT
admet-2057	1130	8	z.	z.	PROPN
admet-2057	1130	9	chen	chen	PROPN
admet-2057	1130	10	,	,	PUNCT
admet-2057	1130	11	d.	d.	PROPN
admet-2057	1130	12	zhao	zhao	PROPN
admet-2057	1130	13	,	,	PUNCT
admet-2057	1130	14	d.	d.	PROPN
admet-2057	1130	15	li	li	PROPN
admet-2057	1130	16	,	,	PUNCT
admet-2057	1130	17	c.	c.	PROPN
admet-2057	1130	18	he	he	PROPN
admet-2057	1130	19	,	,	PUNCT
admet-2057	1130	20	x.	x.	PROPN
admet-2057	1130	21	chen	chen	PROPN
admet-2057	1130	22	.	.	PUNCT
admet-2057	1131	1	a	a	DET
admet-2057	1131	2	ph	ph	VERB
admet-2057	1131	3	-	-	PUNCT
admet-2057	1131	4	triggered	trigger	VERB
admet-2057	1131	5	self	self	NOUN
admet-2057	1131	6	-	-	PUNCT
admet-2057	1131	7	unpacking	unpack	VERB
admet-2057	1131	8	capsule	capsule	NOUN
admet-2057	1131	9	containing	contain	VERB
admet-2057	1131	10	zwitterionic	zwitterionic	ADJ
admet-2057	1131	11	hydrogel	hydrogel	NOUN
admet-2057	1131	12	-	-	PUNCT
admet-2057	1131	13	coated	coat	VERB
admet-2057	1131	14	mof	mof	ADJ
admet-2057	1131	15	nanoparticles	nanoparticle	NOUN
admet-2057	1131	16	for	for	ADP
admet-2057	1131	17	efficient	efficient	ADJ
admet-2057	1131	18	oral	oral	ADJ
admet-2057	1131	19	exendin-4	exendin-4	NUM
admet-2057	1131	20	delivery	delivery	NOUN
admet-2057	1131	21	.	.	PUNCT
admet-2057	1132	1	advanced	advanced	ADJ
admet-2057	1132	2	materials	material	NOUN
admet-2057	1132	3	33(32	33(32	NUM
admet-2057	1132	4	)	)	PUNCT
admet-2057	1132	5	(	(	PUNCT
admet-2057	1132	6	2021	2021	NUM
admet-2057	1132	7	)	)	PUNCT
admet-2057	1132	8	2102044	2102044	NUM
admet-2057	1132	9	.	.	PUNCT
admet-2057	1133	1	https://doi.org/10.1002/adma.202102044	https://doi.org/10.1002/adma.202102044	PROPN
admet-2057	1134	1	[	[	X
admet-2057	1134	2	105	105	NUM
admet-2057	1134	3	]	]	X
admet-2057	1134	4	m.	m.	NOUN
admet-2057	1134	5	gao	gao	PROPN
admet-2057	1134	6	,	,	PUNCT
admet-2057	1134	7	c.	c.	PROPN
admet-2057	1134	8	yang	yang	PROPN
admet-2057	1134	9	,	,	PUNCT
admet-2057	1134	10	c.	c.	PROPN
admet-2057	1134	11	wu	wu	PROPN
admet-2057	1134	12	,	,	PUNCT
admet-2057	1134	13	y.	y.	PROPN
admet-2057	1134	14	chen	chen	PROPN
admet-2057	1134	15	,	,	PUNCT
admet-2057	1134	16	h.	h.	PROPN
admet-2057	1134	17	zhuang	zhuang	PROPN
admet-2057	1134	18	,	,	PUNCT
admet-2057	1134	19	j.	j.	PROPN
admet-2057	1134	20	wang	wang	PROPN
admet-2057	1134	21	,	,	PUNCT
admet-2057	1134	22	z.	z.	PROPN
admet-2057	1134	23	cao	cao	PROPN
admet-2057	1134	24	.	.	PUNCT
admet-2057	1134	25	hydrogel	hydrogel	NOUN
admet-2057	1134	26	-	-	PUNCT
admet-2057	1134	27	metal	metal	NOUN
admet-2057	1134	28	-	-	PUNCT
admet-2057	1134	29	organic	organic	VERB
admet-2057	1134	30	-	-	PUNCT
admet-2057	1134	31	framework	framework	NOUN
admet-2057	1134	32	hybrids	hybrid	NOUN
admet-2057	1134	33	mediated	mediate	VERB
admet-2057	1134	34	efficient	efficient	ADJ
admet-2057	1134	35	oral	oral	ADJ
admet-2057	1134	36	delivery	delivery	NOUN
admet-2057	1134	37	of	of	ADP
admet-2057	1134	38	sirna	sirna	PROPN
admet-2057	1134	39	for	for	ADP
admet-2057	1134	40	the	the	DET
admet-2057	1134	41	treatment	treatment	NOUN
admet-2057	1134	42	of	of	ADP
admet-2057	1134	43	ulcerative	ulcerative	ADJ
admet-2057	1134	44	colitis	colitis	NOUN
admet-2057	1134	45	.	.	PUNCT
admet-2057	1135	1	journal	journal	NOUN
admet-2057	1135	2	of	of	ADP
admet-2057	1135	3	nanobiotechnology	nanobiotechnology	NOUN
admet-2057	1135	4	20	20	NUM
admet-2057	1135	5	(	(	PUNCT
admet-2057	1135	6	2022	2022	NUM
admet-2057	1135	7	)	)	PUNCT
admet-2057	1135	8	404	404	NUM
admet-2057	1135	9	.	.	PUNCT
admet-2057	1136	1	https://doi.org/10.1186/s12951-022-01603-6	https://doi.org/10.1186/s12951-022-01603-6	X
admet-2057	1137	1	[	[	X
admet-2057	1137	2	106	106	X
admet-2057	1137	3	]	]	PUNCT
admet-2057	1137	4	s.	s.	PROPN
admet-2057	1137	5	javanbakht	javanbakht	PROPN
admet-2057	1137	6	,	,	PUNCT
admet-2057	1137	7	a.	a.	PROPN
admet-2057	1137	8	hemmati	hemmati	PROPN
admet-2057	1137	9	,	,	PUNCT
admet-2057	1137	10	h.	h.	PROPN
admet-2057	1137	11	namazi	namazi	PROPN
admet-2057	1137	12	,	,	PUNCT
admet-2057	1137	13	a.	a.	NOUN
admet-2057	1137	14	heydari	heydari	NOUN
admet-2057	1137	15	.	.	PUNCT
admet-2057	1138	1	carboxymethylcellulose	carboxymethylcellulose	PROPN
admet-2057	1138	2	-	-	PUNCT
admet-2057	1138	3	coated	coat	VERB
admet-2057	1138	4	5fluorouracil@mof-5	5fluorouracil@mof-5	NUM
admet-2057	1138	5	nano	nano	NOUN
admet-2057	1138	6	-	-	PUNCT
admet-2057	1138	7	hybrid	hybrid	NOUN
admet-2057	1138	8	as	as	ADP
admet-2057	1138	9	a	a	DET
admet-2057	1138	10	bio	bio	ADJ
admet-2057	1138	11	-	-	ADJ
admet-2057	1138	12	nanocomposite	nanocomposite	ADJ
admet-2057	1138	13	carrier	carrier	NOUN
admet-2057	1138	14	for	for	ADP
admet-2057	1138	15	the	the	DET
admet-2057	1138	16	anticancer	anticancer	NOUN
admet-2057	1138	17	oral	oral	ADJ
admet-2057	1138	18	delivery	delivery	NOUN
admet-2057	1138	19	.	.	PUNCT
admet-2057	1139	1	international	international	ADJ
admet-2057	1139	2	journal	journal	NOUN
admet-2057	1139	3	of	of	ADP
admet-2057	1139	4	biolecular	biolecular	ADJ
admet-2057	1139	5	macromolecules	macromolecule	NOUN
admet-2057	1139	6	.	.	PUNCT
admet-2057	1140	1	155	155	NUM
admet-2057	1140	2	(	(	PUNCT
admet-2057	1140	3	2020	2020	NUM
admet-2057	1140	4	)	)	PUNCT
admet-2057	1140	5	876	876	NUM
admet-2057	1140	6	-	-	SYM
admet-2057	1140	7	882	882	NUM
admet-2057	1140	8	.	.	PUNCT
admet-2057	1141	1	https://doi.org/10.1016/j.ijbiomac.2019.12.007	https://doi.org/10.1016/j.ijbiomac.2019.12.007	VERB
admet-2057	1141	2	[	[	X
admet-2057	1141	3	107	107	NUM
admet-2057	1141	4	]	]	PUNCT
admet-2057	1141	5	k.	k.	PROPN
admet-2057	1141	6	jiang	jiang	PROPN
admet-2057	1141	7	,	,	PUNCT
admet-2057	1141	8	w.	w.	PROPN
admet-2057	1141	9	ni	ni	PROPN
admet-2057	1141	10	,	,	PUNCT
admet-2057	1141	11	x.	x.	PROPN
admet-2057	1141	12	cao	cao	PROPN
admet-2057	1141	13	,	,	PUNCT
admet-2057	1141	14	l.	l.	PROPN
admet-2057	1141	15	zhang	zhang	PROPN
admet-2057	1141	16	,	,	PUNCT
admet-2057	1141	17	s.	s.	PROPN
admet-2057	1141	18	lin	lin	PROPN
admet-2057	1141	19	.	.	PUNCT
admet-2057	1142	1	a	a	DET
admet-2057	1142	2	nanosized	nanosized	ADJ
admet-2057	1142	3	anionic	anionic	NOUN
admet-2057	1142	4	mof	mof	NOUN
admet-2057	1142	5	with	with	ADP
admet-2057	1142	6	rich	rich	ADJ
admet-2057	1142	7	thiadiazole	thiadiazole	NOUN
admet-2057	1142	8	groups	group	NOUN
admet-2057	1142	9	for	for	ADP
admet-2057	1142	10	controlled	control	VERB
admet-2057	1142	11	oral	oral	ADJ
admet-2057	1142	12	drug	drug	NOUN
admet-2057	1142	13	delivery	delivery	NOUN
admet-2057	1142	14	.	.	PUNCT
admet-2057	1143	1	matereials	matereial	NOUN
admet-2057	1143	2	today	today	NOUN
admet-2057	1143	3	bio	bio	PROPN
admet-2057	1143	4	13	13	NUM
admet-2057	1143	5	(	(	PUNCT
admet-2057	1143	6	2022	2022	NUM
admet-2057	1143	7	)	)	PUNCT
admet-2057	1143	8	100180	100180	NUM
admet-2057	1143	9	.	.	PUNCT
admet-2057	1144	1	https://doi.org/10.1016/j.mtbio.2021.100180	https://doi.org/10.1016/j.mtbio.2021.100180	NOUN
admet-2057	1145	1	[	[	X
admet-2057	1145	2	108	108	NUM
admet-2057	1145	3	]	]	X
admet-2057	1145	4	j.j	j.j	PROPN
admet-2057	1145	5	.	.	PROPN
admet-2057	1145	6	zou	zou	PROPN
admet-2057	1145	7	,	,	PUNCT
admet-2057	1145	8	g.	g.	PROPN
admet-2057	1145	9	wei	wei	PROPN
admet-2057	1145	10	,	,	PUNCT
admet-2057	1145	11	c.	c.	PROPN
admet-2057	1145	12	xiong	xiong	PROPN
admet-2057	1145	13	,	,	PUNCT
admet-2057	1145	14	y.	y.	PROPN
admet-2057	1145	15	yu	yu	PROPN
admet-2057	1145	16	,	,	PUNCT
admet-2057	1145	17	s.	s.	PROPN
admet-2057	1145	18	li	li	PROPN
admet-2057	1145	19	,	,	PUNCT
admet-2057	1145	20	l.	l.	PROPN
admet-2057	1145	21	hu	hu	PROPN
admet-2057	1145	22	,	,	PUNCT
admet-2057	1145	23	s.	s.	PROPN
admet-2057	1145	24	ma	ma	PROPN
admet-2057	1145	25	,	,	PUNCT
admet-2057	1145	26	j.	j.	PROPN
admet-2057	1145	27	tian	tian	PROPN
admet-2057	1145	28	.	.	PUNCT
admet-2057	1146	1	efficient	efficient	ADJ
admet-2057	1146	2	oral	oral	ADJ
admet-2057	1146	3	insulin	insulin	NOUN
admet-2057	1146	4	delivery	delivery	NOUN
admet-2057	1146	5	enabled	enable	VERB
admet-2057	1146	6	by	by	ADP
admet-2057	1146	7	transferrin	transferrin	NOUN
admet-2057	1146	8	-	-	PUNCT
admet-2057	1146	9	coated	coat	VERB
admet-2057	1146	10	acid	acid	NOUN
admet-2057	1146	11	-	-	PUNCT
admet-2057	1146	12	resistant	resistant	ADJ
admet-2057	1146	13	metal	metal	NOUN
admet-2057	1146	14	-	-	PUNCT
admet-2057	1146	15	organic	organic	ADJ
admet-2057	1146	16	framework	framework	NOUN
admet-2057	1146	17	nanoparticles	nanoparticle	NOUN
admet-2057	1146	18	.	.	PUNCT
admet-2057	1147	1	science	science	NOUN
admet-2057	1147	2	advances	advance	NOUN
admet-2057	1147	3	8(8	8(8	NUM
admet-2057	1147	4	)	)	PUNCT
admet-2057	1147	5	(	(	PUNCT
admet-2057	1147	6	2022	2022	NUM
admet-2057	1147	7	)	)	PUNCT
admet-2057	1147	8	4677	4677	NUM
admet-2057	1147	9	.	.	PUNCT
admet-2057	1148	1	https://doi.org/10.1126/sciadv.abm4677	https://doi.org/10.1126/sciadv.abm4677	PROPN
admet-2057	1149	1	[	[	X
admet-2057	1149	2	109	109	NUM
admet-2057	1149	3	]	]	PUNCT
admet-2057	1149	4	g.	g.	PROPN
admet-2057	1149	5	cheng	cheng	PROPN
admet-2057	1149	6	,	,	PUNCT
admet-2057	1149	7	w.	w.	PROPN
admet-2057	1149	8	li	li	PROPN
admet-2057	1149	9	,	,	PUNCT
admet-2057	1149	10	l.	l.	PROPN
admet-2057	1149	11	ha	ha	PROPN
admet-2057	1149	12	,	,	PUNCT
admet-2057	1149	13	x.	x.	PROPN
admet-2057	1149	14	han	han	PROPN
admet-2057	1149	15	,	,	PUNCT
admet-2057	1149	16	s.	s.	PROPN
admet-2057	1149	17	hao	hao	PROPN
admet-2057	1149	18	,	,	PUNCT
admet-2057	1149	19	y.	y.	PROPN
admet-2057	1149	20	wan	wan	PROPN
admet-2057	1149	21	,	,	PUNCT
admet-2057	1149	22	z.	z.	PROPN
admet-2057	1149	23	wang	wang	PROPN
admet-2057	1149	24	,	,	PUNCT
admet-2057	1149	25	f.	f.	PROPN
admet-2057	1149	26	dong	dong	PROPN
admet-2057	1149	27	,	,	PUNCT
admet-2057	1149	28	x.	x.	PROPN
admet-2057	1149	29	zou	zou	PROPN
admet-2057	1149	30	,	,	PUNCT
admet-2057	1149	31	y.	y.	PROPN
admet-2057	1149	32	mao	mao	PROPN
admet-2057	1149	33	,	,	PUNCT
admet-2057	1149	34	s.y	s.y	PROPN
admet-2057	1149	35	.	.	PUNCT
admet-2057	1150	1	zheng	zheng	PROPN
admet-2057	1150	2	.	.	PUNCT
admet-2057	1151	1	selfassembly	selfassembly	ADV
admet-2057	1151	2	of	of	ADP
admet-2057	1151	3	extracellular	extracellular	ADJ
admet-2057	1151	4	vesicle	vesicle	NOUN
admet-2057	1151	5	-	-	PUNCT
admet-2057	1151	6	like	like	ADJ
admet-2057	1151	7	metal	metal	NOUN
admet-2057	1151	8	-	-	PUNCT
admet-2057	1151	9	organic	organic	ADJ
admet-2057	1151	10	framework	framework	NOUN
admet-2057	1151	11	nanoparticles	nanoparticle	NOUN
admet-2057	1151	12	for	for	ADP
admet-2057	1151	13	protection	protection	NOUN
admet-2057	1151	14	and	and	CCONJ
admet-2057	1151	15	intracellular	intracellular	ADJ
admet-2057	1151	16	delivery	delivery	NOUN
admet-2057	1151	17	of	of	ADP
admet-2057	1151	18	biofunctional	biofunctional	ADJ
admet-2057	1151	19	proteins	protein	NOUN
admet-2057	1151	20	.	.	PUNCT
admet-2057	1152	1	journal	journal	NOUN
admet-2057	1152	2	of	of	ADP
admet-2057	1152	3	american	american	PROPN
admet-2057	1152	4	chemical	chemical	PROPN
admet-2057	1152	5	society	society	PROPN
admet-2057	1152	6	140	140	NUM
admet-2057	1152	7	(	(	PUNCT
admet-2057	1152	8	2018	2018	NUM
admet-2057	1152	9	)	)	PUNCT
admet-2057	1152	10	7282	7282	NUM
admet-2057	1152	11	-	-	SYM
admet-2057	1152	12	7291	7291	NUM
admet-2057	1152	13	.	.	PUNCT
admet-2057	1153	1	https://doi.org/10.1021/jacs.8b03584	https://doi.org/10.1021/jacs.8b03584	X
admet-2057	1154	1	[	[	X
admet-2057	1154	2	110	110	NUM
admet-2057	1154	3	]	]	X
admet-2057	1154	4	w.	w.	PROPN
admet-2057	1154	5	shang	shang	PROPN
admet-2057	1154	6	,	,	PUNCT
admet-2057	1154	7	l.	l.	PROPN
admet-2057	1154	8	peng	peng	PROPN
admet-2057	1154	9	,	,	PUNCT
admet-2057	1154	10	p.	p.	PROPN
admet-2057	1154	11	guo	guo	PROPN
admet-2057	1154	12	,	,	PUNCT
admet-2057	1154	13	h.	h.	PROPN
admet-2057	1154	14	hui	hui	PROPN
admet-2057	1154	15	,	,	PUNCT
admet-2057	1154	16	x.	x.	PROPN
admet-2057	1154	17	yang	yang	PROPN
admet-2057	1154	18	,	,	PUNCT
admet-2057	1154	19	j.	j.	PROPN
admet-2057	1154	20	tian	tian	PROPN
admet-2057	1154	21	.	.	PUNCT
admet-2057	1155	1	metal	metal	NOUN
admet-2057	1155	2	-	-	PUNCT
admet-2057	1155	3	organic	organic	ADJ
admet-2057	1155	4	frameworks	framework	NOUN
admet-2057	1155	5	as	as	ADP
admet-2057	1155	6	a	a	DET
admet-2057	1155	7	theranostic	theranostic	ADJ
admet-2057	1155	8	nanoplatform	nanoplatform	NOUN
admet-2057	1155	9	for	for	ADP
admet-2057	1155	10	combinatorial	combinatorial	ADJ
admet-2057	1155	11	chemophotothermal	chemophotothermal	ADJ
admet-2057	1155	12	therapy	therapy	NOUN
admet-2057	1155	13	adapted	adapt	VERB
admet-2057	1155	14	to	to	ADP
admet-2057	1155	15	different	different	ADJ
admet-2057	1155	16	administration	administration	NOUN
admet-2057	1155	17	.	.	PUNCT
admet-2057	1156	1	acs	acs	PROPN
admet-2057	1156	2	biomaterial	biomaterial	PROPN
admet-2057	1156	3	science	science	PROPN
admet-2057	1156	4	&	&	CCONJ
admet-2057	1156	5	engineering	engineering	PROPN
admet-2057	1156	6	6	6	NUM
admet-2057	1156	7	(	(	PUNCT
admet-2057	1156	8	2020	2020	NUM
admet-2057	1156	9	)	)	PUNCT
admet-2057	1156	10	1008	1008	NUM
admet-2057	1156	11	-	-	SYM
admet-2057	1156	12	1016	1016	NUM
admet-2057	1156	13	.	.	PUNCT
admet-2057	1157	1	https://doi.org/10.1021/acsbiomaterials.9b01075	https://doi.org/10.1021/acsbiomaterials.9b01075	PROPN
admet-2057	1158	1	[	[	X
admet-2057	1158	2	111	111	NUM
admet-2057	1158	3	]	]	PUNCT
admet-2057	1158	4	k.	k.	PROPN
admet-2057	1158	5	abouaitah	abouaitah	PROPN
admet-2057	1158	6	,	,	PUNCT
admet-2057	1158	7	i.m	i.m	PROPN
admet-2057	1158	8	.	.	PROPN
admet-2057	1158	9	higazy	higazy	PROPN
admet-2057	1158	10	,	,	PUNCT
admet-2057	1158	11	a.	a.	PROPN
admet-2057	1158	12	swiderska	swiderska	PROPN
admet-2057	1158	13	-	-	PUNCT
admet-2057	1158	14	sroda	sroda	PROPN
admet-2057	1158	15	,	,	PUNCT
admet-2057	1158	16	r.m	r.m	PROPN
admet-2057	1158	17	.	.	PROPN
admet-2057	1158	18	abdelhameed	abdelhameed	PROPN
admet-2057	1158	19	,	,	PUNCT
admet-2057	1158	20	s.	s.	PROPN
admet-2057	1158	21	gierlotka	gierlotka	PROPN
admet-2057	1158	22	,	,	PUNCT
admet-2057	1158	23	t.a	t.a	PROPN
admet-2057	1158	24	.	.	PROPN
admet-2057	1158	25	mohamed	mohamed	PROPN
admet-2057	1158	26	,	,	PUNCT
admet-2057	1158	27	u.	u.	NOUN
admet-2057	1158	28	szałaj	szałaj	PROPN
admet-2057	1158	29	,	,	PUNCT
admet-2057	1158	30	w.	w.	PROPN
admet-2057	1158	31	lojkowski	lojkowski	PROPN
admet-2057	1158	32	.	.	PUNCT
admet-2057	1159	1	anti	anti	ADJ
admet-2057	1159	2	-	-	ADJ
admet-2057	1159	3	inflammatory	inflammatory	ADJ
admet-2057	1159	4	and	and	CCONJ
admet-2057	1159	5	antioxidant	antioxidant	ADJ
admet-2057	1159	6	effects	effect	NOUN
admet-2057	1159	7	of	of	ADP
admet-2057	1159	8	nanoformulations	nanoformulation	NOUN
admet-2057	1159	9	composed	compose	VERB
admet-2057	1159	10	of	of	ADP
admet-2057	1159	11	metal	metal	NOUN
admet-2057	1159	12	-	-	PUNCT
admet-2057	1159	13	organic	organic	ADJ
admet-2057	1159	14	frameworks	framework	NOUN
admet-2057	1159	15	delivering	deliver	VERB
admet-2057	1159	16	rutin	rutin	NOUN
admet-2057	1159	17	and/or	and/or	CCONJ
admet-2057	1159	18	piperine	piperine	VERB
admet-2057	1159	19	natural	natural	ADJ
admet-2057	1159	20	agents	agent	NOUN
admet-2057	1159	21	.	.	PUNCT
admet-2057	1160	1	drug	drug	NOUN
admet-2057	1160	2	delivery	delivery	NOUN
admet-2057	1160	3	28	28	NUM
admet-2057	1160	4	(	(	PUNCT
admet-2057	1160	5	2021	2021	NUM
admet-2057	1160	6	)	)	PUNCT
admet-2057	1160	7	1478	1478	NUM
admet-2057	1160	8	-	-	SYM
admet-2057	1160	9	1495	1495	NUM
admet-2057	1160	10	.	.	PUNCT
admet-2057	1161	1	https://doi.org/10.1080/10717544.2021.1949073	https://doi.org/10.1080/10717544.2021.1949073	PUNCT
admet-2057	1162	1	[	[	X
admet-2057	1162	2	112	112	NUM
admet-2057	1162	3	]	]	PUNCT
admet-2057	1162	4	c.	c.	PROPN
admet-2057	1162	5	zhang	zhang	PROPN
admet-2057	1162	6	,	,	PUNCT
admet-2057	1162	7	s.	s.	PROPN
admet-2057	1162	8	hong	hong	PROPN
admet-2057	1162	9	,	,	PUNCT
admet-2057	1162	10	m.d	m.d	PROPN
admet-2057	1162	11	.	.	PROPN
admet-2057	1162	12	liu	liu	PROPN
admet-2057	1162	13	,	,	PUNCT
admet-2057	1162	14	x.y	x.y	PROPN
admet-2057	1162	15	.	.	PROPN
admet-2057	1162	16	yu	yu	PROPN
admet-2057	1162	17	,	,	PUNCT
admet-2057	1162	18	m.k	m.k	PROPN
admet-2057	1162	19	.	.	PROPN
admet-2057	1162	20	zhang	zhang	PROPN
admet-2057	1162	21	,	,	PUNCT
admet-2057	1162	22	l.	l.	PROPN
admet-2057	1162	23	zhang	zhang	PROPN
admet-2057	1162	24	,	,	PUNCT
admet-2057	1162	25	x.	x.	PROPN
admet-2057	1162	26	zeng	zeng	PROPN
admet-2057	1162	27	,	,	PUNCT
admet-2057	1162	28	x.z	x.z	PROPN
admet-2057	1162	29	.	.	PROPN
admet-2057	1162	30	zhang	zhang	PROPN
admet-2057	1162	31	.	.	PUNCT
admet-2057	1163	1	ph	ph	VERB
admet-2057	1163	2	-	-	ADJ
admet-2057	1163	3	sensitive	sensitive	ADJ
admet-2057	1163	4	mof	mof	NOUN
admet-2057	1163	5	integrated	integrate	VERB
admet-2057	1163	6	with	with	ADP
admet-2057	1163	7	glucose	glucose	NOUN
admet-2057	1163	8	oxidase	oxidase	NOUN
admet-2057	1163	9	for	for	ADP
admet-2057	1163	10	glucose	glucose	NOUN
admet-2057	1163	11	-	-	PUNCT
admet-2057	1163	12	responsive	responsive	ADJ
admet-2057	1163	13	insulin	insulin	NOUN
admet-2057	1163	14	delivery	delivery	NOUN
admet-2057	1163	15	.	.	PUNCT
admet-2057	1164	1	journal	journal	PROPN
admet-2057	1164	2	of	of	ADP
admet-2057	1164	3	controlled	control	VERB
admet-2057	1164	4	release	release	NOUN
admet-2057	1164	5	320	320	NUM
admet-2057	1164	6	(	(	PUNCT
admet-2057	1164	7	2020	2020	NUM
admet-2057	1164	8	)	)	PUNCT
admet-2057	1164	9	159	159	NUM
admet-2057	1164	10	-	-	SYM
admet-2057	1164	11	167	167	NUM
admet-2057	1164	12	.	.	PUNCT
admet-2057	1165	1	https://doi.org/10.1016/j.jconrel.2020.01.038	https://doi.org/10.1016/j.jconrel.2020.01.038	NOUN
admet-2057	1166	1	[	[	X
admet-2057	1166	2	113	113	NUM
admet-2057	1166	3	]	]	X
admet-2057	1166	4	m.a	m.a	PROPN
admet-2057	1166	5	.	.	PROPN
admet-2057	1166	6	luzuriaga	luzuriaga	PROPN
admet-2057	1166	7	,	,	PUNCT
admet-2057	1166	8	r.p	r.p	PROPN
admet-2057	1166	9	.	.	PROPN
admet-2057	1166	10	welch	welch	PROPN
admet-2057	1166	11	,	,	PUNCT
admet-2057	1166	12	m.	m.	PROPN
admet-2057	1166	13	dharmarwardana	dharmarwardana	PROPN
admet-2057	1166	14	,	,	PUNCT
admet-2057	1166	15	c.e	c.e	PROPN
admet-2057	1166	16	.	.	PROPN
admet-2057	1166	17	benjamin	benjamin	PROPN
admet-2057	1166	18	,	,	PUNCT
admet-2057	1166	19	s.	s.	PROPN
admet-2057	1166	20	li	li	PROPN
admet-2057	1166	21	,	,	PUNCT
admet-2057	1166	22	a.	a.	NOUN
admet-2057	1166	23	shahrivarkevishahi	shahrivarkevishahi	PROPN
admet-2057	1166	24	,	,	PUNCT
admet-2057	1166	25	s.	s.	PROPN
admet-2057	1166	26	popal	popal	PROPN
admet-2057	1166	27	,	,	PUNCT
admet-2057	1166	28	l.h	l.h	PROPN
admet-2057	1166	29	.	.	PROPN
admet-2057	1166	30	tuong	tuong	PROPN
admet-2057	1166	31	,	,	PUNCT
admet-2057	1166	32	c.t	c.t	PROPN
admet-2057	1166	33	.	.	PROPN
admet-2057	1166	34	creswell	creswell	PROPN
admet-2057	1166	35	,	,	PUNCT
admet-2057	1166	36	j.j	j.j	PROPN
admet-2057	1166	37	.	.	PROPN
admet-2057	1166	38	gassensmith	gassensmith	PROPN
admet-2057	1166	39	.	.	PROPN
admet-2057	1166	40	enhanced	enhance	VERB
admet-2057	1166	41	stability	stability	NOUN
admet-2057	1166	42	and	and	CCONJ
admet-2057	1166	43	controlled	control	VERB
admet-2057	1166	44	delivery	delivery	NOUN
admet-2057	1166	45	of	of	ADP
admet-2057	1166	46	mof	mof	NOUN
admet-2057	1166	47	-	-	PUNCT
admet-2057	1166	48	encapsulated	encapsulate	VERB
admet-2057	1166	49	vaccines	vaccine	NOUN
admet-2057	1166	50	and	and	CCONJ
admet-2057	1166	51	their	their	PRON
admet-2057	1166	52	immunogenic	immunogenic	ADJ
admet-2057	1166	53	response	response	NOUN
admet-2057	1166	54	in	in	ADP
admet-2057	1166	55	vivo	vivo	NOUN
admet-2057	1166	56	.	.	PUNCT
admet-2057	1167	1	acs	acs	PROPN
admet-2057	1167	2	applied	apply	VERB
admet-2057	1167	3	material	material	NOUN
admet-2057	1167	4	&	&	CCONJ
admet-2057	1167	5	interfaces	interface	NOUN
admet-2057	1167	6	11(10	11(10	NUM
admet-2057	1167	7	)	)	PUNCT
admet-2057	1167	8	(	(	PUNCT
admet-2057	1167	9	2019	2019	NUM
admet-2057	1167	10	)	)	PUNCT
admet-2057	1167	11	9740	9740	NUM
admet-2057	1167	12	-	-	SYM
admet-2057	1167	13	9746	9746	NUM
admet-2057	1167	14	.	.	PUNCT
admet-2057	1168	1	https://doi.org/10.1021/acsami.8b20504	https://doi.org/10.1021/acsami.8b20504	PRON
admet-2057	1168	2	[	[	X
admet-2057	1168	3	114	114	NUM
admet-2057	1168	4	]	]	PUNCT
admet-2057	1168	5	m.	m.	NOUN
admet-2057	1168	6	he	he	PRON
admet-2057	1168	7	,	,	PUNCT
admet-2057	1168	8	p.	p.	PROPN
admet-2057	1168	9	yu	yu	PROPN
admet-2057	1168	10	,	,	PUNCT
admet-2057	1168	11	y.	y.	PROPN
admet-2057	1168	12	hu	hu	PROPN
admet-2057	1168	13	,	,	PUNCT
admet-2057	1168	14	j.	j.	PROPN
admet-2057	1168	15	zhang	zhang	PROPN
admet-2057	1168	16	,	,	PUNCT
admet-2057	1168	17	m.	m.	NOUN
admet-2057	1168	18	he	he	PRON
admet-2057	1168	19	,	,	PUNCT
admet-2057	1168	20	c.	c.	PROPN
admet-2057	1168	21	nie	nie	PROPN
admet-2057	1168	22	,	,	PUNCT
admet-2057	1168	23	x.	x.	PROPN
admet-2057	1168	24	chu	chu	PROPN
admet-2057	1168	25	.	.	PUNCT
admet-2057	1169	1	erythrocyte	erythrocyte	ADJ
admet-2057	1169	2	-	-	PUNCT
admet-2057	1169	3	membrane	membrane	NOUN
admet-2057	1169	4	-	-	PUNCT
admet-2057	1169	5	enveloped	envelop	VERB
admet-2057	1169	6	biomineralized	biomineralize	VERB
admet-2057	1169	7	metal	metal	NOUN
admet-2057	1169	8	-	-	PUNCT
admet-2057	1169	9	organic	organic	ADJ
admet-2057	1169	10	framework	framework	NOUN
admet-2057	1169	11	nanoparticles	nanoparticle	NOUN
admet-2057	1169	12	enable	enable	VERB
admet-2057	1169	13	intravenous	intravenous	ADJ
admet-2057	1169	14	glucose	glucose	NOUN
admet-2057	1169	15	-	-	PUNCT
admet-2057	1169	16	responsive	responsive	ADJ
admet-2057	1169	17	insulin	insulin	NOUN
admet-2057	1169	18	delivery	delivery	NOUN
admet-2057	1169	19	.	.	PUNCT
admet-2057	1170	1	acs	acs	PROPN
admet-2057	1170	2	applied	apply	VERB
admet-2057	1170	3	material	material	NOUN
admet-2057	1170	4	&	&	CCONJ
admet-2057	1170	5	interfaces	interface	NOUN
admet-2057	1170	6	13(17	13(17	PROPN
admet-2057	1170	7	)	)	PUNCT
admet-2057	1170	8	(	(	PUNCT
admet-2057	1170	9	2021	2021	NUM
admet-2057	1170	10	)	)	PUNCT
admet-2057	1170	11	19648	19648	NUM
admet-2057	1170	12	-	-	SYM
admet-2057	1170	13	19659	19659	NUM
admet-2057	1170	14	.	.	PUNCT
admet-2057	1171	1	https://doi.org/10.1021/acsami.1c01943	https://doi.org/10.1021/acsami.1c01943	X
admet-2057	1172	1	[	[	X
admet-2057	1172	2	115	115	NUM
admet-2057	1172	3	]	]	X
admet-2057	1172	4	c.	c.	PROPN
admet-2057	1172	5	fernández	fernández	PROPN
admet-2057	1172	6	-	-	PUNCT
admet-2057	1172	7	paz	paz	PROPN
admet-2057	1172	8	,	,	PUNCT
admet-2057	1172	9	s.	s.	PROPN
admet-2057	1172	10	rojas	rojas	PROPN
admet-2057	1172	11	,	,	PUNCT
admet-2057	1172	12	p.	p.	PROPN
admet-2057	1172	13	salcedo	salcedo	PROPN
admet-2057	1172	14	-	-	PUNCT
admet-2057	1172	15	abraira	abraira	PROPN
admet-2057	1172	16	,	,	PUNCT
admet-2057	1172	17	t.	t.	PROPN
admet-2057	1172	18	simón	simón	PROPN
admet-2057	1172	19	-	-	PUNCT
admet-2057	1172	20	yarza	yarza	PROPN
admet-2057	1172	21	,	,	PUNCT
admet-2057	1172	22	c.	c.	PROPN
admet-2057	1172	23	remuñán	remuñán	PROPN
admet-2057	1172	24	-	-	PUNCT
admet-2057	1172	25	lópez	lópez	NOUN
admet-2057	1172	26	,	,	PUNCT
admet-2057	1172	27	p.	p.	PROPN
admet-2057	1172	28	horcajada	horcajada	PROPN
admet-2057	1172	29	.	.	PUNCT
admet-2057	1173	1	metal	metal	NOUN
admet-2057	1173	2	-	-	PUNCT
admet-2057	1173	3	organic	organic	ADJ
admet-2057	1173	4	framework	framework	NOUN
admet-2057	1173	5	microsphere	microsphere	AUX
admet-2057	1173	6	formulation	formulation	NOUN
admet-2057	1173	7	for	for	ADP
admet-2057	1173	8	pulmonary	pulmonary	ADJ
admet-2057	1173	9	administration	administration	NOUN
admet-2057	1173	10	.	.	PUNCT
admet-2057	1174	1	acs	acs	PROPN
admet-2057	1174	2	applied	apply	VERB
admet-2057	1174	3	material	material	NOUN
admet-2057	1174	4	&	&	CCONJ
admet-2057	1174	5	interfaces	interface	NOUN
admet-2057	1174	6	12	12	NUM
admet-2057	1174	7	(	(	PUNCT
admet-2057	1174	8	2020	2020	NUM
admet-2057	1174	9	)	)	PUNCT
admet-2057	1174	10	25676	25676	NUM
admet-2057	1174	11	-	-	SYM
admet-2057	1174	12	25682	25682	NUM
admet-2057	1174	13	.	.	PUNCT
admet-2057	1175	1	https://doi.org/10.1021/acsami.0c07356	https://doi.org/10.1021/acsami.0c07356	NOUN
admet-2057	1176	1	[	[	X
admet-2057	1176	2	116	116	X
admet-2057	1176	3	]	]	PUNCT
admet-2057	1176	4	x.	x.	NOUN
admet-2057	1176	5	hu	hu	PROPN
admet-2057	1176	6	,	,	PUNCT
admet-2057	1176	7	c.	c.	PROPN
admet-2057	1176	8	wang	wang	PROPN
admet-2057	1176	9	,	,	PUNCT
admet-2057	1176	10	l.	l.	PROPN
admet-2057	1176	11	wang	wang	PROPN
admet-2057	1176	12	,	,	PUNCT
admet-2057	1176	13	z.	z.	PROPN
admet-2057	1176	14	liu	liu	PROPN
admet-2057	1176	15	,	,	PUNCT
admet-2057	1176	16	l.	l.	PROPN
admet-2057	1176	17	wu	wu	PROPN
admet-2057	1176	18	,	,	PUNCT
admet-2057	1176	19	g.	g.	PROPN
admet-2057	1176	20	zhang	zhang	PROPN
admet-2057	1176	21	,	,	PUNCT
admet-2057	1176	22	l.	l.	PROPN
admet-2057	1176	23	yu	yu	PROPN
admet-2057	1176	24	,	,	PUNCT
admet-2057	1176	25	x.	x.	PROPN
admet-2057	1176	26	ren	ren	PROPN
admet-2057	1176	27	,	,	PUNCT
admet-2057	1176	28	p.	p.	PROPN
admet-2057	1176	29	york	york	PROPN
admet-2057	1176	30	,	,	PUNCT
admet-2057	1176	31	l.	l.	PROPN
admet-2057	1176	32	sun	sun	PROPN
admet-2057	1176	33	,	,	PUNCT
admet-2057	1176	34	j.	j.	PROPN
admet-2057	1176	35	zhang	zhang	PROPN
admet-2057	1176	36	,	,	PUNCT
admet-2057	1176	37	h.	h.	PROPN
admet-2057	1176	38	li	li	PROPN
admet-2057	1176	39	.	.	PROPN
admet-2057	1176	40	nanoporous	nanoporous	PROPN
admet-2057	1176	41	cd	cd	PROPN
admet-2057	1176	42	-	-	PUNCT
admet-2057	1176	43	mof	mof	VERB
admet-2057	1176	44	particles	particle	NOUN
admet-2057	1176	45	with	with	ADP
admet-2057	1176	46	uniform	uniform	NOUN
admet-2057	1176	47	and	and	CCONJ
admet-2057	1176	48	inhalable	inhalable	ADJ
admet-2057	1176	49	size	size	NOUN
admet-2057	1176	50	for	for	ADP
admet-2057	1176	51	pulmonary	pulmonary	ADJ
admet-2057	1176	52	delivery	delivery	NOUN
admet-2057	1176	53	of	of	ADP
admet-2057	1176	54	budesonide	budesonide	NOUN
admet-2057	1176	55	.	.	PUNCT
admet-2057	1177	1	international	international	ADJ
admet-2057	1177	2	journal	journal	PROPN
admet-2057	1177	3	of	of	ADP
admet-2057	1177	4	pharmaceutics	pharmaceutic	NOUN
admet-2057	1177	5	564	564	NUM
admet-2057	1177	6	(	(	PUNCT
admet-2057	1177	7	2019	2019	NUM
admet-2057	1177	8	)	)	PUNCT
admet-2057	1177	9	153	153	NUM
admet-2057	1177	10	-	-	SYM
admet-2057	1177	11	161	161	NUM
admet-2057	1177	12	.	.	PUNCT
admet-2057	1178	1	https://doi.org/10.1016/j.ijpharm.2019.04.030	https://doi.org/10.1016/j.ijpharm.2019.04.030	PROPN
admet-2057	1178	2	https://doi.org/10.1016/j.msec.2018.11.028	https://doi.org/10.1016/j.msec.2018.11.028	PROPN
admet-2057	1178	3	https://doi.org/10.1002/adma.202102044	https://doi.org/10.1002/adma.202102044	PROPN
admet-2057	1178	4	https://doi.org/10.1186/s12951-022-01603-6	https://doi.org/10.1186/s12951-022-01603-6	PROPN
admet-2057	1178	5	https://doi.org/10.1016/j.ijbiomac.2019.12.007	https://doi.org/10.1016/j.ijbiomac.2019.12.007	PROPN
admet-2057	1178	6	https://doi.org/10.1016/j.mtbio.2021.100180	https://doi.org/10.1016/j.mtbio.2021.100180	PROPN
admet-2057	1178	7	https://doi.org/10.1126/sciadv.abm4677	https://doi.org/10.1126/sciadv.abm4677	PROPN
admet-2057	1178	8	https://doi.org/10.1021/jacs.8b03584	https://doi.org/10.1021/jacs.8b03584	NOUN
admet-2057	1178	9	https://doi.org/10.1021/acsbiomaterials.9b01075	https://doi.org/10.1021/acsbiomaterials.9b01075	PROPN
admet-2057	1178	10	https://doi.org/10.1080/10717544.2021.1949073	https://doi.org/10.1080/10717544.2021.1949073	PUNCT
admet-2057	1179	1	https://doi.org/10.1016/j.jconrel.2020.01.038	https://doi.org/10.1016/j.jconrel.2020.01.038	VERB
admet-2057	1179	2	https://doi.org/10.1021/acsami.8b20504	https://doi.org/10.1021/acsami.8b20504	NOUN
admet-2057	1179	3	https://doi.org/10.1021/acsami.1c01943	https://doi.org/10.1021/acsami.1c01943	NOUN
admet-2057	1179	4	https://doi.org/10.1021/acsami.0c07356	https://doi.org/10.1021/acsami.0c07356	NOUN
admet-2057	1179	5	https://doi.org/10.1016/j.ijpharm.2019.04.030	https://doi.org/10.1016/j.ijpharm.2019.04.030	PROPN
admet-2057	1179	6	admet	admet	PROPN
admet-2057	1179	7	&	&	CCONJ
admet-2057	1179	8	dmpk	dmpk	PROPN
admet-2057	1179	9	12(1	12(1	PROPN
admet-2057	1179	10	)	)	PUNCT
admet-2057	1179	11	(	(	PUNCT
admet-2057	1179	12	2024	2024	NUM
admet-2057	1179	13	)	)	PUNCT
admet-2057	1179	14	27	27	NUM
admet-2057	1179	15	-	-	SYM
admet-2057	1179	16	62	62	NUM
admet-2057	1179	17	drug	drug	NOUN
admet-2057	1179	18	delivery	delivery	NOUN
admet-2057	1179	19	applications	application	NOUN
admet-2057	1179	20	of	of	ADP
admet-2057	1179	21	metal	metal	NOUN
admet-2057	1179	22	-	-	PUNCT
admet-2057	1179	23	organic	organic	ADJ
admet-2057	1179	24	framework	framework	NOUN
admet-2057	1179	25	doi	doi	NOUN
admet-2057	1179	26	:	:	PUNCT
admet-2057	1179	27	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	1179	28	61	61	NUM
admet-2057	1179	29	[	[	X
admet-2057	1179	30	117	117	NUM
admet-2057	1179	31	]	]	X
admet-2057	1179	32	y.	y.	PROPN
admet-2057	1179	33	zhou	zhou	PROPN
admet-2057	1179	34	,	,	PUNCT
admet-2057	1179	35	y.	y.	PROPN
admet-2057	1179	36	zhao	zhao	PROPN
admet-2057	1179	37	,	,	PUNCT
admet-2057	1179	38	b.	b.	PROPN
admet-2057	1179	39	niu	niu	PROPN
admet-2057	1179	40	,	,	PUNCT
admet-2057	1179	41	q.	q.	PROPN
admet-2057	1179	42	luo	luo	PROPN
admet-2057	1179	43	,	,	PUNCT
admet-2057	1179	44	y.	y.	PROPN
admet-2057	1179	45	zhang	zhang	PROPN
admet-2057	1179	46	,	,	PUNCT
admet-2057	1179	47	g.	g.	PROPN
admet-2057	1179	48	quan	quan	PROPN
admet-2057	1179	49	,	,	PUNCT
admet-2057	1179	50	x.	x.	PROPN
admet-2057	1179	51	pan	pan	PROPN
admet-2057	1179	52	,	,	PUNCT
admet-2057	1179	53	c.	c.	PROPN
admet-2057	1179	54	wu	wu	PROPN
admet-2057	1179	55	.	.	PUNCT
admet-2057	1180	1	cyclodextrin	cyclodextrin	NOUN
admet-2057	1180	2	-	-	PUNCT
admet-2057	1180	3	based	base	VERB
admet-2057	1180	4	metal	metal	NOUN
admet-2057	1180	5	-	-	PUNCT
admet-2057	1180	6	organic	organic	ADJ
admet-2057	1180	7	frameworks	framework	NOUN
admet-2057	1180	8	for	for	ADP
admet-2057	1180	9	pulmonary	pulmonary	ADJ
admet-2057	1180	10	delivery	delivery	NOUN
admet-2057	1180	11	of	of	ADP
admet-2057	1180	12	curcumin	curcumin	NOUN
admet-2057	1180	13	with	with	ADP
admet-2057	1180	14	improved	improve	VERB
admet-2057	1180	15	solubility	solubility	NOUN
admet-2057	1180	16	and	and	CCONJ
admet-2057	1180	17	fine	fine	ADJ
admet-2057	1180	18	aerodynamic	aerodynamic	ADJ
admet-2057	1180	19	performance	performance	NOUN
admet-2057	1180	20	.	.	PUNCT
admet-2057	1181	1	international	international	ADJ
admet-2057	1181	2	journal	journal	PROPN
admet-2057	1181	3	of	of	ADP
admet-2057	1181	4	pharmaceutics	pharmaceutic	NOUN
admet-2057	1181	5	588	588	NUM
admet-2057	1181	6	(	(	PUNCT
admet-2057	1181	7	2020	2020	NUM
admet-2057	1181	8	)	)	PUNCT
admet-2057	1181	9	119777	119777	NUM
admet-2057	1181	10	.	.	PUNCT
admet-2057	1182	1	https://doi.org/10.1016/j.ijpharm.2020.119777	https://doi.org/10.1016/j.ijpharm.2020.119777	PROPN
admet-2057	1182	2	[	[	X
admet-2057	1182	3	118	118	NUM
admet-2057	1182	4	]	]	X
admet-2057	1182	5	y.	y.	PROPN
admet-2057	1182	6	zhou	zhou	PROPN
admet-2057	1182	7	,	,	PUNCT
admet-2057	1182	8	b.	b.	PROPN
admet-2057	1182	9	niu	niu	PROPN
admet-2057	1182	10	,	,	PUNCT
admet-2057	1182	11	b.	b.	PROPN
admet-2057	1182	12	wu	wu	PROPN
admet-2057	1182	13	,	,	PUNCT
admet-2057	1182	14	s.	s.	PROPN
admet-2057	1182	15	luo	luo	PROPN
admet-2057	1182	16	,	,	PUNCT
admet-2057	1182	17	j.	j.	PROPN
admet-2057	1182	18	fu	fu	PROPN
admet-2057	1182	19	,	,	PUNCT
admet-2057	1182	20	y.	y.	PROPN
admet-2057	1182	21	zhao	zhao	PROPN
admet-2057	1182	22	,	,	PUNCT
admet-2057	1182	23	g.	g.	PROPN
admet-2057	1182	24	quan	quan	PROPN
admet-2057	1182	25	,	,	PUNCT
admet-2057	1182	26	x.	x.	PROPN
admet-2057	1182	27	pan	pan	PROPN
admet-2057	1182	28	,	,	PUNCT
admet-2057	1182	29	c.	c.	PROPN
admet-2057	1182	30	wu	wu	PROPN
admet-2057	1182	31	.	.	PUNCT
admet-2057	1183	1	a	a	DET
admet-2057	1183	2	homogenous	homogenous	ADJ
admet-2057	1183	3	nanoporous	nanoporous	ADJ
admet-2057	1183	4	pulmonary	pulmonary	ADJ
admet-2057	1183	5	drug	drug	NOUN
admet-2057	1183	6	delivery	delivery	NOUN
admet-2057	1183	7	system	system	NOUN
admet-2057	1183	8	based	base	VERB
admet-2057	1183	9	on	on	ADP
admet-2057	1183	10	metal	metal	NOUN
admet-2057	1183	11	-	-	PUNCT
admet-2057	1183	12	organic	organic	ADJ
admet-2057	1183	13	frameworks	framework	NOUN
admet-2057	1183	14	with	with	ADP
admet-2057	1183	15	fine	fine	ADJ
admet-2057	1183	16	aerosolization	aerosolization	NOUN
admet-2057	1183	17	performance	performance	NOUN
admet-2057	1183	18	and	and	CCONJ
admet-2057	1183	19	good	good	ADJ
admet-2057	1183	20	compatibility	compatibility	NOUN
admet-2057	1183	21	.	.	PUNCT
admet-2057	1184	1	acta	acta	PROPN
admet-2057	1184	2	pharmaceutica	pharmaceutica	PROPN
admet-2057	1184	3	sinica	sinica	PROPN
admet-2057	1184	4	b	b	PROPN
admet-2057	1184	5	10(12	10(12	NUM
admet-2057	1184	6	)	)	PUNCT
admet-2057	1184	7	(	(	PUNCT
admet-2057	1184	8	2020	2020	NUM
admet-2057	1184	9	)	)	PUNCT
admet-2057	1184	10	2404	2404	NUM
admet-2057	1184	11	-	-	SYM
admet-2057	1184	12	2416	2416	NUM
admet-2057	1184	13	.	.	PUNCT
admet-2057	1185	1	https://doi.org/10.1016/j.apsb.2020.07.018	https://doi.org/10.1016/j.apsb.2020.07.018	NOUN
admet-2057	1186	1	[	[	X
admet-2057	1186	2	119	119	NUM
admet-2057	1186	3	]	]	X
admet-2057	1186	4	b.m	b.m	PROPN
admet-2057	1186	5	.	.	PROPN
admet-2057	1186	6	jarai	jarai	PROPN
admet-2057	1186	7	,	,	PUNCT
admet-2057	1186	8	z.	z.	PROPN
admet-2057	1186	9	stillman	stillman	PROPN
admet-2057	1186	10	,	,	PUNCT
admet-2057	1186	11	l.	l.	PROPN
admet-2057	1186	12	attia	attia	PROPN
admet-2057	1186	13	,	,	PUNCT
admet-2057	1186	14	g.e	g.e	PROPN
admet-2057	1186	15	.	.	PROPN
admet-2057	1186	16	decker	decker	PROPN
admet-2057	1186	17	,	,	PUNCT
admet-2057	1186	18	e.d	e.d	PROPN
admet-2057	1186	19	.	.	PROPN
admet-2057	1186	20	bloch	bloch	PROPN
admet-2057	1186	21	,	,	PUNCT
admet-2057	1186	22	c.a	c.a	PROPN
admet-2057	1186	23	.	.	PROPN
admet-2057	1186	24	fromen	fromen	PROPN
admet-2057	1186	25	.	.	PUNCT
admet-2057	1187	1	evaluating	evaluate	VERB
admet-2057	1187	2	uio-66	uio-66	NUM
admet-2057	1187	3	metalorganic	metalorganic	ADJ
admet-2057	1187	4	framework	framework	NOUN
admet-2057	1187	5	nanoparticles	nanoparticle	NOUN
admet-2057	1187	6	as	as	ADP
admet-2057	1187	7	acid	acid	NOUN
admet-2057	1187	8	-	-	PUNCT
admet-2057	1187	9	sensitive	sensitive	ADJ
admet-2057	1187	10	carriers	carrier	NOUN
admet-2057	1187	11	for	for	ADP
admet-2057	1187	12	pulmonary	pulmonary	ADJ
admet-2057	1187	13	drug	drug	NOUN
admet-2057	1187	14	delivery	delivery	NOUN
admet-2057	1187	15	applications	application	NOUN
admet-2057	1187	16	.	.	PUNCT
admet-2057	1188	1	acs	acs	PROPN
admet-2057	1188	2	applied	apply	VERB
admet-2057	1188	3	material	material	NOUN
admet-2057	1188	4	&	&	CCONJ
admet-2057	1188	5	interfaces	interface	NOUN
admet-2057	1188	6	12	12	NUM
admet-2057	1188	7	(	(	PUNCT
admet-2057	1188	8	2020	2020	NUM
admet-2057	1188	9	)	)	PUNCT
admet-2057	1188	10	38989	38989	NUM
admet-2057	1188	11	-	-	SYM
admet-2057	1188	12	39004	39004	NUM
admet-2057	1188	13	.	.	PUNCT
admet-2057	1189	1	https://doi.org/10.1021/acsami.0c10900	https://doi.org/10.1021/acsami.0c10900	ADJ
admet-2057	1189	2	[	[	X
admet-2057	1189	3	120	120	NUM
admet-2057	1189	4	]	]	X
admet-2057	1189	5	y.	y.	PROPN
admet-2057	1189	6	zhou	zhou	PROPN
admet-2057	1189	7	,	,	PUNCT
admet-2057	1189	8	m.	m.	PROPN
admet-2057	1189	9	zhang	zhang	PROPN
admet-2057	1189	10	,	,	PUNCT
admet-2057	1189	11	c.	c.	PROPN
admet-2057	1189	12	wang	wang	PROPN
admet-2057	1189	13	,	,	PUNCT
admet-2057	1189	14	x.	x.	PROPN
admet-2057	1189	15	ren	ren	PROPN
admet-2057	1189	16	,	,	PUNCT
admet-2057	1189	17	t.	t.	PROPN
admet-2057	1189	18	guo	guo	PROPN
admet-2057	1189	19	,	,	PUNCT
admet-2057	1189	20	z.	z.	PROPN
admet-2057	1189	21	cao	cao	PROPN
admet-2057	1189	22	,	,	PUNCT
admet-2057	1189	23	j.	j.	PROPN
admet-2057	1189	24	zhang	zhang	PROPN
admet-2057	1189	25	,	,	PUNCT
admet-2057	1189	26	l.	l.	PROPN
admet-2057	1189	27	sun	sun	PROPN
admet-2057	1189	28	,	,	PUNCT
admet-2057	1189	29	l.	l.	PROPN
admet-2057	1189	30	wu	wu	PROPN
admet-2057	1189	31	.	.	PUNCT
admet-2057	1189	32	solidification	solidification	NOUN
admet-2057	1189	33	of	of	ADP
admet-2057	1189	34	volatile	volatile	ADJ
admet-2057	1189	35	d	d	NOUN
admet-2057	1189	36	-	-	PUNCT
admet-2057	1189	37	limonene	limonene	NOUN
admet-2057	1189	38	by	by	ADP
admet-2057	1189	39	cyclodextrin	cyclodextrin	NOUN
admet-2057	1189	40	metal	metal	NOUN
admet-2057	1189	41	-	-	PUNCT
admet-2057	1189	42	organic	organic	ADJ
admet-2057	1189	43	framework	framework	NOUN
admet-2057	1189	44	for	for	ADP
admet-2057	1189	45	pulmonary	pulmonary	ADJ
admet-2057	1189	46	delivery	delivery	NOUN
admet-2057	1189	47	via	via	ADP
admet-2057	1189	48	dry	dry	ADJ
admet-2057	1189	49	powder	powder	NOUN
admet-2057	1189	50	inhalers	inhaler	NOUN
admet-2057	1189	51	:	:	PUNCT
admet-2057	1189	52	in	in	ADP
admet-2057	1189	53	vitro	vitro	X
admet-2057	1189	54	and	and	CCONJ
admet-2057	1189	55	in	in	ADP
admet-2057	1189	56	vivo	vivo	ADJ
admet-2057	1189	57	evaluation	evaluation	NOUN
admet-2057	1189	58	.	.	PUNCT
admet-2057	1190	1	international	international	ADJ
admet-2057	1190	2	journal	journal	PROPN
admet-2057	1190	3	of	of	ADP
admet-2057	1190	4	pharmaceutics	pharmaceutic	NOUN
admet-2057	1190	5	606	606	NUM
admet-2057	1190	6	(	(	PUNCT
admet-2057	1190	7	2021	2021	NUM
admet-2057	1190	8	)	)	PUNCT
admet-2057	1190	9	120825	120825	NUM
admet-2057	1190	10	.	.	PUNCT
admet-2057	1191	1	https://doi.org/10.1016/j.ijpharm.2021.120825	https://doi.org/10.1016/j.ijpharm.2021.120825	PROPN
admet-2057	1191	2	[	[	X
admet-2057	1191	3	121	121	NUM
admet-2057	1191	4	]	]	X
admet-2057	1191	5	a.g	a.g	PROPN
admet-2057	1191	6	.	.	PROPN
admet-2057	1191	7	márquez	márquez	PROPN
admet-2057	1191	8	,	,	PUNCT
admet-2057	1191	9	t.	t.	PROPN
admet-2057	1191	10	hidalgo	hidalgo	PROPN
admet-2057	1191	11	,	,	PUNCT
admet-2057	1191	12	h.	h.	PROPN
admet-2057	1191	13	lana	lana	PROPN
admet-2057	1191	14	,	,	PUNCT
admet-2057	1191	15	d.	d.	PROPN
admet-2057	1191	16	cunha	cunha	PROPN
admet-2057	1191	17	,	,	PUNCT
admet-2057	1191	18	m.j	m.j	PROPN
admet-2057	1191	19	.	.	PROPN
admet-2057	1191	20	blanco	blanco	PROPN
admet-2057	1191	21	-	-	PUNCT
admet-2057	1191	22	prieto	prieto	PROPN
admet-2057	1191	23	,	,	PUNCT
admet-2057	1191	24	c.	c.	PROPN
admet-2057	1191	25	álvarez	álvarez	PROPN
admet-2057	1191	26	-	-	PUNCT
admet-2057	1191	27	lorenzo	lorenzo	PROPN
admet-2057	1191	28	,	,	PUNCT
admet-2057	1191	29	c.	c.	PROPN
admet-2057	1191	30	boissière	boissière	PROPN
admet-2057	1191	31	,	,	PUNCT
admet-2057	1191	32	c.	c.	PROPN
admet-2057	1191	33	sánchez	sánchez	PROPN
admet-2057	1191	34	,	,	PUNCT
admet-2057	1191	35	c.	c.	PROPN
admet-2057	1191	36	serre	serre	PROPN
admet-2057	1191	37	,	,	PUNCT
admet-2057	1191	38	p.	p.	PROPN
admet-2057	1191	39	horcajada	horcajada	PROPN
admet-2057	1191	40	.	.	PUNCT
admet-2057	1192	1	biocompatible	biocompatible	ADJ
admet-2057	1192	2	polymer	polymer	NOUN
admet-2057	1192	3	-	-	PUNCT
admet-2057	1192	4	metal	metal	NOUN
admet-2057	1192	5	-	-	PUNCT
admet-2057	1192	6	organic	organic	ADJ
admet-2057	1192	7	framework	framework	NOUN
admet-2057	1192	8	composite	composite	ADJ
admet-2057	1192	9	patches	patch	NOUN
admet-2057	1192	10	for	for	ADP
admet-2057	1192	11	cutaneous	cutaneous	ADJ
admet-2057	1192	12	administration	administration	NOUN
admet-2057	1192	13	of	of	ADP
admet-2057	1192	14	cosmetic	cosmetic	ADJ
admet-2057	1192	15	molecules	molecule	NOUN
admet-2057	1192	16	.	.	PUNCT
admet-2057	1193	1	journal	journal	NOUN
admet-2057	1193	2	of	of	ADP
admet-2057	1193	3	material	material	NOUN
admet-2057	1193	4	chemistry	chemistry	NOUN
admet-2057	1193	5	b	b	PROPN
admet-2057	1193	6	4	4	NUM
admet-2057	1193	7	(	(	PUNCT
admet-2057	1193	8	2016	2016	NUM
admet-2057	1193	9	)	)	PUNCT
admet-2057	1193	10	7031	7031	NUM
admet-2057	1193	11	-	-	SYM
admet-2057	1193	12	7040	7040	NUM
admet-2057	1193	13	.	.	PUNCT
admet-2057	1194	1	https://doi.org/10.1039/c6tb01652a	https://doi.org/10.1039/c6tb01652a	PROPN
admet-2057	1194	2	[	[	X
admet-2057	1194	3	122	122	NUM
admet-2057	1194	4	]	]	X
admet-2057	1194	5	s.	s.	PROPN
admet-2057	1194	6	rojas	rojas	PROPN
admet-2057	1194	7	,	,	PUNCT
admet-2057	1194	8	i.	i.	PROPN
admet-2057	1194	9	colinet	colinet	PROPN
admet-2057	1194	10	,	,	PUNCT
admet-2057	1194	11	d.	d.	PROPN
admet-2057	1194	12	cunha	cunha	PROPN
admet-2057	1194	13	,	,	PUNCT
admet-2057	1194	14	t.	t.	PROPN
admet-2057	1194	15	hidalgo	hidalgo	PROPN
admet-2057	1194	16	,	,	PUNCT
admet-2057	1194	17	f.	f.	PROPN
admet-2057	1194	18	salles	salles	PROPN
admet-2057	1194	19	,	,	PUNCT
admet-2057	1194	20	c.	c.	PROPN
admet-2057	1194	21	serre	serre	PROPN
admet-2057	1194	22	,	,	PUNCT
admet-2057	1194	23	n.	n.	NOUN
admet-2057	1194	24	guillou	guillou	PROPN
admet-2057	1194	25	,	,	PUNCT
admet-2057	1194	26	p.	p.	PROPN
admet-2057	1194	27	horcajada	horcajada	PROPN
admet-2057	1194	28	.	.	PUNCT
admet-2057	1195	1	toward	toward	ADP
admet-2057	1195	2	understanding	understand	VERB
admet-2057	1195	3	drug	drug	NOUN
admet-2057	1195	4	incorporation	incorporation	NOUN
admet-2057	1195	5	and	and	CCONJ
admet-2057	1195	6	delivery	delivery	NOUN
admet-2057	1195	7	from	from	ADP
admet-2057	1195	8	biocompatible	biocompatible	ADJ
admet-2057	1195	9	metal	metal	NOUN
admet-2057	1195	10	-	-	PUNCT
admet-2057	1195	11	organic	organic	ADJ
admet-2057	1195	12	frameworks	framework	NOUN
admet-2057	1195	13	in	in	ADP
admet-2057	1195	14	view	view	NOUN
admet-2057	1195	15	of	of	ADP
admet-2057	1195	16	cutaneous	cutaneous	ADJ
admet-2057	1195	17	administration	administration	NOUN
admet-2057	1195	18	.	.	PUNCT
admet-2057	1196	1	acs	acs	PROPN
admet-2057	1196	2	omega	omega	NOUN
admet-2057	1196	3	3	3	NUM
admet-2057	1196	4	(	(	PUNCT
admet-2057	1196	5	2018	2018	NUM
admet-2057	1196	6	)	)	PUNCT
admet-2057	1196	7	2994	2994	NUM
admet-2057	1196	8	-	-	SYM
admet-2057	1196	9	3003	3003	NUM
admet-2057	1196	10	.	.	PUNCT
admet-2057	1197	1	https://doi.org/10.1021/acsomega.8b00185	https://doi.org/10.1021/acsomega.8b00185	PRON
admet-2057	1198	1	[	[	X
admet-2057	1198	2	123	123	NUM
admet-2057	1198	3	]	]	PUNCT
admet-2057	1198	4	s.	s.	PROPN
admet-2057	1198	5	rojas	rojas	PROPN
admet-2057	1198	6	,	,	PUNCT
admet-2057	1198	7	p.	p.	PROPN
admet-2057	1198	8	horcajada	horcajada	PROPN
admet-2057	1198	9	.	.	PUNCT
admet-2057	1199	1	understanding	understand	VERB
admet-2057	1199	2	the	the	DET
admet-2057	1199	3	incorporation	incorporation	NOUN
admet-2057	1199	4	and	and	CCONJ
admet-2057	1199	5	release	release	NOUN
admet-2057	1199	6	of	of	ADP
admet-2057	1199	7	salicylic	salicylic	ADJ
admet-2057	1199	8	acid	acid	NOUN
admet-2057	1199	9	in	in	ADP
admet-2057	1199	10	metalorganic	metalorganic	ADJ
admet-2057	1199	11	frameworks	framework	NOUN
admet-2057	1199	12	for	for	ADP
admet-2057	1199	13	topical	topical	ADJ
admet-2057	1199	14	administration	administration	NOUN
admet-2057	1199	15	.	.	PUNCT
admet-2057	1200	1	european	european	PROPN
admet-2057	1200	2	journal	journal	PROPN
admet-2057	1200	3	of	of	ADP
admet-2057	1200	4	inorganic	inorganic	ADJ
admet-2057	1200	5	chemistry	chemistry	NOUN
admet-2057	1200	6	14	14	NUM
admet-2057	1200	7	(	(	PUNCT
admet-2057	1200	8	2021	2021	NUM
admet-2057	1200	9	)	)	PUNCT
admet-2057	1200	10	1325	1325	NUM
admet-2057	1200	11	-	-	SYM
admet-2057	1200	12	1331	1331	NUM
admet-2057	1200	13	.	.	PUNCT
admet-2057	1201	1	https://doi.org/10.1002/ejic.202001134	https://doi.org/10.1002/ejic.202001134	PUNCT
admet-2057	1202	1	[	[	X
admet-2057	1202	2	124	124	NUM
admet-2057	1202	3	]	]	X
admet-2057	1202	4	m.g	m.g	PROPN
admet-2057	1202	5	.	.	PROPN
admet-2057	1202	6	bello	bello	PROPN
admet-2057	1202	7	,	,	PUNCT
admet-2057	1202	8	y.	y.	PROPN
admet-2057	1202	9	yang	yang	PROPN
admet-2057	1202	10	,	,	PUNCT
admet-2057	1202	11	c.	c.	PROPN
admet-2057	1202	12	wang	wang	PROPN
admet-2057	1202	13	,	,	PUNCT
admet-2057	1202	14	l.	l.	PROPN
admet-2057	1202	15	wu	wu	PROPN
admet-2057	1202	16	,	,	PUNCT
admet-2057	1202	17	p.	p.	PROPN
admet-2057	1202	18	zhou	zhou	PROPN
admet-2057	1202	19	,	,	PUNCT
admet-2057	1202	20	h.	h.	PROPN
admet-2057	1202	21	ding	ding	PROPN
admet-2057	1202	22	,	,	PUNCT
admet-2057	1202	23	x.	x.	PROPN
admet-2057	1202	24	ge	ge	PROPN
admet-2057	1202	25	,	,	PUNCT
admet-2057	1202	26	t.	t.	PROPN
admet-2057	1202	27	guo	guo	PROPN
admet-2057	1202	28	,	,	PUNCT
admet-2057	1202	29	l.	l.	PROPN
admet-2057	1202	30	wei	wei	PROPN
admet-2057	1202	31	,	,	PUNCT
admet-2057	1202	32	j.	j.	PROPN
admet-2057	1202	33	zhang	zhang	PROPN
admet-2057	1202	34	.	.	PUNCT
admet-2057	1202	35	facile	facile	ADJ
admet-2057	1202	36	synthesis	synthesis	NOUN
admet-2057	1202	37	and	and	CCONJ
admet-2057	1202	38	size	size	NOUN
admet-2057	1202	39	control	control	NOUN
admet-2057	1202	40	of	of	ADP
admet-2057	1202	41	2d	2d	NUM
admet-2057	1202	42	cyclodextrin	cyclodextrin	NOUN
admet-2057	1202	43	-	-	PUNCT
admet-2057	1202	44	based	base	VERB
admet-2057	1202	45	metal	metal	NOUN
admet-2057	1202	46	-	-	PUNCT
admet-2057	1202	47	organic	organic	ADJ
admet-2057	1202	48	frameworks	framework	NOUN
admet-2057	1202	49	nanosheet	nanosheet	VERB
admet-2057	1202	50	for	for	ADP
admet-2057	1202	51	topical	topical	ADJ
admet-2057	1202	52	drug	drug	NOUN
admet-2057	1202	53	delivery	delivery	NOUN
admet-2057	1202	54	.	.	PUNCT
admet-2057	1203	1	particle	particle	NOUN
admet-2057	1203	2	and	and	CCONJ
admet-2057	1203	3	particle	particle	NOUN
admet-2057	1203	4	systems	system	NOUN
admet-2057	1203	5	characterization	characterization	NOUN
admet-2057	1203	6	37(11	37(11	NUM
admet-2057	1203	7	)	)	PUNCT
admet-2057	1203	8	(	(	PUNCT
admet-2057	1203	9	2020	2020	NUM
admet-2057	1203	10	)	)	PUNCT
admet-2057	1203	11	2000147	2000147	NUM
admet-2057	1203	12	.	.	PUNCT
admet-2057	1204	1	https://doi.org/10.1002/ppsc.202000147	https://doi.org/10.1002/ppsc.202000147	NOUN
admet-2057	1205	1	[	[	X
admet-2057	1205	2	125	125	NUM
admet-2057	1205	3	]	]	PUNCT
admet-2057	1205	4	j.	j.	PROPN
admet-2057	1205	5	gandara	gandara	PROPN
admet-2057	1205	6	-	-	PUNCT
admet-2057	1205	7	loe	loe	PROPN
admet-2057	1205	8	,	,	PUNCT
admet-2057	1205	9	b.e	b.e	PROPN
admet-2057	1205	10	.	.	PROPN
admet-2057	1205	11	souza	souza	PROPN
admet-2057	1205	12	,	,	PUNCT
admet-2057	1205	13	a.	a.	NOUN
admet-2057	1205	14	missyul	missyul	PROPN
admet-2057	1205	15	,	,	PUNCT
admet-2057	1205	16	g.	g.	PROPN
admet-2057	1205	17	giraldo	giraldo	PROPN
admet-2057	1205	18	,	,	PUNCT
admet-2057	1205	19	j.c	j.c	PROPN
admet-2057	1205	20	.	.	PROPN
admet-2057	1205	21	tan	tan	PROPN
admet-2057	1205	22	,	,	PUNCT
admet-2057	1205	23	j.	j.	PROPN
admet-2057	1205	24	silvestre	silvestre	PROPN
admet-2057	1205	25	-	-	PUNCT
admet-2057	1205	26	albero	albero	NOUN
admet-2057	1205	27	.	.	PUNCT
admet-2057	1206	1	mof	mof	VERB
admet-2057	1206	2	-	-	PUNCT
admet-2057	1206	3	based	base	VERB
admet-2057	1206	4	polymeric	polymeric	ADJ
admet-2057	1206	5	nanocomposite	nanocomposite	NOUN
admet-2057	1206	6	films	film	NOUN
admet-2057	1206	7	as	as	ADP
admet-2057	1206	8	potential	potential	ADJ
admet-2057	1206	9	materials	material	NOUN
admet-2057	1206	10	for	for	ADP
admet-2057	1206	11	drug	drug	NOUN
admet-2057	1206	12	delivery	delivery	NOUN
admet-2057	1206	13	devices	device	NOUN
admet-2057	1206	14	in	in	ADP
admet-2057	1206	15	ocular	ocular	ADJ
admet-2057	1206	16	therapeutics	therapeutic	NOUN
admet-2057	1206	17	.	.	PUNCT
admet-2057	1207	1	acs	acs	PROPN
admet-2057	1207	2	applied	apply	VERB
admet-2057	1207	3	material	material	NOUN
admet-2057	1207	4	&	&	CCONJ
admet-2057	1207	5	interfaces	interface	NOUN
admet-2057	1207	6	27	27	NUM
admet-2057	1207	7	(	(	PUNCT
admet-2057	1207	8	2020	2020	NUM
admet-2057	1207	9	)	)	PUNCT
admet-2057	1207	10	30189	30189	NUM
admet-2057	1207	11	-	-	SYM
admet-2057	1207	12	30197	30197	NUM
admet-2057	1207	13	.	.	PUNCT
admet-2057	1208	1	https://doi.org/10.1021/acsami.0c07517	https://doi.org/10.1021/acsami.0c07517	NOUN
admet-2057	1209	1	[	[	X
admet-2057	1209	2	126	126	NUM
admet-2057	1209	3	]	]	PUNCT
admet-2057	1209	4	m.	m.	NOUN
admet-2057	1209	5	ahmadi	ahmadi	PROPN
admet-2057	1209	6	,	,	PUNCT
admet-2057	1209	7	s.m	s.m	PROPN
admet-2057	1209	8	.	.	PROPN
admet-2057	1209	9	ayyoubzadeh	ayyoubzadeh	PROPN
admet-2057	1209	10	,	,	PUNCT
admet-2057	1209	11	f.	f.	PROPN
admet-2057	1209	12	ghorbani	ghorbani	PROPN
admet-2057	1209	13	-	-	PUNCT
admet-2057	1209	14	bidkorbeh	bidkorbeh	PROPN
admet-2057	1209	15	,	,	PUNCT
admet-2057	1209	16	s.	s.	PROPN
admet-2057	1209	17	shahhosseini	shahhosseini	PROPN
admet-2057	1209	18	,	,	PUNCT
admet-2057	1209	19	s.	s.	PROPN
admet-2057	1209	20	dadashzadeh	dadashzadeh	PROPN
admet-2057	1209	21	,	,	PUNCT
admet-2057	1209	22	e.	e.	PROPN
admet-2057	1209	23	asadian	asadian	PROPN
admet-2057	1209	24	,	,	PUNCT
admet-2057	1209	25	m.	m.	NOUN
admet-2057	1209	26	mosayebnia	mosayebnia	PROPN
admet-2057	1209	27	,	,	PUNCT
admet-2057	1209	28	s.	s.	PROPN
admet-2057	1209	29	siavashy	siavashy	PROPN
admet-2057	1209	30	.	.	PUNCT
admet-2057	1210	1	an	an	DET
admet-2057	1210	2	investigation	investigation	NOUN
admet-2057	1210	3	of	of	ADP
admet-2057	1210	4	affecting	affect	VERB
admet-2057	1210	5	factors	factor	NOUN
admet-2057	1210	6	on	on	ADP
admet-2057	1210	7	mof	mof	ADJ
admet-2057	1210	8	characteristics	characteristic	NOUN
admet-2057	1210	9	for	for	ADP
admet-2057	1210	10	biomedical	biomedical	ADJ
admet-2057	1210	11	applications	application	NOUN
admet-2057	1210	12	:	:	PUNCT
admet-2057	1210	13	a	a	DET
admet-2057	1210	14	systematic	systematic	ADJ
admet-2057	1210	15	review	review	NOUN
admet-2057	1210	16	.	.	PUNCT
admet-2057	1211	1	heliyon	heliyon	NOUN
admet-2057	1211	2	7(4	7(4	NUM
admet-2057	1211	3	)	)	PUNCT
admet-2057	1211	4	(	(	PUNCT
admet-2057	1211	5	2021	2021	NUM
admet-2057	1211	6	)	)	PUNCT
admet-2057	1211	7	e06914	e06914	NOUN
admet-2057	1211	8	.	.	PUNCT
admet-2057	1212	1	https://doi.org/10.1016/j.heliyon.2021.e06914	https://doi.org/10.1016/j.heliyon.2021.e06914	PUNCT
admet-2057	1213	1	[	[	X
admet-2057	1213	2	127	127	NUM
admet-2057	1213	3	]	]	X
admet-2057	1213	4	h.d	h.d	PROPN
admet-2057	1213	5	.	.	PROPN
admet-2057	1213	6	lawson	lawson	PROPN
admet-2057	1213	7	,	,	PUNCT
admet-2057	1213	8	s.	s.	PROPN
admet-2057	1213	9	patrick	patrick	PROPN
admet-2057	1213	10	walton	walton	PROPN
admet-2057	1213	11	,	,	PUNCT
admet-2057	1213	12	c.	c.	PROPN
admet-2057	1213	13	chan	chan	PROPN
admet-2057	1213	14	,	,	PUNCT
admet-2057	1213	15	s.p	s.p	PROPN
admet-2057	1213	16	.	.	PROPN
admet-2057	1213	17	walton	walton	PROPN
admet-2057	1213	18	,	,	PUNCT
admet-2057	1213	19	h.	h.	PROPN
admet-2057	1213	20	lawson.metal	lawson.metal	ADV
admet-2057	1213	21	-	-	PUNCT
admet-2057	1213	22	organic	organic	ADJ
admet-2057	1213	23	frameworks	framework	NOUN
admet-2057	1213	24	for	for	ADP
admet-2057	1213	25	drug	drug	NOUN
admet-2057	1213	26	delivery	delivery	NOUN
admet-2057	1213	27	:	:	PUNCT
admet-2057	1213	28	a	a	DET
admet-2057	1213	29	design	design	NOUN
admet-2057	1213	30	perspective	perspective	NOUN
admet-2057	1213	31	.	.	PUNCT
admet-2057	1214	1	acs	acs	PROPN
admet-2057	1214	2	applied	apply	VERB
admet-2057	1214	3	materials	material	NOUN
admet-2057	1214	4	&	&	CCONJ
admet-2057	1214	5	interfaces	interface	NOUN
admet-2057	1214	6	13(6	13(6	PROPN
admet-2057	1214	7	)	)	PUNCT
admet-2057	1214	8	(	(	PUNCT
admet-2057	1214	9	2021	2021	NUM
admet-2057	1214	10	)	)	PUNCT
admet-2057	1214	11	7004	7004	NUM
admet-2057	1214	12	-	-	SYM
admet-2057	1214	13	7020	7020	NUM
admet-2057	1214	14	.	.	PUNCT
admet-2057	1215	1	http://dx.doi.org/10.1021/acsami.1c01089	http://dx.doi.org/10.1021/acsami.1c01089	NOUN
admet-2057	1215	2	[	[	X
admet-2057	1215	3	128	128	NUM
admet-2057	1215	4	]	]	PUNCT
admet-2057	1215	5	m.	m.	NOUN
admet-2057	1215	6	padmaa	padmaa	NOUN
admet-2057	1215	7	paarakh	paarakh	NOUN
admet-2057	1215	8	,	,	PUNCT
admet-2057	1215	9	p.	p.	PROPN
admet-2057	1215	10	ani	ani	X
admet-2057	1216	1	jose	jose	PROPN
admet-2057	1216	2	,	,	PUNCT
admet-2057	1216	3	c.m	c.m	PROPN
admet-2057	1216	4	.	.	PROPN
admet-2057	1216	5	setty	setty	PROPN
admet-2057	1216	6	,	,	PUNCT
admet-2057	1216	7	g.v.p	g.v.p	PROPN
admet-2057	1216	8	.	.	PUNCT
admet-2057	1217	1	christoper	christoper	PROPN
admet-2057	1217	2	.	.	PUNCT
admet-2057	1218	1	release	release	VERB
admet-2057	1218	2	kinetics	kinetic	NOUN
admet-2057	1218	3	concepts	concept	NOUN
admet-2057	1218	4	and	and	CCONJ
admet-2057	1218	5	applications	application	NOUN
admet-2057	1218	6	.	.	PUNCT
admet-2057	1219	1	international	international	ADJ
admet-2057	1219	2	journal	journal	PROPN
admet-2057	1219	3	of	of	ADP
admet-2057	1219	4	pharmacy	pharmacy	NOUN
admet-2057	1219	5	research	research	NOUN
admet-2057	1219	6	&	&	CCONJ
admet-2057	1219	7	technology	technology	NOUN
admet-2057	1219	8	8(1	8(1	NOUN
admet-2057	1219	9	)	)	PUNCT
admet-2057	1219	10	(	(	PUNCT
admet-2057	1219	11	2019	2019	NUM
admet-2057	1219	12	)	)	PUNCT
admet-2057	1219	13	12	12	NUM
admet-2057	1219	14	-	-	SYM
admet-2057	1219	15	20	20	NUM
admet-2057	1219	16	.	.	PUNCT
admet-2057	1219	17	https://doi.org/10.31838/ijprt/2f08.01.02	https://doi.org/10.31838/ijprt/2f08.01.02	PROPN
admet-2057	1220	1	[	[	X
admet-2057	1220	2	129	129	NUM
admet-2057	1220	3	]	]	PUNCT
admet-2057	1220	4	p.	p.	PROPN
admet-2057	1220	5	horcajada	horcajada	PROPN
admet-2057	1220	6	,	,	PUNCT
admet-2057	1220	7	c.	c.	PROPN
admet-2057	1220	8	serre	serre	PROPN
admet-2057	1220	9	,	,	PUNCT
admet-2057	1220	10	g.	g.	PROPN
admet-2057	1220	11	maurin	maurin	PROPN
admet-2057	1220	12	,	,	PUNCT
admet-2057	1220	13	n.a	n.a	PROPN
admet-2057	1220	14	.	.	PROPN
admet-2057	1220	15	ramsahye	ramsahye	PROPN
admet-2057	1220	16	,	,	PUNCT
admet-2057	1220	17	f.	f.	PROPN
admet-2057	1220	18	balas	balas	PROPN
admet-2057	1220	19	,	,	PUNCT
admet-2057	1220	20	m.	m.	NOUN
admet-2057	1220	21	vallet	vallet	NOUN
admet-2057	1220	22	-	-	PUNCT
admet-2057	1220	23	regí	regí	NOUN
admet-2057	1220	24	,	,	PUNCT
admet-2057	1220	25	m.	m.	NOUN
admet-2057	1220	26	sebban	sebban	PROPN
admet-2057	1220	27	,	,	PUNCT
admet-2057	1220	28	f.	f.	PROPN
admet-2057	1220	29	taulelle	taulelle	PROPN
admet-2057	1220	30	,	,	PUNCT
admet-2057	1220	31	g.	g.	PROPN
admet-2057	1220	32	férey	férey	PROPN
admet-2057	1220	33	.	.	PUNCT
admet-2057	1221	1	flexible	flexible	ADJ
admet-2057	1221	2	porous	porous	ADJ
admet-2057	1221	3	metal	metal	NOUN
admet-2057	1221	4	-	-	PUNCT
admet-2057	1221	5	organic	organic	ADJ
admet-2057	1221	6	frameworks	framework	NOUN
admet-2057	1221	7	for	for	ADP
admet-2057	1221	8	a	a	DET
admet-2057	1221	9	controlled	control	VERB
admet-2057	1221	10	drug	drug	NOUN
admet-2057	1221	11	delivery	delivery	NOUN
admet-2057	1221	12	.	.	PUNCT
admet-2057	1222	1	journal	journal	PROPN
admet-2057	1222	2	of	of	ADP
admet-2057	1222	3	american	american	PROPN
admet-2057	1222	4	chemical	chemical	PROPN
admet-2057	1222	5	society	society	NOUN
admet-2057	1222	6	130	130	NUM
admet-2057	1222	7	(	(	PUNCT
admet-2057	1222	8	2008	2008	NUM
admet-2057	1222	9	)	)	PUNCT
admet-2057	1222	10	6774	6774	NUM
admet-2057	1222	11	-	-	SYM
admet-2057	1222	12	6780	6780	NUM
admet-2057	1222	13	.	.	PUNCT
admet-2057	1223	1	https://doi.org/10.1021/ja710973k	https://doi.org/10.1021/ja710973k	X
admet-2057	1224	1	[	[	X
admet-2057	1224	2	130	130	NUM
admet-2057	1224	3	]	]	PUNCT
admet-2057	1224	4	m.	m.	NOUN
admet-2057	1224	5	esfahanian	esfahanian	PROPN
admet-2057	1224	6	,	,	PUNCT
admet-2057	1224	7	m.a	m.a	PROPN
admet-2057	1224	8	.	.	PROPN
admet-2057	1224	9	ghasemzadeh	ghasemzadeh	PROPN
admet-2057	1224	10	,	,	PUNCT
admet-2057	1224	11	s.m.h	s.m.h	ADJ
admet-2057	1224	12	.	.	PUNCT
admet-2057	1224	13	razavian	razavian	NOUN
admet-2057	1224	14	.	.	PUNCT
admet-2057	1225	1	synthesis	synthesis	NOUN
admet-2057	1225	2	,	,	PUNCT
admet-2057	1225	3	identification	identification	NOUN
admet-2057	1225	4	and	and	CCONJ
admet-2057	1225	5	application	application	NOUN
admet-2057	1225	6	of	of	ADP
admet-2057	1225	7	the	the	DET
admet-2057	1225	8	novel	novel	ADJ
admet-2057	1225	9	metal	metal	NOUN
admet-2057	1225	10	-	-	PUNCT
admet-2057	1225	11	organic	organic	ADJ
admet-2057	1225	12	framework	framework	NOUN
admet-2057	1225	13	fe3o4@paa@zif-8	fe3o4@paa@zif-8	VERB
admet-2057	1225	14	for	for	ADP
admet-2057	1225	15	the	the	DET
admet-2057	1225	16	drug	drug	NOUN
admet-2057	1225	17	delivery	delivery	NOUN
admet-2057	1225	18	of	of	ADP
admet-2057	1225	19	ciprofloxacin	ciprofloxacin	NOUN
admet-2057	1225	20	and	and	CCONJ
admet-2057	1225	21	investigation	investigation	NOUN
admet-2057	1225	22	of	of	ADP
admet-2057	1225	23	antibacterial	antibacterial	ADJ
admet-2057	1225	24	activity	activity	NOUN
admet-2057	1225	25	.	.	PUNCT
admet-2057	1226	1	artificial	artificial	ADJ
admet-2057	1226	2	cells	cell	NOUN
admet-2057	1226	3	,	,	PUNCT
admet-2057	1226	4	nanomedicine	nanomedicine	NOUN
admet-2057	1226	5	,	,	PUNCT
admet-2057	1226	6	and	and	CCONJ
admet-2057	1226	7	biotechnology	biotechnology	NOUN
admet-2057	1226	8	47	47	NUM
admet-2057	1226	9	(	(	PUNCT
admet-2057	1226	10	2019	2019	NUM
admet-2057	1226	11	)	)	PUNCT
admet-2057	1226	12	2024	2024	NUM
admet-2057	1226	13	-	-	SYM
admet-2057	1226	14	2030	2030	NUM
admet-2057	1226	15	.	.	PUNCT
admet-2057	1227	1	https://doi.org/10.1080/21691401.2019.1617729	https://doi.org/10.1080/21691401.2019.1617729	PROPN
admet-2057	1227	2	https://doi.org/10.5599/admet.2057	https://doi.org/10.5599/admet.2057	NOUN
admet-2057	1227	3	https://doi.org/10.1016/j.ijpharm.2020.119777	https://doi.org/10.1016/j.ijpharm.2020.119777	PROPN
admet-2057	1227	4	https://doi.org/10.1016/j.apsb.2020.07.018	https://doi.org/10.1016/j.apsb.2020.07.018	VERB
admet-2057	1227	5	https://doi.org/10.1021/acsami.0c10900	https://doi.org/10.1021/acsami.0c10900	ADJ
admet-2057	1227	6	https://doi.org/10.1016/j.ijpharm.2021.120825	https://doi.org/10.1016/j.ijpharm.2021.120825	PROPN
admet-2057	1227	7	https://doi.org/10.1039/c6tb01652a	https://doi.org/10.1039/c6tb01652a	PROPN
admet-2057	1227	8	https://doi.org/10.1021/acsomega.8b00185	https://doi.org/10.1021/acsomega.8b00185	NUM
admet-2057	1227	9	https://doi.org/10.1002/ejic.202001134	https://doi.org/10.1002/ejic.202001134	NOUN
admet-2057	1227	10	https://doi.org/10.1002/ppsc.202000147	https://doi.org/10.1002/ppsc.202000147	NOUN
admet-2057	1227	11	https://doi.org/10.1021/acsami.0c07517	https://doi.org/10.1021/acsami.0c07517	NOUN
admet-2057	1227	12	https://doi.org/10.1016/j.heliyon.2021.e06914	https://doi.org/10.1016/j.heliyon.2021.e06914	ADJ
admet-2057	1227	13	http://dx.doi.org/10.1021/acsami.1c01089	http://dx.doi.org/10.1021/acsami.1c01089	NOUN
admet-2057	1227	14	https://doi.org/10.31838/ijprt/2f08.01.02	https://doi.org/10.31838/ijprt/2f08.01.02	PROPN
admet-2057	1227	15	https://doi.org/10.1021/ja710973k	https://doi.org/10.1021/ja710973k	X
admet-2057	1228	1	https://doi.org/10.1080/21691401.2019.1617729	https://doi.org/10.1080/21691401.2019.1617729	PROPN
admet-2057	1228	2	p.	p.	PROPN
admet-2057	1228	3	mhettar	mhettar	NOUN
admet-2057	1228	4	et	et	PROPN
admet-2057	1228	5	al	al	PROPN
admet-2057	1228	6	.	.	PROPN
admet-2057	1228	7	admet	admet	PROPN
admet-2057	1228	8	&	&	CCONJ
admet-2057	1228	9	dmpk	dmpk	PROPN
admet-2057	1228	10	12(1	12(1	PROPN
admet-2057	1228	11	)	)	PUNCT
admet-2057	1228	12	(	(	PUNCT
admet-2057	1228	13	2024	2024	NUM
admet-2057	1228	14	)	)	PUNCT
admet-2057	1228	15	27	27	NUM
admet-2057	1228	16	-	-	SYM
admet-2057	1228	17	62	62	NUM
admet-2057	1228	18	62	62	NUM
admet-2057	1229	1	[	[	X
admet-2057	1229	2	131	131	NUM
admet-2057	1229	3	]	]	PUNCT
admet-2057	1229	4	m.	m.	NOUN
admet-2057	1229	5	nasrabadi	nasrabadi	NOUN
admet-2057	1229	6	,	,	PUNCT
admet-2057	1229	7	m.a	m.a	PROPN
admet-2057	1229	8	.	.	PROPN
admet-2057	1229	9	ghasemzadeh	ghasemzadeh	PROPN
admet-2057	1229	10	,	,	PUNCT
admet-2057	1229	11	m.r.z	m.r.z	PROPN
admet-2057	1229	12	.	.	PUNCT
admet-2057	1229	13	monfared	monfare	VERB
admet-2057	1229	14	.	.	PUNCT
admet-2057	1230	1	the	the	DET
admet-2057	1230	2	preparation	preparation	NOUN
admet-2057	1230	3	and	and	CCONJ
admet-2057	1230	4	characterization	characterization	NOUN
admet-2057	1230	5	of	of	ADP
admet-2057	1230	6	uio66	uio66	ADJ
admet-2057	1230	7	metal	metal	NOUN
admet-2057	1230	8	-	-	PUNCT
admet-2057	1230	9	organic	organic	ADJ
admet-2057	1230	10	frameworks	framework	NOUN
admet-2057	1230	11	for	for	ADP
admet-2057	1230	12	the	the	DET
admet-2057	1230	13	delivery	delivery	NOUN
admet-2057	1230	14	of	of	ADP
admet-2057	1230	15	the	the	DET
admet-2057	1230	16	drug	drug	NOUN
admet-2057	1230	17	ciprofloxacin	ciprofloxacin	NOUN
admet-2057	1230	18	and	and	CCONJ
admet-2057	1230	19	an	an	DET
admet-2057	1230	20	evaluation	evaluation	NOUN
admet-2057	1230	21	of	of	ADP
admet-2057	1230	22	their	their	PRON
admet-2057	1230	23	antibacterial	antibacterial	ADJ
admet-2057	1230	24	activities	activity	NOUN
admet-2057	1230	25	.	.	PUNCT
admet-2057	1231	1	new	new	ADJ
admet-2057	1231	2	journal	journal	NOUN
admet-2057	1231	3	of	of	ADP
admet-2057	1231	4	chemistry	chemistry	NOUN
admet-2057	1231	5	.	.	PUNCT
admet-2057	1232	1	43(40	43(40	NOUN
admet-2057	1232	2	)	)	PUNCT
admet-2057	1232	3	(	(	PUNCT
admet-2057	1232	4	2019	2019	NUM
admet-2057	1232	5	)	)	PUNCT
admet-2057	1232	6	16033	16033	NUM
admet-2057	1232	7	-	-	SYM
admet-2057	1232	8	16040	16040	NUM
admet-2057	1232	9	.	.	PUNCT
admet-2057	1233	1	https://doi.org/10.1039/c9nj03216a	https://doi.org/10.1039/c9nj03216a	PROPN
admet-2057	1233	2	[	[	X
admet-2057	1233	3	132	132	NUM
admet-2057	1233	4	]	]	PUNCT
admet-2057	1233	5	a.	a.	NOUN
admet-2057	1233	6	bazzazzadeh	bazzazzadeh	NOUN
admet-2057	1233	7	,	,	PUNCT
admet-2057	1233	8	b.f	b.f	PROPN
admet-2057	1233	9	.	.	PROPN
admet-2057	1233	10	dizaji	dizaji	PROPN
admet-2057	1233	11	,	,	PUNCT
admet-2057	1233	12	n.	n.	PROPN
admet-2057	1233	13	kianinejad	kianinejad	PROPN
admet-2057	1233	14	,	,	PUNCT
admet-2057	1233	15	a.	a.	PROPN
admet-2057	1233	16	nouri	nouri	PROPN
admet-2057	1233	17	,	,	PUNCT
admet-2057	1233	18	m.	m.	NOUN
admet-2057	1233	19	irani	irani	PROPN
admet-2057	1233	20	.	.	PUNCT
admet-2057	1234	1	fabrication	fabrication	NOUN
admet-2057	1234	2	of	of	ADP
admet-2057	1234	3	poly(acrylic	poly(acrylic	PROPN
admet-2057	1234	4	acid	acid	NOUN
admet-2057	1234	5	)	)	PUNCT
admet-2057	1234	6	grafted	grafted	NOUN
admet-2057	1234	7	-	-	PUNCT
admet-2057	1234	8	chitosan	chitosan	NOUN
admet-2057	1234	9	/	/	SYM
admet-2057	1234	10	polyurethane	polyurethane	NOUN
admet-2057	1234	11	/	/	SYM
admet-2057	1234	12	magnetic	magnetic	NOUN
admet-2057	1234	13	mil-53	mil-53	NUM
admet-2057	1234	14	metal	metal	NOUN
admet-2057	1234	15	organic	organic	ADJ
admet-2057	1234	16	framework	framework	NOUN
admet-2057	1234	17	composite	composite	ADJ
admet-2057	1234	18	core	core	NOUN
admet-2057	1234	19	-	-	PUNCT
admet-2057	1234	20	shell	shell	NOUN
admet-2057	1234	21	nanofibers	nanofiber	NOUN
admet-2057	1234	22	for	for	ADP
admet-2057	1234	23	codelivery	codelivery	NOUN
admet-2057	1234	24	of	of	ADP
admet-2057	1234	25	temozolomide	temozolomide	NOUN
admet-2057	1234	26	and	and	CCONJ
admet-2057	1234	27	paclitaxel	paclitaxel	VERB
admet-2057	1234	28	against	against	ADP
admet-2057	1234	29	glioblastoma	glioblastoma	NOUN
admet-2057	1234	30	cancer	cancer	NOUN
admet-2057	1234	31	cells	cell	NOUN
admet-2057	1234	32	.	.	PUNCT
admet-2057	1235	1	international	international	ADJ
admet-2057	1235	2	journal	journal	PROPN
admet-2057	1235	3	of	of	ADP
admet-2057	1235	4	pharmaceutics	pharmaceutic	NOUN
admet-2057	1235	5	587	587	NUM
admet-2057	1235	6	(	(	PUNCT
admet-2057	1235	7	2020	2020	NUM
admet-2057	1235	8	)	)	PUNCT
admet-2057	1235	9	119674	119674	NUM
admet-2057	1235	10	.	.	PUNCT
admet-2057	1236	1	https://doi.org/10.1016/j.ijpharm.2020.119674	https://doi.org/10.1016/j.ijpharm.2020.119674	NOUN
admet-2057	1237	1	[	[	X
admet-2057	1237	2	133	133	NUM
admet-2057	1237	3	]	]	PUNCT
admet-2057	1237	4	x.	x.	NOUN
admet-2057	1237	5	leng	leng	PROPN
admet-2057	1237	6	,	,	PUNCT
admet-2057	1237	7	x.	x.	PROPN
admet-2057	1237	8	dong	dong	PROPN
admet-2057	1237	9	,	,	PUNCT
admet-2057	1237	10	w.	w.	PROPN
admet-2057	1237	11	wang	wang	PROPN
admet-2057	1237	12	,	,	PUNCT
admet-2057	1237	13	n.	n.	PROPN
admet-2057	1237	14	sai	sai	PROPN
admet-2057	1237	15	,	,	PUNCT
admet-2057	1237	16	c.	c.	PROPN
admet-2057	1237	17	yang	yang	PROPN
admet-2057	1237	18	,	,	PUNCT
admet-2057	1237	19	l.	l.	PROPN
admet-2057	1237	20	you	you	PRON
admet-2057	1237	21	,	,	PUNCT
admet-2057	1237	22	h.	h.	PROPN
admet-2057	1237	23	huang	huang	PROPN
admet-2057	1237	24	,	,	PUNCT
admet-2057	1237	25	x.	x.	PROPN
admet-2057	1237	26	yin	yin	PROPN
admet-2057	1237	27	,	,	PUNCT
admet-2057	1237	28	j.	j.	PROPN
admet-2057	1237	29	ni	ni	PROPN
admet-2057	1237	30	.	.	PROPN
admet-2057	1237	31	biocompatible	biocompatible	PROPN
admet-2057	1237	32	fe	fe	PROPN
admet-2057	1237	33	-	-	PUNCT
admet-2057	1237	34	based	base	VERB
admet-2057	1237	35	micropore	micropore	NOUN
admet-2057	1237	36	metal	metal	NOUN
admet-2057	1237	37	-	-	PUNCT
admet-2057	1237	38	organic	organic	ADJ
admet-2057	1237	39	frameworks	framework	NOUN
admet-2057	1237	40	as	as	ADP
admet-2057	1237	41	sustained	sustain	VERB
admet-2057	1237	42	-	-	PUNCT
admet-2057	1237	43	release	release	NOUN
admet-2057	1237	44	anticancer	anticancer	NOUN
admet-2057	1237	45	drug	drug	NOUN
admet-2057	1237	46	carriers	carrier	NOUN
admet-2057	1237	47	.	.	PUNCT
admet-2057	1238	1	molecules	molecule	NOUN
admet-2057	1238	2	.	.	PUNCT
admet-2057	1239	1	23(10	23(10	NUM
admet-2057	1239	2	)	)	PUNCT
admet-2057	1239	3	(	(	PUNCT
admet-2057	1239	4	2018	2018	NUM
admet-2057	1239	5	)	)	PUNCT
admet-2057	1239	6	https://doi.org/10.3390/molecules23102490	https://doi.org/10.3390/molecules23102490	VERB
admet-2057	1240	1	[	[	X
admet-2057	1240	2	134	134	NUM
admet-2057	1240	3	]	]	PUNCT
admet-2057	1240	4	q.	q.	PROPN
admet-2057	1240	5	xu	xu	PROPN
admet-2057	1240	6	,	,	PUNCT
admet-2057	1240	7	c.	c.	PROPN
admet-2057	1240	8	li	li	PROPN
admet-2057	1240	9	,	,	PUNCT
admet-2057	1240	10	y.	y.	PROPN
admet-2057	1240	11	chen	chen	PROPN
admet-2057	1240	12	,	,	PUNCT
admet-2057	1240	13	y.	y.	PROPN
admet-2057	1240	14	zhang	zhang	PROPN
admet-2057	1240	15	,	,	PUNCT
admet-2057	1240	16	b.	b.	PROPN
admet-2057	1240	17	lu	lu	PROPN
admet-2057	1240	18	.	.	PUNCT
admet-2057	1241	1	metal	metal	NOUN
admet-2057	1241	2	-	-	PUNCT
admet-2057	1241	3	organic	organic	ADJ
admet-2057	1241	4	framework	framework	NOUN
admet-2057	1241	5	-	-	PUNCT
admet-2057	1241	6	based	base	VERB
admet-2057	1241	7	intelligent	intelligent	ADJ
admet-2057	1241	8	drug	drug	NOUN
admet-2057	1241	9	delivery	delivery	NOUN
admet-2057	1241	10	systems	system	NOUN
admet-2057	1241	11	for	for	ADP
admet-2057	1241	12	cancer	cancer	NOUN
admet-2057	1241	13	theranostic	theranostic	NOUN
admet-2057	1241	14	:	:	PUNCT
admet-2057	1241	15	a	a	DET
admet-2057	1241	16	review	review	NOUN
admet-2057	1241	17	.	.	PUNCT
admet-2057	1242	1	frontiers	frontier	NOUN
admet-2057	1242	2	of	of	ADP
admet-2057	1242	3	materials	material	NOUN
admet-2057	1242	4	science	science	NOUN
admet-2057	1242	5	15	15	NUM
admet-2057	1242	6	(	(	PUNCT
admet-2057	1242	7	2021	2021	NUM
admet-2057	1242	8	)	)	PUNCT
admet-2057	1242	9	374	374	NUM
admet-2057	1242	10	-	-	SYM
admet-2057	1242	11	390	390	NUM
admet-2057	1242	12	.	.	PUNCT
admet-2057	1242	13	https://doi.org/10.1007/s11706-021-0568-2	https://doi.org/10.1007/s11706-021-0568-2	NUM
admet-2057	1243	1	[	[	X
admet-2057	1243	2	135	135	NUM
admet-2057	1243	3	]	]	X
admet-2057	1243	4	w.	w.	PROPN
admet-2057	1243	5	cai	cai	PROPN
admet-2057	1243	6	,	,	PUNCT
admet-2057	1243	7	j.	j.	PROPN
admet-2057	1243	8	wang	wang	PROPN
admet-2057	1243	9	,	,	PUNCT
admet-2057	1243	10	c.	c.	PROPN
admet-2057	1243	11	chu	chu	PROPN
admet-2057	1243	12	,	,	PUNCT
admet-2057	1243	13	w.	w.	PROPN
admet-2057	1243	14	chen	chen	PROPN
admet-2057	1243	15	,	,	PUNCT
admet-2057	1243	16	c.	c.	PROPN
admet-2057	1243	17	wu	wu	PROPN
admet-2057	1243	18	,	,	PUNCT
admet-2057	1243	19	g.	g.	PROPN
admet-2057	1243	20	liu	liu	PROPN
admet-2057	1243	21	.	.	PUNCT
admet-2057	1243	22	metal	metal	NOUN
admet-2057	1243	23	-	-	PUNCT
admet-2057	1243	24	organic	organic	ADJ
admet-2057	1243	25	framework	framework	NOUN
admet-2057	1243	26	-	-	PUNCT
admet-2057	1243	27	based	base	VERB
admet-2057	1243	28	stimuliresponsive	stimuliresponsive	ADJ
admet-2057	1243	29	systems	system	NOUN
admet-2057	1243	30	for	for	ADP
admet-2057	1243	31	drug	drug	NOUN
admet-2057	1243	32	delivery	delivery	NOUN
admet-2057	1243	33	.	.	PUNCT
admet-2057	1244	1	advanced	advanced	ADJ
admet-2057	1244	2	science	science	NOUN
admet-2057	1244	3	6(1	6(1	NUM
admet-2057	1244	4	)	)	PUNCT
admet-2057	1244	5	(	(	PUNCT
admet-2057	1244	6	2019	2019	NUM
admet-2057	1244	7	)	)	PUNCT
admet-2057	1244	8	1801526	1801526	NUM
admet-2057	1244	9	.	.	PUNCT
admet-2057	1245	1	https://doi.org/10.1002/advs.201801526	https://doi.org/10.1002/advs.201801526	NOUN
admet-2057	1246	1	[	[	X
admet-2057	1246	2	136	136	NUM
admet-2057	1246	3	]	]	X
admet-2057	1246	4	m.de	m.de	PROPN
admet-2057	1246	5	j.	j.	PROPN
admet-2057	1246	6	velásquez	velásquez	PROPN
admet-2057	1246	7	-	-	PUNCT
admet-2057	1246	8	hernández	hernández	PROPN
admet-2057	1246	9	,	,	PUNCT
admet-2057	1246	10	m.	m.	NOUN
admet-2057	1246	11	linares	linare	NOUN
admet-2057	1246	12	-	-	PUNCT
admet-2057	1246	13	moreau	moreau	PROPN
admet-2057	1246	14	,	,	PUNCT
admet-2057	1246	15	e.	e.	PROPN
admet-2057	1246	16	astria	astria	PROPN
admet-2057	1246	17	,	,	PUNCT
admet-2057	1246	18	f.	f.	PROPN
admet-2057	1246	19	carraro	carraro	PROPN
admet-2057	1246	20	,	,	PUNCT
admet-2057	1246	21	m.z	m.z	PROPN
admet-2057	1246	22	.	.	PROPN
admet-2057	1246	23	alyami	alyami	NOUN
admet-2057	1246	24	,	,	PUNCT
admet-2057	1246	25	n.m	n.m	PROPN
admet-2057	1246	26	.	.	PROPN
admet-2057	1246	27	khashab	khashab	PROPN
admet-2057	1246	28	,	,	PUNCT
admet-2057	1246	29	c.j	c.j	PROPN
admet-2057	1246	30	.	.	PROPN
admet-2057	1246	31	sumby	sumby	PROPN
admet-2057	1246	32	,	,	PUNCT
admet-2057	1246	33	c.j	c.j	PROPN
admet-2057	1246	34	.	.	PROPN
admet-2057	1246	35	doonan	doonan	PROPN
admet-2057	1246	36	,	,	PUNCT
admet-2057	1246	37	p.	p.	NOUN
admet-2057	1246	38	falcaro	falcaro	NOUN
admet-2057	1246	39	.	.	PUNCT
admet-2057	1247	1	towards	towards	ADP
admet-2057	1247	2	applications	application	NOUN
admet-2057	1247	3	of	of	ADP
admet-2057	1247	4	bioentities@mofs	bioentities@mof	NOUN
admet-2057	1247	5	in	in	ADP
admet-2057	1247	6	biomedicine	biomedicine	NOUN
admet-2057	1247	7	.	.	PUNCT
admet-2057	1248	1	coordination	coordination	NOUN
admet-2057	1248	2	chemistry	chemistry	NOUN
admet-2057	1248	3	reviews	review	VERB
admet-2057	1248	4	429	429	NUM
admet-2057	1248	5	(	(	PUNCT
admet-2057	1248	6	2021	2021	NUM
admet-2057	1248	7	)	)	PUNCT
admet-2057	1248	8	213651	213651	NUM
admet-2057	1248	9	.	.	PUNCT
admet-2057	1249	1	https://doi.org/10.1016/j.ccr.2020.213651	https://doi.org/10.1016/j.ccr.2020.213651	PROPN
admet-2057	1250	1	©	©	PROPN
admet-2057	1250	2	2023	2023	NUM
admet-2057	1250	3	by	by	ADP
admet-2057	1250	4	the	the	DET
admet-2057	1250	5	authors	author	NOUN
admet-2057	1250	6	;	;	PUNCT
admet-2057	1250	7	licensee	licensee	PROPN
admet-2057	1250	8	iapc	iapc	PROPN
admet-2057	1250	9	,	,	PUNCT
admet-2057	1250	10	zagreb	zagreb	PROPN
admet-2057	1250	11	,	,	PUNCT
admet-2057	1250	12	croatia	croatia	PROPN
admet-2057	1250	13	.	.	PUNCT
admet-2057	1251	1	this	this	DET
admet-2057	1251	2	article	article	NOUN
admet-2057	1251	3	is	be	AUX
admet-2057	1251	4	an	an	DET
admet-2057	1251	5	open	open	ADJ
admet-2057	1251	6	-	-	PUNCT
admet-2057	1251	7	access	access	NOUN
admet-2057	1251	8	article	article	NOUN
admet-2057	1251	9	distributed	distribute	VERB
admet-2057	1251	10	under	under	ADP
admet-2057	1251	11	the	the	DET
admet-2057	1251	12	terms	term	NOUN
admet-2057	1251	13	and	and	CCONJ
admet-2057	1251	14	conditions	condition	NOUN
admet-2057	1251	15	of	of	ADP
admet-2057	1251	16	the	the	DET
admet-2057	1251	17	creative	creative	ADJ
admet-2057	1251	18	commons	common	NOUN
admet-2057	1251	19	attribution	attribution	NOUN
admet-2057	1251	20	license	license	NOUN
admet-2057	1251	21	(	(	PUNCT
admet-2057	1251	22	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
admet-2057	1251	23	)	)	PUNCT
admet-2057	1251	24	https://doi.org/10.1039/c9nj03216a	https://doi.org/10.1039/c9nj03216a	PROPN
admet-2057	1251	25	https://doi.org/10.1016/j.ijpharm.2020.119674	https://doi.org/10.1016/j.ijpharm.2020.119674	PROPN
admet-2057	1251	26	https://doi.org/10.3390/molecules23102490	https://doi.org/10.3390/molecules23102490	VERB
admet-2057	1251	27	https://doi.org/10.1007/s11706-021-0568-2	https://doi.org/10.1007/s11706-021-0568-2	NUM
admet-2057	1251	28	https://doi.org/10.1002/advs.201801526	https://doi.org/10.1002/advs.201801526	NOUN
admet-2057	1251	29	https://doi.org/10.1016/j.ccr.2020.213651	https://doi.org/10.1016/j.ccr.2020.213651	PROPN
admet-2057	1251	30	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
